category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,padjust
GO:1901360,1.76E-08,0.999999994,71,3699,organic cyclic compound metabolic process,BP,0.000174936
GO:0019219,2.57E-08,0.999999991,52,2290,regulation of nucleobase-containing compound metabolic process,BP,0.000174936
GO:0045935,3.56E-08,0.99999999,36,1265,positive regulation of nucleobase-containing compound metabolic process,BP,0.000174936
GO:0009725,8.32E-08,0.999999979,28,847,response to hormone,BP,0.000306309
GO:0006139,1.22E-07,0.999999955,66,3452,nucleobase-containing compound metabolic process,BP,0.000320609
GO:0032870,1.31E-07,0.999999973,21,513,cellular response to hormone stimulus,BP,0.000320609
GO:0006725,1.89E-07,0.999999929,67,3567,cellular aromatic compound metabolic process,BP,0.000378762
GO:0048545,2.06E-07,0.999999964,17,345,response to steroid hormone,BP,0.000378762
GO:0046483,3.52E-07,0.999999864,66,3540,heterocycle metabolic process,BP,0.000575892
GO:0090304,5.30E-07,0.999999796,59,3027,nucleic acid metabolic process,BP,0.000781139
GO:0051254,6.54E-07,0.999999802,31,1113,positive regulation of RNA metabolic process,BP,0.000806334
GO:1901362,6.71E-07,0.999999748,51,2445,organic cyclic compound biosynthetic process,BP,0.000806334
GO:0009314,7.12E-07,0.999999869,16,337,response to radiation,BP,0.000806334
GO:0006357,7.70E-07,0.999999756,33,1244,regulation of transcription by RNA polymerase II,BP,0.000809995
GO:0034654,8.45E-07,0.999999684,49,2318,nucleobase-containing compound biosynthetic process,BP,0.000829582
GO:0019438,1.54E-06,0.999999409,49,2363,aromatic compound biosynthetic process,BP,0.001401726
GO:0018130,1.62E-06,0.999999378,49,2367,heterocycle biosynthetic process,BP,0.001401726
GO:0007623,1.94E-06,0.999999747,11,167,circadian rhythm,BP,0.00153202
GO:0006366,1.98E-06,0.999999344,33,1297,transcription by RNA polymerase II,BP,0.00153202
GO:2000112,2.16E-06,0.999999177,46,2177,regulation of cellular macromolecule biosynthetic process,BP,0.001587811
GO:0032922,2.55E-06,0.999999836,7,57,circadian regulation of gene expression,BP,0.001786176
GO:0042752,3.42E-06,0.999999704,8,84,regulation of circadian rhythm,BP,0.002292248
GO:0051252,3.60E-06,0.999998615,44,2072,regulation of RNA metabolic process,BP,0.002305046
GO:0014070,4.23E-06,0.999998746,25,851,response to organic cyclic compound,BP,0.002586343
GO:0009648,4.47E-06,0.999999856,5,23,photoperiodism,BP,0.002586343
GO:0031326,4.57E-06,0.999998177,48,2379,regulation of cellular biosynthetic process,BP,0.002586343
GO:0009719,5.69E-06,0.999998066,31,1236,response to endogenous stimulus,BP,0.003103568
GO:0033993,6.13E-06,0.999998187,24,810,response to lipid,BP,0.003222345
GO:0010556,7.00E-06,0.999997188,46,2269,regulation of macromolecule biosynthetic process,BP,0.003437451
GO:0071495,7.00E-06,0.999997807,26,945,cellular response to endogenous stimulus,BP,0.003437451
GO:0006355,7.42E-06,0.999997147,40,1846,"regulation of transcription, DNA-templated",BP,0.003524881
GO:0009628,7.92E-06,0.999997558,25,884,response to abiotic stimulus,BP,0.003551569
GO:0048511,7.96E-06,0.99999866,12,233,rhythmic process,BP,0.003551569
GO:0009889,8.73E-06,0.999996414,48,2433,regulation of biosynthetic process,BP,0.003781798
GO:1903506,1.20E-05,0.999995262,40,1882,regulation of nucleic acid-templated transcription,BP,0.005065683
GO:0010604,1.32E-05,0.999994623,44,2180,positive regulation of macromolecule metabolic process,BP,0.005391792
GO:2001141,1.37E-05,0.999994554,40,1892,regulation of RNA biosynthetic process,BP,0.005473045
GO:0034641,1.82E-05,0.99999183,67,3998,cellular nitrogen compound metabolic process,BP,0.007060884
GO:0006351,2.05E-05,0.99999174,40,1925,"transcription, DNA-templated",BP,0.007723732
GO:0080090,2.24E-05,0.99998994,61,3549,regulation of primary metabolic process,BP,0.008255763
GO:0009893,2.43E-05,0.999989662,46,2381,positive regulation of metabolic process,BP,0.008714547
GO:2000113,2.48E-05,0.999991763,25,943,negative regulation of cellular macromolecule biosynthetic process,BP,0.008714547
GO:0051173,2.84E-05,0.999988145,42,2097,positive regulation of nitrogen compound metabolic process,BP,0.009736203
GO:0097659,3.13E-05,0.999987103,40,1959,nucleic acid-templated transcription,BP,0.010376562
GO:1901700,3.17E-05,0.999988141,31,1338,response to oxygen-containing compound,BP,0.010376562
GO:0044271,3.36E-05,0.999985072,52,2851,cellular nitrogen compound biosynthetic process,BP,0.010751352
GO:0031327,3.55E-05,0.999987703,26,1025,negative regulation of cellular biosynthetic process,BP,0.011129441
GO:0032774,3.80E-05,0.999984168,40,1975,RNA biosynthetic process,BP,0.011584537
GO:0010468,3.85E-05,0.999983159,47,2495,regulation of gene expression,BP,0.011584537
GO:0051171,3.97E-05,0.999981809,59,3444,regulation of nitrogen compound metabolic process,BP,0.011704977
GO:0042113,4.08E-05,0.999994063,9,151,B cell activation,BP,0.011794484
GO:1903508,4.29E-05,0.999984953,26,1040,positive regulation of nucleic acid-templated transcription,BP,0.011857581
GO:1902680,4.37E-05,0.999984678,26,1041,positive regulation of RNA biosynthetic process,BP,0.011857581
GO:0051726,4.41E-05,0.999986671,20,684,regulation of cell cycle,BP,0.011857581
GO:0010628,4.43E-05,0.999983356,30,1297,positive regulation of gene expression,BP,0.011857581
GO:0071383,4.79E-05,0.999991946,10,192,cellular response to steroid hormone stimulus,BP,0.012593175
GO:0043401,4.94E-05,0.999993678,8,120,steroid hormone mediated signaling pathway,BP,0.012740014
GO:0010558,5.07E-05,0.999982404,25,985,negative regulation of macromolecule biosynthetic process,BP,0.012740014
GO:0010557,5.13E-05,0.999980824,29,1240,positive regulation of macromolecule biosynthetic process,BP,0.012740014
GO:0071396,5.19E-05,0.999986384,16,469,cellular response to lipid,BP,0.012740014
GO:0051172,5.41E-05,0.999978346,34,1581,negative regulation of nitrogen compound metabolic process,BP,0.013055123
GO:0009890,5.76E-05,0.999979422,26,1054,negative regulation of biosynthetic process,BP,0.013686686
GO:0060255,6.03E-05,0.999971841,60,3575,regulation of macromolecule metabolic process,BP,0.014091104
GO:0031328,6.14E-05,0.999976453,30,1317,positive regulation of cellular biosynthetic process,BP,0.014138403
GO:0009416,6.97E-05,0.999987721,10,202,response to light stimulus,BP,0.015784528
GO:0043153,7.45E-05,0.999997272,4,21,entrainment of circadian clock by photoperiod,BP,0.016486237
GO:0010033,7.50E-05,0.999967175,42,2178,response to organic substance,BP,0.016486237
GO:1901652,9.23E-05,0.999975686,15,445,response to peptide,BP,0.01978349
GO:0009891,9.39E-05,0.99996306,30,1347,positive regulation of biosynthetic process,BP,0.01978349
GO:0031325,9.40E-05,0.999958368,42,2204,positive regulation of cellular metabolic process,BP,0.01978349
GO:0007049,9.62E-05,0.99996583,24,966,cell cycle,BP,0.01985399
GO:0044238,9.71E-05,0.999955566,91,6402,primary metabolic process,BP,0.01985399
GO:0009649,0.00010906,0.999995528,4,23,entrainment of circadian clock,BP,0.022004669
GO:0071407,0.000113631,0.999969497,15,451,cellular response to organic cyclic compound,BP,0.022617131
GO:0019222,0.00011663,0.999943618,63,3899,regulation of metabolic process,BP,0.022904587
GO:0097532,0.000123301,1,2,2,stress response to acid chemical,BP,0.023338362
GO:0097533,0.000123301,1,2,2,cellular stress response to acid chemical,BP,0.023338362
GO:0009755,0.000126386,0.999981382,8,137,hormone-mediated signaling pathway,BP,0.023338362
GO:0045168,0.000126761,1,2,2,cell-cell signaling involved in cell fate commitment,BP,0.023338362
GO:0046331,0.000126761,1,2,2,lateral inhibition,BP,0.023338362
GO:0031323,0.000129386,0.999937447,60,3659,regulation of cellular metabolic process,BP,0.023527511
GO:0060674,0.000136885,0.99999398,4,25,placenta blood vessel development,BP,0.024556774
GO:0032501,0.000138381,0.999932776,61,3784,multicellular organismal process,BP,0.024556774
GO:0051384,0.000144993,0.999974955,9,178,response to glucocorticoid,BP,0.025423914
GO:0045893,0.000147543,0.999946034,24,992,"positive regulation of transcription, DNA-templated",BP,0.025566535
GO:0010243,0.000152506,0.999946527,22,866,response to organonitrogen compound,BP,0.026119338
GO:0000122,0.000156517,0.999952786,17,574,negative regulation of transcription by RNA polymerase II,BP,0.026498089
GO:0006950,0.00016408,0.999924291,44,2399,response to stress,BP,0.027462914
GO:0071310,0.000187561,0.999920205,33,1615,cellular response to organic substance,BP,0.030853784
GO:0045944,0.000188529,0.999936227,20,761,positive regulation of transcription by RNA polymerase II,BP,0.030853784
GO:0048856,0.000222447,0.999890936,55,3341,anatomical structure development,BP,0.036004573
GO:0030183,0.000241639,0.999973254,6,81,B cell differentiation,BP,0.038347252
GO:0031960,0.000242127,0.999955091,9,191,response to corticosteroid,BP,0.038347252
GO:0031324,0.000249439,0.99989093,34,1707,negative regulation of cellular metabolic process,BP,0.038467967
GO:0002085,0.000255948,0.999999214,2,3,inhibition of neuroepithelial cell differentiation,BP,0.038467967
GO:0045608,0.000255948,0.999999214,2,3,negative regulation of inner ear auditory receptor cell differentiation,BP,0.038467967
GO:0045632,0.000255948,0.999999214,2,3,negative regulation of mechanoreceptor differentiation,BP,0.038467967
GO:2000981,0.000255948,0.999999214,2,3,negative regulation of inner ear receptor cell differentiation,BP,0.038467967
GO:0016070,0.000259201,0.999875629,47,2676,RNA metabolic process,BP,0.038518735
GO:0071704,0.000263288,0.999874521,92,6632,organic substance metabolic process,BP,0.038518735
GO:1901576,0.000264131,0.999868489,58,3557,organic substance biosynthetic process,BP,0.038518735
GO:0050896,0.000275074,0.999861307,72,4801,response to stimulus,BP,0.039721217
GO:0006006,0.000278111,0.999953805,8,153,glucose metabolic process,BP,0.039769898
GO:0048641,0.000283438,0.999984655,4,29,regulation of skeletal muscle tissue development,BP,0.040141916
GO:0043434,0.000294418,0.999921967,13,387,response to peptide hormone,BP,0.041299899
GO:0007622,0.000309185,0.999982815,4,30,rhythmic behavior,BP,0.042560554
GO:0048512,0.000309185,0.999982815,4,30,circadian behavior,BP,0.042560554
GO:0045934,0.000317835,0.999879631,23,974,negative regulation of nucleobase-containing compound metabolic process,BP,0.043346231
GO:0035019,0.000321247,0.999981907,4,31,somatic stem cell population maintenance,BP,0.043409592
GO:1901698,0.000340508,0.999873145,22,917,response to nitrogen compound,BP,0.045589616
GO:0044249,0.00034357,0.999827116,57,3506,cellular biosynthetic process,BP,0.045589616
GO:0010948,0.000360465,0.999937663,8,161,negative regulation of cell cycle process,BP,0.047404368
GO:1900744,0.00037468,0.999977956,4,32,regulation of p38MAPK cascade,BP,0.048837706
GO:0050793,0.000398348,0.999824454,32,1625,regulation of developmental process,BP,0.051467204
GO:0045598,0.000411582,0.999949425,6,90,regulation of fat cell differentiation,BP,0.052040269
GO:0034645,0.000412417,0.999796391,48,2807,cellular macromolecule biosynthetic process,BP,0.052040269
GO:0006094,0.000413383,0.999961788,5,57,gluconeogenesis,BP,0.052040269
GO:0031099,0.000429504,0.999913616,9,210,regeneration,BP,0.053611543
GO:0009058,0.000434833,0.999778188,58,3618,biosynthetic process,BP,0.053820626
GO:0044839,0.000440878,0.999945114,6,90,cell cycle G2/M phase transition,BP,0.0541141
GO:0070887,0.000447836,0.99979178,37,1981,cellular response to chemical stimulus,BP,0.054218134
GO:0019319,0.000449088,0.999957684,5,58,hexose biosynthetic process,BP,0.054218134
GO:0007093,0.000505057,0.9999354,6,93,mitotic cell cycle checkpoint,BP,0.060194271
GO:0048523,0.000506761,0.999745133,50,3010,negative regulation of cellular process,BP,0.060194271
GO:0009912,0.000533898,0.999996643,2,4,auditory receptor cell fate commitment,BP,0.062410929
GO:0060120,0.000533898,0.999996643,2,4,inner ear receptor cell fate commitment,BP,0.062410929
GO:0010629,0.000558543,0.999771037,25,1146,negative regulation of gene expression,BP,0.06408481
GO:0045607,0.000565621,0.999996338,2,4,regulation of inner ear auditory receptor cell differentiation,BP,0.06408481
GO:0045631,0.000565621,0.999996338,2,4,regulation of mechanoreceptor differentiation,BP,0.06408481
GO:2000980,0.000565621,0.999996338,2,4,regulation of inner ear receptor cell differentiation,BP,0.06408481
GO:0010605,0.00058273,0.999734258,33,1712,negative regulation of macromolecule metabolic process,BP,0.065519282
GO:0006259,0.00059708,0.999796891,17,640,DNA metabolic process,BP,0.066624125
GO:1901654,0.000638487,0.999864157,9,218,response to ketone,BP,0.070708834
GO:0033120,0.000653704,0.999954949,4,36,positive regulation of RNA splicing,BP,0.071853772
GO:0046364,0.00066365,0.999931536,5,63,monosaccharide biosynthetic process,BP,0.072406653
GO:0044260,0.000706034,0.999627755,72,4913,cellular macromolecule metabolic process,BP,0.076464499
GO:0000075,0.000721164,0.99988004,7,137,cell cycle checkpoint,BP,0.077532983
GO:0048519,0.000736115,0.999618868,53,3300,negative regulation of biological process,BP,0.078424702
GO:0019318,0.000740107,0.999856839,8,177,hexose metabolic process,BP,0.078424702
GO:0006109,0.000761025,0.999872242,7,137,regulation of carbohydrate metabolic process,BP,0.080065268
GO:0032502,0.000774658,0.999594828,56,3579,developmental process,BP,0.080391502
GO:0060711,0.000775042,0.999943763,4,39,labyrinthine layer development,BP,0.080391502
GO:0060716,0.000805003,0.999969482,3,17,labyrinthine layer blood vessel development,BP,0.08291531
GO:0009892,0.000832221,0.999604759,35,1893,negative regulation of metabolic process,BP,0.084614652
GO:0045892,0.000832991,0.999689817,19,785,"negative regulation of transcription, DNA-templated",BP,0.084614652
GO:0009059,0.000903763,0.999534658,48,2900,macromolecule biosynthetic process,BP,0.091174844
GO:0038066,0.000914735,0.999930477,4,40,p38MAPK cascade,BP,0.091653955
GO:0050794,0.000939599,0.99950275,80,5712,regulation of cellular process,BP,0.093509149
GO:0042221,0.000956653,0.99950988,46,2757,response to chemical,BP,0.09456738
GO:1901701,0.000967281,0.999625699,20,862,cellular response to oxygen-containing compound,BP,0.094980557
GO:0006975,0.000979265,0.999990281,2,5,DNA damage induced protein phosphorylation,BP,0.095520495
GO:0016310,0.001042653,0.999526861,29,1482,phosphorylation,BP,0.101034415
GO:0030261,0.001051329,0.999955608,3,19,chromosome condensation,BP,0.101209278
GO:0031065,0.001087488,0.999953537,3,19,positive regulation of histone deacetylation,BP,0.104010429
GO:1903507,0.001097508,0.999581262,19,804,negative regulation of nucleic acid-templated transcription,BP,0.104291606
GO:0044770,0.001111391,0.999719456,10,286,cell cycle phase transition,BP,0.104597384
GO:0032868,0.001114929,0.999742806,9,237,response to insulin,BP,0.104597384
GO:1902679,0.001131498,0.999567122,19,806,negative regulation of RNA biosynthetic process,BP,0.105480005
GO:0048731,0.001206572,0.999373673,46,2815,system development,BP,0.11177103
GO:0008152,0.001217629,0.999376996,93,6952,metabolic process,BP,0.111968123
GO:0007346,0.001235693,0.999659011,11,344,regulation of mitotic cell cycle,BP,0.111968123
GO:0043618,0.001244761,0.999896546,4,44,regulation of transcription from RNA polymerase II promoter in response to stress,BP,0.111968123
GO:0051253,0.0012459,0.999507282,20,876,negative regulation of RNA metabolic process,BP,0.111968123
GO:0048869,0.001246709,0.999367305,41,2424,cellular developmental process,BP,0.111968123
GO:0044773,0.001255192,0.999895442,4,44,mitotic DNA damage checkpoint,BP,0.112046776
GO:0048522,0.001263806,0.99932653,53,3375,positive regulation of cellular process,BP,0.112136111
GO:0051093,0.001365413,0.999514071,16,638,negative regulation of developmental process,BP,0.120426182
GO:0010467,0.001386256,0.99925956,52,3279,gene expression,BP,0.121536659
GO:0009266,0.001417883,0.999734336,7,151,response to temperature stimulus,BP,0.123573951
GO:0032570,0.001435632,0.999875796,4,45,response to progesterone,BP,0.124238421
GO:0045605,0.001442377,0.99998104,2,6,negative regulation of epidermal cell differentiation,BP,0.124238421
GO:0005996,0.00145345,0.999686919,8,196,monosaccharide metabolic process,BP,0.12446432
GO:1901988,0.001491237,0.999763308,6,114,negative regulation of cell cycle phase transition,BP,0.126962039
GO:0006793,0.00150357,0.999247388,37,2105,phosphorus metabolic process,BP,0.12719077
GO:0001890,0.001511195,0.999759396,6,116,placenta development,BP,0.12719077
GO:0070229,0.001562842,0.999922927,3,22,negative regulation of lymphocyte apoptotic process,BP,0.130790363
GO:0010675,0.001584696,0.999745447,6,114,regulation of cellular carbohydrate metabolic process,BP,0.131869993
GO:0043620,0.001611973,0.999855708,4,47,regulation of DNA-templated transcription in response to stress,BP,0.133386205
GO:0036003,0.001760966,0.999909034,3,23,positive regulation of transcription from RNA polymerase II promoter in response to stress,BP,0.144900945
GO:2000323,0.001783822,0.999973871,2,6,negative regulation of glucocorticoid receptor signaling pathway,BP,0.145089221
GO:0006302,0.001783952,0.999651566,7,160,double-strand break repair,BP,0.145089221
GO:0050864,0.001792806,0.999766368,5,80,regulation of B cell activation,BP,0.145089221
GO:1903894,0.00185542,0.999972271,2,6,regulation of IRE1-mediated unfolded protein response,BP,0.147818743
GO:0006468,0.001855908,0.999179856,24,1186,protein phosphorylation,BP,0.147818743
GO:0030890,0.001860648,0.999902008,3,23,positive regulation of B cell proliferation,BP,0.147818743
GO:0048518,0.001866677,0.998974995,57,3766,positive regulation of biological process,BP,0.147818743
GO:0045930,0.001981075,0.999605689,7,163,negative regulation of mitotic cell cycle,BP,0.156038778
GO:0044774,0.002041553,0.999804395,4,50,mitotic DNA integrity checkpoint,BP,0.159915527
GO:0007275,0.002052009,0.998893354,48,3048,multicellular organism development,BP,0.159915527
GO:0044237,0.00206367,0.998888453,88,6545,cellular metabolic process,BP,0.159977854
GO:0045444,0.002122103,0.999572284,7,166,fat cell differentiation,BP,0.163219129
GO:0043170,0.002128821,0.998820692,78,5624,macromolecule metabolic process,BP,0.163219129
GO:0048505,0.002138726,0.999963719,2,7,regulation of timing of cell differentiation,BP,0.163219129
GO:0097084,0.002186309,0.999962493,2,7,vascular smooth muscle cell development,BP,0.165990462
GO:0030522,0.002264121,0.999538383,7,166,intracellular receptor signaling pathway,BP,0.170660029
GO:1901976,0.002270987,0.999870698,3,25,regulation of cell cycle checkpoint,BP,0.170660029
GO:0072080,0.002372479,0.999762408,4,53,nephron tubule development,BP,0.175595457
GO:0090312,0.002380007,0.999862231,3,25,positive regulation of protein deacetylation,BP,0.175595457
GO:0032102,0.002392918,0.999440829,8,215,negative regulation of response to external stimulus,BP,0.175595457
GO:1901029,0.002401003,0.999956791,2,7,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,0.175595457
GO:0008202,0.002402597,0.999438336,8,212,steroid metabolic process,BP,0.175595457
GO:0000077,0.002408194,0.99966337,5,86,DNA damage checkpoint,BP,0.175595457
GO:0050789,0.00244268,0.998647676,82,6048,regulation of biological process,BP,0.177232646
GO:0071229,0.002485925,0.999484288,7,172,cellular response to acid chemical,BP,0.178858871
GO:0048642,0.002489379,0.999954364,2,7,negative regulation of skeletal muscle tissue development,BP,0.178858871
GO:0031063,0.00252294,0.999850917,3,25,regulation of histone deacetylation,BP,0.180390239
GO:0006796,0.002590924,0.998665931,36,2092,phosphate-containing compound metabolic process,BP,0.184356142
GO:0030097,0.002729633,0.999030061,14,552,hemopoiesis,BP,0.193292114
GO:0051716,0.002780444,0.998436631,58,3913,cellular response to stimulus,BP,0.195460662
GO:0030330,0.002792104,0.999707246,4,54,"DNA damage response, signal transduction by p53 class mediator",BP,0.195460662
GO:0045786,0.002829596,0.99918724,10,323,negative regulation of cell cycle,BP,0.195460662
GO:0002520,0.002836017,0.998948832,15,615,immune system development,BP,0.195460662
GO:0045683,0.002837925,0.999942219,2,8,negative regulation of epidermis development,BP,0.195460662
GO:0006281,0.002849661,0.999180637,10,324,DNA repair,BP,0.195460662
GO:0003006,0.00285315,0.999070697,12,444,developmental process involved in reproduction,BP,0.195460662
GO:0048710,0.002884591,0.9998201,3,27,regulation of astrocyte differentiation,BP,0.196060536
GO:0042325,0.002888528,0.998743761,21,1014,regulation of phosphorylation,BP,0.196060536
GO:0048513,0.002938594,0.998474083,36,2131,animal organ development,BP,0.198543828
GO:0065007,0.002958702,0.998363146,86,6458,biological regulation,BP,0.198989616
GO:0070227,0.002974901,0.999682276,4,55,lymphocyte apoptotic process,BP,0.19916961
GO:0050728,0.003042633,0.999550552,5,89,negative regulation of inflammatory response,BP,0.202782573
GO:0061326,0.003070005,0.999668715,4,57,renal tubule development,BP,0.203685181
GO:0006974,0.003095885,0.998884165,14,558,cellular response to DNA damage stimulus,BP,0.20448114
GO:0002689,0.003414339,0.999923573,2,8,negative regulation of leukocyte chemotaxis,BP,0.224508006
GO:0005975,0.003439562,0.998915572,11,385,carbohydrate metabolic process,BP,0.225161376
GO:0031570,0.003553691,0.999454828,5,94,DNA integrity checkpoint,BP,0.230251968
GO:0016051,0.003573652,0.999321722,6,135,carbohydrate biosynthetic process,BP,0.230251968
GO:2000026,0.003575146,0.998333271,24,1256,regulation of multicellular organismal development,BP,0.230251968
GO:0042246,0.003579856,0.999596502,4,58,tissue regeneration,BP,0.230251968
GO:0048708,0.003644773,0.999586821,4,59,astrocyte differentiation,BP,0.233408068
GO:0099171,0.003708617,0.999910931,2,9,presynaptic modulation of chemical synaptic transmission,BP,0.236468498
GO:0040034,0.003776091,0.999908467,2,9,"regulation of development, heterochronic",BP,0.239732981
GO:0051248,0.003844209,0.998433855,17,767,negative regulation of protein metabolic process,BP,0.242028865
GO:0010906,0.003846762,0.999398643,5,95,regulation of glucose metabolic process,BP,0.242028865
GO:0006807,0.003861551,0.997807544,82,6081,nitrogen compound metabolic process,BP,0.242028865
GO:0010564,0.003957579,0.998728228,11,401,regulation of cell cycle process,BP,0.246996514
GO:0002521,0.003998201,0.998793536,10,340,leukocyte differentiation,BP,0.248478906
GO:0048534,0.00401948,0.998507311,14,576,hematopoietic or lymphoid organ development,BP,0.248751762
GO:0072009,0.004336476,0.999482528,4,63,nephron epithelium development,BP,0.267246659
GO:0001932,0.004509787,0.998039184,19,916,regulation of protein phosphorylation,BP,0.276769364
GO:0072148,0.004598824,0.999873952,2,10,epithelial cell fate commitment,BP,0.281062563
GO:2000322,0.004673362,0.999870844,2,10,regulation of glucocorticoid receptor signaling pathway,BP,0.284437779
GO:0080134,0.004811721,0.997894884,19,911,regulation of response to stress,BP,0.291257894
GO:0036314,0.004824966,0.99963402,3,32,response to sterol,BP,0.291257894
GO:1901991,0.004922069,0.999182971,5,102,negative regulation of mitotic cell cycle phase transition,BP,0.295906746
GO:0008217,0.005067737,0.999153188,5,101,regulation of blood pressure,BP,0.303425581
GO:0030154,0.005191433,0.997179574,37,2288,cell differentiation,BP,0.309223508
GO:0071850,0.005206561,0.99984787,2,10,mitotic cell cycle arrest,BP,0.309223508
GO:0048469,0.005249095,0.999115312,5,102,cell maturation,BP,0.310497654
GO:0032269,0.005291804,0.997832837,16,724,negative regulation of cellular protein metabolic process,BP,0.311771911
GO:0042749,0.005355368,0.99984123,2,10,regulation of circadian sleep/wake cycle,BP,0.314259797
GO:1901653,0.005390447,0.998421577,9,301,cellular response to peptide,BP,0.314629578
GO:0036498,0.005404392,0.999839021,2,10,IRE1-mediated unfolded protein response,BP,0.314629578
GO:0019220,0.005577249,0.997381046,22,1143,regulation of phosphate metabolic process,BP,0.322159279
GO:0010212,0.005577474,0.998837906,6,148,response to ionizing radiation,BP,0.322159279
GO:0097305,0.005629054,0.998481831,8,248,response to alcohol,BP,0.32303314
GO:0051174,0.005636467,0.997350714,22,1144,regulation of phosphorus metabolic process,BP,0.32303314
GO:0008015,0.005769332,0.998437345,8,250,blood circulation,BP,0.329366237
GO:0016575,0.00588261,0.999233152,4,67,histone deacetylation,BP,0.334536547
GO:0001892,0.005925253,0.999225602,4,68,embryonic placenta development,BP,0.335665568
GO:0007076,0.00609772,0.999803368,2,11,mitotic chromosome condensation,BP,0.344112355
GO:0022402,0.006123951,0.997451774,16,742,cell cycle process,BP,0.344273552
GO:0060675,0.00622183,0.99947996,3,35,ureteric bud morphogenesis,BP,0.347126247
GO:0072171,0.00622183,0.99947996,3,35,mesonephric tubule morphogenesis,BP,0.347126247
GO:0071380,0.006251568,0.999792949,2,12,cellular response to prostaglandin E stimulus,BP,0.347367834
GO:0048608,0.006284957,0.998114186,9,313,reproductive structure development,BP,0.347367834
GO:1901987,0.006296912,0.998448328,7,201,regulation of cell cycle phase transition,BP,0.347367834
GO:0071900,0.006481435,0.998045973,9,311,regulation of protein serine/threonine kinase activity,BP,0.355256375
GO:0042771,0.006500666,0.999447982,3,35,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,0.355256375
GO:0035970,0.00651227,0.999782733,2,11,peptidyl-threonine dephosphorylation,BP,0.355256375
GO:0033127,0.006570937,0.999776691,2,12,regulation of histone phosphorylation,BP,0.357134081
GO:0061458,0.006696715,0.997970307,9,316,reproductive system development,BP,0.36263202
GO:0043066,0.006823476,0.997303757,14,611,negative regulation of apoptotic process,BP,0.366496541
GO:0046649,0.006862688,0.997622518,11,423,lymphocyte activation,BP,0.366496541
GO:0003338,0.006878618,0.999760631,2,12,metanephros morphogenesis,BP,0.366496541
GO:0072273,0.006878618,0.999760631,2,12,metanephric nephron morphogenesis,BP,0.366496541
GO:0003013,0.006892494,0.998075074,8,258,circulatory system process,BP,0.366496541
GO:0033554,0.007090953,0.996449113,25,1377,cellular response to stress,BP,0.374436839
GO:0070482,0.007092666,0.997831167,9,311,response to oxygen levels,BP,0.374436839
GO:0019827,0.007262119,0.998673725,5,114,stem cell population maintenance,BP,0.381473114
GO:0051239,0.007277748,0.996116119,31,1853,regulation of multicellular organismal process,BP,0.381473114
GO:0072413,0.007511811,0.999723242,2,13,signal transduction involved in mitotic cell cycle checkpoint,BP,0.389582601
GO:1902402,0.007511811,0.999723242,2,13,signal transduction involved in mitotic DNA damage checkpoint,BP,0.389582601
GO:1902403,0.007511811,0.999723242,2,13,signal transduction involved in mitotic DNA integrity checkpoint,BP,0.389582601
GO:0030888,0.007580753,0.999316243,3,38,regulation of B cell proliferation,BP,0.39177865
GO:0000003,0.007636341,0.996657482,17,830,reproduction,BP,0.391901295
GO:0022414,0.007636341,0.996657482,17,830,reproductive process,BP,0.391901295
GO:0071379,0.007809862,0.999703551,2,14,cellular response to prostaglandin stimulus,BP,0.399414792
GO:0003143,0.00792258,0.99927387,3,38,embryonic heart tube morphogenesis,BP,0.402472524
GO:0045682,0.007945047,0.999271061,3,38,regulation of epidermis development,BP,0.402472524
GO:0043255,0.007951626,0.998867002,4,73,regulation of carbohydrate biosynthetic process,BP,0.402472524
GO:0007519,0.008151817,0.998468854,5,115,skeletal muscle tissue development,BP,0.409416603
GO:0048585,0.008170504,0.996159375,20,1037,negative regulation of response to stimulus,BP,0.409416603
GO:0070233,0.00817221,0.999685453,2,13,negative regulation of T cell apoptotic process,BP,0.409416603
GO:0031100,0.008229645,0.998450678,5,115,animal organ regeneration,BP,0.410896428
GO:0051052,0.008262157,0.997410838,9,320,regulation of DNA metabolic process,BP,0.41112607
GO:0000278,0.008385388,0.996726233,13,570,mitotic cell cycle,BP,0.41272421
GO:0048711,0.008437854,0.999669786,2,13,positive regulation of astrocyte differentiation,BP,0.41272421
GO:0098727,0.008446169,0.998398957,5,118,maintenance of cell number,BP,0.41272421
GO:2000107,0.008469114,0.999203613,3,39,negative regulation of leukocyte apoptotic process,BP,0.41272421
GO:1902380,0.008482368,1,1,1,positive regulation of endoribonuclease activity,BP,0.41272421
GO:0042770,0.008497353,0.998765372,4,74,signal transduction in response to DNA damage,BP,0.41272421
GO:0072078,0.008529969,0.999195795,3,39,nephron tubule morphogenesis,BP,0.41272421
GO:0072088,0.008529969,0.999195795,3,39,nephron epithelium morphogenesis,BP,0.41272421
GO:0042509,0.008546465,0.999194778,3,38,regulation of tyrosine phosphorylation of STAT protein,BP,0.41272421
GO:0043069,0.008640661,0.996487283,14,628,negative regulation of programmed cell death,BP,0.413692614
GO:0040008,0.008712153,0.996878384,11,447,regulation of growth,BP,0.413692614
GO:0000188,0.008723535,0.999652645,2,13,inactivation of MAPK activity,BP,0.413692614
GO:0045843,0.008743883,0.999168151,3,39,negative regulation of striated muscle tissue development,BP,0.413692614
GO:0048568,0.008757086,0.997449991,8,271,embryonic organ development,BP,0.413692614
GO:0048643,0.008762254,0.999650299,2,13,positive regulation of skeletal muscle tissue development,BP,0.413692614
GO:0042921,0.008763127,0.999646865,2,14,glucocorticoid receptor signaling pathway,BP,0.413692614
GO:0042753,0.008889859,0.999642528,2,13,positive regulation of circadian rhythm,BP,0.418334596
GO:0080135,0.009103511,0.996555769,12,504,regulation of cellular response to stress,BP,0.426782996
GO:0002377,0.009127344,0.998645626,4,75,immunoglobulin production,BP,0.426782996
GO:0006111,0.009173757,0.999111833,3,39,regulation of gluconeogenesis,BP,0.427595804
GO:0097150,0.009259544,0.999612842,2,15,neuronal stem cell population maintenance,BP,0.430164399
GO:0000086,0.009287275,0.998614394,4,76,G2/M transition of mitotic cell cycle,BP,0.430164399
GO:0048635,0.009381868,0.999083022,3,40,negative regulation of muscle organ development,BP,0.433183497
GO:0090311,0.00947111,0.999069948,3,41,regulation of protein deacetylation,BP,0.435037151
GO:0062012,0.009481087,0.997201098,8,269,regulation of small molecule metabolic process,BP,0.435037151
GO:0097306,0.009545812,0.998563342,4,78,cellular response to alcohol,BP,0.436646806
GO:0072028,0.009698844,0.999039272,3,41,nephron morphogenesis,BP,0.43697479
GO:0033278,0.010035977,1,1,1,cell proliferation in midbrain,BP,0.43697479
GO:0035880,0.010035977,1,1,1,embryonic nail plate morphogenesis,BP,0.43697479
GO:0048104,0.010035977,1,1,1,establishment of body hair or bristle planar orientation,BP,0.43697479
GO:0048105,0.010035977,1,1,1,establishment of body hair planar orientation,BP,0.43697479
GO:0060538,0.010060229,0.998009021,5,121,skeletal muscle organ development,BP,0.43697479
GO:1901862,0.010080708,0.998987228,3,41,negative regulation of muscle tissue development,BP,0.43697479
GO:0031958,0.01008179,0.999559363,2,15,corticosteroid receptor signaling pathway,BP,0.43697479
GO:0042326,0.01011175,0.996725792,9,330,negative regulation of phosphorylation,BP,0.43697479
GO:0060548,0.010122783,0.995669572,15,706,negative regulation of cell death,BP,0.43697479
GO:0070987,0.010149943,1,1,1,error-free translesion synthesis,BP,0.43697479
GO:0045595,0.01025886,0.994982488,21,1147,regulation of cell differentiation,BP,0.43697479
GO:0006978,0.010304666,0.999548176,2,14,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",BP,0.43697479
GO:0045321,0.010370208,0.996007249,12,509,leukocyte activation,BP,0.43697479
GO:0001666,0.01037242,0.996888876,8,274,response to hypoxia,BP,0.43697479
GO:0140014,0.010470645,0.997501913,6,173,mitotic nuclear division,BP,0.43697479
GO:0070228,0.010485059,0.998930061,3,42,regulation of lymphocyte apoptotic process,BP,0.43697479
GO:1903047,0.010606768,0.996091437,11,461,mitotic cell cycle process,BP,0.43697479
GO:0009888,0.010704951,0.994742465,21,1156,tissue development,BP,0.43697479
GO:0061333,0.010920892,0.998867547,3,43,renal tubule morphogenesis,BP,0.43697479
GO:0002575,0.010959305,1,1,1,basophil chemotaxis,BP,0.43697479
GO:1903570,0.010959305,1,1,1,regulation of protein kinase D signaling,BP,0.43697479
GO:1903572,0.010959305,1,1,1,positive regulation of protein kinase D signaling,BP,0.43697479
GO:0045662,0.011083206,0.999491052,2,15,negative regulation of myoblast differentiation,BP,0.43697479
GO:2000001,0.011157278,0.999485864,2,15,regulation of DNA damage checkpoint,BP,0.43697479
GO:0007260,0.011170822,0.998833246,3,42,tyrosine phosphorylation of STAT protein,BP,0.43697479
GO:0033577,0.011179164,1,1,1,protein glycosylation in endoplasmic reticulum,BP,0.43697479
GO:0050671,0.011214757,0.998230632,4,79,positive regulation of lymphocyte proliferation,BP,0.43697479
GO:0021679,0.011270105,1,1,1,cerebellar molecular layer development,BP,0.43697479
GO:0021687,0.011270105,1,1,1,cerebellar molecular layer morphogenesis,BP,0.43697479
GO:0021688,0.011270105,1,1,1,cerebellar molecular layer formation,BP,0.43697479
GO:0021693,0.011270105,1,1,1,cerebellar Purkinje cell layer structural organization,BP,0.43697479
GO:0060853,0.011270105,1,1,1,Notch signaling pathway involved in arterial endothelial cell fate commitment,BP,0.43697479
GO:0097102,0.011270105,1,1,1,endothelial tip cell fate specification,BP,0.43697479
GO:0015724,0.01131805,1,1,1,formate transport,BP,0.43697479
GO:0015797,0.01131805,1,1,1,mannitol transport,BP,0.43697479
GO:0006463,0.011337069,1,1,1,steroid hormone receptor complex assembly,BP,0.43697479
GO:0044601,0.01133707,1,1,1,protein denucleotidylation,BP,0.43697479
GO:0044602,0.01133707,1,1,1,protein deadenylylation,BP,0.43697479
GO:0072428,0.011337075,1,1,1,signal transduction involved in intra-S DNA damage checkpoint,BP,0.43697479
GO:1902576,0.011337075,1,1,1,negative regulation of nuclear cell cycle DNA replication,BP,0.43697479
GO:1903464,0.011337075,1,1,1,negative regulation of mitotic cell cycle DNA replication,BP,0.43697479
GO:1903925,0.011337075,1,1,1,response to bisphenol A,BP,0.43697479
GO:1903926,0.011337075,1,1,1,cellular response to bisphenol A,BP,0.43697479
GO:1905255,0.011337078,1,1,1,regulation of RNA binding transcription factor activity,BP,0.43697479
GO:1990968,0.011337078,1,1,1,modulation by host of RNA binding by virus,BP,0.43697479
GO:1990969,0.011337078,1,1,1,modulation by host of viral RNA-binding transcription factor activity,BP,0.43697479
GO:0021557,0.011337136,1,1,1,oculomotor nerve development,BP,0.43697479
GO:0021558,0.011337136,1,1,1,trochlear nerve development,BP,0.43697479
GO:0042668,0.011337136,1,1,1,auditory receptor cell fate determination,BP,0.43697479
GO:0045977,0.011337136,1,1,1,"positive regulation of mitotic cell cycle, embryonic",BP,0.43697479
GO:0061105,0.011337136,1,1,1,regulation of stomach neuroendocrine cell differentiation,BP,0.43697479
GO:0061106,0.011337136,1,1,1,negative regulation of stomach neuroendocrine cell differentiation,BP,0.43697479
GO:0072071,0.011337136,1,1,1,kidney interstitial fibroblast differentiation,BP,0.43697479
GO:0072141,0.011337136,1,1,1,renal interstitial fibroblast development,BP,0.43697479
GO:2000226,0.011337136,1,1,1,regulation of pancreatic A cell differentiation,BP,0.43697479
GO:2000227,0.011337136,1,1,1,negative regulation of pancreatic A cell differentiation,BP,0.43697479
GO:0032572,0.011337487,1,1,1,response to menaquinone,BP,0.43697479
GO:0061078,0.011337487,1,1,1,positive regulation of prostaglandin secretion involved in immune response,BP,0.43697479
GO:0090323,0.011337487,1,1,1,prostaglandin secretion involved in immune response,BP,0.43697479
GO:0045926,0.011390626,0.997232583,6,174,negative regulation of growth,BP,0.43697479
GO:1901028,0.011392377,0.999469278,2,15,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,0.43697479
GO:0031399,0.011429928,0.994262835,22,1218,regulation of protein modification process,BP,0.437276394
GO:0050727,0.011507099,0.996816217,7,222,regulation of inflammatory response,BP,0.439088251
GO:0009968,0.011544808,0.99484337,16,791,negative regulation of signal transduction,BP,0.439388833
GO:0000280,0.011659925,0.996764331,7,229,nuclear division,BP,0.442626394
GO:2000736,0.011764423,0.998744907,3,44,regulation of stem cell differentiation,BP,0.445445223
GO:0042772,0.011827207,0.99943812,2,15,"DNA damage response, signal transduction resulting in transcription",BP,0.446389672
GO:0001709,0.01184998,0.999432475,2,16,cell fate determination,BP,0.446389672
GO:0006476,0.011909072,0.998085178,4,83,protein deacetylation,BP,0.44747123
GO:0010563,0.012118116,0.995688242,10,401,negative regulation of phosphorus metabolic process,BP,0.449645465
GO:0045936,0.012118116,0.995688242,10,401,negative regulation of phosphate metabolic process,BP,0.449645465
GO:0007165,0.012139977,0.992826507,42,2806,signal transduction,BP,0.449645465
GO:0030098,0.012163013,0.996597414,7,227,lymphocyte differentiation,BP,0.449645465
GO:0071887,0.012168195,0.998031819,4,82,leukocyte apoptotic process,BP,0.449645465
GO:0032946,0.012178001,0.998030446,4,81,positive regulation of mononuclear cell proliferation,BP,0.449645465
GO:0007095,0.012186949,0.999407709,2,16,mitotic G2 DNA damage checkpoint,BP,0.449645465
GO:0007569,0.012211161,0.998022169,4,83,cell aging,BP,0.449645465
GO:0001775,0.012288445,0.994961391,13,587,cell activation,BP,0.45136285
GO:0002562,0.012659708,0.998610968,3,45,somatic diversification of immune receptors via germline recombination within a single locus,BP,0.46269192
GO:0016444,0.012659708,0.998610968,3,45,somatic cell DNA recombination,BP,0.46269192
GO:0036293,0.012753874,0.996030992,8,284,response to decreased oxygen levels,BP,0.464979725
GO:0007610,0.012852909,0.995669857,9,350,behavior,BP,0.467433312
GO:0072073,0.0130352,0.997845842,4,86,kidney epithelium development,BP,0.472895212
GO:0042100,0.013141868,0.998536612,3,46,B cell proliferation,BP,0.475593537
GO:0030308,0.013281962,0.997181639,5,129,negative regulation of cell growth,BP,0.479485338
GO:0071156,0.013432073,0.998493591,3,45,regulation of cell cycle arrest,BP,0.483718829
GO:0042745,0.013507261,0.999307175,2,16,circadian sleep/wake cycle,BP,0.485216708
GO:2000737,0.013539552,0.999300357,2,17,negative regulation of stem cell differentiation,BP,0.485216708
GO:0070665,0.013672462,0.997710046,4,84,positive regulation of leukocyte proliferation,BP,0.487758974
GO:0002440,0.013676723,0.997076693,5,129,production of molecular mediator of immune response,BP,0.487758974
GO:0040007,0.013763723,0.994072334,14,679,growth,BP,0.489626742
GO:0072006,0.013804534,0.997678535,4,88,nephron development,BP,0.489626742
GO:0042981,0.013828822,0.993268865,19,1013,regulation of apoptotic process,BP,0.489626742
GO:0035050,0.014080693,0.998390022,3,47,embryonic heart tube development,BP,0.496266148
GO:0001101,0.014083729,0.995183043,9,351,response to acid chemical,BP,0.496266148
GO:0035886,0.014166129,0.999246316,2,18,vascular smooth muscle cell differentiation,BP,0.497978301
GO:0009409,0.014511822,0.998323571,3,46,response to cold,BP,0.508915791
GO:0072658,0.014698785,0.999946023,1,2,maintenance of protein location in membrane,BP,0.513029398
GO:0072660,0.014698785,0.999946023,1,2,maintenance of protein location in plasma membrane,BP,0.513029398
GO:0006629,0.014786688,0.99304089,17,872,lipid metabolic process,BP,0.513941859
GO:0008630,0.014807518,0.997458571,4,87,intrinsic apoptotic signaling pathway in response to DNA damage,BP,0.513941859
GO:0001558,0.014857495,0.995246458,8,296,regulation of cell growth,BP,0.513941859
GO:0061061,0.014922105,0.994515655,10,419,muscle structure development,BP,0.513941859
GO:0007154,0.014923911,0.990955973,45,3091,cell communication,BP,0.513941859
GO:0060993,0.014938184,0.998252557,3,48,kidney morphogenesis,BP,0.513941859
GO:1901522,0.01496918,0.999180171,2,18,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,BP,0.513941859
GO:0071157,0.015117854,0.999172198,2,17,negative regulation of cell cycle arrest,BP,0.517839228
GO:0021698,0.015226938,0.999942058,1,2,cerebellar cortex structural organization,BP,0.520365605
GO:0071398,0.015262982,0.998198731,3,49,cellular response to fatty acid,BP,0.520389951
GO:0001933,0.015749423,0.994907999,8,296,negative regulation of protein phosphorylation,BP,0.535734983
GO:0034695,0.015855303,0.999100652,2,19,response to prostaglandin E,BP,0.538093929
GO:0023052,0.016058693,0.990248906,44,3021,signaling,BP,0.543743644
GO:0003169,0.016188476,0.999934478,1,2,coronary vein morphogenesis,BP,0.545629425
GO:0060948,0.016188476,0.999934478,1,2,cardiac vascular smooth muscle cell development,BP,0.545629425
GO:0032101,0.016287319,0.99361158,11,486,regulation of response to external stimulus,BP,0.547085253
GO:0043067,0.016305956,0.991922904,19,1030,regulation of programmed cell death,BP,0.547085253
GO:0007386,0.016497646,0.99993194,1,2,compartment pattern specification,BP,0.551981776
GO:1905457,0.016564325,0.999931387,1,2,negative regulation of lymphoid progenitor cell differentiation,BP,0.551981776
GO:2000974,0.016564325,0.999931387,1,2,negative regulation of pro-B cell differentiation,BP,0.551981776
GO:0002312,0.016646238,0.997970919,3,49,B cell activation involved in immune response,BP,0.553183807
GO:0002200,0.016675512,0.997964407,3,50,somatic diversification of immune receptors,BP,0.553183807
GO:0045859,0.01674061,0.993407092,11,487,regulation of protein kinase activity,BP,0.554095379
GO:0045686,0.016943192,0.999004724,2,19,negative regulation of glial cell differentiation,BP,0.559543208
GO:0044270,0.017077478,0.993967792,9,356,cellular nitrogen compound catabolic process,BP,0.562716264
GO:0097009,0.017597499,0.998945399,2,19,energy homeostasis,BP,0.578365556
GO:0035556,0.017630941,0.990225346,27,1656,intracellular signal transduction,BP,0.578365556
GO:0035601,0.017815858,0.996764296,4,93,protein deacylation,BP,0.583132841
GO:0002376,0.018043024,0.990287436,24,1406,immune system process,BP,0.589258757
GO:0098732,0.018492321,0.996602988,4,94,macromolecule deacylation,BP,0.602596003
GO:0016071,0.018551681,0.992581783,11,488,mRNA metabolic process,BP,0.603114899
GO:0072210,0.018590139,0.998848216,2,20,metanephric nephron development,BP,0.603114899
GO:0035883,0.018673914,0.9988452,2,19,enteroendocrine cell differentiation,BP,0.604501278
GO:0060142,0.018881384,0.998825521,2,19,regulation of syncytium formation by plasma membrane fusion,BP,0.608493122
GO:0019439,0.018900505,0.993207735,9,362,aromatic compound catabolic process,BP,0.608493122
GO:0050871,0.018921166,0.997574783,3,52,positive regulation of B cell activation,BP,0.608493122
GO:0050891,0.01904353,0.998804982,2,20,multicellular organismal water homeostasis,BP,0.611094003
GO:0044703,0.019200446,0.991946479,12,566,multi-organism reproductive process,BP,0.614572368
GO:0050821,0.01927366,0.995502461,5,141,protein stabilization,BP,0.614572368
GO:0031348,0.019277102,0.99550259,5,139,negative regulation of defense response,BP,0.614572368
GO:0036315,0.019518522,0.998759088,2,20,cellular response to sterol,BP,0.620737065
GO:0008544,0.019609828,0.995401663,5,145,epidermis development,BP,0.620737065
GO:1903670,0.019853476,0.99740532,3,54,regulation of sprouting angiogenesis,BP,0.620737065
GO:0016202,0.019889554,0.996263891,4,96,regulation of striated muscle tissue development,BP,0.620737065
GO:0072049,0.019938089,0.999900419,1,2,comma-shaped body morphogenesis,BP,0.620737065
GO:0070859,0.020095222,0.999898835,1,2,positive regulation of bile acid biosynthetic process,BP,0.620737065
GO:1904253,0.020095222,0.999898835,1,2,positive regulation of bile acid metabolic process,BP,0.620737065
GO:0031400,0.020121198,0.992247274,10,434,negative regulation of protein modification process,BP,0.620737065
GO:1901532,0.020149877,0.998692158,2,21,regulation of hematopoietic progenitor cell differentiation,BP,0.620737065
GO:0071375,0.020203141,0.993744797,7,253,cellular response to peptide hormone stimulus,BP,0.620737065
GO:0021555,0.020225479,0.999897512,1,2,midbrain-hindbrain boundary morphogenesis,BP,0.620737065
GO:0048026,0.020415969,0.998670721,2,20,"positive regulation of mRNA splicing, via spliceosome",BP,0.620737065
GO:0050886,0.020537319,0.997285188,3,52,endocrine process,BP,0.620737065
GO:0042461,0.020802487,0.998626772,2,21,photoreceptor cell development,BP,0.620737065
GO:0036297,0.020871254,0.998625075,2,20,interstrand cross-link repair,BP,0.620737065
GO:1902010,0.020912261,0.999890395,1,2,negative regulation of translation in response to endoplasmic reticulum stress,BP,0.620737065
GO:0048663,0.021129486,0.998593587,2,21,neuron fate commitment,BP,0.620737065
GO:1900101,0.021133886,0.998598497,2,20,regulation of endoplasmic reticulum unfolded protein response,BP,0.620737065
GO:0031016,0.021197138,0.997160485,3,54,pancreas development,BP,0.620737065
GO:0035860,0.021279189,0.999886494,1,2,glial cell-derived neurotrophic factor receptor signaling pathway,BP,0.620737065
GO:0038190,0.021296678,0.999886306,1,2,VEGF-activated neuropilin signaling pathway,BP,0.620737065
GO:0090259,0.021296678,0.999886306,1,2,regulation of retinal ganglion cell axon guidance,BP,0.620737065
GO:1902336,0.021296678,0.999886306,1,2,positive regulation of retinal ganglion cell axon guidance,BP,0.620737065
GO:0003073,0.021296852,0.997142068,3,54,regulation of systemic arterial blood pressure,BP,0.620737065
GO:0048634,0.021330812,0.995906043,4,98,regulation of muscle organ development,BP,0.620737065
GO:1901861,0.021344922,0.995902518,4,98,regulation of muscle tissue development,BP,0.620737065
GO:0060844,0.021370823,0.999885509,1,2,arterial endothelial cell fate commitment,BP,0.620737065
GO:0060846,0.021370823,0.999885509,1,2,blood vessel endothelial cell fate commitment,BP,0.620737065
GO:0060847,0.021370823,0.999885509,1,2,endothelial cell fate specification,BP,0.620737065
GO:0097101,0.021370823,0.999885509,1,2,blood vessel endothelial cell fate specification,BP,0.620737065
GO:0001657,0.021375708,0.99712564,3,55,ureteric bud development,BP,0.620737065
GO:0099575,0.021516213,0.999883937,1,2,"regulation of protein catabolic process at presynapse, modulating synaptic transmission",BP,0.620737065
GO:0051302,0.021533064,0.9958536,4,100,regulation of cell division,BP,0.620737065
GO:0010648,0.021543847,0.989643433,16,851,negative regulation of cell communication,BP,0.620737065
GO:0046697,0.021591838,0.998546189,2,21,decidualization,BP,0.620737065
GO:0043467,0.021610607,0.995836971,4,97,regulation of generation of precursor metabolites and energy,BP,0.620737065
GO:0001783,0.021675259,0.998537578,2,21,B cell apoptotic process,BP,0.620737065
GO:0061003,0.021864692,0.998512843,2,22,positive regulation of dendritic spine morphogenesis,BP,0.620737065
GO:0070528,0.021930404,0.998511129,2,21,protein kinase C signaling,BP,0.620737065
GO:0023057,0.021979857,0.98940812,16,853,negative regulation of signaling,BP,0.620737065
GO:1901492,0.022173132,0.9998767,1,2,positive regulation of lymphangiogenesis,BP,0.620737065
GO:0010941,0.022173253,0.988455426,20,1137,regulation of cell death,BP,0.620737065
GO:0061889,0.022372479,0.999874461,1,2,negative regulation of astrocyte activation,BP,0.620737065
GO:0030901,0.022372971,0.99845956,2,22,midbrain development,BP,0.620737065
GO:0035910,0.022456295,0.999873513,1,2,ascending aorta morphogenesis,BP,0.620737065
GO:0072163,0.022465169,0.996919932,3,56,mesonephric epithelium development,BP,0.620737065
GO:0072164,0.022465169,0.996919932,3,56,mesonephric tubule development,BP,0.620737065
GO:0048295,0.022513617,0.999872862,1,2,positive regulation of isotype switching to IgE isotypes,BP,0.620737065
GO:0051454,0.02252783,0.999872701,1,2,intracellular pH elevation,BP,0.620737065
GO:0046724,0.022527838,0.999872701,1,2,oxalic acid secretion,BP,0.620737065
GO:0035442,0.022527858,0.999872701,1,2,dipeptide transmembrane transport,BP,0.620737065
GO:0042938,0.022527858,0.999872701,1,2,dipeptide transport,BP,0.620737065
GO:0090088,0.022527858,0.999872701,1,2,regulation of oligopeptide transport,BP,0.620737065
GO:0090089,0.022527858,0.999872701,1,2,regulation of dipeptide transport,BP,0.620737065
GO:2000878,0.022527858,0.999872701,1,2,positive regulation of oligopeptide transport,BP,0.620737065
GO:2000880,0.022527858,0.999872701,1,2,positive regulation of dipeptide transport,BP,0.620737065
GO:2001148,0.022527858,0.999872701,1,2,regulation of dipeptide transmembrane transport,BP,0.620737065
GO:2001150,0.022527858,0.999872701,1,2,positive regulation of dipeptide transmembrane transport,BP,0.620737065
GO:0120011,0.022530778,0.999872667,1,2,intermembrane sterol transfer,BP,0.620737065
GO:0018117,0.022546626,0.999872487,1,2,protein adenylylation,BP,0.620737065
GO:0018175,0.022546626,0.999872487,1,2,protein nucleotidylation,BP,0.620737065
GO:0006043,0.022546628,0.999872487,1,2,glucosamine catabolic process,BP,0.620737065
GO:1905178,0.022546633,0.999872487,1,2,regulation of cardiac muscle tissue regeneration,BP,0.620737065
GO:1905179,0.022546633,0.999872487,1,2,negative regulation of cardiac muscle tissue regeneration,BP,0.620737065
GO:0060382,0.022546634,0.999872487,1,2,regulation of DNA strand elongation,BP,0.620737065
GO:0002017,0.022546658,0.999872487,1,2,regulation of blood volume by renal aldosterone,BP,0.620737065
GO:0061102,0.022546724,0.999872486,1,2,stomach neuroendocrine cell differentiation,BP,0.620737065
GO:2000978,0.022546778,0.999872485,1,2,negative regulation of forebrain neuron differentiation,BP,0.620737065
GO:0002023,0.022546846,0.999872485,1,2,reduction of food intake in response to dietary excess,BP,0.620737065
GO:0060400,0.022546847,0.999872485,1,2,negative regulation of growth hormone receptor signaling pathway,BP,0.620737065
GO:0060708,0.02254687,0.999872484,1,2,spongiotrophoblast differentiation,BP,0.620737065
GO:0048664,0.022546904,0.999872484,1,2,neuron fate determination,BP,0.620737065
GO:0044868,0.022546971,0.999872483,1,2,modulation by host of viral molecular function,BP,0.620737065
GO:0007050,0.022858973,0.995519089,4,99,cell cycle arrest,BP,0.628152646
GO:0098773,0.023012672,0.996814074,3,57,skin epidermis development,BP,0.631198597
GO:1900745,0.023531165,0.998335684,2,22,positive regulation of p38MAPK cascade,BP,0.644220307
GO:0033189,0.023730574,0.998308745,2,23,response to vitamin A,BP,0.648474255
GO:0045685,0.023886942,0.996645932,3,57,regulation of glial cell differentiation,BP,0.649856949
GO:0002694,0.023911407,0.991649115,8,316,regulation of leukocyte activation,BP,0.649856949
GO:0071356,0.023913536,0.994097372,5,150,cellular response to tumor necrosis factor,BP,0.649856949
GO:1903706,0.024077591,0.992273206,7,261,regulation of hemopoiesis,BP,0.653110208
GO:0034694,0.024168454,0.998255711,2,24,response to prostaglandin,BP,0.654369767
GO:0009611,0.024371987,0.990846156,9,391,response to wounding,BP,0.65751198
GO:0034655,0.024410779,0.991441272,8,318,nucleobase-containing compound catabolic process,BP,0.65751198
GO:0035767,0.02441843,0.998233003,2,23,endothelial cell chemotaxis,BP,0.65751198
GO:0044818,0.024557527,0.998217543,2,23,mitotic G2/M transition checkpoint,BP,0.660050769
GO:0001823,0.024733505,0.996478788,3,58,mesonephros development,BP,0.663569751
GO:0051412,0.024809958,0.998189365,2,23,response to corticosterone,BP,0.664410668
GO:0001990,0.024883995,0.998186729,2,22,regulation of systemic arterial blood pressure by hormone,BP,0.664980686
GO:0006915,0.024921538,0.986665259,21,1226,apoptotic process,BP,0.664980686
GO:0051894,0.025062057,0.998161068,2,23,positive regulation of focal adhesion assembly,BP,0.667520855
GO:0043405,0.025123474,0.992712324,6,208,regulation of MAP kinase activity,BP,0.667948815
GO:0045747,0.025305435,0.998128293,2,24,positive regulation of Notch signaling pathway,BP,0.670815706
GO:0043094,0.025322393,0.99813749,2,22,cellular metabolic compound salvage,BP,0.670815706
GO:0051249,0.02583729,0.99158781,7,262,regulation of lymphocyte activation,BP,0.683227021
GO:1901361,0.026225534,0.99002572,9,383,organic cyclic compound catabolic process,BP,0.691958882
GO:0072395,0.026421303,0.998000159,2,24,signal transduction involved in cell cycle checkpoint,BP,0.691958882
GO:0072401,0.026421303,0.998000159,2,24,signal transduction involved in DNA integrity checkpoint,BP,0.691958882
GO:0072422,0.026421303,0.998000159,2,24,signal transduction involved in DNA damage checkpoint,BP,0.691958882
GO:0097345,0.026427506,0.998005104,2,23,mitochondrial outer membrane permeabilization,BP,0.691958882
GO:0048285,0.026449375,0.991344621,7,269,organelle fission,BP,0.691958882
GO:0060842,0.026545386,0.999764199,1,3,arterial endothelial cell differentiation,BP,0.693058619
GO:0045604,0.026644477,0.997974171,2,24,regulation of epidermal cell differentiation,BP,0.693058619
GO:1901655,0.02666365,0.994516981,4,104,cellular response to ketone,BP,0.693058619
GO:0010332,0.026765099,0.996071017,3,59,response to gamma radiation,BP,0.693058619
GO:0051591,0.026835312,0.994470846,4,104,response to cAMP,BP,0.693058619
GO:0009408,0.026876207,0.994460954,4,103,response to heat,BP,0.693058619
GO:0072359,0.026880337,0.987372648,14,747,circulatory system development,BP,0.693058619
GO:0071417,0.026886061,0.989140998,10,460,cellular response to organonitrogen compound,BP,0.693058619
GO:0038086,0.026961952,0.999756694,1,3,VEGF-activated platelet-derived growth factor receptor signaling pathway,BP,0.693058619
GO:0038091,0.026961952,0.999756694,1,3,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway,BP,0.693058619
GO:0031572,0.027026175,0.997929445,2,24,G2 DNA damage checkpoint,BP,0.69349918
GO:0042491,0.027255972,0.997896902,2,25,inner ear auditory receptor cell differentiation,BP,0.698179487
GO:0072332,0.027309626,0.995960109,3,59,intrinsic apoptotic signaling pathway by p53 class mediator,BP,0.698339382
GO:0030104,0.027395211,0.997885873,2,24,water homeostasis,BP,0.69897186
GO:0006096,0.027476727,0.995925897,3,59,glycolytic process,BP,0.69897186
GO:0006757,0.027476727,0.995925897,3,59,ATP generation from ADP,BP,0.69897186
GO:0001568,0.027610366,0.988797994,10,471,blood vessel development,BP,0.70116048
GO:0006469,0.027677805,0.992901178,5,155,negative regulation of protein kinase activity,BP,0.701269951
GO:0019042,0.027805123,0.999741139,1,3,viral latency,BP,0.701269951
GO:0019045,0.027805123,0.999741139,1,3,latent virus replication,BP,0.701269951
GO:0019046,0.027805123,0.999741139,1,3,release from viral latency,BP,0.701269951
GO:0006694,0.02815935,0.994111843,4,104,steroid biosynthetic process,BP,0.708078628
GO:2001020,0.028188279,0.992734345,5,157,regulation of response to DNA damage stimulus,BP,0.708078628
GO:0072092,0.028219306,0.999733319,1,3,ureteric bud invasion,BP,0.708078628
GO:0045191,0.028516151,0.997751547,2,24,regulation of isotype switching,BP,0.714310191
GO:0035811,0.028907402,0.999720067,1,3,negative regulation of urine volume,BP,0.722881373
GO:0050731,0.029079141,0.993853421,4,109,positive regulation of peptidyl-tyrosine phosphorylation,BP,0.72594351
GO:0002686,0.029152635,0.997673966,2,24,negative regulation of leukocyte migration,BP,0.726546816
GO:0051246,0.029489515,0.98257903,29,1878,regulation of protein metabolic process,BP,0.733701131
GO:0031347,0.029617184,0.988490562,9,395,regulation of defense response,BP,0.735020569
GO:0017148,0.029642353,0.993698443,4,108,negative regulation of translation,BP,0.735020569
GO:0030263,0.029843932,0.999701507,1,3,apoptotic chromosome condensation,BP,0.738775263
GO:0030321,0.030006851,0.999698216,1,3,transepithelial chloride transport,BP,0.741206365
GO:0089700,0.030042786,0.999697488,1,3,protein kinase D signaling,BP,0.741206365
GO:1902532,0.030097249,0.988270362,9,397,negative regulation of intracellular signal transduction,BP,0.74130833
GO:0050878,0.030165358,0.990871725,6,216,regulation of body fluid levels,BP,0.74174551
GO:0002285,0.030402137,0.993487545,4,107,lymphocyte activation involved in immune response,BP,0.745614965
GO:0070426,0.030474588,0.999688668,1,3,positive regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,0.745614965
GO:0070434,0.030474588,0.999688668,1,3,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,0.745614965
GO:0090238,0.030633564,0.999685389,1,3,positive regulation of arachidonic acid secretion,BP,0.748261641
GO:0070370,0.030839356,0.999681117,1,3,cellular heat acclimation,BP,0.752041173
GO:1902110,0.031001409,0.997436713,2,25,positive regulation of mitochondrial membrane permeability involved in apoptotic process,BP,0.754700826
GO:0072050,0.0310509,0.999676696,1,3,S-shaped body morphogenesis,BP,0.754700826
GO:0021700,0.031267373,0.991713871,5,164,developmental maturation,BP,0.758161562
GO:0062013,0.031526239,0.993169386,4,108,positive regulation of small molecule metabolic process,BP,0.758161562
GO:0012501,0.031534447,0.982695472,21,1256,programmed cell death,BP,0.758161562
GO:0045292,0.031618475,0.997357804,2,25,"mRNA cis splicing, via spliceosome",BP,0.758161562
GO:0000018,0.031627445,0.995040275,3,63,regulation of DNA recombination,BP,0.758161562
GO:0001757,0.031634349,0.999664342,1,3,somite specification,BP,0.758161562
GO:0071456,0.031694942,0.993119041,4,110,cellular response to hypoxia,BP,0.758161562
GO:0006310,0.031784522,0.991541954,5,162,DNA recombination,BP,0.758161562
GO:0050730,0.031828558,0.991526393,5,163,regulation of peptidyl-tyrosine phosphorylation,BP,0.758161562
GO:0070232,0.031909793,0.997313891,2,26,regulation of T cell apoptotic process,BP,0.758161562
GO:0072331,0.031960735,0.993044624,4,109,signal transduction by p53 class mediator,BP,0.758161562
GO:0044262,0.031971489,0.9901938,6,217,cellular carbohydrate metabolic process,BP,0.758161562
GO:0048589,0.031971984,0.986708665,10,484,developmental growth,BP,0.758161562
GO:0048871,0.031972279,0.98911445,7,279,multicellular organismal homeostasis,BP,0.758161562
GO:0045852,0.032004583,0.999656381,1,3,pH elevation,BP,0.758161562
GO:1903672,0.032016871,0.997300009,2,26,positive regulation of sprouting angiogenesis,BP,0.758161562
GO:1901490,0.03237429,0.999648337,1,3,regulation of lymphangiogenesis,BP,0.758562648
GO:0043009,0.032379946,0.986511089,10,482,chordate embryonic development,BP,0.758562648
GO:0038189,0.032394415,0.999647897,1,3,neuropilin signaling pathway,BP,0.758562648
GO:0042866,0.03264508,0.994817758,3,63,pyruvate biosynthetic process,BP,0.758562648
GO:1903313,0.032810195,0.994776702,3,65,positive regulation of mRNA metabolic process,BP,0.758562648
GO:0008594,0.032858563,0.999637657,1,3,photoreceptor cell morphogenesis,BP,0.758562648
GO:0060574,0.0329326,0.99963601,1,3,intestinal epithelial cell maturation,BP,0.758562648
GO:0042303,0.033191371,0.994690116,3,66,molting cycle,BP,0.758562648
GO:0042633,0.033191371,0.994690116,3,66,hair cycle,BP,0.758562648
GO:0043415,0.033321275,0.999627301,1,3,positive regulation of skeletal muscle tissue regeneration,BP,0.758562648
GO:0043416,0.033321275,0.999627301,1,3,regulation of skeletal muscle tissue regeneration,BP,0.758562648
GO:0048839,0.033363282,0.992637098,4,113,inner ear development,BP,0.758562648
GO:0006579,0.033489534,0.999623499,1,3,amino-acid betaine catabolic process,BP,0.758562648
GO:0018298,0.033517556,0.999622864,1,3,protein-chromophore linkage,BP,0.758562648
GO:0035905,0.033540781,0.999622337,1,3,ascending aorta development,BP,0.758562648
GO:0044281,0.033576288,0.981211914,22,1323,small molecule metabolic process,BP,0.758562648
GO:0070236,0.033595936,0.999621084,1,3,negative regulation of activation-induced cell death of T cells,BP,0.758562648
GO:1904184,0.033601913,0.999620948,1,3,positive regulation of pyruvate dehydrogenase activity,BP,0.758562648
GO:1903895,0.033610617,0.99962075,1,3,negative regulation of IRE1-mediated unfolded protein response,BP,0.758562648
GO:0032788,0.033611376,0.999620733,1,3,saturated monocarboxylic acid metabolic process,BP,0.758562648
GO:0032789,0.033611376,0.999620733,1,3,unsaturated monocarboxylic acid metabolic process,BP,0.758562648
GO:1903463,0.033619503,0.999620548,1,3,regulation of mitotic cell cycle DNA replication,BP,0.758562648
GO:0009794,0.033626955,0.999620379,1,3,"regulation of mitotic cell cycle, embryonic",BP,0.758562648
GO:0045448,0.033626955,0.999620379,1,3,"mitotic cell cycle, embryonic",BP,0.758562648
GO:0060086,0.033628021,0.999620354,1,3,circadian temperature homeostasis,BP,0.758562648
GO:0044211,0.033630114,0.999620307,1,3,CTP salvage,BP,0.758562648
GO:0006046,0.033630128,0.999620306,1,3,N-acetylglucosamine catabolic process,BP,0.758562648
GO:0060164,0.033630189,0.999620305,1,3,regulation of timing of neuron differentiation,BP,0.758562648
GO:0019287,0.033630291,0.999620303,1,3,"isopentenyl diphosphate biosynthetic process, mevalonate pathway",BP,0.758562648
GO:0021984,0.033630342,0.999620301,1,3,adenohypophysis development,BP,0.758562648
GO:2000467,0.033630349,0.999620301,1,3,positive regulation of glycogen (starch) synthase activity,BP,0.758562648
GO:0007565,0.034015699,0.990781675,5,166,female pregnancy,BP,0.765904534
GO:0016049,0.034059846,0.987270508,8,347,cell growth,BP,0.765904534
GO:0009201,0.034397326,0.992340481,4,110,ribonucleoside triphosphate biosynthetic process,BP,0.771420176
GO:0030857,0.034409875,0.996970425,2,28,negative regulation of epithelial cell differentiation,BP,0.771420176
GO:2000106,0.034605615,0.994373749,3,66,regulation of leukocyte apoptotic process,BP,0.774629333
GO:0071479,0.034713463,0.994351813,3,65,cellular response to ionizing radiation,BP,0.775864329
GO:0051965,0.034786144,0.996919244,2,28,positive regulation of synapse assembly,BP,0.776310786
GO:0002682,0.034846963,0.982612966,15,820,regulation of immune system process,BP,0.776491562
GO:0014002,0.035073203,0.99687999,2,28,astrocyte development,BP,0.779200928
GO:0032094,0.035074358,0.996886116,2,27,response to food,BP,0.779200928
GO:0038084,0.035169927,0.996866723,2,28,vascular endothelial growth factor signaling pathway,BP,0.780147368
GO:0042276,0.035621536,0.999520806,1,4,error-prone translesion synthesis,BP,0.788976858
GO:1902686,0.035860722,0.99677788,2,27,mitochondrial outer membrane permeabilization involved in programmed cell death,BP,0.793081951
GO:1903393,0.035926067,0.996762311,2,28,positive regulation of adherens junction organization,BP,0.793286006
GO:0009792,0.036171643,0.984648235,10,491,embryo development ending in birth or egg hatching,BP,0.793286006
GO:0097475,0.036175215,0.999505676,1,4,motor neuron migration,BP,0.793286006
GO:0035315,0.036179676,0.996720894,2,29,hair cell differentiation,BP,0.793286006
GO:0090063,0.036182628,0.999505472,1,4,positive regulation of microtubule nucleation,BP,0.793286006
GO:0033144,0.036207836,0.996723088,2,28,negative regulation of intracellular steroid hormone receptor signaling pathway,BP,0.793286006
GO:0014807,0.036286306,0.999502611,1,4,regulation of somitogenesis,BP,0.793286006
GO:0048638,0.036300819,0.988521922,6,234,regulation of developmental growth,BP,0.793286006
GO:0001944,0.036441336,0.984514029,10,493,vasculature development,BP,0.794183354
GO:0042531,0.036449721,0.996695937,2,27,positive regulation of tyrosine phosphorylation of STAT protein,BP,0.794183354
GO:0003044,0.036600604,0.996674827,2,27,regulation of systemic arterial blood pressure mediated by a chemical signal,BP,0.796292894
GO:0046031,0.036830942,0.993865299,3,66,ADP metabolic process,BP,0.798424369
GO:0043549,0.036847765,0.983615007,11,551,regulation of kinase activity,BP,0.798424369
GO:0016572,0.036861197,0.996631482,2,28,histone phosphorylation,BP,0.798424369
GO:0060947,0.037220372,0.999476464,1,4,cardiac vascular smooth muscle cell differentiation,BP,0.805020362
GO:0050865,0.037413163,0.985761974,8,345,regulation of cell activation,BP,0.80755967
GO:0000375,0.03755709,0.988036649,6,222,"RNA splicing, via transesterification reactions",BP,0.80755967
GO:0000377,0.03755709,0.988036649,6,222,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile",BP,0.80755967
GO:0000398,0.03755709,0.988036649,6,222,"mRNA splicing, via spliceosome",BP,0.80755967
GO:0042060,0.037843539,0.986644168,7,293,wound healing,BP,0.80921654
GO:1903580,0.037856014,0.996490256,2,28,positive regulation of ATP metabolic process,BP,0.80921654
GO:1904502,0.037886516,0.9994574,1,4,regulation of lipophagy,BP,0.80921654
GO:1904504,0.037886516,0.9994574,1,4,positive regulation of lipophagy,BP,0.80921654
GO:0060978,0.037925185,0.999456283,1,4,angiogenesis involved in coronary vascular morphogenesis,BP,0.80921654
GO:0036091,0.037963788,0.999455167,1,4,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,0.80921654
GO:0046425,0.038313755,0.993514209,3,68,regulation of JAK-STAT cascade,BP,0.813084608
GO:0070723,0.038331439,0.99641535,2,29,response to cholesterol,BP,0.813084608
GO:0018108,0.03836006,0.987715052,6,230,peptidyl-tyrosine phosphorylation,BP,0.813084608
GO:0043484,0.038366067,0.99115453,4,114,regulation of RNA splicing,BP,0.813084608
GO:0009259,0.038822354,0.985119085,8,345,ribonucleotide metabolic process,BP,0.82106038
GO:0033673,0.038853899,0.98908815,5,170,negative regulation of kinase activity,BP,0.82106038
GO:1904117,0.039073145,0.999422583,1,4,cellular response to vasopressin,BP,0.823677834
GO:1901890,0.039089606,0.996305361,2,29,positive regulation of cell junction assembly,BP,0.823677834
GO:0072093,0.039234541,0.999417763,1,4,metanephric renal vesicle formation,BP,0.825550791
GO:0014908,0.039626864,0.99940596,1,4,myotube differentiation involved in skeletal muscle regeneration,BP,0.832616377
GO:0055088,0.039731403,0.990732916,4,118,lipid homeostasis,BP,0.833623691
GO:0050685,0.039852768,0.996193435,2,29,positive regulation of mRNA processing,BP,0.834980689
GO:0030917,0.040057768,0.999392857,1,4,midbrain-hindbrain boundary development,BP,0.836096494
GO:0072358,0.040070683,0.982694456,10,501,cardiovascular system development,BP,0.836096494
GO:0034612,0.040153506,0.988621641,5,172,response to tumor necrosis factor,BP,0.836096494
GO:0034144,0.040217014,0.999387978,1,4,negative regulation of toll-like receptor 4 signaling pathway,BP,0.836096494
GO:0060562,0.040238516,0.986961974,6,239,epithelial tube morphogenesis,BP,0.836096494
GO:0035878,0.040246616,0.999387069,1,4,nail development,BP,0.836096494
GO:0018212,0.040553844,0.986839119,6,233,peptidyl-tyrosine modification,BP,0.840985926
GO:0097167,0.04059617,0.999376281,1,4,circadian regulation of translation,BP,0.840985926
GO:0008219,0.040744297,0.976717662,22,1367,cell death,BP,0.841741285
GO:0048739,0.04074693,0.999371599,1,4,cardiac muscle fiber development,BP,0.841741285
GO:0060346,0.041065858,0.999361636,1,4,bone trabecula formation,BP,0.842001604
GO:1904892,0.041118267,0.992839182,3,70,regulation of STAT cascade,BP,0.842001604
GO:0051338,0.041174704,0.980671666,12,629,regulation of transferase activity,BP,0.842001604
GO:0034249,0.041182943,0.990282419,4,120,negative regulation of cellular amide metabolic process,BP,0.842001604
GO:1903578,0.041224175,0.99281618,3,69,regulation of ATP metabolic process,BP,0.842001604
GO:0060699,0.041358276,0.99935243,1,4,regulation of endoribonuclease activity,BP,0.842001604
GO:0010677,0.041432839,0.995957873,2,29,negative regulation of cellular carbohydrate metabolic process,BP,0.842001604
GO:0070424,0.041468871,0.999348931,1,4,regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,0.842001604
GO:0070432,0.041468871,0.999348931,1,4,regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,0.842001604
GO:0046530,0.04165131,0.995911268,2,31,photoreceptor cell differentiation,BP,0.842001604
GO:0006776,0.041796776,0.9993385,1,4,vitamin A metabolic process,BP,0.842001604
GO:0010286,0.04182954,0.999337453,1,4,heat acclimation,BP,0.842001604
GO:0036294,0.041978863,0.990034628,4,120,cellular response to decreased oxygen levels,BP,0.842001604
GO:0034620,0.042110517,0.992600264,3,69,cellular response to unfolded protein,BP,0.842001604
GO:0001893,0.042212655,0.99583254,2,30,maternal placenta development,BP,0.842001604
GO:1903416,0.042246175,0.999324067,1,4,response to glycoside,BP,0.842001604
GO:0030397,0.042265745,0.999323435,1,4,membrane disassembly,BP,0.842001604
GO:0051081,0.042265745,0.999323435,1,4,nuclear envelope disassembly,BP,0.842001604
GO:0045981,0.042782953,0.995745212,2,30,positive regulation of nucleotide metabolic process,BP,0.842001604
GO:1900544,0.042782953,0.995745212,2,30,positive regulation of purine nucleotide metabolic process,BP,0.842001604
GO:0046700,0.042975206,0.983192153,8,355,heterocycle catabolic process,BP,0.842001604
GO:2000977,0.042992562,0.999299746,1,4,regulation of forebrain neuron differentiation,BP,0.842001604
GO:0048255,0.043083175,0.995698976,2,30,mRNA stabilization,BP,0.842001604
GO:0061304,0.043156164,0.99924787,1,5,retinal blood vessel morphogenesis,BP,0.842001604
GO:1901699,0.043158072,0.981124108,10,499,cellular response to nitrogen compound,BP,0.842001604
GO:0035794,0.043253367,0.995672684,2,30,positive regulation of mitochondrial membrane permeability,BP,0.842001604
GO:0050767,0.04331757,0.980226303,11,579,regulation of neurogenesis,BP,0.842001604
GO:0031018,0.043452513,0.995641845,2,30,endocrine pancreas development,BP,0.842001604
GO:0071480,0.043567052,0.995624072,2,30,cellular response to gamma radiation,BP,0.842001604
GO:0021575,0.043575442,0.995609126,2,32,hindbrain morphogenesis,BP,0.842001604
GO:1902108,0.043662538,0.995609236,2,30,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,0.842001604
GO:0055090,0.043677145,0.995606964,2,30,acylglycerol homeostasis,BP,0.842001604
GO:0070328,0.043677145,0.995606964,2,30,triglyceride homeostasis,BP,0.842001604
GO:0060319,0.043799182,0.999272969,1,4,primitive erythrocyte differentiation,BP,0.842001604
GO:0002069,0.04389923,0.999269612,1,4,columnar/cuboidal epithelial cell maturation,BP,0.842001604
GO:0031647,0.04397233,0.985451562,6,235,regulation of protein stability,BP,0.842001604
GO:0038033,0.043992628,0.999266471,1,4,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,BP,0.842001604
GO:0009142,0.044030452,0.989390205,4,119,nucleoside triphosphate biosynthetic process,BP,0.842001604
GO:0072282,0.044077757,0.999263602,1,4,metanephric nephron tubule morphogenesis,BP,0.842001604
GO:0034242,0.044142495,0.999261417,1,4,negative regulation of syncytium formation by plasma membrane fusion,BP,0.842001604
GO:0048289,0.044148448,0.999261216,1,4,isotype switching to IgE isotypes,BP,0.842001604
GO:0048293,0.044148448,0.999261216,1,4,regulation of isotype switching to IgE isotypes,BP,0.842001604
GO:0019532,0.044165386,0.999260643,1,4,oxalate transport,BP,0.842001604
GO:2000847,0.044177353,0.999260239,1,4,negative regulation of corticosteroid hormone secretion,BP,0.842001604
GO:2000850,0.044177353,0.999260239,1,4,negative regulation of glucocorticoid secretion,BP,0.842001604
GO:0061026,0.044246804,0.999257889,1,4,cardiac muscle tissue regeneration,BP,0.842001604
GO:0003310,0.04435845,0.999254103,1,4,pancreatic A cell differentiation,BP,0.842001604
GO:0009135,0.044388154,0.99203103,3,71,purine nucleoside diphosphate metabolic process,BP,0.842001604
GO:0009179,0.044388154,0.99203103,3,71,purine ribonucleoside diphosphate metabolic process,BP,0.842001604
GO:0048631,0.044513872,0.999248816,1,4,regulation of skeletal muscle tissue growth,BP,0.842001604
GO:0048633,0.044513872,0.999248816,1,4,positive regulation of skeletal muscle tissue growth,BP,0.842001604
GO:0044706,0.044519915,0.987022093,5,179,multi-multicellular organism process,BP,0.842001604
GO:0015791,0.044520673,0.999248584,1,4,polyol transport,BP,0.842001604
GO:0071332,0.044540428,0.999247911,1,4,cellular response to fructose stimulus,BP,0.842001604
GO:1904182,0.044561027,0.999247208,1,4,regulation of pyruvate dehydrogenase activity,BP,0.842001604
GO:0051105,0.044567939,0.999246973,1,4,regulation of DNA ligation,BP,0.842001604
GO:0051106,0.044567939,0.999246973,1,4,positive regulation of DNA ligation,BP,0.842001604
GO:1905897,0.044573245,0.991984678,3,71,regulation of response to endoplasmic reticulum stress,BP,0.842001604
GO:0090027,0.044588897,0.999246257,1,4,negative regulation of monocyte chemotaxis,BP,0.842001604
GO:1901072,0.044588926,0.999246256,1,4,glucosamine-containing compound catabolic process,BP,0.842001604
GO:0006572,0.044589016,0.999246253,1,4,tyrosine catabolic process,BP,0.842001604
GO:0009240,0.044589178,0.999246248,1,4,isopentenyl diphosphate biosynthetic process,BP,0.842001604
GO:0046490,0.044589178,0.999246248,1,4,isopentenyl diphosphate metabolic process,BP,0.842001604
GO:2000465,0.04458918,0.999246248,1,4,regulation of glycogen (starch) synthase activity,BP,0.842001604
GO:0015074,0.044589183,0.999246248,1,4,DNA integration,BP,0.842001604
GO:0002035,0.044589195,0.999246247,1,4,brain renin-angiotensin system,BP,0.842001604
GO:0010760,0.04458967,0.999246231,1,4,negative regulation of macrophage chemotaxis,BP,0.842001604
GO:0002688,0.044913829,0.991896344,3,72,regulation of leukocyte chemotaxis,BP,0.847036861
GO:0045911,0.045288053,0.995346401,2,31,positive regulation of DNA recombination,BP,0.85300222
GO:0010165,0.045480702,0.995302104,2,33,response to X-ray,BP,0.854137631
GO:0043583,0.045518342,0.988906234,4,125,ear development,BP,0.854137631
GO:0043403,0.045532644,0.995307461,2,31,skeletal muscle tissue regeneration,BP,0.854137631
GO:0008380,0.045580296,0.98326074,7,293,RNA splicing,BP,0.854137631
GO:0010972,0.045916203,0.995239021,2,32,negative regulation of G2/M transition of mitotic cell cycle,BP,0.8592789
GO:1905710,0.045971653,0.995237271,2,31,positive regulation of membrane permeability,BP,0.8592789
GO:0051225,0.046029673,0.991605944,3,75,spindle assembly,BP,0.8592789
GO:0005978,0.046180537,0.995189789,2,33,glycogen biosynthetic process,BP,0.859915453
GO:0009250,0.046180537,0.995189789,2,33,glucan biosynthetic process,BP,0.859915453
GO:0060837,0.046380255,0.999130125,1,5,blood vessel endothelial cell differentiation,BP,0.862543916
GO:0014014,0.046458646,0.995151702,2,32,negative regulation of gliogenesis,BP,0.862912221
GO:0019218,0.046554061,0.991477806,3,73,regulation of steroid metabolic process,BP,0.863595415
GO:1901990,0.046702479,0.9862062,5,181,regulation of mitotic cell cycle phase transition,BP,0.865258881
GO:1900086,0.047139296,0.999101136,1,5,positive regulation of peptidyl-tyrosine autophosphorylation,BP,0.872254633
GO:0045599,0.047334918,0.995002413,2,33,negative regulation of fat cell differentiation,BP,0.874743452
GO:0043488,0.047392578,0.99126,3,74,regulation of mRNA stability,BP,0.874743452
GO:0044283,0.047533268,0.978863032,10,495,small molecule biosynthetic process,BP,0.875734309
GO:0006165,0.047565174,0.99121844,3,73,nucleoside diphosphate phosphorylation,BP,0.875734309
GO:0019693,0.047672413,0.980966116,8,360,ribose phosphate metabolic process,BP,0.876612954
GO:0050922,0.04782997,0.994914565,2,34,negative regulation of chemotaxis,BP,0.87841351
GO:0009987,0.048194178,0.970777877,104,8733,cellular process,BP,0.883560526
GO:0006171,0.048230203,0.999058623,1,5,cAMP biosynthetic process,BP,0.883560526
GO:0051926,0.04853615,0.994811943,2,32,negative regulation of calcium ion transport,BP,0.886025344
GO:0031058,0.048537415,0.990958202,3,76,positive regulation of histone modification,BP,0.886025344
GO:0048468,0.048545214,0.972044171,21,1351,cell development,BP,0.886025344
GO:0043409,0.048685058,0.987875892,4,126,negative regulation of MAPK cascade,BP,0.887329831
GO:0042045,0.04879653,0.999036158,1,5,epithelial fluid transport,BP,0.887329831
GO:0061724,0.048797418,0.999036122,1,5,lipophagy,BP,0.887329831
GO:1900542,0.049010941,0.990840573,3,74,regulation of purine nucleotide metabolic process,BP,0.890113624
GO:0046683,0.04921596,0.987701119,4,126,response to organophosphorus,BP,0.892506712
GO:0009185,0.049263898,0.990774487,3,74,ribonucleoside diphosphate metabolic process,BP,0.892506712
GO:0017145,0.049365401,0.994659503,2,34,stem cell division,BP,0.893246912
GO:0003266,0.049629006,0.999002644,1,5,regulation of secondary heart field cardioblast proliferation,BP,0.895999211
GO:0003263,0.049639171,0.999002231,1,5,cardioblast proliferation,BP,0.895999211
GO:1904116,0.049970696,0.998988719,1,5,response to vasopressin,BP,0.90087929
GO:0090237,0.050035334,0.998986073,1,5,regulation of arachidonic acid secretion,BP,0.900941844
GO:0072283,0.050127128,0.998982311,1,5,metanephric renal vesicle morphogenesis,BP,0.901492628
GO:0009260,0.050524782,0.984753821,5,181,ribonucleotide biosynthetic process,BP,0.907535987
GO:0006110,0.050655962,0.994448892,2,33,regulation of glycolytic process,BP,0.908784007
GO:0043124,0.050737994,0.994427639,2,34,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,0.909148313
GO:0046939,0.050898758,0.990340889,3,75,nucleotide phosphorylation,BP,0.910920778
GO:0009156,0.051338979,0.986997498,4,125,ribonucleoside monophosphate biosynthetic process,BP,0.917684252
GO:0051005,0.051646473,0.998918997,1,5,negative regulation of lipoprotein lipase activity,BP,0.922061703
GO:0048145,0.051807556,0.990090013,3,78,regulation of fibroblast proliferation,BP,0.923479353
GO:0010739,0.052191368,0.998895815,1,5,positive regulation of protein kinase A signaling,BP,0.923479353
GO:2000035,0.052327451,0.998889986,1,5,regulation of stem cell division,BP,0.923479353
GO:0009966,0.052928812,0.967402374,27,1822,regulation of signal transduction,BP,0.923479353
GO:0045687,0.052935322,0.994048979,2,34,positive regulation of glial cell differentiation,BP,0.923479353
GO:0006041,0.052981747,0.998861742,1,5,glucosamine metabolic process,BP,0.923479353
GO:0071676,0.053056851,0.998858476,1,5,negative regulation of mononuclear cell migration,BP,0.923479353
GO:0060839,0.053128055,0.998855376,1,5,endothelial cell fate commitment,BP,0.923479353
GO:0021861,0.05316968,0.998853562,1,5,forebrain radial glial cell differentiation,BP,0.923479353
GO:0002067,0.053296703,0.99398583,2,34,glandular epithelial cell differentiation,BP,0.923479353
GO:0008285,0.053446923,0.976864152,9,441,negative regulation of cell proliferation,BP,0.923479353
GO:0030811,0.053533963,0.993944236,2,34,regulation of nucleotide catabolic process,BP,0.923479353
GO:0050795,0.053740636,0.993900412,2,35,regulation of behavior,BP,0.923479353
GO:0002065,0.053831358,0.989541435,3,79,columnar/cuboidal epithelial cell differentiation,BP,0.923479353
GO:0071466,0.053958522,0.986108279,4,128,cellular response to xenobiotic stimulus,BP,0.923479353
GO:0006140,0.054079829,0.9894799,3,77,regulation of nucleotide metabolic process,BP,0.923479353
GO:0060754,0.054185099,0.998808848,1,5,positive regulation of mast cell chemotaxis,BP,0.923479353
GO:0019359,0.054318627,0.989414837,3,77,nicotinamide nucleotide biosynthetic process,BP,0.923479353
GO:0019363,0.054318627,0.989414837,3,77,pyridine nucleotide biosynthetic process,BP,0.923479353
GO:0051241,0.054333938,0.971852092,14,806,negative regulation of multicellular organismal process,BP,0.923479353
GO:0002204,0.054403137,0.993790964,2,34,somatic recombination of immunoglobulin genes involved in immune response,BP,0.923479353
GO:0002208,0.054403137,0.993790964,2,34,somatic diversification of immunoglobulins involved in immune response,BP,0.923479353
GO:0045190,0.054403137,0.993790964,2,34,isotype switching,BP,0.923479353
GO:0002901,0.054409685,0.998798841,1,5,mature B cell apoptotic process,BP,0.923479353
GO:0002905,0.054409685,0.998798841,1,5,regulation of mature B cell apoptotic process,BP,0.923479353
GO:0002906,0.054409685,0.998798841,1,5,negative regulation of mature B cell apoptotic process,BP,0.923479353
GO:0006323,0.054551774,0.9893421,3,80,DNA packaging,BP,0.923479353
GO:0030518,0.054638444,0.989321355,3,79,intracellular steroid hormone receptor signaling pathway,BP,0.923479353
GO:0060398,0.054682903,0.998786608,1,5,regulation of growth hormone receptor signaling pathway,BP,0.923479353
GO:2000973,0.054690749,0.998736477,1,6,regulation of pro-B cell differentiation,BP,0.923479353
GO:0070286,0.054712914,0.998785261,1,5,axonemal dynein complex assembly,BP,0.923479353
GO:1901727,0.054834751,0.998779782,1,5,positive regulation of histone deacetylase activity,BP,0.923479353
GO:0072173,0.054919096,0.998775982,1,5,metanephric tubule morphogenesis,BP,0.923479353
GO:0048144,0.055007482,0.989217278,3,80,fibroblast proliferation,BP,0.923479353
GO:2000832,0.05501748,0.998771542,1,5,negative regulation of steroid hormone secretion,BP,0.923479353
GO:2000849,0.055017679,0.998771533,1,5,regulation of glucocorticoid secretion,BP,0.923479353
GO:0048665,0.055032568,0.99877086,1,5,neuron fate specification,BP,0.923479353
GO:1903979,0.055087598,0.998768373,1,5,negative regulation of microglial cell activation,BP,0.923479353
GO:0061888,0.055253294,0.998760866,1,5,regulation of astrocyte activation,BP,0.923479353
GO:0015712,0.055308577,0.998758357,1,5,hexose phosphate transport,BP,0.923479353
GO:0015760,0.055308577,0.998758357,1,5,glucose-6-phosphate transport,BP,0.923479353
GO:0007292,0.055314291,0.989132995,3,80,female gamete generation,BP,0.923479353
GO:0014706,0.05533888,0.980631566,6,255,striated muscle tissue development,BP,0.923479353
GO:0006104,0.055343298,0.998756779,1,5,succinyl-CoA metabolic process,BP,0.923479353
GO:0048630,0.05535021,0.998756465,1,5,skeletal muscle tissue growth,BP,0.923479353
GO:0035672,0.055357827,0.998756119,1,5,oligopeptide transmembrane transport,BP,0.923479353
GO:0008655,0.055411066,0.998753697,1,5,pyrimidine-containing compound salvage,BP,0.923479353
GO:0010138,0.055411066,0.998753697,1,5,pyrimidine ribonucleotide salvage,BP,0.923479353
GO:0032262,0.055411066,0.998753697,1,5,pyrimidine nucleotide salvage,BP,0.923479353
GO:0043097,0.055411066,0.998753697,1,5,pyrimidine nucleoside salvage,BP,0.923479353
GO:0044206,0.055411066,0.998753697,1,5,UMP salvage,BP,0.923479353
GO:0090281,0.055414702,0.998753532,1,5,negative regulation of calcium ion import,BP,0.923479353
GO:0071499,0.055419639,0.998753307,1,5,cellular response to laminar fluid shear stress,BP,0.923479353
GO:0046602,0.055424569,0.998753083,1,5,regulation of mitotic centrosome separation,BP,0.923479353
GO:0006703,0.055424689,0.998753077,1,5,estrogen biosynthetic process,BP,0.923479353
GO:0044359,0.055424942,0.998753066,1,5,modulation of molecular function in other organism,BP,0.923479353
GO:0052205,0.055424942,0.998753066,1,5,modulation of molecular function in other organism involved in symbiotic interaction,BP,0.923479353
GO:0052428,0.055424942,0.998753066,1,5,modulation by host of symbiont molecular function,BP,0.923479353
GO:0061101,0.055425063,0.99875306,1,5,neuroendocrine cell differentiation,BP,0.923479353
GO:0060612,0.05600813,0.993496253,2,35,adipose tissue development,BP,0.932139825
GO:0045661,0.056144493,0.993471644,2,35,regulation of myoblast differentiation,BP,0.933354668
GO:0043489,0.05648686,0.993409705,2,35,RNA stabilization,BP,0.937987547
GO:0046390,0.056755112,0.982309938,5,187,ribose phosphate biosynthetic process,BP,0.941380683
GO:0045912,0.056822535,0.993348768,2,35,negative regulation of carbohydrate metabolic process,BP,0.941438827
GO:0061001,0.057355557,0.993236392,2,37,regulation of dendritic spine morphogenesis,BP,0.946545091
GO:0032873,0.057416906,0.99324036,2,35,negative regulation of stress-activated MAPK cascade,BP,0.946545091
GO:0070303,0.057416906,0.99324036,2,35,negative regulation of stress-activated protein kinase signaling cascade,BP,0.946545091
GO:0034404,0.057445998,0.984904302,4,130,nucleobase-containing small molecule biosynthetic process,BP,0.946545091
GO:0010817,0.057454154,0.9777902,7,316,regulation of hormone levels,BP,0.946545091
GO:0002040,0.057516319,0.988516205,3,82,sprouting angiogenesis,BP,0.946545091
GO:2000343,0.057630253,0.99859532,1,6,positive regulation of chemokine (C-X-C motif) ligand 2 production,BP,0.947081047
GO:0048842,0.057789118,0.998587473,1,6,positive regulation of axon extension involved in axon guidance,BP,0.947081047
GO:1902669,0.057789118,0.998587473,1,6,positive regulation of axon guidance,BP,0.947081047
GO:0022603,0.057858193,0.971349754,12,681,regulation of anatomical structure morphogenesis,BP,0.947081047
GO:0010968,0.05790895,0.99858154,1,6,regulation of microtubule nucleation,BP,0.947081047
GO:1900084,0.057934688,0.998580264,1,6,regulation of peptidyl-tyrosine autophosphorylation,BP,0.947081047
GO:0061419,0.058312974,0.99856144,1,6,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,0.952208201
GO:0051385,0.058458494,0.993040791,2,36,response to mineralocorticoid,BP,0.953255836
GO:0060563,0.05850657,0.99302429,2,37,neuroepithelial cell differentiation,BP,0.953255836
GO:0007259,0.058638667,0.988204019,3,81,JAK-STAT cascade,BP,0.954352412
GO:0009746,0.058869801,0.981459156,5,191,response to hexose,BP,0.956906505
GO:0043487,0.058925535,0.988123042,3,81,regulation of RNA stability,BP,0.956906505
GO:0065008,0.059205455,0.96155981,34,2421,regulation of biological quality,BP,0.960393327
GO:0009791,0.060307486,0.987709705,3,88,post-embryonic development,BP,0.97611939
GO:0003264,0.060407862,0.9984549,1,6,regulation of cardioblast proliferation,BP,0.97611939
GO:0002315,0.060432291,0.998453635,1,6,marginal zone B cell differentiation,BP,0.97611939
GO:0072525,0.060440008,0.987692765,3,81,pyridine-containing compound biosynthetic process,BP,0.97611939
GO:1903311,0.060838996,0.980660445,5,193,regulation of mRNA metabolic process,BP,0.980776196
GO:0060677,0.060879988,0.998430351,1,6,ureteric bud elongation,BP,0.980776196
GO:0030949,0.060928116,0.998427837,1,6,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,0.980776196
GO:1901977,0.061337445,0.998406375,1,6,negative regulation of cell cycle checkpoint,BP,0.985211805
GO:2000002,0.061337445,0.998406375,1,6,negative regulation of DNA damage checkpoint,BP,0.985211805
GO:0090307,0.061556112,0.992442939,2,38,mitotic spindle assembly,BP,0.986790158
GO:0061309,0.061569703,0.99839413,1,6,cardiac neural crest cell development involved in outflow tract morphogenesis,BP,0.986790158
GO:0071453,0.06167143,0.983404288,4,136,cellular response to oxygen levels,BP,0.987346185
GO:0070857,0.061887792,0.998377283,1,6,regulation of bile acid biosynthetic process,BP,0.988847321
GO:0009124,0.061899466,0.983328328,4,133,nucleoside monophosphate biosynthetic process,BP,0.988847321
GO:0050670,0.06219924,0.983215628,4,136,regulation of lymphocyte proliferation,BP,0.992349129
GO:0045597,0.062276023,0.968796737,12,683,positive regulation of cell differentiation,BP,0.992349129
GO:0097696,0.062320792,0.987145373,3,83,STAT cascade,BP,0.992349129
GO:0051094,0.062460414,0.966237441,15,909,positive regulation of developmental process,BP,0.993498315
GO:0061626,0.062545628,0.998342155,1,6,pharyngeal arch artery morphogenesis,BP,0.993780536
GO:0035914,0.062644247,0.992234017,2,38,skeletal muscle cell differentiation,BP,0.994274908
GO:0044772,0.062740393,0.977350326,6,259,mitotic cell cycle phase transition,BP,0.994729016
GO:1902373,0.062849135,0.992202453,2,37,negative regulation of mRNA catabolic process,BP,0.995381617
GO:0048024,0.063088936,0.986925697,3,82,"regulation of mRNA splicing, via spliceosome",BP,0.998106264
GO:0006702,0.063179295,0.998307954,1,6,androgen biosynthetic process,BP,0.998463336
GO:0072070,0.063341767,0.998299126,1,6,loop of Henle development,BP,0.999958075
GO:0010646,0.063501662,0.959600476,29,2019,regulation of cell communication,BP,1
GO:0038089,0.063545653,0.998288016,1,6,positive regulation of cell migration by vascular endothelial growth factor signaling pathway,BP,1
GO:0000768,0.063795694,0.992010641,2,38,syncytium formation by plasma membrane fusion,BP,1
GO:0140253,0.063795694,0.992010641,2,38,cell-cell fusion,BP,1
GO:0048514,0.063921874,0.972895418,8,402,blood vessel morphogenesis,BP,1
GO:0090037,0.064163572,0.998254117,1,6,positive regulation of protein kinase C signaling,BP,1
GO:0048662,0.064479681,0.99188516,2,37,negative regulation of smooth muscle cell proliferation,BP,1
GO:0007267,0.064483615,0.966578145,13,761,cell-cell signaling,BP,1
GO:0070231,0.064597922,0.991853623,2,38,T cell apoptotic process,BP,1
GO:0000395,0.06460159,0.99822988,1,6,mRNA 5'-splice site recognition,BP,1
GO:1903589,0.064741765,0.998222088,1,6,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,1
GO:0032944,0.06484317,0.982258456,4,138,regulation of mononuclear cell proliferation,BP,1
GO:0060753,0.064912688,0.998212562,1,6,regulation of mast cell chemotaxis,BP,1
GO:1905953,0.065111413,0.991752521,2,38,negative regulation of lipid localization,BP,1
GO:1905456,0.065117306,0.998150721,1,7,regulation of lymphoid progenitor cell differentiation,BP,1
GO:0021783,0.065180013,0.998147111,1,7,preganglionic parasympathetic fiber development,BP,1
GO:0048486,0.065180013,0.998147111,1,7,parasympathetic nervous system development,BP,1
GO:2000210,0.06521521,0.998195639,1,6,positive regulation of anoikis,BP,1
GO:0045664,0.065291199,0.970629714,9,476,regulation of neuron differentiation,BP,1
GO:1905522,0.065312223,0.998190195,1,6,negative regulation of macrophage migration,BP,1
GO:1903753,0.065319895,0.998189764,1,6,negative regulation of p38MAPK cascade,BP,1
GO:0000012,0.06533225,0.99818907,1,6,single strand break repair,BP,1
GO:0070235,0.06557284,0.998175527,1,6,regulation of activation-induced cell death of T cells,BP,1
GO:0072615,0.065573848,0.99817547,1,6,interleukin-17 secretion,BP,1
GO:0042756,0.065634922,0.998172024,1,6,drinking behavior,BP,1
GO:0051960,0.065709205,0.967846652,11,621,regulation of nervous system development,BP,1
GO:0035933,0.065735831,0.998166323,1,6,glucocorticoid secretion,BP,1
GO:2000288,0.065768535,0.998164473,1,6,positive regulation of myoblast proliferation,BP,1
GO:0010887,0.065800445,0.998162668,1,6,negative regulation of cholesterol storage,BP,1
GO:0010871,0.065860935,0.998159242,1,6,negative regulation of receptor biosynthetic process,BP,1
GO:0051348,0.065868716,0.97858601,5,197,negative regulation of transferase activity,BP,1
GO:0061430,0.065906262,0.998105036,1,7,bone trabecula morphogenesis,BP,1
GO:0006090,0.065913842,0.986088881,3,84,pyruvate metabolic process,BP,1
GO:0071409,0.065960836,0.998153578,1,6,cellular response to cycloheximide,BP,1
GO:0050768,0.065972098,0.97853478,5,204,negative regulation of neurogenesis,BP,1
GO:0048844,0.066007883,0.991525427,2,45,artery morphogenesis,BP,1
GO:0006857,0.066072183,0.998147254,1,6,oligopeptide transport,BP,1
GO:0019262,0.066128067,0.998144076,1,6,N-acetylneuraminate catabolic process,BP,1
GO:0001302,0.066131304,0.998143892,1,6,replicative cell aging,BP,1
GO:0016054,0.067007287,0.978113081,5,195,organic acid catabolic process,BP,1
GO:0046395,0.067007287,0.978113081,5,195,carboxylic acid catabolic process,BP,1
GO:0060982,0.067102188,0.997994583,1,8,coronary artery morphogenesis,BP,1
GO:0016447,0.067502138,0.99126727,2,39,somatic recombination of immunoglobulin gene segments,BP,1
GO:0002009,0.068834578,0.972276054,7,342,morphogenesis of an epithelium,BP,1
GO:0001701,0.068853042,0.972270623,7,336,in utero embryonic development,BP,1
GO:0046427,0.068962235,0.990970898,2,39,positive regulation of JAK-STAT cascade,BP,1
GO:0019216,0.069055734,0.974464417,6,264,regulation of lipid metabolic process,BP,1
GO:0071897,0.069105963,0.980686165,4,141,DNA biosynthetic process,BP,1
GO:0060537,0.069211907,0.974387105,6,270,muscle tissue development,BP,1
GO:0002712,0.069238759,0.990914353,2,39,regulation of B cell mediated immunity,BP,1
GO:0002889,0.069238759,0.990914353,2,39,regulation of immunoglobulin mediated immune response,BP,1
GO:0006986,0.06929843,0.98507022,3,85,response to unfolded protein,BP,1
GO:0031113,0.069514422,0.990833923,2,42,regulation of microtubule polymerization,BP,1
GO:0002327,0.06959293,0.997883964,1,7,immature B cell differentiation,BP,1
GO:0071901,0.069696997,0.984938901,3,88,negative regulation of protein serine/threonine kinase activity,BP,1
GO:1902965,0.069945841,0.997862144,1,7,regulation of protein localization to early endosome,BP,1
GO:1902966,0.069945841,0.997862144,1,7,positive regulation of protein localization to early endosome,BP,1
GO:0006949,0.070003595,0.990748799,2,40,syncytium formation,BP,1
GO:0048562,0.070065236,0.980319411,4,146,embryonic organ morphogenesis,BP,1
GO:0023051,0.070079764,0.95496165,29,2038,regulation of signaling,BP,1
GO:0060136,0.070243687,0.997843639,1,7,embryonic process involved in female pregnancy,BP,1
GO:0002244,0.070440353,0.984705699,3,90,hematopoietic progenitor cell differentiation,BP,1
GO:0070542,0.07045058,0.984705827,3,89,response to fatty acid,BP,1
GO:1901533,0.071068463,0.997791968,1,7,negative regulation of hematopoietic progenitor cell differentiation,BP,1
GO:0017144,0.071294702,0.96591738,10,529,drug metabolic process,BP,1
GO:0034284,0.071318358,0.976281799,5,202,response to monosaccharide,BP,1
GO:0030856,0.07145205,0.984398795,3,89,regulation of epithelial cell differentiation,BP,1
GO:0010793,0.071530285,0.99776276,1,7,regulation of mRNA export from nucleus,BP,1
GO:0072033,0.071552365,0.997761359,1,7,renal vesicle formation,BP,1
GO:0072077,0.071552365,0.997761359,1,7,renal vesicle morphogenesis,BP,1
GO:0072087,0.071552365,0.997761359,1,7,renal vesicle development,BP,1
GO:0070663,0.071807695,0.979671102,4,143,regulation of leukocyte proliferation,BP,1
GO:1905269,0.072121802,0.984189057,3,90,positive regulation of chromatin organization,BP,1
GO:0021903,0.072349231,0.997710481,1,7,rostrocaudal neural tube patterning,BP,1
GO:1902750,0.072851701,0.990145956,2,41,negative regulation of cell cycle G2/M phase transition,BP,1
GO:0010749,0.073075044,0.997663628,1,7,regulation of nitric oxide mediated signal transduction,BP,1
GO:0015701,0.073142219,0.997659267,1,7,bicarbonate transport,BP,1
GO:0070244,0.073157678,0.997658262,1,7,negative regulation of thymocyte apoptotic process,BP,1
GO:0007614,0.073268737,0.997651042,1,7,short-term memory,BP,1
GO:0051145,0.073347058,0.990032878,2,42,smooth muscle cell differentiation,BP,1
GO:0003091,0.073672244,0.99762471,1,7,renal water homeostasis,BP,1
GO:0031290,0.073755776,0.997570752,1,8,retinal ganglion cell axon guidance,BP,1
GO:0007631,0.073997045,0.989902865,2,41,feeding behavior,BP,1
GO:0032075,0.074019907,0.997601901,1,7,positive regulation of nuclease activity,BP,1
GO:0090084,0.074049387,0.997599962,1,7,negative regulation of inclusion body assembly,BP,1
GO:2000489,0.074098248,0.997596746,1,7,regulation of hepatic stellate cell activation,BP,1
GO:0071347,0.074169136,0.983556374,3,89,cellular response to interleukin-1,BP,1
GO:0071679,0.074198344,0.997590151,1,7,commissural neuron axon guidance,BP,1
GO:0014841,0.074212341,0.997589228,1,7,skeletal muscle satellite cell proliferation,BP,1
GO:0014842,0.074212341,0.997589228,1,7,regulation of skeletal muscle satellite cell proliferation,BP,1
GO:0007379,0.074803826,0.99755006,1,7,segment specification,BP,1
GO:0051247,0.074810287,0.956341856,18,1151,positive regulation of protein metabolic process,BP,1
GO:1904894,0.074997935,0.989688614,2,41,positive regulation of STAT cascade,BP,1
GO:0051196,0.075095935,0.989667545,2,41,regulation of coenzyme metabolic process,BP,1
GO:0009132,0.0751751,0.983244651,3,88,nucleoside diphosphate metabolic process,BP,1
GO:0001954,0.075183403,0.989640202,2,42,positive regulation of cell-matrix adhesion,BP,1
GO:0032055,0.075187073,0.997524507,1,7,negative regulation of translation in response to stress,BP,1
GO:0060113,0.075229348,0.989622174,2,43,inner ear receptor cell differentiation,BP,1
GO:0042891,0.07588181,0.997477838,1,7,antibiotic transport,BP,1
GO:1903573,0.075888534,0.989496552,2,41,negative regulation of response to endoplasmic reticulum stress,BP,1
GO:0007507,0.075889813,0.966640401,8,421,heart development,BP,1
GO:0035967,0.07598721,0.982988771,3,88,cellular response to topologically incorrect protein,BP,1
GO:0045669,0.076008304,0.989470621,2,41,positive regulation of osteoblast differentiation,BP,1
GO:0060426,0.07606714,0.997465313,1,7,lung vasculature development,BP,1
GO:1901725,0.076150515,0.997459667,1,7,regulation of histone deacetylase activity,BP,1
GO:0032308,0.076167073,0.997458545,1,7,positive regulation of prostaglandin secretion,BP,1
GO:0070371,0.076179863,0.974177253,5,208,ERK1 and ERK2 cascade,BP,1
GO:0008272,0.076321626,0.997448061,1,7,sulfate transport,BP,1
GO:1902358,0.076321626,0.997448061,1,7,sulfate transmembrane transport,BP,1
GO:0031666,0.076393395,0.997443185,1,7,positive regulation of lipopolysaccharide-mediated signaling pathway,BP,1
GO:0006303,0.0764988,0.989355427,2,42,double-strand break repair via nonhomologous end joining,BP,1
GO:0035947,0.076566127,0.99743143,1,7,regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter,BP,1
GO:0009150,0.076596046,0.96839837,7,331,purine ribonucleotide metabolic process,BP,1
GO:0009954,0.076647138,0.99737353,1,8,proximal/distal pattern formation,BP,1
GO:0006048,0.076687831,0.99742313,1,7,UDP-N-acetylglucosamine biosynthetic process,BP,1
GO:0006222,0.076718002,0.997421071,1,7,UMP biosynthetic process,BP,1
GO:0009173,0.076718002,0.997421071,1,7,pyrimidine ribonucleoside monophosphate metabolic process,BP,1
GO:0009174,0.076718002,0.997421071,1,7,pyrimidine ribonucleoside monophosphate biosynthetic process,BP,1
GO:0046049,0.076718002,0.997421071,1,7,UMP metabolic process,BP,1
GO:0002016,0.076730507,0.997420217,1,7,regulation of blood volume by renin-angiotensin,BP,1
GO:0006559,0.076731179,0.997420171,1,7,L-phenylalanine catabolic process,BP,1
GO:1902222,0.076731179,0.997420171,1,7,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,BP,1
GO:0043102,0.076731441,0.997420153,1,7,amino acid salvage,BP,1
GO:0071265,0.076731441,0.997420153,1,7,L-methionine biosynthetic process,BP,1
GO:0071267,0.076731441,0.997420153,1,7,L-methionine salvage,BP,1
GO:0030099,0.077348382,0.970562071,6,272,myeloid cell differentiation,BP,1
GO:0002066,0.077532558,0.989121084,2,43,columnar/cuboidal epithelial cell development,BP,1
GO:0098661,0.077765001,0.98907002,2,43,inorganic anion transmembrane transport,BP,1
GO:0090399,0.078049753,0.997274998,1,8,replicative senescence,BP,1
GO:0007568,0.078202441,0.967574373,7,341,aging,BP,1
GO:0061013,0.078272485,0.982247514,3,92,regulation of mRNA catabolic process,BP,1
GO:0035924,0.078298598,0.988944223,2,44,cellular response to vascular endothelial growth factor stimulus,BP,1
GO:0048646,0.078311757,0.959258329,12,714,anatomical structure formation involved in morphogenesis,BP,1
GO:0033692,0.078366096,0.988929307,2,44,cellular polysaccharide biosynthetic process,BP,1
GO:0051963,0.078619205,0.988873307,2,44,regulation of synapse assembly,BP,1
GO:0051128,0.078704645,0.95018979,25,1741,regulation of cellular component organization,BP,1
GO:0002328,0.07892347,0.99716951,1,9,pro-B cell differentiation,BP,1
GO:0002381,0.079105833,0.988782465,2,42,immunoglobulin production involved in immunoglobulin mediated immune response,BP,1
GO:0034198,0.079355375,0.988718224,2,43,cellular response to amino acid starvation,BP,1
GO:0032793,0.079376258,0.997136428,1,9,positive regulation of CREB transcription factor activity,BP,1
GO:0016445,0.079432169,0.98870113,2,43,somatic diversification of immunoglobulins,BP,1
GO:0048699,0.07958733,0.955442489,15,952,generation of neurons,BP,1
GO:0033262,0.080091494,0.997128219,1,8,regulation of nuclear cell cycle DNA replication,BP,1
GO:0032526,0.080288519,0.98159119,3,94,response to retinoic acid,BP,1
GO:0000226,0.080563845,0.966360045,7,349,microtubule cytoskeleton organization,BP,1
GO:0060997,0.080675173,0.988406263,2,45,dendritic spine morphogenesis,BP,1
GO:0072014,0.080748974,0.997080108,1,8,proximal tubule development,BP,1
GO:0043406,0.080927841,0.976138717,4,152,positive regulation of MAP kinase activity,BP,1
GO:0008286,0.080943804,0.981382124,3,93,insulin receptor signaling pathway,BP,1
GO:0061009,0.081001633,0.997061509,1,8,common bile duct development,BP,1
GO:0014074,0.081147429,0.976056237,4,150,response to purine-containing compound,BP,1
GO:1903265,0.081680815,0.997011212,1,8,positive regulation of tumor necrosis factor-mediated signaling pathway,BP,1
GO:1990253,0.081894512,0.996995296,1,8,cellular response to leucine starvation,BP,1
GO:0043249,0.082005397,0.99698702,1,8,erythrocyte maturation,BP,1
GO:0060509,0.082059331,0.99698299,1,8,type I pneumocyte differentiation,BP,1
GO:2000197,0.082062631,0.996982743,1,8,regulation of ribonucleoprotein complex localization,BP,1
GO:0060019,0.082172552,0.996974521,1,8,radial glial cell differentiation,BP,1
GO:1904251,0.082243148,0.996969235,1,8,regulation of bile acid metabolic process,BP,1
GO:0048008,0.082817884,0.987912154,2,46,platelet-derived growth factor receptor signaling pathway,BP,1
GO:0060215,0.082893921,0.996920278,1,8,primitive hemopoiesis,BP,1
GO:0014013,0.082932028,0.980721574,3,96,regulation of gliogenesis,BP,1
GO:0015718,0.082950152,0.980726459,3,93,monocarboxylic acid transport,BP,1
GO:0001656,0.08305794,0.987857208,2,46,metanephros development,BP,1
GO:0036490,0.08322799,0.996894989,1,8,regulation of translation in response to endoplasmic reticulum stress,BP,1
GO:0007167,0.083561456,0.958852657,10,566,enzyme linked receptor protein signaling pathway,BP,1
GO:0051961,0.083948336,0.970724173,5,219,negative regulation of nervous system development,BP,1
GO:0060700,0.08411417,0.996827387,1,8,regulation of ribonuclease activity,BP,1
GO:0035239,0.084154289,0.958503123,10,574,tube morphogenesis,BP,1
GO:1902806,0.084239236,0.980294008,3,95,regulation of cell cycle G1/S phase transition,BP,1
GO:0060707,0.084270732,0.996815365,1,8,trophoblast giant cell differentiation,BP,1
GO:1902369,0.084281764,0.987592786,2,44,negative regulation of RNA catabolic process,BP,1
GO:0061299,0.084386522,0.996757095,1,9,retina vasculature morphogenesis in camera-type eye,BP,1
GO:0002700,0.084420699,0.980237626,3,94,regulation of production of molecular mediator of immune response,BP,1
GO:0043470,0.084637013,0.987510698,2,44,regulation of carbohydrate catabolic process,BP,1
GO:0014857,0.084714498,0.996781163,1,8,regulation of skeletal muscle cell proliferation,BP,1
GO:0034351,0.084890723,0.996767528,1,8,negative regulation of glial cell apoptotic process,BP,1
GO:0007566,0.085007007,0.987416095,2,45,embryo implantation,BP,1
GO:0031077,0.08505495,0.996754795,1,8,post-embryonic camera-type eye development,BP,1
GO:0002551,0.085203184,0.99674328,1,8,mast cell chemotaxis,BP,1
GO:0002366,0.085494876,0.974324395,4,151,leukocyte activation involved in immune response,BP,1
GO:0060712,0.085597788,0.996661727,1,9,spongiotrophoblast layer development,BP,1
GO:0043117,0.085662496,0.996707465,1,8,positive regulation of vascular permeability,BP,1
GO:0006570,0.085721951,0.996702814,1,8,tyrosine metabolic process,BP,1
GO:0003007,0.085900029,0.974145158,4,159,heart morphogenesis,BP,1
GO:0048537,0.085966927,0.996683615,1,8,mucosal-associated lymphoid tissue development,BP,1
GO:0048541,0.085966927,0.996683615,1,8,Peyer's patch development,BP,1
GO:0106106,0.085979921,0.979707995,3,97,cold-induced thermogenesis,BP,1
GO:0120161,0.085979921,0.979707995,3,97,regulation of cold-induced thermogenesis,BP,1
GO:1902166,0.086221425,0.996663609,1,8,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,1
GO:0031401,0.086229009,0.953208383,13,788,positive regulation of protein modification process,BP,1
GO:0009199,0.086258906,0.969693646,5,210,ribonucleoside triphosphate metabolic process,BP,1
GO:0048715,0.086567207,0.996584371,1,9,negative regulation of oligodendrocyte differentiation,BP,1
GO:0070986,0.086589545,0.996582577,1,9,left/right axis specification,BP,1
GO:0090045,0.086634952,0.996630969,1,8,positive regulation of deacetylase activity,BP,1
GO:0006397,0.086756785,0.963151425,7,343,mRNA processing,BP,1
GO:0150079,0.086784544,0.996619121,1,8,negative regulation of neuroinflammatory response,BP,1
GO:2000291,0.086843641,0.996614434,1,8,regulation of myoblast proliferation,BP,1
GO:0046902,0.086855326,0.986984291,2,45,regulation of mitochondrial membrane permeability,BP,1
GO:0043031,0.08687931,0.996611604,1,8,negative regulation of macrophage activation,BP,1
GO:1903862,0.086953113,0.996605744,1,8,positive regulation of oxidative phosphorylation,BP,1
GO:0071493,0.087004964,0.996601624,1,8,cellular response to UV-B,BP,1
GO:2001014,0.087031116,0.996599545,1,8,regulation of skeletal muscle cell differentiation,BP,1
GO:0048845,0.087103915,0.996541149,1,9,venous blood vessel morphogenesis,BP,1
GO:0002637,0.087171508,0.986909871,2,45,regulation of immunoglobulin production,BP,1
GO:0046348,0.087179371,0.996587746,1,8,amino sugar catabolic process,BP,1
GO:0044829,0.087205731,0.996585646,1,8,positive regulation by host of viral genome replication,BP,1
GO:0061077,0.087305886,0.986887443,2,44,chaperone-mediated protein folding,BP,1
GO:0019752,0.087523214,0.953615684,12,698,carboxylic acid metabolic process,BP,1
GO:0048477,0.08766282,0.98679391,2,45,oogenesis,BP,1
GO:1902531,0.087680028,0.948483699,17,1103,regulation of intracellular signal transduction,BP,1
GO:0031667,0.087783,0.958149196,9,490,response to nutrient levels,BP,1
GO:0048872,0.0878979,0.968940013,5,216,homeostasis of number of cells,BP,1
GO:0042490,0.088118525,0.986668459,2,47,mechanoreceptor differentiation,BP,1
GO:0000070,0.088130489,0.978978323,3,99,mitotic sister chromatid segregation,BP,1
GO:0050769,0.088232148,0.962363676,7,361,positive regulation of neurogenesis,BP,1
GO:0050775,0.088500599,0.986577618,2,47,positive regulation of dendrite morphogenesis,BP,1
GO:0071233,0.088640873,0.996415819,1,9,cellular response to leucine,BP,1
GO:0043619,0.088699112,0.996411025,1,9,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,1
GO:0090231,0.089236805,0.996366603,1,9,regulation of spindle checkpoint,BP,1
GO:0090266,0.089236805,0.996366603,1,9,regulation of mitotic cell cycle spindle assembly checkpoint,BP,1
GO:1903504,0.089236805,0.996366603,1,9,regulation of mitotic spindle checkpoint,BP,1
GO:2000341,0.089333736,0.996358565,1,9,regulation of chemokine (C-X-C motif) ligand 2 production,BP,1
GO:0046058,0.089423222,0.996351136,1,9,cAMP metabolic process,BP,1
GO:0006163,0.08968433,0.961610836,7,344,purine nucleotide metabolic process,BP,1
GO:0006955,0.089709143,0.95100965,13,782,immune response,BP,1
GO:0006754,0.089911294,0.978389188,3,95,ATP biosynthetic process,BP,1
GO:0060999,0.090338992,0.986120543,2,49,positive regulation of dendritic spine development,BP,1
GO:2000278,0.090410187,0.978215056,3,96,regulation of DNA biosynthetic process,BP,1
GO:0042492,0.090559022,0.996256163,1,9,gamma-delta T cell differentiation,BP,1
GO:0045586,0.090559022,0.996256163,1,9,regulation of gamma-delta T cell differentiation,BP,1
GO:0046643,0.090559022,0.996256163,1,9,regulation of gamma-delta T cell activation,BP,1
GO:0009161,0.090640942,0.967687352,5,213,ribonucleoside monophosphate metabolic process,BP,1
GO:0002263,0.090858919,0.972136369,4,155,cell activation involved in immune response,BP,1
GO:1904321,0.091072137,0.996212843,1,9,response to forskolin,BP,1
GO:1904322,0.091072137,0.996212843,1,9,cellular response to forskolin,BP,1
GO:0051409,0.091487018,0.996177628,1,9,response to nitrosative stress,BP,1
GO:0009166,0.091703936,0.977771725,3,96,nucleotide catabolic process,BP,1
GO:0032268,0.091829338,0.940849496,25,1752,regulation of cellular protein metabolic process,BP,1
GO:0043497,0.092258249,0.996111716,1,9,regulation of protein heterodimerization activity,BP,1
GO:2000479,0.092272787,0.996063262,1,10,regulation of cAMP-dependent protein kinase activity,BP,1
GO:0003151,0.092304547,0.985635088,2,50,outflow tract morphogenesis,BP,1
GO:0045665,0.092311526,0.97152284,4,162,negative regulation of neuron differentiation,BP,1
GO:0030218,0.092540146,0.977471934,3,99,erythrocyte differentiation,BP,1
GO:0032787,0.092623927,0.957518699,8,417,monocarboxylic acid metabolic process,BP,1
GO:0051592,0.092929419,0.977337379,3,99,response to calcium ion,BP,1
GO:0061308,0.093145016,0.996035207,1,9,cardiac neural crest cell development involved in heart development,BP,1
GO:0046903,0.093158471,0.950097289,12,720,secretion,BP,1
GO:0045844,0.093171326,0.985439289,2,48,positive regulation of striated muscle tissue development,BP,1
GO:0048636,0.093171326,0.985439289,2,48,positive regulation of muscle organ development,BP,1
GO:1901863,0.093171326,0.985439289,2,48,positive regulation of muscle tissue development,BP,1
GO:0007338,0.093200139,0.985441144,2,47,single fertilization,BP,1
GO:0048146,0.093270763,0.985414853,2,48,positive regulation of fibroblast proliferation,BP,1
GO:0060576,0.093305125,0.996021311,1,9,intestinal epithelial cell development,BP,1
GO:0009605,0.093585177,0.94109932,22,1515,response to external stimulus,BP,1
GO:0032305,0.094207544,0.995942516,1,9,positive regulation of icosanoid secretion,BP,1
GO:0045779,0.0942275,0.995940764,1,9,negative regulation of bone resorption,BP,1
GO:1905168,0.094258362,0.995938055,1,9,positive regulation of double-strand break repair via homologous recombination,BP,1
GO:0070417,0.09446479,0.995919907,1,9,cellular response to cold,BP,1
GO:0031115,0.094733268,0.995896242,1,9,negative regulation of microtubule polymerization,BP,1
GO:0008643,0.094736294,0.976709504,3,99,carbohydrate transport,BP,1
GO:0001977,0.095081821,0.995865413,1,9,renal system process involved in regulation of blood volume,BP,1
GO:0014856,0.095098461,0.995863938,1,9,skeletal muscle cell proliferation,BP,1
GO:0032693,0.095360567,0.995840671,1,9,negative regulation of interleukin-10 production,BP,1
GO:0097531,0.095560917,0.995822841,1,9,mast cell migration,BP,1
GO:1903587,0.095807974,0.9958008,1,9,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,1
GO:0061213,0.095848502,0.995797178,1,9,positive regulation of mesonephros development,BP,1
GO:0090190,0.095848502,0.995797178,1,9,positive regulation of branching involved in ureteric bud morphogenesis,BP,1
GO:0010823,0.096100904,0.984722157,2,47,negative regulation of mitochondrion organization,BP,1
GO:0007517,0.096106057,0.965125879,5,227,muscle organ development,BP,1
GO:0045820,0.096108566,0.995773901,1,9,negative regulation of glycolytic process,BP,1
GO:0032966,0.096340513,0.995753084,1,9,negative regulation of collagen biosynthetic process,BP,1
GO:1990928,0.096489507,0.984615422,2,48,response to amino acid starvation,BP,1
GO:0043129,0.096511629,0.995737692,1,9,surfactant homeostasis,BP,1
GO:0000271,0.096516745,0.984590906,2,50,polysaccharide biosynthetic process,BP,1
GO:0000726,0.096898663,0.984512632,2,48,non-recombinational repair,BP,1
GO:0051893,0.096998442,0.984469712,2,50,regulation of focal adhesion assembly,BP,1
GO:0090109,0.096998442,0.984469712,2,50,regulation of cell-substrate junction assembly,BP,1
GO:0045187,0.097058072,0.995688347,1,9,"regulation of circadian sleep/wake cycle, sleep",BP,1
GO:0051447,0.097100852,0.995684471,1,9,negative regulation of meiotic cell cycle,BP,1
GO:0061469,0.097174251,0.995677818,1,9,regulation of type B pancreatic cell proliferation,BP,1
GO:0048368,0.09732888,0.995663783,1,9,lateral mesoderm development,BP,1
GO:0006977,0.097389404,0.995658283,1,9,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",BP,1
GO:0046349,0.097449631,0.995652807,1,9,amino sugar biosynthetic process,BP,1
GO:0048240,0.097534115,0.995645118,1,9,sperm capacitation,BP,1
GO:0120009,0.097546146,0.995644023,1,9,intermembrane lipid transfer,BP,1
GO:0007100,0.097554503,0.995643262,1,9,mitotic centrosome separation,BP,1
GO:0051299,0.097554503,0.995643262,1,9,centrosome separation,BP,1
GO:0006558,0.097561297,0.995642643,1,9,L-phenylalanine metabolic process,BP,1
GO:1902221,0.097561297,0.995642643,1,9,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,BP,1
GO:0007088,0.097653005,0.975665177,3,104,regulation of mitotic nuclear division,BP,1
GO:0006402,0.098141898,0.96908856,4,160,mRNA catabolic process,BP,1
GO:0060284,0.098342586,0.948336757,11,669,regulation of cell development,BP,1
GO:0032355,0.098355602,0.968993672,4,162,response to estradiol,BP,1
GO:1990845,0.098518788,0.975361781,3,103,adaptive thermogenesis,BP,1
GO:2001169,0.098781458,0.984036249,2,48,regulation of ATP biosynthetic process,BP,1
GO:0001503,0.099008215,0.963755318,5,228,ossification,BP,1
GO:0050810,0.099610644,0.983815236,2,49,regulation of steroid biosynthetic process,BP,1
GO:0072567,0.099665475,0.995393727,1,10,chemokine (C-X-C motif) ligand 2 production,BP,1
GO:0051546,0.099856114,0.995375738,1,10,keratinocyte migration,BP,1
GO:2000027,0.099917976,0.974859023,3,104,regulation of animal organ morphogenesis,BP,1
GO:1902946,0.10043539,0.995320855,1,10,protein localization to early endosome,BP,1
GO:0072431,0.100469371,0.995317625,1,10,signal transduction involved in mitotic G1 DNA damage checkpoint,BP,1
GO:1902400,0.100469371,0.995317625,1,10,intracellular signal transduction involved in G1 DNA damage checkpoint,BP,1
GO:0032496,0.100784341,0.958913808,6,289,response to lipopolysaccharide,BP,1
GO:0060977,0.100895763,0.995192376,1,12,coronary vasculature morphogenesis,BP,1
GO:0009743,0.101132891,0.962747593,5,226,response to carbohydrate,BP,1
GO:1905668,0.101241494,0.99524392,1,10,positive regulation of protein localization to endosome,BP,1
GO:0010001,0.101272205,0.967749781,4,163,glial cell differentiation,BP,1
GO:0061307,0.101315431,0.99523683,1,10,cardiac neural crest cell differentiation involved in heart development,BP,1
GO:0061478,0.101384623,0.995230191,1,10,response to platelet aggregation inhibitor,BP,1
GO:0001976,0.101602835,0.995209221,1,10,neurological system process involved in regulation of systemic arterial blood pressure,BP,1
GO:0002903,0.101682342,0.995201569,1,10,negative regulation of B cell apoptotic process,BP,1
GO:0035733,0.102190969,0.995152464,1,10,hepatic stellate cell activation,BP,1
GO:0000185,0.102234555,0.995148244,1,10,activation of MAPKKK activity,BP,1
GO:0008593,0.102744438,0.982986968,2,51,regulation of Notch signaling pathway,BP,1
GO:0042754,0.102869359,0.995086564,1,10,negative regulation of circadian rhythm,BP,1
GO:0001946,0.103142424,0.995059907,1,10,lymphangiogenesis,BP,1
GO:0007169,0.103205143,0.954310548,7,369,transmembrane receptor protein tyrosine kinase signaling pathway,BP,1
GO:0060670,0.103985097,0.994977171,1,10,branching involved in labyrinthine layer morphogenesis,BP,1
GO:0038166,0.104293596,0.994946703,1,10,angiotensin-activated signaling pathway,BP,1
GO:0070243,0.104346129,0.994941505,1,10,regulation of thymocyte apoptotic process,BP,1
GO:1902807,0.104355797,0.982573653,2,50,negative regulation of cell cycle G1/S phase transition,BP,1
GO:0070423,0.104405937,0.994935584,1,10,nucleotide-binding oligomerization domain containing signaling pathway,BP,1
GO:0070431,0.104405937,0.994935584,1,10,nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,1
GO:0046851,0.104504392,0.994925829,1,10,negative regulation of bone remodeling,BP,1
GO:0043436,0.104586694,0.942849056,12,721,oxoacid metabolic process,BP,1
GO:1902969,0.104614706,0.994914888,1,10,mitotic DNA replication,BP,1
GO:0071481,0.104648829,0.994861823,1,11,cellular response to X-ray,BP,1
GO:0010389,0.104894039,0.982422242,2,51,regulation of G2/M transition of mitotic cell cycle,BP,1
GO:0009991,0.104954201,0.94810834,9,509,response to extracellular stimulus,BP,1
GO:0030502,0.105084438,0.994868159,1,10,negative regulation of bone mineralization,BP,1
GO:0097011,0.105202136,0.994856416,1,10,cellular response to granulocyte macrophage colony-stimulating factor stimulus,BP,1
GO:0097012,0.105202136,0.994856416,1,10,response to granulocyte macrophage colony-stimulating factor,BP,1
GO:0032306,0.10537972,0.994838671,1,10,regulation of prostaglandin secretion,BP,1
GO:0002052,0.105523249,0.994773792,1,11,positive regulation of neuroblast proliferation,BP,1
GO:0032507,0.105548474,0.982239772,2,52,maintenance of protein location in cell,BP,1
GO:0000165,0.105782202,0.94761178,9,514,MAPK cascade,BP,1
GO:0043407,0.105839198,0.982171687,2,51,negative regulation of MAP kinase activity,BP,1
GO:0061217,0.106107155,0.994765649,1,10,regulation of mesonephros development,BP,1
GO:0090189,0.106107155,0.994765649,1,10,regulation of branching involved in ureteric bud morphogenesis,BP,1
GO:1905214,0.106174132,0.994758899,1,10,regulation of RNA binding,BP,1
GO:0071222,0.106185368,0.965629981,4,162,cellular response to lipopolysaccharide,BP,1
GO:0031848,0.106350868,0.994741065,1,10,protection from non-homologous end joining at telomere,BP,1
GO:0010713,0.106593909,0.994716489,1,10,negative regulation of collagen metabolic process,BP,1
GO:0010975,0.106618941,0.952420506,7,381,regulation of neuron projection development,BP,1
GO:0060850,0.10670356,0.994705382,1,10,regulation of transcription involved in cell fate commitment,BP,1
GO:0019985,0.106841985,0.994639555,1,11,translesion synthesis,BP,1
GO:0002070,0.106957488,0.994679613,1,10,epithelial cell maturation,BP,1
GO:0006488,0.106964832,0.994678867,1,10,dolichol-linked oligosaccharide biosynthetic process,BP,1
GO:0051601,0.107039584,0.994671268,1,10,exocyst localization,BP,1
GO:0150065,0.10723912,0.994650956,1,10,regulation of deacetylase activity,BP,1
GO:0072234,0.107296988,0.994645058,1,10,metanephric nephron tubule development,BP,1
GO:0045725,0.107338955,0.994588507,1,11,positive regulation of glycogen biosynthetic process,BP,1
GO:0051251,0.107451959,0.965071958,4,164,positive regulation of lymphocyte activation,BP,1
GO:0046898,0.10751087,0.994623229,1,10,response to cycloheximide,BP,1
GO:1901575,0.107580623,0.931750671,21,1443,organic substance catabolic process,BP,1
GO:0060914,0.107665931,0.994510985,1,12,heart formation,BP,1
GO:0006047,0.10767478,0.994606469,1,10,UDP-N-acetylglucosamine metabolic process,BP,1
GO:1900102,0.107706971,0.994603174,1,10,negative regulation of endoplasmic reticulum unfolded protein response,BP,1
GO:1901292,0.10776025,0.972008014,3,103,nucleoside phosphate catabolic process,BP,1
GO:0043174,0.10778821,0.994594854,1,10,nucleoside salvage,BP,1
GO:0010721,0.107876678,0.959478638,5,236,negative regulation of cell development,BP,1
GO:0048583,0.108010636,0.92619487,32,2379,regulation of response to stimulus,BP,1
GO:0048680,0.108012309,0.994518939,1,11,positive regulation of axon regeneration,BP,1
GO:0002260,0.108066121,0.981575935,2,51,lymphocyte homeostasis,BP,1
GO:1903036,0.108246434,0.981508769,2,53,positive regulation of response to wounding,BP,1
GO:0051782,0.108545012,0.994463573,1,11,negative regulation of cell division,BP,1
GO:0060395,0.108619025,0.981426848,2,51,SMAD protein signal transduction,BP,1
GO:0032872,0.108658242,0.964535604,4,167,regulation of stress-activated MAPK cascade,BP,1
GO:0002250,0.10922775,0.958830791,5,228,adaptive immune response,BP,1
GO:0009190,0.109336803,0.994380743,1,11,cyclic nucleotide biosynthetic process,BP,1
GO:0052652,0.109336803,0.994380743,1,11,cyclic purine nucleotide metabolic process,BP,1
GO:0048532,0.109466057,0.994367161,1,11,anatomical structure arrangement,BP,1
GO:0070206,0.109688713,0.98113709,2,51,protein trimerization,BP,1
GO:0051301,0.110021064,0.954080271,6,304,cell division,BP,1
GO:2001028,0.110026028,0.99430812,1,11,positive regulation of endothelial cell chemotaxis,BP,1
GO:0042737,0.11005325,0.971154812,3,103,drug catabolic process,BP,1
GO:0046883,0.110435399,0.963749345,4,168,regulation of hormone secretion,BP,1
GO:0061081,0.110454946,0.99426268,1,11,positive regulation of myeloid leukocyte cytokine production involved in immune response,BP,1
GO:0009206,0.110619244,0.970938561,3,104,purine ribonucleoside triphosphate biosynthetic process,BP,1
GO:0001542,0.110690591,0.994237635,1,11,ovulation from ovarian follicle,BP,1
GO:1905666,0.110836502,0.994222098,1,11,regulation of protein localization to endosome,BP,1
GO:0034101,0.11098101,0.970790163,3,107,erythrocyte homeostasis,BP,1
GO:0046629,0.111079265,0.994196201,1,11,gamma-delta T cell activation,BP,1
GO:0000079,0.111333352,0.980678316,2,52,regulation of cyclin-dependent protein serine/threonine kinase activity,BP,1
GO:0072537,0.111579999,0.994142593,1,11,fibroblast activation,BP,1
GO:0090036,0.111669822,0.994132949,1,11,regulation of protein kinase C signaling,BP,1
GO:2001021,0.111819893,0.980544669,2,52,negative regulation of response to DNA damage stimulus,BP,1
GO:1903978,0.111875411,0.994110845,1,11,regulation of microglial cell activation,BP,1
GO:0030903,0.111993436,0.994098136,1,11,notochord development,BP,1
GO:0070302,0.11228627,0.96292537,4,169,regulation of stress-activated protein kinase signaling cascade,BP,1
GO:0051962,0.112503597,0.949137982,7,384,positive regulation of nervous system development,BP,1
GO:0055086,0.112556598,0.943541235,9,507,nucleobase-containing small molecule metabolic process,BP,1
GO:0050482,0.112814784,0.994009296,1,11,arachidonic acid secretion,BP,1
GO:1903963,0.112814784,0.994009296,1,11,arachidonate transport,BP,1
GO:0009145,0.113025629,0.970027648,3,105,purine nucleoside triphosphate biosynthetic process,BP,1
GO:0045787,0.113168636,0.956875461,5,237,positive regulation of cell cycle,BP,1
GO:0061158,0.113361551,0.993949771,1,11,3'-UTR-mediated mRNA destabilization,BP,1
GO:0002237,0.113647649,0.952160861,6,299,response to molecule of bacterial origin,BP,1
GO:0034143,0.11375781,0.993906439,1,11,regulation of toll-like receptor 4 signaling pathway,BP,1
GO:1903391,0.113831883,0.979959809,2,55,regulation of adherens junction organization,BP,1
GO:0097193,0.113851952,0.956542866,5,233,intrinsic apoptotic signaling pathway,BP,1
GO:0009141,0.114005887,0.956473006,5,229,nucleoside triphosphate metabolic process,BP,1
GO:0072538,0.114183164,0.993859746,1,11,T-helper 17 type immune response,BP,1
GO:0072539,0.114183164,0.993859746,1,11,T-helper 17 cell differentiation,BP,1
GO:0060192,0.11438778,0.993837218,1,11,negative regulation of lipase activity,BP,1
GO:0035872,0.114568258,0.993817311,1,11,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway",BP,1
GO:0021692,0.114624759,0.993761415,1,12,cerebellar Purkinje cell layer morphogenesis,BP,1
GO:2000193,0.114646113,0.993808714,1,11,positive regulation of fatty acid transport,BP,1
GO:0060326,0.114655406,0.961863661,4,170,cell chemotaxis,BP,1
GO:0035051,0.114864887,0.969299339,3,112,cardiocyte differentiation,BP,1
GO:0033151,0.114990999,0.993720576,1,12,V(D)J recombination,BP,1
GO:0051127,0.114995381,0.993770067,1,11,positive regulation of actin nucleation,BP,1
GO:0007219,0.115138644,0.969206887,3,109,Notch signaling pathway,BP,1
GO:0035148,0.115230531,0.96915573,3,113,tube formation,BP,1
GO:0050930,0.115266632,0.993739965,1,11,induction of positive chemotaxis,BP,1
GO:0035966,0.115277562,0.969166636,3,106,response to topologically incorrect protein,BP,1
GO:0050796,0.115283982,0.969151339,3,109,regulation of insulin secretion,BP,1
GO:0006082,0.115335717,0.935881812,12,734,organic acid metabolic process,BP,1
GO:0071219,0.115429701,0.961523004,4,167,cellular response to molecule of bacterial origin,BP,1
GO:0006869,0.11551318,0.955711272,5,236,lipid transport,BP,1
GO:0032310,0.115530422,0.993710619,1,11,prostaglandin secretion,BP,1
GO:0009123,0.11564852,0.955653595,5,230,nucleoside monophosphate metabolic process,BP,1
GO:0031573,0.115775818,0.993683255,1,11,intra-S DNA damage checkpoint,BP,1
GO:0034637,0.115940522,0.979369286,2,55,cellular carbohydrate biosynthetic process,BP,1
GO:0009086,0.116093371,0.993647752,1,11,methionine biosynthetic process,BP,1
GO:0043524,0.116118368,0.968831807,3,109,negative regulation of neuron apoptotic process,BP,1
GO:0042493,0.116181782,0.932373165,14,900,response to drug,BP,1
GO:0023014,0.116430699,0.941173967,9,526,signal transduction by protein phosphorylation,BP,1
GO:0009750,0.116464319,0.993606148,1,11,response to fructose,BP,1
GO:0030812,0.116504564,0.993601626,1,11,negative regulation of nucleotide catabolic process,BP,1
GO:0051198,0.116504564,0.993601626,1,11,negative regulation of coenzyme metabolic process,BP,1
GO:0030808,0.116529485,0.97922238,2,53,regulation of nucleotide biosynthetic process,BP,1
GO:1900371,0.116529485,0.97922238,2,53,regulation of purine nucleotide biosynthetic process,BP,1
GO:0003018,0.116565804,0.968655836,3,110,vascular process in circulatory system,BP,1
GO:0001942,0.116684665,0.979159296,2,55,hair follicle development,BP,1
GO:0090559,0.116764003,0.979146319,2,54,regulation of membrane permeability,BP,1
GO:0043201,0.116896532,0.993505843,1,12,response to leucine,BP,1
GO:0048875,0.116898599,0.99355726,1,11,chemical homeostasis within a tissue,BP,1
GO:1902165,0.116923929,0.993554403,1,11,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,1
GO:0046459,0.117191736,0.993524151,1,11,short-chain fatty acid metabolic process,BP,1
GO:0006054,0.117334894,0.993507949,1,11,N-acetylneuraminate metabolic process,BP,1
GO:2000846,0.117357995,0.993505332,1,11,regulation of corticosteroid hormone secretion,BP,1
GO:0006924,0.117381545,0.993502664,1,11,activation-induced cell death of T cells,BP,1
GO:0014015,0.117584619,0.978895013,2,56,positive regulation of gliogenesis,BP,1
GO:0045721,0.11759323,0.993478658,1,11,negative regulation of gluconeogenesis,BP,1
GO:0010885,0.117624713,0.993422786,1,12,regulation of cholesterol storage,BP,1
GO:0035435,0.117710471,0.993465342,1,11,phosphate ion transmembrane transport,BP,1
GO:1900402,0.117766658,0.993458956,1,11,regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter,BP,1
GO:0009165,0.117809657,0.95456669,5,233,nucleotide biosynthetic process,BP,1
GO:0009130,0.117912126,0.993442406,1,11,pyrimidine nucleoside monophosphate biosynthetic process,BP,1
GO:0002683,0.11802614,0.949807404,6,303,negative regulation of immune system process,BP,1
GO:0009152,0.118035036,0.960340373,4,169,purine ribonucleotide biosynthetic process,BP,1
GO:0048813,0.118091851,0.968051282,3,114,dendrite morphogenesis,BP,1
GO:0070572,0.118118589,0.99336614,1,12,positive regulation of neuron projection regeneration,BP,1
GO:0060429,0.11812403,0.935815064,11,691,epithelium development,BP,1
GO:0010738,0.118248024,0.993351252,1,12,regulation of protein kinase A signaling,BP,1
GO:1904029,0.118734332,0.978586311,2,54,regulation of cyclin-dependent protein kinase activity,BP,1
GO:0002320,0.118967101,0.993222981,1,13,lymphoid progenitor cell differentiation,BP,1
GO:0061323,0.118972858,0.993267557,1,12,cell proliferation involved in heart morphogenesis,BP,1
GO:0046785,0.119011978,0.978478769,2,57,microtubule polymerization,BP,1
GO:0030182,0.119110407,0.931802017,13,854,neuron differentiation,BP,1
GO:0033077,0.119583404,0.978333399,2,55,T cell differentiation in thymus,BP,1
GO:0016052,0.119636658,0.967472732,3,109,carbohydrate catabolic process,BP,1
GO:0045475,0.120179452,0.993127018,1,12,locomotor rhythm,BP,1
GO:0061418,0.120301701,0.993112694,1,12,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,1
GO:1905952,0.120509085,0.967115801,3,113,regulation of lipid localization,BP,1
GO:0009117,0.120714664,0.941280386,8,442,nucleotide metabolic process,BP,1
GO:0046651,0.120828557,0.959058799,4,172,lymphocyte proliferation,BP,1
GO:0048712,0.120919144,0.993040108,1,12,negative regulation of astrocyte differentiation,BP,1
GO:0046626,0.121120851,0.977890273,2,55,regulation of insulin receptor signaling pathway,BP,1
GO:0019915,0.121142599,0.977874347,2,56,lipid storage,BP,1
GO:0040015,0.121517226,0.992969419,1,12,negative regulation of multicellular organism growth,BP,1
GO:0048266,0.121525182,0.992968476,1,12,behavioral response to pain,BP,1
GO:0030813,0.121989849,0.992913293,1,12,positive regulation of nucleotide catabolic process,BP,1
GO:0045821,0.121989849,0.992913293,1,12,positive regulation of glycolytic process,BP,1
GO:0051197,0.121989849,0.992913293,1,12,positive regulation of coenzyme metabolic process,BP,1
GO:0045165,0.122045787,0.966509834,3,114,cell fate commitment,BP,1
GO:1904262,0.122275216,0.99283149,1,13,negative regulation of TORC1 signaling,BP,1
GO:0010977,0.122527325,0.966312403,3,116,negative regulation of neuron projection development,BP,1
GO:0002313,0.122591353,0.992841523,1,12,mature B cell differentiation involved in immune response,BP,1
GO:1901293,0.122624826,0.95212693,5,236,nucleoside phosphate biosynthetic process,BP,1
GO:0034350,0.122728027,0.992825162,1,12,regulation of glial cell apoptotic process,BP,1
GO:0032270,0.122784799,0.925366326,16,1073,positive regulation of cellular protein metabolic process,BP,1
GO:0008210,0.122843767,0.992811292,1,12,estrogen metabolic process,BP,1
GO:0045860,0.123034254,0.947076435,6,313,positive regulation of protein kinase activity,BP,1
GO:0015908,0.123116346,0.977309896,2,55,fatty acid transport,BP,1
GO:0036303,0.123369178,0.992748152,1,12,lymph vessel morphogenesis,BP,1
GO:0035809,0.123659485,0.992713141,1,12,regulation of urine volume,BP,1
GO:0022404,0.123687511,0.977123176,2,57,molting cycle process,BP,1
GO:0022405,0.123687511,0.977123176,2,57,hair cycle process,BP,1
GO:0033273,0.123771702,0.965833775,3,113,response to vitamin,BP,1
GO:0060135,0.123961459,0.977052358,2,56,maternal process involved in female pregnancy,BP,1
GO:0042532,0.124016128,0.992670008,1,12,negative regulation of tyrosine phosphorylation of STAT protein,BP,1
GO:0032943,0.124471506,0.957374858,4,174,mononuclear cell proliferation,BP,1
GO:0034605,0.12450261,0.976893212,2,56,cellular response to heat,BP,1
GO:0070262,0.124793617,0.992575514,1,12,peptidyl-serine dephosphorylation,BP,1
GO:0090287,0.124924665,0.957154709,4,178,regulation of cellular response to growth factor stimulus,BP,1
GO:0060037,0.125022838,0.992497556,1,13,pharyngeal system development,BP,1
GO:0001655,0.125114061,0.95083703,5,247,urogenital system development,BP,1
GO:0051783,0.125404261,0.96517365,3,116,regulation of nuclear division,BP,1
GO:0010878,0.125450304,0.992444886,1,13,cholesterol storage,BP,1
GO:0007051,0.125640167,0.965079723,3,116,spindle organization,BP,1
GO:0072170,0.125784117,0.992454211,1,12,metanephric tubule development,BP,1
GO:0048535,0.126062725,0.992419905,1,12,lymph node development,BP,1
GO:0000819,0.126122939,0.964887247,3,116,sister chromatid segregation,BP,1
GO:0046717,0.126268704,0.976360941,2,57,acid secretion,BP,1
GO:0006753,0.1265043,0.937804259,8,447,nucleoside phosphate metabolic process,BP,1
GO:0070555,0.126510268,0.964745327,3,113,response to interleukin-1,BP,1
GO:0030968,0.126646295,0.976268827,2,55,endoplasmic reticulum unfolded protein response,BP,1
GO:0070373,0.126682137,0.976247868,2,56,negative regulation of ERK1 and ERK2 cascade,BP,1
GO:1901741,0.126717222,0.992338991,1,12,positive regulation of myoblast fusion,BP,1
GO:0050909,0.126954256,0.992309577,1,12,sensory perception of taste,BP,1
GO:0006490,0.127117793,0.992289248,1,12,oligosaccharide-lipid intermediate biosynthetic process,BP,1
GO:0051193,0.12720608,0.976091691,2,56,regulation of cofactor metabolic process,BP,1
GO:0035930,0.127374508,0.992257279,1,12,corticosteroid hormone secretion,BP,1
GO:0043649,0.127785961,0.992205896,1,12,dicarboxylic acid catabolic process,BP,1
GO:1905330,0.127818588,0.975888832,2,58,regulation of morphogenesis of an epithelium,BP,1
GO:0042448,0.127862865,0.992196272,1,12,progesterone metabolic process,BP,1
GO:0061298,0.127895472,0.992095075,1,14,retina vasculature development in camera-type eye,BP,1
GO:0009129,0.127922709,0.992188779,1,12,pyrimidine nucleoside monophosphate metabolic process,BP,1
GO:0006241,0.127935445,0.992187184,1,12,CTP biosynthetic process,BP,1
GO:0046036,0.127935445,0.992187184,1,12,CTP metabolic process,BP,1
GO:0070633,0.128129809,0.99211032,1,13,transepithelial transport,BP,1
GO:0048666,0.128359689,0.92915055,11,708,neuron development,BP,1
GO:0031503,0.128574886,0.95545027,4,178,protein-containing complex localization,BP,1
GO:2000136,0.128961935,0.992004869,1,13,regulation of cell proliferation involved in heart morphogenesis,BP,1
GO:0042755,0.129007521,0.991999071,1,13,eating behavior,BP,1
GO:0035136,0.129050564,0.99194797,1,14,forelimb morphogenesis,BP,1
GO:0001570,0.129960815,0.975234059,2,59,vasculogenesis,BP,1
GO:0090050,0.130080605,0.991861944,1,13,positive regulation of cell migration involved in sprouting angiogenesis,BP,1
GO:0002021,0.130425555,0.991817604,1,13,response to dietary excess,BP,1
GO:0060840,0.130473235,0.975019295,2,66,artery development,BP,1
GO:0032303,0.130556158,0.991800783,1,13,regulation of icosanoid secretion,BP,1
GO:0006825,0.130653406,0.991788246,1,13,copper ion transport,BP,1
GO:0048729,0.130736329,0.938663943,7,403,tissue morphogenesis,BP,1
GO:0007017,0.130809121,0.935178981,8,469,microtubule-based process,BP,1
GO:1902894,0.130856495,0.991762032,1,13,negative regulation of pri-miRNA transcription by RNA polymerase II,BP,1
GO:0050684,0.131061478,0.962907232,3,114,regulation of mRNA processing,BP,1
GO:0032024,0.13155239,0.97476,2,58,positive regulation of insulin secretion,BP,1
GO:0045445,0.132125693,0.974584871,2,58,myoblast differentiation,BP,1
GO:1901135,0.132153543,0.924715564,12,753,carbohydrate derivative metabolic process,BP,1
GO:2001234,0.132584412,0.953556036,4,178,negative regulation of apoptotic signaling pathway,BP,1
GO:0072521,0.132746331,0.937505071,7,381,purine-containing compound metabolic process,BP,1
GO:0031056,0.133001388,0.962098638,3,118,regulation of histone modification,BP,1
GO:0048660,0.133041533,0.962090894,3,116,regulation of smooth muscle cell proliferation,BP,1
GO:0045913,0.133374186,0.974201835,2,58,positive regulation of carbohydrate metabolic process,BP,1
GO:0006164,0.133397005,0.953171997,4,177,purine nucleotide biosynthetic process,BP,1
GO:0009209,0.134013989,0.991348808,1,13,pyrimidine ribonucleoside triphosphate biosynthetic process,BP,1
GO:0051004,0.134382106,0.991299938,1,13,regulation of lipoprotein lipase activity,BP,1
GO:0045596,0.134443439,0.932957776,8,470,negative regulation of cell differentiation,BP,1
GO:0071542,0.134744658,0.991251666,1,13,dopaminergic neuron differentiation,BP,1
GO:0006266,0.134836673,0.991239392,1,13,DNA ligation,BP,1
GO:0072243,0.134837528,0.991239278,1,13,metanephric nephron epithelium development,BP,1
GO:0060841,0.135003772,0.99116714,1,14,venous blood vessel development,BP,1
GO:0097201,0.135089617,0.991205605,1,13,negative regulation of transcription from RNA polymerase II promoter in response to stress,BP,1
GO:0001659,0.13514904,0.961216227,3,118,temperature homeostasis,BP,1
GO:0003323,0.1352775,0.991180464,1,13,type B pancreatic cell development,BP,1
GO:0032869,0.135288449,0.952257803,4,181,cellular response to insulin stimulus,BP,1
GO:0090083,0.135322842,0.991174391,1,13,regulation of inclusion body assembly,BP,1
GO:0031110,0.135694225,0.973436089,2,63,regulation of microtubule polymerization or depolymerization,BP,1
GO:0003085,0.135699297,0.991123885,1,13,negative regulation of systemic arterial blood pressure,BP,1
GO:0030809,0.135827312,0.991106676,1,13,negative regulation of nucleotide biosynthetic process,BP,1
GO:1900372,0.135827312,0.991106676,1,13,negative regulation of purine nucleotide biosynthetic process,BP,1
GO:2001170,0.135827312,0.991106676,1,13,negative regulation of ATP biosynthetic process,BP,1
GO:0033138,0.135862172,0.973421506,2,59,positive regulation of peptidyl-serine phosphorylation,BP,1
GO:0000097,0.136028019,0.991079659,1,13,sulfur amino acid biosynthetic process,BP,1
GO:0051450,0.136337751,0.991037881,1,13,myoblast proliferation,BP,1
GO:0043247,0.13643104,0.991025278,1,13,telomere maintenance in response to DNA damage,BP,1
GO:0042692,0.136439715,0.944933395,5,252,muscle cell differentiation,BP,1
GO:0043518,0.136755651,0.99098135,1,13,"negative regulation of DNA damage response, signal transduction by p53 class mediator",BP,1
GO:0042462,0.137254553,0.990861994,1,14,eye photoreceptor cell development,BP,1
GO:0003014,0.137300708,0.972972009,2,59,renal system process,BP,1
GO:0022410,0.137328208,0.990903593,1,13,circadian sleep/wake cycle process,BP,1
GO:0050802,0.137328208,0.990903593,1,13,"circadian sleep/wake cycle, sleep",BP,1
GO:0022008,0.137360416,0.916347525,15,1037,neurogenesis,BP,1
GO:0070875,0.137373721,0.990845686,1,14,positive regulation of glycogen metabolic process,BP,1
GO:0043173,0.137465271,0.990884927,1,13,nucleotide salvage,BP,1
GO:0006044,0.137764735,0.990844074,1,13,N-acetylglucosamine metabolic process,BP,1
GO:0043408,0.137986321,0.930777915,8,470,regulation of MAPK cascade,BP,1
GO:0009411,0.138500168,0.959830466,3,117,response to UV,BP,1
GO:0033143,0.138669282,0.972531372,2,60,regulation of intracellular steroid hormone receptor signaling pathway,BP,1
GO:0048339,0.138717624,0.990660707,1,14,paraxial mesoderm development,BP,1
GO:0045778,0.13884067,0.972477262,2,60,positive regulation of ossification,BP,1
GO:0005977,0.138878112,0.972455527,2,61,glycogen metabolic process,BP,1
GO:0006073,0.138878112,0.972455527,2,61,cellular glucan metabolic process,BP,1
GO:0044042,0.138878112,0.972455527,2,61,glucan metabolic process,BP,1
GO:0002043,0.139191747,0.990594981,1,14,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,1
GO:0060253,0.139507217,0.990551113,1,14,negative regulation of glial cell proliferation,BP,1
GO:0097061,0.139566148,0.972228111,2,62,dendritic spine organization,BP,1
GO:0009127,0.139902284,0.959248677,3,116,purine nucleoside monophosphate biosynthetic process,BP,1
GO:0009168,0.139902284,0.959248677,3,116,purine ribonucleoside monophosphate biosynthetic process,BP,1
GO:0043923,0.140031314,0.990477997,1,14,positive regulation by host of viral transcription,BP,1
GO:0034616,0.140551819,0.990405088,1,14,response to laminar fluid shear stress,BP,1
GO:0007498,0.140971673,0.971781005,2,62,mesoderm development,BP,1
GO:0048705,0.141053591,0.958742208,3,121,skeletal system morphogenesis,BP,1
GO:0001649,0.141335085,0.95863254,3,119,osteoblast differentiation,BP,1
GO:1900746,0.141455732,0.990277774,1,14,regulation of vascular endothelial growth factor signaling pathway,BP,1
GO:0019362,0.141593724,0.958532752,3,117,pyridine nucleotide metabolic process,BP,1
GO:0046496,0.141593724,0.958532752,3,117,nicotinamide nucleotide metabolic process,BP,1
GO:0042044,0.141628675,0.990253314,1,14,fluid transport,BP,1
GO:1900153,0.14164978,0.990202696,1,15,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",BP,1
GO:0048639,0.141999139,0.958322198,3,126,positive regulation of developmental growth,BP,1
GO:0034063,0.142143047,0.990132409,1,15,stress granule assembly,BP,1
GO:0046034,0.142565467,0.948736681,4,180,ATP metabolic process,BP,1
GO:0060749,0.142636843,0.990110079,1,14,mammary gland alveolus development,BP,1
GO:0061377,0.142636843,0.990110079,1,14,mammary gland lobule development,BP,1
GO:0046323,0.142642733,0.971255707,2,61,glucose import,BP,1
GO:0060396,0.142739572,0.990095422,1,14,growth hormone receptor signaling pathway,BP,1
GO:0033033,0.143033033,0.990053489,1,14,negative regulation of myeloid cell apoptotic process,BP,1
GO:0007263,0.143088416,0.990045564,1,14,nitric oxide mediated signal transduction,BP,1
GO:0010224,0.143110059,0.990042467,1,14,response to UV-B,BP,1
GO:1901673,0.143198441,0.989981132,1,15,regulation of mitotic spindle assembly,BP,1
GO:0009749,0.143265875,0.948382718,4,184,response to glucose,BP,1
GO:0060575,0.143267392,0.990019933,1,14,intestinal epithelial cell differentiation,BP,1
GO:0006401,0.143277759,0.948376891,4,184,RNA catabolic process,BP,1
GO:0051131,0.143383924,0.990003226,1,14,chaperone-mediated protein complex assembly,BP,1
GO:0003156,0.143598618,0.989923453,1,15,regulation of animal organ formation,BP,1
GO:0003084,0.143679506,0.989960781,1,14,positive regulation of systemic arterial blood pressure,BP,1
GO:0003008,0.143774716,0.916811605,12,790,system process,BP,1
GO:0009208,0.143843113,0.989937247,1,14,pyrimidine ribonucleoside triphosphate metabolic process,BP,1
GO:0070242,0.144000255,0.989914616,1,14,thymocyte apoptotic process,BP,1
GO:0048659,0.14433814,0.957351339,3,121,smooth muscle cell proliferation,BP,1
GO:0010469,0.14491325,0.947575835,4,183,regulation of signaling receptor activity,BP,1
GO:0015732,0.145254665,0.98973299,1,14,prostaglandin transport,BP,1
GO:0001676,0.145428124,0.970365497,2,60,long-chain fatty acid metabolic process,BP,1
GO:0120162,0.14555552,0.970293202,2,63,positive regulation of cold-induced thermogenesis,BP,1
GO:0072522,0.145617313,0.947228703,4,183,purine-containing compound biosynthetic process,BP,1
GO:0090305,0.145674053,0.947200698,4,183,nucleic acid phosphodiester bond hydrolysis,BP,1
GO:0070661,0.146032774,0.947018073,4,185,leukocyte proliferation,BP,1
GO:2000831,0.146272816,0.98958431,1,14,regulation of steroid hormone secretion,BP,1
GO:0031397,0.146288519,0.970064036,2,62,negative regulation of protein ubiquitination,BP,1
GO:1901739,0.146428026,0.989561545,1,14,regulation of myoblast fusion,BP,1
GO:0006112,0.1466718,0.969928642,2,63,energy reserve metabolic process,BP,1
GO:1904706,0.146798099,0.98950716,1,14,negative regulation of vascular smooth muscle cell proliferation,BP,1
GO:0051403,0.146997512,0.946535333,4,187,stress-activated MAPK cascade,BP,1
GO:0060343,0.14706989,0.989415771,1,15,trabecula formation,BP,1
GO:0072330,0.147729955,0.946177475,4,185,monocarboxylic acid biosynthetic process,BP,1
GO:0018105,0.147818416,0.946117604,4,191,peptidyl-serine phosphorylation,BP,1
GO:0007045,0.148021887,0.969475474,2,64,cell-substrate adherens junction assembly,BP,1
GO:0048041,0.148021887,0.969475474,2,64,focal adhesion assembly,BP,1
GO:0051347,0.148287806,0.928198686,7,403,positive regulation of transferase activity,BP,1
GO:0014910,0.148479489,0.969334508,2,63,regulation of smooth muscle cell migration,BP,1
GO:0046689,0.14870494,0.989172058,1,15,response to mercury ion,BP,1
GO:0045672,0.149138747,0.989106903,1,15,positive regulation of osteoclast differentiation,BP,1
GO:0046831,0.149270424,0.989040817,1,16,regulation of RNA export from nucleus,BP,1
GO:1902547,0.149725333,0.989018472,1,15,regulation of cellular response to vascular endothelial growth factor stimulus,BP,1
GO:0010720,0.149953912,0.927175272,7,414,positive regulation of cell development,BP,1
GO:0043491,0.150013072,0.954902728,3,123,protein kinase B signaling,BP,1
GO:1902749,0.150070324,0.9688078,2,63,regulation of cell cycle G2/M phase transition,BP,1
GO:0072012,0.150453775,0.988861123,1,16,glomerulus vasculature development,BP,1
GO:0006954,0.150463015,0.926879823,7,399,inflammatory response,BP,1
GO:0042634,0.150580146,0.988888926,1,15,regulation of hair cycle,BP,1
GO:0021915,0.151052297,0.954428799,3,128,neural tube development,BP,1
GO:0048863,0.151065814,0.954431586,3,126,stem cell differentiation,BP,1
GO:0002902,0.151141333,0.98880344,1,15,regulation of B cell apoptotic process,BP,1
GO:0150077,0.151424932,0.988760107,1,15,regulation of neuroinflammatory response,BP,1
GO:0021983,0.151692625,0.988719123,1,15,pituitary gland development,BP,1
GO:0071216,0.152125553,0.943979403,4,186,cellular response to biotic stimulus,BP,1
GO:0072207,0.152758764,0.98855511,1,15,metanephric epithelium development,BP,1
GO:0051897,0.15301282,0.967813732,2,64,positive regulation of protein kinase B signaling,BP,1
GO:0072524,0.153312189,0.953468252,3,122,pyridine-containing compound metabolic process,BP,1
GO:0043567,0.15364999,0.98841704,1,15,regulation of insulin-like growth factor receptor signaling pathway,BP,1
GO:0034104,0.153876393,0.988381825,1,15,negative regulation of tissue remodeling,BP,1
GO:2001026,0.154246232,0.988274769,1,16,regulation of endothelial cell chemotaxis,BP,1
GO:0044827,0.154474372,0.988288542,1,15,modulation by host of viral genome replication,BP,1
GO:0090025,0.154505945,0.988283606,1,15,regulation of monocyte chemotaxis,BP,1
GO:1900076,0.154637787,0.967265076,2,64,regulation of cellular response to insulin stimulus,BP,1
GO:0031664,0.154791183,0.98823896,1,15,regulation of lipopolysaccharide-mediated signaling pathway,BP,1
GO:0044794,0.154915966,0.988219401,1,15,positive regulation by host of viral process,BP,1
GO:0044344,0.15506473,0.967110056,2,65,cellular response to fibroblast growth factor stimulus,BP,1
GO:0006464,0.155159916,0.889196359,33,2548,cellular protein modification process,BP,1
GO:0036211,0.155159916,0.889196359,33,2548,protein modification process,BP,1
GO:0042592,0.155309643,0.900740317,17,1199,homeostatic process,BP,1
GO:0048667,0.155482059,0.928612105,6,351,cell morphogenesis involved in neuron differentiation,BP,1
GO:0070932,0.155826419,0.988025737,1,16,histone H3 deacetylation,BP,1
GO:1902254,0.155932546,0.988059409,1,15,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,1
GO:0060143,0.155938549,0.988058461,1,15,positive regulation of syncytium formation by plasma membrane fusion,BP,1
GO:0006635,0.155951514,0.96681878,2,64,fatty acid beta-oxidation,BP,1
GO:0048305,0.156191447,0.988018479,1,15,immunoglobulin secretion,BP,1
GO:0010888,0.1562646,0.988006901,1,15,negative regulation of lipid storage,BP,1
GO:0097529,0.156374679,0.952109062,3,124,myeloid leukocyte migration,BP,1
GO:0002702,0.156701865,0.96656278,2,64,positive regulation of production of molecular mediator of immune response,BP,1
GO:0090407,0.156757742,0.923016219,7,403,organophosphate biosynthetic process,BP,1
GO:0030595,0.157124409,0.951771887,3,125,leukocyte chemotaxis,BP,1
GO:0001562,0.157131915,0.987869173,1,15,response to protozoan,BP,1
GO:0006103,0.157230993,0.987853387,1,15,2-oxoglutarate metabolic process,BP,1
GO:0009226,0.157252536,0.987849953,1,15,nucleotide-sugar biosynthetic process,BP,1
GO:0019373,0.15729374,0.987843383,1,15,epoxygenase P450 pathway,BP,1
GO:0045927,0.157553159,0.941199842,4,198,positive regulation of growth,BP,1
GO:2000463,0.157610302,0.987695757,1,17,positive regulation of excitatory postsynaptic potential,BP,1
GO:0002230,0.157861241,0.987700955,1,16,positive regulation of defense response to virus by host,BP,1
GO:0060998,0.158019567,0.966071022,2,68,regulation of dendritic spine development,BP,1
GO:0048143,0.158156647,0.98765342,1,16,astrocyte activation,BP,1
GO:0000902,0.158221264,0.911628407,10,663,cell morphogenesis,BP,1
GO:2001032,0.158251825,0.987638084,1,16,regulation of double-strand break repair via nonhomologous end joining,BP,1
GO:0033687,0.158351292,0.987622046,1,16,osteoblast proliferation,BP,1
GO:0031571,0.158788996,0.987551339,1,16,mitotic G1 DNA damage checkpoint,BP,1
GO:0002696,0.158803685,0.940582896,4,190,positive regulation of leukocyte activation,BP,1
GO:0042445,0.159403317,0.950756555,3,125,hormone metabolic process,BP,1
GO:1903034,0.159459812,0.950717229,3,128,regulation of response to wounding,BP,1
GO:0030316,0.159632575,0.96552418,2,67,osteoclast differentiation,BP,1
GO:0009566,0.160018093,0.965400735,2,66,fertilization,BP,1
GO:0043588,0.160110062,0.950417018,3,130,skin development,BP,1
GO:0051054,0.160379395,0.939764224,4,194,positive regulation of DNA metabolic process,BP,1
GO:0050920,0.160590692,0.950201404,3,130,regulation of chemotaxis,BP,1
GO:1900151,0.161026084,0.98713911,1,17,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",BP,1
GO:0060071,0.161347606,0.987133724,1,16,"Wnt signaling pathway, planar cell polarity pathway",BP,1
GO:0106027,0.161534766,0.964853334,2,68,neuron projection organization,BP,1
GO:2001237,0.161701892,0.964804953,2,67,negative regulation of extrinsic apoptotic signaling pathway,BP,1
GO:0045639,0.161800513,0.964770526,2,67,positive regulation of myeloid cell differentiation,BP,1
GO:0006699,0.16206874,0.987014695,1,16,bile acid biosynthetic process,BP,1
GO:0030073,0.162305994,0.949438527,3,128,insulin secretion,BP,1
GO:0035295,0.162443896,0.906147572,11,737,tube development,BP,1
GO:1903312,0.162451097,0.964564033,2,65,negative regulation of mRNA metabolic process,BP,1
GO:0050926,0.162783796,0.986896091,1,16,regulation of positive chemotaxis,BP,1
GO:0050927,0.162783796,0.986896091,1,16,positive regulation of positive chemotaxis,BP,1
GO:0006555,0.162802588,0.986892966,1,16,methionine metabolic process,BP,1
GO:2000726,0.162881294,0.986879875,1,16,negative regulation of cardiac muscle cell differentiation,BP,1
GO:0006805,0.162901984,0.964417157,2,64,xenobiotic metabolic process,BP,1
GO:0006309,0.163006999,0.986858952,1,16,apoptotic DNA fragmentation,BP,1
GO:0071774,0.16303238,0.964339346,2,67,response to fibroblast growth factor,BP,1
GO:0030301,0.16312553,0.964296581,2,68,cholesterol transport,BP,1
GO:0010869,0.163229334,0.986821901,1,16,regulation of receptor biosynthetic process,BP,1
GO:0001829,0.16346493,0.986733632,1,17,trophectodermal cell differentiation,BP,1
GO:0051651,0.16378301,0.964065433,2,68,maintenance of location in cell,BP,1
GO:0002685,0.163953833,0.948697886,3,127,regulation of leukocyte migration,BP,1
GO:0060972,0.1639709,0.986648669,1,17,left/right pattern formation,BP,1
GO:0048265,0.164018729,0.986640623,1,17,response to pain,BP,1
GO:0010876,0.164145262,0.929768861,5,266,lipid localization,BP,1
GO:0070372,0.164153867,0.937810863,4,196,regulation of ERK1 and ERK2 cascade,BP,1
GO:0048593,0.16424038,0.963884808,2,70,camera-type eye morphogenesis,BP,1
GO:0010770,0.164584019,0.948371178,3,136,positive regulation of cell morphogenesis involved in differentiation,BP,1
GO:1901071,0.164638827,0.986585722,1,16,glucosamine-containing compound metabolic process,BP,1
GO:0043086,0.164741952,0.913832056,8,489,negative regulation of catalytic activity,BP,1
GO:0006577,0.164796778,0.986559116,1,16,amino-acid betaine metabolic process,BP,1
GO:0070168,0.165123249,0.986454087,1,17,negative regulation of biomineral tissue development,BP,1
GO:0006720,0.165410906,0.963522328,2,65,isoprenoid metabolic process,BP,1
GO:0003081,0.165460123,0.98644707,1,16,regulation of systemic arterial blood pressure by renin-angiotensin,BP,1
GO:0051195,0.165519202,0.986437067,1,16,negative regulation of cofactor metabolic process,BP,1
GO:0042327,0.165525069,0.906682608,10,648,positive regulation of phosphorylation,BP,1
GO:0030431,0.166351655,0.9862957,1,16,sleep,BP,1
GO:0051090,0.166525254,0.928424521,5,265,regulation of DNA-binding transcription factor activity,BP,1
GO:0042219,0.166609795,0.986251703,1,16,cellular modified amino acid catabolic process,BP,1
GO:0010737,0.16668671,0.986187682,1,17,protein kinase A signaling,BP,1
GO:0001516,0.16671241,0.986234193,1,16,prostaglandin biosynthetic process,BP,1
GO:0046457,0.16671241,0.986234193,1,16,prostanoid biosynthetic process,BP,1
GO:0045684,0.166771851,0.986173094,1,17,positive regulation of epidermis development,BP,1
GO:0002460,0.166951395,0.936363688,4,193,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,1
GO:0032239,0.167055713,0.986078977,1,18,regulation of nucleobase-containing compound transport,BP,1
GO:0090344,0.167129052,0.986111806,1,17,negative regulation of cell aging,BP,1
GO:0051194,0.16750275,0.986047532,1,17,positive regulation of cofactor metabolic process,BP,1
GO:0090276,0.168001866,0.946831785,3,131,regulation of peptide hormone secretion,BP,1
GO:0006417,0.168012802,0.927577627,5,266,regulation of translation,BP,1
GO:0007052,0.168066656,0.962524509,2,70,mitotic spindle organization,BP,1
GO:0071397,0.168099546,0.985944558,1,17,cellular response to cholesterol,BP,1
GO:0010831,0.168232484,0.985921565,1,17,positive regulation of myotube differentiation,BP,1
GO:0044819,0.168334778,0.985903858,1,17,mitotic G1/S transition checkpoint,BP,1
GO:0044783,0.16833899,0.985903129,1,17,G1 DNA damage checkpoint,BP,1
GO:0043122,0.168371447,0.946666723,3,130,regulation of I-kappaB kinase/NF-kappaB signaling,BP,1
GO:0061437,0.16888767,0.985761524,1,18,renal system vasculature development,BP,1
GO:0061440,0.16888767,0.985761524,1,18,kidney vasculature development,BP,1
GO:0090175,0.168988668,0.985790393,1,17,regulation of establishment of planar polarity,BP,1
GO:0007589,0.169062243,0.962167213,2,70,body fluid secretion,BP,1
GO:0051146,0.169653712,0.934927934,4,200,striated muscle cell differentiation,BP,1
GO:0007044,0.169902455,0.961836021,2,73,cell-substrate junction assembly,BP,1
GO:0030282,0.170150242,0.961795688,2,68,bone mineralization,BP,1
GO:2000104,0.170189629,0.985580731,1,17,negative regulation of DNA-dependent DNA replication,BP,1
GO:1901099,0.170354061,0.985551897,1,17,negative regulation of signal transduction in absence of ligand,BP,1
GO:2001240,0.170354061,0.985551897,1,17,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,1
GO:0035137,0.170775055,0.985388004,1,19,hindlimb morphogenesis,BP,1
GO:0090596,0.171121524,0.945365388,3,137,sensory organ morphogenesis,BP,1
GO:0000731,0.171576439,0.985288662,1,18,DNA synthesis involved in DNA repair,BP,1
GO:0071378,0.17160362,0.985331773,1,17,cellular response to growth hormone stimulus,BP,1
GO:1905332,0.171640385,0.985277315,1,18,positive regulation of morphogenesis of an epithelium,BP,1
GO:0035335,0.171844194,0.961151549,2,71,peptidyl-tyrosine dephosphorylation,BP,1
GO:0008211,0.172171911,0.985231072,1,17,glucocorticoid metabolic process,BP,1
GO:0046394,0.172272846,0.925140722,5,267,carboxylic acid biosynthetic process,BP,1
GO:0033197,0.172462495,0.985179438,1,17,response to vitamin E,BP,1
GO:0009148,0.172523809,0.985168531,1,17,pyrimidine nucleoside triphosphate biosynthetic process,BP,1
GO:0006301,0.172699583,0.985088691,1,18,postreplication repair,BP,1
GO:0071498,0.172701622,0.985136876,1,17,cellular response to fluid shear stress,BP,1
GO:0010893,0.173095644,0.9850666,1,17,positive regulation of steroid biosynthetic process,BP,1
GO:0046628,0.173244988,0.985039918,1,17,positive regulation of insulin receptor signaling pathway,BP,1
GO:0044321,0.173306228,0.985028969,1,17,response to leptin,BP,1
GO:0003309,0.173560878,0.984983395,1,17,type B pancreatic cell differentiation,BP,1
GO:0046879,0.173592852,0.932843984,4,201,hormone secretion,BP,1
GO:0002068,0.17381137,0.984938493,1,17,glandular epithelial cell development,BP,1
GO:0048569,0.173814785,0.984888704,1,18,post-embryonic animal organ development,BP,1
GO:0003071,0.173976463,0.984908861,1,17,renal system process involved in regulation of systemic arterial blood pressure,BP,1
GO:1901888,0.174021085,0.960356897,2,71,regulation of cell junction assembly,BP,1
GO:0002262,0.174066663,0.944017374,3,132,myeloid cell homeostasis,BP,1
GO:0007143,0.174071266,0.984842508,1,18,female meiotic nuclear division,BP,1
GO:0014909,0.174349827,0.9602465,2,70,smooth muscle cell migration,BP,1
GO:0006690,0.174476314,0.960232491,2,67,icosanoid metabolic process,BP,1
GO:0033674,0.174556567,0.917180186,6,348,positive regulation of kinase activity,BP,1
GO:0021697,0.17483539,0.984704429,1,18,cerebellar cortex formation,BP,1
GO:0035929,0.175019485,0.984720925,1,17,steroid hormone secretion,BP,1
GO:0034333,0.175317317,0.959870623,2,72,adherens junction assembly,BP,1
GO:0060216,0.175900942,0.984510762,1,18,definitive hemopoiesis,BP,1
GO:0016053,0.176048435,0.922960139,5,269,organic acid biosynthetic process,BP,1
GO:0030278,0.176840952,0.942710618,3,133,regulation of ossification,BP,1
GO:0043268,0.17687893,0.984286311,1,19,positive regulation of potassium ion transport,BP,1
GO:0048841,0.176896465,0.984283085,1,19,regulation of axon extension involved in axon guidance,BP,1
GO:0048103,0.17692523,0.984277791,1,19,somatic stem cell division,BP,1
GO:0018209,0.177914142,0.930526653,4,205,peptidyl-serine modification,BP,1
GO:0034754,0.177942996,0.95892995,2,69,cellular hormone metabolic process,BP,1
GO:1903321,0.177979258,0.958905667,2,70,negative regulation of protein modification by small protein conjugation or removal,BP,1
GO:1902692,0.178172063,0.984047399,1,19,regulation of neuroblast proliferation,BP,1
GO:0008209,0.178265265,0.98407637,1,18,androgen metabolic process,BP,1
GO:0001822,0.178434725,0.930241686,4,207,kidney development,BP,1
GO:0045736,0.179168167,0.98390878,1,18,negative regulation of cyclin-dependent protein serine/threonine kinase activity,BP,1
GO:0060706,0.179210676,0.983900867,1,18,cell differentiation involved in embryonic placenta development,BP,1
GO:0001776,0.179260348,0.95842804,2,70,leukocyte homeostasis,BP,1
GO:0001945,0.179279507,0.983888049,1,18,lymph vessel development,BP,1
GO:1905208,0.179370931,0.983871015,1,18,negative regulation of cardiocyte differentiation,BP,1
GO:0071902,0.179373037,0.929742649,4,205,positive regulation of protein serine/threonine kinase activity,BP,1
GO:0002335,0.179870792,0.983777712,1,18,mature B cell differentiation,BP,1
GO:0071385,0.180051145,0.958121405,2,71,cellular response to glucocorticoid stimulus,BP,1
GO:0050867,0.180126527,0.929351114,4,200,positive regulation of cell activation,BP,1
GO:0034976,0.180235888,0.92929512,4,199,response to endoplasmic reticulum stress,BP,1
GO:0045830,0.180283459,0.983700467,1,18,positive regulation of isotype switching,BP,1
GO:0001889,0.180677657,0.929042106,4,204,liver development,BP,1
GO:0051704,0.180941144,0.880179825,18,1313,multi-organism process,BP,1
GO:0002675,0.18114308,0.983538926,1,18,positive regulation of acute inflammatory response,BP,1
GO:0015698,0.181578792,0.957547092,2,71,inorganic anion transport,BP,1
GO:0009187,0.181649873,0.983395247,1,19,cyclic nucleotide metabolic process,BP,1
GO:0009267,0.181697919,0.940401388,3,134,cellular response to starvation,BP,1
GO:0045765,0.181894519,0.928378416,4,206,regulation of angiogenesis,BP,1
GO:0031345,0.181986035,0.940239885,3,139,negative regulation of cell projection organization,BP,1
GO:0009220,0.182052926,0.983367013,1,18,pyrimidine ribonucleotide biosynthetic process,BP,1
GO:0046132,0.182052926,0.983367013,1,18,pyrimidine ribonucleoside biosynthetic process,BP,1
GO:0046134,0.182052926,0.983367013,1,18,pyrimidine nucleoside biosynthetic process,BP,1
GO:0032800,0.182122296,0.983353866,1,18,receptor biosynthetic process,BP,1
GO:2000209,0.182364435,0.983259515,1,19,regulation of anoikis,BP,1
GO:0071103,0.182384796,0.940063183,3,136,DNA conformation change,BP,1
GO:0071478,0.18257596,0.939981428,3,134,cellular response to radiation,BP,1
GO:0070841,0.182638562,0.983255851,1,18,inclusion body assembly,BP,1
GO:0007416,0.182751951,0.957053667,2,76,synapse assembly,BP,1
GO:0007399,0.182781324,0.877513846,19,1426,nervous system development,BP,1
GO:0006637,0.182841288,0.957080951,2,70,acyl-CoA metabolic process,BP,1
GO:0035383,0.182841288,0.957080951,2,70,thioester metabolic process,BP,1
GO:0032620,0.182856048,0.983214467,1,18,interleukin-17 production,BP,1
GO:0090169,0.183033663,0.983087975,1,20,regulation of spindle assembly,BP,1
GO:0048483,0.183246771,0.983047111,1,20,autonomic nervous system development,BP,1
GO:0051593,0.183303105,0.983129229,1,18,response to folic acid,BP,1
GO:0014912,0.1835777,0.983027692,1,19,negative regulation of smooth muscle cell migration,BP,1
GO:0002092,0.183629378,0.98301778,1,19,positive regulation of receptor internalization,BP,1
GO:0050434,0.184311016,0.982886744,1,19,positive regulation of viral transcription,BP,1
GO:0007281,0.18454697,0.939020211,3,137,germ cell development,BP,1
GO:0044264,0.184804205,0.956302693,2,73,cellular polysaccharide metabolic process,BP,1
GO:0006733,0.185092569,0.938777155,3,133,oxidoreduction coenzyme metabolic process,BP,1
GO:0033559,0.185534111,0.956056324,2,70,unsaturated fatty acid metabolic process,BP,1
GO:0061008,0.186260778,0.925999042,4,207,hepaticobiliary system development,BP,1
GO:0019953,0.186398891,0.904204046,7,432,sexual reproduction,BP,1
GO:0031954,0.186515189,0.982459306,1,19,positive regulation of protein autophosphorylation,BP,1
GO:0042593,0.186680721,0.925772099,4,206,glucose homeostasis,BP,1
GO:0023061,0.187826878,0.916036931,5,280,signal release,BP,1
GO:0060713,0.188017199,0.982164779,1,19,labyrinthine layer morphogenesis,BP,1
GO:0090277,0.188119507,0.955029993,2,73,positive regulation of peptide hormone secretion,BP,1
GO:0071384,0.188220882,0.954990838,2,73,cellular response to corticosteroid stimulus,BP,1
GO:1904030,0.188489036,0.982071712,1,19,negative regulation of cyclin-dependent protein kinase activity,BP,1
GO:0033500,0.188964421,0.924515447,4,207,carbohydrate homeostasis,BP,1
GO:0040019,0.189212922,0.981928421,1,19,positive regulation of embryonic development,BP,1
GO:0070507,0.189844423,0.936421686,3,143,regulation of microtubule cytoskeleton organization,BP,1
GO:0090100,0.19043109,0.954123026,2,74,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,1
GO:0001843,0.190584831,0.954042659,2,76,neural tube closure,BP,1
GO:0060606,0.190584831,0.954042659,2,76,tube closure,BP,1
GO:0031098,0.190642841,0.923586901,4,208,stress-activated protein kinase signaling cascade,BP,1
GO:1902236,0.191036797,0.981564663,1,19,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,1
GO:1900078,0.191218534,0.981528202,1,19,positive regulation of cellular response to insulin stimulus,BP,1
GO:0043555,0.191291288,0.981513595,1,19,regulation of translation in response to stress,BP,1
GO:0009914,0.191684351,0.923007821,4,209,hormone transport,BP,1
GO:0032069,0.191855411,0.981400124,1,19,regulation of nuclease activity,BP,1
GO:0062014,0.192071677,0.953493102,2,73,negative regulation of small molecule metabolic process,BP,1
GO:0035909,0.192347714,0.981132315,1,23,aorta morphogenesis,BP,1
GO:0032042,0.192875162,0.981194053,1,19,mitochondrial DNA metabolic process,BP,1
GO:0044342,0.192980339,0.981172729,1,19,type B pancreatic cell proliferation,BP,1
GO:0030947,0.193189167,0.981081467,1,20,regulation of vascular endothelial growth factor receptor signaling pathway,BP,1
GO:0006376,0.193272632,0.9811134,1,19,mRNA splice site selection,BP,1
GO:0035082,0.193536903,0.981059673,1,19,axoneme assembly,BP,1
GO:0007178,0.193716234,0.921871168,4,212,transmembrane receptor protein serine/threonine kinase signaling pathway,BP,1
GO:0014902,0.194039864,0.952698143,2,75,myotube differentiation,BP,1
GO:0006817,0.194098087,0.980945307,1,19,phosphate ion transport,BP,1
GO:0015918,0.194274014,0.952595356,2,76,sterol transport,BP,1
GO:0009126,0.19453973,0.921436492,4,204,purine nucleoside monophosphate metabolic process,BP,1
GO:0009167,0.19453973,0.921436492,4,204,purine ribonucleoside monophosphate metabolic process,BP,1
GO:0043616,0.194548598,0.980803652,1,20,keratinocyte proliferation,BP,1
GO:0044282,0.194605988,0.911997823,5,276,small molecule catabolic process,BP,1
GO:0009074,0.194917342,0.980777681,1,19,aromatic amino acid family catabolic process,BP,1
GO:0009205,0.194993209,0.92118364,4,204,purine ribonucleoside triphosphate metabolic process,BP,1
GO:0044843,0.195529511,0.933636037,3,140,cell cycle G1/S phase transition,BP,1
GO:0031297,0.195605713,0.980586105,1,20,replication fork processing,BP,1
GO:0005979,0.195853203,0.980489542,1,21,regulation of glycogen biosynthetic process,BP,1
GO:0010962,0.195853203,0.980489542,1,21,regulation of glucan biosynthetic process,BP,1
GO:2000352,0.196019912,0.980500504,1,20,negative regulation of endothelial cell apoptotic process,BP,1
GO:0061082,0.196043768,0.980495568,1,20,myeloid leukocyte cytokine production,BP,1
GO:0034349,0.196560013,0.980388578,1,20,glial cell apoptotic process,BP,1
GO:0090279,0.196781581,0.980342562,1,20,regulation of calcium ion import,BP,1
GO:0045666,0.196974529,0.910539131,5,292,positive regulation of neuron differentiation,BP,1
GO:0072593,0.197180106,0.919948288,4,208,reactive oxygen species metabolic process,BP,1
GO:0032309,0.197273419,0.980240206,1,20,icosanoid secretion,BP,1
GO:0016525,0.197611612,0.951259572,2,77,negative regulation of angiogenesis,BP,1
GO:0099175,0.198115821,0.951047837,2,78,regulation of postsynapse organization,BP,1
GO:0007212,0.198609431,0.979913991,1,21,dopamine receptor signaling pathway,BP,1
GO:0045995,0.199216007,0.95060668,2,78,regulation of embryonic development,BP,1
GO:0006631,0.199221522,0.909205275,5,279,fatty acid metabolic process,BP,1
GO:0045637,0.199349987,0.931720782,3,142,regulation of myeloid cell differentiation,BP,1
GO:0009894,0.199878773,0.882658282,10,675,regulation of catabolic process,BP,1
GO:0048640,0.200041819,0.950274457,2,78,negative regulation of developmental growth,BP,1
GO:0048814,0.200118201,0.950243682,2,78,regulation of dendrite morphogenesis,BP,1
GO:0051125,0.200210416,0.979623,1,20,regulation of actin nucleation,BP,1
GO:0009147,0.200393705,0.979584141,1,20,pyrimidine nucleoside triphosphate metabolic process,BP,1
GO:0009218,0.200520408,0.979557255,1,20,pyrimidine ribonucleotide metabolic process,BP,1
GO:0021680,0.200531499,0.979463974,1,22,cerebellar Purkinje cell layer development,BP,1
GO:1902230,0.200549272,0.979551128,1,20,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,1
GO:0031109,0.200797259,0.949949821,2,80,microtubule polymerization or depolymerization,BP,1
GO:0010758,0.201067799,0.979440881,1,20,regulation of macrophage chemotaxis,BP,1
GO:0006732,0.201106318,0.90806033,5,279,coenzyme metabolic process,BP,1
GO:0006775,0.201423652,0.979365036,1,20,fat-soluble vitamin metabolic process,BP,1
GO:0045185,0.201883864,0.949530056,2,78,maintenance of protein location,BP,1
GO:0051457,0.201930211,0.979256809,1,20,maintenance of protein location in nucleus,BP,1
GO:2000191,0.202272366,0.979135067,1,21,regulation of fatty acid transport,BP,1
GO:0043114,0.202454881,0.979095835,1,21,regulation of vascular permeability,BP,1
GO:0098813,0.202800845,0.929968457,3,145,nuclear chromosome segregation,BP,1
GO:0021545,0.202951005,0.978944649,1,22,cranial nerve development,BP,1
GO:0010608,0.20360751,0.898941569,6,360,posttranscriptional regulation of gene expression,BP,1
GO:0007094,0.203840198,0.978752024,1,22,mitotic spindle assembly checkpoint,BP,1
GO:0031577,0.203840198,0.978752024,1,22,spindle checkpoint,BP,1
GO:0071173,0.203840198,0.978752024,1,22,spindle assembly checkpoint,BP,1
GO:0071174,0.203840198,0.978752024,1,22,mitotic spindle checkpoint,BP,1
GO:0022616,0.203909913,0.978781642,1,21,DNA strand elongation,BP,1
GO:0060992,0.204065294,0.978747939,1,21,response to fungicide,BP,1
GO:0006275,0.204117414,0.94863184,2,77,regulation of DNA replication,BP,1
GO:0030509,0.204161348,0.948592968,2,79,BMP signaling pathway,BP,1
GO:0046856,0.204192319,0.978675481,1,22,phosphatidylinositol dephosphorylation,BP,1
GO:0048846,0.204227747,0.978667772,1,22,axon extension involved in axon guidance,BP,1
GO:1902284,0.204227747,0.978667772,1,22,neuron projection extension involved in neuron projection guidance,BP,1
GO:0034504,0.204750302,0.915647458,4,215,protein localization to nucleus,BP,1
GO:0007020,0.20494131,0.978512172,1,22,microtubule nucleation,BP,1
GO:0090092,0.205088193,0.928808033,3,145,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,1
GO:0002573,0.205089001,0.928812562,3,144,myeloid leukocyte differentiation,BP,1
GO:0010959,0.205726896,0.91508426,4,217,regulation of metal ion transport,BP,1
GO:1902275,0.205915458,0.928381774,3,146,regulation of chromatin organization,BP,1
GO:0008585,0.206231447,0.947754806,2,78,female gonad development,BP,1
GO:0010719,0.206543776,0.978206422,1,21,negative regulation of epithelial to mesenchymal transition,BP,1
GO:0072001,0.206783384,0.91447132,4,220,renal system development,BP,1
GO:0035270,0.207215458,0.947349438,2,78,endocrine system development,BP,1
GO:0001754,0.207500269,0.977949111,1,22,eye photoreceptor cell differentiation,BP,1
GO:0050678,0.207583416,0.914015732,4,219,regulation of epithelial cell proliferation,BP,1
GO:0009299,0.207740117,0.977895931,1,22,mRNA transcription,BP,1
GO:2000181,0.208869634,0.946643935,2,80,negative regulation of blood vessel morphogenesis,BP,1
GO:0014020,0.209018228,0.946572088,2,81,primary neural tube formation,BP,1
GO:0000737,0.20945833,0.977560148,1,21,"DNA catabolic process, endonucleolytic",BP,1
GO:0046426,0.209508017,0.977549041,1,21,negative regulation of JAK-STAT cascade,BP,1
GO:1904893,0.209508017,0.977549041,1,21,negative regulation of STAT cascade,BP,1
GO:2000379,0.210573752,0.945956067,2,78,positive regulation of reactive oxygen species metabolic process,BP,1
GO:0009067,0.210771887,0.97726552,1,21,aspartate family amino acid biosynthetic process,BP,1
GO:0005976,0.210805857,0.945837823,2,80,polysaccharide metabolic process,BP,1
GO:0042063,0.210848757,0.912136421,4,219,gliogenesis,BP,1
GO:0002053,0.210892896,0.977190397,1,22,positive regulation of mesenchymal cell proliferation,BP,1
GO:0060669,0.2112665,0.977105991,1,22,embryonic placenta morphogenesis,BP,1
GO:0033762,0.211288196,0.97714914,1,21,response to glucagon,BP,1
GO:0045841,0.212418039,0.976800434,1,23,negative regulation of mitotic metaphase/anaphase transition,BP,1
GO:2000816,0.212418039,0.976800434,1,23,negative regulation of mitotic sister chromatid separation,BP,1
GO:0033260,0.213174659,0.976672248,1,22,nuclear DNA replication,BP,1
GO:0051153,0.21318383,0.944840836,2,80,regulation of striated muscle cell differentiation,BP,1
GO:0009144,0.213756301,0.910473946,4,212,purine nucleoside triphosphate metabolic process,BP,1
GO:0036010,0.214003894,0.976482372,1,22,protein localization to endosome,BP,1
GO:0014812,0.214337081,0.944354565,2,80,muscle cell migration,BP,1
GO:0043921,0.214871579,0.976282793,1,22,modulation by host of viral transcription,BP,1
GO:0052312,0.214871579,0.976282793,1,22,modulation of transcription in other organism involved in symbiotic interaction,BP,1
GO:0052472,0.214871579,0.976282793,1,22,modulation by host of symbiont transcription,BP,1
GO:2001171,0.215255734,0.976194139,1,22,positive regulation of ATP biosynthetic process,BP,1
GO:2001243,0.215424056,0.943916654,2,78,negative regulation of intrinsic apoptotic signaling pathway,BP,1
GO:2000758,0.216440077,0.975919683,1,22,positive regulation of peptidyl-lysine acetylation,BP,1
GO:0090184,0.21655849,0.975892148,1,22,positive regulation of kidney development,BP,1
GO:0001934,0.216588196,0.874364597,9,610,positive regulation of protein phosphorylation,BP,1
GO:0009913,0.217399015,0.943033489,2,82,epidermal cell differentiation,BP,1
GO:0051235,0.21753456,0.908230416,4,225,maintenance of location,BP,1
GO:0045446,0.217566148,0.942962151,2,82,endothelial cell differentiation,BP,1
GO:0044788,0.217605806,0.975647864,1,22,modulation by host of viral process,BP,1
GO:0042542,0.217607149,0.922337129,3,145,response to hydrogen peroxide,BP,1
GO:0060325,0.217699206,0.975536787,1,24,face morphogenesis,BP,1
GO:0034142,0.218009359,0.975553378,1,22,toll-like receptor 4 signaling pathway,BP,1
GO:0090162,0.21804797,0.975497618,1,23,establishment of epithelial cell polarity,BP,1
GO:0046131,0.218578013,0.975419896,1,22,pyrimidine ribonucleoside metabolic process,BP,1
GO:0071168,0.218719448,0.975339638,1,23,protein localization to chromatin,BP,1
GO:1901137,0.218859623,0.882536079,7,442,carbohydrate derivative biosynthetic process,BP,1
GO:1901342,0.219048447,0.907348338,4,223,regulation of vasculature development,BP,1
GO:0045980,0.219307874,0.975247991,1,22,negative regulation of nucleotide metabolic process,BP,1
GO:1900543,0.219307874,0.975247991,1,22,negative regulation of purine nucleotide metabolic process,BP,1
GO:1903579,0.219307874,0.975247991,1,22,negative regulation of ATP metabolic process,BP,1
GO:0065009,0.219410757,0.84306299,24,1866,regulation of molecular function,BP,1
GO:2001252,0.219470574,0.921330903,3,150,positive regulation of chromosome organization,BP,1
GO:1902667,0.219564254,0.975056775,1,25,regulation of axon guidance,BP,1
GO:0021696,0.21962739,0.975081718,1,24,cerebellar cortex morphogenesis,BP,1
GO:0061157,0.220262009,0.974974615,1,23,mRNA destabilization,BP,1
GO:0021782,0.220370164,0.941770366,2,81,glial cell development,BP,1
GO:0071772,0.220610813,0.941635283,2,84,response to BMP,BP,1
GO:0071773,0.220610813,0.941635283,2,84,cellular response to BMP stimulus,BP,1
GO:1902253,0.220739897,0.974908803,1,22,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,1
GO:0035162,0.220976262,0.974804605,1,23,embryonic hemopoiesis,BP,1
GO:2000826,0.221039827,0.97474546,1,24,regulation of heart morphogenesis,BP,1
GO:0008645,0.221165549,0.941427388,2,81,hexose transmembrane transport,BP,1
GO:1904659,0.221165549,0.941427388,2,81,glucose transmembrane transport,BP,1
GO:0071236,0.221348146,0.920353733,3,147,cellular response to antibiotic,BP,1
GO:1902100,0.22136389,0.974667963,1,24,negative regulation of metaphase/anaphase transition of cell cycle,BP,1
GO:1905819,0.22136389,0.974667963,1,24,negative regulation of chromosome separation,BP,1
GO:0055078,0.221757615,0.974617902,1,23,sodium ion homeostasis,BP,1
GO:0000302,0.221768858,0.905761315,4,218,response to reactive oxygen species,BP,1
GO:0031639,0.221875835,0.974637949,1,22,plasminogen activation,BP,1
GO:0007249,0.222033698,0.919979833,3,149,I-kappaB kinase/NF-kappaB signaling,BP,1
GO:0046545,0.222366403,0.940897098,2,82,development of primary female sexual characteristics,BP,1
GO:0009306,0.222423394,0.886624787,6,372,protein secretion,BP,1
GO:0055067,0.222425303,0.940893547,2,80,monovalent inorganic cation homeostasis,BP,1
GO:0034629,0.223078442,0.974300579,1,23,cellular protein-containing complex localization,BP,1
GO:0034122,0.223455832,0.974209516,1,23,negative regulation of toll-like receptor signaling pathway,BP,1
GO:0035107,0.224242478,0.940040193,2,86,appendage morphogenesis,BP,1
GO:0035108,0.224242478,0.940040193,2,86,limb morphogenesis,BP,1
GO:1904031,0.225021661,0.973829803,1,23,positive regulation of cyclin-dependent protein kinase activity,BP,1
GO:0032989,0.225026537,0.864351997,10,719,cellular component morphogenesis,BP,1
GO:0030855,0.225046231,0.884866563,6,381,epithelial cell differentiation,BP,1
GO:0010562,0.225536088,0.863989476,10,697,positive regulation of phosphorus metabolic process,BP,1
GO:0045937,0.225536088,0.863989476,10,697,positive regulation of phosphate metabolic process,BP,1
GO:0060996,0.225765318,0.939374294,2,86,dendritic spine development,BP,1
GO:0045648,0.226179612,0.973500996,1,24,positive regulation of erythrocyte differentiation,BP,1
GO:0000038,0.227141289,0.973310948,1,23,very long-chain fatty acid metabolic process,BP,1
GO:1904385,0.227274754,0.973231595,1,24,cellular response to angiotensin,BP,1
GO:1901343,0.227471075,0.938634872,2,85,negative regulation of vasculature development,BP,1
GO:0043648,0.227559742,0.938639091,2,81,dicarboxylic acid metabolic process,BP,1
GO:0002082,0.227952618,0.973110867,1,23,regulation of oxidative phosphorylation,BP,1
GO:0015850,0.228774917,0.916357554,3,152,organic hydroxy compound transport,BP,1
GO:0008299,0.228779863,0.972906018,1,23,isoprenoid biosynthetic process,BP,1
GO:0010803,0.228836987,0.972844705,1,24,regulation of tumor necrosis factor-mediated signaling pathway,BP,1
GO:2000377,0.228909153,0.916295524,3,150,regulation of reactive oxygen species metabolic process,BP,1
GO:1900006,0.228927942,0.937971316,2,87,positive regulation of dendrite development,BP,1
GO:0050691,0.229031971,0.972796204,1,24,regulation of defense response to virus by host,BP,1
GO:0030728,0.229093384,0.972780917,1,24,ovulation,BP,1
GO:0015749,0.229458759,0.937777923,2,83,monosaccharide transmembrane transport,BP,1
GO:0045667,0.230294968,0.937406937,2,83,regulation of osteoblast differentiation,BP,1
GO:0060042,0.230904044,0.972283974,1,25,retina morphogenesis in camera-type eye,BP,1
GO:0001952,0.231055922,0.937036512,2,86,regulation of cell-matrix adhesion,BP,1
GO:0030072,0.231463821,0.914892376,3,154,peptide hormone secretion,BP,1
GO:0030810,0.231949089,0.972064898,1,24,positive regulation of nucleotide biosynthetic process,BP,1
GO:1900373,0.231949089,0.972064898,1,24,positive regulation of purine nucleotide biosynthetic process,BP,1
GO:0030212,0.232230042,0.971993902,1,24,hyaluronan metabolic process,BP,1
GO:0071715,0.232439089,0.971941012,1,24,icosanoid transport,BP,1
GO:1901571,0.232439089,0.971941012,1,24,fatty acid derivative transport,BP,1
GO:0033048,0.232579012,0.971819483,1,26,negative regulation of mitotic sister chromatid segregation,BP,1
GO:1902533,0.232941386,0.862501878,9,624,positive regulation of intracellular signal transduction,BP,1
GO:0030262,0.23309754,0.971774063,1,24,apoptotic nuclear changes,BP,1
GO:0060122,0.233281649,0.971682237,1,25,inner ear receptor cell stereocilium organization,BP,1
GO:0046434,0.233471079,0.91381585,3,151,organophosphate catabolic process,BP,1
GO:0048592,0.233812159,0.935763627,2,90,eye morphogenesis,BP,1
GO:0000724,0.233975239,0.935740979,2,85,double-strand break repair via homologous recombination,BP,1
GO:0030513,0.234914026,0.971264991,1,25,positive regulation of BMP signaling pathway,BP,1
GO:0050892,0.235646353,0.971122675,1,24,intestinal absorption,BP,1
GO:0048679,0.236369255,0.970847518,1,26,regulation of axon regeneration,BP,1
GO:0045940,0.236638451,0.970866916,1,24,positive regulation of steroid metabolic process,BP,1
GO:0006282,0.237190112,0.934278703,2,86,regulation of DNA repair,BP,1
GO:0034248,0.237304348,0.885233891,5,302,regulation of cellular amide metabolic process,BP,1
GO:0050779,0.237797789,0.970519667,1,25,RNA destabilization,BP,1
GO:0034219,0.237842233,0.933993403,2,85,carbohydrate transmembrane transport,BP,1
GO:0008207,0.237958372,0.970524721,1,24,C21-steroid hormone metabolic process,BP,1
GO:0043271,0.238132272,0.933840004,2,87,negative regulation of ion transport,BP,1
GO:0000725,0.238169687,0.933833609,2,86,recombinational repair,BP,1
GO:1901797,0.238323442,0.970429686,1,24,negative regulation of signal transduction by p53 class mediator,BP,1
GO:0098815,0.238358921,0.970330023,1,26,modulation of excitatory postsynaptic potential,BP,1
GO:0045577,0.238706137,0.970282722,1,25,regulation of B cell differentiation,BP,1
GO:0009967,0.23933119,0.844296004,13,963,positive regulation of signal transduction,BP,1
GO:1903671,0.239739153,0.969968088,1,26,negative regulation of sprouting angiogenesis,BP,1
GO:1901215,0.239851919,0.910289219,3,155,negative regulation of neuron death,BP,1
GO:0010976,0.239946333,0.894766038,4,238,positive regulation of neuron projection development,BP,1
GO:0044092,0.240016754,0.853195937,10,704,negative regulation of molecular function,BP,1
GO:0033135,0.240091024,0.932956849,2,86,regulation of peptidyl-serine phosphorylation,BP,1
GO:0031116,0.240176359,0.969812155,1,27,positive regulation of microtubule polymerization,BP,1
GO:0033032,0.240725357,0.969752254,1,25,regulation of myeloid cell apoptotic process,BP,1
GO:0032271,0.241159389,0.909549034,3,158,regulation of protein polymerization,BP,1
GO:0009895,0.24120091,0.894024145,4,229,negative regulation of catabolic process,BP,1
GO:0019395,0.241269825,0.932427559,2,85,fatty acid oxidation,BP,1
GO:0034440,0.241269825,0.932427559,2,85,lipid oxidation,BP,1
GO:0033046,0.241297664,0.969515332,1,27,negative regulation of sister chromatid segregation,BP,1
GO:0043276,0.241460372,0.969513345,1,26,anoikis,BP,1
GO:0006921,0.241810385,0.969465067,1,25,cellular component disassembly involved in execution phase of apoptosis,BP,1
GO:0090102,0.241969153,0.969378204,1,26,cochlea development,BP,1
GO:0008206,0.242142283,0.969376921,1,25,bile acid metabolic process,BP,1
GO:0033002,0.242169582,0.908992659,3,157,muscle cell proliferation,BP,1
GO:0001816,0.242224221,0.866252924,7,465,cytokine production,BP,1
GO:0097190,0.242471078,0.866083159,7,461,apoptotic signaling pathway,BP,1
GO:0060236,0.242867035,0.969097208,1,27,regulation of mitotic spindle organization,BP,1
GO:0032885,0.243106232,0.969033204,1,27,regulation of polysaccharide biosynthetic process,BP,1
GO:1903432,0.243241029,0.969038928,1,26,regulation of TORC1 signaling,BP,1
GO:0031175,0.243281602,0.854862847,9,648,neuron projection development,BP,1
GO:0032886,0.243644124,0.908140826,3,163,regulation of microtubule-based process,BP,1
GO:0048565,0.243851979,0.931193971,2,89,digestive tract development,BP,1
GO:2000781,0.243955885,0.968847331,1,26,positive regulation of double-strand break repair,BP,1
GO:0014823,0.244413825,0.930944233,2,88,response to activity,BP,1
GO:1902850,0.244493803,0.930886296,2,90,microtubule cytoskeleton organization involved in mitosis,BP,1
GO:0009057,0.244670652,0.840126565,13,956,macromolecule catabolic process,BP,1
GO:0045777,0.24470485,0.96869162,1,25,positive regulation of blood pressure,BP,1
GO:0032940,0.245434568,0.853281035,9,626,secretion by cell,BP,1
GO:0051049,0.245553923,0.834684765,15,1133,regulation of transport,BP,1
GO:0001782,0.245655271,0.968389237,1,26,B cell homeostasis,BP,1
GO:0046456,0.24616633,0.968297024,1,25,icosanoid biosynthetic process,BP,1
GO:0000002,0.246241203,0.968276735,1,25,mitochondrial genome maintenance,BP,1
GO:0034332,0.246598435,0.929907179,2,90,adherens junction organization,BP,1
GO:0072348,0.246732233,0.968143498,1,25,sulfur compound transport,BP,1
GO:0009072,0.246733596,0.968143127,1,25,aromatic amino acid family metabolic process,BP,1
GO:0055007,0.246863345,0.929783515,2,90,cardiac muscle cell differentiation,BP,1
GO:0048009,0.246950731,0.967994435,1,27,insulin-like growth factor receptor signaling pathway,BP,1
GO:0060485,0.247156078,0.90617186,3,163,mesenchyme development,BP,1
GO:0043412,0.247310315,0.813126327,33,2684,macromolecule modification,BP,1
GO:0046822,0.247395542,0.92954528,2,89,regulation of nucleocytoplasmic transport,BP,1
GO:0032368,0.247571209,0.929463108,2,89,regulation of lipid transport,BP,1
GO:0009056,0.247836415,0.821752166,22,1718,catabolic process,BP,1
GO:0070873,0.249117016,0.967400756,1,27,regulation of glycogen metabolic process,BP,1
GO:0033028,0.249352276,0.967379864,1,26,myeloid cell apoptotic process,BP,1
GO:0048609,0.249748115,0.860892094,7,474,multicellular organismal reproductive process,BP,1
GO:0008637,0.249748326,0.928474673,2,86,apoptotic mitochondrial changes,BP,1
GO:0051985,0.249918046,0.967138719,1,28,negative regulation of chromosome segregation,BP,1
GO:0001736,0.250008427,0.967154706,1,27,establishment of planar polarity,BP,1
GO:0002534,0.250284735,0.967122504,1,26,cytokine production involved in inflammatory response,BP,1
GO:1900015,0.250284735,0.967122504,1,26,regulation of cytokine production involved in inflammatory response,BP,1
GO:0071158,0.250288934,0.967121342,1,26,positive regulation of cell cycle arrest,BP,1
GO:0001774,0.250419176,0.967085306,1,26,microglial cell activation,BP,1
GO:0002269,0.250419176,0.967085306,1,26,leukocyte activation involved in inflammatory response,BP,1
GO:1902476,0.250693377,0.966964947,1,27,chloride transmembrane transport,BP,1
GO:0001569,0.250694035,0.96692353,1,28,branching involved in blood vessel morphogenesis,BP,1
GO:0032715,0.250746953,0.966994516,1,26,negative regulation of interleukin-6 production,BP,1
GO:0048246,0.250793704,0.966981555,1,26,macrophage chemotaxis,BP,1
GO:0009790,0.251271034,0.844665339,10,733,embryo development,BP,1
GO:0046329,0.251508159,0.966783136,1,26,negative regulation of JNK cascade,BP,1
GO:0070570,0.251704053,0.966642276,1,28,regulation of neuron projection regeneration,BP,1
GO:0009653,0.25206219,0.820796696,20,1598,anatomical structure morphogenesis,BP,1
GO:0001841,0.252219482,0.927242063,2,92,neural tube formation,BP,1
GO:0060412,0.252317477,0.966470815,1,28,ventricular septum morphogenesis,BP,1
GO:0048645,0.252485675,0.966423716,1,28,animal organ formation,BP,1
GO:0044248,0.25263696,0.820331937,20,1550,cellular catabolic process,BP,1
GO:0060323,0.25264751,0.966378364,1,28,head morphogenesis,BP,1
GO:0009062,0.252728734,0.927043143,2,88,fatty acid catabolic process,BP,1
GO:0042026,0.253888599,0.966117279,1,26,protein refolding,BP,1
GO:0051085,0.25432611,0.9659941,1,26,chaperone cofactor-dependent protein refolding,BP,1
GO:0035329,0.254631822,0.965819527,1,28,hippo signaling,BP,1
GO:0048147,0.254967184,0.965767222,1,27,negative regulation of fibroblast proliferation,BP,1
GO:0072583,0.255010504,0.965712299,1,28,clathrin-dependent endocytosis,BP,1
GO:0009410,0.255200431,0.88530448,4,233,response to xenobiotic stimulus,BP,1
GO:0030224,0.255462873,0.965626773,1,27,monocyte differentiation,BP,1
GO:1903131,0.255462873,0.965626773,1,27,mononuclear cell differentiation,BP,1
GO:0007006,0.2556605,0.925645466,2,88,mitochondrial membrane organization,BP,1
GO:0032369,0.255874632,0.965509862,1,27,negative regulation of lipid transport,BP,1
GO:0031112,0.256104102,0.965361538,1,29,positive regulation of microtubule polymerization or depolymerization,BP,1
GO:1901568,0.256359526,0.925322065,2,87,fatty acid derivative metabolic process,BP,1
GO:0032504,0.256664396,0.855920542,7,478,multicellular organism reproduction,BP,1
GO:0021532,0.25699809,0.965189755,1,27,neural tube patterning,BP,1
GO:0008610,0.257428156,0.862722135,6,389,lipid biosynthetic process,BP,1
GO:0051091,0.257652715,0.900205323,3,161,positive regulation of DNA-binding transcription factor activity,BP,1
GO:0046660,0.258333903,0.924316694,2,92,female sex differentiation,BP,1
GO:0007164,0.258530647,0.96470659,1,28,establishment of tissue polarity,BP,1
GO:0002790,0.258533913,0.861940821,6,393,peptide secretion,BP,1
GO:0031214,0.258613754,0.924192294,2,91,biomineral tissue development,BP,1
GO:0090224,0.258966486,0.964540001,1,29,regulation of spindle organization,BP,1
GO:2000648,0.259286226,0.964488612,1,28,positive regulation of stem cell proliferation,BP,1
GO:0035567,0.259669226,0.964422061,1,27,non-canonical Wnt signaling pathway,BP,1
GO:0035150,0.259738439,0.923648368,2,91,regulation of tube size,BP,1
GO:0035296,0.259738439,0.923648368,2,91,regulation of tube diameter,BP,1
GO:0050880,0.259738439,0.923648368,2,91,regulation of blood vessel size,BP,1
GO:0097746,0.259738439,0.923648368,2,91,regulation of blood vessel diameter,BP,1
GO:0010647,0.259749278,0.825614397,14,1064,positive regulation of cell communication,BP,1
GO:0006536,0.259909786,0.964352466,1,27,glutamate metabolic process,BP,1
GO:0006636,0.260150655,0.964282705,1,27,unsaturated fatty acid biosynthetic process,BP,1
GO:0048821,0.260158919,0.964235917,1,28,erythrocyte development,BP,1
GO:1905521,0.260438874,0.964199131,1,27,regulation of macrophage migration,BP,1
GO:1902235,0.260441478,0.964198376,1,27,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,1
GO:0006213,0.261034085,0.964026195,1,27,pyrimidine nucleoside metabolic process,BP,1
GO:0071868,0.261063285,0.963972999,1,28,cellular response to monoamine stimulus,BP,1
GO:0071870,0.261063285,0.963972999,1,28,cellular response to catecholamine stimulus,BP,1
GO:0016064,0.261119904,0.923000355,2,89,immunoglobulin mediated immune response,BP,1
GO:0048732,0.261728732,0.859680808,6,402,gland development,BP,1
GO:0003158,0.261796195,0.922627242,2,93,endothelium development,BP,1
GO:0045005,0.261830059,0.963749241,1,28,DNA-dependent DNA replication maintenance of fidelity,BP,1
GO:0010464,0.261925273,0.963721402,1,28,regulation of mesenchymal cell proliferation,BP,1
GO:0048873,0.261976866,0.963706312,1,28,homeostasis of number of cells within a tissue,BP,1
GO:0048878,0.262072183,0.83640169,10,722,chemical homeostasis,BP,1
GO:0010569,0.263177386,0.963354197,1,28,regulation of double-strand break repair via homologous recombination,BP,1
GO:0070848,0.263194894,0.85118106,7,484,response to growth factor,BP,1
GO:0006952,0.263416538,0.831568288,11,800,defense response,BP,1
GO:0042176,0.263531676,0.867787305,5,317,regulation of protein catabolic process,BP,1
GO:0009225,0.264357134,0.963052157,1,27,nucleotide-sugar metabolic process,BP,1
GO:0032892,0.264714599,0.96290056,1,28,positive regulation of organic acid transport,BP,1
GO:0006308,0.264851888,0.962859894,1,28,DNA catabolic process,BP,1
GO:0042738,0.265017542,0.962856851,1,27,exogenous drug catabolic process,BP,1
GO:0002548,0.265040906,0.962803865,1,28,monocyte chemotaxis,BP,1
GO:0019724,0.265326876,0.920931758,2,90,B cell mediated immunity,BP,1
GO:0033865,0.265388312,0.920901539,2,90,nucleoside bisphosphate metabolic process,BP,1
GO:0033875,0.265388312,0.920901539,2,90,ribonucleoside bisphosphate metabolic process,BP,1
GO:0034032,0.265388312,0.920901539,2,90,purine nucleoside bisphosphate metabolic process,BP,1
GO:0007606,0.265480766,0.962673298,1,28,sensory perception of chemical stimulus,BP,1
GO:0043516,0.265509949,0.962664627,1,28,"regulation of DNA damage response, signal transduction by p53 class mediator",BP,1
GO:0021879,0.265782489,0.96254047,1,29,forebrain neuron differentiation,BP,1
GO:0030225,0.266098558,0.962489483,1,28,macrophage differentiation,BP,1
GO:0030317,0.26626238,0.962397383,1,29,flagellated sperm motility,BP,1
GO:0097722,0.26626238,0.962397383,1,29,sperm motility,BP,1
GO:0060487,0.266774718,0.962287724,1,28,lung epithelial cell differentiation,BP,1
GO:0038083,0.26679251,0.962238963,1,29,peptidyl-tyrosine autophosphorylation,BP,1
GO:0009108,0.266899888,0.894826398,3,161,coenzyme biosynthetic process,BP,1
GO:0007010,0.266909895,0.828817129,11,827,cytoskeleton organization,BP,1
GO:0023056,0.267118527,0.819680905,14,1070,positive regulation of signaling,BP,1
GO:1990776,0.26753766,0.962015658,1,29,response to angiotensin,BP,1
GO:2000351,0.268043353,0.961863694,1,29,regulation of endothelial cell apoptotic process,BP,1
GO:0048010,0.268951233,0.96159002,1,29,vascular endothelial growth factor receptor signaling pathway,BP,1
GO:0021587,0.269587437,0.961356201,1,30,cerebellum morphogenesis,BP,1
GO:0035690,0.2696802,0.863592521,5,319,cellular response to drug,BP,1
GO:0010811,0.270566858,0.918280153,2,95,positive regulation of cell-substrate adhesion,BP,1
GO:0031111,0.270820566,0.960942249,1,31,negative regulation of microtubule polymerization or depolymerization,BP,1
GO:0046887,0.270854808,0.918158011,2,93,positive regulation of hormone secretion,BP,1
GO:0032653,0.271109866,0.960979771,1,28,regulation of interleukin-10 production,BP,1
GO:0006040,0.271174929,0.960959951,1,28,amino sugar metabolic process,BP,1
GO:0055026,0.271224642,0.960899911,1,29,negative regulation of cardiac muscle tissue development,BP,1
GO:0030324,0.271400716,0.892137281,3,167,lung development,BP,1
GO:0007520,0.271538858,0.960803988,1,29,myoblast fusion,BP,1
GO:0060041,0.271829442,0.917617829,2,98,retina development in camera-type eye,BP,1
GO:0044060,0.271957483,0.96072112,1,28,regulation of endocrine process,BP,1
GO:0008156,0.272801621,0.960417166,1,29,negative regulation of DNA replication,BP,1
GO:0001708,0.27286529,0.960355212,1,30,cell fate specification,BP,1
GO:0046839,0.273711829,0.960094366,1,30,phospholipid dephosphorylation,BP,1
GO:0061005,0.274232833,0.959893306,1,31,cell differentiation involved in kidney development,BP,1
GO:0006091,0.274546572,0.860254094,5,316,generation of precursor metabolites and energy,BP,1
GO:0045124,0.274557588,0.959832803,1,30,regulation of bone resorption,BP,1
GO:0002714,0.274969101,0.959748237,1,29,positive regulation of B cell mediated immunity,BP,1
GO:0002891,0.274969101,0.959748237,1,29,positive regulation of immunoglobulin mediated immune response,BP,1
GO:0060479,0.275105477,0.959705938,1,29,lung cell differentiation,BP,1
GO:0002831,0.275628335,0.915736237,2,95,regulation of response to biotic stimulus,BP,1
GO:0048713,0.275648957,0.959493866,1,30,regulation of oligodendrocyte differentiation,BP,1
GO:0042088,0.275736094,0.959510021,1,29,T-helper 1 type immune response,BP,1
GO:0055123,0.275970681,0.915541603,2,97,digestive system development,BP,1
GO:0006814,0.276044798,0.915525384,2,95,sodium ion transport,BP,1
GO:0032965,0.276167431,0.959375708,1,29,regulation of collagen biosynthetic process,BP,1
GO:0046627,0.276232715,0.959311917,1,30,negative regulation of insulin receptor signaling pathway,BP,1
GO:0090049,0.276327576,0.959282308,1,30,regulation of cell migration involved in sprouting angiogenesis,BP,1
GO:1901985,0.276466917,0.959282305,1,29,positive regulation of protein acetylation,BP,1
GO:0071695,0.277114666,0.9149508,2,98,anatomical structure maturation,BP,1
GO:0045070,0.277209034,0.959006591,1,30,positive regulation of viral genome replication,BP,1
GO:2000242,0.277281953,0.959027504,1,29,negative regulation of reproductive process,BP,1
GO:0007423,0.277380052,0.858259369,5,332,sensory organ development,BP,1
GO:0044786,0.277965657,0.958769088,1,30,cell cycle DNA replication,BP,1
GO:0045776,0.278753972,0.958565051,1,29,negative regulation of blood pressure,BP,1
GO:0001838,0.279541719,0.913703133,2,99,embryonic epithelial tube formation,BP,1
GO:0050918,0.279705667,0.958139291,1,32,positive chemotaxis,BP,1
GO:2001239,0.279715004,0.958217021,1,30,regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,1
GO:0001658,0.280062072,0.958107001,1,30,branching involved in ureteric bud morphogenesis,BP,1
GO:0030323,0.280642131,0.886586583,3,170,respiratory tube development,BP,1
GO:0051154,0.281059905,0.957789783,1,30,negative regulation of striated muscle cell differentiation,BP,1
GO:0120035,0.281091491,0.837982403,7,501,regulation of plasma membrane bounded cell projection organization,BP,1
GO:0006692,0.281348474,0.957742848,1,29,prostanoid metabolic process,BP,1
GO:0006693,0.281348474,0.957742848,1,29,prostaglandin metabolic process,BP,1
GO:0045839,0.28215376,0.957358395,1,32,negative regulation of mitotic nuclear division,BP,1
GO:1903707,0.283263808,0.911822098,2,96,negative regulation of hemopoiesis,BP,1
GO:0090183,0.284083566,0.956820311,1,30,regulation of kidney development,BP,1
GO:0060070,0.284582824,0.884163085,3,176,canonical Wnt signaling pathway,BP,1
GO:0045601,0.28476191,0.956517501,1,32,regulation of endothelial cell differentiation,BP,1
GO:0071345,0.285036079,0.828561074,8,569,cellular response to cytokine stimulus,BP,1
GO:0010862,0.285363832,0.956406083,1,30,positive regulation of pathway-restricted SMAD protein phosphorylation,BP,1
GO:0007186,0.285724653,0.865477259,4,250,G protein-coupled receptor signaling pathway,BP,1
GO:0097502,0.285935499,0.956220402,1,30,mannosylation,BP,1
GO:0030521,0.286009801,0.9561527,1,31,androgen receptor signaling pathway,BP,1
GO:0038202,0.286109481,0.956079404,1,32,TORC1 signaling,BP,1
GO:0045744,0.286123821,0.956115566,1,31,negative regulation of G protein-coupled receptor signaling pathway,BP,1
GO:0072175,0.286460995,0.910110852,2,101,epithelial tube formation,BP,1
GO:1902229,0.286829827,0.955929024,1,30,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,1
GO:0050790,0.287049747,0.794783622,18,1425,regulation of catalytic activity,BP,1
GO:0051445,0.287232781,0.955753477,1,31,regulation of meiotic cell cycle,BP,1
GO:0051051,0.287268853,0.851357578,5,330,negative regulation of transport,BP,1
GO:0048015,0.287294211,0.909656329,2,103,phosphatidylinositol-mediated signaling,BP,1
GO:2000179,0.288279073,0.955329931,1,33,positive regulation of neural precursor cell proliferation,BP,1
GO:0072577,0.288628544,0.955253806,1,32,endothelial cell apoptotic process,BP,1
GO:0060251,0.289000011,0.955131327,1,32,regulation of glial cell proliferation,BP,1
GO:0042073,0.289226297,0.955098346,1,31,intraciliary transport,BP,1
GO:0048736,0.28938774,0.908570181,2,102,appendage development,BP,1
GO:0060173,0.28938774,0.908570181,2,102,limb development,BP,1
GO:0070301,0.289855346,0.908389121,2,96,cellular response to hydrogen peroxide,BP,1
GO:0031344,0.290003076,0.831300946,7,506,regulation of cell projection organization,BP,1
GO:0048017,0.290598174,0.907913844,2,104,inositol lipid-mediated signaling,BP,1
GO:0002753,0.291280167,0.954375377,1,32,cytoplasmic pattern recognition receptor signaling pathway,BP,1
GO:0032273,0.291420794,0.907520939,2,100,positive regulation of protein polymerization,BP,1
GO:0001947,0.292186676,0.954072854,1,32,heart looping,BP,1
GO:1904036,0.292503075,0.953966998,1,32,negative regulation of epithelial cell apoptotic process,BP,1
GO:0002833,0.292602199,0.953933807,1,32,positive regulation of response to biotic stimulus,BP,1
GO:0070207,0.29272114,0.953936689,1,31,protein homotrimerization,BP,1
GO:0002639,0.293047951,0.953827202,1,31,positive regulation of immunoglobulin production,BP,1
GO:0016233,0.293068102,0.953737394,1,33,telomere capping,BP,1
GO:0032881,0.293263661,0.953671693,1,33,regulation of polysaccharide metabolic process,BP,1
GO:0051896,0.293340389,0.906516494,2,99,regulation of protein kinase B signaling,BP,1
GO:0006998,0.293350249,0.953725796,1,31,nuclear envelope organization,BP,1
GO:0000096,0.293414611,0.953704189,1,31,sulfur amino acid metabolic process,BP,1
GO:0071867,0.294089771,0.953434067,1,32,response to monoamine,BP,1
GO:0071869,0.294089771,0.953434067,1,32,response to catecholamine,BP,1
GO:0001525,0.294244774,0.846408128,5,337,angiogenesis,BP,1
GO:0021536,0.294454139,0.953270592,1,33,diencephalon development,BP,1
GO:0034097,0.294483836,0.815724233,9,658,response to cytokine,BP,1
GO:0006221,0.294810029,0.953234339,1,31,pyrimidine nucleotide biosynthetic process,BP,1
GO:0018193,0.294830006,0.806598478,11,832,peptidyl-amino acid modification,BP,1
GO:0030001,0.295157282,0.835543259,6,416,metal ion transport,BP,1
GO:0009952,0.295513084,0.905318987,2,103,anterior/posterior pattern specification,BP,1
GO:0032613,0.295652046,0.952949524,1,31,interleukin-10 production,BP,1
GO:0055093,0.295996296,0.952789116,1,32,response to hyperoxia,BP,1
GO:0000387,0.296473921,0.952670577,1,31,spliceosomal snRNP assembly,BP,1
GO:0043523,0.297032436,0.876482336,3,175,regulation of neuron apoptotic process,BP,1
GO:0002697,0.297058637,0.857860433,4,251,regulation of immune effector process,BP,1
GO:0061041,0.297068435,0.904519671,2,100,regulation of wound healing,BP,1
GO:0042127,0.297133967,0.79794325,13,1001,regulation of cell proliferation,BP,1
GO:0019637,0.297434642,0.808628341,10,738,organophosphate metabolic process,BP,1
GO:0019369,0.297595534,0.952288389,1,31,arachidonic acid metabolic process,BP,1
GO:0010463,0.298096972,0.952031056,1,33,mesenchymal cell proliferation,BP,1
GO:0060119,0.298775833,0.951798027,1,33,inner ear receptor cell development,BP,1
GO:0043030,0.299649753,0.951539134,1,32,regulation of macrophage activation,BP,1
GO:0032757,0.299883668,0.951458471,1,32,positive regulation of interleukin-8 production,BP,1
GO:0008203,0.300048198,0.902918767,2,100,cholesterol metabolic process,BP,1
GO:0061371,0.300233295,0.951295567,1,33,determination of heart left/right asymmetry,BP,1
GO:0071675,0.3008274,0.951132264,1,32,regulation of mononuclear cell migration,BP,1
GO:0006261,0.301173099,0.902311275,2,100,DNA-dependent DNA replication,BP,1
GO:0001818,0.301243229,0.873844989,3,174,negative regulation of cytokine production,BP,1
GO:0043029,0.301506029,0.950896924,1,32,T cell homeostasis,BP,1
GO:0032147,0.301699932,0.873535597,3,178,activation of protein kinase activity,BP,1
GO:0060976,0.302473431,0.950337297,1,38,coronary vasculature development,BP,1
GO:0010830,0.302484877,0.950513512,1,33,regulation of myotube differentiation,BP,1
GO:0030071,0.302506355,0.950465712,1,34,regulation of mitotic metaphase/anaphase transition,BP,1
GO:0009163,0.302776703,0.950454542,1,32,nucleoside biosynthetic process,BP,1
GO:0042455,0.302776703,0.950454542,1,32,ribonucleoside biosynthetic process,BP,1
GO:0045429,0.303183973,0.950269249,1,33,positive regulation of nitric oxide biosynthetic process,BP,1
GO:0002221,0.3031917,0.901205729,2,101,pattern recognition receptor signaling pathway,BP,1
GO:0002758,0.3031917,0.901205729,2,101,innate immune response-activating signal transduction,BP,1
GO:0051084,0.303755448,0.950112255,1,32,'de novo' posttranslational protein folding,BP,1
GO:0060986,0.304434981,0.94987382,1,32,endocrine hormone secretion,BP,1
GO:0002684,0.305299454,0.812867064,8,580,positive regulation of immune system process,BP,1
GO:0090342,0.305439499,0.949476507,1,33,regulation of cell aging,BP,1
GO:0006084,0.305848359,0.949332043,1,33,acetyl-CoA metabolic process,BP,1
GO:0030010,0.306022877,0.899618374,2,105,establishment of cell polarity,BP,1
GO:0022412,0.306023869,0.870785802,3,180,cellular process involved in reproduction in multicellular organism,BP,1
GO:0051186,0.306248901,0.827310248,6,408,cofactor metabolic process,BP,1
GO:0010883,0.306343672,0.94911539,1,34,regulation of lipid storage,BP,1
GO:0051784,0.306358455,0.949071189,1,35,negative regulation of nuclear division,BP,1
GO:0030850,0.307006263,0.948880136,1,34,prostate gland development,BP,1
GO:0016311,0.308367509,0.836255237,5,340,dephosphorylation,BP,1
GO:1900077,0.308373588,0.948392707,1,34,negative regulation of cellular response to insulin stimulus,BP,1
GO:0042594,0.309019693,0.868890391,3,177,response to starvation,BP,1
GO:0051353,0.310083526,0.94782176,1,33,positive regulation of oxidoreductase activity,BP,1
GO:0048538,0.310416879,0.9476194,1,35,thymus development,BP,1
GO:1902099,0.310436585,0.947612294,1,35,regulation of metaphase/anaphase transition of cell cycle,BP,1
GO:1901031,0.311422577,0.947338977,1,33,regulation of response to reactive oxygen species,BP,1
GO:0072329,0.311471331,0.896647129,2,102,monocarboxylic acid catabolic process,BP,1
GO:0006458,0.311671292,0.947249026,1,33,'de novo' protein folding,BP,1
GO:0022604,0.311740164,0.833772983,5,353,regulation of cell morphogenesis,BP,1
GO:0042093,0.311907698,0.947120618,1,34,T-helper cell differentiation,BP,1
GO:0001523,0.311912574,0.947161678,1,33,retinoid metabolic process,BP,1
GO:0001961,0.312091388,0.947054016,1,34,positive regulation of cytokine-mediated signaling pathway,BP,1
GO:0061351,0.312139317,0.896212451,2,108,neural precursor cell proliferation,BP,1
GO:0010907,0.312421917,0.946934052,1,34,positive regulation of glucose metabolic process,BP,1
GO:0000413,0.312458493,0.946963744,1,33,protein peptidyl-prolyl isomerization,BP,1
GO:0007059,0.313077809,0.866251547,3,183,chromosome segregation,BP,1
GO:0072528,0.313461503,0.946555729,1,34,pyrimidine-containing compound biosynthetic process,BP,1
GO:1905517,0.313688796,0.946472808,1,34,macrophage migration,BP,1
GO:0030258,0.314047788,0.865635892,3,181,lipid modification,BP,1
GO:0010038,0.314169452,0.832030921,5,338,response to metal ion,BP,1
GO:0021872,0.31433132,0.946158305,1,36,forebrain generation of neurons,BP,1
GO:0061383,0.314530733,0.946048557,1,37,trabecula morphogenesis,BP,1
GO:0032007,0.314946496,0.945971495,1,35,negative regulation of TOR signaling,BP,1
GO:0006821,0.31514434,0.945898852,1,35,chloride transport,BP,1
GO:0031646,0.315250506,0.945820916,1,36,positive regulation of neurological system process,BP,1
GO:0045010,0.316566822,0.945416487,1,34,actin nucleation,BP,1
GO:0120163,0.316582124,0.945369262,1,35,negative regulation of cold-induced thermogenesis,BP,1
GO:0009880,0.316582745,0.945369032,1,35,embryonic pattern specification,BP,1
GO:0001817,0.316623705,0.819461292,6,423,regulation of cytokine production,BP,1
GO:1902652,0.316701358,0.893703906,2,104,secondary alcohol metabolic process,BP,1
GO:0034405,0.317714736,0.944949996,1,35,response to fluid shear stress,BP,1
GO:0000723,0.317908636,0.893002505,2,106,telomere maintenance,BP,1
GO:1904407,0.31893722,0.944495401,1,35,positive regulation of nitric oxide metabolic process,BP,1
GO:0060541,0.318963161,0.86242914,3,184,respiratory system development,BP,1
GO:0072595,0.319439689,0.944350253,1,34,maintenance of protein localization in organelle,BP,1
GO:0002293,0.319731906,0.944198737,1,35,alpha-beta T cell differentiation involved in immune response,BP,1
GO:0002294,0.319731906,0.944198737,1,35,"CD4-positive, alpha-beta T cell differentiation involved in immune response",BP,1
GO:0060688,0.319896131,0.944137318,1,35,regulation of morphogenesis of a branching structure,BP,1
GO:0032964,0.320033305,0.944085985,1,35,collagen biosynthetic process,BP,1
GO:0050714,0.320201426,0.861636635,3,181,positive regulation of protein secretion,BP,1
GO:0032200,0.322079953,0.890627838,2,107,telomere organization,BP,1
GO:0046850,0.322158927,0.943246448,1,36,regulation of bone remodeling,BP,1
GO:0030336,0.322348003,0.860214409,3,184,negative regulation of cell migration,BP,1
GO:0033344,0.322415215,0.943111125,1,37,cholesterol efflux,BP,1
GO:0051147,0.3230337,0.890073343,2,108,regulation of muscle cell differentiation,BP,1
GO:0010712,0.323486737,0.942784735,1,35,regulation of collagen metabolic process,BP,1
GO:0060416,0.324212708,0.942509001,1,35,response to growth hormone,BP,1
GO:0001974,0.324483957,0.942325574,1,37,blood vessel remodeling,BP,1
GO:0061900,0.324525741,0.942348639,1,36,glial cell activation,BP,1
GO:0001756,0.324587974,0.942248963,1,38,somitogenesis,BP,1
GO:0016125,0.325032708,0.888950923,2,106,sterol metabolic process,BP,1
GO:0061014,0.325084092,0.942096529,1,37,positive regulation of mRNA catabolic process,BP,1
GO:0009612,0.325136314,0.858368782,3,186,response to mechanical stimulus,BP,1
GO:0046685,0.325615121,0.941932679,1,36,response to arsenic-containing substance,BP,1
GO:1990868,0.325736958,0.94188605,1,36,response to chemokine,BP,1
GO:1990869,0.325736958,0.94188605,1,36,cellular response to chemokine,BP,1
GO:0033044,0.325997311,0.837707431,4,267,regulation of chromosome organization,BP,1
GO:0050673,0.326304756,0.837485566,4,268,epithelial cell proliferation,BP,1
GO:0017001,0.326596548,0.941598218,1,35,antibiotic catabolic process,BP,1
GO:0002706,0.326998232,0.887832111,2,105,regulation of lymphocyte mediated immunity,BP,1
GO:0048747,0.327269426,0.941297718,1,36,muscle fiber development,BP,1
GO:0007091,0.3273572,0.941186671,1,38,metaphase/anaphase transition of mitotic cell cycle,BP,1
GO:0010965,0.3273572,0.941186671,1,38,regulation of mitotic sister chromatid separation,BP,1
GO:0007405,0.327359469,0.941185796,1,38,neuroblast proliferation,BP,1
GO:0002287,0.327467868,0.941221284,1,36,alpha-beta T cell activation involved in immune response,BP,1
GO:0002720,0.327969046,0.941027991,1,36,positive regulation of cytokine production involved in immune response,BP,1
GO:0045931,0.328068795,0.887160121,2,110,positive regulation of mitotic cell cycle,BP,1
GO:2000725,0.328127508,0.940926944,1,37,regulation of cardiac muscle cell differentiation,BP,1
GO:2000279,0.328160409,0.94099624,1,35,negative regulation of DNA biosynthetic process,BP,1
GO:1902893,0.329234847,0.940498049,1,37,regulation of pri-miRNA transcription by RNA polymerase II,BP,1
GO:0046677,0.330208102,0.82014182,5,345,response to antibiotic,BP,1
GO:0016331,0.330699876,0.885614218,2,112,morphogenesis of embryonic epithelium,BP,1
GO:0008150,0.33074813,0.756464487,108,9615,biological_process,BP,1
GO:0031334,0.33081747,0.85460011,3,186,positive regulation of protein complex assembly,BP,1
GO:0046825,0.331095941,0.939773178,1,37,regulation of protein export from nucleus,BP,1
GO:0045727,0.331364906,0.8852802,2,107,positive regulation of translation,BP,1
GO:0051053,0.331526826,0.885174874,2,108,negative regulation of DNA metabolic process,BP,1
GO:0001578,0.331768132,0.939510123,1,37,microtubule bundle formation,BP,1
GO:0021695,0.331788752,0.939426854,1,39,cerebellar cortex development,BP,1
GO:0090329,0.332831856,0.939092493,1,37,regulation of DNA-dependent DNA replication,BP,1
GO:1901659,0.333952898,0.938691828,1,36,glycosyl compound biosynthetic process,BP,1
GO:0016358,0.334207069,0.852286083,3,195,dendrite development,BP,1
GO:0046326,0.334368845,0.93848612,1,37,positive regulation of glucose import,BP,1
GO:0060324,0.334468224,0.938370401,1,39,face development,BP,1
GO:0002292,0.334761887,0.9383305,1,37,T cell differentiation involved in immune response,BP,1
GO:0044784,0.335007095,0.938156661,1,39,metaphase/anaphase transition of cell cycle,BP,1
GO:0000186,0.335082698,0.938163962,1,38,activation of MAPKK activity,BP,1
GO:0097066,0.335646874,0.937979267,1,37,response to thyroid hormone,BP,1
GO:0015909,0.335902758,0.937877497,1,37,long-chain fatty acid transport,BP,1
GO:0051129,0.3386297,0.793548783,7,526,negative regulation of cellular component organization,BP,1
GO:0007548,0.338773684,0.849223364,3,192,sex differentiation,BP,1
GO:0070509,0.338815767,0.936671904,1,38,calcium ion import,BP,1
GO:0044255,0.338952361,0.779898931,9,684,cellular lipid metabolic process,BP,1
GO:0010821,0.339009739,0.88076589,2,109,regulation of mitochondrion organization,BP,1
GO:0010035,0.339710317,0.792696147,7,518,response to inorganic substance,BP,1
GO:0000245,0.339737178,0.93634089,1,37,spliceosomal complex assembly,BP,1
GO:1902105,0.339956752,0.848437649,3,189,regulation of leukocyte differentiation,BP,1
GO:0021675,0.339969405,0.936168235,1,39,nerve development,BP,1
GO:0009896,0.340508887,0.812349735,5,356,positive regulation of catabolic process,BP,1
GO:1903793,0.340739022,0.935895153,1,38,positive regulation of anion transport,BP,1
GO:1901570,0.34096134,0.935845732,1,37,fatty acid derivative biosynthetic process,BP,1
GO:0006396,0.341078928,0.778151741,9,677,RNA processing,BP,1
GO:0031952,0.341355682,0.935644937,1,38,regulation of protein autophosphorylation,BP,1
GO:0090303,0.341719467,0.935458267,1,39,positive regulation of wound healing,BP,1
GO:0016101,0.341725112,0.935535669,1,37,diterpenoid metabolic process,BP,1
GO:0045670,0.34251005,0.93509903,1,40,regulation of osteoclast differentiation,BP,1
GO:0032722,0.34326127,0.934868149,1,38,positive regulation of chemokine production,BP,1
GO:0043536,0.344281421,0.9344107,1,39,positive regulation of blood vessel endothelial cell migration,BP,1
GO:0046942,0.344503012,0.845341689,3,189,carboxylic acid transport,BP,1
GO:0010639,0.344813656,0.824104158,4,275,negative regulation of organelle organization,BP,1
GO:0032680,0.345459614,0.876901779,2,110,regulation of tumor necrosis factor production,BP,1
GO:0002042,0.345522009,0.933899908,1,39,cell migration involved in sprouting angiogenesis,BP,1
GO:0042149,0.346292494,0.93362134,1,38,cellular response to glucose starvation,BP,1
GO:0035196,0.346504599,0.933493706,1,39,production of miRNAs involved in gene silencing by miRNA,BP,1
GO:0015849,0.347610408,0.843205429,3,190,organic acid transport,BP,1
GO:0048260,0.348338791,0.932693305,1,40,positive regulation of receptor-mediated endocytosis,BP,1
GO:0006220,0.349018666,0.93248824,1,38,pyrimidine nucleotide metabolic process,BP,1
GO:0036296,0.349397773,0.93228925,1,39,response to increased oxygen levels,BP,1
GO:1903555,0.349583668,0.874396719,2,111,regulation of tumor necrosis factor superfamily cytokine production,BP,1
GO:0019538,0.349799812,0.71767994,43,3699,protein metabolic process,BP,1
GO:0051306,0.349888509,0.932008379,1,41,mitotic sister chromatid separation,BP,1
GO:0046782,0.350032331,0.932023393,1,39,regulation of viral transcription,BP,1
GO:0032835,0.35041338,0.931752844,1,42,glomerulus development,BP,1
GO:1904705,0.350481495,0.931834841,1,39,regulation of vascular smooth muscle cell proliferation,BP,1
GO:0030902,0.350628522,0.873697518,2,117,hindbrain development,BP,1
GO:0015711,0.351605142,0.819112403,4,273,organic anion transport,BP,1
GO:0060428,0.352035222,0.931180263,1,39,lung epithelium development,BP,1
GO:2000146,0.353235799,0.839295831,3,194,negative regulation of cell motility,BP,1
GO:0031050,0.353665585,0.930450038,1,40,dsRNA processing,BP,1
GO:0070918,0.353665585,0.930450038,1,40,production of small RNA involved in gene silencing by RNA,BP,1
GO:0035904,0.353840936,0.930174794,1,46,aorta development,BP,1
GO:0002763,0.353948926,0.930329511,1,40,positive regulation of myeloid leukocyte differentiation,BP,1
GO:0150076,0.354670073,0.930022202,1,40,neuroinflammatory response,BP,1
GO:0060760,0.354912198,0.929918846,1,40,positive regulation of response to cytokine stimulus,BP,1
GO:0031648,0.356065837,0.929387161,1,41,protein destabilization,BP,1
GO:1905818,0.357442792,0.928758507,1,42,regulation of chromosome separation,BP,1
GO:0055001,0.357623064,0.869401758,2,117,muscle cell development,BP,1
GO:0048812,0.357762219,0.799042609,5,379,neuron projection morphogenesis,BP,1
GO:0032640,0.357802678,0.869333382,2,113,tumor necrosis factor production,BP,1
GO:1990874,0.357870448,0.928648843,1,40,vascular smooth muscle cell proliferation,BP,1
GO:0010171,0.357948238,0.9285403,1,42,body morphogenesis,BP,1
GO:0007276,0.358162355,0.798761745,5,365,gamete generation,BP,1
GO:0051321,0.358559836,0.868831726,2,116,meiotic cell cycle,BP,1
GO:0000288,0.358695214,0.928253823,1,41,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",BP,1
GO:0042446,0.359113872,0.92811104,1,40,hormone biosynthetic process,BP,1
GO:0007166,0.35928762,0.734419947,17,1416,cell surface receptor signaling pathway,BP,1
GO:0022602,0.359323306,0.927981533,1,41,ovulation cycle process,BP,1
GO:0043388,0.36017634,0.927610757,1,41,positive regulation of DNA binding,BP,1
GO:0000904,0.360410349,0.785210243,6,469,cell morphogenesis involved in differentiation,BP,1
GO:0045773,0.360865289,0.927204108,1,44,positive regulation of axon extension,BP,1
GO:0010828,0.361160256,0.927181706,1,41,positive regulation of glucose transmembrane transport,BP,1
GO:0002793,0.361627149,0.833417534,3,195,positive regulation of peptide secretion,BP,1
GO:0043068,0.361685506,0.784222886,6,447,positive regulation of programmed cell death,BP,1
GO:0071706,0.361900036,0.86677383,2,114,tumor necrosis factor superfamily cytokine production,BP,1
GO:0045646,0.362121364,0.926761164,1,41,regulation of erythrocyte differentiation,BP,1
GO:0031330,0.362589721,0.832738265,3,195,negative regulation of cellular catabolic process,BP,1
GO:0048598,0.362746159,0.795165971,5,374,embryonic morphogenesis,BP,1
GO:0045619,0.362944099,0.866109662,2,115,regulation of lymphocyte differentiation,BP,1
GO:0009066,0.363030476,0.926401545,1,40,aspartate family amino acid metabolic process,BP,1
GO:0051148,0.363653168,0.926050247,1,42,negative regulation of muscle cell differentiation,BP,1
GO:0010631,0.363706129,0.831912186,3,202,epithelial cell migration,BP,1
GO:0008283,0.364523813,0.734710797,15,1232,cell proliferation,BP,1
GO:0032720,0.364945502,0.925557089,1,40,negative regulation of tumor necrosis factor production,BP,1
GO:0043433,0.365274786,0.864646022,2,115,negative regulation of DNA-binding transcription factor activity,BP,1
GO:0042472,0.365418731,0.925269465,1,42,inner ear morphogenesis,BP,1
GO:0002218,0.365506742,0.864478268,2,117,activation of innate immune response,BP,1
GO:0043085,0.365573152,0.747548921,11,883,positive regulation of catalytic activity,BP,1
GO:0090132,0.366256908,0.830097667,3,203,epithelium migration,BP,1
GO:2001236,0.366819462,0.863639408,2,118,regulation of extrinsic apoptotic signaling pathway,BP,1
GO:0002822,0.36722325,0.863416582,2,115,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,1
GO:0051155,0.367250438,0.924454331,1,42,positive regulation of striated muscle cell differentiation,BP,1
GO:0099173,0.367450363,0.86319967,2,122,postsynapse organization,BP,1
GO:0032874,0.367503311,0.863196497,2,119,positive regulation of stress-activated MAPK cascade,BP,1
GO:0060393,0.367512134,0.92437596,1,41,regulation of pathway-restricted SMAD protein phosphorylation,BP,1
GO:0001825,0.368477633,0.923868396,1,43,blastocyst formation,BP,1
GO:1903428,0.368499513,0.92389549,1,42,positive regulation of reactive oxygen species biosynthetic process,BP,1
GO:0031103,0.368799221,0.92368879,1,44,axon regeneration,BP,1
GO:0045766,0.369049543,0.862216215,2,119,positive regulation of angiogenesis,BP,1
GO:0061912,0.369365181,0.923434296,1,44,selective autophagy,BP,1
GO:0051258,0.369491753,0.827801656,3,201,protein polymerization,BP,1
GO:0009617,0.369605074,0.777835391,6,446,response to bacterium,BP,1
GO:0002673,0.369683376,0.923363583,1,42,regulation of acute inflammatory response,BP,1
GO:0031663,0.369975876,0.923270848,1,41,lipopolysaccharide-mediated signaling pathway,BP,1
GO:0019083,0.370099857,0.92317594,1,42,viral transcription,BP,1
GO:0001501,0.370274834,0.805061458,4,286,skeletal system development,BP,1
GO:0046605,0.371026297,0.922757567,1,42,regulation of centrosome cycle,BP,1
GO:0042733,0.371357842,0.922570046,1,43,embryonic digit morphogenesis,BP,1
GO:0070304,0.371421951,0.860695198,2,120,positive regulation of stress-activated protein kinase signaling cascade,BP,1
GO:0030155,0.37154423,0.776237842,6,460,regulation of cell adhesion,BP,1
GO:0051402,0.371913447,0.826066628,3,201,neuron apoptotic process,BP,1
GO:0034121,0.371988691,0.922321538,1,42,regulation of toll-like receptor signaling pathway,BP,1
GO:1903556,0.372171202,0.922278161,1,41,negative regulation of tumor necrosis factor superfamily cytokine production,BP,1
GO:0061614,0.372296762,0.922143996,1,43,pri-miRNA transcription by RNA polymerase II,BP,1
GO:0030163,0.372452593,0.751816439,9,711,protein catabolic process,BP,1
GO:0071363,0.372985646,0.77506402,6,461,cellular response to growth factor stimulus,BP,1
GO:0002090,0.373238271,0.921715384,1,43,regulation of receptor internalization,BP,1
GO:0032272,0.374527341,0.921126293,1,43,negative regulation of protein polymerization,BP,1
GO:0090130,0.375531807,0.823434702,3,206,tissue migration,BP,1
GO:0009798,0.376040022,0.92039503,1,44,axis specification,BP,1
GO:0097755,0.376150268,0.920380919,1,43,positive regulation of blood vessel diameter,BP,1
GO:0060079,0.376475406,0.920194354,1,44,excitatory postsynaptic potential,BP,1
GO:0044089,0.376686758,0.784161176,5,372,positive regulation of cellular component biogenesis,BP,1
GO:1903510,0.376792141,0.920084976,1,43,mucopolysaccharide metabolic process,BP,1
GO:0051781,0.377536638,0.919703961,1,44,positive regulation of cell division,BP,1
GO:0001738,0.379212901,0.918890137,1,45,morphogenesis of a polarized epithelium,BP,1
GO:0022618,0.379329927,0.820718546,3,199,ribonucleoprotein complex assembly,BP,1
GO:0006695,0.379411437,0.918870571,1,43,cholesterol biosynthetic process,BP,1
GO:0002252,0.381384802,0.76820763,6,453,immune effector process,BP,1
GO:0014068,0.381532258,0.917805575,1,45,positive regulation of phosphatidylinositol 3-kinase signaling,BP,1
GO:0061053,0.382483541,0.917323644,1,46,somite development,BP,1
GO:0050732,0.382783747,0.917291023,1,43,negative regulation of peptidyl-tyrosine phosphorylation,BP,1
GO:1905114,0.38311795,0.795167647,4,295,cell surface receptor signaling pathway involved in cell-cell signaling,BP,1
GO:0009887,0.383660933,0.756631328,7,562,animal organ morphogenesis,BP,1
GO:0120039,0.384433207,0.777912841,5,392,plasma membrane bounded cell projection morphogenesis,BP,1
GO:0032370,0.38488744,0.916221491,1,45,positive regulation of lipid transport,BP,1
GO:0001541,0.385116783,0.91614925,1,44,ovarian follicle development,BP,1
GO:0034764,0.385576634,0.851464888,2,125,positive regulation of transmembrane transport,BP,1
GO:2000300,0.385787096,0.915830498,1,44,regulation of synaptic vesicle exocytosis,BP,1
GO:1902653,0.386473841,0.915503186,1,44,secondary alcohol biosynthetic process,BP,1
GO:0018208,0.386732893,0.915418246,1,43,peptidyl-proline modification,BP,1
GO:0014855,0.386991398,0.915218965,1,45,striated muscle cell proliferation,BP,1
GO:0060389,0.38813695,0.914707388,1,44,pathway-restricted SMAD protein phosphorylation,BP,1
GO:1905207,0.388767206,0.914331522,1,46,regulation of cardiocyte differentiation,BP,1
GO:0048858,0.388907966,0.774295831,5,394,cell projection morphogenesis,BP,1
GO:0007595,0.389595585,0.913897973,1,47,lactation,BP,1
GO:0071331,0.389823818,0.848665129,2,124,cellular response to hexose stimulus,BP,1
GO:0097237,0.389839353,0.812990769,3,202,cellular response to toxic substance,BP,1
GO:0014911,0.389945115,0.913763572,1,46,positive regulation of smooth muscle cell migration,BP,1
GO:0050900,0.39002086,0.812840107,3,205,leukocyte migration,BP,1
GO:0007266,0.390236555,0.848360332,2,127,Rho protein signal transduction,BP,1
GO:0006029,0.390821769,0.913375542,1,45,proteoglycan metabolic process,BP,1
GO:0043266,0.391116817,0.913128585,1,48,regulation of potassium ion transport,BP,1
GO:0033555,0.391429438,0.913044688,1,46,multicellular organismal response to stress,BP,1
GO:0002819,0.391498337,0.847582261,2,121,regulation of adaptive immune response,BP,1
GO:0051453,0.391544652,0.913062893,1,44,regulation of intracellular pH,BP,1
GO:0031669,0.391707119,0.811584103,3,206,cellular response to nutrient levels,BP,1
GO:0031638,0.391882346,0.912898906,1,44,zymogen activation,BP,1
GO:0032677,0.392234577,0.912689629,1,45,regulation of interleukin-8 production,BP,1
GO:0030500,0.392252132,0.912681086,1,45,regulation of bone mineralization,BP,1
GO:0048286,0.392498698,0.912524619,1,46,lung alveolus development,BP,1
GO:0033047,0.392833024,0.912293237,1,48,regulation of mitotic sister chromatid segregation,BP,1
GO:0044265,0.392871967,0.728607969,10,808,cellular macromolecule catabolic process,BP,1
GO:0032890,0.393326115,0.912120905,1,46,regulation of organic acid transport,BP,1
GO:0002532,0.39400565,0.911825211,1,45,production of molecular mediator involved in inflammatory response,BP,1
GO:0071300,0.395900742,0.910857575,1,46,cellular response to retinoic acid,BP,1
GO:0071326,0.396739816,0.844013719,2,126,cellular response to monosaccharide stimulus,BP,1
GO:0099565,0.39741485,0.910073854,1,47,"chemical synaptic transmission, postsynaptic",BP,1
GO:0061178,0.39767308,0.909945865,1,47,regulation of insulin secretion involved in cellular response to glucose stimulus,BP,1
GO:0014009,0.398298437,0.909635461,1,47,glial cell proliferation,BP,1
GO:2000756,0.398926238,0.909359192,1,46,regulation of peptidyl-lysine acetylation,BP,1
GO:0043207,0.398993203,0.735627306,8,634,response to external biotic stimulus,BP,1
GO:0051707,0.398993203,0.735627306,8,634,response to other organism,BP,1
GO:0035265,0.399601099,0.842057347,2,128,organ growth,BP,1
GO:0045807,0.399832463,0.841900275,2,128,positive regulation of endocytosis,BP,1
GO:0060021,0.400192764,0.908691276,1,47,roof of mouth development,BP,1
GO:0071277,0.400217296,0.90867901,1,47,cellular response to calcium ion,BP,1
GO:0071364,0.400381112,0.908597076,1,47,cellular response to epidermal growth factor stimulus,BP,1
GO:0051188,0.40087819,0.804724945,3,205,cofactor biosynthetic process,BP,1
GO:0033574,0.40103851,0.908304195,1,46,response to testosterone,BP,1
GO:0006406,0.401215407,0.908179113,1,47,mRNA export from nucleus,BP,1
GO:0071427,0.401215407,0.908179113,1,47,mRNA-containing ribonucleoprotein complex export from nucleus,BP,1
GO:1903530,0.401711297,0.751277423,6,466,regulation of secretion by cell,BP,1
GO:0009636,0.402163089,0.750904046,6,462,response to toxic substance,BP,1
GO:0006935,0.402314228,0.780045994,4,304,chemotaxis,BP,1
GO:1902803,0.404717374,0.906412189,1,47,regulation of synaptic vesicle transport,BP,1
GO:0014032,0.405018623,0.906189656,1,49,neural crest cell development,BP,1
GO:0032637,0.405269129,0.906131951,1,47,interleukin-8 production,BP,1
GO:0043367,0.405363539,0.90608395,1,47,"CD4-positive, alpha-beta T cell differentiation",BP,1
GO:0120036,0.405560925,0.712469211,11,931,plasma membrane bounded cell projection organization,BP,1
GO:0071674,0.405652423,0.905936978,1,47,mononuclear cell migration,BP,1
GO:0007265,0.406953256,0.776345201,4,301,Ras protein signal transduction,BP,1
GO:0016126,0.407186205,0.905154338,1,47,sterol biosynthetic process,BP,1
GO:0060191,0.40739987,0.90500907,1,48,regulation of lipase activity,BP,1
GO:0046888,0.407427829,0.904994752,1,48,negative regulation of hormone secretion,BP,1
GO:0042330,0.407448988,0.775931514,4,306,taxis,BP,1
GO:0046328,0.408133245,0.836203733,2,129,regulation of JNK cascade,BP,1
GO:0002931,0.409020094,0.904177216,1,48,response to ischemia,BP,1
GO:0034250,0.409129028,0.83553563,2,127,positive regulation of cellular amide metabolic process,BP,1
GO:0071826,0.409412677,0.798219623,3,209,ribonucleoprotein complex subunit organization,BP,1
GO:0010769,0.409856661,0.797799088,3,225,regulation of cell morphogenesis involved in differentiation,BP,1
GO:2000134,0.411956555,0.902658407,1,48,negative regulation of G1/S transition of mitotic cell cycle,BP,1
GO:0031331,0.412035864,0.772248946,4,302,positive regulation of cellular catabolic process,BP,1
GO:0006487,0.412446982,0.902440144,1,47,protein N-linked glycosylation,BP,1
GO:0051271,0.412696989,0.795668036,3,215,negative regulation of cellular component movement,BP,1
GO:0030512,0.412751623,0.902209347,1,49,negative regulation of transforming growth factor beta receptor signaling pathway,BP,1
GO:0003281,0.412773282,0.902100192,1,52,ventricular septum development,BP,1
GO:1904018,0.413324651,0.832576306,2,131,positive regulation of vasculature development,BP,1
GO:0060078,0.413720049,0.901669748,1,50,regulation of postsynaptic membrane potential,BP,1
GO:0010676,0.413775525,0.901710343,1,48,positive regulation of cellular carbohydrate metabolic process,BP,1
GO:0014031,0.413826341,0.901581392,1,51,mesenchymal cell development,BP,1
GO:0071549,0.414395748,0.901350183,1,49,cellular response to dexamethasone stimulus,BP,1
GO:0031102,0.414612252,0.9011696,1,51,neuron projection regeneration,BP,1
GO:0061138,0.414666482,0.831607971,2,134,morphogenesis of a branching epithelium,BP,1
GO:0007189,0.414708397,0.901186288,1,49,adenylate cyclase-activating G protein-coupled receptor signaling pathway,BP,1
GO:0031346,0.414890918,0.769911594,4,310,positive regulation of cell projection organization,BP,1
GO:0045453,0.41497847,0.90104458,1,49,bone resorption,BP,1
GO:0070059,0.415236906,0.900908862,1,49,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,1
GO:0050708,0.416180956,0.768898966,4,299,regulation of protein secretion,BP,1
GO:2000779,0.416697488,0.900105155,1,50,regulation of double-strand break repair,BP,1
GO:0042471,0.416820902,0.90003998,1,50,ear morphogenesis,BP,1
GO:0008284,0.417012274,0.728129613,7,566,positive regulation of cell proliferation,BP,1
GO:0090398,0.417018033,0.899970435,1,49,cellular senescence,BP,1
GO:0048762,0.417374096,0.829705448,2,134,mesenchymal cell differentiation,BP,1
GO:0045428,0.417610676,0.899656999,1,49,regulation of nitric oxide biosynthetic process,BP,1
GO:0050773,0.417781797,0.829408389,2,135,regulation of dendrite development,BP,1
GO:0022600,0.418824215,0.899013325,1,49,digestive system process,BP,1
GO:0035264,0.419124501,0.828460126,2,135,multicellular organism growth,BP,1
GO:1903845,0.419437552,0.898652047,1,50,negative regulation of cellular response to transforming growth factor beta stimulus,BP,1
GO:0035282,0.420820815,0.89784725,1,52,segmentation,BP,1
GO:0048864,0.421003043,0.897749674,1,52,stem cell development,BP,1
GO:0050688,0.421535338,0.897496972,1,51,regulation of defense response to virus,BP,1
GO:0110110,0.421664898,0.8973948,1,52,positive regulation of animal organ morphogenesis,BP,1
GO:0060411,0.422105661,0.897126564,1,53,cardiac septum morphogenesis,BP,1
GO:0046890,0.422422517,0.826159896,2,131,regulation of lipid biosynthetic process,BP,1
GO:0043902,0.422747663,0.825918074,2,132,positive regulation of multi-organism process,BP,1
GO:0030307,0.423952864,0.825018687,2,136,positive regulation of cell growth,BP,1
GO:0071320,0.424273464,0.896021902,1,51,cellular response to cAMP,BP,1
GO:0030510,0.424319759,0.895963787,1,52,regulation of BMP signaling pathway,BP,1
GO:1901565,0.424924646,0.695071764,11,917,organonitrogen compound catabolic process,BP,1
GO:0006721,0.42502234,0.895686656,1,49,terpenoid metabolic process,BP,1
GO:0030279,0.42695496,0.894564877,1,51,negative regulation of ossification,BP,1
GO:0033209,0.427003329,0.894538482,1,51,tumor necrosis factor-mediated signaling pathway,BP,1
GO:0070374,0.427867715,0.822230813,2,134,positive regulation of ERK1 and ERK2 cascade,BP,1
GO:0060420,0.428053675,0.893898309,1,53,regulation of heart growth,BP,1
GO:0051149,0.428693356,0.893613681,1,51,positive regulation of muscle cell differentiation,BP,1
GO:0044093,0.42896081,0.683091181,13,1107,positive regulation of molecular function,BP,1
GO:0030030,0.430211516,0.690250333,11,948,cell projection organization,BP,1
GO:0032990,0.430907998,0.739329397,5,413,cell part morphogenesis,BP,1
GO:0000381,0.431147215,0.892297583,1,50,"regulation of alternative mRNA splicing, via spliceosome",BP,1
GO:0072091,0.431396771,0.892089925,1,52,regulation of stem cell proliferation,BP,1
GO:0007586,0.431830206,0.891884062,1,51,digestion,BP,1
GO:0030641,0.431941555,0.891857954,1,50,regulation of cellular pH,BP,1
GO:0071322,0.432105816,0.819156022,2,135,cellular response to carbohydrate stimulus,BP,1
GO:0043966,0.433725403,0.890796288,1,52,histone H3 acetylation,BP,1
GO:0008654,0.433732686,0.817982648,2,134,phospholipid biosynthetic process,BP,1
GO:0006979,0.433877452,0.736838761,5,391,response to oxidative stress,BP,1
GO:0006835,0.434047372,0.890583436,1,53,dicarboxylic acid transport,BP,1
GO:0045087,0.435063606,0.735819646,5,392,innate immune response,BP,1
GO:0001678,0.436169838,0.816182067,2,136,cellular glucose homeostasis,BP,1
GO:0009607,0.436282129,0.702777843,8,656,response to biotic stimulus,BP,1
GO:0021510,0.436644469,0.889064068,1,55,spinal cord development,BP,1
GO:0014033,0.436765988,0.889026843,1,54,neural crest cell differentiation,BP,1
GO:0006470,0.437621048,0.776049291,3,224,protein dephosphorylation,BP,1
GO:0031329,0.439116105,0.708673457,7,575,regulation of cellular catabolic process,BP,1
GO:0033045,0.43944617,0.887479526,1,55,regulation of sister chromatid segregation,BP,1
GO:0040014,0.440150424,0.887110734,1,54,regulation of multicellular organism growth,BP,1
GO:0016239,0.440170219,0.887099467,1,54,positive regulation of macroautophagy,BP,1
GO:1903708,0.440679403,0.81285435,2,137,positive regulation of hemopoiesis,BP,1
GO:0097194,0.440840987,0.886784531,1,52,execution phase of apoptosis,BP,1
GO:0035773,0.443972209,0.884922693,1,54,insulin secretion involved in cellular response to glucose stimulus,BP,1
GO:0002028,0.444078019,0.884861746,1,54,regulation of sodium ion transport,BP,1
GO:0032642,0.444351341,0.884737714,1,53,regulation of chemokine production,BP,1
GO:0007254,0.445462128,0.809282463,2,139,JNK cascade,BP,1
GO:0061045,0.445869194,0.883860715,1,53,negative regulation of wound healing,BP,1
GO:0070167,0.445985563,0.883759576,1,54,regulation of biomineral tissue development,BP,1
GO:0010942,0.446655606,0.712426131,6,491,positive regulation of cell death,BP,1
GO:0031349,0.447005723,0.768472305,3,224,positive regulation of defense response,BP,1
GO:0046928,0.447898221,0.882647929,1,54,regulation of neurotransmitter secretion,BP,1
GO:0043112,0.448292783,0.807154103,2,140,receptor metabolic process,BP,1
GO:0001763,0.448581293,0.806899395,2,144,morphogenesis of a branching structure,BP,1
GO:0045739,0.449013359,0.881963853,1,55,positive regulation of DNA repair,BP,1
GO:0098656,0.449375832,0.806350212,2,139,anion transmembrane transport,BP,1
GO:0038034,0.449696157,0.881596984,1,54,signal transduction in absence of ligand,BP,1
GO:0097192,0.449696157,0.881596984,1,54,extrinsic apoptotic signaling pathway in absence of ligand,BP,1
GO:0040013,0.450025377,0.765989446,3,228,negative regulation of locomotion,BP,1
GO:0070849,0.450141744,0.881302539,1,55,response to epidermal growth factor,BP,1
GO:0055013,0.450249097,0.881176793,1,57,cardiac muscle cell development,BP,1
GO:0006457,0.450893869,0.805247889,2,135,protein folding,BP,1
GO:0051924,0.451634505,0.804627694,2,141,regulation of calcium ion transport,BP,1
GO:0043967,0.451898242,0.880268545,1,55,histone H4 acetylation,BP,1
GO:0007160,0.452237407,0.804152598,2,143,cell-matrix adhesion,BP,1
GO:0035725,0.452594644,0.879824817,1,56,sodium ion transmembrane transport,BP,1
GO:1901607,0.452884693,0.87971889,1,54,alpha-amino acid biosynthetic process,BP,1
GO:0050663,0.454524608,0.802437539,2,141,cytokine secretion,BP,1
GO:0032482,0.454570909,0.87871826,1,54,Rab protein signal transduction,BP,1
GO:1903902,0.454886792,0.878496473,1,55,positive regulation of viral life cycle,BP,1
GO:0018394,0.456186317,0.801172554,2,141,peptidyl-lysine acetylation,BP,1
GO:0046324,0.456301324,0.877652073,1,55,regulation of glucose import,BP,1
GO:0002286,0.456873426,0.877309525,1,55,T cell activation involved in immune response,BP,1
GO:0032602,0.456937556,0.877271089,1,55,chemokine production,BP,1
GO:0006790,0.457187721,0.760122256,3,224,sulfur compound metabolic process,BP,1
GO:0019080,0.45719379,0.877117445,1,55,viral gene expression,BP,1
GO:2001242,0.458381982,0.799525136,2,138,regulation of intrinsic apoptotic signaling pathway,BP,1
GO:0051851,0.458635109,0.876250962,1,55,modification by host of symbiont morphology or physiology,BP,1
GO:0072527,0.459221781,0.875897183,1,55,pyrimidine-containing compound metabolic process,BP,1
GO:0006810,0.459912938,0.621494079,31,2754,transport,BP,1
GO:1901796,0.460250814,0.875275127,1,55,regulation of signal transduction by p53 class mediator,BP,1
GO:0002791,0.460532609,0.731650551,4,318,regulation of peptide secretion,BP,1
GO:0030168,0.460722341,0.874956075,1,56,platelet activation,BP,1
GO:0051046,0.461144186,0.699484341,6,497,regulation of secretion,BP,1
GO:1904035,0.461144965,0.874667365,1,57,regulation of epithelial cell apoptotic process,BP,1
GO:0061515,0.461269316,0.874591825,1,57,myeloid cell development,BP,1
GO:0090087,0.461527023,0.699139838,6,497,regulation of peptide transport,BP,1
GO:0006809,0.461750554,0.874331541,1,56,nitric oxide biosynthetic process,BP,1
GO:0035195,0.462044893,0.874088792,1,58,gene silencing by miRNA,BP,1
GO:0051304,0.462119107,0.87404358,1,58,chromosome separation,BP,1
GO:0031668,0.462406297,0.755758581,3,230,cellular response to extracellular stimulus,BP,1
GO:0042116,0.462758928,0.873717169,1,56,macrophage activation,BP,1
GO:0002718,0.462907239,0.87362665,1,56,regulation of cytokine production involved in immune response,BP,1
GO:0009064,0.46291105,0.873624323,1,56,glutamine family amino acid metabolic process,BP,1
GO:0017158,0.463016543,0.873527415,1,57,regulation of calcium ion-dependent exocytosis,BP,1
GO:0097421,0.463530437,0.873245847,1,56,liver regeneration,BP,1
GO:0006885,0.463557909,0.873262802,1,55,regulation of pH,BP,1
GO:1901983,0.463816315,0.873070922,1,56,regulation of protein acetylation,BP,1
GO:0034103,0.464227437,0.872786438,1,57,regulation of tissue remodeling,BP,1
GO:0048738,0.46457476,0.794655294,2,148,cardiac muscle tissue development,BP,1
GO:0006766,0.464583154,0.872600959,1,56,vitamin metabolic process,BP,1
GO:0031589,0.465639244,0.753021602,3,237,cell-substrate adhesion,BP,1
GO:0060828,0.466041333,0.793507192,2,149,regulation of canonical Wnt signaling pathway,BP,1
GO:0007611,0.466989401,0.792778309,2,148,learning or memory,BP,1
GO:0051276,0.468635625,0.666070523,9,778,chromosome organization,BP,1
GO:0043154,0.469099438,0.869811004,1,56,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,1
GO:0050807,0.469153958,0.791069781,2,150,regulation of synapse organization,BP,1
GO:0015672,0.470142284,0.749254726,3,233,monovalent inorganic cation transport,BP,1
GO:0008652,0.470703233,0.868777575,1,57,cellular amino acid biosynthetic process,BP,1
GO:0034329,0.471100392,0.789525708,2,152,cell junction assembly,BP,1
GO:0001938,0.472366844,0.867640556,1,60,positive regulation of endothelial cell proliferation,BP,1
GO:0002703,0.472606531,0.7884258,2,143,regulation of leukocyte mediated immunity,BP,1
GO:0030203,0.473003227,0.867302238,1,58,glycosaminoglycan metabolic process,BP,1
GO:0002690,0.473452695,0.867019092,1,58,positive regulation of leukocyte chemotaxis,BP,1
GO:0035710,0.474393377,0.866425272,1,58,"CD4-positive, alpha-beta T cell activation",BP,1
GO:0043410,0.47449627,0.719436711,4,328,positive regulation of MAPK cascade,BP,1
GO:0071248,0.474698796,0.786744622,2,146,cellular response to metal ion,BP,1
GO:0055006,0.475619141,0.865527561,1,62,cardiac cell development,BP,1
GO:0007368,0.475995362,0.865317446,1,61,determination of left/right symmetry,BP,1
GO:0043542,0.476363085,0.785397353,2,149,endothelial cell migration,BP,1
GO:1905954,0.476868424,0.864761852,1,61,positive regulation of lipid localization,BP,1
GO:0007018,0.478281607,0.78385325,2,151,microtubule-based movement,BP,1
GO:0043269,0.478852246,0.715579996,4,331,regulation of ion transport,BP,1
GO:0002699,0.479768306,0.78271457,2,146,positive regulation of immune effector process,BP,1
GO:0051341,0.479896363,0.862917906,1,58,regulation of oxidoreductase activity,BP,1
GO:0050803,0.479969248,0.782488325,2,153,regulation of synapse structure or activity,BP,1
GO:2000573,0.480148113,0.862723587,1,59,positive regulation of DNA biosynthetic process,BP,1
GO:1990090,0.482108296,0.86136728,1,62,cellular response to nerve growth factor stimulus,BP,1
GO:1900182,0.482441134,0.861212028,1,60,positive regulation of protein localization to nucleus,BP,1
GO:0045089,0.482758621,0.780299073,2,148,positive regulation of innate immune response,BP,1
GO:0014066,0.483934316,0.860182102,1,62,regulation of phosphatidylinositol 3-kinase signaling,BP,1
GO:0035194,0.484107294,0.860069499,1,62,posttranscriptional gene silencing by RNA,BP,1
GO:0051702,0.485960519,0.858920639,1,60,interaction with symbiont,BP,1
GO:0043254,0.48650527,0.708769039,4,330,regulation of protein complex assembly,BP,1
GO:0042102,0.48715291,0.85813889,1,60,positive regulation of T cell proliferation,BP,1
GO:2001233,0.487262445,0.708103856,4,326,regulation of apoptotic signaling pathway,BP,1
GO:0010810,0.487311058,0.776568125,2,154,regulation of cell-substrate adhesion,BP,1
GO:0042698,0.487491735,0.85785474,1,62,ovulation cycle,BP,1
GO:2000177,0.488103349,0.857422787,1,63,regulation of neural precursor cell proliferation,BP,1
GO:2000117,0.488528777,0.857233435,1,60,negative regulation of cysteine-type endopeptidase activity,BP,1
GO:0051130,0.489290715,0.640453566,10,891,positive regulation of cellular component organization,BP,1
GO:0045638,0.489568213,0.856515436,1,61,negative regulation of myeloid cell differentiation,BP,1
GO:0006898,0.48968701,0.774646107,2,153,receptor-mediated endocytosis,BP,1
GO:0016441,0.489986882,0.856178171,1,63,posttranscriptional gene silencing,BP,1
GO:0006913,0.490210038,0.732006018,3,242,nucleocytoplasmic transport,BP,1
GO:0030004,0.490643921,0.855834302,1,60,cellular monovalent inorganic cation homeostasis,BP,1
GO:0006022,0.4907556,0.855728525,1,61,aminoglycan metabolic process,BP,1
GO:0046209,0.49092107,0.855618646,1,61,nitric oxide metabolic process,BP,1
GO:1902905,0.491035794,0.773545902,2,153,positive regulation of supramolecular fiber organization,BP,1
GO:0000380,0.492044102,0.854903314,1,60,"alternative mRNA splicing, via spliceosome",BP,1
GO:0010923,0.492862388,0.854264751,1,63,negative regulation of phosphatase activity,BP,1
GO:0051169,0.493082352,0.729494378,3,243,nuclear transport,BP,1
GO:1990089,0.493830885,0.853587584,1,64,response to nerve growth factor,BP,1
GO:0010717,0.49395777,0.853531612,1,63,regulation of epithelial to mesenchymal transition,BP,1
GO:0007155,0.495866881,0.647756051,8,714,cell adhesion,BP,1
GO:0050772,0.497940231,0.850707333,1,68,positive regulation of axonogenesis,BP,1
GO:0090263,0.499055147,0.850002633,1,66,positive regulation of canonical Wnt signaling pathway,BP,1
GO:0006839,0.49908694,0.766957221,2,149,mitochondrial transport,BP,1
GO:0006820,0.499757775,0.696791109,4,334,anion transport,BP,1
GO:0060322,0.500216383,0.663506369,6,537,head development,BP,1
GO:0071426,0.500299829,0.849240464,1,63,ribonucleoprotein complex export from nucleus,BP,1
GO:0016055,0.500514272,0.72291795,3,251,Wnt signaling pathway,BP,1
GO:0055024,0.500558738,0.849004853,1,65,regulation of cardiac muscle tissue development,BP,1
GO:0016043,0.50080701,0.574293195,43,3917,cellular component organization,BP,1
GO:2001057,0.502460664,0.847760209,1,63,reactive nitrogen species metabolic process,BP,1
GO:0007584,0.502555455,0.721127988,3,247,response to nutrient,BP,1
GO:0034614,0.502700768,0.763929462,2,151,cellular response to reactive oxygen species,BP,1
GO:0071230,0.503424178,0.847009454,1,66,cellular response to amino acid stimulus,BP,1
GO:0007163,0.503902338,0.762832948,2,161,establishment or maintenance of cell polarity,BP,1
GO:0022610,0.504391379,0.639632074,8,719,biological adhesion,BP,1
GO:0050804,0.50450654,0.719379253,3,250,modulation of chemical synaptic transmission,BP,1
GO:0051983,0.504686908,0.846109661,1,67,regulation of chromosome segregation,BP,1
GO:0198738,0.505735406,0.718270116,3,253,cell-cell signaling by wnt,BP,1
GO:0071166,0.505993357,0.845289649,1,64,ribonucleoprotein complex localization,BP,1
GO:0070925,0.506898174,0.657234956,6,522,organelle assembly,BP,1
GO:0099177,0.507338668,0.716847607,3,251,regulation of trans-synaptic signaling,BP,1
GO:0044267,0.507806006,0.570428131,37,3344,cellular protein metabolic process,BP,1
GO:0042180,0.507905504,0.759531077,2,154,cellular ketone metabolic process,BP,1
GO:0048584,0.508562294,0.600858863,15,1354,positive regulation of response to stimulus,BP,1
GO:0002367,0.50937469,0.842930208,1,64,cytokine production involved in immune response,BP,1
GO:0000041,0.509843257,0.842542475,1,66,transition metal ion transport,BP,1
GO:0009799,0.510456253,0.842083332,1,67,specification of symmetry,BP,1
GO:0009855,0.510456253,0.842083332,1,67,determination of bilateral symmetry,BP,1
GO:1901264,0.51057094,0.842120918,1,63,carbohydrate derivative transport,BP,1
GO:0016079,0.510610549,0.842032062,1,65,synaptic vesicle exocytosis,BP,1
GO:0046632,0.510801236,0.841897817,1,65,alpha-beta T cell differentiation,BP,1
GO:1903035,0.510876879,0.841844543,1,65,negative regulation of response to wounding,BP,1
GO:0034599,0.511691378,0.712971726,3,245,cellular response to oxidative stress,BP,1
GO:1901564,0.512530483,0.560978963,48,4339,organonitrogen compound metabolic process,BP,1
GO:1902903,0.513531974,0.711264456,3,255,regulation of supramolecular fiber organization,BP,1
GO:1901617,0.513698724,0.754587438,2,157,organic hydroxy compound biosynthetic process,BP,1
GO:0008406,0.513821954,0.754455012,2,160,gonad development,BP,1
GO:0048678,0.515320701,0.838608192,1,68,response to axon injury,BP,1
GO:0034502,0.516196774,0.838038902,1,66,protein localization to chromosome,BP,1
GO:0060560,0.517349452,0.751390518,2,165,developmental growth involved in morphogenesis,BP,1
GO:0010827,0.5175937,0.837037638,1,66,regulation of glucose transmembrane transport,BP,1
GO:0030217,0.517749077,0.751099662,2,159,T cell differentiation,BP,1
GO:0032963,0.519165929,0.835905916,1,66,collagen metabolic process,BP,1
GO:0065003,0.51927583,0.593628335,14,1256,protein-containing complex assembly,BP,1
GO:0030433,0.519525975,0.835676097,1,65,ubiquitin-dependent ERAD pathway,BP,1
GO:0030326,0.51999853,0.835192684,1,70,embryonic limb morphogenesis,BP,1
GO:0035113,0.51999853,0.835192684,1,70,embryonic appendage morphogenesis,BP,1
GO:1901214,0.520292852,0.705143576,3,252,regulation of neuron death,BP,1
GO:0043535,0.521034365,0.834496547,1,68,regulation of blood vessel endothelial cell migration,BP,1
GO:0071548,0.521090734,0.834484113,1,67,response to dexamethasone,BP,1
GO:0010595,0.521673674,0.834032291,1,68,positive regulation of endothelial cell migration,BP,1
GO:0008277,0.524386213,0.832053029,1,68,regulation of G protein-coupled receptor signaling pathway,BP,1
GO:0046849,0.524829025,0.831728464,1,68,bone remodeling,BP,1
GO:0002064,0.526094964,0.743794874,2,167,epithelial cell development,BP,1
GO:0045137,0.527183823,0.74286821,2,164,development of primary sexual characteristics,BP,1
GO:0035305,0.529869204,0.827948977,1,70,negative regulation of dephosphorylation,BP,1
GO:0007417,0.530114721,0.623763226,7,645,central nervous system development,BP,1
GO:0051346,0.531169668,0.695120537,3,256,negative regulation of hydrolase activity,BP,1
GO:0040029,0.531497948,0.739066542,2,165,"regulation of gene expression, epigenetic",BP,1
GO:0090101,0.532395484,0.826034933,1,71,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,1
GO:0043065,0.533098735,0.64644535,5,443,positive regulation of apoptotic process,BP,1
GO:0006970,0.533763109,0.825034948,1,70,response to osmotic stress,BP,1
GO:0032760,0.534076764,0.82482693,1,69,positive regulation of tumor necrosis factor production,BP,1
GO:1903557,0.534076764,0.82482693,1,69,positive regulation of tumor necrosis factor superfamily cytokine production,BP,1
GO:0031396,0.534155113,0.73674176,2,162,regulation of protein ubiquitination,BP,1
GO:0140013,0.534603219,0.824402013,1,70,meiotic nuclear division,BP,1
GO:0010638,0.535284953,0.644321547,5,449,positive regulation of organelle organization,BP,1
GO:0061448,0.535500922,0.735528172,2,164,connective tissue development,BP,1
GO:0060419,0.536480758,0.822927702,1,72,heart growth,BP,1
GO:0090066,0.53662284,0.662304983,4,359,regulation of anatomical structure size,BP,1
GO:0044242,0.537257527,0.733963083,2,164,cellular lipid catabolic process,BP,1
GO:0050890,0.537347412,0.733839365,2,169,cognition,BP,1
GO:0051234,0.538056655,0.544782066,31,2839,establishment of localization,BP,1
GO:0044272,0.538355916,0.821556294,1,70,sulfur compound biosynthetic process,BP,1
GO:0030516,0.538485945,0.821325875,1,75,regulation of axon extension,BP,1
GO:0098693,0.539591868,0.820612425,1,70,regulation of synaptic vesicle cycle,BP,1
GO:0007264,0.540527676,0.658555523,4,361,small GTPase mediated signal transduction,BP,1
GO:0071214,0.540702397,0.686205702,3,258,cellular response to abiotic stimulus,BP,1
GO:0104004,0.540702397,0.686205702,3,258,cellular response to environmental stimulus,BP,1
GO:0042136,0.540878412,0.819626412,1,70,neurotransmitter biosynthetic process,BP,1
GO:0051260,0.541842321,0.685136902,3,257,protein homooligomerization,BP,1
GO:0007613,0.541865445,0.818759826,1,74,memory,BP,1
GO:0006473,0.54244961,0.729297563,2,165,protein acetylation,BP,1
GO:0042632,0.542539853,0.818292296,1,72,cholesterol homeostasis,BP,1
GO:0044070,0.542841214,0.818059669,1,72,regulation of anion transport,BP,1
GO:0051495,0.54418998,0.727691322,2,169,positive regulation of cytoskeleton organization,BP,1
GO:0045069,0.545217649,0.816245907,1,71,regulation of viral genome replication,BP,1
GO:0003002,0.545458859,0.726508909,2,173,regionalization,BP,1
GO:0034644,0.545682844,0.815884054,1,71,cellular response to UV,BP,1
GO:0002224,0.546927755,0.814913365,1,71,toll-like receptor signaling pathway,BP,1
GO:0055092,0.547555168,0.814367999,1,73,sterol homeostasis,BP,1
GO:0071621,0.548185835,0.81392895,1,71,granulocyte chemotaxis,BP,1
GO:0031047,0.549328268,0.812950333,1,74,gene silencing by RNA,BP,1
GO:0032006,0.550902792,0.811735601,1,73,regulation of TOR signaling,BP,1
GO:0032436,0.551151802,0.811566183,1,72,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,1
GO:0071560,0.55117713,0.721313742,2,171,cellular response to transforming growth factor beta stimulus,BP,1
GO:0006405,0.552123328,0.81074294,1,74,RNA export from nucleus,BP,1
GO:0016570,0.553610079,0.645869606,4,362,histone modification,BP,1
GO:0030838,0.553960914,0.809309144,1,73,positive regulation of actin filament polymerization,BP,1
GO:0051240,0.554735892,0.566156342,12,1120,positive regulation of multicellular organismal process,BP,1
GO:0048259,0.554784454,0.808625184,1,74,regulation of receptor-mediated endocytosis,BP,1
GO:1902882,0.555518888,0.808092739,1,72,regulation of response to oxidative stress,BP,1
GO:0046620,0.555711367,0.807831871,1,76,regulation of organ growth,BP,1
GO:1903532,0.556927805,0.670719637,3,264,positive regulation of secretion by cell,BP,1
GO:0007188,0.557113858,0.806731974,1,75,adenylate cyclase-modulating G protein-coupled receptor signaling pathway,BP,1
GO:0019933,0.558046043,0.806007959,1,74,cAMP-mediated signaling,BP,1
GO:0071241,0.558353388,0.714693262,2,171,cellular response to inorganic substance,BP,1
GO:0060249,0.559302802,0.668401896,3,269,anatomical structure homeostasis,BP,1
GO:0006811,0.560609082,0.576852124,9,832,ion transport,BP,1
GO:0046889,0.561459577,0.80324313,1,74,positive regulation of lipid biosynthetic process,BP,1
GO:0097191,0.561957266,0.711317465,2,173,extrinsic apoptotic signaling pathway,BP,1
GO:0007187,0.562167546,0.80261333,1,76,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger",BP,1
GO:0090090,0.562553236,0.802248191,1,78,negative regulation of canonical Wnt signaling pathway,BP,1
GO:0051588,0.562857106,0.802076614,1,75,regulation of neurotransmitter transport,BP,1
GO:1901605,0.56323223,0.710158641,2,169,alpha-amino acid metabolic process,BP,1
GO:0006260,0.563302817,0.710074831,2,171,DNA replication,BP,1
GO:1903426,0.563609587,0.801461121,1,75,regulation of reactive oxygen species biosynthetic process,BP,1
GO:0051028,0.563909016,0.801163875,1,77,mRNA transport,BP,1
GO:0071559,0.564259278,0.709143238,2,175,response to transforming growth factor beta,BP,1
GO:0002708,0.564514731,0.800746137,1,74,positive regulation of lymphocyte mediated immunity,BP,1
GO:0007286,0.564568416,0.800622892,1,77,spermatid development,BP,1
GO:0000187,0.564922101,0.800332313,1,77,activation of MAPK activity,BP,1
GO:0009119,0.566349406,0.799236395,1,74,ribonucleoside metabolic process,BP,1
GO:0001959,0.567470454,0.798256102,1,76,regulation of cytokine-mediated signaling pathway,BP,1
GO:0007041,0.567474929,0.798176559,1,79,lysosomal transport,BP,1
GO:0048709,0.567719765,0.798049662,1,76,oligodendrocyte differentiation,BP,1
GO:0031644,0.567855535,0.797885907,1,78,regulation of neurological system process,BP,1
GO:0031623,0.569021154,0.796943667,1,77,receptor internalization,BP,1
GO:0003231,0.571150875,0.795069253,1,81,cardiac ventricle development,BP,1
GO:0003279,0.571610942,0.794638347,1,83,cardiac septum development,BP,1
GO:1904019,0.571647669,0.794726342,1,78,epithelial cell apoptotic process,BP,1
GO:0051817,0.572465758,0.794092376,1,76,modification of morphology or physiology of other organism involved in symbiotic interaction,BP,1
Other,0.572823617,0.564466449,9,820,NA,NA,1
GO:0098869,0.572905652,0.793750035,1,75,cellular oxidant detoxification,BP,1
GO:0048661,0.57368888,0.793011792,1,78,positive regulation of smooth muscle cell proliferation,BP,1
GO:0006119,0.574343248,0.792539657,1,75,oxidative phosphorylation,BP,1
GO:0046777,0.575004993,0.698914875,2,179,protein autophosphorylation,BP,1
GO:0048524,0.575527102,0.791459412,1,78,positive regulation of viral process,BP,1
GO:0071482,0.575589059,0.791432884,1,77,cellular response to light stimulus,BP,1
GO:0006644,0.577421657,0.650597145,3,274,phospholipid metabolic process,BP,1
GO:0034330,0.578010372,0.695978818,2,185,cell junction organization,BP,1
GO:0061387,0.578061463,0.789184913,1,83,regulation of extent of cell growth,BP,1
GO:0003206,0.57831371,0.788992742,1,82,cardiac chamber morphogenesis,BP,1
GO:0016569,0.580106503,0.61947241,4,374,covalent chromatin modification,BP,1
GO:0014065,0.58170607,0.786060291,1,83,phosphatidylinositol 3-kinase signaling,BP,1
GO:0001667,0.583011994,0.644976331,3,282,ameboidal-type cell migration,BP,1
GO:1901606,0.583094862,0.785011003,1,77,alpha-amino acid catabolic process,BP,1
GO:0006641,0.584800732,0.783454705,1,80,triglyceride metabolic process,BP,1
GO:0050715,0.585408975,0.782925793,1,80,positive regulation of cytokine secretion,BP,1
GO:0021549,0.585779495,0.782530539,1,83,cerebellum development,BP,1
GO:2001022,0.586090708,0.782307087,1,81,positive regulation of response to DNA damage stimulus,BP,1
GO:0017015,0.58661057,0.78185343,1,81,regulation of transforming growth factor beta receptor signaling pathway,BP,1
GO:0007162,0.587286548,0.686975013,2,183,negative regulation of cell adhesion,BP,1
GO:0015748,0.587455872,0.781139321,1,80,organophosphate ester transport,BP,1
GO:0006812,0.587502476,0.577558648,6,567,cation transport,BP,1
GO:0051493,0.587691444,0.611728063,4,384,regulation of cytoskeleton organization,BP,1
GO:0048515,0.587738231,0.780842788,1,82,spermatid differentiation,BP,1
GO:0050776,0.587782819,0.591935734,5,465,regulation of immune response,BP,1
GO:0072089,0.588995215,0.779739661,1,82,stem cell proliferation,BP,1
GO:0001936,0.589261368,0.779481725,1,83,regulation of endothelial cell proliferation,BP,1
GO:0043900,0.589418922,0.638537641,3,277,regulation of multi-organism process,BP,1
GO:0030177,0.590012558,0.778773959,1,85,positive regulation of Wnt signaling pathway,BP,1
GO:1903844,0.591330244,0.777680255,1,82,regulation of cellular response to transforming growth factor beta stimulus,BP,1
GO:0045785,0.59160909,0.636288615,3,283,positive regulation of cell adhesion,BP,1
GO:0030111,0.591788609,0.682494101,2,189,regulation of Wnt signaling pathway,BP,1
GO:0051101,0.592434516,0.776701698,1,82,regulation of DNA binding,BP,1
GO:0002449,0.593188121,0.681196257,2,178,lymphocyte mediated immunity,BP,1
GO:0002761,0.593247979,0.775954774,1,83,regulation of myeloid leukocyte differentiation,BP,1
GO:2000060,0.593335008,0.775926279,1,81,positive regulation of ubiquitin-dependent protein catabolic process,BP,1
GO:0017156,0.594184062,0.775145213,1,82,calcium ion regulated exocytosis,BP,1
GO:0006813,0.594986282,0.774357861,1,85,potassium ion transport,BP,1
GO:0060271,0.596340294,0.67801961,2,183,cilium assembly,BP,1
GO:0050778,0.596631069,0.602559023,4,375,positive regulation of immune response,BP,1
GO:0045732,0.597592834,0.67676059,2,184,positive regulation of protein catabolic process,BP,1
GO:0002824,0.597845282,0.771888712,1,81,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,1
GO:0045088,0.599870511,0.674486391,2,183,regulation of innate immune response,BP,1
GO:0050729,0.601152429,0.768870775,1,82,positive regulation of inflammatory response,BP,1
GO:0051223,0.601240523,0.577965861,5,476,regulation of protein transport,BP,1
GO:1990748,0.601339486,0.768726047,1,81,cellular detoxification,BP,1
GO:0007269,0.601734243,0.76829246,1,84,neurotransmitter secretion,BP,1
GO:0099643,0.601734243,0.76829246,1,84,signal release from synapse,BP,1
GO:2000241,0.603182444,0.766970967,1,84,regulation of reproductive process,BP,1
GO:0022037,0.603474474,0.766634271,1,87,metencephalon development,BP,1
GO:0070997,0.604707665,0.622826005,3,286,neuron death,BP,1
GO:0002821,0.606978387,0.763506619,1,83,positive regulation of adaptive immune response,BP,1
GO:0051047,0.60707599,0.620374075,3,284,positive regulation of secretion,BP,1
GO:0043534,0.607672147,0.762792951,1,86,blood vessel endothelial cell migration,BP,1
GO:0060759,0.608224471,0.762304719,1,85,regulation of response to cytokine stimulus,BP,1
GO:0035023,0.608258838,0.762181978,1,89,regulation of Rho protein signal transduction,BP,1
GO:0036503,0.608294739,0.762288302,1,83,ERAD pathway,BP,1
GO:2000045,0.608815729,0.761732527,1,86,regulation of G1/S transition of mitotic cell cycle,BP,1
GO:0050921,0.609284727,0.761296668,1,86,positive regulation of chemotaxis,BP,1
GO:0048675,0.609539124,0.760949811,1,91,axon extension,BP,1
GO:0007420,0.610361167,0.568339015,5,501,brain development,BP,1
GO:1900180,0.610610061,0.760038811,1,87,regulation of protein localization to nucleus,BP,1
GO:0050806,0.610665608,0.75998696,1,87,positive regulation of synaptic transmission,BP,1
GO:0007098,0.613503698,0.757350448,1,86,centrosome cycle,BP,1
GO:0097530,0.613672953,0.757215064,1,85,granulocyte migration,BP,1
GO:0032103,0.615443282,0.658561825,2,190,positive regulation of response to external stimulus,BP,1
GO:0019935,0.615953694,0.755014271,1,87,cyclic-nucleotide-mediated signaling,BP,1
GO:0019079,0.616147637,0.754830519,1,87,viral genome replication,BP,1
GO:0032675,0.616873789,0.754165201,1,86,regulation of interleukin-6 production,BP,1
GO:0051222,0.616898118,0.610052998,3,289,positive regulation of protein transport,BP,1
GO:1903046,0.617367533,0.75364943,1,88,meiotic cell cycle process,BP,1
GO:1903320,0.619659007,0.654193348,2,189,regulation of protein modification by small protein conjugation or removal,BP,1
GO:0009063,0.619694674,0.751500576,1,85,cellular amino acid catabolic process,BP,1
GO:0031929,0.619819479,0.751309876,1,88,TOR signaling,BP,1
GO:0002526,0.621956895,0.749257546,1,88,acute inflammatory response,BP,1
GO:0033043,0.622314035,0.512790332,9,885,regulation of organelle organization,BP,1
GO:0042110,0.622376892,0.604232014,3,291,T cell activation,BP,1
GO:0050863,0.622562957,0.651150656,2,190,regulation of T cell activation,BP,1
GO:0071840,0.622601529,0.450833082,43,4063,cellular component organization or biogenesis,BP,1
GO:1903409,0.622643709,0.748595513,1,88,reactive oxygen species biosynthetic process,BP,1
GO:0006997,0.622686527,0.748531332,1,89,nucleus organization,BP,1
GO:0035821,0.623206026,0.748075982,1,87,modification of morphology or physiology of other organism,BP,1
GO:1990823,0.62619082,0.745133351,1,89,response to leukemia inhibitory factor,BP,1
GO:1990830,0.62619082,0.745133351,1,89,cellular response to leukemia inhibitory factor,BP,1
GO:0002687,0.626592706,0.744741565,1,89,positive regulation of leukocyte migration,BP,1
GO:0016241,0.627369042,0.743938712,1,91,regulation of macroautophagy,BP,1
GO:1902904,0.627813016,0.743461493,1,93,negative regulation of supramolecular fiber organization,BP,1
GO:0016579,0.628700485,0.742634695,1,91,protein deubiquitination,BP,1
GO:0071346,0.628808819,0.742573363,1,89,cellular response to interferon-gamma,BP,1
GO:1903305,0.629334725,0.742034115,1,90,regulation of regulated secretory pathway,BP,1
GO:0015980,0.630526305,0.642727167,2,192,energy derivation by oxidation of organic compounds,BP,1
GO:0001764,0.631825384,0.739450299,1,96,neuron migration,BP,1
GO:0001837,0.63218964,0.739151285,1,93,epithelial to mesenchymal transition,BP,1
GO:0031023,0.63229343,0.739091893,1,91,microtubule organizing center organization,BP,1
GO:0000956,0.632464971,0.73892187,1,91,nuclear-transcribed mRNA catabolic process,BP,1
GO:0006959,0.632499636,0.738909968,1,90,humoral immune response,BP,1
GO:0031398,0.633354859,0.738061094,1,90,positive regulation of protein ubiquitination,BP,1
GO:0007272,0.633521745,0.737850648,1,92,ensheathment of neurons,BP,1
GO:0008366,0.633521745,0.737850648,1,92,axon ensheathment,BP,1
GO:0043010,0.634021954,0.638907676,2,204,camera-type eye development,BP,1
GO:0044782,0.634142855,0.63883613,2,196,cilium organization,BP,1
GO:0090288,0.634884972,0.736449806,1,94,negative regulation of cellular response to growth factor stimulus,BP,1
GO:0045580,0.635374193,0.736026182,1,91,regulation of T cell differentiation,BP,1
GO:0032635,0.635730241,0.7356702,1,91,interleukin-6 production,BP,1
GO:0098754,0.636347534,0.735098113,1,89,detoxification,BP,1
GO:0021953,0.636636457,0.734676501,1,95,central nervous system neuron differentiation,BP,1
GO:0030178,0.638000212,0.733285584,1,96,negative regulation of Wnt signaling pathway,BP,1
GO:0051092,0.638160859,0.733230714,1,91,positive regulation of NF-kappaB transcription factor activity,BP,1
GO:0046631,0.638907686,0.732455527,1,92,alpha-beta T cell activation,BP,1
GO:0071496,0.639112382,0.586143161,3,298,cellular response to external stimulus,BP,1
GO:0031333,0.639206887,0.732153472,1,92,negative regulation of protein complex assembly,BP,1
GO:1901136,0.639672436,0.731728301,1,90,carbohydrate derivative catabolic process,BP,1
GO:0033365,0.6402359,0.521572429,6,598,protein localization to organelle,BP,1
GO:0043123,0.641452056,0.729856921,1,93,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,1
GO:0006638,0.641868457,0.729433507,1,93,neutral lipid metabolic process,BP,1
GO:0006639,0.641868457,0.729433507,1,93,acylglycerol metabolic process,BP,1
GO:0009116,0.642396867,0.728940155,1,91,nucleoside metabolic process,BP,1
GO:0032386,0.643116826,0.581732433,3,303,regulation of intracellular transport,BP,1
GO:0044257,0.643532374,0.517968962,6,597,cellular protein catabolic process,BP,1
GO:0048489,0.644747679,0.726470767,1,94,synaptic vesicle transport,BP,1
GO:0097480,0.644747679,0.726470767,1,94,establishment of synaptic vesicle localization,BP,1
GO:0050680,0.645428861,0.725750198,1,95,negative regulation of epithelial cell proliferation,BP,1
GO:0070201,0.645734105,0.530192799,5,500,regulation of establishment of protein localization,BP,1
GO:0051494,0.64712459,0.723942088,1,98,negative regulation of cytoskeleton organization,BP,1
GO:0043543,0.647500584,0.624324455,2,199,protein acylation,BP,1
GO:0001935,0.648711748,0.722319987,1,97,endothelial cell proliferation,BP,1
GO:0019932,0.648770773,0.622883957,2,205,second-messenger-mediated signaling,BP,1
GO:0001824,0.650495262,0.720466036,1,97,blastocyst development,BP,1
GO:0010634,0.65109545,0.719819769,1,98,positive regulation of epithelial cell migration,BP,1
GO:0097479,0.6522955,0.71860628,1,96,synaptic vesicle localization,BP,1
GO:0002705,0.653749806,0.717101681,1,95,positive regulation of leukocyte mediated immunity,BP,1
GO:1904951,0.65419445,0.569436321,3,305,positive regulation of establishment of protein localization,BP,1
GO:0046330,0.654251146,0.716511475,1,98,positive regulation of JNK cascade,BP,1
GO:0002757,0.655321529,0.615647073,2,202,immune response-activating signal transduction,BP,1
GO:1901800,0.655548733,0.715184349,1,96,positive regulation of proteasomal protein catabolic process,BP,1
GO:0007224,0.655617391,0.715070236,1,98,smoothened signaling pathway,BP,1
GO:0001505,0.657398373,0.613312436,2,204,regulation of neurotransmitter levels,BP,1
GO:0006633,0.657955119,0.712633403,1,96,fatty acid biosynthetic process,BP,1
GO:0007389,0.65867233,0.611822508,2,213,pattern specification process,BP,1
GO:0043279,0.660423491,0.709957058,1,98,response to alkaloid,BP,1
GO:0032880,0.660975736,0.48735855,7,709,regulation of protein localization,BP,1
GO:0042177,0.661737105,0.708527236,1,99,negative regulation of protein catabolic process,BP,1
GO:0007411,0.664577727,0.705293659,1,108,axon guidance,BP,1
GO:0097485,0.664577727,0.705293659,1,108,neuron projection guidance,BP,1
GO:0010565,0.665601028,0.704331551,1,100,regulation of cellular ketone metabolic process,BP,1
GO:0046488,0.665697275,0.704187658,1,102,phosphatidylinositol metabolic process,BP,1
GO:0010508,0.669560875,0.699985812,1,101,positive regulation of autophagy,BP,1
GO:0006325,0.670313445,0.502675257,5,522,chromatin organization,BP,1
GO:2001251,0.670955535,0.698411892,1,103,negative regulation of chromosome organization,BP,1
GO:0050877,0.673348952,0.518882046,4,427,nervous system process,BP,1
GO:0002764,0.67396392,0.594437859,2,209,immune response-regulating signaling pathway,BP,1
GO:0006816,0.679498266,0.587968253,2,215,calcium ion transport,BP,1
GO:0030100,0.680843806,0.586394906,2,215,regulation of endocytosis,BP,1
GO:0051259,0.681798242,0.509164446,4,418,protein complex oligomerization,BP,1
GO:0030879,0.682375551,0.685523718,1,108,mammary gland development,BP,1
GO:0007268,0.683166021,0.536196636,3,327,chemical synaptic transmission,BP,1
GO:0098916,0.683166021,0.536196636,3,327,anterograde trans-synaptic signaling,BP,1
GO:0042133,0.685950761,0.681508495,1,104,neurotransmitter metabolic process,BP,1
GO:0070646,0.686356288,0.681003838,1,106,protein modification by small protein removal,BP,1
GO:0032434,0.686883497,0.68043488,1,104,regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,1
GO:0043933,0.689253024,0.415612887,14,1407,protein-containing complex subunit organization,BP,1
GO:0055002,0.68999208,0.676760961,1,108,striated muscle cell development,BP,1
GO:0006887,0.690476388,0.57500453,2,216,exocytosis,BP,1
GO:0055114,0.690842257,0.453607422,7,712,oxidation-reduction process,BP,1
GO:0006412,0.690944555,0.478969699,5,519,translation,BP,1
GO:0007034,0.691407858,0.6750757,1,110,vacuolar transport,BP,1
GO:0048754,0.692173817,0.674163097,1,111,branching morphogenesis of an epithelial tube,BP,1
GO:0042129,0.692846424,0.673466322,1,106,regulation of T cell proliferation,BP,1
GO:0060341,0.695026284,0.459849103,6,637,regulation of cellular localization,BP,1
GO:1903052,0.695085909,0.670814704,1,107,positive regulation of proteolysis involved in cellular protein catabolic process,BP,1
GO:0099537,0.695463141,0.521637854,3,333,trans-synaptic signaling,BP,1
GO:0001654,0.696970624,0.567119986,2,230,eye development,BP,1
GO:1902107,0.69715554,0.66834827,1,108,positive regulation of leukocyte differentiation,BP,1
GO:0016042,0.699352587,0.564291487,2,221,lipid catabolic process,BP,1
GO:1901615,0.701123271,0.514867348,3,328,organic hydroxy compound metabolic process,BP,1
GO:0006611,0.701129935,0.663589212,1,109,protein export from nucleus,BP,1
GO:0003205,0.701248034,0.663326944,1,116,cardiac chamber development,BP,1
GO:0150063,0.701398485,0.561735517,2,232,visual system development,BP,1
GO:0034341,0.70162029,0.663019172,1,108,response to interferon-gamma,BP,1
GO:0010970,0.701659936,0.662882217,1,113,transport along microtubule,BP,1
GO:0048880,0.70384411,0.55874216,2,233,sensory system development,BP,1
GO:0016999,0.704424499,0.65963787,1,108,antibiotic metabolic process,BP,1
GO:0032879,0.704955455,0.389591103,17,1731,regulation of localization,BP,1
GO:0099111,0.705008944,0.658822753,1,114,microtubule-based transport,BP,1
GO:0007626,0.707089905,0.656258298,1,116,locomotory behavior,BP,1
GO:0008360,0.707186233,0.656191265,1,113,regulation of cell shape,BP,1
GO:1903322,0.707312932,0.656089921,1,110,positive regulation of protein modification by small protein conjugation or removal,BP,1
GO:0099536,0.707605774,0.506979084,3,339,synaptic signaling,BP,1
GO:0010921,0.708610064,0.6544333,1,114,regulation of phosphatase activity,BP,1
GO:0046165,0.709849144,0.652947431,1,112,alcohol biosynthetic process,BP,1
GO:0043043,0.710203459,0.456257451,5,531,peptide biosynthetic process,BP,1
GO:1990138,0.710743826,0.651745281,1,118,neuron projection extension,BP,1
GO:0050657,0.710830858,0.65170411,1,114,nucleic acid transport,BP,1
GO:0050658,0.710830858,0.65170411,1,114,RNA transport,BP,1
GO:1901657,0.712565137,0.649632118,1,110,glycosyl compound metabolic process,BP,1
GO:0034622,0.714210975,0.426410944,7,742,cellular protein-containing complex assembly,BP,1
GO:1903829,0.714632017,0.545408957,2,230,positive regulation of cellular protein localization,BP,1
GO:0033036,0.71593016,0.371077465,20,2015,macromolecule localization,BP,1
GO:0046661,0.717677746,0.643130682,1,117,male sex differentiation,BP,1
GO:0051236,0.718819753,0.641692927,1,117,establishment of RNA localization,BP,1
GO:0044087,0.719001197,0.431603349,6,656,regulation of cellular component biogenesis,BP,1
GO:0050679,0.719770256,0.640460176,1,119,positive regulation of epithelial cell proliferation,BP,1
GO:0051050,0.721066033,0.429137681,6,654,positive regulation of transport,BP,1
GO:0010594,0.721448307,0.638349449,1,118,regulation of endothelial cell migration,BP,1
GO:0015893,0.723051223,0.636358762,1,115,drug transport,BP,1
GO:0050770,0.723223408,0.6359658,1,126,regulation of axonogenesis,BP,1
GO:0002695,0.724016942,0.635124645,1,115,negative regulation of leukocyte activation,BP,1
GO:1903900,0.724123775,0.634987912,1,115,regulation of viral life cycle,BP,1
GO:0006606,0.724274562,0.634744302,1,118,protein import into nucleus,BP,1
GO:0030833,0.724579096,0.63437068,1,117,regulation of actin filament polymerization,BP,1
GO:0002443,0.724685474,0.53271951,2,228,leukocyte mediated immunity,BP,1
GO:0007596,0.727872524,0.630129301,1,117,blood coagulation,BP,1
GO:0006520,0.728057228,0.528395847,2,229,cellular amino acid metabolic process,BP,1
GO:0050870,0.728178696,0.629732975,1,117,positive regulation of T cell activation,BP,1
GO:1901566,0.729520552,0.377189814,12,1234,organonitrogen compound biosynthetic process,BP,1
GO:0009100,0.729685983,0.526281388,2,232,glycoprotein metabolic process,BP,1
GO:0022607,0.730413726,0.356578973,19,1936,cellular component assembly,BP,1
GO:0043547,0.730947276,0.524606681,2,240,positive regulation of GTPase activity,BP,1
GO:0030705,0.731701706,0.625050833,1,123,cytoskeleton-dependent intracellular transport,BP,1
GO:0051170,0.73364169,0.62253694,1,121,import into nucleus,BP,1
GO:0007599,0.734070789,0.622004465,1,119,hemostasis,BP,1
GO:0050817,0.734071574,0.62200343,1,119,coagulation,BP,1
GO:0022408,0.734200293,0.621833862,1,119,negative regulation of cell-cell adhesion,BP,1
GO:0051603,0.736030993,0.424894935,5,556,proteolysis involved in cellular protein catabolic process,BP,1
GO:0099504,0.736609459,0.618616,1,121,synaptic vesicle cycle,BP,1
GO:0071333,0.736887455,0.618231127,1,122,cellular response to glucose stimulus,BP,1
GO:0045834,0.738009151,0.616755118,1,121,positive regulation of lipid metabolic process,BP,1
GO:0050707,0.738395614,0.616239996,1,121,regulation of cytokine secretion,BP,1
GO:0097327,0.739188505,0.615165396,1,122,response to antineoplastic agent,BP,1
GO:0051179,0.743579549,0.323108763,37,3666,localization,BP,1
GO:0006066,0.743997805,0.507514889,2,240,alcohol metabolic process,BP,1
GO:0050808,0.744979358,0.506145647,2,252,synapse organization,BP,1
GO:0007179,0.745445423,0.606663478,1,126,transforming growth factor beta receptor signaling pathway,BP,1
GO:1903364,0.746898247,0.604696761,1,125,positive regulation of cellular protein catabolic process,BP,1
GO:0051168,0.748265985,0.602808137,1,126,nuclear export,BP,1
GO:0016573,0.751541496,0.598275976,1,127,histone acetylation,BP,1
GO:1903039,0.75188024,0.5978214,1,126,positive regulation of leukocyte cell-cell adhesion,BP,1
GO:0010951,0.754531164,0.594115056,1,127,negative regulation of endopeptidase activity,BP,1
GO:2000058,0.754593267,0.594043359,1,126,regulation of ubiquitin-dependent protein catabolic process,BP,1
GO:0006511,0.75814194,0.415592786,4,467,ubiquitin-dependent protein catabolic process,BP,1
GO:0051345,0.758330145,0.415339426,4,472,positive regulation of hydrolase activity,BP,1
GO:0043200,0.758528911,0.588449518,1,130,response to amino acid,BP,1
GO:0022407,0.759424106,0.486661133,2,249,regulation of cell-cell adhesion,BP,1
GO:0061024,0.760418869,0.412635922,4,470,membrane organization,BP,1
GO:0030041,0.761682475,0.583968067,1,130,actin filament polymerization,BP,1
GO:1903531,0.762408984,0.58292971,1,130,negative regulation of secretion by cell,BP,1
GO:0000082,0.762704652,0.582492085,1,131,G1/S transition of mitotic cell cycle,BP,1
GO:0018393,0.762739321,0.582442434,1,131,internal peptidyl-lysine acetylation,BP,1
GO:0070838,0.763651356,0.480821086,2,253,divalent metal ion transport,BP,1
GO:0001894,0.7637043,0.581044199,1,132,tissue homeostasis,BP,1
GO:0008064,0.764180901,0.580359157,1,132,regulation of actin polymerization or depolymerization,BP,1
GO:0030832,0.764180901,0.580359157,1,132,regulation of actin filament length,BP,1
GO:0042098,0.765089551,0.579079124,1,130,T cell proliferation,BP,1
GO:0016458,0.765755504,0.578061126,1,134,gene silencing,BP,1
GO:0050866,0.766508148,0.577028895,1,130,negative regulation of cell activation,BP,1
GO:0045055,0.767011686,0.576284564,1,131,regulated exocytosis,BP,1
GO:0002274,0.767246505,0.575958352,1,130,myeloid leukocyte activation,BP,1
GO:0072511,0.767653932,0.475252908,2,255,divalent inorganic cation transport,BP,1
GO:0010466,0.768285679,0.574418805,1,132,negative regulation of peptidase activity,BP,1
GO:0006996,0.768779228,0.304983138,24,2480,organelle organization,BP,1
GO:0071702,0.769307398,0.317972882,16,1683,organic substance transport,BP,1
GO:0008104,0.769804892,0.315098324,17,1790,protein localization,BP,1
GO:0006475,0.770754042,0.570783363,1,134,internal protein amino acid acetylation,BP,1
GO:0019941,0.771633099,0.397939379,4,476,modification-dependent protein catabolic process,BP,1
GO:0046486,0.771678825,0.469610984,2,256,glycerolipid metabolic process,BP,1
GO:0017157,0.771721247,0.569376495,1,133,regulation of exocytosis,BP,1
GO:0008361,0.774420285,0.565270688,1,142,regulation of cell size,BP,1
GO:0098660,0.775147357,0.419849379,3,373,inorganic ion transmembrane transport,BP,1
GO:0006403,0.777973675,0.560022932,1,138,RNA localization,BP,1
GO:0006836,0.778067708,0.559895226,1,137,neurotransmitter transport,BP,1
GO:0002253,0.778208327,0.460357184,2,257,activation of immune response,BP,1
GO:0022411,0.779001288,0.459190595,2,264,cellular component disassembly,BP,1
GO:0048771,0.779588503,0.557596047,1,138,tissue remodeling,BP,1
GO:0061564,0.783478939,0.45269723,2,278,axon development,BP,1
GO:0022613,0.784569221,0.406892127,3,369,ribonucleoprotein complex biogenesis,BP,1
GO:0001819,0.784678187,0.451037986,2,262,positive regulation of cytokine production,BP,1
GO:0060627,0.785502804,0.405570039,3,378,regulation of vesicle-mediated transport,BP,1
GO:0035303,0.785963456,0.547846106,1,142,regulation of dephosphorylation,BP,1
GO:0006575,0.786948852,0.54639544,1,137,cellular modified amino acid metabolic process,BP,1
GO:0043632,0.787282582,0.376991764,4,487,modification-dependent macromolecule catabolic process,BP,1
GO:0007283,0.787450066,0.446986904,2,268,spermatogenesis,BP,1
GO:0006479,0.789763714,0.541961293,1,143,protein methylation,BP,1
GO:0008213,0.789763714,0.541961293,1,143,protein alkylation,BP,1
GO:0060348,0.789977818,0.541615995,1,144,bone development,BP,1
GO:0034762,0.791201386,0.441494456,2,270,regulation of transmembrane transport,BP,1
GO:0010498,0.791572806,0.397084992,3,377,proteasomal protein catabolic process,BP,1
GO:0051607,0.792410422,0.537843279,1,142,defense response to virus,BP,1
GO:0051048,0.793321387,0.536401087,1,143,negative regulation of secretion,BP,1
GO:0007005,0.793390363,0.394527677,3,376,mitochondrion organization,BP,1
GO:0099003,0.793904357,0.535484117,1,143,vesicle-mediated transport in synapse,BP,1
GO:0045471,0.793995765,0.535352837,1,142,response to ethanol,BP,1
GO:0032535,0.795682829,0.434856787,2,276,regulation of cellular component size,BP,1
GO:0043281,0.795847285,0.532428668,1,142,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,1
GO:0048232,0.796774716,0.433244902,2,274,male gamete generation,BP,1
GO:1902115,0.801750344,0.522906077,1,149,regulation of organelle assembly,BP,1
GO:0006486,0.802162913,0.522300389,1,144,protein glycosylation,BP,1
GO:0043413,0.802162913,0.522300389,1,144,macromolecule glycosylation,BP,1
GO:1903827,0.803459426,0.380145074,3,392,regulation of cellular protein localization,BP,1
GO:0051099,0.805738525,0.516429964,1,149,positive regulation of binding,BP,1
GO:0043603,0.807397375,0.310505747,7,812,cellular amide metabolic process,BP,1
GO:0050792,0.809620858,0.510046355,1,149,regulation of viral process,BP,1
GO:0008154,0.811429563,0.507010425,1,152,actin polymerization or depolymerization,BP,1
GO:0015931,0.812504146,0.505219035,1,152,nucleobase-containing compound transport,BP,1
GO:0043604,0.813273328,0.324277814,5,609,amide biosynthetic process,BP,1
GO:0022409,0.813522947,0.503503597,1,153,positive regulation of cell-cell adhesion,BP,1
GO:0070085,0.817362672,0.497052934,1,151,glycosylation,BP,1
GO:0043087,0.819582871,0.398379431,2,290,regulation of GTPase activity,BP,1
GO:0015833,0.820466067,0.270571961,11,1252,peptide transport,BP,1
GO:0090068,0.820882421,0.490948787,1,160,positive regulation of cell cycle process,BP,1
GO:0051098,0.821373951,0.395587691,2,285,regulation of binding,BP,1
GO:0046578,0.82183716,0.489287252,1,162,regulation of Ras protein signal transduction,BP,1
GO:0043270,0.822997616,0.487306014,1,160,positive regulation of ion transport,BP,1
GO:0051650,0.824666615,0.484413666,1,160,establishment of vesicle localization,BP,1
GO:0061136,0.825548101,0.482922177,1,156,regulation of proteasomal protein catabolic process,BP,1
GO:2000116,0.826216836,0.481744528,1,157,regulation of cysteine-type endopeptidase activity,BP,1
GO:0010632,0.826521764,0.481149288,1,163,regulation of epithelial cell migration,BP,1
GO:0048588,0.826548069,0.481083519,1,165,developmental cell growth,BP,1
GO:0018205,0.827127059,0.386453094,2,290,peptidyl-lysine modification,BP,1
GO:0043903,0.8300841,0.474924279,1,159,"regulation of symbiosis, encompassing mutualism through parasitism",BP,1
GO:0042886,0.834865142,0.251996777,11,1270,amide transport,BP,1
GO:0033157,0.837436571,0.461699482,1,164,regulation of intracellular protein transport,BP,1
GO:0051648,0.839432366,0.458027176,1,168,vesicle localization,BP,1
GO:0016236,0.842084825,0.453149949,1,169,macroautophagy,BP,1
GO:0017038,0.844419166,0.448828711,1,169,protein import,BP,1
GO:0016567,0.847765019,0.29068173,4,537,protein ubiquitination,BP,1
GO:0019058,0.849824452,0.438676286,1,170,viral life cycle,BP,1
GO:0006518,0.851475953,0.269992715,5,645,peptide metabolic process,BP,1
GO:0097435,0.851478661,0.307601082,3,439,supramolecular fiber organization,BP,1
GO:0044057,0.856079873,0.338471249,2,312,regulation of system process,BP,1
GO:0016485,0.85703977,0.424791825,1,174,protein processing,BP,1
GO:0051336,0.859499626,0.24748173,6,782,regulation of hydrolase activity,BP,1
GO:0051056,0.860768042,0.417392684,1,186,regulation of small GTPase mediated signal transduction,BP,1
GO:0043393,0.861393457,0.416215296,1,179,regulation of protein binding,BP,1
GO:0021537,0.861740053,0.415473235,1,186,telencephalon development,BP,1
GO:1903037,0.863202751,0.412628601,1,179,regulation of leukocyte cell-cell adhesion,BP,1
GO:0044085,0.863385874,0.196980809,19,2122,cellular component biogenesis,BP,1
GO:0007600,0.864416304,0.410160323,1,185,sensory perception,BP,1
GO:0120031,0.865835422,0.321468363,2,321,plasma membrane bounded cell projection assembly,BP,1
GO:0070647,0.866635709,0.247434706,5,671,protein modification by small protein conjugation or removal,BP,1
GO:0110053,0.867073331,0.404824812,1,185,regulation of actin filament organization,BP,1
GO:1903050,0.869129343,0.400683382,1,182,regulation of proteolysis involved in cellular protein catabolic process,BP,1
GO:0006650,0.87180687,0.395177542,1,186,glycerophospholipid metabolic process,BP,1
GO:0030031,0.873563985,0.307670942,2,328,cell projection assembly,BP,1
GO:0043161,0.874374958,0.306228903,2,321,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,1
GO:0015031,0.878524513,0.197051691,10,1230,protein transport,BP,1
GO:0042391,0.878750246,0.380662716,1,193,regulation of membrane potential,BP,1
GO:0009615,0.881249717,0.375366336,1,192,response to virus,BP,1
GO:0009101,0.88233637,0.373051307,1,191,glycoprotein biosynthetic process,BP,1
GO:0010506,0.885227946,0.366785716,1,196,regulation of autophagy,BP,1
GO:0032446,0.885636886,0.231417239,4,578,protein modification by small protein conjugation,BP,1
GO:0034613,0.888013718,0.183728713,10,1250,cellular protein localization,BP,1
GO:0007159,0.890499942,0.355215332,1,199,leukocyte cell-cell adhesion,BP,1
GO:0048870,0.893313471,0.189985,7,956,cell motility,BP,1
GO:0051674,0.893313471,0.189985,7,956,localization of cell,BP,1
GO:0070727,0.894122984,0.175046294,10,1261,cellular macromolecule localization,BP,1
GO:0030334,0.897250156,0.212224255,4,611,regulation of cell migration,BP,1
GO:0055082,0.89955305,0.226827308,3,479,cellular chemical homeostasis,BP,1
GO:1903362,0.903155635,0.326341874,1,210,regulation of cellular protein catabolic process,BP,1
GO:0072659,0.904445123,0.323292791,1,214,protein localization to plasma membrane,BP,1
GO:0030335,0.912890771,0.232222224,2,377,positive regulation of cell migration,BP,1
GO:0045861,0.912958387,0.302833806,1,219,negative regulation of proteolysis,BP,1
GO:2000145,0.917286663,0.177814706,4,641,regulation of cell motility,BP,1
GO:0045184,0.918674707,0.139223244,10,1305,establishment of protein localization,BP,1
GO:2000147,0.919058539,0.219464075,2,385,positive regulation of cell motility,BP,1
GO:0019221,0.919059699,0.287642862,1,225,cytokine-mediated signaling pathway,BP,1
GO:0051604,0.919927153,0.285450324,1,225,protein maturation,BP,1
GO:0007409,0.920755544,0.2832553,1,245,axonogenesis,BP,1
GO:0048193,0.921174948,0.282255073,1,230,Golgi vesicle transport,BP,1
GO:0043414,0.921824103,0.280597647,1,230,macromolecule methylation,BP,1
GO:0051272,0.925385298,0.206065049,2,394,positive regulation of cellular component movement,BP,1
GO:0034220,0.926156927,0.177399762,3,520,ion transmembrane transport,BP,1
GO:0016477,0.92654129,0.143829175,6,902,cell migration,BP,1
GO:0016032,0.926599777,0.268209229,1,235,viral process,BP,1
GO:0071705,0.929509278,0.120429293,11,1439,nitrogen compound transport,BP,1
GO:0055080,0.931544518,0.192710977,2,393,cation homeostasis,BP,1
GO:0032956,0.93180106,0.254334046,1,246,regulation of actin cytoskeleton organization,BP,1
GO:0006928,0.931892253,0.125426145,8,1152,movement of cell or subcellular component,BP,1
GO:0040017,0.932815122,0.189893296,2,405,positive regulation of locomotion,BP,1
GO:1990778,0.933507663,0.249710299,1,246,protein localization to cell periphery,BP,1
GO:0052548,0.934462026,0.247109231,1,245,regulation of endopeptidase activity,BP,1
GO:0055085,0.937428247,0.132044708,5,788,transmembrane transport,BP,1
GO:0098771,0.937672801,0.179057344,2,403,inorganic ion homeostasis,BP,1
GO:0051270,0.939186783,0.137892115,4,684,regulation of cellular component movement,BP,1
GO:0030900,0.93947975,0.233100628,1,265,forebrain development,BP,1
GO:0098609,0.941067715,0.171326308,2,413,cell-cell adhesion,BP,1
GO:0040012,0.94138566,0.133725234,4,688,regulation of locomotion,BP,1
GO:0040011,0.941475019,0.11371715,7,1058,locomotion,BP,1
GO:0098542,0.942406811,0.224813009,1,255,defense response to other organism,BP,1
GO:0006897,0.94244054,0.168170191,2,414,endocytosis,BP,1
GO:0032259,0.943584575,0.221411055,1,258,methylation,BP,1
GO:0052547,0.946898165,0.211713079,1,264,regulation of peptidase activity,BP,1
GO:0007015,0.948344047,0.207402631,1,271,actin filament organization,BP,1
GO:0032970,0.94991654,0.202682935,1,274,regulation of actin filament-based process,BP,1
GO:0045862,0.952294729,0.195465255,1,273,positive regulation of proteolysis,BP,1
GO:0019725,0.954569455,0.119309397,3,576,cellular homeostasis,BP,1
GO:0044403,0.954588149,0.188375511,1,277,symbiont process,BP,1
GO:0030036,0.955931429,0.135948516,2,448,actin cytoskeleton organization,BP,1
GO:0050801,0.956812565,0.133771144,2,442,ion homeostasis,BP,1
GO:0044419,0.960533563,0.169426705,1,289,interspecies interaction between organisms,BP,1
GO:0051656,0.963042997,0.161148657,1,300,establishment of organelle localization,BP,1
GO:0010256,0.963498202,0.159633379,1,300,endomembrane system organization,BP,1
GO:0016192,0.963542141,0.078767143,6,987,vesicle-mediated transport,BP,1
GO:0072594,0.963575942,0.159378486,1,298,establishment of protein localization to organelle,BP,1
GO:0098657,0.965991999,0.110280191,2,470,import into cell,BP,1
GO:0006914,0.966931837,0.147993759,1,308,autophagy,BP,1
GO:0061919,0.966931837,0.147993759,1,308,process utilizing autophagic mechanism,BP,1
GO:0030029,0.969141742,0.101880332,2,487,actin filament-based process,BP,1
GO:0006508,0.971084382,0.06146232,7,1132,proteolysis,BP,1
GO:0051641,0.972741342,0.049723943,13,1841,cellular localization,BP,1
GO:0098662,0.978120694,0.107274248,1,345,inorganic cation transmembrane transport,BP,1
GO:0030003,0.978521568,0.105722847,1,345,cellular cation homeostasis,BP,1
GO:0030162,0.978708945,0.075076601,2,513,regulation of proteolysis,BP,1
GO:0055065,0.97985735,0.10048791,1,352,metal ion homeostasis,BP,1
GO:0006873,0.980403536,0.09832392,1,353,cellular ion homeostasis,BP,1
GO:0006886,0.986136274,0.043791341,3,708,intracellular protein transport,BP,1
GO:0051640,0.986752447,0.07185739,1,392,organelle localization,BP,1
GO:0072657,0.986832674,0.071508357,1,389,protein localization to membrane,BP,1
GO:0098655,0.987129447,0.070201422,1,392,cation transmembrane transport,BP,1
GO:0046907,0.996473223,0.010584129,5,1154,intracellular transport,BP,1
GO:0051649,0.998256134,0.005190343,6,1376,establishment of localization in cell,BP,1
GO:0032928,1,0.8013364,0,20,regulation of superoxide anion generation,BP,1
GO:0050701,1,0.660032754,0,37,interleukin-1 secretion,BP,1
GO:0071257,1,0.85600449,0,14,cellular response to electrical stimulus,BP,1
GO:0010259,1,0.745541797,0,28,multicellular organism aging,BP,1
GO:0014888,1,0.725061157,0,30,striated muscle adaptation,BP,1
GO:0006739,1,0.715968709,0,30,NADP metabolic process,BP,1
GO:0000019,1,0.948773321,0,5,regulation of mitotic recombination,BP,1
GO:0000022,1,0.966369906,0,3,mitotic spindle elongation,BP,1
GO:0000023,1,0.988662885,0,1,maltose metabolic process,BP,1
GO:0000027,1,0.743895215,0,26,ribosomal large subunit assembly,BP,1
GO:0000028,1,0.82531845,0,17,ribosomal small subunit assembly,BP,1
GO:0000032,1,0.988662881,0,1,cell wall mannoprotein biosynthetic process,BP,1
GO:0000045,1,0.414350476,0,79,autophagosome assembly,BP,1
GO:0000050,1,0.920481323,0,8,urea cycle,BP,1
GO:0000052,1,0.93471876,0,7,citrulline metabolic process,BP,1
GO:0000053,1,0.977453344,0,2,argininosuccinate metabolic process,BP,1
GO:0000054,1,0.862852873,0,13,ribosomal subunit export from nucleus,BP,1
GO:0000055,1,0.913070735,0,8,ribosomal large subunit export from nucleus,BP,1
GO:0000056,1,0.923546598,0,7,ribosomal small subunit export from nucleus,BP,1
GO:0000076,1,0.904953962,0,9,DNA replication checkpoint,BP,1
GO:0000083,1,0.912238406,0,9,regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,1
GO:0000098,1,0.912842732,0,8,sulfur amino acid catabolic process,BP,1
GO:0000101,1,0.955411065,0,4,sulfur amino acid transport,BP,1
GO:0000103,1,0.966874665,0,3,sulfate assimilation,BP,1
GO:0000105,1,0.98905161,0,1,histidine biosynthetic process,BP,1
GO:0000117,1,0.988954145,0,1,regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,1
GO:0000132,1,0.788844864,0,22,establishment of mitotic spindle orientation,BP,1
GO:0000147,1,0.94690563,0,5,actin cortical patch assembly,BP,1
GO:0000154,1,0.778059652,0,22,rRNA modification,BP,1
GO:0000183,1,0.929857243,0,7,chromatin silencing at rDNA,BP,1
GO:0000184,1,0.755415308,0,25,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",BP,1
GO:0000209,1,0.177476357,0,158,protein polyubiquitination,BP,1
GO:0000212,1,0.885075174,0,12,meiotic spindle organization,BP,1
GO:0000244,1,0.91457973,0,8,spliceosomal tri-snRNP complex assembly,BP,1
GO:0000266,1,0.683049219,0,34,mitochondrial fission,BP,1
GO:0000270,1,0.988662931,0,1,peptidoglycan metabolic process,BP,1
GO:0000272,1,0.833632856,0,17,polysaccharide catabolic process,BP,1
GO:0000281,1,0.592108883,0,50,mitotic cytokinesis,BP,1
GO:0000289,1,0.783624022,0,23,nuclear-transcribed mRNA poly(A) tail shortening,BP,1
GO:0000290,1,0.913698726,0,8,deadenylation-dependent decapping of nuclear-transcribed mRNA,BP,1
GO:0000291,1,0.843621048,0,15,"nuclear-transcribed mRNA catabolic process, exonucleolytic",BP,1
GO:0000294,1,0.977470365,0,2,"nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay",BP,1
GO:0000301,1,0.977453514,0,2,"retrograde transport, vesicle recycling within Golgi",BP,1
GO:0000303,1,0.77494271,0,23,response to superoxide,BP,1
GO:0000304,1,0.988662929,0,1,response to singlet oxygen,BP,1
GO:0000305,1,0.766139296,0,24,response to oxygen radical,BP,1
GO:0000320,1,0.956577078,0,4,re-entry into mitotic cell cycle,BP,1
GO:0000338,1,0.892210935,0,10,protein deneddylation,BP,1
GO:0000349,1,0.97749422,0,2,generation of catalytic spliceosome for first transesterification step,BP,1
GO:0000350,1,0.980073536,0,2,generation of catalytic spliceosome for second transesterification step,BP,1
GO:0000378,1,0.988662931,0,1,RNA exon ligation,BP,1
GO:0000379,1,0.966369843,0,3,tRNA-type intron splice site recognition and cleavage,BP,1
GO:0000388,1,0.988662931,0,1,spliceosome conformational change to release U4 (or U4atac) and U1 (or U11),BP,1
GO:0000389,1,0.977454148,0,2,mRNA 3'-splice site recognition,BP,1
GO:0000390,1,0.978636427,0,2,spliceosomal complex disassembly,BP,1
GO:0000393,1,0.94714794,0,5,spliceosomal conformational changes to generate catalytic conformation,BP,1
GO:0000394,1,0.882171996,0,11,"RNA splicing, via endonucleolytic cleavage and ligation",BP,1
GO:0000409,1,0.991217712,0,1,regulation of transcription by galactose,BP,1
GO:0000411,1,0.991217712,0,1,positive regulation of transcription by galactose,BP,1
GO:0000414,1,0.933580736,0,7,regulation of histone H3-K36 methylation,BP,1
GO:0000415,1,0.977453375,0,2,negative regulation of histone H3-K36 methylation,BP,1
GO:0000416,1,0.971111197,0,3,positive regulation of histone H3-K36 methylation,BP,1
GO:0000422,1,0.526299703,0,59,autophagy of mitochondrion,BP,1
GO:0000423,1,0.797308209,0,21,mitophagy,BP,1
GO:0000429,1,0.957880883,0,4,carbon catabolite regulation of transcription from RNA polymerase II promoter,BP,1
GO:0000430,1,0.96637014,0,3,regulation of transcription from RNA polymerase II promoter by glucose,BP,1
GO:0000431,1,0.991217712,0,1,regulation of transcription from RNA polymerase II promoter by galactose,BP,1
GO:0000432,1,0.96637014,0,3,positive regulation of transcription from RNA polymerase II promoter by glucose,BP,1
GO:0000435,1,0.991217712,0,1,positive regulation of transcription from RNA polymerase II promoter by galactose,BP,1
GO:0000436,1,0.957880883,0,4,carbon catabolite activation of transcription from RNA polymerase II promoter,BP,1
GO:0000447,1,0.944574964,0,5,"endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",BP,1
GO:0000448,1,0.966381397,0,3,"cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",BP,1
GO:0000451,1,0.988760247,0,1,rRNA 2'-O-methylation,BP,1
GO:0000453,1,0.988760247,0,1,enzyme-directed rRNA 2'-O-methylation,BP,1
GO:0000454,1,0.955410545,0,4,snoRNA guided rRNA pseudouridine synthesis,BP,1
GO:0000455,1,0.988662931,0,1,enzyme-directed rRNA pseudouridine synthesis,BP,1
GO:0000459,1,0.912794729,0,8,exonucleolytic trimming involved in rRNA processing,BP,1
GO:0000460,1,0.752003975,0,25,maturation of 5.8S rRNA,BP,1
GO:0000461,1,0.988662388,0,1,"endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",BP,1
GO:0000462,1,0.736970835,0,27,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",BP,1
GO:0000463,1,0.842798861,0,15,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",BP,1
GO:0000466,1,0.796024717,0,20,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",BP,1
GO:0000467,1,0.912794729,0,8,"exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",BP,1
GO:0000469,1,0.795945817,0,20,cleavage involved in rRNA processing,BP,1
GO:0000470,1,0.786992691,0,21,maturation of LSU-rRNA,BP,1
GO:0000472,1,0.988662855,0,1,"endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",BP,1
GO:0000478,1,0.902449214,0,9,endonucleolytic cleavage involved in rRNA processing,BP,1
GO:0000479,1,0.902449214,0,9,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",BP,1
GO:0000480,1,0.955410808,0,4,"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",BP,1
GO:0000481,1,0.988680233,0,1,maturation of 5S rRNA,BP,1
GO:0000491,1,0.892200133,0,10,small nucleolar ribonucleoprotein complex assembly,BP,1
GO:0000492,1,0.912794974,0,8,box C/D snoRNP assembly,BP,1
GO:0000493,1,0.977453878,0,2,box H/ACA snoRNP assembly,BP,1
GO:0000494,1,0.988662821,0,1,box C/D snoRNA 3'-end processing,BP,1
GO:0000495,1,0.977453375,0,2,box H/ACA snoRNA 3'-end processing,BP,1
GO:0000578,1,0.811955043,0,19,embryonic axis specification,BP,1
GO:0000706,1,0.988662931,0,1,meiotic DNA double-strand break processing,BP,1
GO:0000710,1,0.966369762,0,3,meiotic mismatch repair,BP,1
GO:0000711,1,0.988662931,0,1,meiotic DNA repair synthesis,BP,1
GO:0000712,1,0.914704007,0,8,resolution of meiotic recombination intermediates,BP,1
GO:0000715,1,0.967075256,0,3,"nucleotide-excision repair, DNA damage recognition",BP,1
GO:0000717,1,0.978056609,0,2,"nucleotide-excision repair, DNA duplex unwinding",BP,1
GO:0000720,1,0.977453117,0,2,pyrimidine dimer repair by nucleotide-excision repair,BP,1
GO:0000722,1,0.911642382,0,9,telomere maintenance via recombination,BP,1
GO:0000727,1,0.913552815,0,8,double-strand break repair via break-induced replication,BP,1
GO:0000729,1,0.866715518,0,13,DNA double-strand break processing,BP,1
GO:0000730,1,0.977453373,0,2,DNA recombinase assembly,BP,1
GO:0000732,1,0.988662931,0,1,strand displacement,BP,1
GO:0000733,1,0.936121061,0,6,DNA strand renaturation,BP,1
GO:0000735,1,0.988662931,0,1,removal of nonhomologous ends,BP,1
GO:0000738,1,0.945384692,0,5,"DNA catabolic process, exonucleolytic",BP,1
GO:0000820,1,0.94012538,0,6,regulation of glutamine family amino acid metabolic process,BP,1
GO:0000821,1,0.967419845,0,3,regulation of arginine metabolic process,BP,1
GO:0000910,1,0.295918798,0,114,cytokinesis,BP,1
GO:0000912,1,0.988662926,0,1,assembly of actomyosin apparatus involved in cytokinesis,BP,1
GO:0000915,1,0.988662926,0,1,actomyosin contractile ring assembly,BP,1
GO:0000917,1,0.988662892,0,1,division septum assembly,BP,1
GO:0000957,1,0.946341619,0,5,mitochondrial RNA catabolic process,BP,1
GO:0000958,1,0.966844457,0,3,mitochondrial mRNA catabolic process,BP,1
GO:0000959,1,0.657515251,0,37,mitochondrial RNA metabolic process,BP,1
GO:0000960,1,0.957197206,0,4,regulation of mitochondrial RNA catabolic process,BP,1
GO:0000961,1,0.978799727,0,2,negative regulation of mitochondrial RNA catabolic process,BP,1
GO:0000962,1,0.977933322,0,2,positive regulation of mitochondrial RNA catabolic process,BP,1
GO:0000963,1,0.862695536,0,13,mitochondrial RNA processing,BP,1
GO:0000964,1,0.955880118,0,4,mitochondrial RNA 5'-end processing,BP,1
GO:0000965,1,0.945039691,0,5,mitochondrial RNA 3'-end processing,BP,1
GO:0000966,1,0.833894738,0,16,RNA 5'-end processing,BP,1
GO:0000967,1,0.988662855,0,1,rRNA 5'-end processing,BP,1
GO:0000968,1,0.988662931,0,1,tRNA exon ligation,BP,1
GO:0000971,1,0.988662931,0,1,"tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate",BP,1
GO:0000972,1,0.93910329,0,6,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,BP,1
GO:0000973,1,0.970362395,0,3,posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery,BP,1
GO:0001079,1,0.988662931,0,1,nitrogen catabolite regulation of transcription from RNA polymerase II promoter,BP,1
GO:0001081,1,0.988662931,0,1,nitrogen catabolite repression of transcription from RNA polymerase II promoter,BP,1
GO:0001112,1,0.988758009,0,1,DNA-templated transcriptional open complex formation,BP,1
GO:0001113,1,0.988758009,0,1,transcriptional open complex formation at RNA polymerase II promoter,BP,1
GO:0001120,1,0.988758009,0,1,protein-DNA complex remodeling,BP,1
GO:0001172,1,0.989079059,0,1,"transcription, RNA-templated",BP,1
GO:0001173,1,0.988662834,0,1,DNA-templated transcriptional start site selection,BP,1
GO:0001174,1,0.988662834,0,1,transcriptional start site selection at RNA polymerase II promoter,BP,1
GO:0001188,1,0.919528243,0,8,RNA polymerase I preinitiation complex assembly,BP,1
GO:0001192,1,0.988662653,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation,BP,1
GO:0001193,1,0.988662653,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter,BP,1
GO:0001207,1,0.988662916,0,1,histone displacement,BP,1
GO:0001300,1,0.977634283,0,2,chronological cell aging,BP,1
GO:0001306,1,0.966369865,0,3,age-dependent response to oxidative stress,BP,1
GO:0001315,1,0.988662931,0,1,age-dependent response to reactive oxygen species,BP,1
GO:0001325,1,0.923308215,0,7,formation of extrachromosomal circular DNA,BP,1
GO:0001502,1,0.924714168,0,7,cartilage condensation,BP,1
GO:0001504,1,0.820245623,0,18,neurotransmitter uptake,BP,1
GO:0001507,1,0.988662931,0,1,acetylcholine catabolic process in synaptic cleft,BP,1
GO:0001508,1,0.589831918,0,50,action potential,BP,1
GO:0001510,1,0.480058635,0,65,RNA methylation,BP,1
GO:0001514,1,0.914639461,0,8,selenocysteine incorporation,BP,1
GO:0001519,1,0.989452114,0,1,peptide amidation,BP,1
GO:0001522,1,0.833146774,0,16,pseudouridine synthesis,BP,1
GO:0001539,1,0.924155515,0,7,cilium or flagellum-dependent cell motility,BP,1
GO:0001543,1,0.982405793,0,2,ovarian follicle rupture,BP,1
GO:0001544,1,0.977549225,0,2,initiation of primordial ovarian follicle growth,BP,1
GO:0001545,1,0.988662931,0,1,primary ovarian follicle growth,BP,1
GO:0001546,1,0.988662931,0,1,preantral ovarian follicle growth,BP,1
GO:0001547,1,0.966464523,0,3,antral ovarian follicle growth,BP,1
GO:0001552,1,0.977463251,0,2,ovarian follicle atresia,BP,1
GO:0001553,1,0.859385999,0,14,luteinization,BP,1
GO:0001554,1,0.928915837,0,7,luteolysis,BP,1
GO:0001555,1,0.988662931,0,1,oocyte growth,BP,1
GO:0001556,1,0.779267975,0,22,oocyte maturation,BP,1
GO:0001561,1,0.946557244,0,5,fatty acid alpha-oxidation,BP,1
GO:0001572,1,0.991591574,0,1,lactosylceramide biosynthetic process,BP,1
GO:0001573,1,0.854966593,0,14,ganglioside metabolic process,BP,1
GO:0001574,1,0.92606537,0,7,ganglioside biosynthetic process,BP,1
GO:0001575,1,0.988662921,0,1,globoside metabolic process,BP,1
GO:0001579,1,0.966851969,0,3,medium-chain fatty acid transport,BP,1
GO:0001580,1,0.923269212,0,7,detection of chemical stimulus involved in sensory perception of bitter taste,BP,1
GO:0001660,1,0.882403076,0,11,fever generation,BP,1
GO:0001661,1,0.988662912,0,1,conditioned taste aversion,BP,1
GO:0001662,1,0.811364102,0,20,behavioral fear response,BP,1
GO:0001672,1,0.92993472,0,7,regulation of chromatin assembly or disassembly,BP,1
GO:0001675,1,0.914961644,0,8,acrosome assembly,BP,1
GO:0001680,1,0.988663288,0,1,tRNA 3'-terminal CCA addition,BP,1
GO:0001682,1,0.882441671,0,11,tRNA 5'-leader removal,BP,1
GO:0001692,1,0.988665758,0,1,histamine metabolic process,BP,1
GO:0001694,1,0.988665758,0,1,histamine biosynthetic process,BP,1
GO:0001696,1,0.956938152,0,4,gastric acid secretion,BP,1
GO:0001698,1,0.988662843,0,1,gastrin-induced gastric acid secretion,BP,1
GO:0001702,1,0.76486028,0,25,gastrulation with mouth forming second,BP,1
GO:0001704,1,0.460636793,0,74,formation of primary germ layer,BP,1
GO:0001705,1,0.966993061,0,3,ectoderm formation,BP,1
GO:0001706,1,0.71333558,0,32,endoderm formation,BP,1
GO:0001707,1,0.663948155,0,39,mesoderm formation,BP,1
GO:0001710,1,0.955783059,0,4,mesodermal cell fate commitment,BP,1
GO:0001711,1,0.90520207,0,9,endodermal cell fate commitment,BP,1
GO:0001712,1,0.978083374,0,2,ectodermal cell fate commitment,BP,1
GO:0001714,1,0.977455459,0,2,endodermal cell fate specification,BP,1
GO:0001715,1,0.988662931,0,1,ectodermal cell fate specification,BP,1
GO:0001731,1,0.903539315,0,9,formation of translation preinitiation complex,BP,1
GO:0001732,1,0.843291337,0,15,formation of cytoplasmic translation initiation complex,BP,1
GO:0001743,1,0.982431233,0,2,optic placode formation,BP,1
GO:0001755,1,0.732860985,0,30,neural crest cell migration,BP,1
GO:0001759,1,0.921965103,0,8,organ induction,BP,1
GO:0001762,1,0.988673949,0,1,beta-alanine transport,BP,1
GO:0001765,1,0.902988462,0,9,membrane raft assembly,BP,1
GO:0001766,1,0.988676099,0,1,membrane raft polarization,BP,1
GO:0001767,1,0.927695713,0,7,establishment of lymphocyte polarity,BP,1
GO:0001768,1,0.927695713,0,7,establishment of T cell polarity,BP,1
GO:0001771,1,0.907216122,0,9,immunological synapse formation,BP,1
GO:0001773,1,0.828873034,0,17,myeloid dendritic cell activation,BP,1
GO:0001777,1,0.977452976,0,2,T cell homeostatic proliferation,BP,1
GO:0001778,1,0.931115678,0,7,plasma membrane repair,BP,1
GO:0001779,1,0.783589622,0,22,natural killer cell differentiation,BP,1
GO:0001780,1,0.838165551,0,16,neutrophil homeostasis,BP,1
GO:0001781,1,0.927329309,0,7,neutrophil apoptotic process,BP,1
GO:0001787,1,0.944634215,0,5,natural killer cell proliferation,BP,1
GO:0001788,1,0.955449108,0,4,antibody-dependent cellular cytotoxicity,BP,1
GO:0001794,1,0.936107077,0,6,type IIa hypersensitivity,BP,1
GO:0001796,1,0.936107077,0,6,regulation of type IIa hypersensitivity,BP,1
GO:0001798,1,0.936107077,0,6,positive regulation of type IIa hypersensitivity,BP,1
GO:0001802,1,0.966369416,0,3,type III hypersensitivity,BP,1
GO:0001803,1,0.966369416,0,3,regulation of type III hypersensitivity,BP,1
GO:0001805,1,0.966369416,0,3,positive regulation of type III hypersensitivity,BP,1
GO:0001806,1,0.978593225,0,2,type IV hypersensitivity,BP,1
GO:0001807,1,0.988662931,0,1,regulation of type IV hypersensitivity,BP,1
GO:0001808,1,0.988662931,0,1,negative regulation of type IV hypersensitivity,BP,1
GO:0001810,1,0.955410674,0,4,regulation of type I hypersensitivity,BP,1
GO:0001811,1,0.988662879,0,1,negative regulation of type I hypersensitivity,BP,1
GO:0001812,1,0.966369503,0,3,positive regulation of type I hypersensitivity,BP,1
GO:0001813,1,0.977492314,0,2,regulation of antibody-dependent cellular cytotoxicity,BP,1
GO:0001815,1,0.988702358,0,1,positive regulation of antibody-dependent cellular cytotoxicity,BP,1
GO:0001820,1,0.92567037,0,7,serotonin secretion,BP,1
GO:0001821,1,0.925324141,0,7,histamine secretion,BP,1
GO:0001826,1,0.937204131,0,6,inner cell mass cell differentiation,BP,1
GO:0001827,1,0.97960116,0,2,inner cell mass cell fate commitment,BP,1
GO:0001828,1,0.968495605,0,3,inner cell mass cellular morphogenesis,BP,1
GO:0001830,1,0.982286335,0,2,trophectodermal cell fate commitment,BP,1
GO:0001831,1,0.990055434,0,1,trophectodermal cellular morphogenesis,BP,1
GO:0001832,1,0.813455667,0,19,blastocyst growth,BP,1
GO:0001833,1,0.875888689,0,12,inner cell mass cell proliferation,BP,1
GO:0001834,1,0.9663699,0,3,trophectodermal cell proliferation,BP,1
GO:0001835,1,0.817700205,0,19,blastocyst hatching,BP,1
GO:0001836,1,0.586772257,0,47,release of cytochrome c from mitochondria,BP,1
GO:0001839,1,0.973109149,0,3,neural plate morphogenesis,BP,1
GO:0001840,1,0.94174955,0,6,neural plate development,BP,1
GO:0001842,1,0.930534821,0,7,neural fold formation,BP,1
GO:0001844,1,0.966369509,0,3,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,1
GO:0001845,1,0.886242624,0,11,phagolysosome assembly,BP,1
GO:0001865,1,0.92806761,0,7,NK T cell differentiation,BP,1
GO:0001866,1,0.956411203,0,4,NK T cell proliferation,BP,1
GO:0001867,1,0.916606831,0,8,"complement activation, lectin pathway",BP,1
GO:0001868,1,0.979204267,0,2,"regulation of complement activation, lectin pathway",BP,1
GO:0001869,1,0.979204267,0,2,"negative regulation of complement activation, lectin pathway",BP,1
GO:0001878,1,0.944630988,0,5,response to yeast,BP,1
GO:0001879,1,0.988662931,0,1,detection of yeast,BP,1
GO:0001880,1,0.977689281,0,2,Mullerian duct regression,BP,1
GO:0001881,1,0.723816811,0,30,receptor recycling,BP,1
GO:0001885,1,0.570963081,0,52,endothelial cell development,BP,1
GO:0001886,1,0.898985002,0,10,endothelial cell morphogenesis,BP,1
GO:0001887,1,0.946956333,0,5,selenium compound metabolic process,BP,1
GO:0001895,1,0.772833383,0,24,retina homeostasis,BP,1
GO:0001905,1,0.968807186,0,3,activation of membrane attack complex,BP,1
GO:0001906,1,0.355875976,0,91,cell killing,BP,1
GO:0001907,1,0.966378698,0,3,killing by symbiont of host cells,BP,1
GO:0001909,1,0.456675902,0,69,leukocyte mediated cytotoxicity,BP,1
GO:0001910,1,0.586795228,0,47,regulation of leukocyte mediated cytotoxicity,BP,1
GO:0001911,1,0.854591132,0,14,negative regulation of leukocyte mediated cytotoxicity,BP,1
GO:0001912,1,0.665171533,0,36,positive regulation of leukocyte mediated cytotoxicity,BP,1
GO:0001913,1,0.657596441,0,37,T cell mediated cytotoxicity,BP,1
GO:0001914,1,0.728685799,0,28,regulation of T cell mediated cytotoxicity,BP,1
GO:0001915,1,0.968787975,0,3,negative regulation of T cell mediated cytotoxicity,BP,1
GO:0001916,1,0.75374239,0,25,positive regulation of T cell mediated cytotoxicity,BP,1
GO:0001919,1,0.793610989,0,21,regulation of receptor recycling,BP,1
GO:0001920,1,0.967309306,0,3,negative regulation of receptor recycling,BP,1
GO:0001921,1,0.864334162,0,13,positive regulation of receptor recycling,BP,1
GO:0001922,1,0.978229871,0,2,B-1 B cell homeostasis,BP,1
GO:0001923,1,0.945507563,0,5,B-1 B cell differentiation,BP,1
GO:0001927,1,0.98866293,0,1,exocyst assembly,BP,1
GO:0001928,1,0.98866293,0,1,regulation of exocyst assembly,BP,1
GO:0001937,1,0.734784804,0,29,negative regulation of endothelial cell proliferation,BP,1
GO:0001941,1,0.787706469,0,24,postsynaptic membrane organization,BP,1
GO:0001951,1,0.977577143,0,2,intestinal D-glucose absorption,BP,1
GO:0001953,1,0.763809653,0,26,negative regulation of cell-matrix adhesion,BP,1
GO:0001955,1,0.920881673,0,8,blood vessel maturation,BP,1
GO:0001956,1,0.89744272,0,10,positive regulation of neurotransmitter secretion,BP,1
GO:0001957,1,0.958826375,0,4,intramembranous ossification,BP,1
GO:0001958,1,0.808459798,0,20,endochondral ossification,BP,1
GO:0001960,1,0.70018049,0,32,negative regulation of cytokine-mediated signaling pathway,BP,1
GO:0001963,1,0.892713824,0,10,"synaptic transmission, dopaminergic",BP,1
GO:0001964,1,0.904927912,0,10,startle response,BP,1
GO:0001966,1,0.977453064,0,2,thigmotaxis,BP,1
GO:0001967,1,0.895177324,0,10,suckling behavior,BP,1
GO:0001969,1,0.968807186,0,3,regulation of activation of membrane attack complex,BP,1
GO:0001970,1,0.979918715,0,2,positive regulation of activation of membrane attack complex,BP,1
GO:0001971,1,0.988662594,0,1,negative regulation of activation of membrane attack complex,BP,1
GO:0001973,1,0.91494482,0,8,adenosine receptor signaling pathway,BP,1
GO:0001975,1,0.770862974,0,23,response to amphetamine,BP,1
GO:0001978,1,0.97746705,0,2,regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback,BP,1
GO:0001980,1,0.988662931,0,1,regulation of systemic arterial blood pressure by ischemic conditions,BP,1
GO:0001982,1,0.97746705,0,2,baroreceptor response to decreased systemic arterial blood pressure,BP,1
GO:0001987,1,0.988676804,0,1,vasoconstriction of artery involved in baroreceptor response to lowering of systemic arterial blood pressure,BP,1
GO:0001988,1,0.988662889,0,1,positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure,BP,1
GO:0001991,1,0.903954817,0,9,regulation of systemic arterial blood pressure by circulatory renin-angiotensin,BP,1
GO:0001992,1,0.988662912,0,1,regulation of systemic arterial blood pressure by vasopressin,BP,1
GO:0001993,1,0.966383169,0,3,regulation of systemic arterial blood pressure by norepinephrine-epinephrine,BP,1
GO:0001994,1,0.988676804,0,1,norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure,BP,1
GO:0001996,1,0.966383169,0,3,positive regulation of heart rate by epinephrine-norepinephrine,BP,1
GO:0001997,1,0.988676804,0,1,positive regulation of the force of heart contraction by epinephrine-norepinephrine,BP,1
GO:0001998,1,0.96636969,0,3,angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure,BP,1
GO:0001999,1,0.944970921,0,5,renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure,BP,1
GO:0002001,1,0.955810911,0,4,renin secretion into blood stream,BP,1
GO:0002002,1,0.956614598,0,4,regulation of angiotensin levels in blood,BP,1
GO:0002003,1,0.966369683,0,3,angiotensin maturation,BP,1
GO:0002011,1,0.637559816,0,45,morphogenesis of an epithelial sheet,BP,1
GO:0002014,1,0.988662931,0,1,vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure,BP,1
GO:0002018,1,0.966369951,0,3,renin-angiotensin regulation of aldosterone production,BP,1
GO:0002019,1,0.966369536,0,3,regulation of renal output by angiotensin,BP,1
GO:0002024,1,0.937022681,0,6,diet induced thermogenesis,BP,1
GO:0002026,1,0.849879907,0,15,regulation of the force of heart contraction,BP,1
GO:0002027,1,0.677054555,0,35,regulation of heart rate,BP,1
GO:0002029,1,0.875100881,0,12,desensitization of G protein-coupled receptor signaling pathway,BP,1
GO:0002030,1,0.978105744,0,2,inhibitory G protein-coupled receptor phosphorylation,BP,1
GO:0002031,1,0.915287965,0,8,G protein-coupled receptor internalization,BP,1
GO:0002032,1,0.988662917,0,1,desensitization of G protein-coupled receptor signaling pathway by arrestin,BP,1
GO:0002033,1,0.988663105,0,1,angiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,1
GO:0002034,1,0.955410961,0,4,regulation of blood vessel diameter by renin-angiotensin,BP,1
GO:0002036,1,0.947486693,0,5,regulation of L-glutamate import across plasma membrane,BP,1
GO:0002037,1,0.988662522,0,1,negative regulation of L-glutamate import across plasma membrane,BP,1
GO:0002038,1,0.977453329,0,2,positive regulation of L-glutamate import across plasma membrane,BP,1
GO:0002041,1,0.977453375,0,2,intussusceptive angiogenesis,BP,1
GO:0002044,1,0.988662931,0,1,blood vessel endothelial cell migration involved in intussusceptive angiogenesis,BP,1
GO:0002051,1,0.966638039,0,3,osteoblast fate commitment,BP,1
GO:0002062,1,0.503910448,0,63,chondrocyte differentiation,BP,1
GO:0002063,1,0.819663969,0,19,chondrocyte development,BP,1
GO:0002071,1,0.988662931,0,1,glandular epithelial cell maturation,BP,1
GO:0002072,1,0.959562637,0,4,optic cup morphogenesis involved in camera-type eye development,BP,1
GO:0002076,1,0.876805272,0,12,osteoblast development,BP,1
GO:0002084,1,0.902702114,0,9,protein depalmitoylation,BP,1
GO:0002086,1,0.988662885,0,1,diaphragm contraction,BP,1
GO:0002087,1,0.948075948,0,5,regulation of respiratory gaseous exchange by neurological system process,BP,1
GO:0002088,1,0.61610789,0,46,lens development in camera-type eye,BP,1
GO:0002089,1,0.842307387,0,16,lens morphogenesis in camera-type eye,BP,1
GO:0002091,1,0.926613653,0,7,negative regulation of receptor internalization,BP,1
GO:0002093,1,0.874264957,0,13,auditory receptor cell morphogenesis,BP,1
GO:0002097,1,0.843008688,0,15,tRNA wobble base modification,BP,1
GO:0002098,1,0.852687929,0,14,tRNA wobble uridine modification,BP,1
GO:0002101,1,0.988662931,0,1,tRNA wobble cytosine modification,BP,1
GO:0002115,1,0.868560408,0,13,store-operated calcium entry,BP,1
GO:0002118,1,0.988662912,0,1,aggressive behavior,BP,1
GO:0002125,1,0.988662912,0,1,maternal aggressive behavior,BP,1
GO:0002128,1,0.988662931,0,1,tRNA nucleoside ribose methylation,BP,1
GO:0002138,1,0.944575129,0,5,retinoic acid biosynthetic process,BP,1
GO:0002143,1,0.955411583,0,4,tRNA wobble position uridine thiolation,BP,1
GO:0002152,1,0.988662922,0,1,bile acid conjugation,BP,1
GO:0002154,1,0.939211279,0,6,thyroid hormone mediated signaling pathway,BP,1
GO:0002155,1,0.957884989,0,4,regulation of thyroid hormone mediated signaling pathway,BP,1
GO:0002158,1,0.956183635,0,4,osteoclast proliferation,BP,1
GO:0002159,1,0.967240938,0,3,desmosome assembly,BP,1
GO:0002176,1,0.944574698,0,5,male germ cell proliferation,BP,1
GO:0002181,1,0.400346843,0,81,cytoplasmic translation,BP,1
GO:0002182,1,0.923927629,0,7,cytoplasmic translational elongation,BP,1
GO:0002183,1,0.71917636,0,29,cytoplasmic translational initiation,BP,1
GO:0002184,1,0.977472293,0,2,cytoplasmic translational termination,BP,1
GO:0002188,1,0.977453277,0,2,translation reinitiation,BP,1
GO:0002190,1,0.944604487,0,5,cap-independent translational initiation,BP,1
GO:0002191,1,0.977453343,0,2,cap-dependent translational initiation,BP,1
GO:0002192,1,0.977453073,0,2,IRES-dependent translational initiation of linear mRNA,BP,1
GO:0002194,1,0.989874949,0,1,hepatocyte cell migration,BP,1
GO:0002209,1,0.802150299,0,21,behavioral defense response,BP,1
GO:0002220,1,0.977476333,0,2,innate immune response activating cell surface receptor signaling pathway,BP,1
GO:0002225,1,0.98918315,0,1,positive regulation of antimicrobial peptide production,BP,1
GO:0002227,1,0.955912882,0,4,innate immune response in mucosa,BP,1
GO:0002228,1,0.695663945,0,32,natural killer cell mediated immunity,BP,1
GO:0002232,1,0.955410558,0,4,leukocyte chemotaxis involved in inflammatory response,BP,1
GO:0002238,1,0.95791353,0,4,response to molecule of fungal origin,BP,1
GO:0002246,1,0.925227368,0,7,wound healing involved in inflammatory response,BP,1
GO:0002248,1,0.945562513,0,5,connective tissue replacement involved in inflammatory response wound healing,BP,1
GO:0002249,1,0.944993286,0,5,lymphocyte anergy,BP,1
GO:0002251,1,0.895592761,0,10,organ or tissue specific immune response,BP,1
GO:0002254,1,0.97745723,0,2,kinin cascade,BP,1
GO:0002264,1,0.988662931,0,1,endothelial cell activation involved in immune response,BP,1
GO:0002265,1,0.963955273,0,4,astrocyte activation involved in immune response,BP,1
GO:0002266,1,0.977645771,0,2,follicular dendritic cell activation,BP,1
GO:0002268,1,0.977645771,0,2,follicular dendritic cell differentiation,BP,1
GO:0002270,1,0.977453635,0,2,plasmacytoid dendritic cell activation,BP,1
GO:0002275,1,0.573274356,0,50,myeloid cell activation involved in immune response,BP,1
GO:0002276,1,0.966434803,0,3,basophil activation involved in immune response,BP,1
GO:0002277,1,0.98866253,0,1,myeloid dendritic cell activation involved in immune response,BP,1
GO:0002278,1,0.966369421,0,3,eosinophil activation involved in immune response,BP,1
GO:0002279,1,0.723750484,0,29,mast cell activation involved in immune response,BP,1
GO:0002280,1,0.992203716,0,1,monocyte activation involved in immune response,BP,1
GO:0002281,1,0.899611666,0,10,macrophage activation involved in immune response,BP,1
GO:0002282,1,0.966377519,0,3,microglial cell activation involved in immune response,BP,1
GO:0002283,1,0.875634969,0,12,neutrophil activation involved in immune response,BP,1
GO:0002291,1,0.925379218,0,7,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,1
GO:0002295,1,0.951461443,0,5,T-helper cell lineage commitment,BP,1
GO:0002296,1,0.971826541,0,3,T-helper 1 cell lineage commitment,BP,1
GO:0002298,1,0.988662892,0,1,"CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response",BP,1
GO:0002309,1,0.955410637,0,4,T cell proliferation involved in immune response,BP,1
GO:0002314,1,0.977453325,0,2,germinal center B cell differentiation,BP,1
GO:0002316,1,0.988663643,0,1,follicular B cell differentiation,BP,1
GO:0002317,1,0.966382441,0,3,plasma cell differentiation,BP,1
GO:0002318,1,0.924086489,0,7,myeloid progenitor cell differentiation,BP,1
GO:0002322,1,0.967706565,0,3,B cell proliferation involved in immune response,BP,1
GO:0002323,1,0.913858,0,8,natural killer cell activation involved in immune response,BP,1
GO:0002325,1,0.988662931,0,1,natural killer cell differentiation involved in immune response,BP,1
GO:0002326,1,0.963074118,0,4,B cell lineage commitment,BP,1
GO:0002329,1,0.951040717,0,5,pre-B cell differentiation,BP,1
GO:0002331,1,0.99507895,0,1,pre-B cell allelic exclusion,BP,1
GO:0002336,1,0.988662913,0,1,B-1 B cell lineage commitment,BP,1
GO:0002337,1,0.967323185,0,3,B-1a B cell differentiation,BP,1
GO:0002339,1,0.966369488,0,3,B cell selection,BP,1
GO:0002343,1,0.988662902,0,1,peripheral B cell selection,BP,1
GO:0002344,1,0.988662902,0,1,B cell affinity maturation,BP,1
GO:0002347,1,0.884002328,0,11,response to tumor cell,BP,1
GO:0002349,1,0.944992325,0,5,histamine production involved in inflammatory response,BP,1
GO:0002351,1,0.968877674,0,3,serotonin production involved in inflammatory response,BP,1
GO:0002352,1,0.977452978,0,2,B cell negative selection,BP,1
GO:0002353,1,0.97745723,0,2,plasma kallikrein-kinin cascade,BP,1
GO:0002357,1,0.988662931,0,1,defense response to tumor cell,BP,1
GO:0002358,1,0.98866253,0,1,B cell homeostatic proliferation,BP,1
GO:0002360,1,0.895875699,0,11,T cell lineage commitment,BP,1
GO:0002361,1,0.955411026,0,4,"CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation",BP,1
GO:0002363,1,0.940670008,0,6,alpha-beta T cell lineage commitment,BP,1
GO:0002368,1,0.988663345,0,1,B cell cytokine production,BP,1
GO:0002369,1,0.738882394,0,27,T cell cytokine production,BP,1
GO:0002370,1,0.966408393,0,3,natural killer cell cytokine production,BP,1
GO:0002371,1,0.880154625,0,12,dendritic cell cytokine production,BP,1
GO:0002372,1,0.950419786,0,5,myeloid dendritic cell cytokine production,BP,1
GO:0002373,1,0.988662586,0,1,plasmacytoid dendritic cell cytokine production,BP,1
GO:0002374,1,0.864654372,0,13,cytokine secretion involved in immune response,BP,1
GO:0002378,1,0.969196051,0,3,immunoglobulin biosynthetic process,BP,1
GO:0002379,1,0.988662749,0,1,immunoglobulin biosynthetic process involved in immune response,BP,1
GO:0002380,1,0.977453375,0,2,immunoglobulin secretion involved in immune response,BP,1
GO:0002383,1,0.988662749,0,1,immune response in brain or nervous system,BP,1
GO:0002385,1,0.905870926,0,9,mucosal immune response,BP,1
GO:0002386,1,0.977453576,0,2,immune response in mucosal-associated lymphoid tissue,BP,1
GO:0002396,1,0.933861717,0,6,MHC protein complex assembly,BP,1
GO:0002397,1,0.966369884,0,3,MHC class I protein complex assembly,BP,1
GO:0002398,1,0.988662909,0,1,MHC class Ib protein complex assembly,BP,1
GO:0002399,1,0.966369581,0,3,MHC class II protein complex assembly,BP,1
GO:0002407,1,0.887102037,0,11,dendritic cell chemotaxis,BP,1
GO:0002408,1,0.966369592,0,3,myeloid dendritic cell chemotaxis,BP,1
GO:0002413,1,0.988662931,0,1,tolerance induction to tumor cell,BP,1
GO:0002414,1,0.977453576,0,2,immunoglobulin transcytosis in epithelial cells,BP,1
GO:0002415,1,0.977453576,0,2,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,BP,1
GO:0002418,1,0.894100307,0,10,immune response to tumor cell,BP,1
GO:0002420,1,0.977919638,0,2,natural killer cell mediated cytotoxicity directed against tumor cell target,BP,1
GO:0002423,1,0.977919638,0,2,natural killer cell mediated immune response to tumor cell,BP,1
GO:0002424,1,0.956917196,0,4,T cell mediated immune response to tumor cell,BP,1
GO:0002426,1,0.977452822,0,2,immunoglobulin production in mucosal tissue,BP,1
GO:0002428,1,0.842744915,0,15,antigen processing and presentation of peptide antigen via MHC class Ib,BP,1
GO:0002429,1,0.284970016,0,112,immune response-activating cell surface receptor signaling pathway,BP,1
GO:0002430,1,0.955689831,0,4,complement receptor mediated signaling pathway,BP,1
GO:0002431,1,0.84548254,0,15,Fc receptor mediated stimulatory signaling pathway,BP,1
GO:0002432,1,0.97855241,0,2,granuloma formation,BP,1
GO:0002433,1,0.894676868,0,10,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,BP,1
GO:0002434,1,0.977453322,0,2,immune complex clearance,BP,1
GO:0002437,1,0.653730965,0,39,inflammatory response to antigenic stimulus,BP,1
GO:0002438,1,0.828129769,0,17,acute inflammatory response to antigenic stimulus,BP,1
GO:0002439,1,0.955410773,0,4,chronic inflammatory response to antigenic stimulus,BP,1
GO:0002441,1,0.944992325,0,5,histamine secretion involved in inflammatory response,BP,1
GO:0002442,1,0.968877674,0,3,serotonin secretion involved in inflammatory response,BP,1
GO:0002444,1,0.524628557,0,58,myeloid leukocyte mediated immunity,BP,1
GO:0002445,1,0.936107077,0,6,type II hypersensitivity,BP,1
GO:0002446,1,0.808489785,0,19,neutrophil mediated immunity,BP,1
GO:0002447,1,0.966369421,0,3,eosinophil mediated immunity,BP,1
GO:0002448,1,0.72370177,0,29,mast cell mediated immunity,BP,1
GO:0002455,1,0.674050319,0,35,humoral immune response mediated by circulating immunoglobulin,BP,1
GO:0002456,1,0.417074007,0,78,T cell mediated immunity,BP,1
GO:0002457,1,0.944674013,0,5,T cell antigen processing and presentation,BP,1
GO:0002461,1,0.977453353,0,2,tolerance induction dependent upon immune response,BP,1
GO:0002462,1,0.988662909,0,1,tolerance induction to nonself antigen,BP,1
GO:0002465,1,0.988662931,0,1,peripheral tolerance induction,BP,1
GO:0002467,1,0.874827866,0,12,germinal center formation,BP,1
GO:0002468,1,0.894388281,0,10,dendritic cell antigen processing and presentation,BP,1
GO:0002470,1,0.988662642,0,1,plasmacytoid dendritic cell antigen processing and presentation,BP,1
GO:0002472,1,0.989366886,0,1,macrophage antigen processing and presentation,BP,1
GO:0002474,1,0.706048098,0,31,antigen processing and presentation of peptide antigen via MHC class I,BP,1
GO:0002475,1,0.816620643,0,18,antigen processing and presentation via MHC class Ib,BP,1
GO:0002476,1,0.852421485,0,14,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,BP,1
GO:0002477,1,0.944619665,0,5,antigen processing and presentation of exogenous peptide antigen via MHC class Ib,BP,1
GO:0002478,1,0.77081474,0,23,antigen processing and presentation of exogenous peptide antigen,BP,1
GO:0002479,1,0.977492133,0,2,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent",BP,1
GO:0002481,1,0.966376419,0,3,"antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent",BP,1
GO:0002483,1,0.780920451,0,22,antigen processing and presentation of endogenous peptide antigen,BP,1
GO:0002484,1,0.842745245,0,15,antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway,BP,1
GO:0002485,1,0.977460386,0,2,"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent",BP,1
GO:0002486,1,0.852415345,0,14,"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent",BP,1
GO:0002488,1,0.977499392,0,2,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway,BP,1
GO:0002489,1,0.977499392,0,2,"antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent",BP,1
GO:0002495,1,0.842744159,0,15,antigen processing and presentation of peptide antigen via MHC class II,BP,1
GO:0002501,1,0.944575311,0,5,peptide antigen assembly with MHC protein complex,BP,1
GO:0002502,1,0.977453372,0,2,peptide antigen assembly with MHC class I protein complex,BP,1
GO:0002503,1,0.966369581,0,3,peptide antigen assembly with MHC class II protein complex,BP,1
GO:0002504,1,0.805116746,0,19,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,1
GO:0002507,1,0.8359957,0,16,tolerance induction,BP,1
GO:0002513,1,0.9667917,0,3,tolerance induction to self antigen,BP,1
GO:0002514,1,0.988662931,0,1,B cell tolerance induction,BP,1
GO:0002517,1,0.923677322,0,7,T cell tolerance induction,BP,1
GO:0002518,1,0.988662786,0,1,lymphocyte chemotaxis across high endothelial venule,BP,1
GO:0002519,1,0.97749232,0,2,natural killer cell tolerance induction,BP,1
GO:0002523,1,0.864999781,0,13,leukocyte migration involved in inflammatory response,BP,1
GO:0002524,1,0.905664867,0,9,hypersensitivity,BP,1
GO:0002525,1,0.988662907,0,1,acute inflammatory response to non-antigenic stimulus,BP,1
GO:0002528,1,0.988679762,0,1,regulation of vascular permeability involved in acute inflammatory response,BP,1
GO:0002536,1,0.944617135,0,5,respiratory burst involved in inflammatory response,BP,1
GO:0002537,1,0.977834014,0,2,nitric oxide production involved in inflammatory response,BP,1
GO:0002538,1,0.966548575,0,3,arachidonic acid metabolite production involved in inflammatory response,BP,1
GO:0002539,1,0.98866293,0,1,prostaglandin production involved in inflammatory response,BP,1
GO:0002540,1,0.977634075,0,2,leukotriene production involved in inflammatory response,BP,1
GO:0002541,1,0.988662931,0,1,activation of plasma proteins involved in acute inflammatory response,BP,1
GO:0002542,1,0.988662931,0,1,Factor XII activation,BP,1
GO:0002543,1,0.991229526,0,1,activation of blood coagulation via clotting cascade,BP,1
GO:0002544,1,0.853663244,0,14,chronic inflammatory response,BP,1
GO:0002552,1,0.988662931,0,1,serotonin secretion by mast cell,BP,1
GO:0002553,1,0.944992325,0,5,histamine secretion by mast cell,BP,1
GO:0002554,1,0.979989671,0,2,serotonin secretion by platelet,BP,1
GO:0002560,1,0.988662913,0,1,basophil mediated immunity,BP,1
GO:0002561,1,0.988662913,0,1,basophil degranulation,BP,1
GO:0002566,1,0.896198755,0,10,somatic diversification of immune receptors via somatic mutation,BP,1
GO:0002568,1,0.974376751,0,3,somatic diversification of T cell receptor genes,BP,1
GO:0002572,1,0.988975156,0,1,pro-T cell differentiation,BP,1
GO:0002576,1,0.937199801,0,6,platelet degranulation,BP,1
GO:0002577,1,0.844779957,0,15,regulation of antigen processing and presentation,BP,1
GO:0002578,1,0.934526865,0,6,negative regulation of antigen processing and presentation,BP,1
GO:0002579,1,0.914388774,0,8,positive regulation of antigen processing and presentation,BP,1
GO:0002580,1,0.966369222,0,3,regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,1
GO:0002581,1,0.977453077,0,2,negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,1
GO:0002582,1,0.98866253,0,1,positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,1
GO:0002583,1,0.944581714,0,5,regulation of antigen processing and presentation of peptide antigen,BP,1
GO:0002584,1,0.966369565,0,3,negative regulation of antigen processing and presentation of peptide antigen,BP,1
GO:0002585,1,0.977460012,0,2,positive regulation of antigen processing and presentation of peptide antigen,BP,1
GO:0002586,1,0.97745268,0,2,regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,1
GO:0002587,1,0.988662629,0,1,negative regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,1
GO:0002588,1,0.98866253,0,1,positive regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,1
GO:0002589,1,0.966376815,0,3,regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,1
GO:0002590,1,0.977453326,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,1
GO:0002591,1,0.988670045,0,1,positive regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,1
GO:0002604,1,0.915033963,0,8,regulation of dendritic cell antigen processing and presentation,BP,1
GO:0002605,1,0.967058014,0,3,negative regulation of dendritic cell antigen processing and presentation,BP,1
GO:0002606,1,0.946217817,0,5,positive regulation of dendritic cell antigen processing and presentation,BP,1
GO:0002616,1,0.989366886,0,1,regulation of macrophage antigen processing and presentation,BP,1
GO:0002617,1,0.989366886,0,1,negative regulation of macrophage antigen processing and presentation,BP,1
GO:0002625,1,0.977453267,0,2,regulation of T cell antigen processing and presentation,BP,1
GO:0002626,1,0.988662883,0,1,negative regulation of T cell antigen processing and presentation,BP,1
GO:0002634,1,0.934055321,0,6,regulation of germinal center formation,BP,1
GO:0002636,1,0.955410839,0,4,positive regulation of germinal center formation,BP,1
GO:0002638,1,0.910746853,0,9,negative regulation of immunoglobulin production,BP,1
GO:0002643,1,0.882588736,0,11,regulation of tolerance induction,BP,1
GO:0002644,1,0.988662709,0,1,negative regulation of tolerance induction,BP,1
GO:0002645,1,0.934404811,0,6,positive regulation of tolerance induction,BP,1
GO:0002649,1,0.988662931,0,1,regulation of tolerance induction to self antigen,BP,1
GO:0002651,1,0.988662931,0,1,positive regulation of tolerance induction to self antigen,BP,1
GO:0002652,1,0.977453353,0,2,regulation of tolerance induction dependent upon immune response,BP,1
GO:0002654,1,0.977453353,0,2,positive regulation of tolerance induction dependent upon immune response,BP,1
GO:0002655,1,0.988662909,0,1,regulation of tolerance induction to nonself antigen,BP,1
GO:0002657,1,0.988662909,0,1,positive regulation of tolerance induction to nonself antigen,BP,1
GO:0002658,1,0.988662931,0,1,regulation of peripheral tolerance induction,BP,1
GO:0002660,1,0.988662931,0,1,positive regulation of peripheral tolerance induction,BP,1
GO:0002661,1,0.988662931,0,1,regulation of B cell tolerance induction,BP,1
GO:0002663,1,0.988662931,0,1,positive regulation of B cell tolerance induction,BP,1
GO:0002664,1,0.934275011,0,6,regulation of T cell tolerance induction,BP,1
GO:0002665,1,0.988662709,0,1,negative regulation of T cell tolerance induction,BP,1
GO:0002666,1,0.966797337,0,3,positive regulation of T cell tolerance induction,BP,1
GO:0002667,1,0.944993286,0,5,regulation of T cell anergy,BP,1
GO:0002668,1,0.988662709,0,1,negative regulation of T cell anergy,BP,1
GO:0002669,1,0.977885666,0,2,positive regulation of T cell anergy,BP,1
GO:0002674,1,0.919141915,0,8,negative regulation of acute inflammatory response,BP,1
GO:0002679,1,0.912889191,0,8,respiratory burst involved in defense response,BP,1
GO:0002681,1,0.974376751,0,3,somatic recombination of T cell receptor gene segments,BP,1
GO:0002691,1,0.799428244,0,20,regulation of cellular extravasation,BP,1
GO:0002692,1,0.957887063,0,4,negative regulation of cellular extravasation,BP,1
GO:0002693,1,0.844210385,0,15,positive regulation of cellular extravasation,BP,1
GO:0002698,1,0.353927396,0,93,negative regulation of immune effector process,BP,1
GO:0002701,1,0.760591614,0,25,negative regulation of production of molecular mediator of immune response,BP,1
GO:0002704,1,0.651743076,0,38,negative regulation of leukocyte mediated immunity,BP,1
GO:0002707,1,0.705418404,0,31,negative regulation of lymphocyte mediated immunity,BP,1
GO:0002709,1,0.52195344,0,58,regulation of T cell mediated immunity,BP,1
GO:0002710,1,0.866015971,0,13,negative regulation of T cell mediated immunity,BP,1
GO:0002711,1,0.62326046,0,42,positive regulation of T cell mediated immunity,BP,1
GO:0002713,1,0.913186861,0,8,negative regulation of B cell mediated immunity,BP,1
GO:0002715,1,0.778987071,0,22,regulation of natural killer cell mediated immunity,BP,1
GO:0002716,1,0.872557497,0,12,negative regulation of natural killer cell mediated immunity,BP,1
GO:0002717,1,0.872758936,0,12,positive regulation of natural killer cell mediated immunity,BP,1
GO:0002719,1,0.826112579,0,17,negative regulation of cytokine production involved in immune response,BP,1
GO:0002724,1,0.77320568,0,23,regulation of T cell cytokine production,BP,1
GO:0002725,1,0.935193024,0,6,negative regulation of T cell cytokine production,BP,1
GO:0002726,1,0.835159952,0,16,positive regulation of T cell cytokine production,BP,1
GO:0002727,1,0.966408393,0,3,regulation of natural killer cell cytokine production,BP,1
GO:0002728,1,0.988662913,0,1,negative regulation of natural killer cell cytokine production,BP,1
GO:0002729,1,0.966408393,0,3,positive regulation of natural killer cell cytokine production,BP,1
GO:0002730,1,0.889474246,0,11,regulation of dendritic cell cytokine production,BP,1
GO:0002731,1,0.978270436,0,2,negative regulation of dendritic cell cytokine production,BP,1
GO:0002732,1,0.940135075,0,6,positive regulation of dendritic cell cytokine production,BP,1
GO:0002733,1,0.950419786,0,5,regulation of myeloid dendritic cell cytokine production,BP,1
GO:0002735,1,0.950419786,0,5,positive regulation of myeloid dendritic cell cytokine production,BP,1
GO:0002736,1,0.988662586,0,1,regulation of plasmacytoid dendritic cell cytokine production,BP,1
GO:0002737,1,0.988662586,0,1,negative regulation of plasmacytoid dendritic cell cytokine production,BP,1
GO:0002739,1,0.904539102,0,9,regulation of cytokine secretion involved in immune response,BP,1
GO:0002740,1,0.977452879,0,2,negative regulation of cytokine secretion involved in immune response,BP,1
GO:0002741,1,0.946674824,0,5,positive regulation of cytokine secretion involved in immune response,BP,1
GO:0002752,1,0.977476333,0,2,cell surface pattern recognition receptor signaling pathway,BP,1
GO:0002755,1,0.843800305,0,15,MyD88-dependent toll-like receptor signaling pathway,BP,1
GO:0002756,1,0.893282333,0,10,MyD88-independent toll-like receptor signaling pathway,BP,1
GO:0002759,1,0.977967729,0,2,regulation of antimicrobial humoral response,BP,1
GO:0002760,1,0.98918315,0,1,positive regulation of antimicrobial humoral response,BP,1
GO:0002762,1,0.714102642,0,31,negative regulation of myeloid leukocyte differentiation,BP,1
GO:0002765,1,0.989094412,0,1,immune response-inhibiting signal transduction,BP,1
GO:0002767,1,0.989094412,0,1,immune response-inhibiting cell surface receptor signaling pathway,BP,1
GO:0002768,1,0.263146888,0,119,immune response-regulating cell surface receptor signaling pathway,BP,1
GO:0002774,1,0.989094412,0,1,Fc receptor mediated inhibitory signaling pathway,BP,1
GO:0002775,1,0.98918315,0,1,antimicrobial peptide production,BP,1
GO:0002777,1,0.98918315,0,1,antimicrobial peptide biosynthetic process,BP,1
GO:0002778,1,0.98918315,0,1,antibacterial peptide production,BP,1
GO:0002780,1,0.98918315,0,1,antibacterial peptide biosynthetic process,BP,1
GO:0002784,1,0.98918315,0,1,regulation of antimicrobial peptide production,BP,1
GO:0002786,1,0.98918315,0,1,regulation of antibacterial peptide production,BP,1
GO:0002792,1,0.361798565,0,92,negative regulation of peptide secretion,BP,1
GO:0002803,1,0.98918315,0,1,positive regulation of antibacterial peptide production,BP,1
GO:0002805,1,0.98918315,0,1,regulation of antimicrobial peptide biosynthetic process,BP,1
GO:0002807,1,0.98918315,0,1,positive regulation of antimicrobial peptide biosynthetic process,BP,1
GO:0002808,1,0.98918315,0,1,regulation of antibacterial peptide biosynthetic process,BP,1
GO:0002815,1,0.98918315,0,1,biosynthetic process of antibacterial peptides active against Gram-positive bacteria,BP,1
GO:0002816,1,0.98918315,0,1,regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria,BP,1
GO:0002820,1,0.731337109,0,28,negative regulation of adaptive immune response,BP,1
GO:0002825,1,0.844555595,0,15,regulation of T-helper 1 type immune response,BP,1
GO:0002826,1,0.967186156,0,3,negative regulation of T-helper 1 type immune response,BP,1
GO:0002827,1,0.873240547,0,12,positive regulation of T-helper 1 type immune response,BP,1
GO:0002828,1,0.79835985,0,20,regulation of type 2 immune response,BP,1
GO:0002829,1,0.914506231,0,8,negative regulation of type 2 immune response,BP,1
GO:0002830,1,0.883102006,0,11,positive regulation of type 2 immune response,BP,1
GO:0002832,1,0.716557367,0,30,negative regulation of response to biotic stimulus,BP,1
GO:0002834,1,0.914670978,0,8,regulation of response to tumor cell,BP,1
GO:0002835,1,0.989134498,0,1,negative regulation of response to tumor cell,BP,1
GO:0002836,1,0.935334174,0,6,positive regulation of response to tumor cell,BP,1
GO:0002837,1,0.914670978,0,8,regulation of immune response to tumor cell,BP,1
GO:0002838,1,0.989134498,0,1,negative regulation of immune response to tumor cell,BP,1
GO:0002839,1,0.935334174,0,6,positive regulation of immune response to tumor cell,BP,1
GO:0002840,1,0.956917196,0,4,regulation of T cell mediated immune response to tumor cell,BP,1
GO:0002842,1,0.967892853,0,3,positive regulation of T cell mediated immune response to tumor cell,BP,1
GO:0002843,1,0.988662931,0,1,regulation of tolerance induction to tumor cell,BP,1
GO:0002845,1,0.988662931,0,1,positive regulation of tolerance induction to tumor cell,BP,1
GO:0002855,1,0.977919638,0,2,regulation of natural killer cell mediated immune response to tumor cell,BP,1
GO:0002856,1,0.989134498,0,1,negative regulation of natural killer cell mediated immune response to tumor cell,BP,1
GO:0002857,1,0.988662931,0,1,positive regulation of natural killer cell mediated immune response to tumor cell,BP,1
GO:0002858,1,0.977919638,0,2,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,1
GO:0002859,1,0.989134498,0,1,negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,1
GO:0002860,1,0.988662931,0,1,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,1
GO:0002861,1,0.816716785,0,18,regulation of inflammatory response to antigenic stimulus,BP,1
GO:0002862,1,0.902913412,0,9,negative regulation of inflammatory response to antigenic stimulus,BP,1
GO:0002863,1,0.904609144,0,9,positive regulation of inflammatory response to antigenic stimulus,BP,1
GO:0002864,1,0.884196725,0,11,regulation of acute inflammatory response to antigenic stimulus,BP,1
GO:0002865,1,0.955410664,0,4,negative regulation of acute inflammatory response to antigenic stimulus,BP,1
GO:0002866,1,0.925488643,0,7,positive regulation of acute inflammatory response to antigenic stimulus,BP,1
GO:0002870,1,0.944993286,0,5,T cell anergy,BP,1
GO:0002883,1,0.91498995,0,8,regulation of hypersensitivity,BP,1
GO:0002884,1,0.977453324,0,2,negative regulation of hypersensitivity,BP,1
GO:0002885,1,0.936107077,0,6,positive regulation of hypersensitivity,BP,1
GO:0002886,1,0.63616214,0,41,regulation of myeloid leukocyte mediated immunity,BP,1
GO:0002887,1,0.933935471,0,6,negative regulation of myeloid leukocyte mediated immunity,BP,1
GO:0002888,1,0.745333236,0,27,positive regulation of myeloid leukocyte mediated immunity,BP,1
GO:0002890,1,0.913186861,0,8,negative regulation of immunoglobulin mediated immune response,BP,1
GO:0002892,1,0.936107077,0,6,regulation of type II hypersensitivity,BP,1
GO:0002894,1,0.936107077,0,6,positive regulation of type II hypersensitivity,BP,1
GO:0002904,1,0.966370544,0,3,positive regulation of B cell apoptotic process,BP,1
GO:0002911,1,0.944993286,0,5,regulation of lymphocyte anergy,BP,1
GO:0002912,1,0.988662709,0,1,negative regulation of lymphocyte anergy,BP,1
GO:0002913,1,0.977885666,0,2,positive regulation of lymphocyte anergy,BP,1
GO:0002920,1,0.760497301,0,25,regulation of humoral immune response,BP,1
GO:0002921,1,0.895927506,0,10,negative regulation of humoral immune response,BP,1
GO:0002922,1,0.90702623,0,9,positive regulation of humoral immune response,BP,1
GO:0002923,1,0.915126828,0,8,regulation of humoral immune response mediated by circulating immunoglobulin,BP,1
GO:0002924,1,0.955412784,0,4,negative regulation of humoral immune response mediated by circulating immunoglobulin,BP,1
GO:0002925,1,0.957849036,0,4,positive regulation of humoral immune response mediated by circulating immunoglobulin,BP,1
GO:0002926,1,0.988662931,0,1,tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation,BP,1
GO:0002933,1,0.966369908,0,3,lipid hydroxylation,BP,1
GO:0002934,1,0.913618337,0,8,desmosome organization,BP,1
GO:0002939,1,0.988662962,0,1,tRNA N1-guanine methylation,BP,1
GO:0002940,1,0.97746471,0,2,tRNA N2-guanine methylation,BP,1
GO:0002943,1,0.955411123,0,4,tRNA dihydrouridine synthesis,BP,1
GO:0002946,1,0.977453359,0,2,tRNA C5-cytosine methylation,BP,1
GO:0002949,1,0.977453292,0,2,tRNA threonylcarbamoyladenosine modification,BP,1
GO:0003009,1,0.796118764,0,21,skeletal muscle contraction,BP,1
GO:0003010,1,0.98200386,0,2,voluntary skeletal muscle contraction,BP,1
GO:0003011,1,0.988662885,0,1,involuntary skeletal muscle contraction,BP,1
GO:0003012,1,0.088755497,0,221,muscle system process,BP,1
GO:0003015,1,0.304900127,0,108,heart process,BP,1
GO:0003016,1,0.837976519,0,16,respiratory system process,BP,1
GO:0003017,1,0.988662931,0,1,lymph circulation,BP,1
GO:0003025,1,0.9730784,0,3,regulation of systemic arterial blood pressure by baroreceptor feedback,BP,1
GO:0003032,1,0.956840634,0,4,detection of oxygen,BP,1
GO:0003050,1,0.988662931,0,1,regulation of systemic arterial blood pressure by atrial natriuretic peptide,BP,1
GO:0003051,1,0.977453374,0,2,angiotensin-mediated drinking behavior,BP,1
GO:0003056,1,0.928134131,0,7,regulation of vascular smooth muscle contraction,BP,1
GO:0003057,1,0.956431351,0,4,regulation of the force of heart contraction by chemical signal,BP,1
GO:0003062,1,0.966369606,0,3,regulation of heart rate by chemical signal,BP,1
GO:0003065,1,0.988662919,0,1,positive regulation of heart rate by epinephrine,BP,1
GO:0003068,1,0.988662931,0,1,regulation of systemic arterial blood pressure by acetylcholine,BP,1
GO:0003069,1,0.988662931,0,1,acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,1
GO:0003070,1,0.988662931,0,1,regulation of systemic arterial blood pressure by neurotransmitter,BP,1
GO:0003072,1,0.955410961,0,4,renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure,BP,1
GO:0003083,1,0.988662463,0,1,negative regulation of renal output by angiotensin,BP,1
GO:0003093,1,0.925804712,0,7,regulation of glomerular filtration,BP,1
GO:0003094,1,0.843925513,0,16,glomerular filtration,BP,1
GO:0003096,1,0.966381948,0,3,renal sodium ion transport,BP,1
GO:0003097,1,0.966397546,0,3,renal water transport,BP,1
GO:0003099,1,0.988676804,0,1,positive regulation of the force of heart contraction by chemical signal,BP,1
GO:0003100,1,0.967441311,0,3,regulation of systemic arterial blood pressure by endothelin,BP,1
GO:0003104,1,0.977687492,0,2,positive regulation of glomerular filtration,BP,1
GO:0003105,1,0.968575139,0,3,negative regulation of glomerular filtration,BP,1
GO:0003106,1,0.988662463,0,1,negative regulation of glomerular filtration by angiotensin,BP,1
GO:0003108,1,0.988662931,0,1,negative regulation of the force of heart contraction by chemical signal,BP,1
GO:0003116,1,0.988662931,0,1,regulation of vasoconstriction by norepinephrine,BP,1
GO:0003117,1,0.988662931,0,1,regulation of vasoconstriction by circulating norepinephrine,BP,1
GO:0003127,1,0.988662931,0,1,detection of nodal flow,BP,1
GO:0003128,1,0.960210426,0,5,heart field specification,BP,1
GO:0003129,1,0.983219931,0,2,heart induction,BP,1
GO:0003130,1,0.988662842,0,1,BMP signaling pathway involved in heart induction,BP,1
GO:0003133,1,0.988662842,0,1,endodermal-mesodermal cell signaling,BP,1
GO:0003134,1,0.988662842,0,1,endodermal-mesodermal cell signaling involved in heart induction,BP,1
GO:0003137,1,0.994495178,0,1,Notch signaling pathway involved in heart induction,BP,1
GO:0003138,1,0.988662931,0,1,primary heart field specification,BP,1
GO:0003139,1,0.965526979,0,4,secondary heart field specification,BP,1
GO:0003140,1,0.966374355,0,3,determination of left/right asymmetry in lateral mesoderm,BP,1
GO:0003142,1,0.988665047,0,1,cardiogenic plate morphogenesis,BP,1
GO:0003148,1,0.831450165,0,18,outflow tract septum morphogenesis,BP,1
GO:0003149,1,0.936811514,0,6,membranous septum morphogenesis,BP,1
GO:0003150,1,0.979947051,0,2,muscular septum morphogenesis,BP,1
GO:0003157,1,0.881987058,0,12,endocardium development,BP,1
GO:0003159,1,0.86795003,0,13,morphogenesis of an endothelium,BP,1
GO:0003160,1,0.952606121,0,5,endocardium morphogenesis,BP,1
GO:0003161,1,0.910981276,0,9,cardiac conduction system development,BP,1
GO:0003162,1,0.986152079,0,2,atrioventricular node development,BP,1
GO:0003163,1,0.977454085,0,2,sinoatrial node development,BP,1
GO:0003164,1,0.966369996,0,3,His-Purkinje system development,BP,1
GO:0003165,1,0.988662931,0,1,Purkinje myocyte development,BP,1
GO:0003166,1,0.977453463,0,2,bundle of His development,BP,1
GO:0003167,1,0.988663335,0,1,atrioventricular bundle cell differentiation,BP,1
GO:0003170,1,0.660672423,0,41,heart valve development,BP,1
GO:0003171,1,0.837201358,0,17,atrioventricular valve development,BP,1
GO:0003172,1,0.988662931,0,1,sinoatrial valve development,BP,1
GO:0003174,1,0.92554997,0,8,mitral valve development,BP,1
GO:0003175,1,0.9562322,0,4,tricuspid valve development,BP,1
GO:0003176,1,0.841473725,0,17,aortic valve development,BP,1
GO:0003177,1,0.883863387,0,13,pulmonary valve development,BP,1
GO:0003178,1,0.994713354,0,1,coronary sinus valve development,BP,1
GO:0003179,1,0.719860734,0,33,heart valve morphogenesis,BP,1
GO:0003180,1,0.879151539,0,13,aortic valve morphogenesis,BP,1
GO:0003181,1,0.837201358,0,17,atrioventricular valve morphogenesis,BP,1
GO:0003182,1,0.994713354,0,1,coronary sinus valve morphogenesis,BP,1
GO:0003183,1,0.92554997,0,8,mitral valve morphogenesis,BP,1
GO:0003184,1,0.923423349,0,9,pulmonary valve morphogenesis,BP,1
GO:0003185,1,0.988662931,0,1,sinoatrial valve morphogenesis,BP,1
GO:0003186,1,0.9562322,0,4,tricuspid valve morphogenesis,BP,1
GO:0003188,1,0.925069263,0,8,heart valve formation,BP,1
GO:0003190,1,0.957273574,0,5,atrioventricular valve formation,BP,1
GO:0003192,1,0.979007967,0,3,mitral valve formation,BP,1
GO:0003195,1,0.988662931,0,1,tricuspid valve formation,BP,1
GO:0003197,1,0.719209459,0,32,endocardial cushion development,BP,1
GO:0003198,1,0.892898944,0,11,epithelial to mesenchymal transition involved in endocardial cushion formation,BP,1
GO:0003199,1,0.977453332,0,2,endocardial cushion to mesenchymal transition involved in heart valve formation,BP,1
GO:0003203,1,0.79977274,0,22,endocardial cushion morphogenesis,BP,1
GO:0003207,1,0.972284425,0,3,cardiac chamber formation,BP,1
GO:0003208,1,0.670025324,0,39,cardiac ventricle morphogenesis,BP,1
GO:0003209,1,0.839991276,0,17,cardiac atrium morphogenesis,BP,1
GO:0003211,1,0.972284425,0,3,cardiac ventricle formation,BP,1
GO:0003213,1,0.985757973,0,2,cardiac right atrium morphogenesis,BP,1
GO:0003214,1,0.929996534,0,7,cardiac left ventricle morphogenesis,BP,1
GO:0003215,1,0.918772612,0,9,cardiac right ventricle morphogenesis,BP,1
GO:0003219,1,0.983435181,0,2,cardiac right ventricle formation,BP,1
GO:0003220,1,0.988662926,0,1,left ventricular cardiac muscle tissue morphogenesis,BP,1
GO:0003221,1,0.994865956,0,1,right ventricular cardiac muscle tissue morphogenesis,BP,1
GO:0003222,1,0.890334282,0,12,ventricular trabecula myocardium morphogenesis,BP,1
GO:0003223,1,0.952384019,0,6,ventricular compact myocardium morphogenesis,BP,1
GO:0003226,1,0.994865956,0,1,right ventricular compact myocardium morphogenesis,BP,1
GO:0003228,1,0.956582441,0,4,atrial cardiac muscle tissue development,BP,1
GO:0003229,1,0.700888966,0,35,ventricular cardiac muscle tissue development,BP,1
GO:0003230,1,0.802557892,0,21,cardiac atrium development,BP,1
GO:0003241,1,0.961299275,0,4,growth involved in heart morphogenesis,BP,1
GO:0003243,1,0.98868351,0,1,circumferential growth involved in left ventricle morphogenesis,BP,1
GO:0003245,1,0.977473314,0,2,cardiac muscle tissue growth involved in heart morphogenesis,BP,1
GO:0003247,1,0.988662916,0,1,post-embryonic cardiac muscle cell growth involved in heart morphogenesis,BP,1
GO:0003249,1,0.972885611,0,3,cell proliferation involved in heart valve morphogenesis,BP,1
GO:0003250,1,0.972885611,0,3,regulation of cell proliferation involved in heart valve morphogenesis,BP,1
GO:0003251,1,0.988662926,0,1,positive regulation of cell proliferation involved in heart valve morphogenesis,BP,1
GO:0003252,1,0.984043212,0,2,negative regulation of cell proliferation involved in heart valve morphogenesis,BP,1
GO:0003253,1,0.968293454,0,3,cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,1
GO:0003254,1,0.742280069,0,27,regulation of membrane depolarization,BP,1
GO:0003256,1,0.974555275,0,3,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,1
GO:0003257,1,0.989847689,0,1,positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,1
GO:0003270,1,0.994713354,0,1,Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,1
GO:0003271,1,0.98867343,0,1,smoothened signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,1
GO:0003272,1,0.855061209,0,16,endocardial cushion formation,BP,1
GO:0003273,1,0.967907008,0,4,cell migration involved in endocardial cushion formation,BP,1
GO:0003274,1,0.966459284,0,3,endocardial cushion fusion,BP,1
GO:0003275,1,0.988754356,0,1,apoptotic process involved in outflow tract morphogenesis,BP,1
GO:0003278,1,0.966458738,0,3,apoptotic process involved in heart morphogenesis,BP,1
GO:0003283,1,0.877545862,0,12,atrial septum development,BP,1
GO:0003284,1,0.955841639,0,4,septum primum development,BP,1
GO:0003285,1,0.977803316,0,2,septum secundum development,BP,1
GO:0003289,1,0.955841639,0,4,atrial septum primum morphogenesis,BP,1
GO:0003290,1,0.977803316,0,2,atrial septum secundum morphogenesis,BP,1
GO:0003292,1,0.991393591,0,1,cardiac septum cell differentiation,BP,1
GO:0003294,1,0.988882047,0,1,atrial ventricular junction remodeling,BP,1
GO:0003298,1,0.721178839,0,31,physiological muscle hypertrophy,BP,1
GO:0003299,1,0.835061158,0,17,muscle hypertrophy in response to stress,BP,1
GO:0003300,1,0.458250245,0,73,cardiac muscle hypertrophy,BP,1
GO:0003301,1,0.721178839,0,31,physiological cardiac muscle hypertrophy,BP,1
GO:0003306,1,0.947886907,0,5,Wnt signaling pathway involved in heart development,BP,1
GO:0003307,1,0.958756902,0,4,regulation of Wnt signaling pathway involved in heart development,BP,1
GO:0003308,1,0.968654146,0,3,negative regulation of Wnt signaling pathway involved in heart development,BP,1
GO:0003311,1,0.988831442,0,1,pancreatic D cell differentiation,BP,1
GO:0003321,1,0.966383169,0,3,positive regulation of blood pressure by epinephrine-norepinephrine,BP,1
GO:0003330,1,0.939677287,0,6,regulation of extracellular matrix constituent secretion,BP,1
GO:0003331,1,0.977453333,0,2,positive regulation of extracellular matrix constituent secretion,BP,1
GO:0003332,1,0.9613595,0,4,negative regulation of extracellular matrix constituent secretion,BP,1
GO:0003333,1,0.604644761,0,45,amino acid transmembrane transport,BP,1
GO:0003334,1,0.928670069,0,7,keratinocyte development,BP,1
GO:0003335,1,0.988663033,0,1,corneocyte development,BP,1
GO:0003337,1,0.967280422,0,3,mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,1
GO:0003339,1,0.978369747,0,2,regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,1
GO:0003340,1,0.978369747,0,2,negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,1
GO:0003341,1,0.838806488,0,16,cilium movement,BP,1
GO:0003342,1,0.988699351,0,1,proepicardium development,BP,1
GO:0003343,1,0.988699351,0,1,septum transversum development,BP,1
GO:0003344,1,0.93536104,0,7,pericardium morphogenesis,BP,1
GO:0003345,1,0.988738755,0,1,proepicardium cell migration involved in pericardium morphogenesis,BP,1
GO:0003348,1,0.929215609,0,7,cardiac endothelial cell differentiation,BP,1
GO:0003350,1,0.990631058,0,1,pulmonary myocardium development,BP,1
GO:0003351,1,0.918086438,0,8,epithelial cilium movement,BP,1
GO:0003352,1,0.934758816,0,6,regulation of cilium movement,BP,1
GO:0003356,1,0.945482597,0,5,regulation of cilium beat frequency,BP,1
GO:0003357,1,0.988662898,0,1,noradrenergic neuron differentiation,BP,1
GO:0003358,1,0.988662898,0,1,noradrenergic neuron development,BP,1
GO:0003359,1,0.988662898,0,1,noradrenergic neuron fate commitment,BP,1
GO:0003360,1,0.945005754,0,5,brainstem development,BP,1
GO:0003363,1,0.989224764,0,1,lamellipodium assembly involved in ameboidal cell migration,BP,1
GO:0003365,1,0.978671705,0,2,establishment of cell polarity involved in ameboidal cell migration,BP,1
GO:0003366,1,0.988698193,0,1,cell-matrix adhesion involved in ameboidal cell migration,BP,1
GO:0003373,1,0.955917579,0,4,dynamin family protein polymerization involved in membrane fission,BP,1
GO:0003374,1,0.955917579,0,4,dynamin family protein polymerization involved in mitochondrial fission,BP,1
GO:0003376,1,0.934922183,0,6,sphingosine-1-phosphate receptor signaling pathway,BP,1
GO:0003382,1,0.734172272,0,30,epithelial cell morphogenesis,BP,1
GO:0003383,1,0.959499793,0,4,apical constriction,BP,1
GO:0003400,1,0.977453258,0,2,regulation of COPII vesicle coating,BP,1
GO:0003401,1,0.815627283,0,19,axis elongation,BP,1
GO:0003402,1,0.988662931,0,1,planar cell polarity pathway involved in axis elongation,BP,1
GO:0003406,1,0.958479731,0,4,retinal pigment epithelium development,BP,1
GO:0003407,1,0.734069801,0,29,neural retina development,BP,1
GO:0003408,1,0.992957797,0,1,optic cup formation involved in camera-type eye development,BP,1
GO:0003413,1,0.851085664,0,15,chondrocyte differentiation involved in endochondral bone morphogenesis,BP,1
GO:0003414,1,0.948651523,0,5,chondrocyte morphogenesis involved in endochondral bone morphogenesis,BP,1
GO:0003415,1,0.955488492,0,4,chondrocyte hypertrophy,BP,1
GO:0003416,1,0.795710801,0,21,endochondral bone growth,BP,1
GO:0003417,1,0.839496219,0,16,growth plate cartilage development,BP,1
GO:0003418,1,0.909085641,0,9,growth plate cartilage chondrocyte differentiation,BP,1
GO:0003419,1,0.977705376,0,2,growth plate cartilage chondrocyte proliferation,BP,1
GO:0003420,1,0.977705376,0,2,regulation of growth plate cartilage chondrocyte proliferation,BP,1
GO:0003422,1,0.948651523,0,5,growth plate cartilage morphogenesis,BP,1
GO:0003429,1,0.948651523,0,5,growth plate cartilage chondrocyte morphogenesis,BP,1
GO:0003430,1,0.977532511,0,2,growth plate cartilage chondrocyte growth,BP,1
GO:0003431,1,0.969269826,0,3,growth plate cartilage chondrocyte development,BP,1
GO:0003433,1,0.900793803,0,10,chondrocyte development involved in endochondral bone morphogenesis,BP,1
GO:0005513,1,0.967232669,0,3,detection of calcium ion,BP,1
GO:0005980,1,0.842612709,0,16,glycogen catabolic process,BP,1
GO:0005981,1,0.914479365,0,8,regulation of glycogen catabolic process,BP,1
GO:0005984,1,0.955412274,0,4,disaccharide metabolic process,BP,1
GO:0005985,1,0.988662855,0,1,sucrose metabolic process,BP,1
GO:0005986,1,0.988662855,0,1,sucrose biosynthetic process,BP,1
GO:0005988,1,0.988664241,0,1,lactose metabolic process,BP,1
GO:0005989,1,0.988664241,0,1,lactose biosynthetic process,BP,1
GO:0005991,1,0.988662931,0,1,trehalose metabolic process,BP,1
GO:0005997,1,0.977792189,0,2,xylulose metabolic process,BP,1
GO:0006000,1,0.912795058,0,8,fructose metabolic process,BP,1
GO:0006002,1,0.9129442,0,8,fructose 6-phosphate metabolic process,BP,1
GO:0006003,1,0.944577826,0,5,"fructose 2,6-bisphosphate metabolic process",BP,1
GO:0006004,1,0.955411703,0,4,fucose metabolic process,BP,1
GO:0006007,1,0.864936002,0,13,glucose catabolic process,BP,1
GO:0006011,1,0.96636984,0,3,UDP-glucose metabolic process,BP,1
GO:0006012,1,0.912871318,0,8,galactose metabolic process,BP,1
GO:0006013,1,0.918531747,0,8,mannose metabolic process,BP,1
GO:0006014,1,0.96636969,0,3,D-ribose metabolic process,BP,1
GO:0006015,1,0.93394616,0,6,5-phosphoribose 1-diphosphate biosynthetic process,BP,1
GO:0006020,1,0.885348339,0,11,inositol metabolic process,BP,1
GO:0006021,1,0.958953692,0,4,inositol biosynthetic process,BP,1
GO:0006023,1,0.68898732,0,34,aminoglycan biosynthetic process,BP,1
GO:0006024,1,0.704842058,0,32,glycosaminoglycan biosynthetic process,BP,1
GO:0006026,1,0.883217551,0,11,aminoglycan catabolic process,BP,1
GO:0006027,1,0.893354677,0,10,glycosaminoglycan catabolic process,BP,1
GO:0006030,1,0.988662915,0,1,chitin metabolic process,BP,1
GO:0006032,1,0.988662915,0,1,chitin catabolic process,BP,1
GO:0006042,1,0.98866386,0,1,glucosamine biosynthetic process,BP,1
GO:0006045,1,0.977527964,0,2,N-acetylglucosamine biosynthetic process,BP,1
GO:0006049,1,0.988679996,0,1,UDP-N-acetylglucosamine catabolic process,BP,1
GO:0006050,1,0.988662857,0,1,mannosamine metabolic process,BP,1
GO:0006051,1,0.988662857,0,1,N-acetylmannosamine metabolic process,BP,1
GO:0006056,1,0.988662881,0,1,mannoprotein metabolic process,BP,1
GO:0006057,1,0.988662881,0,1,mannoprotein biosynthetic process,BP,1
GO:0006059,1,0.96636979,0,3,hexitol metabolic process,BP,1
GO:0006060,1,0.977453321,0,2,sorbitol metabolic process,BP,1
GO:0006061,1,0.988662869,0,1,sorbitol biosynthetic process,BP,1
GO:0006062,1,0.988662939,0,1,sorbitol catabolic process,BP,1
GO:0006063,1,0.944593457,0,5,uronic acid metabolic process,BP,1
GO:0006064,1,0.988662801,0,1,glucuronate catabolic process,BP,1
GO:0006065,1,0.988665076,0,1,UDP-glucuronate biosynthetic process,BP,1
GO:0006067,1,0.892199548,0,10,ethanol metabolic process,BP,1
GO:0006068,1,0.912794939,0,8,ethanol catabolic process,BP,1
GO:0006069,1,0.955410978,0,4,ethanol oxidation,BP,1
GO:0006071,1,0.856522905,0,14,glycerol metabolic process,BP,1
GO:0006072,1,0.945832968,0,5,glycerol-3-phosphate metabolic process,BP,1
GO:0006081,1,0.550664564,0,53,cellular aldehyde metabolic process,BP,1
GO:0006083,1,0.967071203,0,3,acetate metabolic process,BP,1
GO:0006085,1,0.844649455,0,15,acetyl-CoA biosynthetic process,BP,1
GO:0006086,1,0.892291232,0,10,acetyl-CoA biosynthetic process from pyruvate,BP,1
GO:0006089,1,0.832542976,0,17,lactate metabolic process,BP,1
GO:0006097,1,0.977453356,0,2,glyoxylate cycle,BP,1
GO:0006098,1,0.876769025,0,12,pentose-phosphate shunt,BP,1
GO:0006099,1,0.745437967,0,26,tricarboxylic acid cycle,BP,1
GO:0006101,1,0.738055692,0,27,citrate metabolic process,BP,1
GO:0006102,1,0.934169091,0,6,isocitrate metabolic process,BP,1
GO:0006105,1,0.923270117,0,7,succinate metabolic process,BP,1
GO:0006106,1,0.966372006,0,3,fumarate metabolic process,BP,1
GO:0006107,1,0.894489501,0,10,oxaloacetate metabolic process,BP,1
GO:0006108,1,0.934144888,0,6,malate metabolic process,BP,1
GO:0006113,1,0.944575612,0,5,fermentation,BP,1
GO:0006114,1,0.955456415,0,4,glycerol biosynthetic process,BP,1
GO:0006116,1,0.96644475,0,3,NADH oxidation,BP,1
GO:0006117,1,0.988671149,0,1,acetaldehyde metabolic process,BP,1
GO:0006120,1,0.814324984,0,18,"mitochondrial electron transport, NADH to ubiquinone",BP,1
GO:0006121,1,0.955412058,0,4,"mitochondrial electron transport, succinate to ubiquinone",BP,1
GO:0006122,1,0.89219896,0,10,"mitochondrial electron transport, ubiquinol to cytochrome c",BP,1
GO:0006123,1,0.93386001,0,6,"mitochondrial electron transport, cytochrome c to oxygen",BP,1
GO:0006127,1,0.988739393,0,1,glycerophosphate shuttle,BP,1
GO:0006144,1,0.802037004,0,20,purine nucleobase metabolic process,BP,1
GO:0006145,1,0.939169441,0,6,purine nucleobase catabolic process,BP,1
GO:0006147,1,0.988662895,0,1,guanine catabolic process,BP,1
GO:0006148,1,0.988662931,0,1,inosine catabolic process,BP,1
GO:0006150,1,0.989996103,0,1,hypoxanthine oxidation,BP,1
GO:0006152,1,0.914475522,0,8,purine nucleoside catabolic process,BP,1
GO:0006154,1,0.977453326,0,2,adenosine catabolic process,BP,1
GO:0006157,1,0.988662881,0,1,deoxyadenosine catabolic process,BP,1
GO:0006166,1,0.944574897,0,5,purine ribonucleoside salvage,BP,1
GO:0006167,1,0.923322251,0,7,AMP biosynthetic process,BP,1
GO:0006168,1,0.977452865,0,2,adenine salvage,BP,1
GO:0006172,1,0.966369671,0,3,ADP biosynthetic process,BP,1
GO:0006175,1,0.988662924,0,1,dATP biosynthetic process,BP,1
GO:0006177,1,0.95541892,0,4,GMP biosynthetic process,BP,1
GO:0006178,1,0.988662838,0,1,guanine salvage,BP,1
GO:0006182,1,0.946168061,0,5,cGMP biosynthetic process,BP,1
GO:0006183,1,0.902445587,0,9,GTP biosynthetic process,BP,1
GO:0006185,1,0.98866263,0,1,dGDP biosynthetic process,BP,1
GO:0006188,1,0.905757283,0,9,IMP biosynthetic process,BP,1
GO:0006189,1,0.936909385,0,6,'de novo' IMP biosynthetic process,BP,1
GO:0006193,1,0.988662822,0,1,ITP catabolic process,BP,1
GO:0006195,1,0.770956504,0,23,purine nucleotide catabolic process,BP,1
GO:0006196,1,0.988733776,0,1,AMP catabolic process,BP,1
GO:0006198,1,0.966823583,0,3,cAMP catabolic process,BP,1
GO:0006203,1,0.966369393,0,3,dGTP catabolic process,BP,1
GO:0006206,1,0.844227271,0,16,pyrimidine nucleobase metabolic process,BP,1
GO:0006207,1,0.944738005,0,6,'de novo' pyrimidine nucleobase biosynthetic process,BP,1
GO:0006208,1,0.967942953,0,3,pyrimidine nucleobase catabolic process,BP,1
GO:0006210,1,0.967942953,0,3,thymine catabolic process,BP,1
GO:0006211,1,0.977453375,0,2,5-methylcytosine catabolic process,BP,1
GO:0006212,1,0.978683444,0,2,uracil catabolic process,BP,1
GO:0006214,1,0.989906994,0,1,thymidine catabolic process,BP,1
GO:0006216,1,0.97745324,0,2,cytidine catabolic process,BP,1
GO:0006218,1,0.988662791,0,1,uridine catabolic process,BP,1
GO:0006225,1,0.988662928,0,1,UDP biosynthetic process,BP,1
GO:0006226,1,0.977453083,0,2,dUMP biosynthetic process,BP,1
GO:0006227,1,0.966541531,0,3,dUDP biosynthetic process,BP,1
GO:0006228,1,0.916835369,0,8,UTP biosynthetic process,BP,1
GO:0006231,1,0.966369794,0,3,dTMP biosynthetic process,BP,1
GO:0006233,1,0.977626953,0,2,dTDP biosynthetic process,BP,1
GO:0006235,1,0.955580677,0,4,dTTP biosynthetic process,BP,1
GO:0006238,1,0.98866291,0,1,CMP salvage,BP,1
GO:0006240,1,0.988662928,0,1,dCDP biosynthetic process,BP,1
GO:0006244,1,0.944579701,0,5,pyrimidine nucleotide catabolic process,BP,1
GO:0006253,1,0.988662931,0,1,dCTP catabolic process,BP,1
GO:0006256,1,0.988667778,0,1,UDP catabolic process,BP,1
GO:0006258,1,0.988662861,0,1,UDP-glucose catabolic process,BP,1
GO:0006264,1,0.853935306,0,14,mitochondrial DNA replication,BP,1
GO:0006265,1,0.914857093,0,8,DNA topological change,BP,1
GO:0006267,1,0.934637142,0,6,pre-replicative complex assembly involved in nuclear cell cycle DNA replication,BP,1
GO:0006268,1,0.885653069,0,11,DNA unwinding involved in DNA replication,BP,1
GO:0006269,1,0.957845261,0,4,"DNA replication, synthesis of RNA primer",BP,1
GO:0006270,1,0.818518576,0,18,DNA replication initiation,BP,1
GO:0006271,1,0.859650877,0,14,DNA strand elongation involved in DNA replication,BP,1
GO:0006272,1,0.972960573,0,3,leading strand elongation,BP,1
GO:0006273,1,0.92682297,0,7,lagging strand elongation,BP,1
GO:0006274,1,0.988662931,0,1,DNA replication termination,BP,1
GO:0006278,1,0.521320033,0,59,RNA-dependent DNA biosynthetic process,BP,1
GO:0006283,1,0.89768286,0,10,transcription-coupled nucleotide-excision repair,BP,1
GO:0006284,1,0.67370372,0,36,base-excision repair,BP,1
GO:0006285,1,0.955496468,0,4,"base-excision repair, AP site formation",BP,1
GO:0006287,1,0.938856071,0,6,"base-excision repair, gap-filling",BP,1
GO:0006288,1,0.989565978,0,1,"base-excision repair, DNA ligation",BP,1
GO:0006289,1,0.60713397,0,45,nucleotide-excision repair,BP,1
GO:0006290,1,0.927472883,0,7,pyrimidine dimer repair,BP,1
GO:0006294,1,0.988662918,0,1,"nucleotide-excision repair, preincision complex assembly",BP,1
GO:0006295,1,0.978230281,0,2,"nucleotide-excision repair, DNA incision, 3'-to lesion",BP,1
GO:0006296,1,0.977453081,0,2,"nucleotide-excision repair, DNA incision, 5'-to lesion",BP,1
GO:0006297,1,0.950017093,0,5,"nucleotide-excision repair, DNA gap filling",BP,1
GO:0006298,1,0.794067974,0,21,mismatch repair,BP,1
GO:0006304,1,0.499556578,0,64,DNA modification,BP,1
GO:0006305,1,0.634718577,0,42,DNA alkylation,BP,1
GO:0006306,1,0.634718577,0,42,DNA methylation,BP,1
GO:0006307,1,0.938177359,0,6,DNA dealkylation involved in DNA repair,BP,1
GO:0006311,1,0.988704665,0,1,meiotic gene conversion,BP,1
GO:0006312,1,0.85493087,0,15,mitotic recombination,BP,1
GO:0006333,1,0.449102238,0,74,chromatin assembly or disassembly,BP,1
GO:0006334,1,0.626830166,0,43,nucleosome assembly,BP,1
GO:0006335,1,0.924049529,0,7,DNA replication-dependent nucleosome assembly,BP,1
GO:0006336,1,0.867130809,0,14,DNA replication-independent nucleosome assembly,BP,1
GO:0006337,1,0.899512643,0,10,nucleosome disassembly,BP,1
GO:0006338,1,0.35009651,0,99,chromatin remodeling,BP,1
GO:0006342,1,0.522424482,0,60,chromatin silencing,BP,1
GO:0006343,1,0.990030533,0,1,establishment of chromatin silencing,BP,1
GO:0006344,1,0.970568795,0,3,maintenance of chromatin silencing,BP,1
GO:0006346,1,0.832756134,0,17,methylation-dependent chromatin silencing,BP,1
GO:0006348,1,0.938356009,0,6,chromatin silencing at telomere,BP,1
GO:0006349,1,0.851353631,0,15,regulation of gene expression by genetic imprinting,BP,1
GO:0006352,1,0.355530043,0,94,"DNA-templated transcription, initiation",BP,1
GO:0006353,1,0.817460448,0,18,"DNA-templated transcription, termination",BP,1
GO:0006354,1,0.52774364,0,58,"DNA-templated transcription, elongation",BP,1
GO:0006356,1,0.769382204,0,25,regulation of transcription by RNA polymerase I,BP,1
GO:0006359,1,0.858614683,0,15,regulation of transcription by RNA polymerase III,BP,1
GO:0006360,1,0.605643149,0,47,transcription by RNA polymerase I,BP,1
GO:0006361,1,0.889242188,0,11,transcription initiation from RNA polymerase I promoter,BP,1
GO:0006362,1,0.94885972,0,5,transcription elongation from RNA polymerase I promoter,BP,1
GO:0006363,1,0.945274741,0,5,termination of RNA polymerase I transcription,BP,1
GO:0006364,1,0.157643058,0,162,rRNA processing,BP,1
GO:0006367,1,0.532118525,0,57,transcription initiation from RNA polymerase II promoter,BP,1
GO:0006368,1,0.621954091,0,43,transcription elongation from RNA polymerase II promoter,BP,1
GO:0006369,1,0.933861851,0,6,termination of RNA polymerase II transcription,BP,1
GO:0006370,1,0.935108582,0,6,7-methylguanosine mRNA capping,BP,1
GO:0006378,1,0.659282282,0,38,mRNA polyadenylation,BP,1
GO:0006379,1,0.830568753,0,17,mRNA cleavage,BP,1
GO:0006382,1,0.959579689,0,4,adenosine to inosine editing,BP,1
GO:0006383,1,0.640935057,0,42,transcription by RNA polymerase III,BP,1
GO:0006384,1,0.89219766,0,11,transcription initiation from RNA polymerase III promoter,BP,1
GO:0006386,1,0.988662733,0,1,termination of RNA polymerase III transcription,BP,1
GO:0006388,1,0.892297203,0,10,"tRNA splicing, via endonucleolytic cleavage and ligation",BP,1
GO:0006390,1,0.853146123,0,14,mitochondrial transcription,BP,1
GO:0006391,1,0.977453337,0,2,transcription initiation from mitochondrial promoter,BP,1
GO:0006392,1,0.988662931,0,1,transcription elongation from mitochondrial promoter,BP,1
GO:0006393,1,0.977453375,0,2,termination of mitochondrial transcription,BP,1
GO:0006398,1,0.968430829,0,3,mRNA 3'-end processing by stem-loop binding and cleavage,BP,1
GO:0006399,1,0.180634975,0,150,tRNA metabolic process,BP,1
GO:0006400,1,0.472822869,0,66,tRNA modification,BP,1
GO:0006404,1,0.970993398,0,3,RNA import into nucleus,BP,1
GO:0006407,1,0.977973335,0,2,rRNA export from nucleus,BP,1
GO:0006408,1,0.977453352,0,2,snRNA export from nucleus,BP,1
GO:0006409,1,0.967414547,0,3,tRNA export from nucleus,BP,1
GO:0006413,1,0.309045635,0,105,translational initiation,BP,1
GO:0006414,1,0.594678066,0,46,translational elongation,BP,1
GO:0006415,1,0.892656675,0,10,translational termination,BP,1
GO:0006418,1,0.621789827,0,42,tRNA aminoacylation for protein translation,BP,1
GO:0006419,1,0.967483211,0,3,alanyl-tRNA aminoacylation,BP,1
GO:0006420,1,0.966369901,0,3,arginyl-tRNA aminoacylation,BP,1
GO:0006421,1,0.966371206,0,3,asparaginyl-tRNA aminoacylation,BP,1
GO:0006422,1,0.988662902,0,1,aspartyl-tRNA aminoacylation,BP,1
GO:0006423,1,0.977592698,0,2,cysteinyl-tRNA aminoacylation,BP,1
GO:0006424,1,0.979069357,0,2,glutamyl-tRNA aminoacylation,BP,1
GO:0006425,1,0.977453375,0,2,glutaminyl-tRNA aminoacylation,BP,1
GO:0006426,1,0.988662931,0,1,glycyl-tRNA aminoacylation,BP,1
GO:0006427,1,0.977453375,0,2,histidyl-tRNA aminoacylation,BP,1
GO:0006428,1,0.977453375,0,2,isoleucyl-tRNA aminoacylation,BP,1
GO:0006429,1,0.977548117,0,2,leucyl-tRNA aminoacylation,BP,1
GO:0006430,1,0.988662949,0,1,lysyl-tRNA aminoacylation,BP,1
GO:0006431,1,0.977453375,0,2,methionyl-tRNA aminoacylation,BP,1
GO:0006432,1,0.966369948,0,3,phenylalanyl-tRNA aminoacylation,BP,1
GO:0006433,1,0.979400088,0,2,prolyl-tRNA aminoacylation,BP,1
GO:0006434,1,0.977453373,0,2,seryl-tRNA aminoacylation,BP,1
GO:0006435,1,0.966374308,0,3,threonyl-tRNA aminoacylation,BP,1
GO:0006436,1,0.977453375,0,2,tryptophanyl-tRNA aminoacylation,BP,1
GO:0006437,1,0.977453353,0,2,tyrosyl-tRNA aminoacylation,BP,1
GO:0006438,1,0.978644725,0,2,valyl-tRNA aminoacylation,BP,1
GO:0006446,1,0.518575672,0,59,regulation of translational initiation,BP,1
GO:0006447,1,0.988662883,0,1,regulation of translational initiation by iron,BP,1
GO:0006448,1,0.836324657,0,16,regulation of translational elongation,BP,1
GO:0006449,1,0.966370349,0,3,regulation of translational termination,BP,1
GO:0006450,1,0.807074893,0,19,regulation of translational fidelity,BP,1
GO:0006451,1,0.914639461,0,8,translational readthrough,BP,1
GO:0006452,1,0.988662826,0,1,translational frameshifting,BP,1
GO:0006465,1,0.903703983,0,9,signal peptide processing,BP,1
GO:0006471,1,0.759527298,0,25,protein ADP-ribosylation,BP,1
GO:0006474,1,0.858094623,0,14,N-terminal protein amino acid acetylation,BP,1
GO:0006477,1,0.956496942,0,4,protein sulfation,BP,1
GO:0006478,1,0.977453358,0,2,peptidyl-tyrosine sulfation,BP,1
GO:0006480,1,0.988662931,0,1,N-terminal protein amino acid methylation,BP,1
GO:0006481,1,0.966369834,0,3,C-terminal protein methylation,BP,1
GO:0006482,1,0.7444329,0,27,protein demethylation,BP,1
GO:0006489,1,0.967018026,0,3,dolichyl diphosphate biosynthetic process,BP,1
GO:0006491,1,0.889603308,0,11,N-glycan processing,BP,1
GO:0006493,1,0.605367321,0,45,protein O-linked glycosylation,BP,1
GO:0006497,1,0.42888104,0,75,protein lipidation,BP,1
GO:0006498,1,0.955705779,0,4,N-terminal protein lipidation,BP,1
GO:0006499,1,0.955705779,0,4,N-terminal protein myristoylation,BP,1
GO:0006501,1,0.934003632,0,6,C-terminal protein lipidation,BP,1
GO:0006505,1,0.719959514,0,29,GPI anchor metabolic process,BP,1
GO:0006506,1,0.736403871,0,27,GPI anchor biosynthetic process,BP,1
GO:0006507,1,0.977723354,0,2,GPI anchor release,BP,1
GO:0006509,1,0.696192552,0,33,membrane protein ectodomain proteolysis,BP,1
GO:0006513,1,0.513014271,0,60,protein monoubiquitination,BP,1
GO:0006515,1,0.762037695,0,24,protein quality control for misfolded or incompletely synthesized proteins,BP,1
GO:0006516,1,0.864273387,0,13,glycoprotein catabolic process,BP,1
GO:0006517,1,0.868247063,0,13,protein deglycosylation,BP,1
GO:0006521,1,0.918918208,0,8,regulation of cellular amino acid metabolic process,BP,1
GO:0006522,1,0.94457559,0,5,alanine metabolic process,BP,1
GO:0006524,1,0.955411086,0,4,alanine catabolic process,BP,1
GO:0006525,1,0.836478933,0,16,arginine metabolic process,BP,1
GO:0006526,1,0.946053984,0,5,arginine biosynthetic process,BP,1
GO:0006527,1,0.915018781,0,8,arginine catabolic process,BP,1
GO:0006528,1,0.944592979,0,5,asparagine metabolic process,BP,1
GO:0006529,1,0.97745577,0,2,asparagine biosynthetic process,BP,1
GO:0006530,1,0.988662797,0,1,asparagine catabolic process,BP,1
GO:0006531,1,0.933880493,0,6,aspartate metabolic process,BP,1
GO:0006532,1,0.977455495,0,2,aspartate biosynthetic process,BP,1
GO:0006533,1,0.966371863,0,3,aspartate catabolic process,BP,1
GO:0006534,1,0.826441399,0,17,cysteine metabolic process,BP,1
GO:0006535,1,0.988678846,0,1,cysteine biosynthetic process from serine,BP,1
GO:0006537,1,0.956733089,0,4,glutamate biosynthetic process,BP,1
GO:0006538,1,0.95550227,0,4,glutamate catabolic process,BP,1
GO:0006539,1,0.988662929,0,1,glutamate catabolic process via 2-oxoglutarate,BP,1
GO:0006541,1,0.804081566,0,20,glutamine metabolic process,BP,1
GO:0006542,1,0.988662931,0,1,glutamine biosynthetic process,BP,1
GO:0006543,1,0.968702474,0,3,glutamine catabolic process,BP,1
GO:0006544,1,0.853202585,0,14,glycine metabolic process,BP,1
GO:0006545,1,0.933954716,0,6,glycine biosynthetic process,BP,1
GO:0006546,1,0.966773206,0,3,glycine catabolic process,BP,1
GO:0006547,1,0.934232047,0,6,histidine metabolic process,BP,1
GO:0006548,1,0.944578351,0,5,histidine catabolic process,BP,1
GO:0006549,1,0.977453342,0,2,isoleucine metabolic process,BP,1
GO:0006550,1,0.977453342,0,2,isoleucine catabolic process,BP,1
GO:0006551,1,0.923273554,0,7,leucine metabolic process,BP,1
GO:0006552,1,0.944580293,0,5,leucine catabolic process,BP,1
GO:0006553,1,0.944743457,0,5,lysine metabolic process,BP,1
GO:0006554,1,0.955581018,0,4,lysine catabolic process,BP,1
GO:0006556,1,0.955440071,0,4,S-adenosylmethionine biosynthetic process,BP,1
GO:0006557,1,0.98886652,0,1,S-adenosylmethioninamine biosynthetic process,BP,1
GO:0006560,1,0.933861998,0,6,proline metabolic process,BP,1
GO:0006561,1,0.966369903,0,3,proline biosynthetic process,BP,1
GO:0006562,1,0.966369853,0,3,proline catabolic process,BP,1
GO:0006563,1,0.912809689,0,8,L-serine metabolic process,BP,1
GO:0006564,1,0.966369787,0,3,L-serine biosynthetic process,BP,1
GO:0006565,1,0.944590717,0,5,L-serine catabolic process,BP,1
GO:0006566,1,0.944575467,0,5,threonine metabolic process,BP,1
GO:0006567,1,0.955410962,0,4,threonine catabolic process,BP,1
GO:0006568,1,0.903905313,0,9,tryptophan metabolic process,BP,1
GO:0006569,1,0.923268725,0,7,tryptophan catabolic process,BP,1
GO:0006571,1,0.988662931,0,1,tyrosine biosynthetic process,BP,1
GO:0006573,1,0.955763447,0,4,valine metabolic process,BP,1
GO:0006574,1,0.966726263,0,3,valine catabolic process,BP,1
GO:0006576,1,0.688462029,0,33,cellular biogenic amine metabolic process,BP,1
GO:0006578,1,0.934275104,0,6,amino-acid betaine biosynthetic process,BP,1
GO:0006580,1,0.988679185,0,1,ethanolamine metabolic process,BP,1
GO:0006581,1,0.988662931,0,1,acetylcholine catabolic process,BP,1
GO:0006582,1,0.937858453,0,6,melanin metabolic process,BP,1
GO:0006584,1,0.72887288,0,28,catecholamine metabolic process,BP,1
GO:0006586,1,0.903905313,0,9,indolalkylamine metabolic process,BP,1
GO:0006587,1,0.988662931,0,1,serotonin biosynthetic process from tryptophan,BP,1
GO:0006590,1,0.939212865,0,6,thyroid hormone generation,BP,1
GO:0006591,1,0.924570486,0,7,ornithine metabolic process,BP,1
GO:0006593,1,0.988662903,0,1,ornithine catabolic process,BP,1
GO:0006595,1,0.85376052,0,14,polyamine metabolic process,BP,1
GO:0006596,1,0.914270139,0,8,polyamine biosynthetic process,BP,1
GO:0006597,1,0.977654658,0,2,spermine biosynthetic process,BP,1
GO:0006598,1,0.955411605,0,4,polyamine catabolic process,BP,1
GO:0006599,1,0.98866289,0,1,phosphagen metabolic process,BP,1
GO:0006600,1,0.977452743,0,2,creatine metabolic process,BP,1
GO:0006601,1,0.977452743,0,2,creatine biosynthetic process,BP,1
GO:0006603,1,0.98866289,0,1,phosphocreatine metabolic process,BP,1
GO:0006605,1,0.095893509,0,210,protein targeting,BP,1
GO:0006607,1,0.912795793,0,8,NLS-bearing protein import into nucleus,BP,1
GO:0006610,1,0.966517286,0,3,ribosomal protein import into nucleus,BP,1
GO:0006612,1,0.392913696,0,84,protein targeting to membrane,BP,1
GO:0006613,1,0.845613404,0,15,cotranslational protein targeting to membrane,BP,1
GO:0006614,1,0.855322312,0,14,SRP-dependent cotranslational protein targeting to membrane,BP,1
GO:0006616,1,0.934076225,0,6,"SRP-dependent cotranslational protein targeting to membrane, translocation",BP,1
GO:0006617,1,0.977453098,0,2,"SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition",BP,1
GO:0006620,1,0.903925754,0,10,posttranslational protein targeting to endoplasmic reticulum membrane,BP,1
GO:0006621,1,0.93388867,0,6,protein retention in ER lumen,BP,1
GO:0006622,1,0.83005012,0,17,protein targeting to lysosome,BP,1
GO:0006623,1,0.738674061,0,29,protein targeting to vacuole,BP,1
GO:0006624,1,0.977453096,0,2,vacuolar protein processing,BP,1
GO:0006625,1,0.846502513,0,15,protein targeting to peroxisome,BP,1
GO:0006626,1,0.499375251,0,61,protein targeting to mitochondrion,BP,1
GO:0006627,1,0.933864931,0,6,protein processing involved in protein targeting to mitochondrion,BP,1
GO:0006642,1,0.95302738,0,5,triglyceride mobilization,BP,1
GO:0006643,1,0.279134482,0,113,membrane lipid metabolic process,BP,1
GO:0006646,1,0.905601285,0,9,phosphatidylethanolamine biosynthetic process,BP,1
GO:0006649,1,0.989237578,0,1,phospholipid transfer to membrane,BP,1
GO:0006654,1,0.876432809,0,12,phosphatidic acid biosynthetic process,BP,1
GO:0006655,1,0.923697438,0,7,phosphatidylglycerol biosynthetic process,BP,1
GO:0006656,1,0.806873955,0,19,phosphatidylcholine biosynthetic process,BP,1
GO:0006657,1,0.92391535,0,7,CDP-choline pathway,BP,1
GO:0006658,1,0.892481758,0,10,phosphatidylserine metabolic process,BP,1
GO:0006659,1,0.955666794,0,4,phosphatidylserine biosynthetic process,BP,1
GO:0006660,1,0.977453375,0,2,phosphatidylserine catabolic process,BP,1
GO:0006661,1,0.584550713,0,50,phosphatidylinositol biosynthetic process,BP,1
GO:0006662,1,0.872064298,0,12,glycerol ether metabolic process,BP,1
GO:0006663,1,0.977453343,0,2,platelet activating factor biosynthetic process,BP,1
GO:0006664,1,0.484864333,0,64,glycolipid metabolic process,BP,1
GO:0006665,1,0.42109154,0,77,sphingolipid metabolic process,BP,1
GO:0006666,1,0.988677855,0,1,3-keto-sphinganine metabolic process,BP,1
GO:0006667,1,0.9776216,0,2,sphinganine metabolic process,BP,1
GO:0006668,1,0.977457635,0,2,sphinganine-1-phosphate metabolic process,BP,1
GO:0006669,1,0.988667239,0,1,sphinganine-1-phosphate biosynthetic process,BP,1
GO:0006670,1,0.904789934,0,9,sphingosine metabolic process,BP,1
GO:0006671,1,0.988662931,0,1,phytosphingosine metabolic process,BP,1
GO:0006672,1,0.52138267,0,58,ceramide metabolic process,BP,1
GO:0006677,1,0.853321443,0,14,glycosylceramide metabolic process,BP,1
GO:0006678,1,0.934792761,0,6,glucosylceramide metabolic process,BP,1
GO:0006679,1,0.989438987,0,1,glucosylceramide biosynthetic process,BP,1
GO:0006680,1,0.966573904,0,3,glucosylceramide catabolic process,BP,1
GO:0006681,1,0.933896378,0,6,galactosylceramide metabolic process,BP,1
GO:0006682,1,0.977489193,0,2,galactosylceramide biosynthetic process,BP,1
GO:0006683,1,0.977453476,0,2,galactosylceramide catabolic process,BP,1
GO:0006684,1,0.884713218,0,11,sphingomyelin metabolic process,BP,1
GO:0006685,1,0.947235374,0,5,sphingomyelin catabolic process,BP,1
GO:0006686,1,0.944738196,0,5,sphingomyelin biosynthetic process,BP,1
GO:0006687,1,0.71362258,0,30,glycosphingolipid metabolic process,BP,1
GO:0006688,1,0.895638746,0,10,glycosphingolipid biosynthetic process,BP,1
GO:0006689,1,0.933863234,0,6,ganglioside catabolic process,BP,1
GO:0006691,1,0.894927152,0,10,leukotriene metabolic process,BP,1
GO:0006696,1,0.977691928,0,2,ergosterol biosynthetic process,BP,1
GO:0006700,1,0.853962569,0,14,C21-steroid hormone biosynthetic process,BP,1
GO:0006701,1,0.955430915,0,4,progesterone biosynthetic process,BP,1
GO:0006704,1,0.886515119,0,11,glucocorticoid biosynthetic process,BP,1
GO:0006705,1,0.904092936,0,9,mineralocorticoid biosynthetic process,BP,1
GO:0006706,1,0.834099437,0,16,steroid catabolic process,BP,1
GO:0006707,1,0.913821971,0,8,cholesterol catabolic process,BP,1
GO:0006710,1,0.966395614,0,3,androgen catabolic process,BP,1
GO:0006713,1,0.977453338,0,2,glucocorticoid catabolic process,BP,1
GO:0006714,1,0.988801447,0,1,sesquiterpenoid metabolic process,BP,1
GO:0006722,1,0.988662911,0,1,triterpenoid metabolic process,BP,1
GO:0006729,1,0.923268014,0,7,tetrahydrobiopterin biosynthetic process,BP,1
GO:0006730,1,0.780703348,0,22,one-carbon metabolic process,BP,1
GO:0006734,1,0.778817869,0,22,NADH metabolic process,BP,1
GO:0006735,1,0.944740268,0,5,NADH regeneration,BP,1
GO:0006738,1,0.988662931,0,1,nicotinamide riboside catabolic process,BP,1
GO:0006740,1,0.978666009,0,2,NADPH regeneration,BP,1
GO:0006741,1,0.955868001,0,4,NADP biosynthetic process,BP,1
GO:0006742,1,0.977942331,0,2,NADP catabolic process,BP,1
GO:0006743,1,0.8249931,0,17,ubiquinone metabolic process,BP,1
GO:0006744,1,0.83325298,0,16,ubiquinone biosynthetic process,BP,1
GO:0006747,1,0.988751856,0,1,FAD biosynthetic process,BP,1
GO:0006749,1,0.59984196,0,45,glutathione metabolic process,BP,1
GO:0006750,1,0.914486742,0,8,glutathione biosynthetic process,BP,1
GO:0006751,1,0.966369719,0,3,glutathione catabolic process,BP,1
GO:0006756,1,0.988662771,0,1,AMP phosphorylation,BP,1
GO:0006760,1,0.78912924,0,21,folic acid-containing compound metabolic process,BP,1
GO:0006767,1,0.688040121,0,33,water-soluble vitamin metabolic process,BP,1
GO:0006768,1,0.988662931,0,1,biotin metabolic process,BP,1
GO:0006771,1,0.98866315,0,1,riboflavin metabolic process,BP,1
GO:0006772,1,0.966689938,0,3,thiamine metabolic process,BP,1
GO:0006777,1,0.93403788,0,6,Mo-molybdopterin cofactor biosynthetic process,BP,1
GO:0006778,1,0.720193573,0,29,porphyrin-containing compound metabolic process,BP,1
GO:0006779,1,0.798191342,0,20,porphyrin-containing compound biosynthetic process,BP,1
GO:0006780,1,0.988662911,0,1,uroporphyrinogen III biosynthetic process,BP,1
GO:0006782,1,0.913173642,0,8,protoporphyrinogen IX biosynthetic process,BP,1
GO:0006783,1,0.807289023,0,19,heme biosynthetic process,BP,1
GO:0006784,1,0.977601932,0,2,heme a biosynthetic process,BP,1
GO:0006787,1,0.955410727,0,4,porphyrin-containing compound catabolic process,BP,1
GO:0006788,1,0.977453347,0,2,heme oxidation,BP,1
GO:0006797,1,0.988662931,0,1,polyphosphate metabolic process,BP,1
GO:0006798,1,0.988662931,0,1,polyphosphate catabolic process,BP,1
GO:0006801,1,0.598857439,0,46,superoxide metabolic process,BP,1
GO:0006808,1,0.966369517,0,3,regulation of nitrogen utilization,BP,1
GO:0006824,1,0.956987595,0,4,cobalt ion transport,BP,1
GO:0006826,1,0.69436982,0,34,iron ion transport,BP,1
GO:0006828,1,0.939308434,0,6,manganese ion transport,BP,1
GO:0006829,1,0.780411908,0,23,zinc ion transport,BP,1
GO:0006833,1,0.90246863,0,9,water transport,BP,1
GO:0006837,1,0.915447522,0,8,serotonin transport,BP,1
GO:0006842,1,0.9448612,0,5,tricarboxylic acid transport,BP,1
GO:0006843,1,0.988662917,0,1,mitochondrial citrate transmembrane transport,BP,1
GO:0006844,1,0.966369907,0,3,acyl carnitine transport,BP,1
GO:0006848,1,0.944576656,0,5,pyruvate transport,BP,1
GO:0006850,1,0.977453375,0,2,mitochondrial pyruvate transmembrane transport,BP,1
GO:0006851,1,0.834106883,0,16,mitochondrial calcium ion transmembrane transport,BP,1
GO:0006855,1,0.562144203,0,52,drug transmembrane transport,BP,1
GO:0006858,1,0.96648085,0,3,extracellular transport,BP,1
GO:0006862,1,0.816199356,0,18,nucleotide transport,BP,1
GO:0006863,1,0.977453357,0,2,purine nucleobase transport,BP,1
GO:0006864,1,0.988662931,0,1,pyrimidine nucleotide transport,BP,1
GO:0006865,1,0.400714245,0,83,amino acid transport,BP,1
GO:0006867,1,0.977456098,0,2,asparagine transport,BP,1
GO:0006868,1,0.957162032,0,4,glutamine transport,BP,1
GO:0006874,1,0.080038589,0,230,cellular calcium ion homeostasis,BP,1
GO:0006875,1,0.033804001,0,306,cellular metal ion homeostasis,BP,1
GO:0006876,1,0.988662931,0,1,cellular cadmium ion homeostasis,BP,1
GO:0006878,1,0.886042767,0,11,cellular copper ion homeostasis,BP,1
GO:0006879,1,0.617859,0,43,cellular iron ion homeostasis,BP,1
GO:0006880,1,0.966369651,0,3,intracellular sequestering of iron ion,BP,1
GO:0006882,1,0.806419346,0,20,cellular zinc ion homeostasis,BP,1
GO:0006883,1,0.908990908,0,9,cellular sodium ion homeostasis,BP,1
GO:0006884,1,0.811377799,0,20,cell volume homeostasis,BP,1
GO:0006888,1,0.305359774,0,106,ER to Golgi vesicle-mediated transport,BP,1
GO:0006890,1,0.629881298,0,42,"retrograde vesicle-mediated transport, Golgi to ER",BP,1
GO:0006891,1,0.784050151,0,22,intra-Golgi vesicle-mediated transport,BP,1
GO:0006892,1,0.389787966,0,87,post-Golgi vesicle-mediated transport,BP,1
GO:0006893,1,0.527691394,0,59,Golgi to plasma membrane transport,BP,1
GO:0006895,1,0.868293161,0,13,Golgi to endosome transport,BP,1
GO:0006896,1,0.8706134,0,13,Golgi to vacuole transport,BP,1
GO:0006900,1,0.567512374,0,51,vesicle budding from membrane,BP,1
GO:0006901,1,0.854936748,0,14,vesicle coating,BP,1
GO:0006903,1,0.676924094,0,35,vesicle targeting,BP,1
GO:0006904,1,0.727204696,0,29,vesicle docking involved in exocytosis,BP,1
GO:0006906,1,0.476003102,0,67,vesicle fusion,BP,1
GO:0006907,1,0.823271168,0,18,pinocytosis,BP,1
GO:0006909,1,0.193474848,0,149,phagocytosis,BP,1
GO:0006910,1,0.884438096,0,11,"phagocytosis, recognition",BP,1
GO:0006911,1,0.647876236,0,40,"phagocytosis, engulfment",BP,1
GO:0006919,1,0.554864281,0,54,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,1
GO:0006925,1,0.837750758,0,16,inflammatory cell apoptotic process,BP,1
GO:0006929,1,0.828880541,0,18,substrate-dependent cell migration,BP,1
GO:0006930,1,0.950132049,0,5,"substrate-dependent cell migration, cell extension",BP,1
GO:0006931,1,0.960677953,0,4,"substrate-dependent cell migration, cell attachment to substrate",BP,1
GO:0006932,1,0.988920188,0,1,"substrate-dependent cell migration, cell contraction",BP,1
GO:0006933,1,0.957345177,0,4,negative regulation of cell adhesion involved in substrate-bound cell migration,BP,1
GO:0006936,1,0.217495577,0,140,muscle contraction,BP,1
GO:0006937,1,0.420469705,0,79,regulation of muscle contraction,BP,1
GO:0006939,1,0.564612689,0,53,smooth muscle contraction,BP,1
GO:0006940,1,0.705439562,0,32,regulation of smooth muscle contraction,BP,1
GO:0006941,1,0.424743308,0,79,striated muscle contraction,BP,1
GO:0006942,1,0.605023306,0,46,regulation of striated muscle contraction,BP,1
GO:0006948,1,0.988662925,0,1,induction by virus of host cell-cell fusion,BP,1
GO:0006953,1,0.672344693,0,36,acute-phase response,BP,1
GO:0006956,1,0.63334831,0,41,complement activation,BP,1
GO:0006957,1,0.925455911,0,7,"complement activation, alternative pathway",BP,1
GO:0006958,1,0.753759066,0,25,"complement activation, classical pathway",BP,1
GO:0006963,1,0.98918315,0,1,positive regulation of antibacterial peptide biosynthetic process,BP,1
GO:0006965,1,0.98918315,0,1,positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria,BP,1
GO:0006968,1,0.95635664,0,4,cellular defense response,BP,1
GO:0006971,1,0.953150268,0,5,hypotonic response,BP,1
GO:0006972,1,0.773813316,0,23,hyperosmotic response,BP,1
GO:0006982,1,0.977452578,0,2,response to lipid hydroperoxide,BP,1
GO:0006983,1,0.87615198,0,12,ER overload response,BP,1
GO:0006984,1,0.699856503,0,32,ER-nucleus signaling pathway,BP,1
GO:0006990,1,0.9663698,0,3,positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response,BP,1
GO:0006991,1,0.895798616,0,10,response to sterol depletion,BP,1
GO:0006995,1,0.902440609,0,9,cellular response to nitrogen starvation,BP,1
GO:0006999,1,0.870172412,0,14,nuclear pore organization,BP,1
GO:0007000,1,0.926284868,0,7,nucleolus organization,BP,1
GO:0007004,1,0.524539446,0,58,telomere maintenance via telomerase,BP,1
GO:0007007,1,0.726672617,0,28,inner mitochondrial membrane organization,BP,1
GO:0007008,1,0.924904633,0,7,outer mitochondrial membrane organization,BP,1
GO:0007009,1,0.471172886,0,70,plasma membrane organization,BP,1
GO:0007014,1,0.98890353,0,1,actin ubiquitination,BP,1
GO:0007016,1,0.962186465,0,4,cytoskeletal anchoring at plasma membrane,BP,1
GO:0007019,1,0.747411806,0,29,microtubule depolymerization,BP,1
GO:0007021,1,0.923268154,0,7,tubulin complex assembly,BP,1
GO:0007023,1,0.944575065,0,5,post-chaperonin tubulin folding pathway,BP,1
GO:0007026,1,0.798892326,0,23,negative regulation of microtubule depolymerization,BP,1
GO:0007028,1,0.941930284,0,6,cytoplasm organization,BP,1
GO:0007029,1,0.58902661,0,48,endoplasmic reticulum organization,BP,1
GO:0007030,1,0.300038497,0,110,Golgi organization,BP,1
GO:0007031,1,0.715123618,0,30,peroxisome organization,BP,1
GO:0007032,1,0.629042216,0,43,endosome organization,BP,1
GO:0007033,1,0.213685199,0,139,vacuole organization,BP,1
GO:0007035,1,0.824180161,0,17,vacuolar acidification,BP,1
GO:0007039,1,0.899318325,0,11,protein catabolic process in the vacuole,BP,1
GO:0007040,1,0.559873124,0,52,lysosome organization,BP,1
GO:0007042,1,0.923268749,0,7,lysosomal lumen acidification,BP,1
GO:0007043,1,0.491739894,0,66,cell-cell junction assembly,BP,1
GO:0007056,1,0.977456499,0,2,spindle assembly involved in female meiosis,BP,1
GO:0007057,1,0.98866609,0,1,spindle assembly involved in female meiosis I,BP,1
GO:0007060,1,0.98866404,0,1,male meiosis chromosome segregation,BP,1
GO:0007062,1,0.681964749,0,37,sister chromatid cohesion,BP,1
GO:0007063,1,0.837104675,0,17,regulation of sister chromatid cohesion,BP,1
GO:0007064,1,0.819651596,0,20,mitotic sister chromatid cohesion,BP,1
GO:0007072,1,0.988662923,0,1,positive regulation of transcription involved in exit from mitosis,BP,1
GO:0007079,1,0.977602429,0,2,mitotic chromosome movement towards spindle pole,BP,1
GO:0007080,1,0.736582935,0,27,mitotic metaphase plate congression,BP,1
GO:0007084,1,0.966463816,0,3,mitotic nuclear envelope reassembly,BP,1
GO:0007089,1,0.988751502,0,1,traversing start control point of mitotic cell cycle,BP,1
GO:0007096,1,0.913513302,0,8,regulation of exit from mitosis,BP,1
GO:0007097,1,0.795245775,0,23,nuclear migration,BP,1
GO:0007099,1,0.772297608,0,24,centriole replication,BP,1
GO:0007113,1,0.977453183,0,2,endomitotic cell cycle,BP,1
GO:0007127,1,0.64380164,0,40,meiosis I,BP,1
GO:0007129,1,0.874740829,0,12,synapsis,BP,1
GO:0007130,1,0.926098942,0,7,synaptonemal complex assembly,BP,1
GO:0007131,1,0.82902011,0,17,reciprocal meiotic recombination,BP,1
GO:0007135,1,0.979202234,0,2,meiosis II,BP,1
GO:0007140,1,0.88076305,0,12,male meiotic nuclear division,BP,1
GO:0007141,1,0.923945708,0,7,male meiosis I,BP,1
GO:0007144,1,0.958077997,0,4,female meiosis I,BP,1
GO:0007156,1,0.660316603,0,41,homophilic cell adhesion via plasma membrane adhesion molecules,BP,1
GO:0007157,1,0.805815685,0,20,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,BP,1
GO:0007161,1,0.983460079,0,2,calcium-independent cell-matrix adhesion,BP,1
GO:0007168,1,0.979098084,0,2,receptor guanylyl cyclase signaling pathway,BP,1
GO:0007171,1,0.955710574,0,4,activation of transmembrane receptor protein tyrosine kinase activity,BP,1
GO:0007172,1,0.980055251,0,2,signal complex assembly,BP,1
GO:0007173,1,0.485912622,0,67,epidermal growth factor receptor signaling pathway,BP,1
GO:0007174,1,0.977453479,0,2,epidermal growth factor catabolic process,BP,1
GO:0007175,1,0.893902252,0,10,negative regulation of epidermal growth factor-activated receptor activity,BP,1
GO:0007176,1,0.819536407,0,18,regulation of epidermal growth factor-activated receptor activity,BP,1
GO:0007181,1,0.967341276,0,3,transforming growth factor beta receptor complex assembly,BP,1
GO:0007182,1,0.948919683,0,5,common-partner SMAD protein phosphorylation,BP,1
GO:0007183,1,0.875480895,0,12,SMAD protein complex assembly,BP,1
GO:0007190,1,0.955452709,0,4,activation of adenylate cyclase activity,BP,1
GO:0007191,1,0.968390853,0,3,adenylate cyclase-activating dopamine receptor signaling pathway,BP,1
GO:0007193,1,0.799672636,0,21,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway,BP,1
GO:0007194,1,0.941553696,0,6,negative regulation of adenylate cyclase activity,BP,1
GO:0007195,1,0.973740487,0,3,adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,1
GO:0007200,1,0.716089091,0,30,phospholipase C-activating G protein-coupled receptor signaling pathway,BP,1
GO:0007202,1,0.945999254,0,5,activation of phospholipase C activity,BP,1
GO:0007204,1,0.195102427,0,150,positive regulation of cytosolic calcium ion concentration,BP,1
GO:0007205,1,0.892550334,0,11,protein kinase C-activating G protein-coupled receptor signaling pathway,BP,1
GO:0007213,1,0.962135441,0,4,G protein-coupled acetylcholine receptor signaling pathway,BP,1
GO:0007214,1,0.942097931,0,6,gamma-aminobutyric acid signaling pathway,BP,1
GO:0007215,1,0.726585787,0,31,glutamate receptor signaling pathway,BP,1
GO:0007216,1,0.955539928,0,4,G protein-coupled glutamate receptor signaling pathway,BP,1
GO:0007217,1,0.977455298,0,2,tachykinin receptor signaling pathway,BP,1
GO:0007218,1,0.931055164,0,7,neuropeptide signaling pathway,BP,1
GO:0007220,1,0.913999014,0,8,Notch receptor processing,BP,1
GO:0007221,1,0.96500949,0,4,positive regulation of transcription of Notch receptor target,BP,1
GO:0007223,1,0.978439227,0,2,"Wnt signaling pathway, calcium modulating pathway",BP,1
GO:0007225,1,0.990919325,0,1,patched ligand maturation,BP,1
GO:0007227,1,0.968596451,0,3,signal transduction downstream of smoothened,BP,1
GO:0007228,1,0.97970525,0,2,positive regulation of hh target transcription factor activity,BP,1
GO:0007229,1,0.473981651,0,69,integrin-mediated signaling pathway,BP,1
GO:0007231,1,0.990356457,0,1,osmosensory signaling pathway,BP,1
GO:0007250,1,0.885771003,0,11,activation of NF-kappaB-inducing kinase activity,BP,1
GO:0007252,1,0.831799061,0,17,I-kappaB phosphorylation,BP,1
GO:0007253,1,0.933882907,0,6,cytoplasmic sequestering of NF-kappaB,BP,1
GO:0007256,1,0.901832659,0,10,activation of JNKK activity,BP,1
GO:0007257,1,0.742368586,0,28,activation of JUN kinase activity,BP,1
GO:0007258,1,0.95561819,0,4,JUN phosphorylation,BP,1
GO:0007270,1,0.951392285,0,5,neuron-neuron synaptic transmission,BP,1
GO:0007271,1,0.903524695,0,9,"synaptic transmission, cholinergic",BP,1
GO:0007274,1,0.856620715,0,15,neuromuscular synaptic transmission,BP,1
GO:0007284,1,0.988662931,0,1,spermatogonial cell division,BP,1
GO:0007288,1,0.912996686,0,8,sperm axoneme assembly,BP,1
GO:0007289,1,0.860672963,0,14,spermatid nucleus differentiation,BP,1
GO:0007290,1,0.979207925,0,2,spermatid nucleus elongation,BP,1
GO:0007296,1,0.974176406,0,3,vitellogenesis,BP,1
GO:0007320,1,0.944665817,0,5,insemination,BP,1
GO:0007339,1,0.814430401,0,18,binding of sperm to zona pellucida,BP,1
GO:0007340,1,0.906846397,0,9,acrosome reaction,BP,1
GO:0007341,1,0.977454668,0,2,penetration of zona pellucida,BP,1
GO:0007342,1,0.966369684,0,3,fusion of sperm to egg plasma membrane involved in single fertilization,BP,1
GO:0007343,1,0.970440035,0,3,egg activation,BP,1
GO:0007350,1,0.898301522,0,10,blastoderm segmentation,BP,1
GO:0007351,1,0.927899219,0,7,tripartite regional subdivision,BP,1
GO:0007352,1,0.977471318,0,2,zygotic specification of dorsal/ventral axis,BP,1
GO:0007354,1,0.967477426,0,3,"zygotic determination of anterior/posterior axis, embryo",BP,1
GO:0007356,1,0.98866287,0,1,thorax and anterior abdomen determination,BP,1
GO:0007369,1,0.257351286,0,127,gastrulation,BP,1
GO:0007371,1,0.988667479,0,1,ventral midline determination,BP,1
GO:0007398,1,0.856637859,0,14,ectoderm development,BP,1
GO:0007400,1,0.988662898,0,1,neuroblast fate determination,BP,1
GO:0007403,1,0.969166977,0,3,glial cell fate determination,BP,1
GO:0007406,1,0.929392871,0,7,negative regulation of neuroblast proliferation,BP,1
GO:0007412,1,0.989195603,0,1,axon target recognition,BP,1
GO:0007413,1,0.88526736,0,12,axonal fasciculation,BP,1
GO:0007418,1,0.977457869,0,2,ventral midline development,BP,1
GO:0007422,1,0.628561138,0,43,peripheral nervous system development,BP,1
GO:0007431,1,0.710363356,0,32,salivary gland development,BP,1
GO:0007435,1,0.743390846,0,28,salivary gland morphogenesis,BP,1
GO:0007439,1,0.977706031,0,2,ectodermal digestive tract development,BP,1
GO:0007440,1,0.900365703,0,10,foregut morphogenesis,BP,1
GO:0007442,1,0.966369909,0,3,hindgut morphogenesis,BP,1
GO:0007492,1,0.58760002,0,50,endoderm development,BP,1
GO:0007493,1,0.977455454,0,2,endodermal cell fate determination,BP,1
GO:0007494,1,0.851479364,0,15,midgut development,BP,1
GO:0007497,1,0.988662724,0,1,posterior midgut development,BP,1
GO:0007501,1,0.966615674,0,3,mesodermal cell fate specification,BP,1
GO:0007509,1,0.988662931,0,1,mesoderm migration involved in gastrulation,BP,1
GO:0007512,1,0.895406203,0,11,adult heart development,BP,1
GO:0007521,1,0.988662931,0,1,muscle cell fate determination,BP,1
GO:0007525,1,0.991102132,0,1,somatic muscle development,BP,1
GO:0007528,1,0.693841093,0,37,neuromuscular junction development,BP,1
GO:0007529,1,0.977782536,0,2,establishment of synaptic specificity at neuromuscular junction,BP,1
GO:0007530,1,0.90904818,0,9,sex determination,BP,1
GO:0007538,1,0.979564831,0,2,primary sex determination,BP,1
GO:0007542,1,0.979564831,0,2,"primary sex determination, germ-line",BP,1
GO:0007549,1,0.818209628,0,18,dosage compensation,BP,1
GO:0007567,1,0.910551079,0,9,parturition,BP,1
GO:0007571,1,0.966369865,0,3,age-dependent general metabolic decline,BP,1
GO:0007576,1,0.988680352,0,1,nucleolar fragmentation,BP,1
GO:0007585,1,0.762614108,0,25,respiratory gaseous exchange,BP,1
GO:0007588,1,0.749523946,0,26,excretion,BP,1
GO:0007597,1,0.960485638,0,4,"blood coagulation, intrinsic pathway",BP,1
GO:0007598,1,0.992260169,0,1,"blood coagulation, extrinsic pathway",BP,1
GO:0007601,1,0.672444863,0,37,visual perception,BP,1
GO:0007602,1,0.968861272,0,3,phototransduction,BP,1
GO:0007603,1,0.977453415,0,2,"phototransduction, visible light",BP,1
GO:0007605,1,0.479023981,0,72,sensory perception of sound,BP,1
GO:0007608,1,0.851074027,0,15,sensory perception of smell,BP,1
GO:0007612,1,0.459467644,0,75,learning,BP,1
GO:0007616,1,0.806224888,0,21,long-term memory,BP,1
GO:0007617,1,0.837006221,0,16,mating behavior,BP,1
GO:0007618,1,0.75677631,0,25,mating,BP,1
GO:0007619,1,0.966370436,0,3,courtship behavior,BP,1
GO:0007620,1,0.883956013,0,11,copulation,BP,1
GO:0007621,1,0.977453325,0,2,negative regulation of female receptivity,BP,1
GO:0007624,1,0.988662931,0,1,ultradian rhythm,BP,1
GO:0007625,1,0.923296278,0,8,grooming behavior,BP,1
GO:0007628,1,0.809407468,0,20,adult walking behavior,BP,1
GO:0007632,1,0.686837867,0,36,visual behavior,BP,1
GO:0007635,1,0.916506423,0,9,chemosensory behavior,BP,1
GO:0007638,1,0.952144963,0,6,mechanosensory behavior,BP,1
GO:0008016,1,0.395551922,0,84,regulation of heart contraction,BP,1
GO:0008033,1,0.331535808,0,97,tRNA processing,BP,1
GO:0008037,1,0.515047617,0,61,cell recognition,BP,1
GO:0008038,1,0.816669597,0,20,neuron recognition,BP,1
GO:0008039,1,0.988662927,0,1,synaptic target recognition,BP,1
GO:0008045,1,0.896618688,0,11,motor neuron axon guidance,BP,1
GO:0008049,1,0.988662929,0,1,male courtship behavior,BP,1
GO:0008050,1,0.977453911,0,2,female courtship behavior,BP,1
GO:0008053,1,0.807577551,0,19,mitochondrial fusion,BP,1
GO:0008063,1,0.938291088,0,6,Toll signaling pathway,BP,1
GO:0008065,1,0.966646224,0,3,establishment of blood-nerve barrier,BP,1
GO:0008078,1,0.977792978,0,2,mesodermal cell migration,BP,1
GO:0008088,1,0.561173787,0,55,axo-dendritic transport,BP,1
GO:0008089,1,0.700395486,0,33,anterograde axonal transport,BP,1
GO:0008090,1,0.893375998,0,12,retrograde axonal transport,BP,1
GO:0008204,1,0.977691928,0,2,ergosterol metabolic process,BP,1
GO:0008212,1,0.904092936,0,9,mineralocorticoid metabolic process,BP,1
GO:0008214,1,0.7444329,0,27,protein dealkylation,BP,1
GO:0008215,1,0.934054742,0,6,spermine metabolic process,BP,1
GO:0008216,1,0.912982775,0,8,spermidine metabolic process,BP,1
GO:0008218,1,0.988662931,0,1,bioluminescence,BP,1
GO:0008228,1,0.977453375,0,2,opsonization,BP,1
GO:0008291,1,0.966370559,0,3,acetylcholine metabolic process,BP,1
GO:0008292,1,0.988663763,0,1,acetylcholine biosynthetic process,BP,1
GO:0008295,1,0.955607757,0,4,spermidine biosynthetic process,BP,1
GO:0008298,1,0.863288985,0,14,intracellular mRNA localization,BP,1
GO:0008300,1,0.955425073,0,4,isoprenoid catabolic process,BP,1
GO:0008306,1,0.598187461,0,49,associative learning,BP,1
GO:0008315,1,0.966882426,0,3,G2/MI transition of meiotic cell cycle,BP,1
GO:0008333,1,0.624458083,0,44,endosome to lysosome transport,BP,1
GO:0008334,1,0.859751555,0,14,histone mRNA metabolic process,BP,1
GO:0008340,1,0.852345915,0,16,determination of adult lifespan,BP,1
GO:0008343,1,0.9663694,0,3,adult feeding behavior,BP,1
GO:0008344,1,0.585238728,0,50,adult locomotory behavior,BP,1
GO:0008347,1,0.712933948,0,33,glial cell migration,BP,1
GO:0008354,1,0.938233968,0,6,germ cell migration,BP,1
GO:0008355,1,0.990460165,0,1,olfactory learning,BP,1
GO:0008356,1,0.861333625,0,14,asymmetric cell division,BP,1
GO:0008535,1,0.805203118,0,19,respiratory chain complex IV assembly,BP,1
GO:0008542,1,0.702726514,0,34,visual learning,BP,1
GO:0008543,1,0.654128523,0,39,fibroblast growth factor receptor signaling pathway,BP,1
GO:0008582,1,0.993131088,0,1,regulation of synaptic growth at neuromuscular junction,BP,1
GO:0008584,1,0.333900558,0,102,male gonad development,BP,1
GO:0008589,1,0.530086313,0,59,regulation of smoothened signaling pathway,BP,1
GO:0008592,1,0.9558945,0,4,regulation of Toll signaling pathway,BP,1
GO:0008595,1,0.927899219,0,7,"anterior/posterior axis specification, embryo",BP,1
GO:0008608,1,0.839784819,0,16,attachment of spindle microtubules to kinetochore,BP,1
GO:0008611,1,0.933861377,0,6,ether lipid biosynthetic process,BP,1
GO:0008612,1,0.977453276,0,2,peptidyl-lysine modification to peptidyl-hypusine,BP,1
GO:0008614,1,0.988662931,0,1,pyridoxine metabolic process,BP,1
GO:0008615,1,0.988662931,0,1,pyridoxine biosynthetic process,BP,1
GO:0008616,1,0.988662884,0,1,queuosine biosynthetic process,BP,1
GO:0008625,1,0.526985734,0,59,extrinsic apoptotic signaling pathway via death domain receptors,BP,1
GO:0008626,1,0.955411034,0,4,granzyme-mediated apoptotic signaling pathway,BP,1
GO:0008627,1,0.956677524,0,4,intrinsic apoptotic signaling pathway in response to osmotic stress,BP,1
GO:0008631,1,0.681826542,0,34,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,1
GO:0008635,1,0.936726604,0,6,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,BP,1
GO:0009048,1,0.82760639,0,17,dosage compensation by inactivation of X chromosome,BP,1
GO:0009051,1,0.97745749,0,2,"pentose-phosphate shunt, oxidative branch",BP,1
GO:0009052,1,0.944635962,0,5,"pentose-phosphate shunt, non-oxidative branch",BP,1
GO:0009060,1,0.542406418,0,54,aerobic respiration,BP,1
GO:0009065,1,0.809071841,0,19,glutamine family amino acid catabolic process,BP,1
GO:0009068,1,0.86234935,0,13,aspartate family amino acid catabolic process,BP,1
GO:0009069,1,0.63064416,0,41,serine family amino acid metabolic process,BP,1
GO:0009070,1,0.854967144,0,14,serine family amino acid biosynthetic process,BP,1
GO:0009071,1,0.852751885,0,14,serine family amino acid catabolic process,BP,1
GO:0009073,1,0.977837682,0,2,aromatic amino acid family biosynthetic process,BP,1
GO:0009078,1,0.94457559,0,5,pyruvate family amino acid metabolic process,BP,1
GO:0009080,1,0.955411086,0,4,pyruvate family amino acid catabolic process,BP,1
GO:0009081,1,0.852700996,0,14,branched-chain amino acid metabolic process,BP,1
GO:0009082,1,0.988662907,0,1,branched-chain amino acid biosynthetic process,BP,1
GO:0009083,1,0.862490635,0,13,branched-chain amino acid catabolic process,BP,1
GO:0009084,1,0.86471436,0,13,glutamine family amino acid biosynthetic process,BP,1
GO:0009085,1,0.977562225,0,2,lysine biosynthetic process,BP,1
GO:0009087,1,0.988692938,0,1,methionine catabolic process,BP,1
GO:0009088,1,0.988662925,0,1,threonine biosynthetic process,BP,1
GO:0009092,1,0.955801951,0,4,homoserine metabolic process,BP,1
GO:0009093,1,0.955426455,0,4,cysteine catabolic process,BP,1
GO:0009095,1,0.988662931,0,1,"aromatic amino acid family biosynthetic process, prephenate pathway",BP,1
GO:0009098,1,0.988662907,0,1,leucine biosynthetic process,BP,1
GO:0009099,1,0.988662907,0,1,valine biosynthetic process,BP,1
GO:0009106,1,0.977453356,0,2,lipoate metabolic process,BP,1
GO:0009107,1,0.988662912,0,1,lipoate biosynthetic process,BP,1
GO:0009109,1,0.873264912,0,12,coenzyme catabolic process,BP,1
GO:0009110,1,0.833253144,0,16,vitamin biosynthetic process,BP,1
GO:0009111,1,0.955463989,0,4,vitamin catabolic process,BP,1
GO:0009112,1,0.683821557,0,35,nucleobase metabolic process,BP,1
GO:0009113,1,0.914584282,0,8,purine nucleobase biosynthetic process,BP,1
GO:0009114,1,0.989996103,0,1,hypoxanthine catabolic process,BP,1
GO:0009115,1,0.970639074,0,3,xanthine catabolic process,BP,1
GO:0009120,1,0.935042064,0,6,deoxyribonucleoside metabolic process,BP,1
GO:0009125,1,0.923440879,0,7,nucleoside monophosphate catabolic process,BP,1
GO:0009128,1,0.944751744,0,5,purine nucleoside monophosphate catabolic process,BP,1
GO:0009131,1,0.988662581,0,1,pyrimidine nucleoside monophosphate catabolic process,BP,1
GO:0009133,1,0.912956797,0,8,nucleoside diphosphate biosynthetic process,BP,1
GO:0009134,1,0.923273283,0,7,nucleoside diphosphate catabolic process,BP,1
GO:0009136,1,0.9554106,0,4,purine nucleoside diphosphate biosynthetic process,BP,1
GO:0009137,1,0.944575405,0,5,purine nucleoside diphosphate catabolic process,BP,1
GO:0009138,1,0.955585503,0,4,pyrimidine nucleoside diphosphate metabolic process,BP,1
GO:0009139,1,0.966541531,0,3,pyrimidine nucleoside diphosphate biosynthetic process,BP,1
GO:0009140,1,0.988667778,0,1,pyrimidine nucleoside diphosphate catabolic process,BP,1
GO:0009143,1,0.882180925,0,11,nucleoside triphosphate catabolic process,BP,1
GO:0009146,1,0.933861325,0,6,purine nucleoside triphosphate catabolic process,BP,1
GO:0009149,1,0.977453136,0,2,pyrimidine nucleoside triphosphate catabolic process,BP,1
GO:0009151,1,0.872064387,0,12,purine deoxyribonucleotide metabolic process,BP,1
GO:0009153,1,0.977453071,0,2,purine deoxyribonucleotide biosynthetic process,BP,1
GO:0009154,1,0.807000578,0,19,purine ribonucleotide catabolic process,BP,1
GO:0009155,1,0.933861378,0,6,purine deoxyribonucleotide catabolic process,BP,1
GO:0009157,1,0.92327306,0,7,deoxyribonucleoside monophosphate biosynthetic process,BP,1
GO:0009158,1,0.944751744,0,5,ribonucleoside monophosphate catabolic process,BP,1
GO:0009159,1,0.977453029,0,2,deoxyribonucleoside monophosphate catabolic process,BP,1
GO:0009162,1,0.89220322,0,10,deoxyribonucleoside monophosphate metabolic process,BP,1
GO:0009164,1,0.845326233,0,15,nucleoside catabolic process,BP,1
GO:0009169,1,0.944751744,0,5,purine ribonucleoside monophosphate catabolic process,BP,1
GO:0009170,1,0.98866263,0,1,purine deoxyribonucleoside monophosphate metabolic process,BP,1
GO:0009176,1,0.944574957,0,5,pyrimidine deoxyribonucleoside monophosphate metabolic process,BP,1
GO:0009177,1,0.955410779,0,4,pyrimidine deoxyribonucleoside monophosphate biosynthetic process,BP,1
GO:0009178,1,0.988662581,0,1,pyrimidine deoxyribonucleoside monophosphate catabolic process,BP,1
GO:0009180,1,0.9554106,0,4,purine ribonucleoside diphosphate biosynthetic process,BP,1
GO:0009181,1,0.944575405,0,5,purine ribonucleoside diphosphate catabolic process,BP,1
GO:0009182,1,0.977453025,0,2,purine deoxyribonucleoside diphosphate metabolic process,BP,1
GO:0009183,1,0.98866263,0,1,purine deoxyribonucleoside diphosphate biosynthetic process,BP,1
GO:0009184,1,0.988662878,0,1,purine deoxyribonucleoside diphosphate catabolic process,BP,1
GO:0009186,1,0.944743079,0,5,deoxyribonucleoside diphosphate metabolic process,BP,1
GO:0009188,1,0.944575111,0,5,ribonucleoside diphosphate biosynthetic process,BP,1
GO:0009189,1,0.955580526,0,4,deoxyribonucleoside diphosphate biosynthetic process,BP,1
GO:0009191,1,0.923273283,0,7,ribonucleoside diphosphate catabolic process,BP,1
GO:0009192,1,0.988662878,0,1,deoxyribonucleoside diphosphate catabolic process,BP,1
GO:0009193,1,0.977458164,0,2,pyrimidine ribonucleoside diphosphate metabolic process,BP,1
GO:0009194,1,0.988662928,0,1,pyrimidine ribonucleoside diphosphate biosynthetic process,BP,1
GO:0009195,1,0.988667778,0,1,pyrimidine ribonucleoside diphosphate catabolic process,BP,1
GO:0009196,1,0.966541531,0,3,pyrimidine deoxyribonucleoside diphosphate metabolic process,BP,1
GO:0009197,1,0.966541531,0,3,pyrimidine deoxyribonucleoside diphosphate biosynthetic process,BP,1
GO:0009200,1,0.805222323,0,19,deoxyribonucleoside triphosphate metabolic process,BP,1
GO:0009202,1,0.944743271,0,5,deoxyribonucleoside triphosphate biosynthetic process,BP,1
GO:0009203,1,0.988662822,0,1,ribonucleoside triphosphate catabolic process,BP,1
GO:0009204,1,0.912794285,0,8,deoxyribonucleoside triphosphate catabolic process,BP,1
GO:0009207,1,0.988662822,0,1,purine ribonucleoside triphosphate catabolic process,BP,1
GO:0009211,1,0.934027587,0,6,pyrimidine deoxyribonucleoside triphosphate metabolic process,BP,1
GO:0009212,1,0.955580677,0,4,pyrimidine deoxyribonucleoside triphosphate biosynthetic process,BP,1
GO:0009213,1,0.977453136,0,2,pyrimidine deoxyribonucleoside triphosphate catabolic process,BP,1
GO:0009214,1,0.946137536,0,5,cyclic nucleotide catabolic process,BP,1
GO:0009215,1,0.882074557,0,11,purine deoxyribonucleoside triphosphate metabolic process,BP,1
GO:0009216,1,0.988662924,0,1,purine deoxyribonucleoside triphosphate biosynthetic process,BP,1
GO:0009217,1,0.944574997,0,5,purine deoxyribonucleoside triphosphate catabolic process,BP,1
GO:0009219,1,0.882231865,0,11,pyrimidine deoxyribonucleotide metabolic process,BP,1
GO:0009221,1,0.912956996,0,8,pyrimidine deoxyribonucleotide biosynthetic process,BP,1
GO:0009222,1,0.988667778,0,1,pyrimidine ribonucleotide catabolic process,BP,1
GO:0009223,1,0.955410554,0,4,pyrimidine deoxyribonucleotide catabolic process,BP,1
GO:0009224,1,0.98866291,0,1,CMP biosynthetic process,BP,1
GO:0009227,1,0.977470179,0,2,nucleotide-sugar catabolic process,BP,1
GO:0009229,1,0.988977449,0,1,thiamine diphosphate biosynthetic process,BP,1
GO:0009231,1,0.98866315,0,1,riboflavin biosynthetic process,BP,1
GO:0009233,1,0.988798145,0,1,menaquinone metabolic process,BP,1
GO:0009234,1,0.988798145,0,1,menaquinone biosynthetic process,BP,1
GO:0009235,1,0.925242512,0,7,cobalamin metabolic process,BP,1
GO:0009236,1,0.988662922,0,1,cobalamin biosynthetic process,BP,1
GO:0009237,1,0.988662813,0,1,siderophore metabolic process,BP,1
GO:0009247,1,0.62288926,0,42,glycolipid biosynthetic process,BP,1
GO:0009249,1,0.944646941,0,5,protein lipoylation,BP,1
GO:0009251,1,0.842612709,0,16,glucan catabolic process,BP,1
GO:0009253,1,0.988662931,0,1,peptidoglycan catabolic process,BP,1
GO:0009256,1,0.966749893,0,3,10-formyltetrahydrofolate metabolic process,BP,1
GO:0009257,1,0.98905161,0,1,10-formyltetrahydrofolate biosynthetic process,BP,1
GO:0009258,1,0.977453375,0,2,10-formyltetrahydrofolate catabolic process,BP,1
GO:0009261,1,0.797839859,0,20,ribonucleotide catabolic process,BP,1
GO:0009262,1,0.726537913,0,28,deoxyribonucleotide metabolic process,BP,1
GO:0009263,1,0.862320394,0,13,deoxyribonucleotide biosynthetic process,BP,1
GO:0009264,1,0.882074637,0,11,deoxyribonucleotide catabolic process,BP,1
GO:0009265,1,0.892357791,0,10,2'-deoxyribonucleotide biosynthetic process,BP,1
GO:0009268,1,0.701158049,0,32,response to pH,BP,1
GO:0009298,1,0.955410974,0,4,GDP-mannose biosynthetic process,BP,1
GO:0009301,1,0.904166845,0,9,snRNA transcription,BP,1
GO:0009303,1,0.765931249,0,25,rRNA transcription,BP,1
GO:0009305,1,0.988662931,0,1,protein biotinylation,BP,1
GO:0009308,1,0.545904337,0,54,amine metabolic process,BP,1
GO:0009309,1,0.90390019,0,9,amine biosynthetic process,BP,1
GO:0009310,1,0.853518418,0,14,amine catabolic process,BP,1
GO:0009311,1,0.778456983,0,22,oligosaccharide metabolic process,BP,1
GO:0009312,1,0.913102058,0,8,oligosaccharide biosynthetic process,BP,1
GO:0009313,1,0.923545052,0,7,oligosaccharide catabolic process,BP,1
GO:0009372,1,0.988823445,0,1,quorum sensing,BP,1
GO:0009386,1,0.988663498,0,1,translational attenuation,BP,1
GO:0009394,1,0.769257344,0,23,2'-deoxyribonucleotide metabolic process,BP,1
GO:0009395,1,0.712541559,0,31,phospholipid catabolic process,BP,1
GO:0009396,1,0.913620629,0,8,folic acid-containing compound biosynthetic process,BP,1
GO:0009397,1,0.966423565,0,3,folic acid-containing compound catabolic process,BP,1
GO:0009398,1,0.98866315,0,1,FMN biosynthetic process,BP,1
GO:0009403,1,0.960115697,0,4,toxin biosynthetic process,BP,1
GO:0009404,1,0.820253014,0,18,toxin metabolic process,BP,1
GO:0009405,1,0.96637093,0,3,pathogenesis,BP,1
GO:0009407,1,0.944576915,0,5,toxin catabolic process,BP,1
GO:0009414,1,0.904367018,0,9,response to water deprivation,BP,1
GO:0009415,1,0.82819297,0,17,response to water,BP,1
GO:0009435,1,0.805225714,0,19,NAD biosynthetic process,BP,1
GO:0009436,1,0.966369891,0,3,glyoxylate catabolic process,BP,1
GO:0009437,1,0.873713214,0,12,carnitine metabolic process,BP,1
GO:0009438,1,0.923332343,0,7,methylglyoxal metabolic process,BP,1
GO:0009441,1,0.977453187,0,2,glycolate metabolic process,BP,1
GO:0009443,1,0.988662724,0,1,pyridoxal 5'-phosphate salvage,BP,1
GO:0009445,1,0.945906654,0,5,putrescine metabolic process,BP,1
GO:0009446,1,0.956757526,0,4,putrescine biosynthetic process,BP,1
GO:0009447,1,0.988662931,0,1,putrescine catabolic process,BP,1
GO:0009448,1,0.977453368,0,2,gamma-aminobutyric acid metabolic process,BP,1
GO:0009449,1,0.988662924,0,1,gamma-aminobutyric acid biosynthetic process,BP,1
GO:0009450,1,0.977453368,0,2,gamma-aminobutyric acid catabolic process,BP,1
GO:0009451,1,0.239967253,0,126,RNA modification,BP,1
GO:0009452,1,0.925839797,0,7,7-methylguanosine RNA capping,BP,1
GO:0009581,1,0.661770423,0,38,detection of external stimulus,BP,1
GO:0009582,1,0.66938354,0,37,detection of abiotic stimulus,BP,1
GO:0009583,1,0.911173032,0,9,detection of light stimulus,BP,1
GO:0009584,1,0.929679923,0,7,detection of visible light,BP,1
GO:0009589,1,0.988795818,0,1,detection of UV,BP,1
GO:0009593,1,0.722686837,0,29,detection of chemical stimulus,BP,1
GO:0009595,1,0.838109212,0,16,detection of biotic stimulus,BP,1
GO:0009597,1,0.956978516,0,4,detection of virus,BP,1
GO:0009608,1,0.966712492,0,3,response to symbiont,BP,1
GO:0009609,1,0.977799884,0,2,response to symbiotic bacterium,BP,1
GO:0009610,1,0.988662902,0,1,response to symbiotic fungus,BP,1
GO:0009620,1,0.73888739,0,27,response to fungus,BP,1
GO:0009623,1,0.988662902,0,1,response to parasitic fungus,BP,1
GO:0009629,1,0.915858116,0,8,response to gravity,BP,1
GO:0009631,1,0.955544089,0,4,cold acclimation,BP,1
GO:0009635,1,0.872093643,0,12,response to herbicide,BP,1
GO:0009642,1,0.913132566,0,8,response to light intensity,BP,1
GO:0009644,1,0.977483214,0,2,response to high light intensity,BP,1
GO:0009645,1,0.988986705,0,1,response to low light intensity stimulus,BP,1
GO:0009646,1,0.988662931,0,1,response to absence of light,BP,1
GO:0009650,1,0.903724703,0,9,UV protection,BP,1
GO:0009651,1,0.747856399,0,26,response to salt stress,BP,1
GO:0009682,1,0.988662958,0,1,induced systemic resistance,BP,1
GO:0009698,1,0.966369861,0,3,phenylpropanoid metabolic process,BP,1
GO:0009712,1,0.72887288,0,28,catechol-containing compound metabolic process,BP,1
GO:0009713,1,0.854146331,0,14,catechol-containing compound biosynthetic process,BP,1
GO:0009726,1,0.977453195,0,2,detection of endogenous stimulus,BP,1
GO:0009730,1,0.966372364,0,3,detection of carbohydrate stimulus,BP,1
GO:0009732,1,0.966372364,0,3,detection of hexose stimulus,BP,1
GO:0009737,1,0.988662911,0,1,response to abscisic acid,BP,1
GO:0009738,1,0.988662911,0,1,abscisic acid-activated signaling pathway,BP,1
GO:0009741,1,0.988662931,0,1,response to brassinosteroid,BP,1
GO:0009744,1,0.914199816,0,8,response to sucrose,BP,1
GO:0009751,1,0.977453119,0,2,response to salicylic acid,BP,1
GO:0009756,1,0.980278989,0,2,carbohydrate mediated signaling,BP,1
GO:0009757,1,0.980278989,0,2,hexose mediated signaling,BP,1
GO:0009758,1,0.971803148,0,3,carbohydrate utilization,BP,1
GO:0009786,1,0.995167874,0,1,regulation of asymmetric cell division,BP,1
GO:0009787,1,0.988662911,0,1,regulation of abscisic acid-activated signaling pathway,BP,1
GO:0009789,1,0.988662911,0,1,positive regulation of abscisic acid-activated signaling pathway,BP,1
GO:0009804,1,0.966369861,0,3,coumarin metabolic process,BP,1
GO:0009810,1,0.98866293,0,1,stilbene metabolic process,BP,1
GO:0009812,1,0.94458652,0,5,flavonoid metabolic process,BP,1
GO:0009814,1,0.977454175,0,2,"defense response, incompatible interaction",BP,1
GO:0009816,1,0.988663778,0,1,"defense response to bacterium, incompatible interaction",BP,1
GO:0009817,1,0.988662893,0,1,"defense response to fungus, incompatible interaction",BP,1
GO:0009820,1,0.944575611,0,5,alkaloid metabolic process,BP,1
GO:0009822,1,0.966369908,0,3,alkaloid catabolic process,BP,1
GO:0009826,1,0.95541095,0,4,unidimensional cell growth,BP,1
GO:0009838,1,0.933861952,0,6,abscission,BP,1
GO:0009850,1,0.977453337,0,2,auxin metabolic process,BP,1
GO:0009852,1,0.977453337,0,2,auxin catabolic process,BP,1
GO:0009886,1,0.888555066,0,12,post-embryonic animal morphogenesis,BP,1
GO:0009948,1,0.767449396,0,24,anterior/posterior axis specification,BP,1
GO:0009950,1,0.915439737,0,8,dorsal/ventral axis specification,BP,1
GO:0009953,1,0.587394328,0,49,dorsal/ventral pattern formation,BP,1
GO:0009955,1,0.977453249,0,2,adaxial/abaxial pattern specification,BP,1
GO:0009956,1,0.988662909,0,1,radial pattern formation,BP,1
GO:0009957,1,0.979988128,0,2,epidermal cell fate specification,BP,1
GO:0009972,1,0.97745324,0,2,cytidine deamination,BP,1
GO:0009992,1,0.977466788,0,2,cellular water homeostasis,BP,1
GO:0009994,1,0.715948491,0,30,oocyte differentiation,BP,1
GO:0009996,1,0.977455467,0,2,negative regulation of cell fate specification,BP,1
GO:0010002,1,0.904910124,0,10,cardioblast differentiation,BP,1
GO:0010025,1,0.988662923,0,1,wax biosynthetic process,BP,1
GO:0010032,1,0.948323331,0,5,meiotic chromosome condensation,BP,1
GO:0010034,1,0.966917239,0,3,response to acetate,BP,1
GO:0010037,1,0.969710797,0,3,response to carbon dioxide,BP,1
GO:0010039,1,0.672235474,0,36,response to iron ion,BP,1
GO:0010040,1,0.903427008,0,9,response to iron(II) ion,BP,1
GO:0010041,1,0.946449198,0,5,response to iron(III) ion,BP,1
GO:0010042,1,0.745675789,0,27,response to manganese ion,BP,1
GO:0010043,1,0.598592961,0,46,response to zinc ion,BP,1
GO:0010044,1,0.893729152,0,10,response to aluminum ion,BP,1
GO:0010045,1,0.977453375,0,2,response to nickel cation,BP,1
GO:0010046,1,0.944575267,0,5,response to mycotoxin,BP,1
GO:0010070,1,0.988662931,0,1,zygote asymmetric cell division,BP,1
GO:0010092,1,0.891514054,0,12,specification of animal organ identity,BP,1
GO:0010106,1,0.988662883,0,1,cellular response to iron ion starvation,BP,1
GO:0010107,1,0.865756819,0,14,potassium ion import,BP,1
GO:0010121,1,0.98866295,0,1,arginine catabolic process to proline via ornithine,BP,1
GO:0010124,1,0.977453337,0,2,phenylacetate catabolic process,BP,1
GO:0010133,1,0.977453334,0,2,proline catabolic process to glutamate,BP,1
GO:0010142,1,0.968093358,0,3,"farnesyl diphosphate biosynthetic process, mevalonate pathway",BP,1
GO:0010155,1,0.854235053,0,14,regulation of proton transport,BP,1
GO:0010157,1,0.99010276,0,1,response to chlorate,BP,1
GO:0010159,1,0.988663335,0,1,specification of animal organ position,BP,1
GO:0010164,1,0.98866274,0,1,response to cesium ion,BP,1
GO:0010166,1,0.988662923,0,1,wax metabolic process,BP,1
GO:0010172,1,0.869271668,0,13,embryonic body morphogenesis,BP,1
GO:0010182,1,0.980278989,0,2,sugar mediated signaling pathway,BP,1
GO:0010189,1,0.988662931,0,1,vitamin E biosynthetic process,BP,1
GO:0010193,1,0.938956833,0,6,response to ozone,BP,1
GO:0010216,1,0.959717198,0,4,maintenance of DNA methylation,BP,1
GO:0010225,1,0.865022979,0,13,response to UV-C,BP,1
GO:0010226,1,0.738923597,0,28,response to lithium ion,BP,1
GO:0010232,1,0.988882047,0,1,vascular transport,BP,1
GO:0010238,1,0.988662885,0,1,response to proline,BP,1
GO:0010248,1,0.918136946,0,8,establishment or maintenance of transmembrane electrochemical gradient,BP,1
GO:0010255,1,0.980278989,0,2,glucose mediated signaling pathway,BP,1
GO:0010257,1,0.611893163,0,43,NADH dehydrogenase complex assembly,BP,1
GO:0010260,1,0.988662931,0,1,animal organ senescence,BP,1
GO:0010265,1,0.990185163,0,1,SCF complex assembly,BP,1
GO:0010266,1,0.966456126,0,3,response to vitamin B1,BP,1
GO:0010269,1,0.831241795,0,17,response to selenium ion,BP,1
GO:0010272,1,0.988677323,0,1,response to silver ion,BP,1
GO:0010273,1,0.956962162,0,4,detoxification of copper ion,BP,1
GO:0010288,1,0.67262385,0,36,response to lead ion,BP,1
GO:0010310,1,0.877733757,0,12,regulation of hydrogen peroxide metabolic process,BP,1
GO:0010324,1,0.554889317,0,54,membrane invagination,BP,1
GO:0010359,1,0.925176072,0,7,regulation of anion channel activity,BP,1
GO:0010360,1,0.957044445,0,4,negative regulation of anion channel activity,BP,1
GO:0010383,1,0.988663984,0,1,cell wall polysaccharide metabolic process,BP,1
GO:0010387,1,0.966382063,0,3,COP9 signalosome assembly,BP,1
GO:0010390,1,0.742444177,0,27,histone monoubiquitination,BP,1
GO:0010412,1,0.989357365,0,1,mannan metabolic process,BP,1
GO:0010421,1,0.853866872,0,14,hydrogen peroxide-mediated programmed cell death,BP,1
GO:0010424,1,0.972319038,0,3,DNA methylation on cytosine within a CG sequence,BP,1
GO:0010430,1,0.977716366,0,2,fatty acid omega-oxidation,BP,1
GO:0010446,1,0.981289175,0,2,response to alkaline pH,BP,1
GO:0010447,1,0.827733633,0,17,response to acidic pH,BP,1
GO:0010452,1,0.882329833,0,13,histone H3-K36 methylation,BP,1
GO:0010453,1,0.89505556,0,10,regulation of cell fate commitment,BP,1
GO:0010454,1,0.977455467,0,2,negative regulation of cell fate commitment,BP,1
GO:0010455,1,0.98978507,0,1,positive regulation of cell fate commitment,BP,1
GO:0010457,1,0.898816087,0,10,centriole-centriole cohesion,BP,1
GO:0010458,1,0.810075061,0,19,exit from mitosis,BP,1
GO:0010459,1,0.955495722,0,4,negative regulation of heart rate,BP,1
GO:0010460,1,0.883272757,0,11,positive regulation of heart rate,BP,1
GO:0010470,1,0.753820703,0,26,regulation of gastrulation,BP,1
GO:0010477,1,0.97747824,0,2,response to sulfur dioxide,BP,1
GO:0010481,1,0.988662931,0,1,epidermal cell division,BP,1
GO:0010482,1,0.988662931,0,1,regulation of epidermal cell division,BP,1
GO:0010496,1,0.977463334,0,2,intercellular transport,BP,1
GO:0010499,1,0.791308001,0,21,proteasomal ubiquitin-independent protein catabolic process,BP,1
GO:0010501,1,0.928680569,0,7,RNA secondary structure unwinding,BP,1
GO:0010507,1,0.528722957,0,58,negative regulation of autophagy,BP,1
GO:0010510,1,0.966370074,0,3,regulation of acetyl-CoA biosynthetic process from pyruvate,BP,1
GO:0010511,1,0.988662821,0,1,regulation of phosphatidylinositol biosynthetic process,BP,1
GO:0010512,1,0.988662821,0,1,negative regulation of phosphatidylinositol biosynthetic process,BP,1
GO:0010517,1,0.716943363,0,31,regulation of phospholipase activity,BP,1
GO:0010518,1,0.760968542,0,25,positive regulation of phospholipase activity,BP,1
GO:0010519,1,0.966369521,0,3,negative regulation of phospholipase activity,BP,1
GO:0010520,1,0.97749464,0,2,regulation of reciprocal meiotic recombination,BP,1
GO:0010522,1,0.506205512,0,62,regulation of calcium ion transport into cytosol,BP,1
GO:0010523,1,0.892296667,0,10,negative regulation of calcium ion transport into cytosol,BP,1
GO:0010524,1,0.69136674,0,34,positive regulation of calcium ion transport into cytosol,BP,1
GO:0010525,1,0.967179202,0,3,"regulation of transposition, RNA-mediated",BP,1
GO:0010526,1,0.967179202,0,3,"negative regulation of transposition, RNA-mediated",BP,1
GO:0010528,1,0.936309885,0,6,regulation of transposition,BP,1
GO:0010529,1,0.936309885,0,6,negative regulation of transposition,BP,1
GO:0010533,1,0.955411085,0,4,regulation of activation of Janus kinase activity,BP,1
GO:0010536,1,0.977453375,0,2,positive regulation of activation of Janus kinase activity,BP,1
GO:0010543,1,0.767317396,0,24,regulation of platelet activation,BP,1
GO:0010544,1,0.866551071,0,13,negative regulation of platelet activation,BP,1
GO:0010559,1,0.736658237,0,28,regulation of glycoprotein biosynthetic process,BP,1
GO:0010560,1,0.829418238,0,17,positive regulation of glycoprotein biosynthetic process,BP,1
GO:0010561,1,0.88832019,0,11,negative regulation of glycoprotein biosynthetic process,BP,1
GO:0010566,1,0.873663899,0,12,regulation of ketone biosynthetic process,BP,1
GO:0010571,1,0.951934475,0,5,positive regulation of nuclear cell cycle DNA replication,BP,1
GO:0010572,1,0.956007846,0,4,positive regulation of platelet activation,BP,1
GO:0010573,1,0.806228754,0,20,vascular endothelial growth factor production,BP,1
GO:0010574,1,0.815489022,0,19,regulation of vascular endothelial growth factor production,BP,1
GO:0010575,1,0.851918722,0,15,positive regulation of vascular endothelial growth factor production,BP,1
GO:0010585,1,0.988679996,0,1,glutamine secretion,BP,1
GO:0010586,1,0.779587553,0,22,miRNA metabolic process,BP,1
GO:0010587,1,0.913772064,0,8,miRNA catabolic process,BP,1
GO:0010591,1,0.758687135,0,25,regulation of lamellipodium assembly,BP,1
GO:0010592,1,0.830439205,0,17,positive regulation of lamellipodium assembly,BP,1
GO:0010593,1,0.977453238,0,2,negative regulation of lamellipodium assembly,BP,1
GO:0010596,1,0.635221135,0,42,negative regulation of endothelial cell migration,BP,1
GO:0010603,1,0.915765155,0,8,regulation of cytoplasmic mRNA processing body assembly,BP,1
GO:0010606,1,0.93601404,0,6,positive regulation of cytoplasmic mRNA processing body assembly,BP,1
GO:0010609,1,0.977456163,0,2,mRNA localization resulting in posttranscriptional regulation of gene expression,BP,1
GO:0010610,1,0.977547384,0,2,regulation of mRNA stability involved in response to stress,BP,1
GO:0010611,1,0.54080702,0,57,regulation of cardiac muscle hypertrophy,BP,1
GO:0010612,1,0.915785183,0,8,regulation of cardiac muscle adaptation,BP,1
GO:0010613,1,0.718112148,0,31,positive regulation of cardiac muscle hypertrophy,BP,1
GO:0010614,1,0.759536818,0,25,negative regulation of cardiac muscle hypertrophy,BP,1
GO:0010615,1,0.988665619,0,1,positive regulation of cardiac muscle adaptation,BP,1
GO:0010616,1,0.936917999,0,6,negative regulation of cardiac muscle adaptation,BP,1
GO:0010623,1,0.882239562,0,12,programmed cell death involved in cell development,BP,1
GO:0010624,1,0.913303387,0,8,regulation of Schwann cell proliferation,BP,1
GO:0010625,1,0.977800684,0,2,positive regulation of Schwann cell proliferation,BP,1
GO:0010626,1,0.944765564,0,5,negative regulation of Schwann cell proliferation,BP,1
GO:0010633,1,0.556467385,0,54,negative regulation of epithelial cell migration,BP,1
GO:0010635,1,0.924696061,0,7,regulation of mitochondrial fusion,BP,1
GO:0010636,1,0.977584766,0,2,positive regulation of mitochondrial fusion,BP,1
GO:0010637,1,0.945908141,0,5,negative regulation of mitochondrial fusion,BP,1
GO:0010640,1,0.831263566,0,18,regulation of platelet-derived growth factor receptor signaling pathway,BP,1
GO:0010641,1,0.961288987,0,4,positive regulation of platelet-derived growth factor receptor signaling pathway,BP,1
GO:0010642,1,0.903153361,0,10,negative regulation of platelet-derived growth factor receptor signaling pathway,BP,1
GO:0010643,1,0.977710252,0,2,cell communication by chemical coupling,BP,1
GO:0010644,1,0.917429823,0,8,cell communication by electrical coupling,BP,1
GO:0010645,1,0.988882047,0,1,regulation of cell communication by chemical coupling,BP,1
GO:0010649,1,0.938356075,0,6,regulation of cell communication by electrical coupling,BP,1
GO:0010650,1,0.99340307,0,1,positive regulation of cell communication by electrical coupling,BP,1
GO:0010651,1,0.988662795,0,1,negative regulation of cell communication by electrical coupling,BP,1
GO:0010652,1,0.988882047,0,1,positive regulation of cell communication by chemical coupling,BP,1
GO:0010656,1,0.626864352,0,42,negative regulation of muscle cell apoptotic process,BP,1
GO:0010657,1,0.442282035,0,73,muscle cell apoptotic process,BP,1
GO:0010658,1,0.603198743,0,45,striated muscle cell apoptotic process,BP,1
GO:0010659,1,0.617165786,0,43,cardiac muscle cell apoptotic process,BP,1
GO:0010660,1,0.461599145,0,69,regulation of muscle cell apoptotic process,BP,1
GO:0010661,1,0.730572457,0,28,positive regulation of muscle cell apoptotic process,BP,1
GO:0010662,1,0.622314342,0,42,regulation of striated muscle cell apoptotic process,BP,1
GO:0010663,1,0.825441692,0,17,positive regulation of striated muscle cell apoptotic process,BP,1
GO:0010664,1,0.74676113,0,26,negative regulation of striated muscle cell apoptotic process,BP,1
GO:0010665,1,0.636720368,0,40,regulation of cardiac muscle cell apoptotic process,BP,1
GO:0010666,1,0.825441692,0,17,positive regulation of cardiac muscle cell apoptotic process,BP,1
GO:0010667,1,0.771676682,0,23,negative regulation of cardiac muscle cell apoptotic process,BP,1
GO:0010668,1,0.9461279,0,5,ectodermal cell differentiation,BP,1
GO:0010669,1,0.855526525,0,14,epithelial structure maintenance,BP,1
GO:0010692,1,0.935955352,0,6,regulation of alkaline phosphatase activity,BP,1
GO:0010693,1,0.9664794,0,3,negative regulation of alkaline phosphatase activity,BP,1
GO:0010694,1,0.968425758,0,3,positive regulation of alkaline phosphatase activity,BP,1
GO:0010700,1,0.955712449,0,4,negative regulation of norepinephrine secretion,BP,1
GO:0010701,1,0.988722564,0,1,positive regulation of norepinephrine secretion,BP,1
GO:0010706,1,0.980349054,0,2,ganglioside biosynthetic process via lactosylceramide,BP,1
GO:0010710,1,0.956101617,0,4,regulation of collagen catabolic process,BP,1
GO:0010711,1,0.988662611,0,1,negative regulation of collagen catabolic process,BP,1
GO:0010714,1,0.783069285,0,22,positive regulation of collagen metabolic process,BP,1
GO:0010715,1,0.909785465,0,9,regulation of extracellular matrix disassembly,BP,1
GO:0010716,1,0.979372173,0,2,negative regulation of extracellular matrix disassembly,BP,1
GO:0010718,1,0.696379829,0,34,positive regulation of epithelial to mesenchymal transition,BP,1
GO:0010722,1,0.988662931,0,1,regulation of ferrochelatase activity,BP,1
GO:0010724,1,0.977453375,0,2,regulation of definitive erythrocyte differentiation,BP,1
GO:0010725,1,0.97788746,0,2,regulation of primitive erythrocyte differentiation,BP,1
GO:0010726,1,0.968472689,0,3,positive regulation of hydrogen peroxide metabolic process,BP,1
GO:0010727,1,0.935362175,0,6,negative regulation of hydrogen peroxide metabolic process,BP,1
GO:0010728,1,0.925616639,0,7,regulation of hydrogen peroxide biosynthetic process,BP,1
GO:0010729,1,0.978366494,0,2,positive regulation of hydrogen peroxide biosynthetic process,BP,1
GO:0010730,1,0.946092924,0,5,negative regulation of hydrogen peroxide biosynthetic process,BP,1
GO:0010731,1,0.977452963,0,2,protein glutathionylation,BP,1
GO:0010732,1,0.977452963,0,2,regulation of protein glutathionylation,BP,1
GO:0010734,1,0.977452963,0,2,negative regulation of protein glutathionylation,BP,1
GO:0010735,1,0.967628277,0,3,positive regulation of transcription via serum response element binding,BP,1
GO:0010742,1,0.823197968,0,18,macrophage derived foam cell differentiation,BP,1
GO:0010743,1,0.851484667,0,15,regulation of macrophage derived foam cell differentiation,BP,1
GO:0010744,1,0.922026289,0,8,positive regulation of macrophage derived foam cell differentiation,BP,1
GO:0010745,1,0.923540586,0,7,negative regulation of macrophage derived foam cell differentiation,BP,1
GO:0010746,1,0.94798243,0,5,regulation of plasma membrane long-chain fatty acid transport,BP,1
GO:0010747,1,0.988663271,0,1,positive regulation of plasma membrane long-chain fatty acid transport,BP,1
GO:0010748,1,0.958856359,0,4,negative regulation of plasma membrane long-chain fatty acid transport,BP,1
GO:0010750,1,0.978710459,0,2,positive regulation of nitric oxide mediated signal transduction,BP,1
GO:0010751,1,0.978515256,0,2,negative regulation of nitric oxide mediated signal transduction,BP,1
GO:0010752,1,0.948160253,0,5,regulation of cGMP-mediated signaling,BP,1
GO:0010753,1,0.979098084,0,2,positive regulation of cGMP-mediated signaling,BP,1
GO:0010754,1,0.978608422,0,2,negative regulation of cGMP-mediated signaling,BP,1
GO:0010755,1,0.872227144,0,12,regulation of plasminogen activation,BP,1
GO:0010756,1,0.944575601,0,5,positive regulation of plasminogen activation,BP,1
GO:0010757,1,0.934034974,0,6,negative regulation of plasminogen activation,BP,1
GO:0010759,1,0.86363343,0,13,positive regulation of macrophage chemotaxis,BP,1
GO:0010761,1,0.638774121,0,40,fibroblast migration,BP,1
GO:0010762,1,0.707630393,0,31,regulation of fibroblast migration,BP,1
GO:0010763,1,0.858368803,0,14,positive regulation of fibroblast migration,BP,1
GO:0010764,1,0.934185651,0,6,negative regulation of fibroblast migration,BP,1
GO:0010765,1,0.754330182,0,26,positive regulation of sodium ion transport,BP,1
GO:0010766,1,0.886055962,0,12,negative regulation of sodium ion transport,BP,1
GO:0010767,1,0.991293742,0,1,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,1
GO:0010768,1,0.991293742,0,1,negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,1
GO:0010771,1,0.522388713,0,62,negative regulation of cell morphogenesis involved in differentiation,BP,1
GO:0010792,1,0.955620484,0,4,DNA double-strand break processing involved in repair via single-strand annealing,BP,1
GO:0010795,1,0.988662771,0,1,regulation of ubiquinone biosynthetic process,BP,1
GO:0010796,1,0.966370292,0,3,regulation of multivesicular body size,BP,1
GO:0010797,1,0.988662642,0,1,regulation of multivesicular body size involved in endosome transport,BP,1
GO:0010799,1,0.68993759,0,34,regulation of peptidyl-threonine phosphorylation,BP,1
GO:0010800,1,0.822683688,0,18,positive regulation of peptidyl-threonine phosphorylation,BP,1
GO:0010801,1,0.830440401,0,17,negative regulation of peptidyl-threonine phosphorylation,BP,1
GO:0010804,1,0.902460432,0,9,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,1
GO:0010807,1,0.945628114,0,5,regulation of synaptic vesicle priming,BP,1
GO:0010812,1,0.652072022,0,41,negative regulation of cell-substrate adhesion,BP,1
GO:0010813,1,0.97751924,0,2,neuropeptide catabolic process,BP,1
GO:0010814,1,0.988729603,0,1,substance P catabolic process,BP,1
GO:0010815,1,0.945989351,0,5,bradykinin catabolic process,BP,1
GO:0010816,1,0.988729603,0,1,calcitonin catabolic process,BP,1
GO:0010818,1,0.871908503,0,13,T cell chemotaxis,BP,1
GO:0010819,1,0.898921933,0,10,regulation of T cell chemotaxis,BP,1
GO:0010820,1,0.909237949,0,9,positive regulation of T cell chemotaxis,BP,1
GO:0010822,1,0.521172623,0,59,positive regulation of mitochondrion organization,BP,1
GO:0010824,1,0.713301047,0,31,regulation of centrosome duplication,BP,1
GO:0010825,1,0.926447263,0,7,positive regulation of centrosome duplication,BP,1
GO:0010826,1,0.896870176,0,10,negative regulation of centrosome duplication,BP,1
GO:0010829,1,0.826155377,0,17,negative regulation of glucose transmembrane transport,BP,1
GO:0010832,1,0.898233075,0,10,negative regulation of myotube differentiation,BP,1
GO:0010833,1,0.460848575,0,70,telomere maintenance via telomere lengthening,BP,1
GO:0010835,1,0.925816497,0,7,regulation of protein ADP-ribosylation,BP,1
GO:0010836,1,0.966369886,0,3,negative regulation of protein ADP-ribosylation,BP,1
GO:0010837,1,0.840647883,0,16,regulation of keratinocyte proliferation,BP,1
GO:0010838,1,0.971307744,0,3,positive regulation of keratinocyte proliferation,BP,1
GO:0010839,1,0.905902129,0,9,negative regulation of keratinocyte proliferation,BP,1
GO:0010840,1,0.988662843,0,1,"regulation of circadian sleep/wake cycle, wakefulness",BP,1
GO:0010842,1,0.912166167,0,9,retina layer formation,BP,1
GO:0010845,1,0.97749464,0,2,positive regulation of reciprocal meiotic recombination,BP,1
GO:0010847,1,0.970993594,0,3,regulation of chromatin assembly,BP,1
GO:0010848,1,0.988924706,0,1,regulation of chromatin disassembly,BP,1
GO:0010849,1,0.988662897,0,1,"regulation of proton-transporting ATPase activity, rotational mechanism",BP,1
GO:0010863,1,0.881129487,0,12,positive regulation of phospholipase C activity,BP,1
GO:0010866,1,0.790648651,0,21,regulation of triglyceride biosynthetic process,BP,1
GO:0010867,1,0.824313726,0,17,positive regulation of triglyceride biosynthetic process,BP,1
GO:0010868,1,0.988662931,0,1,negative regulation of triglyceride biosynthetic process,BP,1
GO:0010870,1,0.923954997,0,7,positive regulation of receptor biosynthetic process,BP,1
GO:0010872,1,0.894940414,0,10,regulation of cholesterol esterification,BP,1
GO:0010873,1,0.915082671,0,8,positive regulation of cholesterol esterification,BP,1
GO:0010874,1,0.814456833,0,20,regulation of cholesterol efflux,BP,1
GO:0010875,1,0.858648402,0,15,positive regulation of cholesterol efflux,BP,1
GO:0010877,1,0.979902508,0,2,lipid transport involved in lipid storage,BP,1
GO:0010879,1,0.991140072,0,1,cholesterol transport involved in cholesterol storage,BP,1
GO:0010880,1,0.882610917,0,12,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,1
GO:0010881,1,0.955450456,0,4,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,BP,1
GO:0010882,1,0.9076102,0,9,regulation of cardiac muscle contraction by calcium ion signaling,BP,1
GO:0010884,1,0.841339933,0,17,positive regulation of lipid storage,BP,1
GO:0010886,1,0.94455486,0,6,positive regulation of cholesterol storage,BP,1
GO:0010889,1,0.884565815,0,11,regulation of sequestering of triglyceride,BP,1
GO:0010890,1,0.936496786,0,6,positive regulation of sequestering of triglyceride,BP,1
GO:0010891,1,0.944575906,0,5,negative regulation of sequestering of triglyceride,BP,1
GO:0010894,1,0.826244215,0,17,negative regulation of steroid biosynthetic process,BP,1
GO:0010896,1,0.864333558,0,13,regulation of triglyceride catabolic process,BP,1
GO:0010897,1,0.957641318,0,4,negative regulation of triglyceride catabolic process,BP,1
GO:0010898,1,0.902597068,0,9,positive regulation of triglyceride catabolic process,BP,1
GO:0010899,1,0.966550115,0,3,regulation of phosphatidylcholine catabolic process,BP,1
GO:0010900,1,0.988662434,0,1,negative regulation of phosphatidylcholine catabolic process,BP,1
GO:0010901,1,0.955410636,0,4,regulation of very-low-density lipoprotein particle remodeling,BP,1
GO:0010902,1,0.988662926,0,1,positive regulation of very-low-density lipoprotein particle remodeling,BP,1
GO:0010903,1,0.966369419,0,3,negative regulation of very-low-density lipoprotein particle remodeling,BP,1
GO:0010908,1,0.966373111,0,3,regulation of heparan sulfate proteoglycan biosynthetic process,BP,1
GO:0010909,1,0.966373111,0,3,positive regulation of heparan sulfate proteoglycan biosynthetic process,BP,1
GO:0010911,1,0.946717564,0,5,regulation of isomerase activity,BP,1
GO:0010912,1,0.946717564,0,5,positive regulation of isomerase activity,BP,1
GO:0010915,1,0.955410168,0,4,regulation of very-low-density lipoprotein particle clearance,BP,1
GO:0010916,1,0.955410168,0,4,negative regulation of very-low-density lipoprotein particle clearance,BP,1
GO:0010917,1,0.874518739,0,12,negative regulation of mitochondrial membrane potential,BP,1
GO:0010918,1,0.874205934,0,12,positive regulation of mitochondrial membrane potential,BP,1
GO:0010919,1,0.914287274,0,8,regulation of inositol phosphate biosynthetic process,BP,1
GO:0010920,1,0.988662918,0,1,negative regulation of inositol phosphate biosynthetic process,BP,1
GO:0010922,1,0.770521286,0,24,positive regulation of phosphatase activity,BP,1
GO:0010924,1,0.988662918,0,1,regulation of inositol-polyphosphate 5-phosphatase activity,BP,1
GO:0010925,1,0.988662918,0,1,positive regulation of inositol-polyphosphate 5-phosphatase activity,BP,1
GO:0010927,1,0.521731879,0,60,cellular component assembly involved in morphogenesis,BP,1
GO:0010931,1,0.988800025,0,1,macrophage tolerance induction,BP,1
GO:0010932,1,0.988800025,0,1,regulation of macrophage tolerance induction,BP,1
GO:0010933,1,0.988800025,0,1,positive regulation of macrophage tolerance induction,BP,1
GO:0010934,1,0.894467316,0,10,macrophage cytokine production,BP,1
GO:0010935,1,0.904716328,0,9,regulation of macrophage cytokine production,BP,1
GO:0010936,1,0.944819978,0,5,negative regulation of macrophage cytokine production,BP,1
GO:0010939,1,0.755974737,0,25,regulation of necrotic cell death,BP,1
GO:0010940,1,0.946188236,0,5,positive regulation of necrotic cell death,BP,1
GO:0010944,1,0.945922109,0,5,negative regulation of transcription by competitive promoter binding,BP,1
GO:0010949,1,0.979019822,0,2,negative regulation of intestinal phytosterol absorption,BP,1
GO:0010950,1,0.293467587,0,111,positive regulation of endopeptidase activity,BP,1
GO:0010952,1,0.246770224,0,127,positive regulation of peptidase activity,BP,1
GO:0010954,1,0.792099475,0,21,positive regulation of protein processing,BP,1
GO:0010955,1,0.718368994,0,30,negative regulation of protein processing,BP,1
GO:0010956,1,0.988662931,0,1,negative regulation of calcidiol 1-monooxygenase activity,BP,1
GO:0010957,1,0.966369891,0,3,negative regulation of vitamin D biosynthetic process,BP,1
GO:0010958,1,0.92611463,0,7,regulation of amino acid import across plasma membrane,BP,1
GO:0010960,1,0.909960014,0,9,magnesium ion homeostasis,BP,1
GO:0010961,1,0.966369879,0,3,cellular magnesium ion homeostasis,BP,1
GO:0010963,1,0.977453333,0,2,regulation of L-arginine import,BP,1
GO:0010966,1,0.944812498,0,5,regulation of phosphate transport,BP,1
GO:0010967,1,0.988662931,0,1,regulation of polyamine biosynthetic process,BP,1
GO:0010971,1,0.849354494,0,15,positive regulation of G2/M transition of mitotic cell cycle,BP,1
GO:0010982,1,0.977723376,0,2,regulation of high-density lipoprotein particle clearance,BP,1
GO:0010983,1,0.988936004,0,1,positive regulation of high-density lipoprotein particle clearance,BP,1
GO:0010984,1,0.8356556,0,16,regulation of lipoprotein particle clearance,BP,1
GO:0010985,1,0.904579795,0,9,negative regulation of lipoprotein particle clearance,BP,1
GO:0010986,1,0.966972687,0,3,positive regulation of lipoprotein particle clearance,BP,1
GO:0010987,1,0.988662931,0,1,negative regulation of high-density lipoprotein particle clearance,BP,1
GO:0010988,1,0.874457371,0,12,regulation of low-density lipoprotein particle clearance,BP,1
GO:0010989,1,0.93607743,0,6,negative regulation of low-density lipoprotein particle clearance,BP,1
GO:0010990,1,0.9463929,0,5,regulation of SMAD protein complex assembly,BP,1
GO:0010991,1,0.956696686,0,4,negative regulation of SMAD protein complex assembly,BP,1
GO:0010992,1,0.94805808,0,5,ubiquitin recycling,BP,1
GO:0010994,1,0.979615234,0,2,free ubiquitin chain polymerization,BP,1
GO:0010996,1,0.777256736,0,24,response to auditory stimulus,BP,1
GO:0010998,1,0.866042253,0,13,regulation of translational initiation by eIF2 alpha phosphorylation,BP,1
GO:0010999,1,0.966499459,0,3,regulation of eIF2 alpha phosphorylation by heme,BP,1
GO:0014003,1,0.722439703,0,29,oligodendrocyte development,BP,1
GO:0014004,1,0.955436477,0,4,microglia differentiation,BP,1
GO:0014005,1,0.966395586,0,3,microglia development,BP,1
GO:0014006,1,0.988662893,0,1,regulation of microglia differentiation,BP,1
GO:0014008,1,0.988662893,0,1,positive regulation of microglia differentiation,BP,1
GO:0014010,1,0.874010347,0,12,Schwann cell proliferation,BP,1
GO:0014011,1,0.988662931,0,1,Schwann cell proliferation involved in axon regeneration,BP,1
GO:0014012,1,0.920169565,0,8,peripheral nervous system axon regeneration,BP,1
GO:0014016,1,0.977453341,0,2,neuroblast differentiation,BP,1
GO:0014017,1,0.988662898,0,1,neuroblast fate commitment,BP,1
GO:0014022,1,0.988793062,0,1,neural plate elongation,BP,1
GO:0014028,1,0.978349592,0,2,notochord formation,BP,1
GO:0014029,1,0.907300715,0,9,neural crest formation,BP,1
GO:0014034,1,0.988662931,0,1,neural crest cell fate commitment,BP,1
GO:0014037,1,0.7343994,0,29,Schwann cell differentiation,BP,1
GO:0014038,1,0.966377871,0,3,regulation of Schwann cell differentiation,BP,1
GO:0014040,1,0.966377871,0,3,positive regulation of Schwann cell differentiation,BP,1
GO:0014041,1,0.918043649,0,8,regulation of neuron maturation,BP,1
GO:0014042,1,0.960903086,0,4,positive regulation of neuron maturation,BP,1
GO:0014043,1,0.977453144,0,2,negative regulation of neuron maturation,BP,1
GO:0014044,1,0.783724067,0,23,Schwann cell development,BP,1
GO:0014045,1,0.968172695,0,3,establishment of endothelial blood-brain barrier,BP,1
GO:0014046,1,0.885184249,0,11,dopamine secretion,BP,1
GO:0014047,1,0.817785076,0,19,glutamate secretion,BP,1
GO:0014048,1,0.86897431,0,13,regulation of glutamate secretion,BP,1
GO:0014049,1,0.899241349,0,10,positive regulation of glutamate secretion,BP,1
GO:0014050,1,0.966369691,0,3,negative regulation of glutamate secretion,BP,1
GO:0014051,1,0.932383338,0,7,gamma-aminobutyric acid secretion,BP,1
GO:0014052,1,0.948219652,0,5,regulation of gamma-aminobutyric acid secretion,BP,1
GO:0014053,1,0.978987447,0,2,negative regulation of gamma-aminobutyric acid secretion,BP,1
GO:0014054,1,0.979134047,0,2,positive regulation of gamma-aminobutyric acid secretion,BP,1
GO:0014055,1,0.988673862,0,1,"acetylcholine secretion, neurotransmission",BP,1
GO:0014056,1,0.988673862,0,1,"regulation of acetylcholine secretion, neurotransmission",BP,1
GO:0014057,1,0.988673862,0,1,"positive regulation of acetylcholine secretion, neurotransmission",BP,1
GO:0014059,1,0.885184249,0,11,regulation of dopamine secretion,BP,1
GO:0014060,1,0.967951412,0,3,regulation of epinephrine secretion,BP,1
GO:0014061,1,0.913148383,0,8,regulation of norepinephrine secretion,BP,1
GO:0014062,1,0.9663747,0,3,regulation of serotonin secretion,BP,1
GO:0014063,1,0.977458423,0,2,negative regulation of serotonin secretion,BP,1
GO:0014064,1,0.988662726,0,1,positive regulation of serotonin secretion,BP,1
GO:0014067,1,0.888061009,0,11,negative regulation of phosphatidylinositol 3-kinase signaling,BP,1
GO:0014072,1,0.69496789,0,33,response to isoquinoline alkaloid,BP,1
GO:0014075,1,0.660821569,0,37,response to amine,BP,1
GO:0014707,1,0.988662833,0,1,branchiomeric skeletal muscle development,BP,1
GO:0014721,1,0.98200386,0,2,twitch skeletal muscle contraction,BP,1
GO:0014722,1,0.977454646,0,2,regulation of skeletal muscle contraction by calcium ion signaling,BP,1
GO:0014732,1,0.955754803,0,4,skeletal muscle atrophy,BP,1
GO:0014733,1,0.910048477,0,9,regulation of skeletal muscle adaptation,BP,1
GO:0014734,1,0.982938878,0,2,skeletal muscle hypertrophy,BP,1
GO:0014735,1,0.97188902,0,3,regulation of muscle atrophy,BP,1
GO:0014736,1,0.994210854,0,1,negative regulation of muscle atrophy,BP,1
GO:0014737,1,0.977549225,0,2,positive regulation of muscle atrophy,BP,1
GO:0014738,1,0.967379585,0,3,regulation of muscle hyperplasia,BP,1
GO:0014739,1,0.988662575,0,1,positive regulation of muscle hyperplasia,BP,1
GO:0014740,1,0.978474891,0,2,negative regulation of muscle hyperplasia,BP,1
GO:0014741,1,0.750907026,0,26,negative regulation of muscle hypertrophy,BP,1
GO:0014742,1,0.718112148,0,31,positive regulation of muscle hypertrophy,BP,1
GO:0014743,1,0.534645791,0,58,regulation of muscle hypertrophy,BP,1
GO:0014744,1,0.949973496,0,5,positive regulation of muscle adaptation,BP,1
GO:0014745,1,0.901088907,0,10,negative regulation of muscle adaptation,BP,1
GO:0014805,1,0.978470908,0,2,smooth muscle adaptation,BP,1
GO:0014806,1,0.989692508,0,1,smooth muscle hyperplasia,BP,1
GO:0014808,1,0.862699798,0,14,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,1
GO:0014809,1,0.988664587,0,1,regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,1
GO:0014816,1,0.968079812,0,3,skeletal muscle satellite cell differentiation,BP,1
GO:0014819,1,0.955412309,0,4,regulation of skeletal muscle contraction,BP,1
GO:0014820,1,0.930780499,0,7,tonic smooth muscle contraction,BP,1
GO:0014821,1,0.924977935,0,7,phasic smooth muscle contraction,BP,1
GO:0014822,1,0.988662931,0,1,detection of wounding,BP,1
GO:0014824,1,0.937801061,0,6,artery smooth muscle contraction,BP,1
GO:0014826,1,0.988662724,0,1,vein smooth muscle contraction,BP,1
GO:0014827,1,0.978312674,0,2,intestine smooth muscle contraction,BP,1
GO:0014828,1,0.989532094,0,1,distal stomach smooth muscle contraction,BP,1
GO:0014829,1,0.841436868,0,16,vascular smooth muscle contraction,BP,1
GO:0014831,1,0.957831296,0,4,gastro-intestinal system smooth muscle contraction,BP,1
GO:0014832,1,0.946505453,0,5,urinary bladder smooth muscle contraction,BP,1
GO:0014834,1,0.955480188,0,4,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,BP,1
GO:0014835,1,0.97790522,0,2,myoblast differentiation involved in skeletal muscle regeneration,BP,1
GO:0014839,1,0.966369903,0,3,myoblast migration involved in skeletal muscle regeneration,BP,1
GO:0014846,1,0.98994501,0,1,esophagus smooth muscle contraction,BP,1
GO:0014848,1,0.946505453,0,5,urinary tract smooth muscle contraction,BP,1
GO:0014850,1,0.779435639,0,22,response to muscle activity,BP,1
GO:0014852,1,0.977452948,0,2,regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction,BP,1
GO:0014853,1,0.977452948,0,2,regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction,BP,1
GO:0014854,1,0.878616305,0,13,response to inactivity,BP,1
GO:0014858,1,0.968682059,0,3,positive regulation of skeletal muscle cell proliferation,BP,1
GO:0014859,1,0.977466873,0,2,negative regulation of skeletal muscle cell proliferation,BP,1
GO:0014866,1,0.978651754,0,2,skeletal myofibril assembly,BP,1
GO:0014870,1,0.905907428,0,10,response to muscle inactivity,BP,1
GO:0014873,1,0.977453375,0,2,response to muscle activity involved in regulation of muscle adaptation,BP,1
GO:0014874,1,0.893376754,0,11,response to stimulus involved in regulation of muscle adaptation,BP,1
GO:0014877,1,0.92448535,0,8,response to muscle inactivity involved in regulation of muscle adaptation,BP,1
GO:0014878,1,0.977454473,0,2,response to electrical stimulus involved in regulation of muscle adaptation,BP,1
GO:0014883,1,0.946004794,0,5,transition between fast and slow fiber,BP,1
GO:0014886,1,0.978708689,0,2,transition between slow and fast fiber,BP,1
GO:0014887,1,0.825580427,0,18,cardiac muscle adaptation,BP,1
GO:0014889,1,0.870579107,0,13,muscle atrophy,BP,1
GO:0014891,1,0.944928034,0,5,striated muscle atrophy,BP,1
GO:0014894,1,0.92448535,0,8,response to denervation involved in regulation of muscle adaptation,BP,1
GO:0014895,1,0.988662463,0,1,smooth muscle hypertrophy,BP,1
GO:0014896,1,0.447854056,0,75,muscle hypertrophy,BP,1
GO:0014897,1,0.453022672,0,74,striated muscle hypertrophy,BP,1
GO:0014898,1,0.835061158,0,17,cardiac muscle hypertrophy in response to stress,BP,1
GO:0014900,1,0.967379585,0,3,muscle hyperplasia,BP,1
GO:0014904,1,0.771817556,0,23,myotube cell development,BP,1
GO:0014905,1,0.969357874,0,3,myoblast fusion involved in skeletal muscle regeneration,BP,1
GO:0014916,1,0.957776118,0,4,regulation of lung blood pressure,BP,1
GO:0015012,1,0.8188618,0,18,heparan sulfate proteoglycan biosynthetic process,BP,1
GO:0015014,1,0.917204732,0,8,"heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process",BP,1
GO:0015015,1,0.978943121,0,2,"heparan sulfate proteoglycan biosynthetic process, enzymatic modification",BP,1
GO:0015669,1,0.882099981,0,11,gas transport,BP,1
GO:0015670,1,0.966397516,0,3,carbon dioxide transport,BP,1
GO:0015671,1,0.912794145,0,8,oxygen transport,BP,1
GO:0015675,1,0.990114565,0,1,nickel cation transport,BP,1
GO:0015676,1,0.990114565,0,1,vanadium ion transport,BP,1
GO:0015677,1,0.939596732,0,6,copper ion import,BP,1
GO:0015679,1,0.968510638,0,3,plasma membrane copper ion transport,BP,1
GO:0015680,1,0.99144317,0,1,protein maturation by copper ion transfer,BP,1
GO:0015682,1,0.903281095,0,10,ferric iron transport,BP,1
GO:0015684,1,0.988662715,0,1,ferrous iron transport,BP,1
GO:0015688,1,0.977455933,0,2,iron chelate transport,BP,1
GO:0015689,1,0.988662931,0,1,molybdate ion transport,BP,1
GO:0015691,1,0.957001779,0,4,cadmium ion transport,BP,1
GO:0015692,1,0.990114565,0,1,lead ion transport,BP,1
GO:0015693,1,0.862621145,0,13,magnesium ion transport,BP,1
GO:0015694,1,0.988662911,0,1,mercury ion transport,BP,1
GO:0015695,1,0.791292572,0,21,organic cation transport,BP,1
GO:0015696,1,0.575271527,0,50,ammonium transport,BP,1
GO:0015697,1,0.914598843,0,8,quaternary ammonium group transport,BP,1
GO:0015705,1,0.971879069,0,3,iodide transport,BP,1
GO:0015707,1,0.988662931,0,1,nitrite transport,BP,1
GO:0015709,1,0.966369875,0,3,thiosulfate transport,BP,1
GO:0015721,1,0.865724907,0,13,bile acid and bile salt transport,BP,1
GO:0015722,1,0.935937438,0,6,canalicular bile acid transport,BP,1
GO:0015727,1,0.955423649,0,4,lactate transport,BP,1
GO:0015729,1,0.966369875,0,3,oxaloacetate transport,BP,1
GO:0015734,1,0.956062147,0,4,taurine transport,BP,1
GO:0015739,1,0.923390359,0,7,sialic acid transport,BP,1
GO:0015740,1,0.833954899,0,16,C4-dicarboxylate transport,BP,1
GO:0015742,1,0.988662726,0,1,alpha-ketoglutarate transport,BP,1
GO:0015743,1,0.966369875,0,3,malate transport,BP,1
GO:0015744,1,0.944823132,0,5,succinate transport,BP,1
GO:0015746,1,0.95566122,0,4,citrate transport,BP,1
GO:0015747,1,0.966369973,0,3,urate transport,BP,1
GO:0015755,1,0.97746291,0,2,fructose transmembrane transport,BP,1
GO:0015766,1,0.977756828,0,2,disaccharide transport,BP,1
GO:0015770,1,0.977756828,0,2,sucrose transport,BP,1
GO:0015772,1,0.977756828,0,2,oligosaccharide transport,BP,1
GO:0015774,1,0.990918221,0,1,polysaccharide transport,BP,1
GO:0015780,1,0.862900853,0,13,nucleotide-sugar transmembrane transport,BP,1
GO:0015783,1,0.988822398,0,1,GDP-fucose transmembrane transport,BP,1
GO:0015786,1,0.977453299,0,2,UDP-glucose transmembrane transport,BP,1
GO:0015787,1,0.977476887,0,2,UDP-glucuronic acid transmembrane transport,BP,1
GO:0015789,1,0.977476887,0,2,UDP-N-acetylgalactosamine transmembrane transport,BP,1
GO:0015790,1,0.989308325,0,1,UDP-xylose transmembrane transport,BP,1
GO:0015793,1,0.977481373,0,2,glycerol transport,BP,1
GO:0015800,1,0.658685745,0,39,acidic amino acid transport,BP,1
GO:0015801,1,0.912981228,0,8,aromatic amino acid transport,BP,1
GO:0015802,1,0.882135062,0,11,basic amino acid transport,BP,1
GO:0015803,1,0.966369901,0,3,branched-chain amino acid transport,BP,1
GO:0015804,1,0.791341707,0,21,neutral amino acid transport,BP,1
GO:0015805,1,0.988663396,0,1,S-adenosyl-L-methionine transport,BP,1
GO:0015807,1,0.64238375,0,40,L-amino acid transport,BP,1
GO:0015808,1,0.944709292,0,5,L-alanine transport,BP,1
GO:0015809,1,0.912807198,0,8,arginine transport,BP,1
GO:0015810,1,0.924130178,0,7,aspartate transmembrane transport,BP,1
GO:0015811,1,0.977453375,0,2,L-cystine transport,BP,1
GO:0015812,1,0.911362106,0,9,gamma-aminobutyric acid transport,BP,1
GO:0015813,1,0.865041681,0,13,L-glutamate transmembrane transport,BP,1
GO:0015816,1,0.955663822,0,4,glycine transport,BP,1
GO:0015817,1,0.977506168,0,2,histidine transport,BP,1
GO:0015819,1,0.988662931,0,1,lysine transport,BP,1
GO:0015820,1,0.988662931,0,1,leucine transport,BP,1
GO:0015821,1,0.988662928,0,1,methionine transport,BP,1
GO:0015822,1,0.966382482,0,3,ornithine transport,BP,1
GO:0015824,1,0.966503933,0,3,proline transport,BP,1
GO:0015825,1,0.955427644,0,4,L-serine transport,BP,1
GO:0015826,1,0.988662931,0,1,threonine transport,BP,1
GO:0015827,1,0.966503935,0,3,tryptophan transport,BP,1
GO:0015837,1,0.607078215,0,45,amine transport,BP,1
GO:0015838,1,0.957298268,0,4,amino-acid betaine transport,BP,1
GO:0015840,1,0.97745331,0,2,urea transport,BP,1
GO:0015842,1,0.988662931,0,1,aminergic neurotransmitter loading into synaptic vesicle,BP,1
GO:0015844,1,0.647795937,0,39,monoamine transport,BP,1
GO:0015846,1,0.957564087,0,4,polyamine transport,BP,1
GO:0015851,1,0.977453357,0,2,nucleobase transport,BP,1
GO:0015853,1,0.988662921,0,1,adenine transport,BP,1
GO:0015854,1,0.988662921,0,1,guanine transport,BP,1
GO:0015855,1,0.977453357,0,2,pyrimidine nucleobase transport,BP,1
GO:0015858,1,0.944667769,0,5,nucleoside transport,BP,1
GO:0015860,1,0.988759497,0,1,purine nucleoside transmembrane transport,BP,1
GO:0015862,1,0.977453366,0,2,uridine transport,BP,1
GO:0015864,1,0.977453366,0,2,pyrimidine nucleoside transport,BP,1
GO:0015865,1,0.853841895,0,14,purine nucleotide transport,BP,1
GO:0015866,1,0.95547972,0,4,ADP transport,BP,1
GO:0015867,1,0.903580014,0,9,ATP transport,BP,1
GO:0015868,1,0.853841895,0,14,purine ribonucleotide transport,BP,1
GO:0015870,1,0.966381173,0,3,acetylcholine transport,BP,1
GO:0015871,1,0.945625847,0,5,choline transport,BP,1
GO:0015872,1,0.837986559,0,16,dopamine transport,BP,1
GO:0015874,1,0.882417096,0,11,norepinephrine transport,BP,1
GO:0015876,1,0.988662931,0,1,acetyl-CoA transport,BP,1
GO:0015878,1,0.988851655,0,1,biotin transport,BP,1
GO:0015879,1,0.966526824,0,3,carnitine transport,BP,1
GO:0015880,1,0.977523718,0,2,coenzyme A transport,BP,1
GO:0015881,1,0.978412968,0,2,creatine transmembrane transport,BP,1
GO:0015882,1,0.977638879,0,2,L-ascorbic acid transmembrane transport,BP,1
GO:0015884,1,0.953242246,0,5,folic acid transport,BP,1
GO:0015886,1,0.942759269,0,6,heme transport,BP,1
GO:0015887,1,0.988851655,0,1,pantothenate transmembrane transport,BP,1
GO:0015888,1,0.988916397,0,1,thiamine transport,BP,1
GO:0015889,1,0.977453254,0,2,cobalamin transport,BP,1
GO:0015891,1,0.977455933,0,2,siderophore transport,BP,1
GO:0015910,1,0.978146295,0,2,peroxisomal long-chain fatty acid import,BP,1
GO:0015911,1,0.93723125,0,6,plasma membrane long-chain fatty acid transport,BP,1
GO:0015914,1,0.542274949,0,56,phospholipid transport,BP,1
GO:0015916,1,0.977890105,0,2,fatty-acyl-CoA transport,BP,1
GO:0015917,1,0.956831426,0,4,aminophospholipid transport,BP,1
GO:0015919,1,0.856221569,0,14,peroxisomal membrane transport,BP,1
GO:0015920,1,0.977464094,0,2,lipopolysaccharide transport,BP,1
GO:0015936,1,0.84421136,0,15,coenzyme A metabolic process,BP,1
GO:0015937,1,0.882243389,0,11,coenzyme A biosynthetic process,BP,1
GO:0015938,1,0.988757271,0,1,coenzyme A catabolic process,BP,1
GO:0015939,1,0.977456307,0,2,pantothenate metabolic process,BP,1
GO:0015942,1,0.97745339,0,2,formate metabolic process,BP,1
GO:0015949,1,0.988662944,0,1,nucleobase-containing small molecule interconversion,BP,1
GO:0015950,1,0.988662944,0,1,purine nucleotide interconversion,BP,1
GO:0015951,1,0.988662944,0,1,purine ribonucleotide interconversion,BP,1
GO:0015959,1,0.944684146,0,5,diadenosine polyphosphate metabolic process,BP,1
GO:0015960,1,0.966369891,0,3,diadenosine polyphosphate biosynthetic process,BP,1
GO:0015961,1,0.977565651,0,2,diadenosine polyphosphate catabolic process,BP,1
GO:0015965,1,0.966369891,0,3,diadenosine tetraphosphate metabolic process,BP,1
GO:0015966,1,0.966369891,0,3,diadenosine tetraphosphate biosynthetic process,BP,1
GO:0015969,1,0.988662911,0,1,guanosine tetraphosphate metabolic process,BP,1
GO:0015971,1,0.988662911,0,1,guanosine tetraphosphate catabolic process,BP,1
GO:0015985,1,0.814327263,0,18,"energy coupled proton transport, down electrochemical gradient",BP,1
GO:0015986,1,0.814327263,0,18,ATP synthesis coupled proton transport,BP,1
GO:0015988,1,0.968738958,0,3,"energy coupled proton transmembrane transport, against electrochemical gradient",BP,1
GO:0015990,1,0.988662613,0,1,electron transport coupled proton transport,BP,1
GO:0016024,1,0.944609307,0,5,CDP-diacylglycerol biosynthetic process,BP,1
GO:0016031,1,0.98866274,0,1,tRNA import into mitochondrion,BP,1
GO:0016036,1,0.977459584,0,2,cellular response to phosphate starvation,BP,1
GO:0016045,1,0.894773813,0,10,detection of bacterium,BP,1
GO:0016046,1,0.988662931,0,1,detection of fungus,BP,1
GO:0016048,1,0.902963419,0,9,detection of temperature stimulus,BP,1
GO:0016050,1,0.10913693,0,201,vesicle organization,BP,1
GO:0016056,1,0.977453415,0,2,rhodopsin mediated signaling pathway,BP,1
GO:0016062,1,0.988662915,0,1,adaptation of rhodopsin mediated signaling,BP,1
GO:0016068,1,0.955410674,0,4,type I hypersensitivity,BP,1
GO:0016072,1,0.116209748,0,190,rRNA metabolic process,BP,1
GO:0016073,1,0.656863341,0,37,snRNA metabolic process,BP,1
GO:0016074,1,0.833675208,0,16,snoRNA metabolic process,BP,1
GO:0016075,1,0.83354915,0,16,rRNA catabolic process,BP,1
GO:0016076,1,0.988662931,0,1,snRNA catabolic process,BP,1
GO:0016077,1,0.977453286,0,2,snoRNA catabolic process,BP,1
GO:0016078,1,0.913174356,0,8,tRNA catabolic process,BP,1
GO:0016080,1,0.977453329,0,2,synaptic vesicle targeting,BP,1
GO:0016081,1,0.928904304,0,7,synaptic vesicle docking,BP,1
GO:0016082,1,0.869059987,0,13,synaptic vesicle priming,BP,1
GO:0016093,1,0.923889807,0,7,polyprenol metabolic process,BP,1
GO:0016094,1,0.956051896,0,4,polyprenol biosynthetic process,BP,1
GO:0016095,1,0.98866287,0,1,polyprenol catabolic process,BP,1
GO:0016098,1,0.944575597,0,5,monoterpenoid metabolic process,BP,1
GO:0016102,1,0.944575129,0,5,diterpenoid biosynthetic process,BP,1
GO:0016103,1,0.988662924,0,1,diterpenoid catabolic process,BP,1
GO:0016108,1,0.97746771,0,2,tetraterpenoid metabolic process,BP,1
GO:0016114,1,0.893812738,0,10,terpenoid biosynthetic process,BP,1
GO:0016115,1,0.988662924,0,1,terpenoid catabolic process,BP,1
GO:0016116,1,0.97746771,0,2,carotenoid metabolic process,BP,1
GO:0016119,1,0.97746771,0,2,carotene metabolic process,BP,1
GO:0016121,1,0.97746771,0,2,carotene catabolic process,BP,1
GO:0016122,1,0.988677429,0,1,xanthophyll metabolic process,BP,1
GO:0016127,1,0.913821971,0,8,sterol catabolic process,BP,1
GO:0016128,1,0.966623524,0,3,phytosteroid metabolic process,BP,1
GO:0016129,1,0.966623524,0,3,phytosteroid biosynthetic process,BP,1
GO:0016131,1,0.988681078,0,1,brassinosteroid metabolic process,BP,1
GO:0016132,1,0.988681078,0,1,brassinosteroid biosynthetic process,BP,1
GO:0016137,1,0.842854572,0,15,glycoside metabolic process,BP,1
GO:0016139,1,0.912954605,0,8,glycoside catabolic process,BP,1
GO:0016180,1,0.769402999,0,23,snRNA processing,BP,1
GO:0016182,1,0.95805387,0,4,synaptic vesicle budding from endosome,BP,1
GO:0016183,1,0.988662742,0,1,synaptic vesicle coating,BP,1
GO:0016185,1,0.945453334,0,5,synaptic vesicle budding from presynaptic endocytic zone membrane,BP,1
GO:0016188,1,0.914302405,0,8,synaptic vesicle maturation,BP,1
GO:0016189,1,0.955433366,0,4,synaptic vesicle to endosome fusion,BP,1
GO:0016191,1,0.95848088,0,4,synaptic vesicle uncoating,BP,1
GO:0016197,1,0.157764158,0,169,endosomal transport,BP,1
GO:0016198,1,0.983223049,0,2,axon choice point recognition,BP,1
GO:0016199,1,0.983223049,0,2,axon midline choice point recognition,BP,1
GO:0016226,1,0.777961048,0,22,iron-sulfur cluster assembly,BP,1
GO:0016237,1,0.970691753,0,3,lysosomal microautophagy,BP,1
GO:0016240,1,0.955822955,0,4,autophagosome membrane docking,BP,1
GO:0016242,1,0.728213895,0,29,negative regulation of macroautophagy,BP,1
GO:0016243,1,0.989508562,0,1,regulation of autophagosome size,BP,1
GO:0016246,1,0.876086514,0,12,RNA interference,BP,1
GO:0016255,1,0.944581095,0,5,attachment of GPI anchor to protein,BP,1
GO:0016256,1,0.988662931,0,1,N-glycan processing to lysosome,BP,1
GO:0016259,1,0.95827049,0,4,selenocysteine metabolic process,BP,1
GO:0016260,1,0.979916183,0,2,selenocysteine biosynthetic process,BP,1
GO:0016261,1,0.988662939,0,1,selenocysteine catabolic process,BP,1
GO:0016264,1,0.934699068,0,6,gap junction assembly,BP,1
GO:0016266,1,0.93474839,0,6,O-glycan processing,BP,1
GO:0016267,1,0.977453256,0,2,"O-glycan processing, core 1",BP,1
GO:0016320,1,0.978343885,0,2,endoplasmic reticulum membrane fusion,BP,1
GO:0016321,1,0.977454472,0,2,female meiosis chromosome segregation,BP,1
GO:0016322,1,0.919092296,0,8,neuron remodeling,BP,1
GO:0016332,1,0.989231651,0,1,establishment or maintenance of polarity of embryonic epithelium,BP,1
GO:0016333,1,0.988738755,0,1,morphogenesis of follicular epithelium,BP,1
GO:0016334,1,0.988738755,0,1,establishment or maintenance of polarity of follicular epithelium,BP,1
GO:0016338,1,0.924290038,0,7,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,BP,1
GO:0016339,1,0.910289421,0,9,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,BP,1
GO:0016340,1,0.977453375,0,2,calcium-dependent cell-matrix adhesion,BP,1
GO:0016344,1,0.977453304,0,2,meiotic chromosome movement towards spindle pole,BP,1
GO:0016446,1,0.905900359,0,9,somatic hypermutation of immunoglobulin genes,BP,1
GO:0016476,1,0.977453375,0,2,regulation of embryonic cell shape,BP,1
GO:0016479,1,0.953178321,0,5,negative regulation of transcription by RNA polymerase I,BP,1
GO:0016480,1,0.966760419,0,3,negative regulation of transcription by RNA polymerase III,BP,1
GO:0016482,1,0.252289536,0,127,cytosolic transport,BP,1
GO:0016486,1,0.90449514,0,9,peptide hormone processing,BP,1
GO:0016539,1,0.988663811,0,1,intein-mediated protein splicing,BP,1
GO:0016540,1,0.85412082,0,14,protein autoprocessing,BP,1
GO:0016553,1,0.927298376,0,7,base conversion or substitution editing,BP,1
GO:0016554,1,0.966369821,0,3,cytidine to uridine editing,BP,1
GO:0016556,1,0.758977961,0,25,mRNA modification,BP,1
GO:0016557,1,0.966370466,0,3,peroxisome membrane biogenesis,BP,1
GO:0016558,1,0.875993227,0,12,protein import into peroxisome matrix,BP,1
GO:0016559,1,0.903825789,0,9,peroxisome fission,BP,1
GO:0016560,1,0.968591104,0,3,"protein import into peroxisome matrix, docking",BP,1
GO:0016561,1,0.966619033,0,3,"protein import into peroxisome matrix, translocation",BP,1
GO:0016571,1,0.309923128,0,109,histone methylation,BP,1
GO:0016574,1,0.614634684,0,44,histone ubiquitination,BP,1
GO:0016576,1,0.967299601,0,3,histone dephosphorylation,BP,1
GO:0016577,1,0.76164239,0,25,histone demethylation,BP,1
GO:0016578,1,0.800821619,0,20,histone deubiquitination,BP,1
GO:0016584,1,0.92505837,0,7,nucleosome positioning,BP,1
GO:0016598,1,0.9903553,0,1,protein arginylation,BP,1
GO:0016601,1,0.73124545,0,29,Rac protein signal transduction,BP,1
GO:0016925,1,0.671401452,0,36,protein sumoylation,BP,1
GO:0016926,1,0.937326584,0,6,protein desumoylation,BP,1
GO:0016973,1,0.86607101,0,13,poly(A)+ mRNA export from nucleus,BP,1
GO:0016998,1,0.989357365,0,1,cell wall macromolecule catabolic process,BP,1
GO:0017000,1,0.811145068,0,19,antibiotic biosynthetic process,BP,1
GO:0017003,1,0.988662931,0,1,protein-heme linkage,BP,1
GO:0017004,1,0.718259637,0,29,cytochrome complex assembly,BP,1
GO:0017006,1,0.988662931,0,1,protein-tetrapyrrole linkage,BP,1
GO:0017014,1,0.894000721,0,10,protein nitrosylation,BP,1
GO:0017055,1,0.977454207,0,2,negative regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,1
GO:0017062,1,0.902439263,0,9,respiratory chain complex III assembly,BP,1
GO:0017085,1,0.830652639,0,18,response to insecticide,BP,1
GO:0017121,1,0.906910185,0,9,phospholipid scrambling,BP,1
GO:0017126,1,0.978246718,0,2,nucleologenesis,BP,1
GO:0017182,1,0.944858928,0,5,peptidyl-diphthamide metabolic process,BP,1
GO:0017183,1,0.944858928,0,5,peptidyl-diphthamide biosynthetic process from peptidyl-histidine,BP,1
GO:0017185,1,0.923984842,0,7,peptidyl-lysine hydroxylation,BP,1
GO:0017186,1,0.988662976,0,1,"peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase",BP,1
GO:0017187,1,0.966422346,0,3,peptidyl-glutamic acid carboxylation,BP,1
GO:0017190,1,0.988662931,0,1,N-terminal peptidyl-aspartic acid acetylation,BP,1
GO:0017196,1,0.923269038,0,7,N-terminal peptidyl-methionine acetylation,BP,1
GO:0017198,1,0.977453363,0,2,N-terminal peptidyl-serine acetylation,BP,1
GO:0018002,1,0.966369898,0,3,N-terminal peptidyl-glutamic acid acetylation,BP,1
GO:0018003,1,0.988662704,0,1,peptidyl-lysine N6-acetylation,BP,1
GO:0018008,1,0.977453578,0,2,N-terminal peptidyl-glycine N-myristoylation,BP,1
GO:0018011,1,0.988662931,0,1,N-terminal peptidyl-alanine methylation,BP,1
GO:0018012,1,0.988662931,0,1,N-terminal peptidyl-alanine trimethylation,BP,1
GO:0018013,1,0.988662931,0,1,N-terminal peptidyl-glycine methylation,BP,1
GO:0018016,1,0.988662931,0,1,N-terminal peptidyl-proline dimethylation,BP,1
GO:0018021,1,0.988662931,0,1,peptidyl-histidine methylation,BP,1
GO:0018022,1,0.358888557,0,96,peptidyl-lysine methylation,BP,1
GO:0018023,1,0.681872535,0,36,peptidyl-lysine trimethylation,BP,1
GO:0018026,1,0.909012828,0,9,peptidyl-lysine monomethylation,BP,1
GO:0018027,1,0.896422169,0,11,peptidyl-lysine dimethylation,BP,1
GO:0018032,1,0.989452114,0,1,protein amidation,BP,1
GO:0018057,1,0.956227562,0,4,peptidyl-lysine oxidation,BP,1
GO:0018063,1,0.988662931,0,1,cytochrome c-heme linkage,BP,1
GO:0018065,1,0.923338723,0,7,protein-cofactor linkage,BP,1
GO:0018076,1,0.983996803,0,2,N-terminal peptidyl-lysine acetylation,BP,1
GO:0018095,1,0.923268851,0,7,protein polyglutamylation,BP,1
GO:0018103,1,0.966446553,0,3,protein C-linked glycosylation,BP,1
GO:0018106,1,0.988662624,0,1,peptidyl-histidine phosphorylation,BP,1
GO:0018107,1,0.383843836,0,90,peptidyl-threonine phosphorylation,BP,1
GO:0018119,1,0.894000721,0,10,peptidyl-cysteine S-nitrosylation,BP,1
GO:0018120,1,0.988662897,0,1,peptidyl-arginine ADP-ribosylation,BP,1
GO:0018125,1,0.977856424,0,2,peptidyl-cysteine methylation,BP,1
GO:0018126,1,0.805774632,0,19,protein hydroxylation,BP,1
GO:0018149,1,0.872496206,0,13,peptide cross-linking,BP,1
GO:0018153,1,0.989195603,0,1,isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine,BP,1
GO:0018158,1,0.872820173,0,12,protein oxidation,BP,1
GO:0018160,1,0.988662907,0,1,peptidyl-pyrromethane cofactor linkage,BP,1
GO:0018166,1,0.988662881,0,1,C-terminal protein-tyrosinylation,BP,1
GO:0018171,1,0.955410929,0,4,peptidyl-cysteine oxidation,BP,1
GO:0018192,1,0.988662931,0,1,enzyme active site formation via cysteine modification to L-cysteine persulfide,BP,1
GO:0018194,1,0.988662931,0,1,peptidyl-alanine modification,BP,1
GO:0018195,1,0.834316547,0,16,peptidyl-arginine modification,BP,1
GO:0018196,1,0.817769708,0,18,peptidyl-asparagine modification,BP,1
GO:0018197,1,0.956228471,0,4,peptidyl-aspartic acid modification,BP,1
GO:0018198,1,0.680428614,0,34,peptidyl-cysteine modification,BP,1
GO:0018199,1,0.9779801,0,2,peptidyl-glutamine modification,BP,1
GO:0018200,1,0.83506592,0,16,peptidyl-glutamic acid modification,BP,1
GO:0018201,1,0.96637011,0,3,peptidyl-glycine modification,BP,1
GO:0018202,1,0.91306872,0,8,peptidyl-histidine modification,BP,1
GO:0018206,1,0.88207536,0,11,peptidyl-methionine modification,BP,1
GO:0018210,1,0.371178726,0,93,peptidyl-threonine modification,BP,1
GO:0018211,1,0.966446553,0,3,peptidyl-tryptophan modification,BP,1
GO:0018214,1,0.966422346,0,3,protein carboxylation,BP,1
GO:0018216,1,0.87329742,0,12,peptidyl-arginine methylation,BP,1
GO:0018217,1,0.989508562,0,1,peptidyl-aspartic acid phosphorylation,BP,1
GO:0018230,1,0.833788759,0,16,peptidyl-L-cysteine S-palmitoylation,BP,1
GO:0018231,1,0.833788759,0,16,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine,BP,1
GO:0018242,1,0.945424654,0,5,protein O-linked glycosylation via serine,BP,1
GO:0018243,1,0.967252238,0,3,protein O-linked glycosylation via threonine,BP,1
GO:0018262,1,0.989195603,0,1,isopeptide cross-linking,BP,1
GO:0018279,1,0.827161511,0,17,protein N-linked glycosylation via asparagine,BP,1
GO:0018282,1,0.977453375,0,2,metal incorporation into metallo-sulfur cluster,BP,1
GO:0018283,1,0.977453375,0,2,iron incorporation into metallo-sulfur cluster,BP,1
GO:0018293,1,0.988662929,0,1,protein-FAD linkage,BP,1
GO:0018307,1,0.977453218,0,2,enzyme active site formation,BP,1
GO:0018312,1,0.966927832,0,3,peptidyl-serine ADP-ribosylation,BP,1
GO:0018315,1,0.988676702,0,1,molybdenum incorporation into molybdenum-molybdopterin complex,BP,1
GO:0018317,1,0.966446553,0,3,protein C-linked glycosylation via tryptophan,BP,1
GO:0018322,1,0.988662881,0,1,protein tyrosinylation,BP,1
GO:0018323,1,0.988662773,0,1,enzyme active site formation via L-cysteine sulfinic acid,BP,1
GO:0018335,1,0.95547445,0,4,protein succinylation,BP,1
GO:0018342,1,0.917419807,0,8,protein prenylation,BP,1
GO:0018343,1,0.977476754,0,2,protein farnesylation,BP,1
GO:0018344,1,0.938570064,0,6,protein geranylgeranylation,BP,1
GO:0018345,1,0.752711052,0,25,protein palmitoylation,BP,1
GO:0018364,1,0.966369802,0,3,peptidyl-glutamine methylation,BP,1
GO:0018377,1,0.955705779,0,4,protein myristoylation,BP,1
GO:0018395,1,0.988662894,0,1,peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine,BP,1
GO:0018401,1,0.933941978,0,6,peptidyl-proline hydroxylation to 4-hydroxy-L-proline,BP,1
GO:0018406,1,0.966446553,0,3,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,BP,1
GO:0018410,1,0.883689939,0,11,C-terminal protein amino acid modification,BP,1
GO:0018424,1,0.989233624,0,1,peptidyl-glutamic acid poly-ADP-ribosylation,BP,1
GO:0018872,1,0.977453358,0,2,arsonoacetate metabolic process,BP,1
GO:0018879,1,0.977453366,0,2,biphenyl metabolic process,BP,1
GO:0018880,1,0.988665243,0,1,4-chlorobiphenyl metabolic process,BP,1
GO:0018885,1,0.988662929,0,1,carbon tetrachloride metabolic process,BP,1
GO:0018894,1,0.966369479,0,3,dibenzo-p-dioxin metabolic process,BP,1
GO:0018900,1,0.988662726,0,1,dichloromethane metabolic process,BP,1
GO:0018904,1,0.852380888,0,14,ether metabolic process,BP,1
GO:0018916,1,0.966369398,0,3,nitrobenzene metabolic process,BP,1
GO:0018917,1,0.98866293,0,1,fluorene metabolic process,BP,1
GO:0018924,1,0.988662918,0,1,mandelate metabolic process,BP,1
GO:0018931,1,0.977453285,0,2,naphthalene metabolic process,BP,1
GO:0018933,1,0.988662931,0,1,nicotine metabolic process,BP,1
GO:0018958,1,0.579040494,0,50,phenol-containing compound metabolic process,BP,1
GO:0018960,1,0.988662834,0,1,4-nitrophenol metabolic process,BP,1
GO:0018963,1,0.977453364,0,2,phthalate metabolic process,BP,1
GO:0018979,1,0.988662903,0,1,trichloroethylene metabolic process,BP,1
GO:0018992,1,0.968457609,0,3,germ-line sex determination,BP,1
GO:0019043,1,0.988662823,0,1,establishment of viral latency,BP,1
GO:0019048,1,0.75677314,0,25,modulation by virus of host morphology or physiology,BP,1
GO:0019049,1,0.968158169,0,3,evasion or tolerance of host defenses by virus,BP,1
GO:0019050,1,0.977454292,0,2,suppression by virus of host apoptotic process,BP,1
GO:0019054,1,0.863929185,0,13,modulation by virus of host process,BP,1
GO:0019060,1,0.988662598,0,1,intracellular transport of viral protein in host cell,BP,1
GO:0019062,1,0.933905087,0,6,virion attachment to host cell,BP,1
GO:0019064,1,0.966387173,0,3,fusion of virus membrane with host plasma membrane,BP,1
GO:0019065,1,0.959375865,0,4,receptor-mediated endocytosis of virus by host cell,BP,1
GO:0019068,1,0.773581793,0,23,virion assembly,BP,1
GO:0019072,1,0.978485198,0,2,viral genome packaging,BP,1
GO:0019074,1,0.978485198,0,2,viral RNA genome packaging,BP,1
GO:0019075,1,0.977453375,0,2,virus maturation,BP,1
GO:0019076,1,0.721148646,0,29,viral release from host cell,BP,1
GO:0019081,1,0.853569716,0,14,viral translation,BP,1
GO:0019085,1,0.980345997,0,2,early viral transcription,BP,1
GO:0019086,1,0.969229981,0,3,late viral transcription,BP,1
GO:0019087,1,0.936449184,0,6,transformation of host cell by virus,BP,1
GO:0019088,1,0.988662868,0,1,immortalization of host cell by virus,BP,1
GO:0019089,1,0.991293742,0,1,transmission of virus,BP,1
GO:0019098,1,0.780198466,0,23,reproductive behavior,BP,1
GO:0019100,1,0.979564831,0,2,male germ-line sex determination,BP,1
GO:0019184,1,0.893853465,0,10,nonribosomal peptide biosynthetic process,BP,1
GO:0019217,1,0.442655366,0,74,regulation of fatty acid metabolic process,BP,1
GO:0019226,1,0.767198312,0,25,transmission of nerve impulse,BP,1
GO:0019227,1,0.961636248,0,4,neuronal action potential propagation,BP,1
GO:0019228,1,0.871821724,0,13,neuronal action potential,BP,1
GO:0019229,1,0.644766593,0,40,regulation of vasoconstriction,BP,1
GO:0019230,1,0.966424821,0,3,proprioception,BP,1
GO:0019233,1,0.564354744,0,52,sensory perception of pain,BP,1
GO:0019236,1,0.988662928,0,1,response to pheromone,BP,1
GO:0019240,1,0.97170097,0,3,citrulline biosynthetic process,BP,1
GO:0019242,1,0.96636983,0,3,methylglyoxal biosynthetic process,BP,1
GO:0019243,1,0.977520762,0,2,methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,BP,1
GO:0019244,1,0.995425369,0,1,lactate biosynthetic process from pyruvate,BP,1
GO:0019249,1,0.932453124,0,7,lactate biosynthetic process,BP,1
GO:0019254,1,0.966420332,0,3,"carnitine metabolic process, CoA-linked",BP,1
GO:0019255,1,0.977453375,0,2,glucose 1-phosphate metabolic process,BP,1
GO:0019264,1,0.977453375,0,2,glycine biosynthetic process from serine,BP,1
GO:0019265,1,0.977453356,0,2,"glycine biosynthetic process, by transamination of glyoxylate",BP,1
GO:0019276,1,0.977455217,0,2,UDP-N-acetylgalactosamine metabolic process,BP,1
GO:0019284,1,0.966369588,0,3,L-methionine salvage from S-adenosylmethionine,BP,1
GO:0019285,1,0.977883067,0,2,glycine betaine biosynthetic process from choline,BP,1
GO:0019290,1,0.988662813,0,1,siderophore biosynthetic process,BP,1
GO:0019303,1,0.977453157,0,2,D-ribose catabolic process,BP,1
GO:0019310,1,0.988662758,0,1,inositol catabolic process,BP,1
GO:0019320,1,0.79856015,0,20,hexose catabolic process,BP,1
GO:0019321,1,0.892509361,0,10,pentose metabolic process,BP,1
GO:0019322,1,0.988663105,0,1,pentose biosynthetic process,BP,1
GO:0019323,1,0.955410913,0,4,pentose catabolic process,BP,1
GO:0019336,1,0.966369841,0,3,phenol-containing compound catabolic process,BP,1
GO:0019343,1,0.988678846,0,1,cysteine biosynthetic process via cystathionine,BP,1
GO:0019344,1,0.977469111,0,2,cysteine biosynthetic process,BP,1
GO:0019346,1,0.955801951,0,4,transsulfuration,BP,1
GO:0019348,1,0.934489935,0,6,dolichol metabolic process,BP,1
GO:0019357,1,0.988662931,0,1,nicotinate nucleotide biosynthetic process,BP,1
GO:0019358,1,0.988662931,0,1,nicotinate nucleotide salvage,BP,1
GO:0019364,1,0.977942331,0,2,pyridine nucleotide catabolic process,BP,1
GO:0019365,1,0.988662931,0,1,pyridine nucleotide salvage,BP,1
GO:0019367,1,0.956145288,0,4,"fatty acid elongation, saturated fatty acid",BP,1
GO:0019368,1,0.956145288,0,4,"fatty acid elongation, unsaturated fatty acid",BP,1
GO:0019370,1,0.936285966,0,6,leukotriene biosynthetic process,BP,1
GO:0019371,1,0.988726724,0,1,cyclooxygenase pathway,BP,1
GO:0019372,1,0.98866272,0,1,lipoxygenase pathway,BP,1
GO:0019374,1,0.933896378,0,6,galactolipid metabolic process,BP,1
GO:0019375,1,0.977489193,0,2,galactolipid biosynthetic process,BP,1
GO:0019376,1,0.977453476,0,2,galactolipid catabolic process,BP,1
GO:0019377,1,0.862354426,0,13,glycolipid catabolic process,BP,1
GO:0019388,1,0.923344772,0,7,galactose catabolic process,BP,1
GO:0019389,1,0.966374453,0,3,glucuronoside metabolic process,BP,1
GO:0019391,1,0.977457874,0,2,glucuronoside catabolic process,BP,1
GO:0019400,1,0.827682756,0,17,alditol metabolic process,BP,1
GO:0019401,1,0.944620354,0,5,alditol biosynthetic process,BP,1
GO:0019402,1,0.988662864,0,1,galactitol metabolic process,BP,1
GO:0019405,1,0.945726026,0,5,alditol catabolic process,BP,1
GO:0019406,1,0.988662869,0,1,hexitol biosynthetic process,BP,1
GO:0019407,1,0.988662939,0,1,hexitol catabolic process,BP,1
GO:0019408,1,0.967018013,0,3,dolichol biosynthetic process,BP,1
GO:0019413,1,0.978162648,0,2,acetate biosynthetic process,BP,1
GO:0019417,1,0.978120794,0,2,sulfur oxidation,BP,1
GO:0019418,1,0.988662931,0,1,sulfide oxidation,BP,1
GO:0019427,1,0.978162648,0,2,acetyl-CoA biosynthetic process from acetate,BP,1
GO:0019430,1,0.816506201,0,18,removal of superoxide radicals,BP,1
GO:0019432,1,0.70110604,0,32,triglyceride biosynthetic process,BP,1
GO:0019433,1,0.770837901,0,24,triglyceride catabolic process,BP,1
GO:0019441,1,0.955411109,0,4,tryptophan catabolic process to kynurenine,BP,1
GO:0019442,1,0.977453357,0,2,tryptophan catabolic process to acetyl-CoA,BP,1
GO:0019448,1,0.955426455,0,4,L-cysteine catabolic process,BP,1
GO:0019449,1,0.988662931,0,1,L-cysteine catabolic process to hypotaurine,BP,1
GO:0019452,1,0.988662931,0,1,L-cysteine catabolic process to taurine,BP,1
GO:0019464,1,0.966773206,0,3,glycine decarboxylation via glycine cleavage system,BP,1
GO:0019470,1,0.988662931,0,1,4-hydroxyproline catabolic process,BP,1
GO:0019471,1,0.892276098,0,10,4-hydroxyproline metabolic process,BP,1
GO:0019474,1,0.955581018,0,4,L-lysine catabolic process to acetyl-CoA,BP,1
GO:0019477,1,0.955581018,0,4,L-lysine catabolic process,BP,1
GO:0019478,1,0.977453215,0,2,D-amino acid catabolic process,BP,1
GO:0019481,1,0.98866293,0,1,"L-alanine catabolic process, by transamination",BP,1
GO:0019482,1,0.946113401,0,5,beta-alanine metabolic process,BP,1
GO:0019483,1,0.97868336,0,2,beta-alanine biosynthetic process,BP,1
GO:0019484,1,0.989027454,0,1,beta-alanine catabolic process,BP,1
GO:0019493,1,0.98866295,0,1,arginine catabolic process to proline,BP,1
GO:0019509,1,0.944575148,0,5,L-methionine salvage from methylthioadenosine,BP,1
GO:0019510,1,0.988662931,0,1,S-adenosylhomocysteine catabolic process,BP,1
GO:0019511,1,0.902516543,0,9,peptidyl-proline hydroxylation,BP,1
GO:0019516,1,0.988663844,0,1,lactate oxidation,BP,1
GO:0019519,1,0.988662939,0,1,pentitol metabolic process,BP,1
GO:0019520,1,0.980762266,0,2,aldonic acid metabolic process,BP,1
GO:0019521,1,0.980762266,0,2,D-gluconate metabolic process,BP,1
GO:0019527,1,0.988662939,0,1,pentitol catabolic process,BP,1
GO:0019530,1,0.93460739,0,6,taurine metabolic process,BP,1
GO:0019541,1,0.956134674,0,4,propionate metabolic process,BP,1
GO:0019542,1,0.978162648,0,2,propionate biosynthetic process,BP,1
GO:0019543,1,0.977484186,0,2,propionate catabolic process,BP,1
GO:0019544,1,0.98866295,0,1,arginine catabolic process to glutamate,BP,1
GO:0019547,1,0.988662889,0,1,arginine catabolic process to ornithine,BP,1
GO:0019550,1,0.977455495,0,2,glutamate catabolic process to aspartate,BP,1
GO:0019551,1,0.977455495,0,2,glutamate catabolic process to 2-oxoglutarate,BP,1
GO:0019556,1,0.966369924,0,3,histidine catabolic process to glutamate and formamide,BP,1
GO:0019557,1,0.97745339,0,2,histidine catabolic process to glutamate and formate,BP,1
GO:0019563,1,0.956574601,0,4,glycerol catabolic process,BP,1
GO:0019566,1,0.988662931,0,1,arabinose metabolic process,BP,1
GO:0019585,1,0.944593457,0,5,glucuronate metabolic process,BP,1
GO:0019605,1,0.988662925,0,1,butyrate metabolic process,BP,1
GO:0019606,1,0.988662828,0,1,2-oxobutyrate catabolic process,BP,1
GO:0019614,1,0.977453361,0,2,catechol-containing compound catabolic process,BP,1
GO:0019626,1,0.944605313,0,5,short-chain fatty acid catabolic process,BP,1
GO:0019627,1,0.910038881,0,9,urea metabolic process,BP,1
GO:0019628,1,0.988662873,0,1,urate catabolic process,BP,1
GO:0019646,1,0.93386001,0,6,aerobic electron transport chain,BP,1
GO:0019659,1,0.955411103,0,4,glucose catabolic process to lactate,BP,1
GO:0019660,1,0.955411103,0,4,glycolytic fermentation,BP,1
GO:0019661,1,0.955411103,0,4,glucose catabolic process to lactate via pyruvate,BP,1
GO:0019666,1,0.955411103,0,4,nitrogenous compound fermentation,BP,1
GO:0019673,1,0.923269925,0,7,GDP-mannose metabolic process,BP,1
GO:0019674,1,0.641558911,0,39,NAD metabolic process,BP,1
GO:0019676,1,0.966369909,0,3,ammonia assimilation cycle,BP,1
GO:0019677,1,0.989157653,0,1,NAD catabolic process,BP,1
GO:0019682,1,0.866818595,0,13,glyceraldehyde-3-phosphate metabolic process,BP,1
GO:0019692,1,0.769257344,0,23,deoxyribose phosphate metabolic process,BP,1
GO:0019694,1,0.93460739,0,6,alkanesulfonate metabolic process,BP,1
GO:0019695,1,0.923916409,0,7,choline metabolic process,BP,1
GO:0019720,1,0.93403788,0,6,Mo-molybdopterin cofactor metabolic process,BP,1
GO:0019722,1,0.294243829,0,114,calcium-mediated signaling,BP,1
GO:0019730,1,0.710527609,0,30,antimicrobial humoral response,BP,1
GO:0019731,1,0.882748631,0,11,antibacterial humoral response,BP,1
GO:0019732,1,0.977453028,0,2,antifungal humoral response,BP,1
GO:0019740,1,0.944575252,0,5,nitrogen utilization,BP,1
GO:0019742,1,0.988662911,0,1,pentacyclic triterpenoid metabolic process,BP,1
GO:0019747,1,0.977453215,0,2,regulation of isoprenoid metabolic process,BP,1
GO:0019748,1,0.655434725,0,38,secondary metabolic process,BP,1
GO:0019751,1,0.400178301,0,84,polyol metabolic process,BP,1
GO:0019755,1,0.944602561,0,5,one-carbon compound transport,BP,1
GO:0019800,1,0.966376783,0,3,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,BP,1
GO:0019805,1,0.951038556,0,5,quinolinate biosynthetic process,BP,1
GO:0019835,1,0.797881451,0,20,cytolysis,BP,1
GO:0019852,1,0.923607988,0,7,L-ascorbic acid metabolic process,BP,1
GO:0019853,1,0.955410752,0,4,L-ascorbic acid biosynthetic process,BP,1
GO:0019856,1,0.923427764,0,8,pyrimidine nucleobase biosynthetic process,BP,1
GO:0019857,1,0.977453375,0,2,5-methylcytosine metabolic process,BP,1
GO:0019858,1,0.97745334,0,2,cytosine metabolic process,BP,1
GO:0019859,1,0.967942953,0,3,thymine metabolic process,BP,1
GO:0019860,1,0.967586079,0,3,uracil metabolic process,BP,1
GO:0019878,1,0.977562225,0,2,lysine biosynthetic process via aminoadipic acid,BP,1
GO:0019882,1,0.41461688,0,78,antigen processing and presentation,BP,1
GO:0019883,1,0.763278863,0,24,antigen processing and presentation of endogenous antigen,BP,1
GO:0019884,1,0.730024195,0,28,antigen processing and presentation of exogenous antigen,BP,1
GO:0019885,1,0.780920451,0,22,antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,1
GO:0019886,1,0.872105143,0,12,antigen processing and presentation of exogenous peptide antigen via MHC class II,BP,1
GO:0019889,1,0.988662827,0,1,pteridine metabolic process,BP,1
GO:0019896,1,0.939218695,0,6,axonal transport of mitochondrion,BP,1
GO:0019918,1,0.955429998,0,4,"peptidyl-arginine methylation, to symmetrical-dimethyl arginine",BP,1
GO:0019919,1,0.945155393,0,5,"peptidyl-arginine methylation, to asymmetrical-dimethyl arginine",BP,1
GO:0019934,1,0.86091477,0,14,cGMP-mediated signaling,BP,1
GO:0019988,1,0.98866288,0,1,charged-tRNA amino acid modification,BP,1
GO:0020012,1,0.988662831,0,1,evasion or tolerance of host immune response,BP,1
GO:0020021,1,0.977453312,0,2,immortalization of host cell,BP,1
GO:0020027,1,0.873571268,0,12,hemoglobin metabolic process,BP,1
GO:0020028,1,0.997726229,0,1,endocytic hemoglobin import,BP,1
GO:0021501,1,0.98866293,0,1,prechordal plate formation,BP,1
GO:0021502,1,0.967784342,0,3,neural fold elevation formation,BP,1
GO:0021503,1,0.993305113,0,1,neural fold bending,BP,1
GO:0021506,1,0.990333291,0,1,anterior neuropore closure,BP,1
GO:0021508,1,0.988662928,0,1,floor plate formation,BP,1
GO:0021511,1,0.889590788,0,11,spinal cord patterning,BP,1
GO:0021513,1,0.893082839,0,10,spinal cord dorsal/ventral patterning,BP,1
GO:0021514,1,0.956261736,0,4,ventral spinal cord interneuron differentiation,BP,1
GO:0021515,1,0.858274117,0,15,cell differentiation in spinal cord,BP,1
GO:0021516,1,0.956710803,0,4,dorsal spinal cord development,BP,1
GO:0021517,1,0.840265536,0,17,ventral spinal cord development,BP,1
GO:0021522,1,0.901114887,0,10,spinal cord motor neuron differentiation,BP,1
GO:0021523,1,0.977453662,0,2,somatic motor neuron differentiation,BP,1
GO:0021527,1,0.967682498,0,3,spinal cord association neuron differentiation,BP,1
GO:0021529,1,0.988662898,0,1,spinal cord oligodendrocyte cell differentiation,BP,1
GO:0021530,1,0.988662898,0,1,spinal cord oligodendrocyte cell fate specification,BP,1
GO:0021533,1,0.854239197,0,15,cell differentiation in hindbrain,BP,1
GO:0021534,1,0.91898467,0,8,cell proliferation in hindbrain,BP,1
GO:0021535,1,0.873555029,0,14,cell migration in hindbrain,BP,1
GO:0021538,1,0.988682981,0,1,epithalamus development,BP,1
GO:0021539,1,0.988662898,0,1,subthalamus development,BP,1
GO:0021540,1,0.94602231,0,5,corpus callosum morphogenesis,BP,1
GO:0021542,1,0.910358597,0,9,dentate gyrus development,BP,1
GO:0021543,1,0.23472374,0,136,pallium development,BP,1
GO:0021544,1,0.834268483,0,17,subpallium development,BP,1
GO:0021546,1,0.98866293,0,1,rhombomere development,BP,1
GO:0021547,1,0.98866293,0,1,midbrain-hindbrain boundary initiation,BP,1
GO:0021548,1,0.95757508,0,4,pons development,BP,1
GO:0021550,1,0.988662898,0,1,medulla oblongata development,BP,1
GO:0021553,1,0.953195134,0,5,olfactory nerve development,BP,1
GO:0021554,1,0.951146597,0,5,optic nerve development,BP,1
GO:0021559,1,0.967742331,0,3,trigeminal nerve development,BP,1
GO:0021560,1,0.98866293,0,1,abducens nerve development,BP,1
GO:0021561,1,0.949809994,0,5,facial nerve development,BP,1
GO:0021562,1,0.957884005,0,4,vestibulocochlear nerve development,BP,1
GO:0021563,1,0.995511004,0,1,glossopharyngeal nerve development,BP,1
GO:0021564,1,0.995511004,0,1,vagus nerve development,BP,1
GO:0021566,1,0.992337006,0,1,hypoglossal nerve development,BP,1
GO:0021571,1,0.98866293,0,1,rhombomere 5 development,BP,1
GO:0021572,1,0.98866293,0,1,rhombomere 6 development,BP,1
GO:0021577,1,0.977473059,0,2,hindbrain structural organization,BP,1
GO:0021578,1,0.982705011,0,2,hindbrain maturation,BP,1
GO:0021589,1,0.977473059,0,2,cerebellum structural organization,BP,1
GO:0021590,1,0.982705011,0,2,cerebellum maturation,BP,1
GO:0021591,1,0.820759114,0,19,ventricular system development,BP,1
GO:0021592,1,0.984539152,0,2,fourth ventricle development,BP,1
GO:0021598,1,0.98866293,0,1,abducens nerve morphogenesis,BP,1
GO:0021599,1,0.98866293,0,1,abducens nerve formation,BP,1
GO:0021602,1,0.898310402,0,10,cranial nerve morphogenesis,BP,1
GO:0021603,1,0.967624407,0,3,cranial nerve formation,BP,1
GO:0021604,1,0.946290874,0,5,cranial nerve structural organization,BP,1
GO:0021610,1,0.960700629,0,4,facial nerve morphogenesis,BP,1
GO:0021612,1,0.968121257,0,3,facial nerve structural organization,BP,1
GO:0021618,1,0.992337006,0,1,hypoglossal nerve morphogenesis,BP,1
GO:0021626,1,0.982705011,0,2,central nervous system maturation,BP,1
GO:0021627,1,0.988664587,0,1,olfactory nerve morphogenesis,BP,1
GO:0021629,1,0.988664587,0,1,olfactory nerve structural organization,BP,1
GO:0021631,1,0.98866449,0,1,optic nerve morphogenesis,BP,1
GO:0021633,1,0.98866449,0,1,optic nerve structural organization,BP,1
GO:0021636,1,0.978841472,0,2,trigeminal nerve morphogenesis,BP,1
GO:0021637,1,0.978841472,0,2,trigeminal nerve structural organization,BP,1
GO:0021648,1,0.957884005,0,4,vestibulocochlear nerve morphogenesis,BP,1
GO:0021649,1,0.978712453,0,2,vestibulocochlear nerve structural organization,BP,1
GO:0021650,1,0.978722147,0,2,vestibulocochlear nerve formation,BP,1
GO:0021670,1,0.913002132,0,9,lateral ventricle development,BP,1
GO:0021678,1,0.962338376,0,4,third ventricle development,BP,1
GO:0021681,1,0.902016907,0,10,cerebellar granular layer development,BP,1
GO:0021682,1,0.988662931,0,1,nerve maturation,BP,1
GO:0021683,1,0.921537664,0,8,cerebellar granular layer morphogenesis,BP,1
GO:0021684,1,0.932110984,0,7,cerebellar granular layer formation,BP,1
GO:0021691,1,0.982705011,0,2,cerebellar Purkinje cell layer maturation,BP,1
GO:0021694,1,0.911301833,0,9,cerebellar Purkinje cell layer formation,BP,1
GO:0021699,1,0.982705011,0,2,cerebellar cortex maturation,BP,1
GO:0021702,1,0.921758652,0,8,cerebellar Purkinje cell differentiation,BP,1
GO:0021707,1,0.932110984,0,7,cerebellar granule cell differentiation,BP,1
GO:0021730,1,0.977453515,0,2,trigeminal sensory nucleus development,BP,1
GO:0021740,1,0.977453515,0,2,principal sensory nucleus of trigeminal nerve development,BP,1
GO:0021747,1,0.979666917,0,2,cochlear nucleus development,BP,1
GO:0021750,1,0.988662898,0,1,vestibular nucleus development,BP,1
GO:0021756,1,0.843848207,0,16,striatum development,BP,1
GO:0021759,1,0.988664263,0,1,globus pallidus development,BP,1
GO:0021761,1,0.416780689,0,81,limbic system development,BP,1
GO:0021762,1,0.988930324,0,1,substantia nigra development,BP,1
GO:0021764,1,0.975943806,0,3,amygdala development,BP,1
GO:0021766,1,0.483993828,0,67,hippocampus development,BP,1
GO:0021767,1,0.989332177,0,1,mammillary body development,BP,1
GO:0021768,1,0.988662893,0,1,nucleus accumbens development,BP,1
GO:0021769,1,0.964065353,0,4,orbitofrontal cortex development,BP,1
GO:0021772,1,0.787156153,0,23,olfactory bulb development,BP,1
GO:0021773,1,0.981975791,0,2,striatal medium spiny neuron differentiation,BP,1
GO:0021778,1,0.977497637,0,2,oligodendrocyte cell fate specification,BP,1
GO:0021779,1,0.977497637,0,2,oligodendrocyte cell fate commitment,BP,1
GO:0021780,1,0.977497637,0,2,glial cell fate specification,BP,1
GO:0021781,1,0.906608065,0,9,glial cell fate commitment,BP,1
GO:0021785,1,0.976250363,0,3,branchiomotor neuron axon guidance,BP,1
GO:0021794,1,0.914980766,0,8,thalamus development,BP,1
GO:0021795,1,0.721652638,0,31,cerebral cortex cell migration,BP,1
GO:0021796,1,0.966370464,0,3,cerebral cortex regionalization,BP,1
GO:0021798,1,0.977454692,0,2,forebrain dorsal/ventral pattern formation,BP,1
GO:0021799,1,0.803159215,0,21,cerebral cortex radially oriented cell migration,BP,1
GO:0021800,1,0.963844193,0,4,cerebral cortex tangential migration,BP,1
GO:0021801,1,0.867608416,0,14,cerebral cortex radial glia guided migration,BP,1
GO:0021812,1,0.98055326,0,2,neuronal-glial interaction involved in cerebral cortex radial glia guided migration,BP,1
GO:0021813,1,0.98866292,0,1,cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration,BP,1
GO:0021814,1,0.94868162,0,5,cell motility involved in cerebral cortex radial glia guided migration,BP,1
GO:0021815,1,0.966919173,0,3,modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration,BP,1
GO:0021816,1,0.989224764,0,1,extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration,BP,1
GO:0021817,1,0.977453375,0,2,nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration,BP,1
GO:0021819,1,0.923905748,0,8,layer formation in cerebral cortex,BP,1
GO:0021822,1,0.988662931,0,1,negative regulation of cell motility involved in cerebral cortex radial glia guided migration,BP,1
GO:0021823,1,0.988673601,0,1,cerebral cortex tangential migration using cell-cell interactions,BP,1
GO:0021824,1,0.978712453,0,2,cerebral cortex tangential migration using cell-axon interactions,BP,1
GO:0021825,1,0.967625268,0,3,substrate-dependent cerebral cortex tangential migration,BP,1
GO:0021826,1,0.967218238,0,3,substrate-independent telencephalic tangential migration,BP,1
GO:0021827,1,0.988673601,0,1,postnatal olfactory bulb interneuron migration,BP,1
GO:0021828,1,0.978712453,0,2,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,BP,1
GO:0021830,1,0.978311635,0,2,interneuron migration from the subpallium to the cortex,BP,1
GO:0021831,1,0.988662649,0,1,embryonic olfactory bulb interneuron precursor migration,BP,1
GO:0021837,1,0.988673601,0,1,motogenic signaling involved in postnatal olfactory bulb interneuron migration,BP,1
GO:0021840,1,0.98897287,0,1,directional guidance of interneurons involved in migration from the subpallium to the cortex,BP,1
GO:0021842,1,0.98897287,0,1,chemorepulsion involved in interneuron migration from the subpallium to the cortex,BP,1
GO:0021843,1,0.967218238,0,3,substrate-independent telencephalic tangential interneuron migration,BP,1
GO:0021846,1,0.854978738,0,16,cell proliferation in forebrain,BP,1
GO:0021847,1,0.978947569,0,2,ventricular zone neuroblast division,BP,1
GO:0021849,1,0.980042973,0,2,neuroblast division in subventricular zone,BP,1
GO:0021854,1,0.894218539,0,11,hypothalamus development,BP,1
GO:0021855,1,0.978712453,0,2,hypothalamus cell migration,BP,1
GO:0021856,1,0.978712453,0,2,hypothalamic tangential migration using cell-axon interactions,BP,1
GO:0021859,1,0.947548156,0,5,pyramidal neuron differentiation,BP,1
GO:0021860,1,0.947548156,0,5,pyramidal neuron development,BP,1
GO:0021869,1,0.970451325,0,3,forebrain ventricular zone progenitor cell division,BP,1
GO:0021870,1,0.988662884,0,1,Cajal-Retzius cell differentiation,BP,1
GO:0021871,1,0.923270728,0,7,forebrain regionalization,BP,1
GO:0021873,1,0.946171287,0,6,forebrain neuroblast division,BP,1
GO:0021874,1,0.990997407,0,1,Wnt signaling pathway involved in forebrain neuroblast division,BP,1
GO:0021877,1,0.94514255,0,5,forebrain neuron fate commitment,BP,1
GO:0021882,1,0.988662931,0,1,regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment,BP,1
GO:0021884,1,0.854558059,0,15,forebrain neuron development,BP,1
GO:0021885,1,0.660530212,0,39,forebrain cell migration,BP,1
GO:0021886,1,0.967614466,0,3,hypothalamus gonadotrophin-releasing hormone neuron differentiation,BP,1
GO:0021888,1,0.967614466,0,3,hypothalamus gonadotrophin-releasing hormone neuron development,BP,1
GO:0021889,1,0.940261088,0,6,olfactory bulb interneuron differentiation,BP,1
GO:0021891,1,0.961058687,0,4,olfactory bulb interneuron development,BP,1
GO:0021892,1,0.966370903,0,3,cerebral cortex GABAergic interneuron differentiation,BP,1
GO:0021894,1,0.988662649,0,1,cerebral cortex GABAergic interneuron development,BP,1
GO:0021895,1,0.873120843,0,12,cerebral cortex neuron differentiation,BP,1
GO:0021896,1,0.983288394,0,2,forebrain astrocyte differentiation,BP,1
GO:0021897,1,0.983288394,0,2,forebrain astrocyte development,BP,1
GO:0021898,1,0.988662931,0,1,commitment of multipotent stem cells to neuronal lineage in forebrain,BP,1
GO:0021902,1,0.966948497,0,3,commitment of neuronal cell to specific neuron type in forebrain,BP,1
GO:0021904,1,0.824901072,0,17,dorsal/ventral neural tube patterning,BP,1
GO:0021910,1,0.966374355,0,3,smoothened signaling pathway involved in ventral spinal cord patterning,BP,1
GO:0021914,1,0.966693309,0,3,negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning,BP,1
GO:0021919,1,0.988993731,0,1,BMP signaling pathway involved in spinal cord dorsal/ventral patterning,BP,1
GO:0021924,1,0.929528932,0,7,cell proliferation in external granule layer,BP,1
GO:0021930,1,0.929528932,0,7,cerebellar granule cell precursor proliferation,BP,1
GO:0021932,1,0.896463095,0,11,hindbrain radial glia guided cell migration,BP,1
GO:0021933,1,0.990781668,0,1,radial glia guided migration of cerebellar granule cell,BP,1
GO:0021934,1,0.984353136,0,2,hindbrain tangential cell migration,BP,1
GO:0021935,1,0.984353136,0,2,cerebellar granule cell precursor tangential migration,BP,1
GO:0021936,1,0.957222279,0,4,regulation of cerebellar granule cell precursor proliferation,BP,1
GO:0021937,1,0.988667479,0,1,cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation,BP,1
GO:0021938,1,0.988667479,0,1,smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation,BP,1
GO:0021940,1,0.957222279,0,4,positive regulation of cerebellar granule cell precursor proliferation,BP,1
GO:0021942,1,0.938463231,0,6,radial glia guided migration of Purkinje cell,BP,1
GO:0021943,1,0.964158615,0,4,formation of radial glial scaffolds,BP,1
GO:0021952,1,0.897805901,0,11,central nervous system projection neuron axonogenesis,BP,1
GO:0021954,1,0.603619336,0,48,central nervous system neuron development,BP,1
GO:0021955,1,0.79587305,0,22,central nervous system neuron axonogenesis,BP,1
GO:0021956,1,0.988662931,0,1,central nervous system interneuron axonogenesis,BP,1
GO:0021957,1,0.970560351,0,3,corticospinal tract morphogenesis,BP,1
GO:0021960,1,0.97747374,0,2,anterior commissure morphogenesis,BP,1
GO:0021965,1,0.992337006,0,1,spinal cord ventral commissure morphogenesis,BP,1
GO:0021966,1,0.9886629,0,1,corticospinal neuron axon guidance,BP,1
GO:0021978,1,0.944576091,0,5,telencephalon regionalization,BP,1
GO:0021979,1,0.967614466,0,3,hypothalamus cell differentiation,BP,1
GO:0021986,1,0.988682981,0,1,habenula development,BP,1
GO:0021987,1,0.375703866,0,93,cerebral cortex development,BP,1
GO:0021988,1,0.783548262,0,24,olfactory lobe development,BP,1
GO:0021990,1,0.995425369,0,1,neural plate formation,BP,1
GO:0021993,1,0.991010551,0,1,initiation of neural tube closure,BP,1
GO:0021995,1,0.990333291,0,1,neuropore closure,BP,1
GO:0021997,1,0.978877008,0,2,neural plate axis specification,BP,1
GO:0021998,1,0.988901531,0,1,neural plate mediolateral regionalization,BP,1
GO:0021999,1,0.966950143,0,3,neural plate anterior/posterior regionalization,BP,1
GO:0022007,1,0.988793062,0,1,convergent extension involved in neural plate elongation,BP,1
GO:0022009,1,0.968172695,0,3,central nervous system vasculogenesis,BP,1
GO:0022010,1,0.885565008,0,11,central nervous system myelination,BP,1
GO:0022011,1,0.808692158,0,20,myelination in peripheral nervous system,BP,1
GO:0022027,1,0.935065871,0,7,interkinetic nuclear migration,BP,1
GO:0022028,1,0.945717912,0,5,tangential migration from the subventricular zone to the olfactory bulb,BP,1
GO:0022029,1,0.675265077,0,37,telencephalon cell migration,BP,1
GO:0022030,1,0.867608416,0,14,telencephalon glial cell migration,BP,1
GO:0022038,1,0.89025809,0,11,corpus callosum development,BP,1
GO:0022401,1,0.875100881,0,12,negative adaptation of signaling pathway,BP,1
GO:0022406,1,0.514426936,0,60,membrane docking,BP,1
GO:0022417,1,0.944575417,0,5,protein maturation by protein folding,BP,1
GO:0022605,1,0.977453101,0,2,mammalian oogenesis stage,BP,1
GO:0022612,1,0.348468114,0,99,gland morphogenesis,BP,1
GO:0022614,1,0.946401307,0,5,membrane to membrane docking,BP,1
GO:0022615,1,0.966374957,0,3,protein to membrane docking,BP,1
GO:0022617,1,0.844440989,0,16,extracellular matrix disassembly,BP,1
GO:0022898,1,0.296392808,0,114,regulation of transmembrane transporter activity,BP,1
GO:0022900,1,0.320297696,0,100,electron transport chain,BP,1
GO:0022904,1,0.498587835,0,61,respiratory electron transport chain,BP,1
GO:0023016,1,0.983633866,0,2,signal transduction by trans-phosphorylation,BP,1
GO:0023019,1,0.888157475,0,11,signal transduction involved in regulation of gene expression,BP,1
GO:0023021,1,0.957925899,0,4,termination of signal transduction,BP,1
GO:0023035,1,0.966796489,0,3,CD40 signaling pathway,BP,1
GO:0023041,1,0.977453373,0,2,neuronal signal transduction,BP,1
GO:0023058,1,0.865169255,0,13,adaptation of signaling pathway,BP,1
GO:0030002,1,0.91491485,0,8,cellular anion homeostasis,BP,1
GO:0030007,1,0.936152528,0,6,cellular potassium ion homeostasis,BP,1
GO:0030011,1,0.878257081,0,13,maintenance of cell polarity,BP,1
GO:0030026,1,0.990688607,0,1,cellular manganese ion homeostasis,BP,1
GO:0030032,1,0.577464442,0,50,lamellipodium assembly,BP,1
GO:0030033,1,0.89504084,0,11,microvillus assembly,BP,1
GO:0030035,1,0.977579984,0,2,microspike assembly,BP,1
GO:0030038,1,0.477252829,0,68,contractile actin filament bundle assembly,BP,1
GO:0030042,1,0.674398828,0,37,actin filament depolymerization,BP,1
GO:0030043,1,0.955582031,0,4,actin filament fragmentation,BP,1
GO:0030046,1,0.98016968,0,2,parallel actin filament bundle assembly,BP,1
GO:0030047,1,0.955735266,0,4,actin modification,BP,1
GO:0030048,1,0.530939912,0,60,actin filament-based movement,BP,1
GO:0030049,1,0.977493581,0,2,muscle filament sliding,BP,1
GO:0030050,1,0.957137114,0,4,vesicle transport along actin filament,BP,1
GO:0030070,1,0.988662931,0,1,insulin processing,BP,1
GO:0030091,1,0.955410852,0,4,protein repair,BP,1
GO:0030101,1,0.62433953,0,42,natural killer cell activation,BP,1
GO:0030148,1,0.597678536,0,46,sphingolipid biosynthetic process,BP,1
GO:0030149,1,0.774451492,0,23,sphingolipid catabolic process,BP,1
GO:0030150,1,0.833138013,0,16,protein import into mitochondrial matrix,BP,1
GO:0030157,1,0.910340222,0,9,pancreatic juice secretion,BP,1
GO:0030166,1,0.701855123,0,32,proteoglycan biosynthetic process,BP,1
GO:0030167,1,0.979150661,0,2,proteoglycan catabolic process,BP,1
GO:0030174,1,0.955780999,0,4,regulation of DNA-dependent DNA replication initiation,BP,1
GO:0030185,1,0.988691255,0,1,nitric oxide transport,BP,1
GO:0030193,1,0.505501875,0,61,regulation of blood coagulation,BP,1
GO:0030194,1,0.79133605,0,21,positive regulation of blood coagulation,BP,1
GO:0030195,1,0.65206955,0,38,negative regulation of blood coagulation,BP,1
GO:0030198,1,0.189433522,0,155,extracellular matrix organization,BP,1
GO:0030199,1,0.733522867,0,30,collagen fibril organization,BP,1
GO:0030200,1,0.988662878,0,1,heparan sulfate proteoglycan catabolic process,BP,1
GO:0030201,1,0.801409636,0,20,heparan sulfate proteoglycan metabolic process,BP,1
GO:0030202,1,0.947190265,0,5,heparin metabolic process,BP,1
GO:0030204,1,0.866529705,0,13,chondroitin sulfate metabolic process,BP,1
GO:0030205,1,0.967579983,0,3,dermatan sulfate metabolic process,BP,1
GO:0030206,1,0.9036442,0,9,chondroitin sulfate biosynthetic process,BP,1
GO:0030208,1,0.978654088,0,2,dermatan sulfate biosynthetic process,BP,1
GO:0030209,1,0.988686295,0,1,dermatan sulfate catabolic process,BP,1
GO:0030210,1,0.967856818,0,3,heparin biosynthetic process,BP,1
GO:0030211,1,0.988686295,0,1,heparin catabolic process,BP,1
GO:0030213,1,0.909665281,0,9,hyaluronan biosynthetic process,BP,1
GO:0030214,1,0.934865792,0,6,hyaluronan catabolic process,BP,1
GO:0030216,1,0.611077651,0,46,keratinocyte differentiation,BP,1
GO:0030219,1,0.688765473,0,34,megakaryocyte differentiation,BP,1
GO:0030220,1,0.838283347,0,16,platelet formation,BP,1
GO:0030221,1,0.990005605,0,1,basophil differentiation,BP,1
GO:0030222,1,0.97788746,0,2,eosinophil differentiation,BP,1
GO:0030223,1,0.946636334,0,5,neutrophil differentiation,BP,1
GO:0030237,1,0.98866283,0,1,female sex determination,BP,1
GO:0030238,1,0.951490778,0,5,male sex determination,BP,1
GO:0030239,1,0.702129787,0,33,myofibril assembly,BP,1
GO:0030240,1,0.989874949,0,1,skeletal muscle thin filament assembly,BP,1
GO:0030242,1,0.950913342,0,5,autophagy of peroxisome,BP,1
GO:0030252,1,0.889281857,0,12,growth hormone secretion,BP,1
GO:0030259,1,0.913391049,0,8,lipid glycosylation,BP,1
GO:0030260,1,0.539299437,0,55,entry into host cell,BP,1
GO:0030277,1,0.913767837,0,8,maintenance of gastrointestinal epithelium,BP,1
GO:0030299,1,0.904044626,0,9,intestinal cholesterol absorption,BP,1
GO:0030300,1,0.924748306,0,7,regulation of intestinal cholesterol absorption,BP,1
GO:0030309,1,0.97756812,0,2,poly-N-acetyllactosamine metabolic process,BP,1
GO:0030311,1,0.97756812,0,2,poly-N-acetyllactosamine biosynthetic process,BP,1
GO:0030318,1,0.831576523,0,17,melanocyte differentiation,BP,1
GO:0030320,1,0.91491485,0,8,cellular monovalent inorganic anion homeostasis,BP,1
GO:0030322,1,0.977933322,0,2,stabilization of membrane potential,BP,1
GO:0030325,1,0.777218611,0,24,adrenal gland development,BP,1
GO:0030327,1,0.977453948,0,2,prenylated protein catabolic process,BP,1
GO:0030328,1,0.988663345,0,1,prenylcysteine catabolic process,BP,1
GO:0030329,1,0.988663345,0,1,prenylcysteine metabolic process,BP,1
GO:0030382,1,0.966779285,0,3,sperm mitochondrion organization,BP,1
GO:0030388,1,0.923418981,0,7,"fructose 1,6-bisphosphate metabolic process",BP,1
GO:0030389,1,0.977453035,0,2,fructosamine metabolic process,BP,1
GO:0030421,1,0.988662435,0,1,defecation,BP,1
GO:0030422,1,0.934254863,0,6,production of siRNA involved in RNA interference,BP,1
GO:0030423,1,0.956697203,0,4,targeting of mRNA for destruction involved in RNA interference,BP,1
GO:0030432,1,0.956338352,0,4,peristalsis,BP,1
GO:0030449,1,0.849545562,0,15,regulation of complement activation,BP,1
GO:0030450,1,0.97745511,0,2,"regulation of complement activation, classical pathway",BP,1
GO:0030451,1,0.988662884,0,1,"regulation of complement activation, alternative pathway",BP,1
GO:0030473,1,0.944878173,0,5,nuclear migration along microtubule,BP,1
GO:0030474,1,0.979108385,0,2,spindle pole body duplication,BP,1
GO:0030488,1,0.711413812,0,30,tRNA methylation,BP,1
GO:0030490,1,0.650450211,0,38,maturation of SSU-rRNA,BP,1
GO:0030497,1,0.903536739,0,9,fatty acid elongation,BP,1
GO:0030501,1,0.751249865,0,26,positive regulation of bone mineralization,BP,1
GO:0030505,1,0.977512508,0,2,inorganic diphosphate transport,BP,1
GO:0030511,1,0.76311016,0,25,positive regulation of transforming growth factor beta receptor signaling pathway,BP,1
GO:0030514,1,0.75756318,0,27,negative regulation of BMP signaling pathway,BP,1
GO:0030517,1,0.776405554,0,25,negative regulation of axon extension,BP,1
GO:0030520,1,0.694897369,0,33,intracellular estrogen receptor signaling pathway,BP,1
GO:0030534,1,0.416628219,0,82,adult behavior,BP,1
GO:0030538,1,0.967344673,0,3,embryonic genitalia morphogenesis,BP,1
GO:0030539,1,0.887718227,0,11,male genitalia development,BP,1
GO:0030540,1,0.886487287,0,12,female genitalia development,BP,1
GO:0030573,1,0.988921227,0,1,bile acid catabolic process,BP,1
GO:0030574,1,0.845064572,0,15,collagen catabolic process,BP,1
GO:0030575,1,0.87498924,0,12,nuclear body organization,BP,1
GO:0030576,1,0.955620462,0,4,Cajal body organization,BP,1
GO:0030578,1,0.936000238,0,6,PML body organization,BP,1
GO:0030579,1,0.948380455,0,5,ubiquitin-dependent SMAD protein catabolic process,BP,1
GO:0030581,1,0.988662598,0,1,symbiont intracellular protein transport in host,BP,1
GO:0030592,1,0.966927832,0,3,DNA ADP-ribosylation,BP,1
GO:0030593,1,0.522972623,0,58,neutrophil chemotaxis,BP,1
GO:0030638,1,0.933862959,0,6,polyketide metabolic process,BP,1
GO:0030643,1,0.955969757,0,4,cellular phosphate ion homeostasis,BP,1
GO:0030644,1,0.957069312,0,4,cellular chloride ion homeostasis,BP,1
GO:0030647,1,0.933862959,0,6,aminoglycoside antibiotic metabolic process,BP,1
GO:0030653,1,0.988662911,0,1,beta-lactam antibiotic metabolic process,BP,1
GO:0030656,1,0.912794796,0,8,regulation of vitamin metabolic process,BP,1
GO:0030682,1,0.988662831,0,1,evasion or tolerance of host defense response,BP,1
GO:0030683,1,0.988662831,0,1,evasion or tolerance by virus of host immune response,BP,1
GO:0030702,1,0.9680097,0,3,chromatin silencing at centromere,BP,1
GO:0030704,1,0.988663811,0,1,vitelline membrane formation,BP,1
GO:0030718,1,0.983996803,0,2,germ-line stem cell population maintenance,BP,1
GO:0030730,1,0.864648261,0,13,sequestering of triglyceride,BP,1
GO:0030834,1,0.705201199,0,33,regulation of actin filament depolymerization,BP,1
GO:0030835,1,0.767141667,0,25,negative regulation of actin filament depolymerization,BP,1
GO:0030836,1,0.908985836,0,9,positive regulation of actin filament depolymerization,BP,1
GO:0030837,1,0.691130038,0,34,negative regulation of actin filament polymerization,BP,1
GO:0030845,1,0.988662918,0,1,phospholipase C-inhibiting G protein-coupled receptor signaling pathway,BP,1
GO:0030846,1,0.988662931,0,1,"termination of RNA polymerase II transcription, poly(A)-coupled",BP,1
GO:0030851,1,0.757888659,0,25,granulocyte differentiation,BP,1
GO:0030852,1,0.874386496,0,12,regulation of granulocyte differentiation,BP,1
GO:0030853,1,0.915223872,0,8,negative regulation of granulocyte differentiation,BP,1
GO:0030854,1,0.944575634,0,5,positive regulation of granulocyte differentiation,BP,1
GO:0030858,1,0.690985935,0,34,positive regulation of epithelial cell differentiation,BP,1
GO:0030859,1,0.845559358,0,16,polarized epithelial cell differentiation,BP,1
GO:0030860,1,0.97768994,0,2,regulation of polarized epithelial cell differentiation,BP,1
GO:0030862,1,0.97768994,0,2,positive regulation of polarized epithelial cell differentiation,BP,1
GO:0030865,1,0.677398865,0,36,cortical cytoskeleton organization,BP,1
GO:0030866,1,0.708455948,0,32,cortical actin cytoskeleton organization,BP,1
GO:0030878,1,0.864919775,0,13,thyroid gland development,BP,1
GO:0030885,1,0.977453259,0,2,regulation of myeloid dendritic cell activation,BP,1
GO:0030886,1,0.988662813,0,1,negative regulation of myeloid dendritic cell activation,BP,1
GO:0030889,1,0.873644265,0,13,negative regulation of B cell proliferation,BP,1
GO:0030908,1,0.988663811,0,1,protein splicing,BP,1
GO:0030910,1,0.988683913,0,1,olfactory placode formation,BP,1
GO:0030913,1,0.966369786,0,3,paranodal junction assembly,BP,1
GO:0030916,1,0.978937003,0,2,otic vesicle formation,BP,1
GO:0030920,1,0.977453363,0,2,peptidyl-serine acetylation,BP,1
GO:0030948,1,0.899358008,0,10,negative regulation of vascular endothelial growth factor receptor signaling pathway,BP,1
GO:0030950,1,0.862495869,0,13,establishment or maintenance of actin cytoskeleton polarity,BP,1
GO:0030951,1,0.96655612,0,3,establishment or maintenance of microtubule cytoskeleton polarity,BP,1
GO:0030952,1,0.833617087,0,16,establishment or maintenance of cytoskeleton polarity,BP,1
GO:0030953,1,0.900090015,0,10,astral microtubule organization,BP,1
GO:0030961,1,0.988662931,0,1,peptidyl-arginine hydroxylation,BP,1
GO:0030970,1,0.753161181,0,25,"retrograde protein transport, ER to cytosol",BP,1
GO:0030974,1,0.977454162,0,2,thiamine pyrophosphate transmembrane transport,BP,1
GO:0030997,1,0.977456614,0,2,regulation of centriole-centriole cohesion,BP,1
GO:0031000,1,0.805132469,0,20,response to caffeine,BP,1
GO:0031001,1,0.988662931,0,1,response to brefeldin A,BP,1
GO:0031017,1,0.947125402,0,5,exocrine pancreas development,BP,1
GO:0031022,1,0.988662931,0,1,nuclear migration along microfilament,BP,1
GO:0031032,1,0.282923541,0,117,actomyosin structure organization,BP,1
GO:0031033,1,0.966792142,0,3,myosin filament organization,BP,1
GO:0031034,1,0.989094854,0,1,myosin filament assembly,BP,1
GO:0031038,1,0.977453347,0,2,myosin II filament organization,BP,1
GO:0031048,1,0.967306336,0,3,chromatin silencing by small RNA,BP,1
GO:0031053,1,0.9354731,0,6,primary miRNA processing,BP,1
GO:0031054,1,0.872626859,0,12,pre-miRNA processing,BP,1
GO:0031055,1,0.933910052,0,6,chromatin remodeling at centromere,BP,1
GO:0031057,1,0.691194691,0,34,negative regulation of histone modification,BP,1
GO:0031060,1,0.561865975,0,54,regulation of histone methylation,BP,1
GO:0031061,1,0.823201191,0,18,negative regulation of histone methylation,BP,1
GO:0031062,1,0.710036907,0,32,positive regulation of histone methylation,BP,1
GO:0031064,1,0.977457635,0,2,negative regulation of histone deacetylation,BP,1
GO:0031069,1,0.860390473,0,14,hair follicle morphogenesis,BP,1
GO:0031076,1,0.780827189,0,24,embryonic camera-type eye development,BP,1
GO:0031081,1,0.977453375,0,2,nuclear pore distribution,BP,1
GO:0031086,1,0.935738232,0,6,"nuclear-transcribed mRNA catabolic process, deadenylation-independent decay",BP,1
GO:0031087,1,0.946438283,0,5,deadenylation-independent decapping of nuclear-transcribed mRNA,BP,1
GO:0031104,1,0.977463188,0,2,dendrite regeneration,BP,1
GO:0031114,1,0.782359735,0,25,regulation of microtubule depolymerization,BP,1
GO:0031117,1,0.979083146,0,2,positive regulation of microtubule depolymerization,BP,1
GO:0031118,1,0.955410545,0,4,rRNA pseudouridine synthesis,BP,1
GO:0031119,1,0.955420449,0,4,tRNA pseudouridine synthesis,BP,1
GO:0031120,1,0.966369322,0,3,snRNA pseudouridine synthesis,BP,1
GO:0031122,1,0.655051815,0,42,cytoplasmic microtubule organization,BP,1
GO:0031123,1,0.386575995,0,85,RNA 3'-end processing,BP,1
GO:0031124,1,0.590522753,0,48,mRNA 3'-end processing,BP,1
GO:0031125,1,0.902438305,0,9,rRNA 3'-end processing,BP,1
GO:0031126,1,0.882075156,0,11,snoRNA 3'-end processing,BP,1
GO:0031128,1,0.838756637,0,17,developmental induction,BP,1
GO:0031129,1,0.98958645,0,1,inductive cell-cell signaling,BP,1
GO:0031133,1,0.988662931,0,1,regulation of axon diameter,BP,1
GO:0031134,1,0.96822409,0,3,sister chromatid biorientation,BP,1
GO:0031145,1,0.898683473,0,10,anaphase-promoting complex-dependent catabolic process,BP,1
GO:0031146,1,0.652696117,0,38,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,1
GO:0031161,1,0.971519084,0,3,phosphatidylinositol catabolic process,BP,1
GO:0031163,1,0.777961048,0,22,metallo-sulfur cluster assembly,BP,1
GO:0031167,1,0.823786839,0,17,rRNA methylation,BP,1
GO:0031179,1,0.978233681,0,2,peptide modification,BP,1
GO:0031204,1,0.947758249,0,5,"posttranslational protein targeting to membrane, translocation",BP,1
GO:0031223,1,0.970005681,0,4,auditory behavior,BP,1
GO:0031247,1,0.977453375,0,2,actin rod assembly,BP,1
GO:0031268,1,0.868335704,0,13,pseudopodium organization,BP,1
GO:0031269,1,0.878303373,0,12,pseudopodium assembly,BP,1
GO:0031270,1,0.988662931,0,1,pseudopodium retraction,BP,1
GO:0031272,1,0.898070106,0,10,regulation of pseudopodium assembly,BP,1
GO:0031274,1,0.898070106,0,10,positive regulation of pseudopodium assembly,BP,1
GO:0031279,1,0.851698483,0,16,regulation of cyclase activity,BP,1
GO:0031280,1,0.941553696,0,6,negative regulation of cyclase activity,BP,1
GO:0031281,1,0.894382359,0,11,positive regulation of cyclase activity,BP,1
GO:0031282,1,0.978768432,0,2,regulation of guanylate cyclase activity,BP,1
GO:0031284,1,0.978768432,0,2,positive regulation of guanylate cyclase activity,BP,1
GO:0031289,1,0.988757639,0,1,actin phosphorylation,BP,1
GO:0031291,1,0.966517028,0,3,Ran protein signal transduction,BP,1
GO:0031293,1,0.933935819,0,6,membrane protein intracellular domain proteolysis,BP,1
GO:0031294,1,0.836035339,0,16,lymphocyte costimulation,BP,1
GO:0031295,1,0.845635257,0,15,T cell costimulation,BP,1
GO:0031296,1,0.977453172,0,2,B cell costimulation,BP,1
GO:0031335,1,0.988662917,0,1,regulation of sulfur amino acid metabolic process,BP,1
GO:0031337,1,0.988662917,0,1,positive regulation of sulfur amino acid metabolic process,BP,1
GO:0031338,1,0.798035253,0,20,regulation of vesicle fusion,BP,1
GO:0031339,1,0.955926006,0,4,negative regulation of vesicle fusion,BP,1
GO:0031340,1,0.9234469,0,7,positive regulation of vesicle fusion,BP,1
GO:0031341,1,0.51187949,0,59,regulation of cell killing,BP,1
GO:0031342,1,0.817152373,0,18,negative regulation of cell killing,BP,1
GO:0031343,1,0.613977716,0,43,positive regulation of cell killing,BP,1
GO:0031365,1,0.79241937,0,21,N-terminal protein amino acid modification,BP,1
GO:0031392,1,0.912898907,0,8,regulation of prostaglandin biosynthetic process,BP,1
GO:0031393,1,0.988662931,0,1,negative regulation of prostaglandin biosynthetic process,BP,1
GO:0031394,1,0.933968114,0,6,positive regulation of prostaglandin biosynthetic process,BP,1
GO:0031424,1,0.955411112,0,4,keratinization,BP,1
GO:0031427,1,0.966369597,0,3,response to methotrexate,BP,1
GO:0031437,1,0.988662931,0,1,regulation of mRNA cleavage,BP,1
GO:0031439,1,0.988662931,0,1,positive regulation of mRNA cleavage,BP,1
GO:0031440,1,0.779004237,0,23,regulation of mRNA 3'-end processing,BP,1
GO:0031441,1,0.926264628,0,7,negative regulation of mRNA 3'-end processing,BP,1
GO:0031442,1,0.905214499,0,9,positive regulation of mRNA 3'-end processing,BP,1
GO:0031443,1,0.993265418,0,1,fast-twitch skeletal muscle fiber contraction,BP,1
GO:0031444,1,0.988662697,0,1,slow-twitch skeletal muscle fiber contraction,BP,1
GO:0031445,1,0.982129665,0,2,regulation of heterochromatin assembly,BP,1
GO:0031453,1,0.982129665,0,2,positive regulation of heterochromatin assembly,BP,1
GO:0031455,1,0.977883067,0,2,glycine betaine metabolic process,BP,1
GO:0031456,1,0.977883067,0,2,glycine betaine biosynthetic process,BP,1
GO:0031460,1,0.990454427,0,1,glycine betaine transport,BP,1
GO:0031468,1,0.88415224,0,11,nuclear envelope reassembly,BP,1
GO:0031494,1,0.988662931,0,1,regulation of mating type switching,BP,1
GO:0031497,1,0.532954603,0,58,chromatin assembly,BP,1
GO:0031498,1,0.889541877,0,11,chromatin disassembly,BP,1
GO:0031506,1,0.988662881,0,1,cell wall glycoprotein biosynthetic process,BP,1
GO:0031507,1,0.910029025,0,9,heterochromatin assembly,BP,1
GO:0031508,1,0.977453362,0,2,pericentric heterochromatin assembly,BP,1
GO:0031509,1,0.977453347,0,2,telomeric heterochromatin assembly,BP,1
GO:0031529,1,0.638673643,0,41,ruffle organization,BP,1
GO:0031532,1,0.420297621,0,80,actin cytoskeleton reorganization,BP,1
GO:0031536,1,0.977453277,0,2,positive regulation of exit from mitosis,BP,1
GO:0031547,1,0.960779936,0,4,brain-derived neurotrophic factor receptor signaling pathway,BP,1
GO:0031554,1,0.969348204,0,3,"regulation of DNA-templated transcription, termination",BP,1
GO:0031579,1,0.82933123,0,17,membrane raft organization,BP,1
GO:0031580,1,0.979444799,0,2,membrane raft distribution,BP,1
GO:0031581,1,0.982098622,0,4,hemidesmosome assembly,BP,1
GO:0031584,1,0.933869493,0,6,activation of phospholipase D activity,BP,1
GO:0031585,1,0.97298106,0,3,"regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity",BP,1
GO:0031587,1,0.984139748,0,2,"positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity",BP,1
GO:0031590,1,0.955411111,0,4,wybutosine metabolic process,BP,1
GO:0031591,1,0.955411111,0,4,wybutosine biosynthetic process,BP,1
GO:0031620,1,0.923354943,0,7,regulation of fever generation,BP,1
GO:0031622,1,0.933949137,0,6,positive regulation of fever generation,BP,1
GO:0031627,1,0.978484045,0,2,telomeric loop formation,BP,1
GO:0031629,1,0.903238519,0,9,synaptic vesicle fusion to presynaptic active zone membrane,BP,1
GO:0031630,1,0.966808579,0,3,regulation of synaptic vesicle fusion to presynaptic active zone membrane,BP,1
GO:0031635,1,0.988662931,0,1,adenylate cyclase-inhibiting opioid receptor signaling pathway,BP,1
GO:0031640,1,0.814381464,0,18,killing of cells of other organism,BP,1
GO:0031641,1,0.696478139,0,33,regulation of myelination,BP,1
GO:0031642,1,0.927226844,0,7,negative regulation of myelination,BP,1
GO:0031643,1,0.895126117,0,10,positive regulation of myelination,BP,1
GO:0031645,1,0.875851652,0,12,negative regulation of neurological system process,BP,1
GO:0031649,1,0.852926345,0,14,heat generation,BP,1
GO:0031650,1,0.892521215,0,10,regulation of heat generation,BP,1
GO:0031651,1,0.988662842,0,1,negative regulation of heat generation,BP,1
GO:0031652,1,0.913124151,0,8,positive regulation of heat generation,BP,1
GO:0031665,1,0.946862963,0,5,negative regulation of lipopolysaccharide-mediated signaling pathway,BP,1
GO:0031670,1,0.503290605,0,63,cellular response to nutrient,BP,1
GO:0031860,1,0.957986347,0,4,telomeric 3' overhang formation,BP,1
GO:0031914,1,0.981010036,0,2,negative regulation of synaptic plasticity,BP,1
GO:0031915,1,0.922848747,0,8,positive regulation of synaptic plasticity,BP,1
GO:0031930,1,0.988662931,0,1,mitochondria-nucleus signaling pathway,BP,1
GO:0031935,1,0.808724422,0,20,regulation of chromatin silencing,BP,1
GO:0031936,1,0.938242531,0,6,negative regulation of chromatin silencing,BP,1
GO:0031937,1,0.880431205,0,12,positive regulation of chromatin silencing,BP,1
GO:0031938,1,0.988662916,0,1,regulation of chromatin silencing at telomere,BP,1
GO:0031940,1,0.988662916,0,1,positive regulation of chromatin silencing at telomere,BP,1
GO:0031943,1,0.906980246,0,9,regulation of glucocorticoid metabolic process,BP,1
GO:0031944,1,0.945884259,0,5,negative regulation of glucocorticoid metabolic process,BP,1
GO:0031945,1,0.98866283,0,1,positive regulation of glucocorticoid metabolic process,BP,1
GO:0031946,1,0.917387949,0,8,regulation of glucocorticoid biosynthetic process,BP,1
GO:0031947,1,0.945884259,0,5,negative regulation of glucocorticoid biosynthetic process,BP,1
GO:0031948,1,0.98866283,0,1,positive regulation of glucocorticoid biosynthetic process,BP,1
GO:0031953,1,0.874245494,0,12,negative regulation of protein autophosphorylation,BP,1
GO:0031959,1,0.989438987,0,1,mineralocorticoid receptor signaling pathway,BP,1
GO:0031987,1,0.91343523,0,8,locomotion involved in locomotory behavior,BP,1
GO:0031990,1,0.982129546,0,2,mRNA export from nucleus in response to heat stress,BP,1
GO:0031998,1,0.841209877,0,17,regulation of fatty acid beta-oxidation,BP,1
GO:0031999,1,0.948806081,0,5,negative regulation of fatty acid beta-oxidation,BP,1
GO:0032000,1,0.912389197,0,9,positive regulation of fatty acid beta-oxidation,BP,1
GO:0032008,1,0.71938526,0,30,positive regulation of TOR signaling,BP,1
GO:0032011,1,0.84983664,0,15,ARF protein signal transduction,BP,1
GO:0032012,1,0.84983664,0,15,regulation of ARF protein signal transduction,BP,1
GO:0032013,1,0.988878261,0,1,negative regulation of ARF protein signal transduction,BP,1
GO:0032014,1,0.991182195,0,1,positive regulation of ARF protein signal transduction,BP,1
GO:0032020,1,0.94475798,0,5,ISG15-protein conjugation,BP,1
GO:0032025,1,0.835117936,0,16,response to cobalt ion,BP,1
GO:0032026,1,0.836237691,0,17,response to magnesium ion,BP,1
GO:0032048,1,0.902857997,0,9,cardiolipin metabolic process,BP,1
GO:0032049,1,0.923697438,0,7,cardiolipin biosynthetic process,BP,1
GO:0032053,1,0.971973635,0,3,ciliary basal body organization,BP,1
GO:0032056,1,0.933888462,0,6,positive regulation of translation in response to stress,BP,1
GO:0032057,1,0.966369348,0,3,negative regulation of translational initiation in response to stress,BP,1
GO:0032058,1,0.966369487,0,3,positive regulation of translational initiation in response to stress,BP,1
GO:0032060,1,0.890011679,0,11,bleb assembly,BP,1
GO:0032070,1,0.913173624,0,8,regulation of deoxyribonuclease activity,BP,1
GO:0032071,1,0.93390319,0,6,regulation of endodeoxyribonuclease activity,BP,1
GO:0032072,1,0.988663199,0,1,regulation of restriction endodeoxyribonuclease activity,BP,1
GO:0032074,1,0.924065264,0,7,negative regulation of nuclease activity,BP,1
GO:0032076,1,0.977815139,0,2,negative regulation of deoxyribonuclease activity,BP,1
GO:0032077,1,0.955453179,0,4,positive regulation of deoxyribonuclease activity,BP,1
GO:0032078,1,0.988662645,0,1,negative regulation of endodeoxyribonuclease activity,BP,1
GO:0032079,1,0.966412556,0,3,positive regulation of endodeoxyribonuclease activity,BP,1
GO:0032088,1,0.539098421,0,55,negative regulation of NF-kappaB transcription factor activity,BP,1
GO:0032091,1,0.400664783,0,82,negative regulation of protein binding,BP,1
GO:0032092,1,0.414016387,0,81,positive regulation of protein binding,BP,1
GO:0032095,1,0.918068237,0,8,regulation of response to food,BP,1
GO:0032096,1,0.934012565,0,6,negative regulation of response to food,BP,1
GO:0032097,1,0.988662504,0,1,positive regulation of response to food,BP,1
GO:0032098,1,0.912941771,0,8,regulation of appetite,BP,1
GO:0032099,1,0.934012565,0,6,negative regulation of appetite,BP,1
GO:0032100,1,0.988662504,0,1,positive regulation of appetite,BP,1
GO:0032104,1,0.869897922,0,13,regulation of response to extracellular stimulus,BP,1
GO:0032105,1,0.912942363,0,8,negative regulation of response to extracellular stimulus,BP,1
GO:0032106,1,0.977454031,0,2,positive regulation of response to extracellular stimulus,BP,1
GO:0032107,1,0.869897922,0,13,regulation of response to nutrient levels,BP,1
GO:0032108,1,0.912942363,0,8,negative regulation of response to nutrient levels,BP,1
GO:0032109,1,0.977454031,0,2,positive regulation of response to nutrient levels,BP,1
GO:0032119,1,0.959898117,0,4,sequestering of zinc ion,BP,1
GO:0032148,1,0.854977595,0,14,activation of protein kinase B activity,BP,1
GO:0032185,1,0.988662931,0,1,septin cytoskeleton organization,BP,1
GO:0032194,1,0.988798145,0,1,"ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate",BP,1
GO:0032196,1,0.904805231,0,9,transposition,BP,1
GO:0032197,1,0.934644168,0,6,"transposition, RNA-mediated",BP,1
GO:0032201,1,0.966369794,0,3,telomere maintenance via semi-conservative replication,BP,1
GO:0032202,1,0.955411062,0,4,telomere assembly,BP,1
GO:0032203,1,0.988662931,0,1,telomere formation via telomerase,BP,1
GO:0032204,1,0.442935341,0,74,regulation of telomere maintenance,BP,1
GO:0032205,1,0.690489141,0,34,negative regulation of telomere maintenance,BP,1
GO:0032206,1,0.600674685,0,47,positive regulation of telomere maintenance,BP,1
GO:0032207,1,0.988662931,0,1,regulation of telomere maintenance via recombination,BP,1
GO:0032208,1,0.988662931,0,1,negative regulation of telomere maintenance via recombination,BP,1
GO:0032210,1,0.593722886,0,47,regulation of telomere maintenance via telomerase,BP,1
GO:0032211,1,0.81464835,0,18,negative regulation of telomere maintenance via telomerase,BP,1
GO:0032212,1,0.734874653,0,28,positive regulation of telomere maintenance via telomerase,BP,1
GO:0032218,1,0.988662931,0,1,riboflavin transport,BP,1
GO:0032222,1,0.977464183,0,2,"regulation of synaptic transmission, cholinergic",BP,1
GO:0032224,1,0.977464183,0,2,"positive regulation of synaptic transmission, cholinergic",BP,1
GO:0032225,1,0.933926555,0,6,"regulation of synaptic transmission, dopaminergic",BP,1
GO:0032226,1,0.966369766,0,3,"positive regulation of synaptic transmission, dopaminergic",BP,1
GO:0032228,1,0.833233295,0,17,"regulation of synaptic transmission, GABAergic",BP,1
GO:0032229,1,0.957268244,0,4,"negative regulation of synaptic transmission, GABAergic",BP,1
GO:0032230,1,0.944704442,0,5,"positive regulation of synaptic transmission, GABAergic",BP,1
GO:0032231,1,0.466571025,0,71,regulation of actin filament bundle assembly,BP,1
GO:0032232,1,0.826491601,0,18,negative regulation of actin filament bundle assembly,BP,1
GO:0032233,1,0.613807498,0,45,positive regulation of actin filament bundle assembly,BP,1
GO:0032237,1,0.947406036,0,5,activation of store-operated calcium channel activity,BP,1
GO:0032240,1,0.985566418,0,2,negative regulation of nucleobase-containing compound transport,BP,1
GO:0032241,1,0.919198812,0,8,positive regulation of nucleobase-containing compound transport,BP,1
GO:0032242,1,0.988662779,0,1,regulation of nucleoside transport,BP,1
GO:0032244,1,0.988662779,0,1,positive regulation of nucleoside transport,BP,1
GO:0032252,1,0.922554842,0,8,secretory granule localization,BP,1
GO:0032253,1,0.95184242,0,5,dense core granule localization,BP,1
GO:0032258,1,0.977453375,0,2,protein localization by the Cvt pathway,BP,1
GO:0032261,1,0.934245623,0,6,purine nucleotide salvage,BP,1
GO:0032263,1,0.988662838,0,1,GMP salvage,BP,1
GO:0032264,1,0.966767186,0,3,IMP salvage,BP,1
GO:0032274,1,0.9343143,0,6,gonadotropin secretion,BP,1
GO:0032275,1,0.966837611,0,3,luteinizing hormone secretion,BP,1
GO:0032276,1,0.966370059,0,3,regulation of gonadotropin secretion,BP,1
GO:0032278,1,0.977453551,0,2,positive regulation of gonadotropin secretion,BP,1
GO:0032286,1,0.96636981,0,3,central nervous system myelin maintenance,BP,1
GO:0032287,1,0.935695842,0,6,peripheral nervous system myelin maintenance,BP,1
GO:0032288,1,0.868062519,0,13,myelin assembly,BP,1
GO:0032289,1,0.978051395,0,2,central nervous system myelin formation,BP,1
GO:0032290,1,0.971248168,0,3,peripheral nervous system myelin formation,BP,1
GO:0032291,1,0.885565008,0,11,axon ensheathment in central nervous system,BP,1
GO:0032292,1,0.808692158,0,20,peripheral nervous system axon ensheathment,BP,1
GO:0032298,1,0.977805054,0,2,positive regulation of DNA-dependent DNA replication initiation,BP,1
GO:0032304,1,0.979505135,0,2,negative regulation of icosanoid secretion,BP,1
GO:0032307,1,0.979505135,0,2,negative regulation of prostaglandin secretion,BP,1
GO:0032324,1,0.955424374,0,4,molybdopterin cofactor biosynthetic process,BP,1
GO:0032328,1,0.935687412,0,6,alanine transport,BP,1
GO:0032329,1,0.944591949,0,5,serine transport,BP,1
GO:0032330,1,0.735658151,0,28,regulation of chondrocyte differentiation,BP,1
GO:0032331,1,0.899176415,0,10,negative regulation of chondrocyte differentiation,BP,1
GO:0032332,1,0.863886213,0,13,positive regulation of chondrocyte differentiation,BP,1
GO:0032341,1,0.904092936,0,9,aldosterone metabolic process,BP,1
GO:0032342,1,0.904092936,0,9,aldosterone biosynthetic process,BP,1
GO:0032344,1,0.914467723,0,8,regulation of aldosterone metabolic process,BP,1
GO:0032345,1,0.956695069,0,4,negative regulation of aldosterone metabolic process,BP,1
GO:0032346,1,0.966573568,0,3,positive regulation of aldosterone metabolic process,BP,1
GO:0032347,1,0.914467723,0,8,regulation of aldosterone biosynthetic process,BP,1
GO:0032348,1,0.956695069,0,4,negative regulation of aldosterone biosynthetic process,BP,1
GO:0032349,1,0.966573568,0,3,positive regulation of aldosterone biosynthetic process,BP,1
GO:0032350,1,0.739367625,0,27,regulation of hormone metabolic process,BP,1
GO:0032351,1,0.924548282,0,7,negative regulation of hormone metabolic process,BP,1
GO:0032352,1,0.853191638,0,14,positive regulation of hormone metabolic process,BP,1
GO:0032353,1,0.924548282,0,7,negative regulation of hormone biosynthetic process,BP,1
GO:0032354,1,0.830633821,0,17,response to follicle-stimulating hormone,BP,1
GO:0032361,1,0.988662931,0,1,pyridoxal phosphate catabolic process,BP,1
GO:0032364,1,0.946430419,0,5,oxygen homeostasis,BP,1
GO:0032365,1,0.7565943,0,26,intracellular lipid transport,BP,1
GO:0032366,1,0.801070032,0,21,intracellular sterol transport,BP,1
GO:0032367,1,0.801070032,0,21,intracellular cholesterol transport,BP,1
GO:0032371,1,0.661541501,0,39,regulation of sterol transport,BP,1
GO:0032372,1,0.897737755,0,10,negative regulation of sterol transport,BP,1
GO:0032373,1,0.793767448,0,22,positive regulation of sterol transport,BP,1
GO:0032374,1,0.661541501,0,39,regulation of cholesterol transport,BP,1
GO:0032375,1,0.897737755,0,10,negative regulation of cholesterol transport,BP,1
GO:0032376,1,0.793767448,0,22,positive regulation of cholesterol transport,BP,1
GO:0032377,1,0.918842509,0,8,regulation of intracellular lipid transport,BP,1
GO:0032378,1,0.989039028,0,1,negative regulation of intracellular lipid transport,BP,1
GO:0032379,1,0.955762967,0,4,positive regulation of intracellular lipid transport,BP,1
GO:0032380,1,0.918842509,0,8,regulation of intracellular sterol transport,BP,1
GO:0032381,1,0.989039028,0,1,negative regulation of intracellular sterol transport,BP,1
GO:0032382,1,0.955762967,0,4,positive regulation of intracellular sterol transport,BP,1
GO:0032383,1,0.918842509,0,8,regulation of intracellular cholesterol transport,BP,1
GO:0032384,1,0.989039028,0,1,negative regulation of intracellular cholesterol transport,BP,1
GO:0032385,1,0.955762967,0,4,positive regulation of intracellular cholesterol transport,BP,1
GO:0032387,1,0.581584555,0,50,negative regulation of intracellular transport,BP,1
GO:0032388,1,0.182961067,0,155,positive regulation of intracellular transport,BP,1
GO:0032392,1,0.552886368,0,54,DNA geometric change,BP,1
GO:0032400,1,0.847700879,0,15,melanosome localization,BP,1
GO:0032401,1,0.867268017,0,13,establishment of melanosome localization,BP,1
GO:0032402,1,0.873494623,0,12,melanosome transport,BP,1
GO:0032409,1,0.268505034,0,123,regulation of transporter activity,BP,1
GO:0032410,1,0.654246281,0,40,negative regulation of transporter activity,BP,1
GO:0032411,1,0.577418004,0,52,positive regulation of transporter activity,BP,1
GO:0032412,1,0.310123596,0,110,regulation of ion transmembrane transporter activity,BP,1
GO:0032413,1,0.705328268,0,33,negative regulation of ion transmembrane transporter activity,BP,1
GO:0032414,1,0.618447571,0,46,positive regulation of ion transmembrane transporter activity,BP,1
GO:0032415,1,0.977453343,0,2,regulation of sodium:proton antiporter activity,BP,1
GO:0032416,1,0.988662899,0,1,negative regulation of sodium:proton antiporter activity,BP,1
GO:0032417,1,0.988662931,0,1,positive regulation of sodium:proton antiporter activity,BP,1
GO:0032418,1,0.572568558,0,50,lysosome localization,BP,1
GO:0032423,1,0.966630913,0,3,regulation of mismatch repair,BP,1
GO:0032425,1,0.977453661,0,2,positive regulation of mismatch repair,BP,1
GO:0032429,1,0.953062843,0,5,regulation of phospholipase A2 activity,BP,1
GO:0032430,1,0.977496657,0,2,positive regulation of phospholipase A2 activity,BP,1
GO:0032435,1,0.738420263,0,27,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,1
GO:0032438,1,0.880647312,0,12,melanosome organization,BP,1
GO:0032445,1,0.988662985,0,1,fructose import,BP,1
GO:0032447,1,0.955411236,0,4,protein urmylation,BP,1
GO:0032456,1,0.634439066,0,41,endocytic recycling,BP,1
GO:0032458,1,0.988662931,0,1,slow endocytic recycling,BP,1
GO:0032459,1,0.720225567,0,29,regulation of protein oligomerization,BP,1
GO:0032460,1,0.863403582,0,13,negative regulation of protein oligomerization,BP,1
GO:0032461,1,0.84391759,0,15,positive regulation of protein oligomerization,BP,1
GO:0032462,1,0.815502838,0,18,regulation of protein homooligomerization,BP,1
GO:0032463,1,0.893477951,0,10,negative regulation of protein homooligomerization,BP,1
GO:0032464,1,0.912803768,0,8,positive regulation of protein homooligomerization,BP,1
GO:0032465,1,0.541556938,0,58,regulation of cytokinesis,BP,1
GO:0032466,1,0.955411017,0,4,negative regulation of cytokinesis,BP,1
GO:0032467,1,0.801256042,0,21,positive regulation of cytokinesis,BP,1
GO:0032468,1,0.990688607,0,1,Golgi calcium ion homeostasis,BP,1
GO:0032469,1,0.795345273,0,21,endoplasmic reticulum calcium ion homeostasis,BP,1
GO:0032470,1,0.990155795,0,1,positive regulation of endoplasmic reticulum calcium ion concentration,BP,1
GO:0032471,1,0.924169875,0,7,negative regulation of endoplasmic reticulum calcium ion concentration,BP,1
GO:0032472,1,0.979456264,0,2,Golgi calcium ion transport,BP,1
GO:0032474,1,0.94457643,0,5,otolith morphogenesis,BP,1
GO:0032475,1,0.988663763,0,1,otolith formation,BP,1
GO:0032479,1,0.507787558,0,63,regulation of type I interferon production,BP,1
GO:0032480,1,0.806384705,0,20,negative regulation of type I interferon production,BP,1
GO:0032481,1,0.642066562,0,41,positive regulation of type I interferon production,BP,1
GO:0032483,1,0.947061499,0,5,regulation of Rab protein signal transduction,BP,1
GO:0032484,1,0.944667183,0,5,Ral protein signal transduction,BP,1
GO:0032485,1,0.966463552,0,3,regulation of Ral protein signal transduction,BP,1
GO:0032486,1,0.905864519,0,9,Rap protein signal transduction,BP,1
GO:0032487,1,0.988662919,0,1,regulation of Rap protein signal transduction,BP,1
GO:0032488,1,0.917281005,0,8,Cdc42 protein signal transduction,BP,1
GO:0032489,1,0.949216591,0,5,regulation of Cdc42 protein signal transduction,BP,1
GO:0032490,1,0.916151552,0,8,detection of molecule of bacterial origin,BP,1
GO:0032493,1,0.955492805,0,4,response to bacterial lipoprotein,BP,1
GO:0032494,1,0.892873567,0,10,response to peptidoglycan,BP,1
GO:0032495,1,0.853809477,0,15,response to muramyl dipeptide,BP,1
GO:0032497,1,0.977831861,0,2,detection of lipopolysaccharide,BP,1
GO:0032498,1,0.98918315,0,1,detection of muramyl dipeptide,BP,1
GO:0032499,1,0.98918315,0,1,detection of peptidoglycan,BP,1
GO:0032506,1,0.744695494,0,27,cytokinetic process,BP,1
GO:0032508,1,0.619849705,0,44,DNA duplex unwinding,BP,1
GO:0032509,1,0.781364001,0,22,endosome transport via multivesicular body sorting pathway,BP,1
GO:0032510,1,0.94490995,0,5,endosome to lysosome transport via multivesicular body sorting pathway,BP,1
GO:0032511,1,0.912794846,0,8,late endosome to vacuole transport via multivesicular body sorting pathway,BP,1
GO:0032515,1,0.714444964,0,31,negative regulation of phosphoprotein phosphatase activity,BP,1
GO:0032516,1,0.852116877,0,15,positive regulation of phosphoprotein phosphatase activity,BP,1
GO:0032525,1,0.933878413,0,6,somite rostral/caudal axis specification,BP,1
GO:0032527,1,0.652760465,0,38,protein exit from endoplasmic reticulum,BP,1
GO:0032528,1,0.874843435,0,13,microvillus organization,BP,1
GO:0032530,1,0.93988102,0,6,regulation of microvillus organization,BP,1
GO:0032532,1,0.977577143,0,2,regulation of microvillus length,BP,1
GO:0032534,1,0.961446098,0,4,regulation of microvillus assembly,BP,1
GO:0032536,1,0.966492285,0,3,regulation of cell projection size,BP,1
GO:0032543,1,0.493150738,0,62,mitochondrial translation,BP,1
GO:0032571,1,0.94808211,0,5,response to vitamin K,BP,1
GO:0032581,1,0.988662831,0,1,ER-dependent peroxisome organization,BP,1
GO:0032594,1,0.786734275,0,22,protein transport within lipid bilayer,BP,1
GO:0032595,1,0.988662929,0,1,B cell receptor transport within lipid bilayer,BP,1
GO:0032596,1,0.960055138,0,4,protein transport into membrane raft,BP,1
GO:0032597,1,0.988662929,0,1,B cell receptor transport into membrane raft,BP,1
GO:0032599,1,0.988662929,0,1,protein transport out of membrane raft,BP,1
GO:0032600,1,0.988662929,0,1,chemokine receptor transport out of membrane raft,BP,1
GO:0032601,1,0.990306596,0,1,connective tissue growth factor production,BP,1
GO:0032604,1,0.959462144,0,4,granulocyte macrophage colony-stimulating factor production,BP,1
GO:0032606,1,0.496277116,0,65,type I interferon production,BP,1
GO:0032607,1,0.782963754,0,23,interferon-alpha production,BP,1
GO:0032608,1,0.6453488,0,41,interferon-beta production,BP,1
GO:0032609,1,0.517645594,0,58,interferon-gamma production,BP,1
GO:0032610,1,0.945392614,0,5,interleukin-1 alpha production,BP,1
GO:0032611,1,0.552343737,0,53,interleukin-1 beta production,BP,1
GO:0032612,1,0.487333646,0,64,interleukin-1 production,BP,1
GO:0032615,1,0.699595939,0,32,interleukin-12 production,BP,1
GO:0032616,1,0.874209845,0,12,interleukin-13 production,BP,1
GO:0032618,1,0.988662931,0,1,interleukin-15 production,BP,1
GO:0032621,1,0.946423717,0,5,interleukin-18 production,BP,1
GO:0032623,1,0.604594819,0,45,interleukin-2 production,BP,1
GO:0032625,1,0.977479569,0,2,interleukin-21 production,BP,1
GO:0032627,1,0.945780181,0,5,interleukin-23 production,BP,1
GO:0032632,1,0.979990039,0,2,interleukin-3 production,BP,1
GO:0032633,1,0.807989127,0,20,interleukin-4 production,BP,1
GO:0032634,1,0.894353371,0,10,interleukin-5 production,BP,1
GO:0032638,1,0.988689163,0,1,interleukin-9 production,BP,1
GO:0032639,1,0.988702358,0,1,TRAIL production,BP,1
GO:0032643,1,0.990306596,0,1,regulation of connective tissue growth factor production,BP,1
GO:0032645,1,0.959462144,0,4,regulation of granulocyte macrophage colony-stimulating factor production,BP,1
GO:0032647,1,0.801056746,0,21,regulation of interferon-alpha production,BP,1
GO:0032648,1,0.6453488,0,41,regulation of interferon-beta production,BP,1
GO:0032649,1,0.548161869,0,53,regulation of interferon-gamma production,BP,1
GO:0032650,1,0.956237402,0,4,regulation of interleukin-1 alpha production,BP,1
GO:0032651,1,0.589195664,0,47,regulation of interleukin-1 beta production,BP,1
GO:0032652,1,0.525874222,0,57,regulation of interleukin-1 production,BP,1
GO:0032655,1,0.715745033,0,30,regulation of interleukin-12 production,BP,1
GO:0032656,1,0.884240541,0,11,regulation of interleukin-13 production,BP,1
GO:0032660,1,0.855261122,0,14,regulation of interleukin-17 production,BP,1
GO:0032661,1,0.968202936,0,3,regulation of interleukin-18 production,BP,1
GO:0032663,1,0.662529556,0,37,regulation of interleukin-2 production,BP,1
GO:0032667,1,0.945780181,0,5,regulation of interleukin-23 production,BP,1
GO:0032672,1,0.991228453,0,1,regulation of interleukin-3 production,BP,1
GO:0032673,1,0.83536819,0,16,regulation of interleukin-4 production,BP,1
GO:0032674,1,0.894353371,0,10,regulation of interleukin-5 production,BP,1
GO:0032679,1,0.988702358,0,1,regulation of TRAIL production,BP,1
GO:0032682,1,0.846851378,0,15,negative regulation of chemokine production,BP,1
GO:0032687,1,0.969277284,0,3,negative regulation of interferon-alpha production,BP,1
GO:0032688,1,0.873133749,0,13,negative regulation of interferon-beta production,BP,1
GO:0032689,1,0.806008283,0,19,negative regulation of interferon-gamma production,BP,1
GO:0032690,1,0.988839133,0,1,negative regulation of interleukin-1 alpha production,BP,1
GO:0032691,1,0.8722015,0,12,negative regulation of interleukin-1 beta production,BP,1
GO:0032692,1,0.815003982,0,18,negative regulation of interleukin-1 production,BP,1
GO:0032695,1,0.863497758,0,13,negative regulation of interleukin-12 production,BP,1
GO:0032696,1,0.978911992,0,2,negative regulation of interleukin-13 production,BP,1
GO:0032700,1,0.8947417,0,10,negative regulation of interleukin-17 production,BP,1
GO:0032701,1,0.98918315,0,1,negative regulation of interleukin-18 production,BP,1
GO:0032703,1,0.826422277,0,17,negative regulation of interleukin-2 production,BP,1
GO:0032707,1,0.977820857,0,2,negative regulation of interleukin-23 production,BP,1
GO:0032713,1,0.966369901,0,3,negative regulation of interleukin-4 production,BP,1
GO:0032714,1,0.990138142,0,1,negative regulation of interleukin-5 production,BP,1
GO:0032717,1,0.896874313,0,10,negative regulation of interleukin-8 production,BP,1
GO:0032723,1,0.990306596,0,1,positive regulation of connective tissue growth factor production,BP,1
GO:0032725,1,0.959462144,0,4,positive regulation of granulocyte macrophage colony-stimulating factor production,BP,1
GO:0032727,1,0.826486835,0,18,positive regulation of interferon-alpha production,BP,1
GO:0032728,1,0.744689474,0,27,positive regulation of interferon-beta production,BP,1
GO:0032729,1,0.688124582,0,33,positive regulation of interferon-gamma production,BP,1
GO:0032730,1,0.967033209,0,3,positive regulation of interleukin-1 alpha production,BP,1
GO:0032731,1,0.698542927,0,32,positive regulation of interleukin-1 beta production,BP,1
GO:0032732,1,0.675103335,0,35,positive regulation of interleukin-1 production,BP,1
GO:0032733,1,0.815120254,0,18,positive regulation of interleukin-10 production,BP,1
GO:0032735,1,0.836787433,0,16,positive regulation of interleukin-12 production,BP,1
GO:0032736,1,0.903304782,0,9,positive regulation of interleukin-13 production,BP,1
GO:0032740,1,0.945072079,0,5,positive regulation of interleukin-17 production,BP,1
GO:0032741,1,0.978792191,0,2,positive regulation of interleukin-18 production,BP,1
GO:0032743,1,0.785562708,0,22,positive regulation of interleukin-2 production,BP,1
GO:0032747,1,0.978331737,0,2,positive regulation of interleukin-23 production,BP,1
GO:0032752,1,0.991228453,0,1,positive regulation of interleukin-3 production,BP,1
GO:0032753,1,0.874397609,0,12,positive regulation of interleukin-4 production,BP,1
GO:0032754,1,0.903268498,0,9,positive regulation of interleukin-5 production,BP,1
GO:0032755,1,0.5415168,0,55,positive regulation of interleukin-6 production,BP,1
GO:0032759,1,0.988702358,0,1,positive regulation of TRAIL production,BP,1
GO:0032762,1,0.956659409,0,4,mast cell cytokine production,BP,1
GO:0032763,1,0.966782317,0,3,regulation of mast cell cytokine production,BP,1
GO:0032764,1,0.977870842,0,2,negative regulation of mast cell cytokine production,BP,1
GO:0032765,1,0.98866256,0,1,positive regulation of mast cell cytokine production,BP,1
GO:0032768,1,0.739113123,0,27,regulation of monooxygenase activity,BP,1
GO:0032769,1,0.914044837,0,8,negative regulation of monooxygenase activity,BP,1
GO:0032770,1,0.826360855,0,17,positive regulation of monooxygenase activity,BP,1
GO:0032775,1,0.977453375,0,2,DNA methylation on adenine,BP,1
GO:0032776,1,0.952611349,0,5,DNA methylation on cytosine,BP,1
GO:0032780,1,0.876562392,0,12,negative regulation of ATPase activity,BP,1
GO:0032781,1,0.636243281,0,40,positive regulation of ATPase activity,BP,1
GO:0032782,1,0.967329862,0,3,bile acid secretion,BP,1
GO:0032784,1,0.630459963,0,42,"regulation of DNA-templated transcription, elongation",BP,1
GO:0032785,1,0.873374834,0,12,"negative regulation of DNA-templated transcription, elongation",BP,1
GO:0032786,1,0.730421483,0,29,"positive regulation of DNA-templated transcription, elongation",BP,1
GO:0032790,1,0.923823517,0,7,ribosome disassembly,BP,1
GO:0032792,1,0.966369261,0,3,negative regulation of CREB transcription factor activity,BP,1
GO:0032796,1,0.977453358,0,2,uropod organization,BP,1
GO:0032799,1,0.875726537,0,12,low-density lipoprotein receptor particle metabolic process,BP,1
GO:0032801,1,0.764837852,0,25,receptor catabolic process,BP,1
GO:0032802,1,0.946435212,0,5,low-density lipoprotein particle receptor catabolic process,BP,1
GO:0032803,1,0.946435212,0,5,regulation of low-density lipoprotein particle receptor catabolic process,BP,1
GO:0032804,1,0.978823122,0,2,negative regulation of low-density lipoprotein particle receptor catabolic process,BP,1
GO:0032805,1,0.977825098,0,2,positive regulation of low-density lipoprotein particle receptor catabolic process,BP,1
GO:0032808,1,0.978937003,0,2,lacrimal gland development,BP,1
GO:0032811,1,0.967951412,0,3,negative regulation of epinephrine secretion,BP,1
GO:0032814,1,0.772009064,0,23,regulation of natural killer cell activation,BP,1
GO:0032815,1,0.944575577,0,5,negative regulation of natural killer cell activation,BP,1
GO:0032816,1,0.815406023,0,18,positive regulation of natural killer cell activation,BP,1
GO:0032817,1,0.944634215,0,5,regulation of natural killer cell proliferation,BP,1
GO:0032819,1,0.944634215,0,5,positive regulation of natural killer cell proliferation,BP,1
GO:0032823,1,0.87527143,0,12,regulation of natural killer cell differentiation,BP,1
GO:0032824,1,0.988662931,0,1,negative regulation of natural killer cell differentiation,BP,1
GO:0032825,1,0.903566779,0,9,positive regulation of natural killer cell differentiation,BP,1
GO:0032826,1,0.988662931,0,1,regulation of natural killer cell differentiation involved in immune response,BP,1
GO:0032827,1,0.988662931,0,1,negative regulation of natural killer cell differentiation involved in immune response,BP,1
GO:0032829,1,0.966369808,0,3,"regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation",BP,1
GO:0032831,1,0.966369808,0,3,"positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation",BP,1
GO:0032832,1,0.988662892,0,1,"regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response",BP,1
GO:0032834,1,0.988662892,0,1,"positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response",BP,1
GO:0032836,1,0.931219362,0,7,glomerular basement membrane development,BP,1
GO:0032847,1,0.966369827,0,3,regulation of cellular pH reduction,BP,1
GO:0032849,1,0.966369827,0,3,positive regulation of cellular pH reduction,BP,1
GO:0032875,1,0.928337235,0,7,regulation of DNA endoreduplication,BP,1
GO:0032876,1,0.938987942,0,6,negative regulation of DNA endoreduplication,BP,1
GO:0032878,1,0.772202465,0,24,regulation of establishment or maintenance of cell polarity,BP,1
GO:0032887,1,0.988662931,0,1,regulation of spindle elongation,BP,1
GO:0032888,1,0.988662931,0,1,regulation of mitotic spindle elongation,BP,1
GO:0032889,1,0.988693283,0,1,"regulation of vacuole fusion, non-autophagic",BP,1
GO:0032891,1,0.868459155,0,13,negative regulation of organic acid transport,BP,1
GO:0032897,1,0.788230963,0,21,negative regulation of viral transcription,BP,1
GO:0032898,1,0.957513636,0,4,neurotrophin production,BP,1
GO:0032899,1,0.977452803,0,2,regulation of neurotrophin production,BP,1
GO:0032900,1,0.988662779,0,1,negative regulation of neurotrophin production,BP,1
GO:0032902,1,0.968496491,0,3,nerve growth factor production,BP,1
GO:0032903,1,0.988662504,0,1,regulation of nerve growth factor production,BP,1
GO:0032905,1,0.914237708,0,8,transforming growth factor beta1 production,BP,1
GO:0032906,1,0.936352857,0,6,transforming growth factor beta2 production,BP,1
GO:0032907,1,0.957179253,0,4,transforming growth factor beta3 production,BP,1
GO:0032908,1,0.92472794,0,7,regulation of transforming growth factor beta1 production,BP,1
GO:0032909,1,0.936352857,0,6,regulation of transforming growth factor beta2 production,BP,1
GO:0032910,1,0.957179253,0,4,regulation of transforming growth factor beta3 production,BP,1
GO:0032911,1,0.945899293,0,5,negative regulation of transforming growth factor beta1 production,BP,1
GO:0032912,1,0.988662918,0,1,negative regulation of transforming growth factor beta2 production,BP,1
GO:0032913,1,0.988662929,0,1,negative regulation of transforming growth factor beta3 production,BP,1
GO:0032914,1,0.967896807,0,3,positive regulation of transforming growth factor beta1 production,BP,1
GO:0032915,1,0.988662911,0,1,positive regulation of transforming growth factor beta2 production,BP,1
GO:0032916,1,0.979261968,0,2,positive regulation of transforming growth factor beta3 production,BP,1
GO:0032917,1,0.97745302,0,2,polyamine acetylation,BP,1
GO:0032918,1,0.97745302,0,2,spermidine acetylation,BP,1
GO:0032919,1,0.97745302,0,2,spermine acetylation,BP,1
GO:0032920,1,0.988662689,0,1,putrescine acetylation,BP,1
GO:0032924,1,0.768466947,0,24,activin receptor signaling pathway,BP,1
GO:0032925,1,0.866624831,0,13,regulation of activin receptor signaling pathway,BP,1
GO:0032926,1,0.947566308,0,5,negative regulation of activin receptor signaling pathway,BP,1
GO:0032927,1,0.937168724,0,6,positive regulation of activin receptor signaling pathway,BP,1
GO:0032929,1,0.955410758,0,4,negative regulation of superoxide anion generation,BP,1
GO:0032930,1,0.836614663,0,16,positive regulation of superoxide anion generation,BP,1
GO:0032933,1,0.905683415,0,9,SREBP signaling pathway,BP,1
GO:0032938,1,0.988662931,0,1,negative regulation of translation in response to oxidative stress,BP,1
GO:0032941,1,0.795733874,0,21,secretion by tissue,BP,1
GO:0032945,1,0.557712944,0,53,negative regulation of mononuclear cell proliferation,BP,1
GO:0032954,1,0.980283667,0,2,regulation of cytokinetic process,BP,1
GO:0032957,1,0.834272018,0,18,inositol trisphosphate metabolic process,BP,1
GO:0032958,1,0.760378043,0,26,inositol phosphate biosynthetic process,BP,1
GO:0032959,1,0.868533957,0,14,inositol trisphosphate biosynthetic process,BP,1
GO:0032960,1,0.956592678,0,4,regulation of inositol trisphosphate biosynthetic process,BP,1
GO:0032962,1,0.966670678,0,3,positive regulation of inositol trisphosphate biosynthetic process,BP,1
GO:0032967,1,0.801145575,0,20,positive regulation of collagen biosynthetic process,BP,1
GO:0032968,1,0.803669312,0,20,positive regulation of transcription elongation from RNA polymerase II promoter,BP,1
GO:0032971,1,0.988703606,0,1,regulation of muscle filament sliding,BP,1
GO:0032976,1,0.98866253,0,1,release of matrix enzymes from mitochondria,BP,1
GO:0032978,1,0.966369821,0,3,protein insertion into membrane from inner side,BP,1
GO:0032979,1,0.966369821,0,3,protein insertion into mitochondrial inner membrane from matrix side,BP,1
GO:0032980,1,0.988662931,0,1,keratinocyte activation,BP,1
GO:0032981,1,0.611893163,0,43,mitochondrial respiratory chain complex I assembly,BP,1
GO:0032984,1,0.197308504,0,150,protein-containing complex disassembly,BP,1
GO:0032986,1,0.879215203,0,12,protein-DNA complex disassembly,BP,1
GO:0032988,1,0.864064763,0,13,ribonucleoprotein complex disassembly,BP,1
GO:0033003,1,0.706956271,0,31,regulation of mast cell activation,BP,1
GO:0033004,1,0.892567759,0,10,negative regulation of mast cell activation,BP,1
GO:0033005,1,0.856736436,0,14,positive regulation of mast cell activation,BP,1
GO:0033006,1,0.756937844,0,25,regulation of mast cell activation involved in immune response,BP,1
GO:0033007,1,0.923403651,0,7,negative regulation of mast cell activation involved in immune response,BP,1
GO:0033008,1,0.876519606,0,12,positive regulation of mast cell activation involved in immune response,BP,1
GO:0033013,1,0.666217561,0,36,tetrapyrrole metabolic process,BP,1
GO:0033014,1,0.789125947,0,21,tetrapyrrole biosynthetic process,BP,1
GO:0033015,1,0.955410727,0,4,tetrapyrrole catabolic process,BP,1
GO:0033023,1,0.959666764,0,4,mast cell homeostasis,BP,1
GO:0033024,1,0.959666764,0,4,mast cell apoptotic process,BP,1
GO:0033025,1,0.959666764,0,4,regulation of mast cell apoptotic process,BP,1
GO:0033026,1,0.969510819,0,3,negative regulation of mast cell apoptotic process,BP,1
GO:0033029,1,0.927329309,0,7,regulation of neutrophil apoptotic process,BP,1
GO:0033030,1,0.967335255,0,3,negative regulation of neutrophil apoptotic process,BP,1
GO:0033031,1,0.958653903,0,4,positive regulation of neutrophil apoptotic process,BP,1
GO:0033034,1,0.926403612,0,7,positive regulation of myeloid cell apoptotic process,BP,1
GO:0033037,1,0.990918221,0,1,polysaccharide localization,BP,1
GO:0033058,1,0.988662931,0,1,directional locomotion,BP,1
GO:0033059,1,0.722591991,0,30,cellular pigmentation,BP,1
GO:0033076,1,0.977453375,0,2,isoquinoline alkaloid metabolic process,BP,1
GO:0033078,1,0.979819506,0,2,extrathymic T cell differentiation,BP,1
GO:0033079,1,0.923269578,0,7,immature T cell proliferation,BP,1
GO:0033080,1,0.933862605,0,6,immature T cell proliferation in thymus,BP,1
GO:0033081,1,0.847904997,0,15,regulation of T cell differentiation in thymus,BP,1
GO:0033082,1,0.991056435,0,1,regulation of extrathymic T cell differentiation,BP,1
GO:0033083,1,0.933862701,0,6,regulation of immature T cell proliferation,BP,1
GO:0033084,1,0.944576284,0,5,regulation of immature T cell proliferation in thymus,BP,1
GO:0033085,1,0.955411914,0,4,negative regulation of T cell differentiation in thymus,BP,1
GO:0033087,1,0.977454245,0,2,negative regulation of immature T cell proliferation,BP,1
GO:0033088,1,0.977454245,0,2,negative regulation of immature T cell proliferation in thymus,BP,1
GO:0033089,1,0.933865446,0,6,positive regulation of T cell differentiation in thymus,BP,1
GO:0033091,1,0.966369716,0,3,positive regulation of immature T cell proliferation,BP,1
GO:0033092,1,0.97745318,0,2,positive regulation of immature T cell proliferation in thymus,BP,1
GO:0033108,1,0.444093726,0,71,mitochondrial respiratory chain complex assembly,BP,1
GO:0033119,1,0.736314183,0,27,negative regulation of RNA splicing,BP,1
GO:0033128,1,0.977453375,0,2,negative regulation of histone phosphorylation,BP,1
GO:0033129,1,0.923227121,0,8,positive regulation of histone phosphorylation,BP,1
GO:0033131,1,0.912795207,0,8,regulation of glucokinase activity,BP,1
GO:0033132,1,0.96637015,0,3,negative regulation of glucokinase activity,BP,1
GO:0033133,1,0.933861808,0,6,positive regulation of glucokinase activity,BP,1
GO:0033137,1,0.774401995,0,23,negative regulation of peptidyl-serine phosphorylation,BP,1
GO:0033139,1,0.970576018,0,3,regulation of peptidyl-serine phosphorylation of STAT protein,BP,1
GO:0033140,1,0.97751396,0,2,negative regulation of peptidyl-serine phosphorylation of STAT protein,BP,1
GO:0033141,1,0.992903752,0,1,positive regulation of peptidyl-serine phosphorylation of STAT protein,BP,1
GO:0033145,1,0.832486341,0,17,positive regulation of intracellular steroid hormone receptor signaling pathway,BP,1
GO:0033146,1,0.757933575,0,25,regulation of intracellular estrogen receptor signaling pathway,BP,1
GO:0033147,1,0.916651683,0,8,negative regulation of intracellular estrogen receptor signaling pathway,BP,1
GO:0033148,1,0.90580349,0,9,positive regulation of intracellular estrogen receptor signaling pathway,BP,1
GO:0033152,1,0.941601718,0,6,immunoglobulin V(D)J recombination,BP,1
GO:0033153,1,0.974376751,0,3,T cell receptor V(D)J recombination,BP,1
GO:0033168,1,0.988662931,0,1,conversion of ds siRNA to ss siRNA involved in RNA interference,BP,1
GO:0033169,1,0.88666419,0,11,histone H3-K9 demethylation,BP,1
GO:0033173,1,0.709107017,0,33,calcineurin-NFAT signaling cascade,BP,1
GO:0033182,1,0.888915315,0,11,regulation of histone ubiquitination,BP,1
GO:0033183,1,0.970738099,0,3,negative regulation of histone ubiquitination,BP,1
GO:0033184,1,0.936863979,0,6,positive regulation of histone ubiquitination,BP,1
GO:0033194,1,0.833588838,0,17,response to hydroperoxide,BP,1
GO:0033195,1,0.988662523,0,1,response to alkyl hydroperoxide,BP,1
GO:0033198,1,0.791757003,0,21,response to ATP,BP,1
GO:0033206,1,0.936458061,0,6,meiotic cytokinesis,BP,1
GO:0033210,1,0.925850644,0,7,leptin-mediated signaling pathway,BP,1
GO:0033211,1,0.924294935,0,7,adiponectin-activated signaling pathway,BP,1
GO:0033212,1,0.990114565,0,1,iron assimilation,BP,1
GO:0033216,1,0.977670096,0,2,ferric iron import,BP,1
GO:0033227,1,0.968353874,0,3,dsRNA transport,BP,1
GO:0033233,1,0.798760991,0,20,regulation of protein sumoylation,BP,1
GO:0033234,1,0.923998566,0,7,negative regulation of protein sumoylation,BP,1
GO:0033235,1,0.864634977,0,13,positive regulation of protein sumoylation,BP,1
GO:0033238,1,0.810886692,0,19,regulation of cellular amine metabolic process,BP,1
GO:0033239,1,0.978515242,0,2,negative regulation of cellular amine metabolic process,BP,1
GO:0033240,1,0.882369203,0,11,positive regulation of cellular amine metabolic process,BP,1
GO:0033241,1,0.989736892,0,1,regulation of cellular amine catabolic process,BP,1
GO:0033242,1,0.989736892,0,1,negative regulation of cellular amine catabolic process,BP,1
GO:0033274,1,0.977453323,0,2,response to vitamin B2,BP,1
GO:0033275,1,0.977493581,0,2,actin-myosin filament sliding,BP,1
GO:0033277,1,0.977453901,0,2,abortive mitotic cell cycle,BP,1
GO:0033280,1,0.69462856,0,34,response to vitamin D,BP,1
GO:0033292,1,0.960286592,0,4,T-tubule organization,BP,1
GO:0033299,1,0.902492001,0,9,secretion of lysosomal enzymes,BP,1
GO:0033306,1,0.977590221,0,2,phytol metabolic process,BP,1
GO:0033313,1,0.969767647,0,3,meiotic cell cycle checkpoint,BP,1
GO:0033314,1,0.935486205,0,6,mitotic DNA replication checkpoint,BP,1
GO:0033319,1,0.988662931,0,1,UDP-D-xylose metabolic process,BP,1
GO:0033320,1,0.988662931,0,1,UDP-D-xylose biosynthetic process,BP,1
GO:0033326,1,0.988691255,0,1,cerebrospinal fluid secretion,BP,1
GO:0033327,1,0.887559362,0,11,Leydig cell differentiation,BP,1
GO:0033341,1,0.98866293,0,1,regulation of collagen binding,BP,1
GO:0033342,1,0.98866293,0,1,negative regulation of collagen binding,BP,1
GO:0033345,1,0.988662797,0,1,asparagine catabolic process via L-aspartate,BP,1
GO:0033353,1,0.925816501,0,7,S-adenosylmethionine cycle,BP,1
GO:0033363,1,0.776431342,0,23,secretory granule organization,BP,1
GO:0033364,1,0.988662854,0,1,mast cell secretory granule organization,BP,1
GO:0033366,1,0.988662854,0,1,protein localization to secretory granule,BP,1
GO:0033367,1,0.988662854,0,1,protein localization to mast cell secretory granule,BP,1
GO:0033368,1,0.988662854,0,1,protease localization to mast cell secretory granule,BP,1
GO:0033370,1,0.988662854,0,1,maintenance of protein location in mast cell secretory granule,BP,1
GO:0033371,1,0.988662854,0,1,T cell secretory granule organization,BP,1
GO:0033373,1,0.988662854,0,1,maintenance of protease location in mast cell secretory granule,BP,1
GO:0033374,1,0.988662854,0,1,protein localization to T cell secretory granule,BP,1
GO:0033375,1,0.988662854,0,1,protease localization to T cell secretory granule,BP,1
GO:0033377,1,0.988662854,0,1,maintenance of protein location in T cell secretory granule,BP,1
GO:0033379,1,0.988662854,0,1,maintenance of protease location in T cell secretory granule,BP,1
GO:0033380,1,0.988662854,0,1,granzyme B localization to T cell secretory granule,BP,1
GO:0033382,1,0.988662854,0,1,maintenance of granzyme B location in T cell secretory granule,BP,1
GO:0033383,1,0.977476449,0,2,geranyl diphosphate metabolic process,BP,1
GO:0033384,1,0.977476449,0,2,geranyl diphosphate biosynthetic process,BP,1
GO:0033385,1,0.98868644,0,1,geranylgeranyl diphosphate metabolic process,BP,1
GO:0033386,1,0.98868644,0,1,geranylgeranyl diphosphate biosynthetic process,BP,1
GO:0033387,1,0.978830669,0,2,putrescine biosynthetic process from ornithine,BP,1
GO:0033388,1,0.988662849,0,1,putrescine biosynthetic process from arginine,BP,1
GO:0033389,1,0.988662849,0,1,"putrescine biosynthetic process from arginine, using agmatinase",BP,1
GO:0033396,1,0.988662846,0,1,beta-alanine biosynthetic process via 3-ureidopropionate,BP,1
GO:0033477,1,0.98866293,0,1,S-methylmethionine metabolic process,BP,1
GO:0033483,1,0.927645993,0,7,gas homeostasis,BP,1
GO:0033484,1,0.980161002,0,2,nitric oxide homeostasis,BP,1
GO:0033488,1,0.988820836,0,1,"cholesterol biosynthetic process via 24,25-dihydrolanosterol",BP,1
GO:0033490,1,0.988662931,0,1,cholesterol biosynthetic process via lathosterol,BP,1
GO:0033499,1,0.944575493,0,5,galactose catabolic process via UDP-galactose,BP,1
GO:0033504,1,0.979404951,0,2,floor plate development,BP,1
GO:0033505,1,0.988662928,0,1,floor plate morphogenesis,BP,1
GO:0033512,1,0.966541744,0,3,L-lysine catabolic process to acetyl-CoA via saccharopine,BP,1
GO:0033514,1,0.988662921,0,1,L-lysine catabolic process to acetyl-CoA via L-pipecolate,BP,1
GO:0033522,1,0.760599255,0,25,histone H2A ubiquitination,BP,1
GO:0033523,1,0.87667173,0,12,histone H2B ubiquitination,BP,1
GO:0033539,1,0.882509193,0,11,fatty acid beta-oxidation using acyl-CoA dehydrogenase,BP,1
GO:0033540,1,0.966409419,0,3,fatty acid beta-oxidation using acyl-CoA oxidase,BP,1
GO:0033552,1,0.988662925,0,1,response to vitamin B3,BP,1
GO:0033561,1,0.880016548,0,12,regulation of water loss via skin,BP,1
GO:0033564,1,0.977582366,0,2,anterior/posterior axon guidance,BP,1
GO:0033567,1,0.944937638,0,5,"DNA replication, Okazaki fragment processing",BP,1
GO:0033572,1,0.923925181,0,8,transferrin transport,BP,1
GO:0033575,1,0.988662891,0,1,protein glycosylation at cell surface,BP,1
GO:0033578,1,0.94685903,0,5,protein glycosylation in Golgi,BP,1
GO:0033580,1,0.988662891,0,1,protein galactosylation at cell surface,BP,1
GO:0033590,1,0.956647858,0,4,response to cobalamin,BP,1
GO:0033591,1,0.892787016,0,10,response to L-ascorbic acid,BP,1
GO:0033594,1,0.956640041,0,4,response to hydroxyisoflavone,BP,1
GO:0033595,1,0.966369865,0,3,response to genistein,BP,1
GO:0033598,1,0.809230338,0,20,mammary gland epithelial cell proliferation,BP,1
GO:0033599,1,0.89263827,0,11,regulation of mammary gland epithelial cell proliferation,BP,1
GO:0033600,1,0.98866287,0,1,negative regulation of mammary gland epithelial cell proliferation,BP,1
GO:0033601,1,0.94496399,0,6,positive regulation of mammary gland epithelial cell proliferation,BP,1
GO:0033602,1,0.956910831,0,4,negative regulation of dopamine secretion,BP,1
GO:0033603,1,0.968251698,0,3,positive regulation of dopamine secretion,BP,1
GO:0033604,1,0.914519089,0,8,negative regulation of catecholamine secretion,BP,1
GO:0033605,1,0.946472423,0,5,positive regulation of catecholamine secretion,BP,1
GO:0033606,1,0.988662929,0,1,chemokine receptor transport within lipid bilayer,BP,1
GO:0033609,1,0.988662931,0,1,oxalate metabolic process,BP,1
GO:0033615,1,0.934036928,0,6,mitochondrial proton-transporting ATP synthase complex assembly,BP,1
GO:0033617,1,0.833139368,0,16,mitochondrial respiratory chain complex IV assembly,BP,1
GO:0033619,1,0.63536052,0,41,membrane protein proteolysis,BP,1
GO:0033622,1,0.863674488,0,14,integrin activation,BP,1
GO:0033623,1,0.924637428,0,7,regulation of integrin activation,BP,1
GO:0033625,1,0.933864196,0,6,positive regulation of integrin activation,BP,1
GO:0033627,1,0.618582045,0,45,cell adhesion mediated by integrin,BP,1
GO:0033628,1,0.708320615,0,32,regulation of cell adhesion mediated by integrin,BP,1
GO:0033629,1,0.94147867,0,6,negative regulation of cell adhesion mediated by integrin,BP,1
GO:0033630,1,0.858620855,0,14,positive regulation of cell adhesion mediated by integrin,BP,1
GO:0033631,1,0.87304511,0,13,cell-cell adhesion mediated by integrin,BP,1
GO:0033632,1,0.901209666,0,10,regulation of cell-cell adhesion mediated by integrin,BP,1
GO:0033633,1,0.982864516,0,2,negative regulation of cell-cell adhesion mediated by integrin,BP,1
GO:0033634,1,0.946987019,0,5,positive regulation of cell-cell adhesion mediated by integrin,BP,1
GO:0033668,1,0.966370812,0,3,negative regulation by symbiont of host apoptotic process,BP,1
GO:0033683,1,0.914084863,0,8,"nucleotide-excision repair, DNA incision",BP,1
GO:0033684,1,0.988662926,0,1,regulation of luteinizing hormone secretion,BP,1
GO:0033686,1,0.988662926,0,1,positive regulation of luteinizing hormone secretion,BP,1
GO:0033688,1,0.861082319,0,14,regulation of osteoblast proliferation,BP,1
GO:0033689,1,0.940890054,0,6,negative regulation of osteoblast proliferation,BP,1
GO:0033690,1,0.925719797,0,7,positive regulation of osteoblast proliferation,BP,1
GO:0033700,1,0.889490498,0,11,phospholipid efflux,BP,1
GO:0033750,1,0.862852873,0,13,ribosome localization,BP,1
GO:0033860,1,0.934038093,0,6,regulation of NAD(P)H oxidase activity,BP,1
GO:0033864,1,0.94475369,0,5,positive regulation of NAD(P)H oxidase activity,BP,1
GO:0033866,1,0.67270275,0,36,nucleoside bisphosphate biosynthetic process,BP,1
GO:0033869,1,0.934368591,0,6,nucleoside bisphosphate catabolic process,BP,1
GO:0033962,1,0.825183228,0,18,cytoplasmic mRNA processing body assembly,BP,1
GO:0033967,1,0.988662821,0,1,box C/D snoRNA metabolic process,BP,1
GO:0033979,1,0.966991818,0,3,box H/ACA snoRNA metabolic process,BP,1
GO:0033986,1,0.98866291,0,1,response to methanol,BP,1
GO:0034014,1,0.934119427,0,6,response to triglyceride,BP,1
GO:0034021,1,0.977453333,0,2,response to silicon dioxide,BP,1
GO:0034030,1,0.67270275,0,36,ribonucleoside bisphosphate biosynthetic process,BP,1
GO:0034031,1,0.934368591,0,6,ribonucleoside bisphosphate catabolic process,BP,1
GO:0034033,1,0.67270275,0,36,purine nucleoside bisphosphate biosynthetic process,BP,1
GO:0034034,1,0.934368591,0,6,purine nucleoside bisphosphate catabolic process,BP,1
GO:0034035,1,0.913320246,0,8,purine ribonucleoside bisphosphate metabolic process,BP,1
GO:0034036,1,0.977963972,0,2,purine ribonucleoside bisphosphate biosynthetic process,BP,1
GO:0034037,1,0.988662911,0,1,purine ribonucleoside bisphosphate catabolic process,BP,1
GO:0034050,1,0.989438987,0,1,host programmed cell death induced by symbiont,BP,1
GO:0034058,1,0.921583635,0,8,endosomal vesicle fusion,BP,1
GO:0034059,1,0.966378474,0,3,response to anoxia,BP,1
GO:0034067,1,0.80009243,0,22,protein localization to Golgi apparatus,BP,1
GO:0034080,1,0.95546023,0,4,CENP-A containing nucleosome assembly,BP,1
GO:0034085,1,0.941420064,0,6,establishment of sister chromatid cohesion,BP,1
GO:0034086,1,0.899580364,0,11,maintenance of sister chromatid cohesion,BP,1
GO:0034087,1,0.988662931,0,1,establishment of mitotic sister chromatid cohesion,BP,1
GO:0034088,1,0.899580364,0,11,maintenance of mitotic sister chromatid cohesion,BP,1
GO:0034091,1,0.923430168,0,8,regulation of maintenance of sister chromatid cohesion,BP,1
GO:0034092,1,0.974449752,0,3,negative regulation of maintenance of sister chromatid cohesion,BP,1
GO:0034093,1,0.947653244,0,5,positive regulation of maintenance of sister chromatid cohesion,BP,1
GO:0034102,1,0.988662929,0,1,erythrocyte clearance,BP,1
GO:0034105,1,0.736941659,0,28,positive regulation of tissue remodeling,BP,1
GO:0034106,1,0.988662929,0,1,regulation of erythrocyte clearance,BP,1
GO:0034107,1,0.988662929,0,1,negative regulation of erythrocyte clearance,BP,1
GO:0034109,1,0.590781329,0,48,homotypic cell-cell adhesion,BP,1
GO:0034110,1,0.78623728,0,22,regulation of homotypic cell-cell adhesion,BP,1
GO:0034111,1,0.85446966,0,14,negative regulation of homotypic cell-cell adhesion,BP,1
GO:0034112,1,0.95999226,0,4,positive regulation of homotypic cell-cell adhesion,BP,1
GO:0034113,1,0.660679319,0,38,heterotypic cell-cell adhesion,BP,1
GO:0034114,1,0.828440765,0,17,regulation of heterotypic cell-cell adhesion,BP,1
GO:0034115,1,0.917079425,0,8,negative regulation of heterotypic cell-cell adhesion,BP,1
GO:0034116,1,0.903410399,0,9,positive regulation of heterotypic cell-cell adhesion,BP,1
GO:0034117,1,0.977452932,0,2,erythrocyte aggregation,BP,1
GO:0034118,1,0.977452932,0,2,regulation of erythrocyte aggregation,BP,1
GO:0034119,1,0.988662929,0,1,negative regulation of erythrocyte aggregation,BP,1
GO:0034120,1,0.988662486,0,1,positive regulation of erythrocyte aggregation,BP,1
GO:0034123,1,0.837453542,0,16,positive regulation of toll-like receptor signaling pathway,BP,1
GO:0034124,1,0.955411121,0,4,regulation of MyD88-dependent toll-like receptor signaling pathway,BP,1
GO:0034125,1,0.97745337,0,2,negative regulation of MyD88-dependent toll-like receptor signaling pathway,BP,1
GO:0034127,1,0.988662931,0,1,regulation of MyD88-independent toll-like receptor signaling pathway,BP,1
GO:0034134,1,0.874642895,0,12,toll-like receptor 2 signaling pathway,BP,1
GO:0034135,1,0.925921274,0,7,regulation of toll-like receptor 2 signaling pathway,BP,1
GO:0034136,1,0.967341798,0,3,negative regulation of toll-like receptor 2 signaling pathway,BP,1
GO:0034137,1,0.957192216,0,4,positive regulation of toll-like receptor 2 signaling pathway,BP,1
GO:0034138,1,0.872603107,0,12,toll-like receptor 3 signaling pathway,BP,1
GO:0034139,1,0.944591224,0,5,regulation of toll-like receptor 3 signaling pathway,BP,1
GO:0034140,1,0.988662937,0,1,negative regulation of toll-like receptor 3 signaling pathway,BP,1
GO:0034141,1,0.955426886,0,4,positive regulation of toll-like receptor 3 signaling pathway,BP,1
GO:0034145,1,0.934200857,0,6,positive regulation of toll-like receptor 4 signaling pathway,BP,1
GO:0034150,1,0.988705094,0,1,toll-like receptor 6 signaling pathway,BP,1
GO:0034154,1,0.945626311,0,5,toll-like receptor 7 signaling pathway,BP,1
GO:0034155,1,0.97805918,0,2,regulation of toll-like receptor 7 signaling pathway,BP,1
GO:0034156,1,0.988662931,0,1,negative regulation of toll-like receptor 7 signaling pathway,BP,1
GO:0034157,1,0.989275628,0,1,positive regulation of toll-like receptor 7 signaling pathway,BP,1
GO:0034162,1,0.886931336,0,11,toll-like receptor 9 signaling pathway,BP,1
GO:0034163,1,0.938999446,0,6,regulation of toll-like receptor 9 signaling pathway,BP,1
GO:0034164,1,0.969277578,0,3,negative regulation of toll-like receptor 9 signaling pathway,BP,1
GO:0034165,1,0.968769846,0,3,positive regulation of toll-like receptor 9 signaling pathway,BP,1
GO:0034182,1,0.923430168,0,8,regulation of maintenance of mitotic sister chromatid cohesion,BP,1
GO:0034183,1,0.974449752,0,3,negative regulation of maintenance of mitotic sister chromatid cohesion,BP,1
GO:0034184,1,0.947653244,0,5,positive regulation of maintenance of mitotic sister chromatid cohesion,BP,1
GO:0034196,1,0.967417089,0,3,acylglycerol transport,BP,1
GO:0034197,1,0.967417089,0,3,triglyceride transport,BP,1
GO:0034199,1,0.988662917,0,1,activation of protein kinase A activity,BP,1
GO:0034201,1,0.936240819,0,6,response to oleic acid,BP,1
GO:0034203,1,0.988662962,0,1,glycolipid translocation,BP,1
GO:0034204,1,0.838608272,0,17,lipid translocation,BP,1
GO:0034205,1,0.753459995,0,26,amyloid-beta formation,BP,1
GO:0034213,1,0.988662822,0,1,quinolinate catabolic process,BP,1
GO:0034214,1,0.884446236,0,11,protein hexamerization,BP,1
GO:0034224,1,0.977532148,0,2,cellular response to zinc ion starvation,BP,1
GO:0034227,1,0.944575723,0,5,tRNA thio-modification,BP,1
GO:0034238,1,0.946233156,0,5,macrophage fusion,BP,1
GO:0034239,1,0.96702625,0,3,regulation of macrophage fusion,BP,1
GO:0034240,1,0.989124907,0,1,negative regulation of macrophage fusion,BP,1
GO:0034241,1,0.977660308,0,2,positive regulation of macrophage fusion,BP,1
GO:0034243,1,0.709807751,0,31,regulation of transcription elongation from RNA polymerase II promoter,BP,1
GO:0034244,1,0.883400294,0,11,negative regulation of transcription elongation from RNA polymerase II promoter,BP,1
GO:0034255,1,0.988662931,0,1,regulation of urea metabolic process,BP,1
GO:0034260,1,0.760779385,0,25,negative regulation of GTPase activity,BP,1
GO:0034263,1,0.966369005,0,3,positive regulation of autophagy in response to ER overload,BP,1
GO:0034275,1,0.988662923,0,1,kynurenic acid metabolic process,BP,1
GO:0034276,1,0.988662923,0,1,kynurenic acid biosynthetic process,BP,1
GO:0034285,1,0.914199816,0,8,response to disaccharide,BP,1
GO:0034287,1,0.966372364,0,3,detection of monosaccharide stimulus,BP,1
GO:0034308,1,0.548255131,0,53,primary alcohol metabolic process,BP,1
GO:0034309,1,0.88369229,0,11,primary alcohol biosynthetic process,BP,1
GO:0034310,1,0.90243898,0,9,primary alcohol catabolic process,BP,1
GO:0034311,1,0.816449943,0,18,diol metabolic process,BP,1
GO:0034312,1,0.835310188,0,16,diol biosynthetic process,BP,1
GO:0034314,1,0.729917292,0,28,Arp2/3 complex-mediated actin nucleation,BP,1
GO:0034315,1,0.856493488,0,14,regulation of Arp2/3 complex-mediated actin nucleation,BP,1
GO:0034316,1,0.946001414,0,5,negative regulation of Arp2/3 complex-mediated actin nucleation,BP,1
GO:0034331,1,0.899018612,0,10,cell junction maintenance,BP,1
GO:0034334,1,0.935995154,0,6,adherens junction maintenance,BP,1
GO:0034337,1,0.988662931,0,1,RNA folding,BP,1
GO:0034340,1,0.670807574,0,36,response to type I interferon,BP,1
GO:0034342,1,0.988662931,0,1,response to type III interferon,BP,1
GO:0034343,1,0.989076451,0,1,type III interferon production,BP,1
GO:0034344,1,0.989076451,0,1,regulation of type III interferon production,BP,1
GO:0034346,1,0.989076451,0,1,positive regulation of type III interferon production,BP,1
GO:0034352,1,0.969677422,0,3,positive regulation of glial cell apoptotic process,BP,1
GO:0034354,1,0.944575536,0,5,'de novo' NAD biosynthetic process from tryptophan,BP,1
GO:0034355,1,0.988662931,0,1,NAD salvage,BP,1
GO:0034356,1,0.988662931,0,1,NAD biosynthesis via nicotinamide riboside salvage pathway,BP,1
GO:0034367,1,0.841090673,0,16,protein-containing complex remodeling,BP,1
GO:0034368,1,0.850666168,0,15,protein-lipid complex remodeling,BP,1
GO:0034369,1,0.850666168,0,15,plasma lipoprotein particle remodeling,BP,1
GO:0034370,1,0.902589568,0,9,triglyceride-rich lipoprotein particle remodeling,BP,1
GO:0034371,1,0.977617319,0,2,chylomicron remodeling,BP,1
GO:0034372,1,0.902589568,0,9,very-low-density lipoprotein particle remodeling,BP,1
GO:0034374,1,0.953320422,0,5,low-density lipoprotein particle remodeling,BP,1
GO:0034375,1,0.882730089,0,11,high-density lipoprotein particle remodeling,BP,1
GO:0034377,1,0.822202242,0,18,plasma lipoprotein particle assembly,BP,1
GO:0034378,1,0.989184104,0,1,chylomicron assembly,BP,1
GO:0034379,1,0.934046543,0,6,very-low-density lipoprotein particle assembly,BP,1
GO:0034380,1,0.899192646,0,10,high-density lipoprotein particle assembly,BP,1
GO:0034381,1,0.718683769,0,30,plasma lipoprotein particle clearance,BP,1
GO:0034382,1,0.93386102,0,6,chylomicron remnant clearance,BP,1
GO:0034383,1,0.796309309,0,21,low-density lipoprotein particle clearance,BP,1
GO:0034384,1,0.913217015,0,8,high-density lipoprotein particle clearance,BP,1
GO:0034389,1,0.84668621,0,15,lipid droplet organization,BP,1
GO:0034390,1,0.813158307,0,19,smooth muscle cell apoptotic process,BP,1
GO:0034391,1,0.813158307,0,19,regulation of smooth muscle cell apoptotic process,BP,1
GO:0034392,1,0.908233937,0,9,negative regulation of smooth muscle cell apoptotic process,BP,1
GO:0034393,1,0.895394386,0,10,positive regulation of smooth muscle cell apoptotic process,BP,1
GO:0034394,1,0.575798976,0,51,protein localization to cell surface,BP,1
GO:0034395,1,0.988662906,0,1,regulation of transcription from RNA polymerase II promoter in response to iron,BP,1
GO:0034397,1,0.932910303,0,7,telomere localization,BP,1
GO:0034398,1,0.981286172,0,2,telomere tethering at nuclear periphery,BP,1
GO:0034401,1,0.95885499,0,4,chromatin organization involved in regulation of transcription,BP,1
GO:0034402,1,0.977453242,0,2,recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex,BP,1
GO:0034414,1,0.977649486,0,2,"tRNA 3'-trailer cleavage, endonucleolytic",BP,1
GO:0034418,1,0.977453375,0,2,urate biosynthetic process,BP,1
GO:0034421,1,0.988664689,0,1,post-translational protein acetylation,BP,1
GO:0034427,1,0.893143405,0,10,"nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'",BP,1
GO:0034433,1,0.866803779,0,13,steroid esterification,BP,1
GO:0034434,1,0.866803779,0,13,sterol esterification,BP,1
GO:0034435,1,0.866803779,0,13,cholesterol esterification,BP,1
GO:0034436,1,0.966913657,0,3,glycoprotein transport,BP,1
GO:0034441,1,0.977452508,0,2,plasma lipoprotein particle oxidation,BP,1
GO:0034444,1,0.977452508,0,2,regulation of plasma lipoprotein oxidation,BP,1
GO:0034445,1,0.977452508,0,2,negative regulation of plasma lipoprotein oxidation,BP,1
GO:0034446,1,0.439088229,0,77,substrate adhesion-dependent cell spreading,BP,1
GO:0034447,1,0.944574548,0,5,very-low-density lipoprotein particle clearance,BP,1
GO:0034453,1,0.80799679,0,20,microtubule anchoring,BP,1
GO:0034454,1,0.917885528,0,8,microtubule anchoring at centrosome,BP,1
GO:0034462,1,0.988662855,0,1,small-subunit processome assembly,BP,1
GO:0034465,1,0.936265973,0,6,response to carbon monoxide,BP,1
GO:0034470,1,0.035879085,0,290,ncRNA processing,BP,1
GO:0034471,1,0.843055729,0,15,ncRNA 5'-end processing,BP,1
GO:0034472,1,0.823947149,0,17,snRNA 3'-end processing,BP,1
GO:0034473,1,0.966369667,0,3,U1 snRNA 3'-end processing,BP,1
GO:0034475,1,0.912794423,0,8,U4 snRNA 3'-end processing,BP,1
GO:0034476,1,0.966369667,0,3,U5 snRNA 3'-end processing,BP,1
GO:0034477,1,0.988662931,0,1,U6 snRNA 3'-end processing,BP,1
GO:0034497,1,0.874219756,0,12,protein localization to phagophore assembly site,BP,1
GO:0034498,1,0.916783212,0,8,early endosome to Golgi transport,BP,1
GO:0034499,1,0.983112652,0,2,late endosome to Golgi transport,BP,1
GO:0034501,1,0.912801714,0,8,protein localization to kinetochore,BP,1
GO:0034505,1,0.855989804,0,14,tooth mineralization,BP,1
GO:0034508,1,0.866311958,0,13,centromere complex assembly,BP,1
GO:0034516,1,0.988662923,0,1,response to vitamin B6,BP,1
GO:0034551,1,0.902439263,0,9,mitochondrial respiratory chain complex III assembly,BP,1
GO:0034552,1,0.955411124,0,4,respiratory chain complex II assembly,BP,1
GO:0034553,1,0.955411124,0,4,mitochondrial respiratory chain complex II assembly,BP,1
GO:0034587,1,0.968091531,0,3,piRNA metabolic process,BP,1
GO:0034589,1,0.988662931,0,1,hydroxyproline transport,BP,1
GO:0034625,1,0.956145288,0,4,"fatty acid elongation, monounsaturated fatty acid",BP,1
GO:0034626,1,0.967112425,0,3,"fatty acid elongation, polyunsaturated fatty acid",BP,1
GO:0034627,1,0.944575536,0,5,'de novo' NAD biosynthetic process,BP,1
GO:0034633,1,0.977460449,0,2,retinol transport,BP,1
GO:0034635,1,0.988662899,0,1,glutathione transport,BP,1
GO:0034638,1,0.93420548,0,6,phosphatidylcholine catabolic process,BP,1
GO:0034640,1,0.988779002,0,1,establishment of mitochondrion localization by microtubule attachment,BP,1
GO:0034642,1,0.988662931,0,1,mitochondrion migration along actin filament,BP,1
GO:0034643,1,0.879032881,0,13,"establishment of mitochondrion localization, microtubule-mediated",BP,1
GO:0034650,1,0.92451,0,7,cortisol metabolic process,BP,1
GO:0034651,1,0.92451,0,7,cortisol biosynthetic process,BP,1
GO:0034653,1,0.988662924,0,1,retinoic acid catabolic process,BP,1
GO:0034656,1,0.826255859,0,17,nucleobase-containing small molecule catabolic process,BP,1
GO:0034660,1,0.01195862,0,386,ncRNA metabolic process,BP,1
GO:0034661,1,0.744675881,0,26,ncRNA catabolic process,BP,1
GO:0034670,1,0.988662781,0,1,chemotaxis to arachidonic acid,BP,1
GO:0034696,1,0.966428114,0,3,response to prostaglandin F,BP,1
GO:0034698,1,0.64930542,0,39,response to gonadotropin,BP,1
GO:0034699,1,0.945559896,0,5,response to luteinizing hormone,BP,1
GO:0034720,1,0.926606566,0,7,histone H3-K4 demethylation,BP,1
GO:0034721,1,0.969861973,0,3,"histone H3-K4 demethylation, trimethyl-H3-K4-specific",BP,1
GO:0034723,1,0.924049529,0,7,DNA replication-dependent nucleosome organization,BP,1
GO:0034724,1,0.85869662,0,15,DNA replication-independent nucleosome organization,BP,1
GO:0034727,1,0.970691753,0,3,piecemeal microautophagy of the nucleus,BP,1
GO:0034728,1,0.466244965,0,71,nucleosome organization,BP,1
GO:0034729,1,0.959930408,0,4,histone H3-K79 methylation,BP,1
GO:0034755,1,0.847400742,0,15,iron ion transmembrane transport,BP,1
GO:0034756,1,0.925050147,0,7,regulation of iron ion transport,BP,1
GO:0034757,1,0.957252675,0,4,negative regulation of iron ion transport,BP,1
GO:0034759,1,0.957252675,0,4,regulation of iron ion transmembrane transport,BP,1
GO:0034760,1,0.957252675,0,4,negative regulation of iron ion transmembrane transport,BP,1
GO:0034763,1,0.440377198,0,76,negative regulation of transmembrane transport,BP,1
GO:0034765,1,0.112298602,0,202,regulation of ion transmembrane transport,BP,1
GO:0034766,1,0.544991606,0,57,negative regulation of ion transmembrane transport,BP,1
GO:0034767,1,0.422483199,0,81,positive regulation of ion transmembrane transport,BP,1
GO:0034769,1,0.977453254,0,2,basement membrane disassembly,BP,1
GO:0034770,1,0.922747644,0,8,histone H4-K20 methylation,BP,1
GO:0034773,1,0.948692775,0,5,histone H4-K20 trimethylation,BP,1
GO:0034776,1,0.978488842,0,2,response to histamine,BP,1
GO:0034959,1,0.988729603,0,1,endothelin maturation,BP,1
GO:0034963,1,0.988662821,0,1,box C/D snoRNA processing,BP,1
GO:0034964,1,0.977453375,0,2,box H/ACA snoRNA processing,BP,1
GO:0034968,1,0.39344427,0,88,histone lysine methylation,BP,1
GO:0034969,1,0.892765423,0,10,histone arginine methylation,BP,1
GO:0034970,1,0.97804408,0,2,histone H3-R2 methylation,BP,1
GO:0034971,1,0.97769725,0,2,histone H3-R17 methylation,BP,1
GO:0034975,1,0.893328856,0,10,protein folding in endoplasmic reticulum,BP,1
GO:0034982,1,0.882262912,0,11,mitochondrial protein processing,BP,1
GO:0034983,1,0.933862011,0,6,peptidyl-lysine deacetylation,BP,1
GO:0035020,1,0.862921287,0,14,regulation of Rac protein signal transduction,BP,1
GO:0035021,1,0.972188721,0,3,negative regulation of Rac protein signal transduction,BP,1
GO:0035022,1,0.947580161,0,5,positive regulation of Rac protein signal transduction,BP,1
GO:0035024,1,0.794642782,0,21,negative regulation of Rho protein signal transduction,BP,1
GO:0035025,1,0.904787555,0,10,positive regulation of Rho protein signal transduction,BP,1
GO:0035026,1,0.97785313,0,2,leading edge cell differentiation,BP,1
GO:0035036,1,0.796037735,0,20,sperm-egg recognition,BP,1
GO:0035037,1,0.988662931,0,1,sperm entry,BP,1
GO:0035054,1,0.977803228,0,2,embryonic heart tube anterior/posterior pattern specification,BP,1
GO:0035063,1,0.989310388,0,1,nuclear speck organization,BP,1
GO:0035065,1,0.658670903,0,38,regulation of histone acetylation,BP,1
GO:0035066,1,0.810847035,0,19,positive regulation of histone acetylation,BP,1
GO:0035067,1,0.877705057,0,12,negative regulation of histone acetylation,BP,1
GO:0035087,1,0.955410816,0,4,siRNA loading onto RISC involved in RNA interference,BP,1
GO:0035088,1,0.704107765,0,34,establishment or maintenance of apical/basal cell polarity,BP,1
GO:0035089,1,0.862640472,0,14,establishment of apical/basal cell polarity,BP,1
GO:0035090,1,0.923543811,0,7,maintenance of apical/basal cell polarity,BP,1
GO:0035092,1,0.94994654,0,5,sperm chromatin condensation,BP,1
GO:0035093,1,0.960843148,0,4,"spermatogenesis, exchange of chromosomal proteins",BP,1
GO:0035094,1,0.667468332,0,36,response to nicotine,BP,1
GO:0035095,1,0.966370915,0,3,behavioral response to nicotine,BP,1
GO:0035106,1,0.977453366,0,2,operant conditioning,BP,1
GO:0035112,1,0.921522771,0,8,genitalia morphogenesis,BP,1
GO:0035115,1,0.904672329,0,10,embryonic forelimb morphogenesis,BP,1
GO:0035116,1,0.874203977,0,14,embryonic hindlimb morphogenesis,BP,1
GO:0035120,1,0.995326928,0,1,post-embryonic appendage morphogenesis,BP,1
GO:0035127,1,0.995326928,0,1,post-embryonic limb morphogenesis,BP,1
GO:0035128,1,0.995326928,0,1,post-embryonic forelimb morphogenesis,BP,1
GO:0035166,1,0.935784591,0,6,post-embryonic hemopoiesis,BP,1
GO:0035176,1,0.791112625,0,26,social behavior,BP,1
GO:0035188,1,0.817700205,0,19,hatching,BP,1
GO:0035212,1,0.988662931,0,1,cell competition in a multicellular organism,BP,1
GO:0035227,1,0.988662898,0,1,regulation of glutamate-cysteine ligase activity,BP,1
GO:0035229,1,0.988662898,0,1,positive regulation of glutamate-cysteine ligase activity,BP,1
GO:0035234,1,0.923412237,0,8,ectopic germ cell programmed cell death,BP,1
GO:0035235,1,0.931740256,0,7,ionotropic glutamate receptor signaling pathway,BP,1
GO:0035246,1,0.893459879,0,10,peptidyl-arginine N-methylation,BP,1
GO:0035247,1,0.903011233,0,9,peptidyl-arginine omega-N-methylation,BP,1
GO:0035249,1,0.665975421,0,39,"synaptic transmission, glutamatergic",BP,1
GO:0035261,1,0.985796843,0,2,external genitalia morphogenesis,BP,1
GO:0035262,1,0.988662926,0,1,gonad morphogenesis,BP,1
GO:0035268,1,0.808958054,0,19,protein mannosylation,BP,1
GO:0035269,1,0.846128079,0,15,protein O-linked mannosylation,BP,1
GO:0035272,1,0.672703004,0,37,exocrine system development,BP,1
GO:0035278,1,0.89663506,0,11,miRNA mediated inhibition of translation,BP,1
GO:0035279,1,0.978271875,0,2,mRNA cleavage involved in gene silencing by miRNA,BP,1
GO:0035280,1,0.934462911,0,6,miRNA loading onto RISC involved in gene silencing by miRNA,BP,1
GO:0035281,1,0.990827365,0,1,pre-miRNA export from nucleus,BP,1
GO:0035283,1,0.98866293,0,1,central nervous system segmentation,BP,1
GO:0035284,1,0.98866293,0,1,brain segmentation,BP,1
GO:0035290,1,0.968121257,0,3,trunk segmentation,BP,1
GO:0035304,1,0.362917193,0,93,regulation of protein dephosphorylation,BP,1
GO:0035306,1,0.628951724,0,42,positive regulation of dephosphorylation,BP,1
GO:0035307,1,0.703669391,0,32,positive regulation of protein dephosphorylation,BP,1
GO:0035308,1,0.675406922,0,36,negative regulation of protein dephosphorylation,BP,1
GO:0035313,1,0.889903744,0,12,"wound healing, spreading of epidermal cells",BP,1
GO:0035330,1,0.902065745,0,10,regulation of hippo signaling,BP,1
GO:0035331,1,0.931897243,0,7,negative regulation of hippo signaling,BP,1
GO:0035332,1,0.992882944,0,1,positive regulation of hippo signaling,BP,1
GO:0035336,1,0.894705817,0,10,long-chain fatty-acyl-CoA metabolic process,BP,1
GO:0035337,1,0.845480151,0,15,fatty-acyl-CoA metabolic process,BP,1
GO:0035338,1,0.936482742,0,6,long-chain fatty-acyl-CoA biosynthetic process,BP,1
GO:0035344,1,0.988662921,0,1,hypoxanthine transport,BP,1
GO:0035349,1,0.977523718,0,2,coenzyme A transmembrane transport,BP,1
GO:0035350,1,0.977455185,0,2,FAD transmembrane transport,BP,1
GO:0035352,1,0.988662925,0,1,NAD transmembrane transport,BP,1
GO:0035356,1,0.946140532,0,5,cellular triglyceride homeostasis,BP,1
GO:0035357,1,0.868267093,0,13,peroxisome proliferator activated receptor signaling pathway,BP,1
GO:0035358,1,0.915371493,0,8,regulation of peroxisome proliferator activated receptor signaling pathway,BP,1
GO:0035359,1,0.96637002,0,3,negative regulation of peroxisome proliferator activated receptor signaling pathway,BP,1
GO:0035360,1,0.947240764,0,5,positive regulation of peroxisome proliferator activated receptor signaling pathway,BP,1
GO:0035364,1,0.988662921,0,1,thymine transport,BP,1
GO:0035372,1,0.847674575,0,15,protein localization to microtubule,BP,1
GO:0035376,1,0.882256863,0,12,sterol import,BP,1
GO:0035377,1,0.988691255,0,1,transepithelial water transport,BP,1
GO:0035378,1,0.988691255,0,1,carbon dioxide transmembrane transport,BP,1
GO:0035384,1,0.771059152,0,24,thioester biosynthetic process,BP,1
GO:0035385,1,0.976240619,0,3,Roundabout signaling pathway,BP,1
GO:0035397,1,0.988662925,0,1,helper T cell enhancement of adaptive immune response,BP,1
GO:0035404,1,0.925818419,0,7,histone-serine phosphorylation,BP,1
GO:0035405,1,0.955896384,0,4,histone-threonine phosphorylation,BP,1
GO:0035406,1,0.989438987,0,1,histone-tyrosine phosphorylation,BP,1
GO:0035407,1,0.988867738,0,1,histone H3-T11 phosphorylation,BP,1
GO:0035408,1,0.988960075,0,1,histone H3-T6 phosphorylation,BP,1
GO:0035409,1,0.989438987,0,1,histone H3-Y41 phosphorylation,BP,1
GO:0035418,1,0.641897019,0,41,protein localization to synapse,BP,1
GO:0035425,1,0.935470727,0,6,autocrine signaling,BP,1
GO:0035426,1,0.968648943,0,3,extracellular matrix-cell signaling,BP,1
GO:0035434,1,0.9294518,0,7,copper ion transmembrane transport,BP,1
GO:0035437,1,0.902488958,0,9,maintenance of protein localization in endoplasmic reticulum,BP,1
GO:0035441,1,0.975684335,0,3,cell migration involved in vasculogenesis,BP,1
GO:0035444,1,0.990114565,0,1,nickel cation transmembrane transport,BP,1
GO:0035455,1,0.774435524,0,23,response to interferon-alpha,BP,1
GO:0035456,1,0.681349014,0,34,response to interferon-beta,BP,1
GO:0035457,1,0.857714731,0,14,cellular response to interferon-alpha,BP,1
GO:0035458,1,0.763625312,0,24,cellular response to interferon-beta,BP,1
GO:0035459,1,0.852337855,0,15,cargo loading into vesicle,BP,1
GO:0035461,1,0.860772823,0,14,vitamin transmembrane transport,BP,1
GO:0035469,1,0.988662931,0,1,determination of pancreatic left/right asymmetry,BP,1
GO:0035470,1,0.966411756,0,3,positive regulation of vascular wound healing,BP,1
GO:0035480,1,0.994495178,0,1,regulation of Notch signaling pathway involved in heart induction,BP,1
GO:0035481,1,0.994495178,0,1,positive regulation of Notch signaling pathway involved in heart induction,BP,1
GO:0035482,1,0.977456521,0,2,gastric motility,BP,1
GO:0035483,1,0.988662837,0,1,gastric emptying,BP,1
GO:0035490,1,0.988845897,0,1,regulation of leukotriene production involved in inflammatory response,BP,1
GO:0035491,1,0.988845897,0,1,positive regulation of leukotriene production involved in inflammatory response,BP,1
GO:0035493,1,0.835610362,0,16,SNARE complex assembly,BP,1
GO:0035494,1,0.977512038,0,2,SNARE complex disassembly,BP,1
GO:0035498,1,0.988662931,0,1,carnosine metabolic process,BP,1
GO:0035502,1,0.988662931,0,1,metanephric part of ureteric bud development,BP,1
GO:0035504,1,0.988662861,0,1,regulation of myosin light chain kinase activity,BP,1
GO:0035505,1,0.988662861,0,1,positive regulation of myosin light chain kinase activity,BP,1
GO:0035507,1,0.929714873,0,7,regulation of myosin-light-chain-phosphatase activity,BP,1
GO:0035508,1,0.988928914,0,1,positive regulation of myosin-light-chain-phosphatase activity,BP,1
GO:0035509,1,0.950826199,0,5,negative regulation of myosin-light-chain-phosphatase activity,BP,1
GO:0035510,1,0.853411293,0,15,DNA dealkylation,BP,1
GO:0035511,1,0.955410927,0,4,oxidative DNA demethylation,BP,1
GO:0035513,1,0.944575499,0,5,oxidative RNA demethylation,BP,1
GO:0035518,1,0.827914905,0,17,histone H2A monoubiquitination,BP,1
GO:0035519,1,0.977474865,0,2,protein K29-linked ubiquitination,BP,1
GO:0035520,1,0.907145998,0,9,monoubiquitinated protein deubiquitination,BP,1
GO:0035521,1,0.956273984,0,4,monoubiquitinated histone deubiquitination,BP,1
GO:0035522,1,0.956273984,0,4,monoubiquitinated histone H2A deubiquitination,BP,1
GO:0035523,1,0.988662931,0,1,protein K29-linked deubiquitination,BP,1
GO:0035524,1,0.966503933,0,3,proline transmembrane transport,BP,1
GO:0035526,1,0.979916354,0,2,"retrograde transport, plasma membrane to Golgi",BP,1
GO:0035542,1,0.91460638,0,8,regulation of SNARE complex assembly,BP,1
GO:0035544,1,0.977980056,0,2,negative regulation of SNARE complex assembly,BP,1
GO:0035546,1,0.959191249,0,4,interferon-beta secretion,BP,1
GO:0035547,1,0.959191249,0,4,regulation of interferon-beta secretion,BP,1
GO:0035549,1,0.959191249,0,4,positive regulation of interferon-beta secretion,BP,1
GO:0035552,1,0.977453271,0,2,oxidative single-stranded DNA demethylation,BP,1
GO:0035553,1,0.966369807,0,3,oxidative single-stranded RNA demethylation,BP,1
GO:0035561,1,0.81781498,0,18,regulation of chromatin binding,BP,1
GO:0035562,1,0.913111187,0,8,negative regulation of chromatin binding,BP,1
GO:0035563,1,0.905983793,0,9,positive regulation of chromatin binding,BP,1
GO:0035564,1,0.977453367,0,2,regulation of kidney size,BP,1
GO:0035565,1,0.988662923,0,1,regulation of pronephros size,BP,1
GO:0035568,1,0.988662931,0,1,N-terminal peptidyl-proline methylation,BP,1
GO:0035570,1,0.988662931,0,1,N-terminal peptidyl-serine methylation,BP,1
GO:0035572,1,0.988662931,0,1,N-terminal peptidyl-serine dimethylation,BP,1
GO:0035573,1,0.988662931,0,1,N-terminal peptidyl-serine trimethylation,BP,1
GO:0035574,1,0.977453375,0,2,histone H4-K20 demethylation,BP,1
GO:0035581,1,0.954003696,0,5,sequestering of extracellular ligand from receptor,BP,1
GO:0035582,1,0.983241574,0,2,sequestering of BMP in extracellular matrix,BP,1
GO:0035583,1,0.975284469,0,3,sequestering of TGFbeta in extracellular matrix,BP,1
GO:0035584,1,0.857459277,0,14,calcium-mediated signaling using intracellular calcium source,BP,1
GO:0035585,1,0.988662931,0,1,calcium-mediated signaling using extracellular calcium source,BP,1
GO:0035587,1,0.84824987,0,15,purinergic receptor signaling pathway,BP,1
GO:0035588,1,0.884467507,0,11,G protein-coupled purinergic receptor signaling pathway,BP,1
GO:0035589,1,0.955989907,0,4,G protein-coupled purinergic nucleotide receptor signaling pathway,BP,1
GO:0035590,1,0.916867386,0,8,purinergic nucleotide receptor signaling pathway,BP,1
GO:0035592,1,0.988662928,0,1,establishment of protein localization to extracellular region,BP,1
GO:0035600,1,0.977453035,0,2,tRNA methylthiolation,BP,1
GO:0035602,1,0.990163438,0,1,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow,BP,1
GO:0035603,1,0.990163438,0,1,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,BP,1
GO:0035604,1,0.990163438,0,1,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,BP,1
GO:0035606,1,0.977452924,0,2,peptidyl-cysteine S-trans-nitrosylation,BP,1
GO:0035607,1,0.978947569,0,2,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,BP,1
GO:0035608,1,0.97909233,0,2,protein deglutamylation,BP,1
GO:0035609,1,0.990320531,0,1,C-terminal protein deglutamylation,BP,1
GO:0035610,1,0.990320531,0,1,protein side chain deglutamylation,BP,1
GO:0035611,1,0.988662931,0,1,protein branching point deglutamylation,BP,1
GO:0035616,1,0.969457686,0,3,histone H2B conserved C-terminal lysine deubiquitination,BP,1
GO:0035617,1,0.955779486,0,4,stress granule disassembly,BP,1
GO:0035621,1,0.955411117,0,4,ER to Golgi ceramide transport,BP,1
GO:0035622,1,0.972901559,0,3,intrahepatic bile duct development,BP,1
GO:0035623,1,0.989223782,0,1,renal glucose absorption,BP,1
GO:0035624,1,0.97862793,0,2,receptor transactivation,BP,1
GO:0035627,1,0.902439307,0,9,ceramide transport,BP,1
GO:0035630,1,0.949700711,0,5,bone mineralization involved in bone maturation,BP,1
GO:0035633,1,0.968175946,0,3,maintenance of permeability of blood-brain barrier,BP,1
GO:0035634,1,0.84286085,0,15,response to stilbenoid,BP,1
GO:0035635,1,0.946316223,0,5,entry of bacterium into host cell,BP,1
GO:0035637,1,0.60427574,0,47,multicellular organismal signaling,BP,1
GO:0035638,1,0.990919325,0,1,signal maturation,BP,1
GO:0035640,1,0.882306899,0,12,exploration behavior,BP,1
GO:0035641,1,0.94004243,0,6,locomotory exploration behavior,BP,1
GO:0035645,1,0.988662724,0,1,enteric smooth muscle cell differentiation,BP,1
GO:0035646,1,0.904242968,0,9,endosome to melanosome transport,BP,1
GO:0035655,1,0.966715577,0,3,interleukin-18-mediated signaling pathway,BP,1
GO:0035660,1,0.988662928,0,1,MyD88-dependent toll-like receptor 4 signaling pathway,BP,1
GO:0035666,1,0.955811386,0,4,TRIF-dependent toll-like receptor signaling pathway,BP,1
GO:0035668,1,0.966732012,0,3,TRAM-dependent toll-like receptor signaling pathway,BP,1
GO:0035669,1,0.966732012,0,3,TRAM-dependent toll-like receptor 4 signaling pathway,BP,1
GO:0035674,1,0.977492959,0,2,tricarboxylic acid transmembrane transport,BP,1
GO:0035675,1,0.988663763,0,1,neuromast hair cell development,BP,1
GO:0035684,1,0.966369364,0,3,helper T cell extravasation,BP,1
GO:0035685,1,0.966369364,0,3,helper T cell diapedesis,BP,1
GO:0035687,1,0.988662523,0,1,T-helper 1 cell extravasation,BP,1
GO:0035688,1,0.988662523,0,1,T-helper 1 cell diapedesis,BP,1
GO:0035691,1,0.988662828,0,1,macrophage migration inhibitory factor signaling pathway,BP,1
GO:0035694,1,0.977718443,0,2,mitochondrial protein catabolic process,BP,1
GO:0035696,1,0.947801565,0,5,monocyte extravasation,BP,1
GO:0035697,1,0.966369192,0,3,"CD8-positive, alpha-beta T cell extravasation",BP,1
GO:0035698,1,0.977453054,0,2,"CD8-positive, alpha-beta cytotoxic T cell extravasation",BP,1
GO:0035701,1,0.958206748,0,4,hematopoietic stem cell migration,BP,1
GO:0035702,1,0.989371131,0,1,monocyte homeostasis,BP,1
GO:0035709,1,0.966383978,0,3,memory T cell activation,BP,1
GO:0035711,1,0.955424766,0,4,T-helper 1 cell activation,BP,1
GO:0035713,1,0.98905161,0,1,response to nitrogen dioxide,BP,1
GO:0035720,1,0.955437442,0,4,intraciliary anterograde transport,BP,1
GO:0035721,1,0.899576248,0,10,intraciliary retrograde transport,BP,1
GO:0035722,1,0.980671886,0,2,interleukin-12-mediated signaling pathway,BP,1
GO:0035723,1,0.936202502,0,6,interleukin-15-mediated signaling pathway,BP,1
GO:0035724,1,0.991140072,0,1,CD24 biosynthetic process,BP,1
GO:0035726,1,0.935241339,0,6,common myeloid progenitor cell proliferation,BP,1
GO:0035728,1,0.82618679,0,18,response to hepatocyte growth factor,BP,1
GO:0035729,1,0.844180268,0,16,cellular response to hepatocyte growth factor stimulus,BP,1
GO:0035735,1,0.937628246,0,6,intraciliary transport involved in cilium assembly,BP,1
GO:0035737,1,0.988662951,0,1,injection of substance in to other organism,BP,1
GO:0035738,1,0.988662951,0,1,envenomation resulting in modification of morphology or physiology of other organism,BP,1
GO:0035739,1,0.904768305,0,9,"CD4-positive, alpha-beta T cell proliferation",BP,1
GO:0035740,1,0.923480247,0,7,"CD8-positive, alpha-beta T cell proliferation",BP,1
GO:0035743,1,0.892760219,0,10,"CD4-positive, alpha-beta T cell cytokine production",BP,1
GO:0035744,1,0.95541021,0,4,T-helper 1 cell cytokine production,BP,1
GO:0035745,1,0.923849067,0,7,T-helper 2 cell cytokine production,BP,1
GO:0035746,1,0.988662386,0,1,granzyme A production,BP,1
GO:0035747,1,0.955409616,0,4,natural killer cell chemotaxis,BP,1
GO:0035750,1,0.988708632,0,1,protein localization to myelin sheath abaxonal region,BP,1
GO:0035751,1,0.882075526,0,11,regulation of lysosomal lumen pH,BP,1
GO:0035752,1,0.988662921,0,1,lysosomal lumen pH elevation,BP,1
GO:0035754,1,0.934769641,0,6,B cell chemotaxis,BP,1
GO:0035759,1,0.988662931,0,1,mesangial cell-matrix adhesion,BP,1
GO:0035766,1,0.966380091,0,3,cell chemotaxis to fibroblast growth factor,BP,1
GO:0035768,1,0.966380091,0,3,endothelial cell chemotaxis to fibroblast growth factor,BP,1
GO:0035769,1,0.988662786,0,1,B cell chemotaxis across high endothelial venule,BP,1
GO:0035771,1,0.945397652,0,5,interleukin-4-mediated signaling pathway,BP,1
GO:0035772,1,0.97745337,0,2,interleukin-13-mediated signaling pathway,BP,1
GO:0035774,1,0.748107439,0,27,positive regulation of insulin secretion involved in cellular response to glucose stimulus,BP,1
GO:0035780,1,0.988667054,0,1,CD80 biosynthetic process,BP,1
GO:0035781,1,0.977457271,0,2,CD86 biosynthetic process,BP,1
GO:0035782,1,0.988662386,0,1,mature natural killer cell chemotaxis,BP,1
GO:0035783,1,0.988662856,0,1,"CD4-positive, alpha-beta T cell costimulation",BP,1
GO:0035787,1,0.968948834,0,3,cell migration involved in kidney development,BP,1
GO:0035788,1,0.968948834,0,3,cell migration involved in metanephros development,BP,1
GO:0035789,1,0.968948834,0,3,metanephric mesenchymal cell migration,BP,1
GO:0035790,1,0.949829768,0,5,platelet-derived growth factor receptor-alpha signaling pathway,BP,1
GO:0035791,1,0.900433402,0,11,platelet-derived growth factor receptor-beta signaling pathway,BP,1
GO:0035793,1,0.980061868,0,2,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,1
GO:0035795,1,0.934998406,0,6,negative regulation of mitochondrial membrane permeability,BP,1
GO:0035801,1,0.988662931,0,1,adrenal cortex development,BP,1
GO:0035802,1,0.988662931,0,1,adrenal cortex formation,BP,1
GO:0035803,1,0.988663811,0,1,egg coat formation,BP,1
GO:0035810,1,0.923279185,0,7,positive regulation of urine volume,BP,1
GO:0035812,1,0.872415142,0,12,renal sodium excretion,BP,1
GO:0035813,1,0.892546455,0,10,regulation of renal sodium excretion,BP,1
GO:0035814,1,0.95577127,0,4,negative regulation of renal sodium excretion,BP,1
GO:0035815,1,0.933872555,0,6,positive regulation of renal sodium excretion,BP,1
GO:0035822,1,0.988704665,0,1,gene conversion,BP,1
GO:0035825,1,0.819607441,0,18,homologous recombination,BP,1
GO:0035844,1,0.988902196,0,1,cloaca development,BP,1
GO:0035845,1,0.945896545,0,5,photoreceptor cell outer segment organization,BP,1
GO:0035846,1,0.990203922,0,1,oviduct epithelium development,BP,1
GO:0035847,1,0.990203922,0,1,uterine epithelium development,BP,1
GO:0035850,1,0.766607831,0,26,epithelial cell differentiation involved in kidney development,BP,1
GO:0035853,1,0.989526477,0,1,chromosome passenger complex localization to spindle midzone,BP,1
GO:0035854,1,0.989101954,0,1,eosinophil fate commitment,BP,1
GO:0035855,1,0.829722416,0,17,megakaryocyte development,BP,1
GO:0035862,1,0.988662841,0,1,dITP metabolic process,BP,1
GO:0035863,1,0.988662841,0,1,dITP catabolic process,BP,1
GO:0035864,1,0.886849871,0,11,response to potassium ion,BP,1
GO:0035865,1,0.917734204,0,8,cellular response to potassium ion,BP,1
GO:0035871,1,0.948978242,0,5,protein K11-linked deubiquitination,BP,1
GO:0035873,1,0.955423649,0,4,lactate transmembrane transport,BP,1
GO:0035879,1,0.955423649,0,4,plasma membrane lactate transport,BP,1
GO:0035887,1,0.98347822,0,2,aortic smooth muscle cell differentiation,BP,1
GO:0035890,1,0.721148646,0,29,exit from host,BP,1
GO:0035891,1,0.721148646,0,29,exit from host cell,BP,1
GO:0035898,1,0.966612278,0,3,parathyroid hormone secretion,BP,1
GO:0035900,1,0.934535838,0,6,response to isolation stress,BP,1
GO:0035902,1,0.75524107,0,25,response to immobilization stress,BP,1
GO:0035906,1,0.988662927,0,1,descending aorta development,BP,1
GO:0035907,1,0.937187295,0,6,dorsal aorta development,BP,1
GO:0035912,1,0.937187295,0,6,dorsal aorta morphogenesis,BP,1
GO:0035915,1,0.988662923,0,1,pore formation in membrane of other organism,BP,1
GO:0035921,1,0.988662931,0,1,desmosome disassembly,BP,1
GO:0035926,1,0.964114308,0,4,chemokine (C-C motif) ligand 2 secretion,BP,1
GO:0035927,1,0.955879809,0,4,RNA import into mitochondrion,BP,1
GO:0035928,1,0.966844112,0,3,rRNA import into mitochondrion,BP,1
GO:0035931,1,0.93405903,0,6,mineralocorticoid secretion,BP,1
GO:0035932,1,0.93405903,0,6,aldosterone secretion,BP,1
GO:0035934,1,0.966672706,0,3,corticosterone secretion,BP,1
GO:0035936,1,0.966838638,0,3,testosterone secretion,BP,1
GO:0035938,1,0.970767682,0,3,estradiol secretion,BP,1
GO:0035945,1,0.988662931,0,1,mitochondrial ncRNA surveillance,BP,1
GO:0035946,1,0.988662931,0,1,mitochondrial mRNA surveillance,BP,1
GO:0035948,1,0.966528893,0,3,positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter,BP,1
GO:0035962,1,0.966431717,0,3,response to interleukin-13,BP,1
GO:0035963,1,0.966431717,0,3,cellular response to interleukin-13,BP,1
GO:0035964,1,0.944632998,0,5,COPI-coated vesicle budding,BP,1
GO:0035965,1,0.988662927,0,1,cardiolipin acyl-chain remodeling,BP,1
GO:0035971,1,0.988662519,0,1,peptidyl-histidine dephosphorylation,BP,1
GO:0035973,1,0.93084535,0,8,aggrephagy,BP,1
GO:0035977,1,0.955411125,0,4,protein deglycosylation involved in glycoprotein catabolic process,BP,1
GO:0035983,1,0.92333583,0,7,response to trichostatin A,BP,1
GO:0035984,1,0.92333583,0,7,cellular response to trichostatin A,BP,1
GO:0035986,1,0.988662374,0,1,senescence-associated heterochromatin focus assembly,BP,1
GO:0035987,1,0.737956586,0,29,endodermal cell differentiation,BP,1
GO:0035988,1,0.903910601,0,9,chondrocyte proliferation,BP,1
GO:0035989,1,0.991530166,0,1,tendon development,BP,1
GO:0035994,1,0.845324557,0,15,response to muscle stretch,BP,1
GO:0035998,1,0.988662733,0,1,"7,8-dihydroneopterin 3'-triphosphate biosynthetic process",BP,1
GO:0035999,1,0.903065484,0,9,tetrahydrofolate interconversion,BP,1
GO:0036005,1,0.915651618,0,8,response to macrophage colony-stimulating factor,BP,1
GO:0036006,1,0.915651618,0,8,cellular response to macrophage colony-stimulating factor stimulus,BP,1
GO:0036015,1,0.936616131,0,6,response to interleukin-3,BP,1
GO:0036016,1,0.936616131,0,6,cellular response to interleukin-3,BP,1
GO:0036017,1,0.93565724,0,6,response to erythropoietin,BP,1
GO:0036018,1,0.956251828,0,4,cellular response to erythropoietin,BP,1
GO:0036022,1,0.988666206,0,1,limb joint morphogenesis,BP,1
GO:0036023,1,0.988666206,0,1,embryonic skeletal limb joint morphogenesis,BP,1
GO:0036031,1,0.988662931,0,1,recruitment of mRNA capping enzyme to RNA polymerase II holoenzyme complex,BP,1
GO:0036034,1,0.988665517,0,1,mediator complex assembly,BP,1
GO:0036035,1,0.884041871,0,12,osteoclast development,BP,1
GO:0036037,1,0.826007066,0,17,"CD8-positive, alpha-beta T cell activation",BP,1
GO:0036046,1,0.988662869,0,1,protein demalonylation,BP,1
GO:0036047,1,0.988662869,0,1,peptidyl-lysine demalonylation,BP,1
GO:0036048,1,0.988662869,0,1,protein desuccinylation,BP,1
GO:0036049,1,0.988662869,0,1,peptidyl-lysine desuccinylation,BP,1
GO:0036058,1,0.990599343,0,1,filtration diaphragm assembly,BP,1
GO:0036060,1,0.990599343,0,1,slit diaphragm assembly,BP,1
GO:0036065,1,0.893255077,0,10,fucosylation,BP,1
GO:0036066,1,0.934013361,0,6,protein O-linked fucosylation,BP,1
GO:0036071,1,0.988662924,0,1,N-glycan fucosylation,BP,1
GO:0036072,1,0.958826375,0,4,direct ossification,BP,1
GO:0036075,1,0.808459798,0,20,replacement ossification,BP,1
GO:0036085,1,0.988822398,0,1,GDP-fucose import into Golgi lumen,BP,1
GO:0036088,1,0.988662915,0,1,D-serine catabolic process,BP,1
GO:0036089,1,0.938846874,0,6,cleavage furrow formation,BP,1
GO:0036090,1,0.977453144,0,2,cleavage furrow ingression,BP,1
GO:0036092,1,0.906884564,0,11,phosphatidylinositol-3-phosphate biosynthetic process,BP,1
GO:0036093,1,0.933861133,0,6,germ cell proliferation,BP,1
GO:0036098,1,0.988662931,0,1,male germ-line stem cell population maintenance,BP,1
GO:0036111,1,0.977914983,0,2,very long-chain fatty-acyl-CoA metabolic process,BP,1
GO:0036112,1,0.966401544,0,3,medium-chain fatty-acyl-CoA metabolic process,BP,1
GO:0036113,1,0.989104629,0,1,very long-chain fatty-acyl-CoA catabolic process,BP,1
GO:0036114,1,0.988662895,0,1,medium-chain fatty-acyl-CoA catabolic process,BP,1
GO:0036115,1,0.977890069,0,2,fatty-acyl-CoA catabolic process,BP,1
GO:0036116,1,0.988662895,0,1,long-chain fatty-acyl-CoA catabolic process,BP,1
GO:0036118,1,0.977453315,0,2,hyaluranon cable assembly,BP,1
GO:0036119,1,0.733711342,0,29,response to platelet-derived growth factor,BP,1
GO:0036120,1,0.742145076,0,28,cellular response to platelet-derived growth factor stimulus,BP,1
GO:0036123,1,0.979013969,0,2,histone H3-K9 dimethylation,BP,1
GO:0036124,1,0.893621522,0,11,histone H3-K9 trimethylation,BP,1
GO:0036135,1,0.942221218,0,6,Schwann cell migration,BP,1
GO:0036138,1,0.988662868,0,1,peptidyl-histidine hydroxylation,BP,1
GO:0036146,1,0.977453264,0,2,cellular response to mycotoxin,BP,1
GO:0036148,1,0.988662931,0,1,phosphatidylglycerol acyl-chain remodeling,BP,1
GO:0036149,1,0.988662931,0,1,phosphatidylinositol acyl-chain remodeling,BP,1
GO:0036151,1,0.966989413,0,3,phosphatidylcholine acyl-chain remodeling,BP,1
GO:0036153,1,0.988662931,0,1,triglyceride acyl-chain remodeling,BP,1
GO:0036155,1,0.988662931,0,1,acylglycerol acyl-chain remodeling,BP,1
GO:0036158,1,0.966429,0,3,outer dynein arm assembly,BP,1
GO:0036159,1,0.977453368,0,2,inner dynein arm assembly,BP,1
GO:0036164,1,0.988662705,0,1,cell-abiotic substrate adhesion,BP,1
GO:0036166,1,0.969516111,0,3,phenotypic switching,BP,1
GO:0036179,1,0.988793518,0,1,osteoclast maturation,BP,1
GO:0036215,1,0.957011723,0,4,response to stem cell factor,BP,1
GO:0036216,1,0.957011723,0,4,cellular response to stem cell factor stimulus,BP,1
GO:0036228,1,0.978892942,0,2,protein localization to nuclear inner membrane,BP,1
GO:0036230,1,0.754908868,0,25,granulocyte activation,BP,1
GO:0036245,1,0.977456068,0,2,cellular response to menadione,BP,1
GO:0036250,1,0.98866293,0,1,peroxisome transport along microtubule,BP,1
GO:0036257,1,0.955524547,0,4,multivesicular body organization,BP,1
GO:0036258,1,0.966446274,0,3,multivesicular body assembly,BP,1
GO:0036260,1,0.925839797,0,7,RNA capping,BP,1
GO:0036261,1,0.990093308,0,1,7-methylguanosine cap hypermethylation,BP,1
GO:0036265,1,0.933862058,0,6,RNA (guanine-N7)-methylation,BP,1
GO:0036268,1,0.988662931,0,1,swimming,BP,1
GO:0036270,1,0.805132469,0,20,response to diuretic,BP,1
GO:0036276,1,0.988662931,0,1,response to antidepressant,BP,1
GO:0036289,1,0.931172992,0,7,peptidyl-serine autophosphorylation,BP,1
GO:0036290,1,0.988662931,0,1,protein trans-autophosphorylation,BP,1
GO:0036292,1,0.977626495,0,2,DNA rewinding,BP,1
GO:0036295,1,0.835732819,0,16,cellular response to increased oxygen levels,BP,1
GO:0036298,1,0.977747176,0,2,recombinational interstrand cross-link repair,BP,1
GO:0036301,1,0.988663191,0,1,macrophage colony-stimulating factor production,BP,1
GO:0036302,1,0.951924622,0,5,atrioventricular canal development,BP,1
GO:0036316,1,0.988669224,0,1,SREBP-SCAP complex retention in endoplasmic reticulum,BP,1
GO:0036323,1,0.990608413,0,1,vascular endothelial growth factor receptor-1 signaling pathway,BP,1
GO:0036324,1,0.981143498,0,2,vascular endothelial growth factor receptor-2 signaling pathway,BP,1
GO:0036333,1,0.978876342,0,2,hepatocyte homeostasis,BP,1
GO:0036334,1,0.977648202,0,2,epidermal stem cell homeostasis,BP,1
GO:0036335,1,0.98919176,0,1,intestinal stem cell homeostasis,BP,1
GO:0036336,1,0.851541323,0,15,dendritic cell migration,BP,1
GO:0036337,1,0.959316773,0,4,Fas signaling pathway,BP,1
GO:0036342,1,0.922376967,0,8,post-anal tail morphogenesis,BP,1
GO:0036343,1,0.97937249,0,2,psychomotor behavior,BP,1
GO:0036344,1,0.828766267,0,17,platelet morphogenesis,BP,1
GO:0036345,1,0.988662904,0,1,platelet maturation,BP,1
GO:0036351,1,0.988719893,0,1,histone H2A-K13 ubiquitination,BP,1
GO:0036352,1,0.988719893,0,1,histone H2A-K15 ubiquitination,BP,1
GO:0036353,1,0.913287003,0,8,histone H2A-K119 monoubiquitination,BP,1
GO:0036359,1,0.988662931,0,1,renal potassium excretion,BP,1
GO:0036363,1,0.927876059,0,7,transforming growth factor beta activation,BP,1
GO:0036364,1,0.978823184,0,2,transforming growth factor beta1 activation,BP,1
GO:0036366,1,0.988662931,0,1,transforming growth factor beta3 activation,BP,1
GO:0036367,1,0.988662915,0,1,light adaption,BP,1
GO:0036369,1,0.968629346,0,3,transcription factor catabolic process,BP,1
GO:0036372,1,0.988662801,0,1,opsin transport,BP,1
GO:0036376,1,0.931349591,0,7,sodium ion export across plasma membrane,BP,1
GO:0036378,1,0.977453185,0,2,calcitriol biosynthetic process from calciol,BP,1
GO:0036388,1,0.934637142,0,6,pre-replicative complex assembly,BP,1
GO:0036392,1,0.98890353,0,1,chemokine (C-C motif) ligand 20 production,BP,1
GO:0036394,1,0.968866275,0,3,amylase secretion,BP,1
GO:0036395,1,0.979939468,0,2,pancreatic amylase secretion,BP,1
GO:0036399,1,0.988880149,0,1,TCR signalosome assembly,BP,1
GO:0036404,1,0.988662931,0,1,conversion of ds siRNA to ss siRNA,BP,1
GO:0036438,1,0.988663903,0,1,maintenance of lens transparency,BP,1
GO:0036444,1,0.892729967,0,10,calcium import into the mitochondrion,BP,1
GO:0036445,1,0.894912073,0,11,neuronal stem cell division,BP,1
GO:0036446,1,0.957796954,0,4,myofibroblast differentiation,BP,1
GO:0036451,1,0.977453375,0,2,cap mRNA methylation,BP,1
GO:0036462,1,0.933861501,0,6,TRAIL-activated apoptotic signaling pathway,BP,1
GO:0036465,1,0.557838165,0,53,synaptic vesicle recycling,BP,1
GO:0036466,1,0.925986172,0,7,synaptic vesicle recycling via endosome,BP,1
GO:0036471,1,0.988662773,0,1,cellular response to glyoxal,BP,1
GO:0036473,1,0.445603573,0,72,cell death in response to oxidative stress,BP,1
GO:0036474,1,0.728935827,0,28,cell death in response to hydrogen peroxide,BP,1
GO:0036475,1,0.749308454,0,26,neuron death in response to oxidative stress,BP,1
GO:0036476,1,0.955410849,0,4,neuron death in response to hydrogen peroxide,BP,1
GO:0036480,1,0.925043345,0,7,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,BP,1
GO:0036481,1,0.933993591,0,6,intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,1
GO:0036482,1,0.977453096,0,2,neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,1
GO:0036483,1,0.990213291,0,1,neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,1
GO:0036484,1,0.968121257,0,3,trunk neural crest cell migration,BP,1
GO:0036486,1,0.968121257,0,3,ventral trunk neural crest cell migration,BP,1
GO:0036491,1,0.927291088,0,7,regulation of translation initiation in response to endoplasmic reticulum stress,BP,1
GO:0036492,1,0.927291088,0,7,eiF2alpha phosphorylation in response to endoplasmic reticulum stress,BP,1
GO:0036493,1,0.966387354,0,3,positive regulation of translation in response to endoplasmic reticulum stress,BP,1
GO:0036494,1,0.988662903,0,1,positive regulation of translation initiation in response to endoplasmic reticulum stress,BP,1
GO:0036496,1,0.988662931,0,1,regulation of translational initiation by eIF2 alpha dephosphorylation,BP,1
GO:0036497,1,0.988662931,0,1,eIF2alpha dephosphorylation in response to endoplasmic reticulum stress,BP,1
GO:0036499,1,0.903966779,0,9,PERK-mediated unfolded protein response,BP,1
GO:0036500,1,0.966715598,0,3,ATF6-mediated unfolded protein response,BP,1
GO:0036506,1,0.977453375,0,2,maintenance of unfolded protein,BP,1
GO:0036507,1,0.955411125,0,4,protein demannosylation,BP,1
GO:0036508,1,0.955411125,0,4,"protein alpha-1,2-demannosylation",BP,1
GO:0036509,1,0.977453374,0,2,trimming of terminal mannose on B branch,BP,1
GO:0036510,1,0.988662931,0,1,trimming of terminal mannose on C branch,BP,1
GO:0036514,1,0.988662921,0,1,dopaminergic neuron axon guidance,BP,1
GO:0036518,1,0.988662921,0,1,chemorepulsion of dopaminergic neuron axon,BP,1
GO:0036525,1,0.988662773,0,1,protein deglycation,BP,1
GO:0036526,1,0.988662773,0,1,peptidyl-cysteine deglycation,BP,1
GO:0036527,1,0.988662773,0,1,peptidyl-arginine deglycation,BP,1
GO:0036528,1,0.988662773,0,1,peptidyl-lysine deglycation,BP,1
GO:0036529,1,0.988662773,0,1,"protein deglycation, glyoxal removal",BP,1
GO:0036530,1,0.988662773,0,1,"protein deglycation, methylglyoxal removal",BP,1
GO:0036531,1,0.988662773,0,1,glutathione deglycation,BP,1
GO:0038002,1,0.988662577,0,1,endocrine signaling,BP,1
GO:0038003,1,0.944947916,0,5,opioid receptor signaling pathway,BP,1
GO:0038007,1,0.955537197,0,4,netrin-activated signaling pathway,BP,1
GO:0038016,1,0.977925396,0,2,insulin receptor internalization,BP,1
GO:0038018,1,0.98866594,0,1,Wnt receptor catabolic process,BP,1
GO:0038026,1,0.955893628,0,5,reelin-mediated signaling pathway,BP,1
GO:0038027,1,0.952257133,0,5,apolipoprotein A-I-mediated signaling pathway,BP,1
GO:0038028,1,0.977453375,0,2,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,BP,1
GO:0038030,1,0.955418743,0,4,non-canonical Wnt signaling pathway via MAPK cascade,BP,1
GO:0038031,1,0.966377711,0,3,non-canonical Wnt signaling pathway via JNK cascade,BP,1
GO:0038032,1,0.991218787,0,1,termination of G protein-coupled receptor signaling pathway,BP,1
GO:0038044,1,0.971983115,0,3,transforming growth factor-beta secretion,BP,1
GO:0038060,1,0.988662931,0,1,nitric oxide-cGMP-mediated signaling pathway,BP,1
GO:0038061,1,0.39676076,0,84,NIK/NF-kappaB signaling,BP,1
GO:0038063,1,0.922274733,0,8,collagen-activated tyrosine kinase receptor signaling pathway,BP,1
GO:0038065,1,0.922274733,0,8,collagen-activated signaling pathway,BP,1
GO:0038092,1,0.914531447,0,8,nodal signaling pathway,BP,1
GO:0038093,1,0.826695651,0,17,Fc receptor signaling pathway,BP,1
GO:0038094,1,0.864562015,0,13,Fc-gamma receptor signaling pathway,BP,1
GO:0038095,1,0.955410658,0,4,Fc-epsilon receptor signaling pathway,BP,1
GO:0038096,1,0.894676868,0,10,Fc-gamma receptor signaling pathway involved in phagocytosis,BP,1
GO:0038098,1,0.978184261,0,2,sequestering of BMP from receptor via BMP binding,BP,1
GO:0038107,1,0.977453375,0,2,nodal signaling pathway involved in determination of left/right asymmetry,BP,1
GO:0038108,1,0.966525978,0,3,negative regulation of appetite by leptin-mediated signaling pathway,BP,1
GO:0038109,1,0.957011723,0,4,Kit signaling pathway,BP,1
GO:0038110,1,0.967765939,0,3,interleukin-2-mediated signaling pathway,BP,1
GO:0038113,1,0.989379644,0,1,interleukin-9-mediated signaling pathway,BP,1
GO:0038116,1,0.983633866,0,2,chemokine (C-C motif) ligand 21 signaling pathway,BP,1
GO:0038127,1,0.449942775,0,74,ERBB signaling pathway,BP,1
GO:0038128,1,0.988662683,0,1,ERBB2 signaling pathway,BP,1
GO:0038129,1,0.979580446,0,2,ERBB3 signaling pathway,BP,1
GO:0038130,1,0.98897287,0,1,ERBB4 signaling pathway,BP,1
GO:0038145,1,0.956885837,0,4,macrophage colony-stimulating factor signaling pathway,BP,1
GO:0038146,1,0.979211109,0,2,chemokine (C-X-C motif) ligand 12 signaling pathway,BP,1
GO:0038154,1,0.977621594,0,2,interleukin-11-mediated signaling pathway,BP,1
GO:0038156,1,0.968877451,0,3,interleukin-3-mediated signaling pathway,BP,1
GO:0038158,1,0.977919195,0,2,granulocyte colony-stimulating factor signaling pathway,BP,1
GO:0038161,1,0.977453356,0,2,prolactin signaling pathway,BP,1
GO:0038162,1,0.989532094,0,1,erythropoietin-mediated signaling pathway,BP,1
GO:0038163,1,0.956095384,0,4,thrombopoietin-mediated signaling pathway,BP,1
GO:0038165,1,0.967074205,0,3,oncostatin-M-mediated signaling pathway,BP,1
GO:0038171,1,0.95579453,0,4,cannabinoid signaling pathway,BP,1
GO:0038172,1,0.988665705,0,1,interleukin-33-mediated signaling pathway,BP,1
GO:0038178,1,0.977453375,0,2,complement component C5a signaling pathway,BP,1
GO:0038179,1,0.722244156,0,31,neurotrophin signaling pathway,BP,1
GO:0038180,1,0.91319012,0,9,nerve growth factor signaling pathway,BP,1
GO:0038183,1,0.988662931,0,1,bile acid signaling pathway,BP,1
GO:0038185,1,0.988662931,0,1,intracellular bile acid receptor signaling pathway,BP,1
GO:0038203,1,0.933973174,0,6,TORC2 signaling,BP,1
GO:0039007,1,0.988902196,0,1,pronephric nephron morphogenesis,BP,1
GO:0039008,1,0.988902196,0,1,pronephric nephron tubule morphogenesis,BP,1
GO:0039019,1,0.966769656,0,3,pronephric nephron development,BP,1
GO:0039020,1,0.977689941,0,2,pronephric nephron tubule development,BP,1
GO:0039022,1,0.988902196,0,1,pronephric duct development,BP,1
GO:0039023,1,0.988902196,0,1,pronephric duct morphogenesis,BP,1
GO:0039519,1,0.977454927,0,2,modulation by virus of host autophagy,BP,1
GO:0039520,1,0.988662528,0,1,induction by virus of host autophagy,BP,1
GO:0039521,1,0.988664904,0,1,suppression by virus of host autophagy,BP,1
GO:0039526,1,0.977454292,0,2,modulation by virus of host apoptotic process,BP,1
GO:0039528,1,0.80979259,0,20,cytoplasmic pattern recognition receptor signaling pathway in response to virus,BP,1
GO:0039529,1,0.846058028,0,16,RIG-I signaling pathway,BP,1
GO:0039530,1,0.941865235,0,6,MDA-5 signaling pathway,BP,1
GO:0039531,1,0.845392231,0,16,regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,1
GO:0039532,1,0.883818566,0,11,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,1
GO:0039533,1,0.951751937,0,5,regulation of MDA-5 signaling pathway,BP,1
GO:0039534,1,0.956273702,0,4,negative regulation of MDA-5 signaling pathway,BP,1
GO:0039535,1,0.87405818,0,13,regulation of RIG-I signaling pathway,BP,1
GO:0039536,1,0.913776645,0,8,negative regulation of RIG-I signaling pathway,BP,1
GO:0039663,1,0.966387173,0,3,membrane fusion involved in viral entry into host cell,BP,1
GO:0039689,1,0.955536629,0,4,negative stranded viral RNA replication,BP,1
GO:0039692,1,0.916217601,0,8,single stranded viral RNA replication via double stranded DNA intermediate,BP,1
GO:0039694,1,0.792749403,0,22,viral RNA genome replication,BP,1
GO:0039695,1,0.989993728,0,1,DNA-templated viral transcription,BP,1
GO:0039702,1,0.892282253,0,10,viral budding via host ESCRT complex,BP,1
GO:0040001,1,0.762385852,0,25,establishment of mitotic spindle localization,BP,1
GO:0040009,1,0.93430326,0,7,regulation of growth rate,BP,1
GO:0040010,1,0.966466355,0,3,positive regulation of growth rate,BP,1
GO:0040016,1,0.91680136,0,8,embryonic cleavage,BP,1
GO:0040018,1,0.816922517,0,19,positive regulation of multicellular organism growth,BP,1
GO:0040020,1,0.876382399,0,12,regulation of meiotic nuclear division,BP,1
GO:0040030,1,0.989254493,0,1,"regulation of molecular function, epigenetic",BP,1
GO:0040031,1,0.955410545,0,4,snRNA modification,BP,1
GO:0040032,1,0.988662901,0,1,post-embryonic body morphogenesis,BP,1
GO:0040033,1,0.89663506,0,11,"negative regulation of translation, ncRNA-mediated",BP,1
GO:0040036,1,0.80979479,0,19,regulation of fibroblast growth factor receptor signaling pathway,BP,1
GO:0040037,1,0.895679057,0,10,negative regulation of fibroblast growth factor receptor signaling pathway,BP,1
GO:0040038,1,0.958066619,0,4,polar body extrusion after meiotic divisions,BP,1
GO:0042000,1,0.988662929,0,1,translocation of peptides or proteins into host,BP,1
GO:0042023,1,0.917806384,0,8,DNA endoreduplication,BP,1
GO:0042033,1,0.93425563,0,6,chemokine biosynthetic process,BP,1
GO:0042035,1,0.516293486,0,60,regulation of cytokine biosynthetic process,BP,1
GO:0042036,1,0.805434851,0,20,negative regulation of cytokine biosynthetic process,BP,1
GO:0042040,1,0.988676702,0,1,metal incorporation into metallo-molybdopterin complex,BP,1
GO:0042048,1,0.942244943,0,6,olfactory behavior,BP,1
GO:0042053,1,0.892576754,0,10,regulation of dopamine metabolic process,BP,1
GO:0042058,1,0.615272176,0,45,regulation of epidermal growth factor receptor signaling pathway,BP,1
GO:0042059,1,0.796160113,0,21,negative regulation of epidermal growth factor receptor signaling pathway,BP,1
GO:0042069,1,0.882510879,0,11,regulation of catecholamine metabolic process,BP,1
GO:0042074,1,0.907041629,0,9,cell migration involved in gastrulation,BP,1
GO:0042078,1,0.967350082,0,3,germ-line stem cell division,BP,1
GO:0042089,1,0.472074846,0,68,cytokine biosynthetic process,BP,1
GO:0042090,1,0.93679334,0,6,interleukin-12 biosynthetic process,BP,1
GO:0042091,1,0.966407425,0,3,interleukin-10 biosynthetic process,BP,1
GO:0042092,1,0.780327442,0,22,type 2 immune response,BP,1
GO:0042094,1,0.874571661,0,12,interleukin-2 biosynthetic process,BP,1
GO:0042095,1,0.924263875,0,7,interferon-gamma biosynthetic process,BP,1
GO:0042097,1,0.966369907,0,3,interleukin-4 biosynthetic process,BP,1
GO:0042103,1,0.988662929,0,1,positive regulation of T cell homeostatic proliferation,BP,1
GO:0042104,1,0.853701364,0,14,positive regulation of activated T cell proliferation,BP,1
GO:0042107,1,0.472074846,0,68,cytokine metabolic process,BP,1
GO:0042108,1,0.641174268,0,40,positive regulation of cytokine biosynthetic process,BP,1
GO:0042117,1,0.92677392,0,7,monocyte activation,BP,1
GO:0042118,1,0.905294231,0,9,endothelial cell activation,BP,1
GO:0042119,1,0.799232379,0,20,neutrophil activation,BP,1
GO:0042125,1,0.988662891,0,1,protein galactosylation,BP,1
GO:0042126,1,0.977461511,0,2,nitrate metabolic process,BP,1
GO:0042128,1,0.988662942,0,1,nitrate assimilation,BP,1
GO:0042130,1,0.618060988,0,43,negative regulation of T cell proliferation,BP,1
GO:0042135,1,0.863069699,0,13,neurotransmitter catabolic process,BP,1
GO:0042138,1,0.988662931,0,1,meiotic DNA double-strand break formation,BP,1
GO:0042144,1,0.977483385,0,2,"vacuole fusion, non-autophagic",BP,1
GO:0042147,1,0.468606888,0,69,"retrograde transport, endosome to Golgi",BP,1
GO:0042148,1,0.977453375,0,2,strand invasion,BP,1
GO:0042157,1,0.301057278,0,108,lipoprotein metabolic process,BP,1
GO:0042158,1,0.408496535,0,80,lipoprotein biosynthetic process,BP,1
GO:0042159,1,0.865786108,0,14,lipoprotein catabolic process,BP,1
GO:0042167,1,0.955410727,0,4,heme catabolic process,BP,1
GO:0042168,1,0.745251062,0,26,heme metabolic process,BP,1
GO:0042178,1,0.852981819,0,14,xenobiotic catabolic process,BP,1
GO:0042181,1,0.67959742,0,34,ketone biosynthetic process,BP,1
GO:0042182,1,0.933926266,0,6,ketone catabolic process,BP,1
GO:0042196,1,0.977455633,0,2,chlorinated hydrocarbon metabolic process,BP,1
GO:0042197,1,0.977455633,0,2,halogenated hydrocarbon metabolic process,BP,1
GO:0042214,1,0.97746771,0,2,terpene metabolic process,BP,1
GO:0042220,1,0.69244688,0,34,response to cocaine,BP,1
GO:0042222,1,0.966372435,0,3,interleukin-1 biosynthetic process,BP,1
GO:0042223,1,0.991228453,0,1,interleukin-3 biosynthetic process,BP,1
GO:0042226,1,0.876288915,0,12,interleukin-6 biosynthetic process,BP,1
GO:0042228,1,0.914697785,0,8,interleukin-8 biosynthetic process,BP,1
GO:0042245,1,0.977453354,0,2,RNA repair,BP,1
GO:0042247,1,0.988738755,0,1,establishment of planar polarity of follicular epithelium,BP,1
GO:0042249,1,0.919336802,0,8,establishment of planar polarity of embryonic epithelium,BP,1
GO:0042253,1,0.991228453,0,1,granulocyte macrophage colony-stimulating factor biosynthetic process,BP,1
GO:0042254,1,0.069866261,0,233,ribosome biogenesis,BP,1
GO:0042255,1,0.529598378,0,56,ribosome assembly,BP,1
GO:0042256,1,0.935299012,0,6,mature ribosome assembly,BP,1
GO:0042262,1,0.955425999,0,4,DNA protection,BP,1
GO:0042264,1,0.977453306,0,2,peptidyl-aspartic acid hydroxylation,BP,1
GO:0042265,1,0.988662868,0,1,peptidyl-asparagine hydroxylation,BP,1
GO:0042267,1,0.703663802,0,31,natural killer cell mediated cytotoxicity,BP,1
GO:0042268,1,0.914847979,0,8,regulation of cytolysis,BP,1
GO:0042269,1,0.778987071,0,22,regulation of natural killer cell mediated cytotoxicity,BP,1
GO:0042270,1,0.944657601,0,5,protection from natural killer cell mediated cytotoxicity,BP,1
GO:0042271,1,0.977453371,0,2,susceptibility to natural killer cell mediated cytotoxicity,BP,1
GO:0042273,1,0.4871706,0,63,ribosomal large subunit biogenesis,BP,1
GO:0042274,1,0.53021927,0,56,ribosomal small subunit biogenesis,BP,1
GO:0042275,1,0.988958587,0,1,error-free postreplication DNA repair,BP,1
GO:0042278,1,0.495435883,0,62,purine nucleoside metabolic process,BP,1
GO:0042297,1,0.981130579,0,3,vocal learning,BP,1
GO:0042304,1,0.654820461,0,38,regulation of fatty acid biosynthetic process,BP,1
GO:0042306,1,0.618452665,0,44,regulation of protein import into nucleus,BP,1
GO:0042307,1,0.704439377,0,32,positive regulation of protein import into nucleus,BP,1
GO:0042308,1,0.918676953,0,8,negative regulation of protein import into nucleus,BP,1
GO:0042310,1,0.577717728,0,50,vasoconstriction,BP,1
GO:0042311,1,0.773764398,0,23,vasodilation,BP,1
GO:0042316,1,0.988662911,0,1,penicillin metabolic process,BP,1
GO:0042321,1,0.977453176,0,2,"negative regulation of circadian sleep/wake cycle, sleep",BP,1
GO:0042323,1,0.977453176,0,2,"negative regulation of circadian sleep/wake cycle, non-REM sleep",BP,1
GO:0042335,1,0.979899442,0,2,cuticle development,BP,1
GO:0042339,1,0.988662924,0,1,keratan sulfate metabolic process,BP,1
GO:0042340,1,0.988662924,0,1,keratan sulfate catabolic process,BP,1
GO:0042350,1,0.977453296,0,2,GDP-L-fucose biosynthetic process,BP,1
GO:0042351,1,0.988662851,0,1,'de novo' GDP-L-fucose biosynthetic process,BP,1
GO:0042352,1,0.988662931,0,1,GDP-L-fucose salvage,BP,1
GO:0042357,1,0.977777087,0,2,thiamine diphosphate metabolic process,BP,1
GO:0042359,1,0.902665481,0,9,vitamin D metabolic process,BP,1
GO:0042360,1,0.977453375,0,2,vitamin E metabolic process,BP,1
GO:0042362,1,0.912919882,0,8,fat-soluble vitamin biosynthetic process,BP,1
GO:0042363,1,0.988662924,0,1,fat-soluble vitamin catabolic process,BP,1
GO:0042364,1,0.91279487,0,8,water-soluble vitamin biosynthetic process,BP,1
GO:0042365,1,0.977507642,0,2,water-soluble vitamin catabolic process,BP,1
GO:0042368,1,0.933861793,0,6,vitamin D biosynthetic process,BP,1
GO:0042371,1,0.988798145,0,1,vitamin K biosynthetic process,BP,1
GO:0042373,1,0.95554118,0,4,vitamin K metabolic process,BP,1
GO:0042374,1,0.988662743,0,1,phylloquinone metabolic process,BP,1
GO:0042376,1,0.988662743,0,1,phylloquinone catabolic process,BP,1
GO:0042396,1,0.98866289,0,1,phosphagen biosynthetic process,BP,1
GO:0042398,1,0.688960278,0,33,cellular modified amino acid biosynthetic process,BP,1
GO:0042401,1,0.90390019,0,9,cellular biogenic amine biosynthetic process,BP,1
GO:0042402,1,0.862379551,0,13,cellular biogenic amine catabolic process,BP,1
GO:0042403,1,0.883662724,0,12,thyroid hormone metabolic process,BP,1
GO:0042407,1,0.842900172,0,15,cristae formation,BP,1
GO:0042412,1,0.977453337,0,2,taurine biosynthetic process,BP,1
GO:0042413,1,0.988662892,0,1,carnitine catabolic process,BP,1
GO:0042414,1,0.990268193,0,1,epinephrine metabolic process,BP,1
GO:0042415,1,0.935428764,0,6,norepinephrine metabolic process,BP,1
GO:0042416,1,0.882464704,0,11,dopamine biosynthetic process,BP,1
GO:0042417,1,0.789509737,0,21,dopamine metabolic process,BP,1
GO:0042420,1,0.977453361,0,2,dopamine catabolic process,BP,1
GO:0042421,1,0.967990957,0,3,norepinephrine biosynthetic process,BP,1
GO:0042423,1,0.854146331,0,14,catecholamine biosynthetic process,BP,1
GO:0042424,1,0.977453361,0,2,catecholamine catabolic process,BP,1
GO:0042426,1,0.977692551,0,2,choline catabolic process,BP,1
GO:0042427,1,0.977453375,0,2,serotonin biosynthetic process,BP,1
GO:0042428,1,0.918037402,0,8,serotonin metabolic process,BP,1
GO:0042430,1,0.847548895,0,15,indole-containing compound metabolic process,BP,1
GO:0042435,1,0.977453375,0,2,indole-containing compound biosynthetic process,BP,1
GO:0042436,1,0.923268725,0,7,indole-containing compound catabolic process,BP,1
GO:0042438,1,0.948550388,0,5,melanin biosynthetic process,BP,1
GO:0042439,1,0.944596103,0,5,ethanolamine-containing compound metabolic process,BP,1
GO:0042440,1,0.638979079,0,40,pigment metabolic process,BP,1
GO:0042443,1,0.988662931,0,1,phenylethylamine metabolic process,BP,1
GO:0042447,1,0.893557644,0,10,hormone catabolic process,BP,1
GO:0042450,1,0.977453348,0,2,arginine biosynthetic process via ornithine,BP,1
GO:0042451,1,0.796163798,0,20,purine nucleoside biosynthetic process,BP,1
GO:0042454,1,0.873675617,0,12,ribonucleoside catabolic process,BP,1
GO:0042473,1,0.945468438,0,5,outer ear morphogenesis,BP,1
GO:0042474,1,0.923285549,0,7,middle ear morphogenesis,BP,1
GO:0042475,1,0.599274717,0,47,odontogenesis of dentin-containing tooth,BP,1
GO:0042476,1,0.470669587,0,70,odontogenesis,BP,1
GO:0042478,1,0.988662899,0,1,regulation of eye photoreceptor cell development,BP,1
GO:0042480,1,0.988662899,0,1,negative regulation of eye photoreceptor cell development,BP,1
GO:0042481,1,0.899762331,0,10,regulation of odontogenesis,BP,1
GO:0042482,1,0.957874897,0,4,positive regulation of odontogenesis,BP,1
GO:0042483,1,0.960836453,0,4,negative regulation of odontogenesis,BP,1
GO:0042487,1,0.945574461,0,5,regulation of odontogenesis of dentin-containing tooth,BP,1
GO:0042488,1,0.989447732,0,1,positive regulation of odontogenesis of dentin-containing tooth,BP,1
GO:0042489,1,0.988727293,0,1,negative regulation of odontogenesis of dentin-containing tooth,BP,1
GO:0042494,1,0.966452548,0,3,detection of bacterial lipoprotein,BP,1
GO:0042495,1,0.977495264,0,2,detection of triacyl bacterial lipopeptide,BP,1
GO:0042496,1,0.977518023,0,2,detection of diacyl bacterial lipopeptide,BP,1
GO:0042501,1,0.948687521,0,5,serine phosphorylation of STAT protein,BP,1
GO:0042533,1,0.826986168,0,17,tumor necrosis factor biosynthetic process,BP,1
GO:0042534,1,0.826986168,0,17,regulation of tumor necrosis factor biosynthetic process,BP,1
GO:0042535,1,0.855683442,0,14,positive regulation of tumor necrosis factor biosynthetic process,BP,1
GO:0042536,1,0.977588923,0,2,negative regulation of tumor necrosis factor biosynthetic process,BP,1
GO:0042537,1,0.787272429,0,21,benzene-containing compound metabolic process,BP,1
GO:0042538,1,0.872602091,0,12,hyperosmotic salinity response,BP,1
GO:0042539,1,0.992061117,0,1,hypotonic salinity response,BP,1
GO:0042541,1,0.91358135,0,8,hemoglobin biosynthetic process,BP,1
GO:0042543,1,0.98866282,0,1,protein N-linked glycosylation via arginine,BP,1
GO:0042546,1,0.988662881,0,1,cell wall biogenesis,BP,1
GO:0042551,1,0.754952813,0,27,neuron maturation,BP,1
GO:0042552,1,0.370594976,0,91,myelination,BP,1
GO:0042554,1,0.767508611,0,24,superoxide anion generation,BP,1
GO:0042558,1,0.736841783,0,27,pteridine-containing compound metabolic process,BP,1
GO:0042559,1,0.862947688,0,13,pteridine-containing compound biosynthetic process,BP,1
GO:0042560,1,0.966423565,0,3,pteridine-containing compound catabolic process,BP,1
GO:0042572,1,0.78897248,0,21,retinol metabolic process,BP,1
GO:0042573,1,0.892199343,0,10,retinoic acid metabolic process,BP,1
GO:0042574,1,0.902479653,0,9,retinal metabolic process,BP,1
GO:0042590,1,0.914716676,0,8,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,1
GO:0042596,1,0.811364102,0,20,fear response,BP,1
GO:0042628,1,0.977546654,0,2,mating plug formation,BP,1
GO:0042631,1,0.977673155,0,2,cellular response to water deprivation,BP,1
GO:0042635,1,0.945060653,0,5,positive regulation of hair cycle,BP,1
GO:0042636,1,0.977457848,0,2,negative regulation of hair cycle,BP,1
GO:0042637,1,0.988754356,0,1,catagen,BP,1
GO:0042640,1,0.988666206,0,1,anagen,BP,1
GO:0042659,1,0.934099599,0,6,regulation of cell fate specification,BP,1
GO:0042661,1,0.966615674,0,3,regulation of mesodermal cell fate specification,BP,1
GO:0042662,1,0.988665047,0,1,negative regulation of mesodermal cell fate specification,BP,1
GO:0042663,1,0.988662923,0,1,regulation of endodermal cell fate specification,BP,1
GO:0042665,1,0.988662931,0,1,regulation of ectodermal cell fate specification,BP,1
GO:0042666,1,0.988662931,0,1,negative regulation of ectodermal cell fate specification,BP,1
GO:0042670,1,0.977689918,0,2,retinal cone cell differentiation,BP,1
GO:0042693,1,0.956496206,0,4,muscle cell fate commitment,BP,1
GO:0042695,1,0.958401177,0,4,thelarche,BP,1
GO:0042699,1,0.955411071,0,4,follicle-stimulating hormone signaling pathway,BP,1
GO:0042701,1,0.94545826,0,5,progesterone secretion,BP,1
GO:0042706,1,0.988663811,0,1,eye photoreceptor cell fate commitment,BP,1
GO:0042711,1,0.932045542,0,7,maternal behavior,BP,1
GO:0042713,1,0.977453537,0,2,sperm ejaculation,BP,1
GO:0042723,1,0.966689938,0,3,thiamine-containing compound metabolic process,BP,1
GO:0042726,1,0.966723349,0,3,flavin-containing compound metabolic process,BP,1
GO:0042727,1,0.977541516,0,2,flavin-containing compound biosynthetic process,BP,1
GO:0042728,1,0.988935291,0,1,flavin-containing compound catabolic process,BP,1
GO:0042730,1,0.805594623,0,19,fibrinolysis,BP,1
GO:0042732,1,0.966704912,0,3,D-xylose metabolic process,BP,1
GO:0042742,1,0.335512397,0,98,defense response to bacterium,BP,1
GO:0042743,1,0.677831681,0,35,hydrogen peroxide metabolic process,BP,1
GO:0042744,1,0.817775657,0,18,hydrogen peroxide catabolic process,BP,1
GO:0042746,1,0.988662843,0,1,"circadian sleep/wake cycle, wakefulness",BP,1
GO:0042747,1,0.966396098,0,3,"circadian sleep/wake cycle, REM sleep",BP,1
GO:0042748,1,0.912795791,0,8,"circadian sleep/wake cycle, non-REM sleep",BP,1
GO:0042758,1,0.945697317,0,5,long-chain fatty acid catabolic process,BP,1
GO:0042759,1,0.944583655,0,5,long-chain fatty acid biosynthetic process,BP,1
GO:0042760,1,0.937386888,0,6,very long-chain fatty acid catabolic process,BP,1
GO:0042761,1,0.91349671,0,8,very long-chain fatty acid biosynthetic process,BP,1
GO:0042762,1,0.929355407,0,7,regulation of sulfur metabolic process,BP,1
GO:0042766,1,0.977477201,0,2,nucleosome mobilization,BP,1
GO:0042769,1,0.925954571,0,7,"DNA damage response, detection of DNA damage",BP,1
GO:0042773,1,0.591226671,0,46,ATP synthesis coupled electron transport,BP,1
GO:0042774,1,0.988662931,0,1,plasma membrane ATP synthesis coupled electron transport,BP,1
GO:0042775,1,0.60491285,0,44,mitochondrial ATP synthesis coupled electron transport,BP,1
GO:0042776,1,0.923268218,0,7,mitochondrial ATP synthesis coupled proton transport,BP,1
GO:0042779,1,0.96656362,0,3,tRNA 3'-trailer cleavage,BP,1
GO:0042780,1,0.913107265,0,8,tRNA 3'-end processing,BP,1
GO:0042789,1,0.847127991,0,16,mRNA transcription by RNA polymerase II,BP,1
GO:0042790,1,0.851463972,0,15,nucleolar large rRNA transcription by RNA polymerase I,BP,1
GO:0042791,1,0.99280012,0,1,5S class rRNA transcription by RNA polymerase III,BP,1
GO:0042795,1,0.924833361,0,7,snRNA transcription by RNA polymerase II,BP,1
GO:0042796,1,0.935444187,0,6,snRNA transcription by RNA polymerase III,BP,1
GO:0042816,1,0.966369706,0,3,vitamin B6 metabolic process,BP,1
GO:0042819,1,0.97745317,0,2,vitamin B6 biosynthetic process,BP,1
GO:0042820,1,0.988662931,0,1,vitamin B6 catabolic process,BP,1
GO:0042822,1,0.966369706,0,3,pyridoxal phosphate metabolic process,BP,1
GO:0042823,1,0.97745317,0,2,pyridoxal phosphate biosynthetic process,BP,1
GO:0042832,1,0.862333706,0,13,defense response to protozoan,BP,1
GO:0042839,1,0.988662801,0,1,D-glucuronate metabolic process,BP,1
GO:0042840,1,0.988662801,0,1,D-glucuronate catabolic process,BP,1
GO:0042843,1,0.988662931,0,1,D-xylose catabolic process,BP,1
GO:0042851,1,0.955411096,0,4,L-alanine metabolic process,BP,1
GO:0042853,1,0.966369884,0,3,L-alanine catabolic process,BP,1
GO:0042868,1,0.988662931,0,1,antisense RNA metabolic process,BP,1
GO:0042883,1,0.988662871,0,1,cysteine transport,BP,1
GO:0042892,1,0.98868615,0,1,chloramphenicol transport,BP,1
GO:0042904,1,0.977453375,0,2,9-cis-retinoic acid biosynthetic process,BP,1
GO:0042905,1,0.977453375,0,2,9-cis-retinoic acid metabolic process,BP,1
GO:0042908,1,0.934520925,0,6,xenobiotic transport,BP,1
GO:0042939,1,0.988662899,0,1,tripeptide transport,BP,1
GO:0042940,1,0.955453577,0,4,D-amino acid transport,BP,1
GO:0042942,1,0.977453383,0,2,D-serine transport,BP,1
GO:0042946,1,0.988662931,0,1,glucoside transport,BP,1
GO:0042953,1,0.8893855,0,12,lipoprotein transport,BP,1
GO:0042976,1,0.904095452,0,9,activation of Janus kinase activity,BP,1
GO:0042982,1,0.621466522,0,43,amyloid precursor protein metabolic process,BP,1
GO:0042983,1,0.916367291,0,8,amyloid precursor protein biosynthetic process,BP,1
GO:0042984,1,0.916367291,0,8,regulation of amyloid precursor protein biosynthetic process,BP,1
GO:0042985,1,0.937417768,0,6,negative regulation of amyloid precursor protein biosynthetic process,BP,1
GO:0042986,1,0.977555665,0,2,positive regulation of amyloid precursor protein biosynthetic process,BP,1
GO:0042987,1,0.688415696,0,34,amyloid precursor protein catabolic process,BP,1
GO:0042989,1,0.955515017,0,4,sequestering of actin monomers,BP,1
GO:0042994,1,0.862187967,0,13,cytoplasmic sequestering of transcription factor,BP,1
GO:0042996,1,0.893459153,0,10,regulation of Golgi to plasma membrane protein transport,BP,1
GO:0042997,1,0.935109213,0,6,negative regulation of Golgi to plasma membrane protein transport,BP,1
GO:0042998,1,0.955471414,0,4,positive regulation of Golgi to plasma membrane protein transport,BP,1
GO:0042999,1,0.989979471,0,1,regulation of Golgi to plasma membrane CFTR protein transport,BP,1
GO:0043000,1,0.967656939,0,3,Golgi to plasma membrane CFTR protein transport,BP,1
GO:0043001,1,0.666535684,0,38,Golgi to plasma membrane protein transport,BP,1
GO:0043002,1,0.989979471,0,1,negative regulation of Golgi to plasma membrane CFTR protein transport,BP,1
GO:0043004,1,0.989979471,0,1,cytoplasmic sequestering of CFTR protein,BP,1
GO:0043007,1,0.988663097,0,1,maintenance of rDNA,BP,1
GO:0043011,1,0.877560922,0,12,myeloid dendritic cell differentiation,BP,1
GO:0043032,1,0.824035122,0,17,positive regulation of macrophage activation,BP,1
GO:0043038,1,0.593961734,0,46,amino acid activation,BP,1
GO:0043039,1,0.600800708,0,45,tRNA aminoacylation,BP,1
GO:0043041,1,0.988662931,0,1,amino acid activation for nonribosomal peptide biosynthetic process,BP,1
GO:0043044,1,0.720303588,0,31,ATP-dependent chromatin remodeling,BP,1
GO:0043045,1,0.949668194,0,5,DNA methylation involved in embryo development,BP,1
GO:0043046,1,0.956267244,0,4,DNA methylation involved in gamete generation,BP,1
GO:0043048,1,0.988662931,0,1,dolichyl monophosphate biosynthetic process,BP,1
GO:0043060,1,0.98866404,0,1,meiotic metaphase I plate congression,BP,1
GO:0043062,1,0.13034898,0,189,extracellular structure organization,BP,1
GO:0043084,1,0.925148151,0,7,penile erection,BP,1
GO:0043090,1,0.842455061,0,16,amino acid import,BP,1
GO:0043095,1,0.988662559,0,1,regulation of GTP cyclohydrolase I activity,BP,1
GO:0043096,1,0.966369356,0,3,purine nucleobase salvage,BP,1
GO:0043101,1,0.913170103,0,8,purine-containing compound salvage,BP,1
GO:0043103,1,0.977453234,0,2,hypoxanthine salvage,BP,1
GO:0043105,1,0.988662559,0,1,negative regulation of GTP cyclohydrolase I activity,BP,1
GO:0043111,1,0.956214536,0,4,replication fork arrest,BP,1
GO:0043113,1,0.662919361,0,40,receptor clustering,BP,1
GO:0043116,1,0.883392882,0,12,negative regulation of vascular permeability,BP,1
GO:0043126,1,0.988662856,0,1,regulation of 1-phosphatidylinositol 4-kinase activity,BP,1
GO:0043128,1,0.988662856,0,1,positive regulation of 1-phosphatidylinositol 4-kinase activity,BP,1
GO:0043132,1,0.978021552,0,2,NAD transport,BP,1
GO:0043133,1,0.988662931,0,1,hindgut contraction,BP,1
GO:0043134,1,0.988662931,0,1,regulation of hindgut contraction,BP,1
GO:0043137,1,0.955605543,0,4,"DNA replication, removal of RNA primer",BP,1
GO:0043144,1,0.882075156,0,11,snoRNA processing,BP,1
GO:0043149,1,0.477252829,0,68,stress fiber assembly,BP,1
GO:0043152,1,0.977453374,0,2,induction of bacterial agglutination,BP,1
GO:0043162,1,0.827570839,0,17,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,1
GO:0043171,1,0.831438404,0,17,peptide catabolic process,BP,1
GO:0043181,1,0.988662885,0,1,vacuolar sequestering,BP,1
GO:0043217,1,0.886691562,0,11,myelin maintenance,BP,1
GO:0043242,1,0.579714852,0,53,negative regulation of protein complex disassembly,BP,1
GO:0043243,1,0.800021866,0,21,positive regulation of protein complex disassembly,BP,1
GO:0043244,1,0.447778971,0,77,regulation of protein complex disassembly,BP,1
GO:0043248,1,0.843081126,0,15,proteasome assembly,BP,1
GO:0043252,1,0.924107363,0,7,sodium-independent organic anion transport,BP,1
GO:0043267,1,0.821774103,0,19,negative regulation of potassium ion transport,BP,1
GO:0043277,1,0.678900229,0,36,apoptotic cell clearance,BP,1
GO:0043278,1,0.711042829,0,31,response to morphine,BP,1
GO:0043280,1,0.395373207,0,84,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,1
GO:0043297,1,0.626739567,0,44,apical junction assembly,BP,1
GO:0043299,1,0.624970254,0,42,leukocyte degranulation,BP,1
GO:0043300,1,0.707485344,0,31,regulation of leukocyte degranulation,BP,1
GO:0043301,1,0.913302668,0,8,negative regulation of leukocyte degranulation,BP,1
GO:0043302,1,0.828388926,0,17,positive regulation of leukocyte degranulation,BP,1
GO:0043303,1,0.732021365,0,28,mast cell degranulation,BP,1
GO:0043304,1,0.765584865,0,24,regulation of mast cell degranulation,BP,1
GO:0043305,1,0.944649882,0,5,negative regulation of mast cell degranulation,BP,1
GO:0043306,1,0.876519606,0,12,positive regulation of mast cell degranulation,BP,1
GO:0043307,1,0.955410644,0,4,eosinophil activation,BP,1
GO:0043308,1,0.966369421,0,3,eosinophil degranulation,BP,1
GO:0043309,1,0.98866274,0,1,regulation of eosinophil degranulation,BP,1
GO:0043311,1,0.98866274,0,1,positive regulation of eosinophil degranulation,BP,1
GO:0043312,1,0.906132682,0,9,neutrophil degranulation,BP,1
GO:0043313,1,0.958468703,0,4,regulation of neutrophil degranulation,BP,1
GO:0043314,1,0.988662931,0,1,negative regulation of neutrophil degranulation,BP,1
GO:0043315,1,0.978042744,0,2,positive regulation of neutrophil degranulation,BP,1
GO:0043316,1,0.977958437,0,2,cytotoxic T cell degranulation,BP,1
GO:0043317,1,0.989134498,0,1,regulation of cytotoxic T cell degranulation,BP,1
GO:0043318,1,0.989134498,0,1,negative regulation of cytotoxic T cell degranulation,BP,1
GO:0043320,1,0.924343909,0,7,natural killer cell degranulation,BP,1
GO:0043321,1,0.966369851,0,3,regulation of natural killer cell degranulation,BP,1
GO:0043322,1,0.977453318,0,2,negative regulation of natural killer cell degranulation,BP,1
GO:0043323,1,0.977453356,0,2,positive regulation of natural killer cell degranulation,BP,1
GO:0043328,1,0.955410454,0,4,protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,1
GO:0043330,1,0.72782532,0,29,response to exogenous dsRNA,BP,1
GO:0043331,1,0.680582022,0,35,response to dsRNA,BP,1
GO:0043353,1,0.932492189,0,7,enucleate erythrocyte differentiation,BP,1
GO:0043366,1,0.968877902,0,3,beta selection,BP,1
GO:0043368,1,0.843178767,0,16,positive T cell selection,BP,1
GO:0043369,1,0.930245801,0,7,"CD4-positive or CD8-positive, alpha-beta T cell lineage commitment",BP,1
GO:0043370,1,0.715192305,0,30,"regulation of CD4-positive, alpha-beta T cell differentiation",BP,1
GO:0043371,1,0.856857179,0,14,"negative regulation of CD4-positive, alpha-beta T cell differentiation",BP,1
GO:0043372,1,0.798621065,0,20,"positive regulation of CD4-positive, alpha-beta T cell differentiation",BP,1
GO:0043373,1,0.951461443,0,5,"CD4-positive, alpha-beta T cell lineage commitment",BP,1
GO:0043374,1,0.925221528,0,7,"CD8-positive, alpha-beta T cell differentiation",BP,1
GO:0043376,1,0.957271477,0,4,"regulation of CD8-positive, alpha-beta T cell differentiation",BP,1
GO:0043377,1,0.988662915,0,1,"negative regulation of CD8-positive, alpha-beta T cell differentiation",BP,1
GO:0043378,1,0.968251444,0,3,"positive regulation of CD8-positive, alpha-beta T cell differentiation",BP,1
GO:0043379,1,0.978391123,0,2,memory T cell differentiation,BP,1
GO:0043380,1,0.989085172,0,1,regulation of memory T cell differentiation,BP,1
GO:0043383,1,0.9251481,0,7,negative T cell selection,BP,1
GO:0043385,1,0.966371257,0,3,mycotoxin metabolic process,BP,1
GO:0043387,1,0.966371257,0,3,mycotoxin catabolic process,BP,1
GO:0043392,1,0.677134676,0,35,negative regulation of DNA binding,BP,1
GO:0043400,1,0.988663451,0,1,cortisol secretion,BP,1
GO:0043402,1,0.965871314,0,4,glucocorticoid mediated signaling pathway,BP,1
GO:0043418,1,0.966390496,0,3,homocysteine catabolic process,BP,1
GO:0043420,1,0.966369808,0,3,anthranilate metabolic process,BP,1
GO:0043435,1,0.977484007,0,2,response to corticotropin-releasing hormone,BP,1
GO:0043455,1,0.931175984,0,7,regulation of secondary metabolic process,BP,1
GO:0043456,1,0.966369336,0,3,regulation of pentose-phosphate shunt,BP,1
GO:0043457,1,0.774353195,0,23,regulation of cellular respiration,BP,1
GO:0043461,1,0.923441904,0,7,proton-transporting ATP synthase complex assembly,BP,1
GO:0043462,1,0.544813551,0,54,regulation of ATPase activity,BP,1
GO:0043465,1,0.955411121,0,4,regulation of fermentation,BP,1
GO:0043471,1,0.873674729,0,12,regulation of cellular carbohydrate catabolic process,BP,1
GO:0043473,1,0.49687051,0,65,pigmentation,BP,1
GO:0043476,1,0.904242968,0,9,pigment accumulation,BP,1
GO:0043482,1,0.904242968,0,9,cellular pigment accumulation,BP,1
GO:0043485,1,0.904242968,0,9,endosome to pigment granule transport,BP,1
GO:0043486,1,0.857276763,0,14,histone exchange,BP,1
GO:0043490,1,0.966369909,0,3,malate-aspartate shuttle,BP,1
GO:0043496,1,0.833930342,0,16,regulation of protein homodimerization activity,BP,1
GO:0043500,1,0.392950035,0,86,muscle adaptation,BP,1
GO:0043501,1,0.869753499,0,13,skeletal muscle adaptation,BP,1
GO:0043502,1,0.432242959,0,78,regulation of muscle adaptation,BP,1
GO:0043504,1,0.946177206,0,5,mitochondrial DNA repair,BP,1
GO:0043506,1,0.488821683,0,66,regulation of JUN kinase activity,BP,1
GO:0043507,1,0.547398363,0,56,positive regulation of JUN kinase activity,BP,1
GO:0043508,1,0.90371639,0,9,negative regulation of JUN kinase activity,BP,1
GO:0043517,1,0.900987193,0,10,"positive regulation of DNA damage response, signal transduction by p53 class mediator",BP,1
GO:0043519,1,0.977453347,0,2,regulation of myosin II filament organization,BP,1
GO:0043525,1,0.51228396,0,61,positive regulation of neuron apoptotic process,BP,1
GO:0043537,1,0.751525153,0,26,negative regulation of blood vessel endothelial cell migration,BP,1
GO:0043538,1,0.988757639,0,1,regulation of actin phosphorylation,BP,1
GO:0043545,1,0.923442863,0,7,molybdopterin cofactor metabolic process,BP,1
GO:0043550,1,0.618535685,0,45,regulation of lipid kinase activity,BP,1
GO:0043551,1,0.67466984,0,37,regulation of phosphatidylinositol 3-kinase activity,BP,1
GO:0043552,1,0.793278958,0,22,positive regulation of phosphatidylinositol 3-kinase activity,BP,1
GO:0043553,1,0.970018548,0,3,negative regulation of phosphatidylinositol 3-kinase activity,BP,1
GO:0043556,1,0.988662931,0,1,regulation of translation in response to oxidative stress,BP,1
GO:0043558,1,0.846493553,0,15,regulation of translational initiation in response to stress,BP,1
GO:0043562,1,0.902440609,0,9,cellular response to nitrogen levels,BP,1
GO:0043568,1,0.923453339,0,7,positive regulation of insulin-like growth factor receptor signaling pathway,BP,1
GO:0043569,1,0.937709446,0,6,negative regulation of insulin-like growth factor receptor signaling pathway,BP,1
GO:0043570,1,0.934198962,0,6,maintenance of DNA repeat elements,BP,1
GO:0043574,1,0.846502513,0,15,peroxisomal transport,BP,1
GO:0043576,1,0.905803039,0,9,regulation of respiratory gaseous exchange,BP,1
GO:0043578,1,0.977453375,0,2,nuclear matrix organization,BP,1
GO:0043584,1,0.922558636,0,8,nose development,BP,1
GO:0043585,1,0.988662931,0,1,nose morphogenesis,BP,1
GO:0043586,1,0.926534457,0,7,tongue development,BP,1
GO:0043587,1,0.96637321,0,3,tongue morphogenesis,BP,1
GO:0043589,1,0.938084695,0,6,skin morphogenesis,BP,1
GO:0043602,1,0.988671149,0,1,nitrate catabolic process,BP,1
GO:0043605,1,0.989186014,0,1,cellular amide catabolic process,BP,1
GO:0043606,1,0.966369924,0,3,formamide metabolic process,BP,1
GO:0043610,1,0.994210854,0,1,regulation of carbohydrate utilization,BP,1
GO:0043615,1,0.956875831,0,4,astrocyte cell migration,BP,1
GO:0043622,1,0.967588111,0,3,cortical microtubule organization,BP,1
GO:0043624,1,0.388488572,0,89,cellular protein complex disassembly,BP,1
GO:0043627,1,0.410552535,0,80,response to estrogen,BP,1
GO:0043628,1,0.678697084,0,34,ncRNA 3'-end processing,BP,1
GO:0043629,1,0.977453375,0,2,ncRNA polyadenylation,BP,1
GO:0043630,1,0.988662931,0,1,ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process,BP,1
GO:0043631,1,0.644368632,0,40,RNA polyadenylation,BP,1
GO:0043633,1,0.913243171,0,8,polyadenylation-dependent RNA catabolic process,BP,1
GO:0043634,1,0.923268535,0,7,polyadenylation-dependent ncRNA catabolic process,BP,1
GO:0043647,1,0.633170076,0,43,inositol phosphate metabolic process,BP,1
GO:0043650,1,0.879599892,0,12,dicarboxylic acid biosynthetic process,BP,1
GO:0043651,1,0.902439111,0,9,linoleic acid metabolic process,BP,1
GO:0043652,1,0.908187079,0,9,engulfment of apoptotic cell,BP,1
GO:0043653,1,0.902698013,0,9,mitochondrial fragmentation involved in apoptotic process,BP,1
GO:0043654,1,0.957003663,0,4,recognition of apoptotic cell,BP,1
GO:0043666,1,0.454896734,0,73,regulation of phosphoprotein phosphatase activity,BP,1
GO:0043686,1,0.969461747,0,3,co-translational protein modification,BP,1
GO:0043687,1,0.815940809,0,18,post-translational protein modification,BP,1
GO:0043691,1,0.896804466,0,10,reverse cholesterol transport,BP,1
GO:0043696,1,0.966369909,0,3,dedifferentiation,BP,1
GO:0043697,1,0.966369909,0,3,cell dedifferentiation,BP,1
GO:0043901,1,0.257117736,0,121,negative regulation of multi-organism process,BP,1
GO:0043922,1,0.892648922,0,10,negative regulation by host of viral transcription,BP,1
GO:0043928,1,0.892948551,0,10,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,BP,1
GO:0043931,1,0.908348011,0,10,ossification involved in bone maturation,BP,1
GO:0043932,1,0.966396378,0,3,ossification involved in bone remodeling,BP,1
GO:0043946,1,0.988662823,0,1,positive regulation of catalytic activity in other organism involved in symbiotic interaction,BP,1
GO:0043947,1,0.988662823,0,1,positive regulation by host of symbiont catalytic activity,BP,1
GO:0043949,1,0.724899871,0,29,regulation of cAMP-mediated signaling,BP,1
GO:0043950,1,0.885735666,0,11,positive regulation of cAMP-mediated signaling,BP,1
GO:0043951,1,0.818168615,0,18,negative regulation of cAMP-mediated signaling,BP,1
GO:0043954,1,0.622913682,0,44,cellular component maintenance,BP,1
GO:0043968,1,0.848941353,0,15,histone H2A acetylation,BP,1
GO:0043969,1,0.966374283,0,3,histone H2B acetylation,BP,1
GO:0043970,1,0.916388975,0,8,histone H3-K9 acetylation,BP,1
GO:0043972,1,0.977453375,0,2,histone H3-K23 acetylation,BP,1
GO:0043973,1,0.988664241,0,1,histone H3-K4 acetylation,BP,1
GO:0043974,1,0.979481837,0,2,histone H3-K27 acetylation,BP,1
GO:0043977,1,0.988667239,0,1,histone H2A-K5 acetylation,BP,1
GO:0043979,1,0.988663097,0,1,histone H2B-K5 acetylation,BP,1
GO:0043980,1,0.988667239,0,1,histone H2B-K12 acetylation,BP,1
GO:0043981,1,0.830932979,0,17,histone H4-K5 acetylation,BP,1
GO:0043982,1,0.830932979,0,17,histone H4-K8 acetylation,BP,1
GO:0043983,1,0.91673976,0,8,histone H4-K12 acetylation,BP,1
GO:0043984,1,0.805348381,0,20,histone H4-K16 acetylation,BP,1
GO:0043985,1,0.955429899,0,4,histone H4-R3 methylation,BP,1
GO:0043987,1,0.969001164,0,3,histone H3-S10 phosphorylation,BP,1
GO:0043988,1,0.969001162,0,3,histone H3-S28 phosphorylation,BP,1
GO:0043990,1,0.991354399,0,1,histone H2A-S1 phosphorylation,BP,1
GO:0044003,1,0.731355213,0,28,modification by symbiont of host morphology or physiology,BP,1
GO:0044004,1,0.966378698,0,3,disruption by symbiont of host cell,BP,1
GO:0044007,1,0.991293742,0,1,dissemination or transmission of symbiont from host,BP,1
GO:0044026,1,0.94817007,0,5,DNA hypermethylation,BP,1
GO:0044027,1,0.956265382,0,4,hypermethylation of CpG island,BP,1
GO:0044028,1,0.979917251,0,2,DNA hypomethylation,BP,1
GO:0044029,1,0.979917251,0,2,hypomethylation of CpG island,BP,1
GO:0044030,1,0.787587145,0,22,regulation of DNA methylation,BP,1
GO:0044033,1,0.988662869,0,1,multi-organism metabolic process,BP,1
GO:0044035,1,0.988662869,0,1,multi-organism catabolic process,BP,1
GO:0044036,1,0.967049789,0,3,cell wall macromolecule metabolic process,BP,1
GO:0044038,1,0.988662881,0,1,cell wall macromolecule biosynthetic process,BP,1
GO:0044053,1,0.988662929,0,1,translocation of peptides or proteins into host cell cytoplasm,BP,1
GO:0044058,1,0.759713592,0,25,regulation of digestive system process,BP,1
GO:0044062,1,0.865207339,0,13,regulation of excretion,BP,1
GO:0044065,1,0.916178673,0,8,regulation of respiratory system process,BP,1
GO:0044068,1,0.844509895,0,15,modulation by symbiont of host cellular process,BP,1
GO:0044088,1,0.686290869,0,34,regulation of vacuole organization,BP,1
GO:0044090,1,0.887234496,0,11,positive regulation of vacuole organization,BP,1
GO:0044091,1,0.759438884,0,26,membrane biogenesis,BP,1
GO:0044106,1,0.557914514,0,52,cellular amine metabolic process,BP,1
GO:0044107,1,0.955644156,0,4,cellular alcohol metabolic process,BP,1
GO:0044108,1,0.955644156,0,4,cellular alcohol biosynthetic process,BP,1
GO:0044110,1,0.988662931,0,1,growth involved in symbiotic interaction,BP,1
GO:0044111,1,0.980054532,0,2,development involved in symbiotic interaction,BP,1
GO:0044115,1,0.988662869,0,1,development of symbiont involved in interaction with host,BP,1
GO:0044116,1,0.988662931,0,1,growth of symbiont involved in interaction with host,BP,1
GO:0044117,1,0.988662931,0,1,growth of symbiont in host,BP,1
GO:0044145,1,0.988662869,0,1,modulation of development of symbiont involved in interaction with host,BP,1
GO:0044147,1,0.988662869,0,1,negative regulation of development of symbiont involved in interaction with host,BP,1
GO:0044154,1,0.94865614,0,5,histone H3-K14 acetylation,BP,1
GO:0044205,1,0.977453331,0,2,'de novo' UMP biosynthetic process,BP,1
GO:0044208,1,0.966387057,0,3,'de novo' AMP biosynthetic process,BP,1
GO:0044209,1,0.97745295,0,2,AMP salvage,BP,1
GO:0044210,1,0.977453375,0,2,'de novo' CTP biosynthetic process,BP,1
GO:0044241,1,0.883678089,0,11,lipid digestion,BP,1
GO:0044247,1,0.833632856,0,17,cellular polysaccharide catabolic process,BP,1
GO:0044273,1,0.805578882,0,19,sulfur compound catabolic process,BP,1
GO:0044275,1,0.711278301,0,31,cellular carbohydrate catabolic process,BP,1
GO:0044313,1,0.989064375,0,1,protein K6-linked deubiquitination,BP,1
GO:0044314,1,0.977880235,0,2,protein K27-linked ubiquitination,BP,1
GO:0044319,1,0.783599681,0,24,"wound healing, spreading of cells",BP,1
GO:0044320,1,0.86458287,0,13,cellular response to leptin stimulus,BP,1
GO:0044324,1,0.988662671,0,1,regulation of transcription involved in anterior/posterior axis specification,BP,1
GO:0044328,1,0.988662931,0,1,canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration,BP,1
GO:0044329,1,0.988662931,0,1,canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion,BP,1
GO:0044330,1,0.988662931,0,1,canonical Wnt signaling pathway involved in positive regulation of wound healing,BP,1
GO:0044331,1,0.867944634,0,13,cell-cell adhesion mediated by cadherin,BP,1
GO:0044332,1,0.977717063,0,2,Wnt signaling pathway involved in dorsal/ventral axis specification,BP,1
GO:0044334,1,0.977456614,0,2,canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,BP,1
GO:0044335,1,0.990997407,0,1,canonical Wnt signaling pathway involved in neural crest cell differentiation,BP,1
GO:0044336,1,0.960774942,0,4,canonical Wnt signaling pathway involved in negative regulation of apoptotic process,BP,1
GO:0044337,1,0.982939941,0,2,canonical Wnt signaling pathway involved in positive regulation of apoptotic process,BP,1
GO:0044338,1,0.990189856,0,1,canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,BP,1
GO:0044339,1,0.990189856,0,1,canonical Wnt signaling pathway involved in osteoblast differentiation,BP,1
GO:0044340,1,0.968655369,0,3,canonical Wnt signaling pathway involved in regulation of cell proliferation,BP,1
GO:0044341,1,0.955912952,0,4,sodium-dependent phosphate transport,BP,1
GO:0044343,1,0.988662931,0,1,canonical Wnt signaling pathway involved in regulation of type B pancreatic cell proliferation,BP,1
GO:0044345,1,0.988662931,0,1,stromal-epithelial cell signaling involved in prostate gland development,BP,1
GO:0044346,1,0.843316594,0,16,fibroblast apoptotic process,BP,1
GO:0044351,1,0.924838754,0,7,macropinocytosis,BP,1
GO:0044362,1,0.955410552,0,4,negative regulation of molecular function in other organism,BP,1
GO:0044364,1,0.814381464,0,18,disruption of cells of other organism,BP,1
GO:0044375,1,0.966370399,0,3,regulation of peroxisome size,BP,1
GO:0044379,1,0.989052455,0,1,protein localization to actin cortical patch,BP,1
GO:0044380,1,0.63980035,0,42,protein localization to cytoskeleton,BP,1
GO:0044387,1,0.927755659,0,7,negative regulation of protein kinase activity by regulation of protein phosphorylation,BP,1
GO:0044395,1,0.988662579,0,1,protein targeting to vacuolar membrane,BP,1
GO:0044396,1,0.94690563,0,5,actin cortical patch organization,BP,1
GO:0044406,1,0.902490812,0,9,adhesion of symbiont to host,BP,1
GO:0044409,1,0.539299437,0,55,entry into host,BP,1
GO:0044413,1,0.968158169,0,3,avoidance of host defenses,BP,1
GO:0044415,1,0.968158169,0,3,evasion or tolerance of host defenses,BP,1
GO:0044417,1,0.902439227,0,9,translocation of molecules into host,BP,1
GO:0044458,1,0.910183255,0,9,motile cilium assembly,BP,1
GO:0044468,1,0.988662951,0,1,envenomation resulting in modulation of blood coagulation in other organism,BP,1
GO:0044501,1,0.966463412,0,3,modulation of signal transduction in other organism,BP,1
GO:0044502,1,0.977453199,0,2,positive regulation of signal transduction in other organism,BP,1
GO:0044528,1,0.955411903,0,4,regulation of mitochondrial mRNA stability,BP,1
GO:0044531,1,0.944585283,0,5,modulation of programmed cell death in other organism,BP,1
GO:0044532,1,0.944585283,0,5,modulation of apoptotic process in other organism,BP,1
GO:0044533,1,0.966378698,0,3,positive regulation of apoptotic process in other organism,BP,1
GO:0044537,1,0.988662906,0,1,regulation of circulating fibrinogen levels,BP,1
GO:0044539,1,0.915478409,0,8,long-chain fatty acid import,BP,1
GO:0044546,1,0.902915146,0,9,NLRP3 inflammasome complex assembly,BP,1
GO:0044550,1,0.900369945,0,10,secondary metabolite biosynthetic process,BP,1
GO:0044557,1,0.92806619,0,7,relaxation of smooth muscle,BP,1
GO:0044558,1,0.990446389,0,1,uterine smooth muscle relaxation,BP,1
GO:0044565,1,0.977600447,0,2,dendritic cell proliferation,BP,1
GO:0044571,1,0.955410757,0,4,[2Fe-2S] cluster assembly,BP,1
GO:0044597,1,0.933862959,0,6,daunorubicin metabolic process,BP,1
GO:0044598,1,0.933862959,0,6,doxorubicin metabolic process,BP,1
GO:0044648,1,0.988662931,0,1,histone H3-K4 dimethylation,BP,1
GO:0044650,1,0.933905087,0,6,adhesion of symbiont to host cell,BP,1
GO:0044691,1,0.959920369,0,4,tooth eruption,BP,1
GO:0044721,1,0.98866293,0,1,"protein import into peroxisome matrix, substrate release",BP,1
GO:0044725,1,0.988662931,0,1,chromatin reprogramming in the zygote,BP,1
GO:0044727,1,0.988662931,0,1,DNA demethylation of male pronucleus,BP,1
GO:0044728,1,0.564049458,0,53,DNA methylation or demethylation,BP,1
GO:0044743,1,0.650835032,0,38,protein transmembrane import into intracellular organelle,BP,1
GO:0044752,1,0.914437322,0,8,response to human chorionic gonadotropin,BP,1
GO:0044764,1,0.735797405,0,29,multi-organism cellular process,BP,1
GO:0044766,1,0.791222253,0,21,multi-organism transport,BP,1
GO:0044771,1,0.955917877,0,4,meiotic cell cycle phase transition,BP,1
GO:0044778,1,0.990281007,0,1,meiotic DNA integrity checkpoint,BP,1
GO:0044785,1,0.988662931,0,1,metaphase/anaphase transition of meiotic cell cycle,BP,1
GO:0044789,1,0.946787477,0,5,modulation by host of viral release from host cell,BP,1
GO:0044790,1,0.988662617,0,1,negative regulation by host of viral release from host cell,BP,1
GO:0044791,1,0.946787477,0,5,positive regulation by host of viral release from host cell,BP,1
GO:0044793,1,0.914647249,0,8,negative regulation by host of viral process,BP,1
GO:0044795,1,0.988662633,0,1,trans-Golgi network to recycling endosome transport,BP,1
GO:0044800,1,0.966387173,0,3,multi-organism membrane fusion,BP,1
GO:0044803,1,0.940260246,0,6,multi-organism membrane organization,BP,1
GO:0044804,1,0.96082086,0,4,autophagy of nucleus,BP,1
GO:0044805,1,0.978612714,0,2,late nucleophagy,BP,1
GO:0044806,1,0.9507913,0,5,G-quadruplex DNA unwinding,BP,1
GO:0044821,1,0.988662931,0,1,meiotic telomere tethering at nuclear periphery,BP,1
GO:0044828,1,0.925142461,0,7,negative regulation by host of viral genome replication,BP,1
GO:0044830,1,0.978734822,0,2,modulation by host of viral RNA genome replication,BP,1
GO:0044837,1,0.988662926,0,1,actomyosin contractile ring organization,BP,1
GO:0044848,1,0.97754701,0,2,biological phase,BP,1
GO:0044849,1,0.865370884,0,14,estrous cycle,BP,1
GO:0044851,1,0.97754701,0,2,hair cycle phase,BP,1
GO:0044854,1,0.955677521,0,4,plasma membrane raft assembly,BP,1
GO:0044855,1,0.979444799,0,2,plasma membrane raft distribution,BP,1
GO:0044856,1,0.979444799,0,2,plasma membrane raft localization,BP,1
GO:0044857,1,0.948436236,0,5,plasma membrane raft organization,BP,1
GO:0044858,1,0.988676099,0,1,plasma membrane raft polarization,BP,1
GO:0044860,1,0.960017653,0,4,protein localization to plasma membrane raft,BP,1
GO:0044861,1,0.982126106,0,2,protein transport into plasma membrane raft,BP,1
GO:0044866,1,0.98866259,0,1,modulation by host of viral exo-alpha-sialidase activity,BP,1
GO:0044867,1,0.98866259,0,1,modulation by host of viral catalytic activity,BP,1
GO:0044869,1,0.98866259,0,1,negative regulation by host of viral exo-alpha-sialidase activity,BP,1
GO:0044870,1,0.98866259,0,1,modulation by host of viral glycoprotein metabolic process,BP,1
GO:0044871,1,0.98866259,0,1,negative regulation by host of viral glycoprotein metabolic process,BP,1
GO:0044872,1,0.8893855,0,12,lipoprotein localization,BP,1
GO:0044878,1,0.955411017,0,4,mitotic cytokinesis checkpoint,BP,1
GO:0045002,1,0.94478251,0,5,double-strand break repair via single-strand annealing,BP,1
GO:0045003,1,0.977453373,0,2,double-strand break repair via synthesis-dependent strand annealing,BP,1
GO:0045004,1,0.981993846,0,2,DNA replication proofreading,BP,1
GO:0045006,1,0.933861378,0,6,DNA deamination,BP,1
GO:0045016,1,0.988662931,0,1,mitochondrial magnesium ion transmembrane transport,BP,1
GO:0045017,1,0.243424304,0,128,glycerolipid biosynthetic process,BP,1
GO:0045019,1,0.875288805,0,12,negative regulation of nitric oxide biosynthetic process,BP,1
GO:0045022,1,0.683932857,0,36,early endosome to late endosome transport,BP,1
GO:0045023,1,0.908905952,0,9,G0 to G1 transition,BP,1
GO:0045026,1,0.956254325,0,4,plasma membrane fusion,BP,1
GO:0045039,1,0.912795252,0,8,protein import into mitochondrial inner membrane,BP,1
GO:0045040,1,0.946249238,0,5,protein import into mitochondrial outer membrane,BP,1
GO:0045041,1,0.977453784,0,2,protein import into mitochondrial intermembrane space,BP,1
GO:0045046,1,0.945498887,0,5,protein import into peroxisome membrane,BP,1
GO:0045047,1,0.753057532,0,26,protein targeting to ER,BP,1
GO:0045048,1,0.933861967,0,6,protein insertion into ER membrane,BP,1
GO:0045053,1,0.982331471,0,3,protein retention in Golgi apparatus,BP,1
GO:0045054,1,0.955821045,0,4,constitutive secretory pathway,BP,1
GO:0045056,1,0.824018915,0,19,transcytosis,BP,1
GO:0045058,1,0.780426921,0,23,T cell selection,BP,1
GO:0045059,1,0.906455828,0,9,positive thymic T cell selection,BP,1
GO:0045060,1,0.9251481,0,7,negative thymic T cell selection,BP,1
GO:0045061,1,0.866015695,0,13,thymic T cell selection,BP,1
GO:0045062,1,0.988662477,0,1,extrathymic T cell selection,BP,1
GO:0045063,1,0.859254411,0,14,T-helper 1 cell differentiation,BP,1
GO:0045064,1,0.883707378,0,11,T-helper 2 cell differentiation,BP,1
GO:0045065,1,0.977470431,0,2,cytotoxic T cell differentiation,BP,1
GO:0045066,1,0.816173655,0,18,regulatory T cell differentiation,BP,1
GO:0045071,1,0.623732003,0,42,negative regulation of viral genome replication,BP,1
GO:0045072,1,0.934868528,0,6,regulation of interferon-gamma biosynthetic process,BP,1
GO:0045073,1,0.93425563,0,6,regulation of chemokine biosynthetic process,BP,1
GO:0045074,1,0.966407425,0,3,regulation of interleukin-10 biosynthetic process,BP,1
GO:0045075,1,0.93679334,0,6,regulation of interleukin-12 biosynthetic process,BP,1
GO:0045076,1,0.89476079,0,10,regulation of interleukin-2 biosynthetic process,BP,1
GO:0045077,1,0.988828748,0,1,negative regulation of interferon-gamma biosynthetic process,BP,1
GO:0045078,1,0.934868528,0,6,positive regulation of interferon-gamma biosynthetic process,BP,1
GO:0045079,1,0.988662913,0,1,negative regulation of chemokine biosynthetic process,BP,1
GO:0045080,1,0.944973703,0,5,positive regulation of chemokine biosynthetic process,BP,1
GO:0045081,1,0.977491322,0,2,negative regulation of interleukin-10 biosynthetic process,BP,1
GO:0045082,1,0.988662927,0,1,positive regulation of interleukin-10 biosynthetic process,BP,1
GO:0045083,1,0.988662931,0,1,negative regulation of interleukin-12 biosynthetic process,BP,1
GO:0045084,1,0.955822142,0,4,positive regulation of interleukin-12 biosynthetic process,BP,1
GO:0045085,1,0.95750584,0,4,negative regulation of interleukin-2 biosynthetic process,BP,1
GO:0045086,1,0.925763021,0,7,positive regulation of interleukin-2 biosynthetic process,BP,1
GO:0045091,1,0.916217601,0,8,regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,1
GO:0045103,1,0.781783609,0,25,intermediate filament-based process,BP,1
GO:0045104,1,0.790765319,0,24,intermediate filament cytoskeleton organization,BP,1
GO:0045109,1,0.894057852,0,10,intermediate filament organization,BP,1
GO:0045112,1,0.96926219,0,3,integrin biosynthetic process,BP,1
GO:0045113,1,0.97754332,0,2,regulation of integrin biosynthetic process,BP,1
GO:0045116,1,0.853451074,0,14,protein neddylation,BP,1
GO:0045117,1,0.854546916,0,14,azole transport,BP,1
GO:0045123,1,0.647655034,0,39,cellular extravasation,BP,1
GO:0045132,1,0.682310621,0,35,meiotic chromosome segregation,BP,1
GO:0045136,1,0.905876865,0,9,development of secondary sexual characteristics,BP,1
GO:0045141,1,0.939926256,0,6,meiotic telomere clustering,BP,1
GO:0045143,1,0.841126894,0,16,homologous chromosome segregation,BP,1
GO:0045144,1,0.979202234,0,2,meiotic sister chromatid segregation,BP,1
GO:0045161,1,0.96458919,0,4,neuronal ion channel clustering,BP,1
GO:0045162,1,0.975652404,0,3,clustering of voltage-gated sodium channels,BP,1
GO:0045175,1,0.989006398,0,1,basal protein localization,BP,1
GO:0045176,1,0.932616325,0,7,apical protein localization,BP,1
GO:0045186,1,0.992882944,0,1,zonula adherens assembly,BP,1
GO:0045188,1,0.923269848,0,7,"regulation of circadian sleep/wake cycle, non-REM sleep",BP,1
GO:0045196,1,0.977463672,0,2,establishment or maintenance of neuroblast polarity,BP,1
GO:0045197,1,0.727191754,0,31,establishment or maintenance of epithelial cell apical/basal polarity,BP,1
GO:0045198,1,0.881073059,0,12,establishment of epithelial cell apical/basal polarity,BP,1
GO:0045199,1,0.93393288,0,6,maintenance of epithelial cell apical/basal polarity,BP,1
GO:0045200,1,0.977463672,0,2,establishment of neuroblast polarity,BP,1
GO:0045204,1,0.977453375,0,2,MAPK export from nucleus,BP,1
GO:0045210,1,0.978270774,0,2,FasL biosynthetic process,BP,1
GO:0045212,1,0.988662931,0,1,neurotransmitter receptor biosynthetic process,BP,1
GO:0045213,1,0.949145231,0,5,neurotransmitter receptor metabolic process,BP,1
GO:0045214,1,0.769381987,0,24,sarcomere organization,BP,1
GO:0045216,1,0.368689016,0,93,cell-cell junction organization,BP,1
GO:0045217,1,0.928559207,0,7,cell-cell junction maintenance,BP,1
GO:0045218,1,0.966740667,0,3,zonula adherens maintenance,BP,1
GO:0045219,1,0.989489632,0,1,regulation of FasL biosynthetic process,BP,1
GO:0045221,1,0.989489632,0,1,negative regulation of FasL biosynthetic process,BP,1
GO:0045222,1,0.988662895,0,1,CD4 biosynthetic process,BP,1
GO:0045223,1,0.988662895,0,1,regulation of CD4 biosynthetic process,BP,1
GO:0045225,1,0.988662895,0,1,negative regulation of CD4 biosynthetic process,BP,1
GO:0045234,1,0.98866293,0,1,protein palmitoleylation,BP,1
GO:0045297,1,0.977546654,0,2,post-mating behavior,BP,1
GO:0045299,1,0.992698941,0,1,otolith mineralization,BP,1
GO:0045324,1,0.83486803,0,16,late endosome to vacuole transport,BP,1
GO:0045329,1,0.955413547,0,4,carnitine biosynthetic process,BP,1
GO:0045332,1,0.848237375,0,16,phospholipid translocation,BP,1
GO:0045333,1,0.242144543,0,125,cellular respiration,BP,1
GO:0045337,1,0.946282864,0,5,farnesyl diphosphate biosynthetic process,BP,1
GO:0045338,1,0.935778483,0,6,farnesyl diphosphate metabolic process,BP,1
GO:0045341,1,0.95677319,0,4,MHC class I biosynthetic process,BP,1
GO:0045342,1,0.905736567,0,9,MHC class II biosynthetic process,BP,1
GO:0045343,1,0.95677319,0,4,regulation of MHC class I biosynthetic process,BP,1
GO:0045345,1,0.95677319,0,4,positive regulation of MHC class I biosynthetic process,BP,1
GO:0045346,1,0.916130036,0,8,regulation of MHC class II biosynthetic process,BP,1
GO:0045347,1,0.957171112,0,4,negative regulation of MHC class II biosynthetic process,BP,1
GO:0045348,1,0.95713722,0,4,positive regulation of MHC class II biosynthetic process,BP,1
GO:0045349,1,0.967248629,0,3,interferon-alpha biosynthetic process,BP,1
GO:0045350,1,0.930788166,0,7,interferon-beta biosynthetic process,BP,1
GO:0045351,1,0.890120229,0,11,type I interferon biosynthetic process,BP,1
GO:0045354,1,0.967248629,0,3,regulation of interferon-alpha biosynthetic process,BP,1
GO:0045355,1,0.988662631,0,1,negative regulation of interferon-alpha biosynthetic process,BP,1
GO:0045356,1,0.97834239,0,2,positive regulation of interferon-alpha biosynthetic process,BP,1
GO:0045357,1,0.930788166,0,7,regulation of interferon-beta biosynthetic process,BP,1
GO:0045358,1,0.972839394,0,3,negative regulation of interferon-beta biosynthetic process,BP,1
GO:0045359,1,0.956784073,0,4,positive regulation of interferon-beta biosynthetic process,BP,1
GO:0045360,1,0.966372435,0,3,regulation of interleukin-1 biosynthetic process,BP,1
GO:0045362,1,0.966372435,0,3,positive regulation of interleukin-1 biosynthetic process,BP,1
GO:0045399,1,0.991228453,0,1,regulation of interleukin-3 biosynthetic process,BP,1
GO:0045401,1,0.991228453,0,1,positive regulation of interleukin-3 biosynthetic process,BP,1
GO:0045402,1,0.966369907,0,3,regulation of interleukin-4 biosynthetic process,BP,1
GO:0045403,1,0.988662931,0,1,negative regulation of interleukin-4 biosynthetic process,BP,1
GO:0045404,1,0.977453373,0,2,positive regulation of interleukin-4 biosynthetic process,BP,1
GO:0045408,1,0.876288915,0,12,regulation of interleukin-6 biosynthetic process,BP,1
GO:0045409,1,0.969079587,0,3,negative regulation of interleukin-6 biosynthetic process,BP,1
GO:0045410,1,0.914648334,0,8,positive regulation of interleukin-6 biosynthetic process,BP,1
GO:0045414,1,0.924073113,0,7,regulation of interleukin-8 biosynthetic process,BP,1
GO:0045415,1,0.966373382,0,3,negative regulation of interleukin-8 biosynthetic process,BP,1
GO:0045416,1,0.956239531,0,4,positive regulation of interleukin-8 biosynthetic process,BP,1
GO:0045423,1,0.991228453,0,1,regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,1
GO:0045425,1,0.991228453,0,1,positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,1
GO:0045454,1,0.537197534,0,55,cell redox homeostasis,BP,1
GO:0045472,1,0.84609754,0,15,response to ether,BP,1
GO:0045494,1,0.827513495,0,18,photoreceptor cell maintenance,BP,1
GO:0045540,1,0.824109316,0,18,regulation of cholesterol biosynthetic process,BP,1
GO:0045541,1,0.95587773,0,4,negative regulation of cholesterol biosynthetic process,BP,1
GO:0045542,1,0.913878653,0,8,positive regulation of cholesterol biosynthetic process,BP,1
GO:0045575,1,0.966434803,0,3,basophil activation,BP,1
GO:0045576,1,0.638823474,0,40,mast cell activation,BP,1
GO:0045578,1,0.966369573,0,3,negative regulation of B cell differentiation,BP,1
GO:0045579,1,0.860709153,0,14,positive regulation of B cell differentiation,BP,1
GO:0045581,1,0.748124031,0,26,negative regulation of T cell differentiation,BP,1
GO:0045582,1,0.518896832,0,59,positive regulation of T cell differentiation,BP,1
GO:0045583,1,0.988680233,0,1,regulation of cytotoxic T cell differentiation,BP,1
GO:0045585,1,0.988680233,0,1,positive regulation of cytotoxic T cell differentiation,BP,1
GO:0045588,1,0.929876252,0,7,positive regulation of gamma-delta T cell differentiation,BP,1
GO:0045589,1,0.825547222,0,17,regulation of regulatory T cell differentiation,BP,1
GO:0045590,1,0.956437448,0,4,negative regulation of regulatory T cell differentiation,BP,1
GO:0045591,1,0.913225559,0,8,positive regulation of regulatory T cell differentiation,BP,1
GO:0045600,1,0.62078825,0,43,positive regulation of fat cell differentiation,BP,1
GO:0045602,1,0.904845346,0,10,negative regulation of endothelial cell differentiation,BP,1
GO:0045603,1,0.872403572,0,13,positive regulation of endothelial cell differentiation,BP,1
GO:0045606,1,0.902163176,0,10,positive regulation of epidermal cell differentiation,BP,1
GO:0045616,1,0.855561626,0,15,regulation of keratinocyte differentiation,BP,1
GO:0045617,1,0.979428407,0,2,negative regulation of keratinocyte differentiation,BP,1
GO:0045618,1,0.932218253,0,7,positive regulation of keratinocyte differentiation,BP,1
GO:0045620,1,0.706565834,0,31,negative regulation of lymphocyte differentiation,BP,1
GO:0045621,1,0.454404192,0,71,positive regulation of lymphocyte differentiation,BP,1
GO:0045622,1,0.800157898,0,20,regulation of T-helper cell differentiation,BP,1
GO:0045623,1,0.886611573,0,11,negative regulation of T-helper cell differentiation,BP,1
GO:0045624,1,0.863464659,0,13,positive regulation of T-helper cell differentiation,BP,1
GO:0045625,1,0.92528672,0,7,regulation of T-helper 1 cell differentiation,BP,1
GO:0045626,1,0.978270777,0,2,negative regulation of T-helper 1 cell differentiation,BP,1
GO:0045627,1,0.945848325,0,5,positive regulation of T-helper 1 cell differentiation,BP,1
GO:0045628,1,0.89385007,0,10,regulation of T-helper 2 cell differentiation,BP,1
GO:0045629,1,0.946313811,0,5,negative regulation of T-helper 2 cell differentiation,BP,1
GO:0045630,1,0.944583671,0,5,positive regulation of T-helper 2 cell differentiation,BP,1
GO:0045634,1,0.952544154,0,5,regulation of melanocyte differentiation,BP,1
GO:0045636,1,0.974521095,0,3,positive regulation of melanocyte differentiation,BP,1
GO:0045643,1,0.988662931,0,1,regulation of eosinophil differentiation,BP,1
GO:0045645,1,0.988662931,0,1,positive regulation of eosinophil differentiation,BP,1
GO:0045647,1,0.873917758,0,12,negative regulation of erythrocyte differentiation,BP,1
GO:0045649,1,0.819371733,0,18,regulation of macrophage differentiation,BP,1
GO:0045650,1,0.944994815,0,5,negative regulation of macrophage differentiation,BP,1
GO:0045651,1,0.86712079,0,13,positive regulation of macrophage differentiation,BP,1
GO:0045652,1,0.845371159,0,15,regulation of megakaryocyte differentiation,BP,1
GO:0045653,1,0.94651509,0,5,negative regulation of megakaryocyte differentiation,BP,1
GO:0045654,1,0.945139696,0,5,positive regulation of megakaryocyte differentiation,BP,1
GO:0045655,1,0.847039113,0,15,regulation of monocyte differentiation,BP,1
GO:0045656,1,0.957496494,0,4,negative regulation of monocyte differentiation,BP,1
GO:0045657,1,0.894830576,0,10,positive regulation of monocyte differentiation,BP,1
GO:0045658,1,0.979585761,0,2,regulation of neutrophil differentiation,BP,1
GO:0045659,1,0.979585761,0,2,negative regulation of neutrophil differentiation,BP,1
GO:0045663,1,0.818206548,0,18,positive regulation of myoblast differentiation,BP,1
GO:0045668,1,0.698062634,0,33,negative regulation of osteoblast differentiation,BP,1
GO:0045671,1,0.856560557,0,15,negative regulation of osteoclast differentiation,BP,1
GO:0045713,1,0.916106929,0,8,low-density lipoprotein particle receptor biosynthetic process,BP,1
GO:0045714,1,0.926618439,0,7,regulation of low-density lipoprotein particle receptor biosynthetic process,BP,1
GO:0045715,1,0.966654385,0,3,negative regulation of low-density lipoprotein particle receptor biosynthetic process,BP,1
GO:0045716,1,0.977473674,0,2,positive regulation of low-density lipoprotein particle receptor biosynthetic process,BP,1
GO:0045717,1,0.857067768,0,14,negative regulation of fatty acid biosynthetic process,BP,1
GO:0045719,1,0.957614959,0,4,negative regulation of glycogen biosynthetic process,BP,1
GO:0045722,1,0.843640946,0,15,positive regulation of gluconeogenesis,BP,1
GO:0045723,1,0.798874342,0,20,positive regulation of fatty acid biosynthetic process,BP,1
GO:0045724,1,0.796793897,0,21,positive regulation of cilium assembly,BP,1
GO:0045726,1,0.988754356,0,1,positive regulation of integrin biosynthetic process,BP,1
GO:0045728,1,0.977453375,0,2,respiratory burst after phagocytosis,BP,1
GO:0045730,1,0.780142299,0,22,respiratory burst,BP,1
GO:0045737,1,0.792885947,0,21,positive regulation of cyclin-dependent protein serine/threonine kinase activity,BP,1
GO:0045738,1,0.839477797,0,16,negative regulation of DNA repair,BP,1
GO:0045740,1,0.736209512,0,28,positive regulation of DNA replication,BP,1
GO:0045741,1,0.93803652,0,6,positive regulation of epidermal growth factor-activated receptor activity,BP,1
GO:0045742,1,0.855618422,0,15,positive regulation of epidermal growth factor receptor signaling pathway,BP,1
GO:0045743,1,0.934134325,0,6,positive regulation of fibroblast growth factor receptor signaling pathway,BP,1
GO:0045745,1,0.855358266,0,14,positive regulation of G protein-coupled receptor signaling pathway,BP,1
GO:0045746,1,0.785747721,0,22,negative regulation of Notch signaling pathway,BP,1
GO:0045751,1,0.977453374,0,2,negative regulation of Toll signaling pathway,BP,1
GO:0045759,1,0.966631757,0,3,negative regulation of action potential,BP,1
GO:0045760,1,0.930570755,0,7,positive regulation of action potential,BP,1
GO:0045761,1,0.90008709,0,11,regulation of adenylate cyclase activity,BP,1
GO:0045762,1,0.945175578,0,6,positive regulation of adenylate cyclase activity,BP,1
GO:0045763,1,0.989736892,0,1,negative regulation of cellular amino acid metabolic process,BP,1
GO:0045764,1,0.96636974,0,3,positive regulation of cellular amino acid metabolic process,BP,1
GO:0045769,1,0.995167874,0,1,negative regulation of asymmetric cell division,BP,1
GO:0045780,1,0.832866127,0,17,positive regulation of bone resorption,BP,1
GO:0045792,1,0.892065521,0,11,negative regulation of cell size,BP,1
GO:0045793,1,0.890530433,0,11,positive regulation of cell size,BP,1
GO:0045794,1,0.952784434,0,5,negative regulation of cell volume,BP,1
GO:0045795,1,0.992349992,0,1,positive regulation of cell volume,BP,1
GO:0045796,1,0.979019822,0,2,negative regulation of intestinal cholesterol absorption,BP,1
GO:0045797,1,0.988662931,0,1,positive regulation of intestinal cholesterol absorption,BP,1
GO:0045799,1,0.972312461,0,3,positive regulation of chromatin assembly or disassembly,BP,1
GO:0045806,1,0.598091836,0,47,negative regulation of endocytosis,BP,1
GO:0045814,1,0.487698551,0,66,"negative regulation of gene expression, epigenetic",BP,1
GO:0045815,1,0.844283134,0,16,"positive regulation of gene expression, epigenetic",BP,1
GO:0045818,1,0.988676804,0,1,negative regulation of glycogen catabolic process,BP,1
GO:0045819,1,0.966383715,0,3,positive regulation of glycogen catabolic process,BP,1
GO:0045822,1,0.847322777,0,15,negative regulation of heart contraction,BP,1
GO:0045823,1,0.806629969,0,19,positive regulation of heart contraction,BP,1
GO:0045824,1,0.65176927,0,38,negative regulation of innate immune response,BP,1
GO:0045828,1,0.988662775,0,1,positive regulation of isoprenoid metabolic process,BP,1
GO:0045829,1,0.955819239,0,4,negative regulation of isotype switching,BP,1
GO:0045833,1,0.497384959,0,63,negative regulation of lipid metabolic process,BP,1
GO:0045835,1,0.966369322,0,3,negative regulation of meiotic nuclear division,BP,1
GO:0045836,1,0.938483088,0,6,positive regulation of meiotic nuclear division,BP,1
GO:0045837,1,0.854780312,0,14,negative regulation of membrane potential,BP,1
GO:0045838,1,0.839286021,0,16,positive regulation of membrane potential,BP,1
GO:0045840,1,0.693383823,0,34,positive regulation of mitotic nuclear division,BP,1
GO:0045842,1,0.937467474,0,6,positive regulation of mitotic metaphase/anaphase transition,BP,1
GO:0045848,1,0.988662931,0,1,positive regulation of nitrogen utilization,BP,1
GO:0045851,1,0.710427305,0,30,pH reduction,BP,1
GO:0045869,1,0.924797726,0,7,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,1
GO:0045870,1,0.99072794,0,1,positive regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,1
GO:0045875,1,0.96340007,0,4,negative regulation of sister chromatid cohesion,BP,1
GO:0045876,1,0.916311221,0,8,positive regulation of sister chromatid cohesion,BP,1
GO:0045879,1,0.791138858,0,21,negative regulation of smoothened signaling pathway,BP,1
GO:0045880,1,0.789955359,0,23,positive regulation of smoothened signaling pathway,BP,1
GO:0045887,1,0.993131088,0,1,positive regulation of synaptic growth at neuromuscular junction,BP,1
GO:0045898,1,0.844154967,0,15,regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,1
GO:0045899,1,0.883456802,0,11,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,1
GO:0045900,1,0.957980868,0,4,negative regulation of translational elongation,BP,1
GO:0045901,1,0.944965476,0,5,positive regulation of translational elongation,BP,1
GO:0045903,1,0.977453072,0,2,positive regulation of translational fidelity,BP,1
GO:0045905,1,0.988662826,0,1,positive regulation of translational termination,BP,1
GO:0045906,1,0.887262523,0,11,negative regulation of vasoconstriction,BP,1
GO:0045907,1,0.78206055,0,22,positive regulation of vasoconstriction,BP,1
GO:0045910,1,0.748224039,0,26,negative regulation of DNA recombination,BP,1
GO:0045914,1,0.988662917,0,1,negative regulation of catecholamine metabolic process,BP,1
GO:0045915,1,0.923576192,0,7,positive regulation of catecholamine metabolic process,BP,1
GO:0045916,1,0.916608202,0,8,negative regulation of complement activation,BP,1
GO:0045917,1,0.957821233,0,4,positive regulation of complement activation,BP,1
GO:0045918,1,0.977452783,0,2,negative regulation of cytolysis,BP,1
GO:0045919,1,0.935962375,0,6,positive regulation of cytolysis,BP,1
GO:0045920,1,0.793830599,0,21,negative regulation of exocytosis,BP,1
GO:0045921,1,0.52223925,0,59,positive regulation of exocytosis,BP,1
GO:0045922,1,0.785858515,0,22,negative regulation of fatty acid metabolic process,BP,1
GO:0045923,1,0.686030771,0,34,positive regulation of fatty acid metabolic process,BP,1
GO:0045924,1,0.948487728,0,5,regulation of female receptivity,BP,1
GO:0045925,1,0.970371588,0,3,positive regulation of female receptivity,BP,1
GO:0045932,1,0.8317973,0,17,negative regulation of muscle contraction,BP,1
GO:0045933,1,0.764020239,0,24,positive regulation of muscle contraction,BP,1
GO:0045938,1,0.955421535,0,4,"positive regulation of circadian sleep/wake cycle, sleep",BP,1
GO:0045939,1,0.826244215,0,17,negative regulation of steroid metabolic process,BP,1
GO:0045943,1,0.823311315,0,18,positive regulation of transcription by RNA polymerase I,BP,1
GO:0045945,1,0.905962843,0,10,positive regulation of transcription by RNA polymerase III,BP,1
GO:0045947,1,0.847853407,0,15,negative regulation of translational initiation,BP,1
GO:0045948,1,0.807921847,0,19,positive regulation of translational initiation,BP,1
GO:0045950,1,0.968531508,0,3,negative regulation of mitotic recombination,BP,1
GO:0045951,1,0.989244522,0,1,positive regulation of mitotic recombination,BP,1
GO:0045953,1,0.872557497,0,12,negative regulation of natural killer cell mediated cytotoxicity,BP,1
GO:0045954,1,0.872758936,0,12,positive regulation of natural killer cell mediated cytotoxicity,BP,1
GO:0045955,1,0.909449594,0,9,negative regulation of calcium ion-dependent exocytosis,BP,1
GO:0045956,1,0.919993313,0,8,positive regulation of calcium ion-dependent exocytosis,BP,1
GO:0045957,1,0.988662884,0,1,"negative regulation of complement activation, alternative pathway",BP,1
GO:0045959,1,0.97745511,0,2,"negative regulation of complement activation, classical pathway",BP,1
GO:0045963,1,0.988662917,0,1,negative regulation of dopamine metabolic process,BP,1
GO:0045964,1,0.923576192,0,7,positive regulation of dopamine metabolic process,BP,1
GO:0045967,1,0.988460572,0,2,negative regulation of growth rate,BP,1
GO:0045974,1,0.89663506,0,11,"regulation of translation, ncRNA-mediated",BP,1
GO:0045976,1,0.988666206,0,1,"negative regulation of mitotic cell cycle, embryonic",BP,1
GO:0045986,1,0.89876178,0,10,negative regulation of smooth muscle contraction,BP,1
GO:0045987,1,0.845199494,0,15,positive regulation of smooth muscle contraction,BP,1
GO:0045988,1,0.946873868,0,5,negative regulation of striated muscle contraction,BP,1
GO:0045989,1,0.924942536,0,7,positive regulation of striated muscle contraction,BP,1
GO:0045990,1,0.948152845,0,5,carbon catabolite regulation of transcription,BP,1
GO:0045991,1,0.948152845,0,5,carbon catabolite activation of transcription,BP,1
GO:0045992,1,0.859852181,0,14,negative regulation of embryonic development,BP,1
GO:0045994,1,0.988662883,0,1,positive regulation of translational initiation by iron,BP,1
GO:0046006,1,0.77032021,0,23,regulation of activated T cell proliferation,BP,1
GO:0046007,1,0.912803159,0,8,negative regulation of activated T cell proliferation,BP,1
GO:0046010,1,0.96636975,0,3,"positive regulation of circadian sleep/wake cycle, non-REM sleep",BP,1
GO:0046013,1,0.988662929,0,1,regulation of T cell homeostatic proliferation,BP,1
GO:0046014,1,0.988662929,0,1,negative regulation of T cell homeostatic proliferation,BP,1
GO:0046015,1,0.934981875,0,6,regulation of transcription by glucose,BP,1
GO:0046016,1,0.956556577,0,4,positive regulation of transcription by glucose,BP,1
GO:0046032,1,0.988662881,0,1,ADP catabolic process,BP,1
GO:0046033,1,0.872537348,0,12,AMP metabolic process,BP,1
GO:0046035,1,0.98866291,0,1,CMP metabolic process,BP,1
GO:0046037,1,0.933869406,0,6,GMP metabolic process,BP,1
GO:0046038,1,0.988662838,0,1,GMP catabolic process,BP,1
GO:0046039,1,0.735985171,0,27,GTP metabolic process,BP,1
GO:0046040,1,0.875288406,0,12,IMP metabolic process,BP,1
GO:0046041,1,0.97745311,0,2,ITP metabolic process,BP,1
GO:0046048,1,0.977458164,0,2,UDP metabolic process,BP,1
GO:0046051,1,0.906433815,0,9,UTP metabolic process,BP,1
GO:0046054,1,0.98866263,0,1,dGMP metabolic process,BP,1
GO:0046056,1,0.988662878,0,1,dADP metabolic process,BP,1
GO:0046057,1,0.988662878,0,1,dADP catabolic process,BP,1
GO:0046060,1,0.91279444,0,8,dATP metabolic process,BP,1
GO:0046061,1,0.966369617,0,3,dATP catabolic process,BP,1
GO:0046062,1,0.988662928,0,1,dCDP metabolic process,BP,1
GO:0046065,1,0.988662931,0,1,dCTP metabolic process,BP,1
GO:0046066,1,0.977453025,0,2,dGDP metabolic process,BP,1
GO:0046067,1,0.988662878,0,1,dGDP catabolic process,BP,1
GO:0046068,1,0.919154805,0,8,cGMP metabolic process,BP,1
GO:0046069,1,0.989831118,0,1,cGMP catabolic process,BP,1
GO:0046070,1,0.95541044,0,4,dGTP metabolic process,BP,1
GO:0046072,1,0.977626953,0,2,dTDP metabolic process,BP,1
GO:0046073,1,0.966369794,0,3,dTMP metabolic process,BP,1
GO:0046075,1,0.955580677,0,4,dTTP metabolic process,BP,1
GO:0046077,1,0.966541531,0,3,dUDP metabolic process,BP,1
GO:0046078,1,0.95541044,0,4,dUMP metabolic process,BP,1
GO:0046079,1,0.988662581,0,1,dUMP catabolic process,BP,1
GO:0046080,1,0.98866269,0,1,dUTP metabolic process,BP,1
GO:0046081,1,0.98866269,0,1,dUTP catabolic process,BP,1
GO:0046083,1,0.955834059,0,4,adenine metabolic process,BP,1
GO:0046084,1,0.966797736,0,3,adenine biosynthetic process,BP,1
GO:0046085,1,0.92333514,0,7,adenosine metabolic process,BP,1
GO:0046086,1,0.988733776,0,1,adenosine biosynthetic process,BP,1
GO:0046087,1,0.97745324,0,2,cytidine metabolic process,BP,1
GO:0046090,1,0.988662881,0,1,deoxyadenosine metabolic process,BP,1
GO:0046092,1,0.988667778,0,1,deoxycytidine metabolic process,BP,1
GO:0046098,1,0.966369783,0,3,guanine metabolic process,BP,1
GO:0046099,1,0.988662838,0,1,guanine biosynthetic process,BP,1
GO:0046100,1,0.956699672,0,4,hypoxanthine metabolic process,BP,1
GO:0046101,1,0.966369769,0,3,hypoxanthine biosynthetic process,BP,1
GO:0046102,1,0.966369861,0,3,inosine metabolic process,BP,1
GO:0046103,1,0.977453326,0,2,inosine biosynthetic process,BP,1
GO:0046104,1,0.967590885,0,3,thymidine metabolic process,BP,1
GO:0046108,1,0.988662791,0,1,uridine metabolic process,BP,1
GO:0046110,1,0.959632214,0,4,xanthine metabolic process,BP,1
GO:0046111,1,0.988662881,0,1,xanthine biosynthetic process,BP,1
GO:0046112,1,0.844504402,0,16,nucleobase biosynthetic process,BP,1
GO:0046113,1,0.918322486,0,8,nucleobase catabolic process,BP,1
GO:0046116,1,0.988662884,0,1,queuosine metabolic process,BP,1
GO:0046121,1,0.967586092,0,3,deoxyribonucleoside catabolic process,BP,1
GO:0046122,1,0.977453146,0,2,purine deoxyribonucleoside metabolic process,BP,1
GO:0046124,1,0.988662881,0,1,purine deoxyribonucleoside catabolic process,BP,1
GO:0046125,1,0.967590885,0,3,pyrimidine deoxyribonucleoside metabolic process,BP,1
GO:0046127,1,0.989906994,0,1,pyrimidine deoxyribonucleoside catabolic process,BP,1
GO:0046128,1,0.512771425,0,59,purine ribonucleoside metabolic process,BP,1
GO:0046129,1,0.796163798,0,20,purine ribonucleoside biosynthetic process,BP,1
GO:0046130,1,0.914475522,0,8,purine ribonucleoside catabolic process,BP,1
GO:0046133,1,0.955415544,0,4,pyrimidine ribonucleoside catabolic process,BP,1
GO:0046135,1,0.935041941,0,6,pyrimidine nucleoside catabolic process,BP,1
GO:0046136,1,0.977453152,0,2,positive regulation of vitamin metabolic process,BP,1
GO:0046137,1,0.966369891,0,3,negative regulation of vitamin metabolic process,BP,1
GO:0046144,1,0.988662915,0,1,D-alanine family amino acid metabolic process,BP,1
GO:0046146,1,0.912794214,0,8,tetrahydrobiopterin metabolic process,BP,1
GO:0046148,1,0.700149712,0,32,pigment biosynthetic process,BP,1
GO:0046149,1,0.955410727,0,4,pigment catabolic process,BP,1
GO:0046160,1,0.977601932,0,2,heme a metabolic process,BP,1
GO:0046164,1,0.655598447,0,38,alcohol catabolic process,BP,1
GO:0046166,1,0.977453335,0,2,glyceraldehyde-3-phosphate biosynthetic process,BP,1
GO:0046167,1,0.989865462,0,1,glycerol-3-phosphate biosynthetic process,BP,1
GO:0046168,1,0.966445782,0,3,glycerol-3-phosphate catabolic process,BP,1
GO:0046173,1,0.56188557,0,53,polyol biosynthetic process,BP,1
GO:0046174,1,0.804460515,0,20,polyol catabolic process,BP,1
GO:0046176,1,0.988662931,0,1,aldonic acid catabolic process,BP,1
GO:0046177,1,0.988662931,0,1,D-gluconate catabolic process,BP,1
GO:0046184,1,0.836001359,0,16,aldehyde biosynthetic process,BP,1
GO:0046185,1,0.892261143,0,10,aldehyde catabolic process,BP,1
GO:0046189,1,0.810146805,0,19,phenol-containing compound biosynthetic process,BP,1
GO:0046203,1,0.977453305,0,2,spermidine catabolic process,BP,1
GO:0046204,1,0.988662689,0,1,nor-spermidine metabolic process,BP,1
GO:0046208,1,0.977454052,0,2,spermine catabolic process,BP,1
GO:0046210,1,0.988671149,0,1,nitric oxide catabolic process,BP,1
GO:0046218,1,0.923268725,0,7,indolalkylamine catabolic process,BP,1
GO:0046222,1,0.966371257,0,3,aflatoxin metabolic process,BP,1
GO:0046223,1,0.966371257,0,3,aflatoxin catabolic process,BP,1
GO:0046226,1,0.988662892,0,1,coumarin catabolic process,BP,1
GO:0046247,1,0.97746771,0,2,terpene catabolic process,BP,1
GO:0046271,1,0.988662892,0,1,phenylpropanoid catabolic process,BP,1
GO:0046272,1,0.98866293,0,1,stilbene catabolic process,BP,1
GO:0046292,1,0.957070776,0,4,formaldehyde metabolic process,BP,1
GO:0046293,1,0.990241356,0,1,formaldehyde biosynthetic process,BP,1
GO:0046294,1,0.977453161,0,2,formaldehyde catabolic process,BP,1
GO:0046295,1,0.988662773,0,1,glycolate biosynthetic process,BP,1
GO:0046296,1,0.9886629,0,1,glycolate catabolic process,BP,1
GO:0046305,1,0.977453337,0,2,alkanesulfonate biosynthetic process,BP,1
GO:0046314,1,0.98866289,0,1,phosphocreatine biosynthetic process,BP,1
GO:0046320,1,0.725217223,0,30,regulation of fatty acid oxidation,BP,1
GO:0046321,1,0.842331284,0,16,positive regulation of fatty acid oxidation,BP,1
GO:0046322,1,0.896323628,0,10,negative regulation of fatty acid oxidation,BP,1
GO:0046325,1,0.854942736,0,14,negative regulation of glucose import,BP,1
GO:0046327,1,0.977484186,0,2,glycerol biosynthetic process from pyruvate,BP,1
GO:0046337,1,0.865218497,0,13,phosphatidylethanolamine metabolic process,BP,1
GO:0046338,1,0.977485294,0,2,phosphatidylethanolamine catabolic process,BP,1
GO:0046339,1,0.893680833,0,10,diacylglycerol metabolic process,BP,1
GO:0046340,1,0.967215197,0,3,diacylglycerol catabolic process,BP,1
GO:0046341,1,0.933895351,0,6,CDP-diacylglycerol metabolic process,BP,1
GO:0046351,1,0.977454596,0,2,disaccharide biosynthetic process,BP,1
GO:0046355,1,0.989357365,0,1,mannan catabolic process,BP,1
GO:0046356,1,0.977546644,0,2,acetyl-CoA catabolic process,BP,1
GO:0046359,1,0.988662925,0,1,butyrate catabolic process,BP,1
GO:0046360,1,0.988662925,0,1,2-oxobutyrate biosynthetic process,BP,1
GO:0046361,1,0.977453267,0,2,2-oxobutyrate metabolic process,BP,1
GO:0046365,1,0.754222727,0,25,monosaccharide catabolic process,BP,1
GO:0046368,1,0.966369824,0,3,GDP-L-fucose metabolic process,BP,1
GO:0046370,1,0.988662939,0,1,fructose biosynthetic process,BP,1
GO:0046373,1,0.988662931,0,1,L-arabinose metabolic process,BP,1
GO:0046380,1,0.977527964,0,2,N-acetylneuraminate biosynthetic process,BP,1
GO:0046385,1,0.892357791,0,10,deoxyribose phosphate biosynthetic process,BP,1
GO:0046386,1,0.892198735,0,10,deoxyribose phosphate catabolic process,BP,1
GO:0046391,1,0.93394616,0,6,5-phosphoribose 1-diphosphate metabolic process,BP,1
GO:0046398,1,0.977457338,0,2,UDP-glucuronate metabolic process,BP,1
GO:0046415,1,0.912795201,0,8,urate metabolic process,BP,1
GO:0046416,1,0.96636975,0,3,D-amino acid metabolic process,BP,1
GO:0046436,1,0.988662915,0,1,D-alanine metabolic process,BP,1
GO:0046437,1,0.988662931,0,1,D-amino acid biosynthetic process,BP,1
GO:0046439,1,0.884524697,0,11,L-cysteine metabolic process,BP,1
GO:0046440,1,0.955581018,0,4,L-lysine metabolic process,BP,1
GO:0046443,1,0.988751856,0,1,FAD metabolic process,BP,1
GO:0046444,1,0.98866315,0,1,FMN metabolic process,BP,1
GO:0046452,1,0.977464959,0,2,dihydrofolate metabolic process,BP,1
GO:0046458,1,0.988801447,0,1,hexadecanal metabolic process,BP,1
GO:0046460,1,0.70110604,0,32,neutral lipid biosynthetic process,BP,1
GO:0046461,1,0.703972145,0,32,neutral lipid catabolic process,BP,1
GO:0046462,1,0.945103334,0,5,monoacylglycerol metabolic process,BP,1
GO:0046463,1,0.70110604,0,32,acylglycerol biosynthetic process,BP,1
GO:0046464,1,0.703972145,0,32,acylglycerol catabolic process,BP,1
GO:0046465,1,0.967018026,0,3,dolichyl diphosphate metabolic process,BP,1
GO:0046466,1,0.76565336,0,24,membrane lipid catabolic process,BP,1
GO:0046467,1,0.415177465,0,78,membrane lipid biosynthetic process,BP,1
GO:0046469,1,0.977453343,0,2,platelet activating factor metabolic process,BP,1
GO:0046470,1,0.680196128,0,34,phosphatidylcholine metabolic process,BP,1
GO:0046471,1,0.892613912,0,10,phosphatidylglycerol metabolic process,BP,1
GO:0046473,1,0.856651318,0,14,phosphatidic acid metabolic process,BP,1
GO:0046474,1,0.32888836,0,101,glycerophospholipid biosynthetic process,BP,1
GO:0046475,1,0.819505861,0,18,glycerophospholipid catabolic process,BP,1
GO:0046476,1,0.967164046,0,3,glycosylceramide biosynthetic process,BP,1
GO:0046477,1,0.923467156,0,7,glycosylceramide catabolic process,BP,1
GO:0046478,1,0.980349054,0,2,lactosylceramide metabolic process,BP,1
GO:0046479,1,0.862354426,0,13,glycosphingolipid catabolic process,BP,1
GO:0046485,1,0.892199142,0,10,ether lipid metabolic process,BP,1
GO:0046487,1,0.933861919,0,6,glyoxylate metabolic process,BP,1
GO:0046491,1,0.988662651,0,1,L-methylmalonyl-CoA metabolic process,BP,1
GO:0046495,1,0.988662931,0,1,nicotinamide riboside metabolic process,BP,1
GO:0046497,1,0.988662931,0,1,nicotinate nucleotide metabolic process,BP,1
GO:0046498,1,0.8645479,0,13,S-adenosylhomocysteine metabolic process,BP,1
GO:0046499,1,0.977654667,0,2,S-adenosylmethioninamine metabolic process,BP,1
GO:0046500,1,0.800650006,0,20,S-adenosylmethionine metabolic process,BP,1
GO:0046501,1,0.892689939,0,10,protoporphyrinogen IX metabolic process,BP,1
GO:0046502,1,0.977453258,0,2,uroporphyrinogen III metabolic process,BP,1
GO:0046503,1,0.603500157,0,46,glycerolipid catabolic process,BP,1
GO:0046504,1,0.933861377,0,6,glycerol ether biosynthetic process,BP,1
GO:0046511,1,0.9776216,0,2,sphinganine biosynthetic process,BP,1
GO:0046512,1,0.915172627,0,8,sphingosine biosynthetic process,BP,1
GO:0046513,1,0.667991924,0,36,ceramide biosynthetic process,BP,1
GO:0046514,1,0.825860056,0,17,ceramide catabolic process,BP,1
GO:0046519,1,0.894537616,0,10,sphingoid metabolic process,BP,1
GO:0046520,1,0.915172627,0,8,sphingoid biosynthetic process,BP,1
GO:0046532,1,0.96125948,0,4,regulation of photoreceptor cell differentiation,BP,1
GO:0046533,1,0.96125948,0,4,negative regulation of photoreceptor cell differentiation,BP,1
GO:0046541,1,0.955982449,0,4,saliva secretion,BP,1
GO:0046543,1,0.926784463,0,7,development of secondary female sexual characteristics,BP,1
GO:0046544,1,0.978112896,0,2,development of secondary male sexual characteristics,BP,1
GO:0046546,1,0.330539333,0,103,development of primary male sexual characteristics,BP,1
GO:0046548,1,0.940911426,0,6,retinal rod cell development,BP,1
GO:0046549,1,0.977689918,0,2,retinal cone cell development,BP,1
GO:0046552,1,0.988663811,0,1,photoreceptor cell fate commitment,BP,1
GO:0046579,1,0.744275348,0,29,positive regulation of Ras protein signal transduction,BP,1
GO:0046580,1,0.613115939,0,45,negative regulation of Ras protein signal transduction,BP,1
GO:0046586,1,0.989602441,0,1,regulation of calcium-dependent cell-cell adhesion,BP,1
GO:0046587,1,0.989602441,0,1,positive regulation of calcium-dependent cell-cell adhesion,BP,1
GO:0046596,1,0.728260696,0,28,regulation of viral entry into host cell,BP,1
GO:0046597,1,0.8162293,0,18,negative regulation of viral entry into host cell,BP,1
GO:0046598,1,0.892391363,0,10,positive regulation of viral entry into host cell,BP,1
GO:0046599,1,0.842482542,0,16,regulation of centriole replication,BP,1
GO:0046600,1,0.937333506,0,6,negative regulation of centriole replication,BP,1
GO:0046601,1,0.946252982,0,5,positive regulation of centriole replication,BP,1
GO:0046604,1,0.966369684,0,3,positive regulation of mitotic centrosome separation,BP,1
GO:0046606,1,0.896870176,0,10,negative regulation of centrosome cycle,BP,1
GO:0046607,1,0.895271823,0,10,positive regulation of centrosome cycle,BP,1
GO:0046618,1,0.95542086,0,4,drug export,BP,1
GO:0046619,1,0.982431233,0,2,optic placode formation involved in camera-type eye formation,BP,1
GO:0046621,1,0.713899034,0,31,negative regulation of organ growth,BP,1
GO:0046622,1,0.676610736,0,37,positive regulation of organ growth,BP,1
GO:0046633,1,0.751546885,0,26,alpha-beta T cell proliferation,BP,1
GO:0046634,1,0.481889196,0,66,regulation of alpha-beta T cell activation,BP,1
GO:0046635,1,0.600577777,0,46,positive regulation of alpha-beta T cell activation,BP,1
GO:0046636,1,0.749023143,0,26,negative regulation of alpha-beta T cell activation,BP,1
GO:0046637,1,0.614745168,0,44,regulation of alpha-beta T cell differentiation,BP,1
GO:0046638,1,0.677168963,0,35,positive regulation of alpha-beta T cell differentiation,BP,1
GO:0046639,1,0.847131741,0,15,negative regulation of alpha-beta T cell differentiation,BP,1
GO:0046640,1,0.760184309,0,25,regulation of alpha-beta T cell proliferation,BP,1
GO:0046641,1,0.849831447,0,15,positive regulation of alpha-beta T cell proliferation,BP,1
GO:0046642,1,0.904736909,0,9,negative regulation of alpha-beta T cell proliferation,BP,1
GO:0046645,1,0.929876252,0,7,positive regulation of gamma-delta T cell activation,BP,1
GO:0046653,1,0.826012473,0,17,tetrahydrofolate metabolic process,BP,1
GO:0046654,1,0.93465445,0,6,tetrahydrofolate biosynthetic process,BP,1
GO:0046655,1,0.933917026,0,6,folic acid metabolic process,BP,1
GO:0046657,1,0.988717815,0,1,folic acid catabolic process,BP,1
GO:0046666,1,0.966369352,0,3,retinal cell programmed cell death,BP,1
GO:0046668,1,0.977453209,0,2,regulation of retinal cell programmed cell death,BP,1
GO:0046670,1,0.988662907,0,1,positive regulation of retinal cell programmed cell death,BP,1
GO:0046676,1,0.737149947,0,28,negative regulation of insulin secretion,BP,1
GO:0046684,1,0.977453344,0,2,response to pyrethroid,BP,1
GO:0046686,1,0.520762625,0,58,response to cadmium ion,BP,1
GO:0046687,1,0.966369711,0,3,response to chromate,BP,1
GO:0046688,1,0.661670688,0,37,response to copper ion,BP,1
GO:0046690,1,0.988986705,0,1,response to tellurium ion,BP,1
GO:0046704,1,0.988662928,0,1,CDP metabolic process,BP,1
GO:0046705,1,0.988662928,0,1,CDP biosynthetic process,BP,1
GO:0046707,1,0.977453236,0,2,IDP metabolic process,BP,1
GO:0046709,1,0.977453236,0,2,IDP catabolic process,BP,1
GO:0046710,1,0.977453025,0,2,GDP metabolic process,BP,1
GO:0046711,1,0.98866263,0,1,GDP biosynthetic process,BP,1
GO:0046712,1,0.988662878,0,1,GDP catabolic process,BP,1
GO:0046716,1,0.811545731,0,19,muscle cell cellular homeostasis,BP,1
GO:0046718,1,0.557297238,0,52,viral entry into host cell,BP,1
GO:0046719,1,0.923873211,0,7,regulation by virus of viral protein levels in host cell,BP,1
GO:0046722,1,0.988663984,0,1,lactic acid secretion,BP,1
GO:0046725,1,0.977909844,0,2,negative regulation by virus of viral protein levels in host cell,BP,1
GO:0046726,1,0.955590145,0,4,positive regulation by virus of viral protein levels in host cell,BP,1
GO:0046745,1,0.988662931,0,1,viral capsid secondary envelopment,BP,1
GO:0046755,1,0.844563863,0,15,viral budding,BP,1
GO:0046784,1,0.912795162,0,8,viral mRNA export from host cell nucleus,BP,1
GO:0046786,1,0.992546862,0,1,viral replication complex formation and maintenance,BP,1
GO:0046794,1,0.907393667,0,9,transport of virus,BP,1
GO:0046813,1,0.966411762,0,3,receptor-mediated virion attachment to host cell,BP,1
GO:0046814,1,0.988662931,0,1,coreceptor-mediated virion attachment to host cell,BP,1
GO:0046823,1,0.84547993,0,16,negative regulation of nucleocytoplasmic transport,BP,1
GO:0046824,1,0.5634051,0,53,positive regulation of nucleocytoplasmic transport,BP,1
GO:0046826,1,0.933861639,0,6,negative regulation of protein export from nucleus,BP,1
GO:0046827,1,0.824157302,0,18,positive regulation of protein export from nucleus,BP,1
GO:0046832,1,0.985566418,0,2,negative regulation of RNA export from nucleus,BP,1
GO:0046833,1,0.929745655,0,7,positive regulation of RNA export from nucleus,BP,1
GO:0046834,1,0.639273539,0,42,lipid phosphorylation,BP,1
GO:0046835,1,0.770145856,0,23,carbohydrate phosphorylation,BP,1
GO:0046836,1,0.966370039,0,3,glycolipid transport,BP,1
GO:0046838,1,0.860455755,0,14,phosphorylated carbohydrate dephosphorylation,BP,1
GO:0046847,1,0.626657523,0,43,filopodium assembly,BP,1
GO:0046852,1,0.832866127,0,17,positive regulation of bone remodeling,BP,1
GO:0046854,1,0.69100489,0,35,phosphatidylinositol phosphorylation,BP,1
GO:0046855,1,0.870333725,0,13,inositol phosphate dephosphorylation,BP,1
GO:0046864,1,0.977460449,0,2,isoprenoid transport,BP,1
GO:0046865,1,0.977460449,0,2,terpenoid transport,BP,1
GO:0046874,1,0.940252154,0,6,quinolinate metabolic process,BP,1
GO:0046877,1,0.97748132,0,2,regulation of saliva secretion,BP,1
GO:0046878,1,0.988691255,0,1,positive regulation of saliva secretion,BP,1
GO:0046880,1,0.966370059,0,3,regulation of follicle-stimulating hormone secretion,BP,1
GO:0046881,1,0.977453551,0,2,positive regulation of follicle-stimulating hormone secretion,BP,1
GO:0046884,1,0.955411664,0,4,follicle-stimulating hormone secretion,BP,1
GO:0046885,1,0.800928802,0,20,regulation of hormone biosynthetic process,BP,1
GO:0046886,1,0.882913473,0,11,positive regulation of hormone biosynthetic process,BP,1
GO:0046900,1,0.977453318,0,2,tetrahydrofolylpolyglutamate metabolic process,BP,1
GO:0046901,1,0.988662931,0,1,tetrahydrofolylpolyglutamate biosynthetic process,BP,1
GO:0046916,1,0.445171394,0,73,cellular transition metal ion homeostasis,BP,1
GO:0046929,1,0.930079043,0,7,negative regulation of neurotransmitter secretion,BP,1
GO:0046931,1,0.827684768,0,18,pore complex assembly,BP,1
GO:0046940,1,0.893900147,0,10,nucleoside monophosphate phosphorylation,BP,1
GO:0046946,1,0.967108787,0,3,hydroxylysine metabolic process,BP,1
GO:0046947,1,0.967108787,0,3,hydroxylysine biosynthetic process,BP,1
GO:0046949,1,0.915357245,0,8,fatty-acyl-CoA biosynthetic process,BP,1
GO:0046950,1,0.933862715,0,6,cellular ketone body metabolic process,BP,1
GO:0046951,1,0.96637061,0,3,ketone body biosynthetic process,BP,1
GO:0046952,1,0.966369887,0,3,ketone body catabolic process,BP,1
GO:0046958,1,0.994438131,0,1,nonassociative learning,BP,1
GO:0046959,1,0.994438131,0,1,habituation,BP,1
GO:0046963,1,0.977453375,0,2,3'-phosphoadenosine 5'-phosphosulfate transport,BP,1
GO:0046967,1,0.977499189,0,2,cytosol to ER transport,BP,1
GO:0046968,1,0.977499189,0,2,peptide antigen transport,BP,1
GO:0046984,1,0.944707202,0,5,regulation of hemoglobin biosynthetic process,BP,1
GO:0046985,1,0.966374568,0,3,positive regulation of hemoglobin biosynthetic process,BP,1
GO:0046986,1,0.988662937,0,1,negative regulation of hemoglobin biosynthetic process,BP,1
GO:0047484,1,0.904215848,0,9,regulation of response to osmotic stress,BP,1
GO:0047496,1,0.698874278,0,35,vesicle transport along microtubule,BP,1
GO:0047497,1,0.879032881,0,13,mitochondrion transport along microtubule,BP,1
GO:0048002,1,0.594734172,0,46,antigen processing and presentation of peptide antigen,BP,1
GO:0048003,1,0.969042723,0,3,antigen processing and presentation of lipid antigen via MHC class Ib,BP,1
GO:0048006,1,0.988662928,0,1,"antigen processing and presentation, endogenous lipid antigen via MHC class Ib",BP,1
GO:0048007,1,0.969042723,0,3,"antigen processing and presentation, exogenous lipid antigen via MHC class Ib",BP,1
GO:0048012,1,0.875876191,0,12,hepatocyte growth factor receptor signaling pathway,BP,1
GO:0048013,1,0.78183727,0,23,ephrin receptor signaling pathway,BP,1
GO:0048014,1,0.990401506,0,1,Tie signaling pathway,BP,1
GO:0048016,1,0.69458385,0,36,inositol phosphate-mediated signaling,BP,1
GO:0048021,1,0.969883804,0,3,regulation of melanin biosynthetic process,BP,1
GO:0048022,1,0.992257257,0,1,negative regulation of melanin biosynthetic process,BP,1
GO:0048023,1,0.977453353,0,2,positive regulation of melanin biosynthetic process,BP,1
GO:0048025,1,0.779607642,0,22,"negative regulation of mRNA splicing, via spliceosome",BP,1
GO:0048033,1,0.988662931,0,1,heme o metabolic process,BP,1
GO:0048034,1,0.988662931,0,1,heme O biosynthetic process,BP,1
GO:0048048,1,0.812839295,0,21,embryonic eye morphogenesis,BP,1
GO:0048050,1,0.930566857,0,7,post-embryonic eye morphogenesis,BP,1
GO:0048066,1,0.694716719,0,33,developmental pigmentation,BP,1
GO:0048069,1,0.945555063,0,5,eye pigmentation,BP,1
GO:0048070,1,0.871022669,0,13,regulation of developmental pigmentation,BP,1
GO:0048073,1,0.978363996,0,2,regulation of eye pigmentation,BP,1
GO:0048074,1,0.988663811,0,1,negative regulation of eye pigmentation,BP,1
GO:0048086,1,0.988663811,0,1,negative regulation of developmental pigmentation,BP,1
GO:0048087,1,0.941740817,0,6,positive regulation of developmental pigmentation,BP,1
GO:0048096,1,0.95272482,0,5,chromatin-mediated maintenance of transcription,BP,1
GO:0048102,1,0.912795024,0,8,autophagic cell death,BP,1
GO:0048133,1,0.967350082,0,3,male germ-line stem cell asymmetric division,BP,1
GO:0048148,1,0.898530891,0,10,behavioral response to cocaine,BP,1
GO:0048149,1,0.955411183,0,4,behavioral response to ethanol,BP,1
GO:0048162,1,0.988662931,0,1,multi-layer follicle stage,BP,1
GO:0048167,1,0.293466039,0,114,regulation of synaptic plasticity,BP,1
GO:0048168,1,0.707596834,0,32,regulation of neuronal synaptic plasticity,BP,1
GO:0048169,1,0.823756987,0,18,regulation of long-term neuronal synaptic plasticity,BP,1
GO:0048170,1,0.960679081,0,4,positive regulation of long-term neuronal synaptic plasticity,BP,1
GO:0048172,1,0.944704823,0,5,regulation of short-term neuronal synaptic plasticity,BP,1
GO:0048194,1,0.702328007,0,32,Golgi vesicle budding,BP,1
GO:0048199,1,0.81681047,0,18,"vesicle targeting, to, from or within Golgi",BP,1
GO:0048200,1,0.955469514,0,4,Golgi transport vesicle coating,BP,1
GO:0048203,1,0.97745337,0,2,"vesicle targeting, trans-Golgi to endosome",BP,1
GO:0048205,1,0.955469514,0,4,COPI coating of Golgi vesicle,BP,1
GO:0048207,1,0.905087427,0,9,"vesicle targeting, rough ER to cis-Golgi",BP,1
GO:0048208,1,0.905087427,0,9,COPII vesicle coating,BP,1
GO:0048209,1,0.966418588,0,3,"regulation of vesicle targeting, to, from or within Golgi",BP,1
GO:0048210,1,0.967437878,0,3,Golgi vesicle fusion to target membrane,BP,1
GO:0048211,1,0.978405012,0,2,Golgi vesicle docking,BP,1
GO:0048213,1,0.977517531,0,2,Golgi vesicle prefusion complex stabilization,BP,1
GO:0048227,1,0.929679656,0,7,plasma membrane to endosome transport,BP,1
GO:0048239,1,0.966369914,0,3,negative regulation of DNA recombination at telomere,BP,1
GO:0048241,1,0.946121668,0,5,epinephrine transport,BP,1
GO:0048242,1,0.956974754,0,4,epinephrine secretion,BP,1
GO:0048243,1,0.902788474,0,9,norepinephrine secretion,BP,1
GO:0048245,1,0.912956219,0,8,eosinophil chemotaxis,BP,1
GO:0048247,1,0.743924383,0,27,lymphocyte chemotaxis,BP,1
GO:0048250,1,0.977453327,0,2,iron import into the mitochondrion,BP,1
GO:0048251,1,0.919015456,0,8,elastic fiber assembly,BP,1
GO:0048252,1,0.955421686,0,4,lauric acid metabolic process,BP,1
GO:0048254,1,0.944575434,0,5,snoRNA localization,BP,1
GO:0048261,1,0.846149268,0,15,negative regulation of receptor-mediated endocytosis,BP,1
GO:0048262,1,0.923962536,0,7,determination of dorsal/ventral asymmetry,BP,1
GO:0048263,1,0.93456345,0,6,determination of dorsal identity,BP,1
GO:0048264,1,0.988662931,0,1,determination of ventral identity,BP,1
GO:0048268,1,0.873705112,0,13,clathrin coat assembly,BP,1
GO:0048278,1,0.62739463,0,42,vesicle docking,BP,1
GO:0048280,1,0.913628622,0,8,vesicle fusion with Golgi apparatus,BP,1
GO:0048284,1,0.367009498,0,90,organelle fusion,BP,1
GO:0048290,1,0.923428846,0,7,isotype switching to IgA isotypes,BP,1
GO:0048291,1,0.915337318,0,8,isotype switching to IgG isotypes,BP,1
GO:0048294,1,0.977870858,0,2,negative regulation of isotype switching to IgE isotypes,BP,1
GO:0048296,1,0.923428846,0,7,regulation of isotype switching to IgA isotypes,BP,1
GO:0048297,1,0.988662901,0,1,negative regulation of isotype switching to IgA isotypes,BP,1
GO:0048298,1,0.934023715,0,6,positive regulation of isotype switching to IgA isotypes,BP,1
GO:0048302,1,0.925839678,0,7,regulation of isotype switching to IgG isotypes,BP,1
GO:0048304,1,0.936461965,0,6,positive regulation of isotype switching to IgG isotypes,BP,1
GO:0048308,1,0.864268409,0,13,organelle inheritance,BP,1
GO:0048311,1,0.836138119,0,17,mitochondrion distribution,BP,1
GO:0048312,1,0.882294929,0,12,intracellular distribution of mitochondria,BP,1
GO:0048313,1,0.864268409,0,13,Golgi inheritance,BP,1
GO:0048318,1,0.95628733,0,4,axial mesoderm development,BP,1
GO:0048319,1,0.967256083,0,3,axial mesoderm morphogenesis,BP,1
GO:0048320,1,0.989569383,0,1,axial mesoderm formation,BP,1
GO:0048332,1,0.637703517,0,43,mesoderm morphogenesis,BP,1
GO:0048333,1,0.851213202,0,15,mesodermal cell differentiation,BP,1
GO:0048338,1,0.988901531,0,1,mesoderm structural organization,BP,1
GO:0048340,1,0.932893136,0,7,paraxial mesoderm morphogenesis,BP,1
GO:0048341,1,0.974062423,0,3,paraxial mesoderm formation,BP,1
GO:0048352,1,0.988901531,0,1,paraxial mesoderm structural organization,BP,1
GO:0048369,1,0.966613605,0,3,lateral mesoderm morphogenesis,BP,1
GO:0048370,1,0.966613605,0,3,lateral mesoderm formation,BP,1
GO:0048371,1,0.966613605,0,3,lateral mesodermal cell differentiation,BP,1
GO:0048372,1,0.977699844,0,2,lateral mesodermal cell fate commitment,BP,1
GO:0048377,1,0.977699844,0,2,lateral mesodermal cell fate specification,BP,1
GO:0048378,1,0.977699844,0,2,regulation of lateral mesodermal cell fate specification,BP,1
GO:0048382,1,0.97772531,0,2,mesendoderm development,BP,1
GO:0048384,1,0.779539792,0,22,retinoic acid receptor signaling pathway,BP,1
GO:0048385,1,0.903089857,0,9,regulation of retinoic acid receptor signaling pathway,BP,1
GO:0048386,1,0.966995283,0,3,positive regulation of retinoic acid receptor signaling pathway,BP,1
GO:0048387,1,0.944643861,0,5,negative regulation of retinoic acid receptor signaling pathway,BP,1
GO:0048388,1,0.988662853,0,1,endosomal lumen acidification,BP,1
GO:0048478,1,0.934813089,0,6,replication fork protection,BP,1
GO:0048484,1,0.94626016,0,5,enteric nervous system development,BP,1
GO:0048485,1,0.909506745,0,9,sympathetic nervous system development,BP,1
GO:0048488,1,0.615583224,0,44,synaptic vesicle endocytosis,BP,1
GO:0048490,1,0.840320466,0,16,anterograde synaptic vesicle transport,BP,1
GO:0048496,1,0.957579975,0,4,maintenance of animal organ identity,BP,1
GO:0048499,1,0.968300421,0,3,synaptic vesicle membrane organization,BP,1
GO:0048520,1,0.858830516,0,14,positive regulation of behavior,BP,1
GO:0048521,1,0.934124369,0,6,negative regulation of behavior,BP,1
GO:0048525,1,0.427326069,0,76,negative regulation of viral process,BP,1
GO:0048536,1,0.73419293,0,28,spleen development,BP,1
GO:0048539,1,0.937960237,0,6,bone marrow development,BP,1
GO:0048546,1,0.743429136,0,28,digestive tract morphogenesis,BP,1
GO:0048548,1,0.899982183,0,10,regulation of pinocytosis,BP,1
GO:0048549,1,0.939184539,0,6,positive regulation of pinocytosis,BP,1
GO:0048550,1,0.958279673,0,4,negative regulation of pinocytosis,BP,1
GO:0048557,1,0.882465853,0,12,embryonic digestive tract morphogenesis,BP,1
GO:0048560,1,0.988662915,0,1,establishment of anatomical structure orientation,BP,1
GO:0048563,1,0.913338168,0,9,post-embryonic animal organ morphogenesis,BP,1
GO:0048566,1,0.806473695,0,20,embryonic digestive tract development,BP,1
GO:0048567,1,0.988662931,0,1,ectodermal digestive tract morphogenesis,BP,1
GO:0048570,1,0.956619599,0,4,notochord morphogenesis,BP,1
GO:0048572,1,0.988662504,0,1,short-day photoperiodism,BP,1
GO:0048596,1,0.845741611,0,17,embryonic camera-type eye morphogenesis,BP,1
GO:0048597,1,0.946434546,0,5,post-embryonic camera-type eye morphogenesis,BP,1
GO:0048599,1,0.724179666,0,29,oocyte development,BP,1
GO:0048611,1,0.977706031,0,2,embryonic ectodermal digestive tract development,BP,1
GO:0048613,1,0.988662931,0,1,embryonic ectodermal digestive tract morphogenesis,BP,1
GO:0048617,1,0.905154765,0,9,embryonic foregut morphogenesis,BP,1
GO:0048619,1,0.966369909,0,3,embryonic hindgut morphogenesis,BP,1
GO:0048625,1,0.977506134,0,2,myoblast fate commitment,BP,1
GO:0048627,1,0.988813681,0,1,myoblast development,BP,1
GO:0048644,1,0.672523894,0,39,muscle organ morphogenesis,BP,1
GO:0048668,1,0.820310144,0,19,collateral sprouting,BP,1
GO:0048669,1,0.968302518,0,3,collateral sprouting in absence of injury,BP,1
GO:0048670,1,0.876004786,0,13,regulation of collateral sprouting,BP,1
GO:0048671,1,0.938680493,0,6,negative regulation of collateral sprouting,BP,1
GO:0048672,1,0.93326267,0,7,positive regulation of collateral sprouting,BP,1
GO:0048673,1,0.988662538,0,1,collateral sprouting of intact axon in response to injury,BP,1
GO:0048674,1,0.98802625,0,2,collateral sprouting of injured axon,BP,1
GO:0048677,1,0.977840238,0,3,axon extension involved in regeneration,BP,1
GO:0048681,1,0.893342236,0,11,negative regulation of axon regeneration,BP,1
GO:0048682,1,0.9685527,0,4,sprouting of injured axon,BP,1
GO:0048683,1,0.988662538,0,1,regulation of collateral sprouting of intact axon in response to injury,BP,1
GO:0048685,1,0.988662538,0,1,negative regulation of collateral sprouting of intact axon in response to injury,BP,1
GO:0048686,1,0.976823708,0,3,regulation of sprouting of injured axon,BP,1
GO:0048687,1,0.976823708,0,3,positive regulation of sprouting of injured axon,BP,1
GO:0048688,1,0.990503689,0,1,negative regulation of sprouting of injured axon,BP,1
GO:0048689,1,0.990503689,0,1,formation of growth cone in injured axon,BP,1
GO:0048690,1,0.986189916,0,2,regulation of axon extension involved in regeneration,BP,1
GO:0048691,1,0.986189916,0,2,positive regulation of axon extension involved in regeneration,BP,1
GO:0048693,1,0.98802625,0,2,regulation of collateral sprouting of injured axon,BP,1
GO:0048694,1,0.98802625,0,2,positive regulation of collateral sprouting of injured axon,BP,1
GO:0048696,1,0.988662931,0,1,regulation of collateral sprouting in absence of injury,BP,1
GO:0048698,1,0.988662931,0,1,negative regulation of collateral sprouting in absence of injury,BP,1
GO:0048701,1,0.788749061,0,23,embryonic cranial skeleton morphogenesis,BP,1
GO:0048702,1,0.945762742,0,5,embryonic neurocranium morphogenesis,BP,1
GO:0048703,1,0.96238988,0,4,embryonic viscerocranium morphogenesis,BP,1
GO:0048704,1,0.674546772,0,37,embryonic skeletal system morphogenesis,BP,1
GO:0048706,1,0.567280987,0,53,embryonic skeletal system development,BP,1
GO:0048714,1,0.847783674,0,15,positive regulation of oligodendrocyte differentiation,BP,1
GO:0048730,1,0.833880763,0,17,epidermis morphogenesis,BP,1
GO:0048733,1,0.944291626,0,6,sebaceous gland development,BP,1
GO:0048741,1,0.789653572,0,21,skeletal muscle fiber development,BP,1
GO:0048742,1,0.955486995,0,4,regulation of skeletal muscle fiber development,BP,1
GO:0048745,1,0.848810397,0,16,smooth muscle tissue development,BP,1
GO:0048752,1,0.983772086,0,2,semicircular canal morphogenesis,BP,1
GO:0048753,1,0.880647312,0,12,pigment granule organization,BP,1
GO:0048755,1,0.92037337,0,8,branching morphogenesis of a nerve,BP,1
GO:0048757,1,0.904242968,0,9,pigment granule maturation,BP,1
GO:0048773,1,0.988662931,0,1,erythrophore differentiation,BP,1
GO:0048790,1,0.97808535,0,2,maintenance of presynaptic active zone structure,BP,1
GO:0048791,1,0.978929447,0,2,calcium ion-regulated exocytosis of neurotransmitter,BP,1
GO:0048792,1,0.988662931,0,1,spontaneous exocytosis of neurotransmitter,BP,1
GO:0048793,1,0.966769656,0,3,pronephros development,BP,1
GO:0048799,1,0.888092573,0,12,animal organ maturation,BP,1
GO:0048806,1,0.732567685,0,30,genitalia development,BP,1
GO:0048807,1,0.988662706,0,1,female genitalia morphogenesis,BP,1
GO:0048818,1,0.988754356,0,1,positive regulation of hair follicle maturation,BP,1
GO:0048819,1,0.97754701,0,2,regulation of hair follicle maturation,BP,1
GO:0048820,1,0.93244706,0,7,hair follicle maturation,BP,1
GO:0048822,1,0.980511952,0,2,enucleate erythrocyte development,BP,1
GO:0048840,1,0.927040928,0,7,otolith development,BP,1
GO:0048843,1,0.860629627,0,15,negative regulation of axon extension involved in axon guidance,BP,1
GO:0048853,1,0.930496031,0,7,forebrain morphogenesis,BP,1
GO:0048854,1,0.787059017,0,23,brain morphogenesis,BP,1
GO:0048857,1,0.915112354,0,8,neural nucleus development,BP,1
GO:0048859,1,0.988662926,0,1,formation of anatomical boundary,BP,1
GO:0048861,1,0.966973336,0,3,leukemia inhibitory factor signaling pathway,BP,1
GO:0048865,1,0.955413123,0,4,stem cell fate commitment,BP,1
GO:0048866,1,0.97745545,0,2,stem cell fate specification,BP,1
GO:0048867,1,0.988662898,0,1,stem cell fate determination,BP,1
GO:0048877,1,0.988732867,0,1,homeostasis of number of retina cells,BP,1
GO:0048882,1,0.988663763,0,1,lateral line development,BP,1
GO:0048884,1,0.988663763,0,1,neuromast development,BP,1
GO:0048886,1,0.988663763,0,1,neuromast hair cell differentiation,BP,1
GO:0048925,1,0.988663763,0,1,lateral line system development,BP,1
GO:0048934,1,0.939251916,0,6,peripheral nervous system neuron differentiation,BP,1
GO:0048935,1,0.939251916,0,6,peripheral nervous system neuron development,BP,1
GO:0048936,1,0.977453368,0,2,peripheral nervous system neuron axonogenesis,BP,1
GO:0050000,1,0.610751219,0,45,chromosome localization,BP,1
GO:0050427,1,0.923800054,0,7,3'-phosphoadenosine 5'-phosphosulfate metabolic process,BP,1
GO:0050428,1,0.977963972,0,2,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process,BP,1
GO:0050432,1,0.756314921,0,25,catecholamine secretion,BP,1
GO:0050433,1,0.789980966,0,21,regulation of catecholamine secretion,BP,1
GO:0050435,1,0.680862305,0,35,amyloid-beta metabolic process,BP,1
GO:0050650,1,0.863894791,0,13,chondroitin sulfate proteoglycan biosynthetic process,BP,1
GO:0050651,1,0.957221581,0,4,dermatan sulfate proteoglycan biosynthetic process,BP,1
GO:0050653,1,0.988664794,0,1,"chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process",BP,1
GO:0050654,1,0.828400374,0,17,chondroitin sulfate proteoglycan metabolic process,BP,1
GO:0050655,1,0.935654121,0,6,dermatan sulfate proteoglycan metabolic process,BP,1
GO:0050665,1,0.856741588,0,14,hydrogen peroxide biosynthetic process,BP,1
GO:0050666,1,0.988662917,0,1,regulation of homocysteine metabolic process,BP,1
GO:0050667,1,0.875259969,0,12,homocysteine metabolic process,BP,1
GO:0050668,1,0.988662917,0,1,positive regulation of homocysteine metabolic process,BP,1
GO:0050672,1,0.557712944,0,53,negative regulation of lymphocyte proliferation,BP,1
GO:0050686,1,0.722012685,0,29,negative regulation of mRNA processing,BP,1
GO:0050687,1,0.790362105,0,21,negative regulation of defense response to virus,BP,1
GO:0050689,1,0.967694964,0,3,negative regulation of defense response to virus by host,BP,1
GO:0050690,1,0.988662831,0,1,regulation of defense response to virus by virus,BP,1
GO:0050702,1,0.690795814,0,33,interleukin-1 beta secretion,BP,1
GO:0050703,1,0.956066964,0,4,interleukin-1 alpha secretion,BP,1
GO:0050704,1,0.696001149,0,32,regulation of interleukin-1 secretion,BP,1
GO:0050705,1,0.967033209,0,3,regulation of interleukin-1 alpha secretion,BP,1
GO:0050706,1,0.720147496,0,29,regulation of interleukin-1 beta secretion,BP,1
GO:0050709,1,0.380953829,0,87,negative regulation of protein secretion,BP,1
GO:0050710,1,0.669920443,0,36,negative regulation of cytokine secretion,BP,1
GO:0050711,1,0.912827339,0,8,negative regulation of interleukin-1 secretion,BP,1
GO:0050713,1,0.933878218,0,6,negative regulation of interleukin-1 beta secretion,BP,1
GO:0050716,1,0.762618233,0,24,positive regulation of interleukin-1 secretion,BP,1
GO:0050717,1,0.967033209,0,3,positive regulation of interleukin-1 alpha secretion,BP,1
GO:0050718,1,0.771245952,0,23,positive regulation of interleukin-1 beta secretion,BP,1
GO:0050720,1,0.966372435,0,3,interleukin-1 beta biosynthetic process,BP,1
GO:0050722,1,0.966372435,0,3,regulation of interleukin-1 beta biosynthetic process,BP,1
GO:0050725,1,0.966372435,0,3,positive regulation of interleukin-1 beta biosynthetic process,BP,1
GO:0050746,1,0.903898081,0,9,regulation of lipoprotein metabolic process,BP,1
GO:0050747,1,0.945821952,0,5,positive regulation of lipoprotein metabolic process,BP,1
GO:0050748,1,0.977741314,0,2,negative regulation of lipoprotein metabolic process,BP,1
GO:0050755,1,0.93425563,0,6,chemokine metabolic process,BP,1
GO:0050757,1,0.988680233,0,1,thymidylate synthase biosynthetic process,BP,1
GO:0050758,1,0.988680233,0,1,regulation of thymidylate synthase biosynthetic process,BP,1
GO:0050760,1,0.988680233,0,1,negative regulation of thymidylate synthase biosynthetic process,BP,1
GO:0050764,1,0.436513299,0,76,regulation of phagocytosis,BP,1
GO:0050765,1,0.811948101,0,19,negative regulation of phagocytosis,BP,1
GO:0050766,1,0.549535895,0,55,positive regulation of phagocytosis,BP,1
GO:0050771,1,0.671723453,0,39,negative regulation of axonogenesis,BP,1
GO:0050774,1,0.868726168,0,13,negative regulation of dendrite morphogenesis,BP,1
GO:0050777,1,0.343973962,0,95,negative regulation of immune response,BP,1
GO:0050787,1,0.977453198,0,2,detoxification of mercury ion,BP,1
GO:0050798,1,0.729793222,0,28,activated T cell proliferation,BP,1
GO:0050805,1,0.666268152,0,38,negative regulation of synaptic transmission,BP,1
GO:0050812,1,0.966370074,0,3,regulation of acyl-CoA biosynthetic process,BP,1
GO:0050818,1,0.488410277,0,64,regulation of coagulation,BP,1
GO:0050819,1,0.644651742,0,39,negative regulation of coagulation,BP,1
GO:0050820,1,0.764674033,0,24,positive regulation of coagulation,BP,1
GO:0050822,1,0.988662909,0,1,peptide stabilization,BP,1
GO:0050823,1,0.988662909,0,1,peptide antigen stabilization,BP,1
GO:0050826,1,0.988662931,0,1,response to freezing,BP,1
GO:0050829,1,0.778857965,0,22,defense response to Gram-negative bacterium,BP,1
GO:0050830,1,0.647221153,0,39,defense response to Gram-positive bacterium,BP,1
GO:0050831,1,0.988663199,0,1,male-specific defense response to bacterium,BP,1
GO:0050832,1,0.854926757,0,14,defense response to fungus,BP,1
GO:0050847,1,0.915251636,0,8,progesterone receptor signaling pathway,BP,1
GO:0050848,1,0.512395287,0,63,regulation of calcium-mediated signaling,BP,1
GO:0050849,1,0.818809173,0,19,negative regulation of calcium-mediated signaling,BP,1
GO:0050850,1,0.70967986,0,32,positive regulation of calcium-mediated signaling,BP,1
GO:0050851,1,0.354285453,0,93,antigen receptor-mediated signaling pathway,BP,1
GO:0050852,1,0.461900267,0,69,T cell receptor signaling pathway,BP,1
GO:0050853,1,0.694601835,0,33,B cell receptor signaling pathway,BP,1
GO:0050854,1,0.654368713,0,38,regulation of antigen receptor-mediated signaling pathway,BP,1
GO:0050855,1,0.848415483,0,15,regulation of B cell receptor signaling pathway,BP,1
GO:0050856,1,0.74554667,0,26,regulation of T cell receptor signaling pathway,BP,1
GO:0050857,1,0.856744876,0,14,positive regulation of antigen receptor-mediated signaling pathway,BP,1
GO:0050858,1,0.799412936,0,20,negative regulation of antigen receptor-mediated signaling pathway,BP,1
GO:0050859,1,0.924860374,0,7,negative regulation of B cell receptor signaling pathway,BP,1
GO:0050860,1,0.854627866,0,14,negative regulation of T cell receptor signaling pathway,BP,1
GO:0050861,1,0.936260711,0,6,positive regulation of B cell receptor signaling pathway,BP,1
GO:0050862,1,0.913264112,0,8,positive regulation of T cell receptor signaling pathway,BP,1
GO:0050868,1,0.431259926,0,75,negative regulation of T cell activation,BP,1
GO:0050869,1,0.797728497,0,21,negative regulation of B cell activation,BP,1
GO:0050872,1,0.886897786,0,12,white fat cell differentiation,BP,1
GO:0050873,1,0.716760217,0,30,brown fat cell differentiation,BP,1
GO:0050879,1,0.705485143,0,33,multicellular organismal movement,BP,1
GO:0050881,1,0.705485143,0,33,musculoskeletal movement,BP,1
GO:0050882,1,0.926548887,0,8,voluntary musculoskeletal movement,BP,1
GO:0050883,1,0.988662898,0,1,"musculoskeletal movement, spinal reflex action",BP,1
GO:0050884,1,0.905909665,0,9,neuromuscular process controlling posture,BP,1
GO:0050885,1,0.727641011,0,30,neuromuscular process controlling balance,BP,1
GO:0050893,1,0.988662889,0,1,sensory processing,BP,1
GO:0050901,1,0.856941999,0,14,leukocyte tethering or rolling,BP,1
GO:0050902,1,0.97762751,0,2,leukocyte adhesive activation,BP,1
GO:0050904,1,0.945782283,0,5,diapedesis,BP,1
GO:0050905,1,0.538545604,0,59,neuromuscular process,BP,1
GO:0050906,1,0.64495442,0,40,detection of stimulus involved in sensory perception,BP,1
GO:0050907,1,0.882272861,0,11,detection of chemical stimulus involved in sensory perception,BP,1
GO:0050908,1,0.940345923,0,6,detection of light stimulus involved in visual perception,BP,1
GO:0050910,1,0.910700186,0,9,detection of mechanical stimulus involved in sensory perception of sound,BP,1
GO:0050911,1,0.97754645,0,2,detection of chemical stimulus involved in sensory perception of smell,BP,1
GO:0050912,1,0.912831255,0,8,detection of chemical stimulus involved in sensory perception of taste,BP,1
GO:0050913,1,0.923269212,0,7,sensory perception of bitter taste,BP,1
GO:0050916,1,0.988662913,0,1,sensory perception of sweet taste,BP,1
GO:0050917,1,0.966407891,0,3,sensory perception of umami taste,BP,1
GO:0050919,1,0.773646889,0,25,negative chemotaxis,BP,1
GO:0050923,1,0.994495178,0,1,regulation of negative chemotaxis,BP,1
GO:0050925,1,0.994495178,0,1,negative regulation of negative chemotaxis,BP,1
GO:0050931,1,0.751835419,0,26,pigment cell differentiation,BP,1
GO:0050932,1,0.931059232,0,7,regulation of pigment cell differentiation,BP,1
GO:0050942,1,0.952544441,0,5,positive regulation of pigment cell differentiation,BP,1
GO:0050951,1,0.882587975,0,11,sensory perception of temperature stimulus,BP,1
GO:0050953,1,0.664797205,0,38,sensory perception of light stimulus,BP,1
GO:0050954,1,0.413423578,0,85,sensory perception of mechanical stimulus,BP,1
GO:0050955,1,0.977539907,0,2,thermoception,BP,1
GO:0050957,1,0.992752435,0,1,equilibrioception,BP,1
GO:0050960,1,0.988750447,0,1,detection of temperature stimulus involved in thermoception,BP,1
GO:0050961,1,0.902963419,0,9,detection of temperature stimulus involved in sensory perception,BP,1
GO:0050962,1,0.940345923,0,6,detection of light stimulus involved in sensory perception,BP,1
GO:0050965,1,0.902963419,0,9,detection of temperature stimulus involved in sensory perception of pain,BP,1
GO:0050966,1,0.923723206,0,7,detection of mechanical stimulus involved in sensory perception of pain,BP,1
GO:0050968,1,0.988750447,0,1,detection of chemical stimulus involved in sensory perception of pain,BP,1
GO:0050974,1,0.813924749,0,19,detection of mechanical stimulus involved in sensory perception,BP,1
GO:0050975,1,0.977453321,0,2,sensory perception of touch,BP,1
GO:0050982,1,0.77794443,0,23,detection of mechanical stimulus,BP,1
GO:0050992,1,0.988662821,0,1,dimethylallyl diphosphate biosynthetic process,BP,1
GO:0050993,1,0.988662821,0,1,dimethylallyl diphosphate metabolic process,BP,1
GO:0050994,1,0.592612567,0,48,regulation of lipid catabolic process,BP,1
GO:0050995,1,0.811829985,0,19,negative regulation of lipid catabolic process,BP,1
GO:0050996,1,0.768960679,0,24,positive regulation of lipid catabolic process,BP,1
GO:0050999,1,0.764884492,0,24,regulation of nitric-oxide synthase activity,BP,1
GO:0051000,1,0.855148292,0,14,positive regulation of nitric-oxide synthase activity,BP,1
GO:0051001,1,0.924532873,0,7,negative regulation of nitric-oxide synthase activity,BP,1
GO:0051006,1,0.912794015,0,8,positive regulation of lipoprotein lipase activity,BP,1
GO:0051012,1,0.980940324,0,2,microtubule sliding,BP,1
GO:0051013,1,0.946520249,0,5,microtubule severing,BP,1
GO:0051014,1,0.914979263,0,8,actin filament severing,BP,1
GO:0051016,1,0.845841749,0,15,barbed-end actin filament capping,BP,1
GO:0051017,1,0.293043782,0,113,actin filament bundle assembly,BP,1
GO:0051023,1,0.883229068,0,11,regulation of immunoglobulin secretion,BP,1
GO:0051024,1,0.923753799,0,7,positive regulation of immunoglobulin secretion,BP,1
GO:0051025,1,0.967088852,0,3,negative regulation of immunoglobulin secretion,BP,1
GO:0051026,1,0.988662931,0,1,chiasma assembly,BP,1
GO:0051029,1,0.945542079,0,5,rRNA transport,BP,1
GO:0051030,1,0.955410895,0,4,snRNA transport,BP,1
GO:0051031,1,0.956443826,0,4,tRNA transport,BP,1
GO:0051036,1,0.936057804,0,6,regulation of endosome size,BP,1
GO:0051037,1,0.977453359,0,2,regulation of transcription involved in meiotic cell cycle,BP,1
GO:0051038,1,0.98866293,0,1,negative regulation of transcription involved in meiotic cell cycle,BP,1
GO:0051039,1,0.988662916,0,1,positive regulation of transcription involved in meiotic cell cycle,BP,1
GO:0051040,1,0.977627507,0,2,regulation of calcium-independent cell-cell adhesion,BP,1
GO:0051041,1,0.988839133,0,1,positive regulation of calcium-independent cell-cell adhesion,BP,1
GO:0051042,1,0.988662842,0,1,negative regulation of calcium-independent cell-cell adhesion,BP,1
GO:0051043,1,0.845587594,0,15,regulation of membrane protein ectodomain proteolysis,BP,1
GO:0051044,1,0.893629642,0,10,positive regulation of membrane protein ectodomain proteolysis,BP,1
GO:0051045,1,0.946286453,0,5,negative regulation of membrane protein ectodomain proteolysis,BP,1
GO:0051055,1,0.676757346,0,35,negative regulation of lipid biosynthetic process,BP,1
GO:0051057,1,0.697616103,0,36,positive regulation of small GTPase mediated signal transduction,BP,1
GO:0051058,1,0.582695227,0,50,negative regulation of small GTPase mediated signal transduction,BP,1
GO:0051066,1,0.988662733,0,1,dihydrobiopterin metabolic process,BP,1
GO:0051068,1,0.988662931,0,1,dihydrolipoamide metabolic process,BP,1
GO:0051086,1,0.98866293,0,1,chaperone mediated protein folding independent of cofactor,BP,1
GO:0051088,1,0.967734593,0,3,PMA-inducible membrane protein ectodomain proteolysis,BP,1
GO:0051089,1,0.988662931,0,1,constitutive protein ectodomain proteolysis,BP,1
GO:0051095,1,0.913174525,0,8,regulation of helicase activity,BP,1
GO:0051096,1,0.933946316,0,6,positive regulation of helicase activity,BP,1
GO:0051097,1,0.977771135,0,2,negative regulation of helicase activity,BP,1
GO:0051100,1,0.252513723,0,123,negative regulation of binding,BP,1
GO:0051102,1,0.988923312,0,1,DNA ligation involved in DNA recombination,BP,1
GO:0051103,1,0.914034638,0,8,DNA ligation involved in DNA repair,BP,1
GO:0051123,1,0.76169226,0,24,RNA polymerase II preinitiation complex assembly,BP,1
GO:0051124,1,0.961763323,0,5,synaptic growth at neuromuscular junction,BP,1
GO:0051126,1,0.924662892,0,7,negative regulation of actin nucleation,BP,1
GO:0051132,1,0.913751038,0,8,NK T cell activation,BP,1
GO:0051133,1,0.934840184,0,6,regulation of NK T cell activation,BP,1
GO:0051134,1,0.977453359,0,2,negative regulation of NK T cell activation,BP,1
GO:0051135,1,0.956411655,0,4,positive regulation of NK T cell activation,BP,1
GO:0051136,1,0.938715261,0,6,regulation of NK T cell differentiation,BP,1
GO:0051138,1,0.947190184,0,5,positive regulation of NK T cell differentiation,BP,1
GO:0051140,1,0.96738181,0,3,regulation of NK T cell proliferation,BP,1
GO:0051141,1,0.988662915,0,1,negative regulation of NK T cell proliferation,BP,1
GO:0051142,1,0.978476804,0,2,positive regulation of NK T cell proliferation,BP,1
GO:0051150,1,0.817860529,0,19,regulation of smooth muscle cell differentiation,BP,1
GO:0051151,1,0.903949549,0,10,negative regulation of smooth muscle cell differentiation,BP,1
GO:0051152,1,0.945406474,0,5,positive regulation of smooth muscle cell differentiation,BP,1
GO:0051156,1,0.800910492,0,20,glucose 6-phosphate metabolic process,BP,1
GO:0051160,1,0.988662939,0,1,L-xylitol catabolic process,BP,1
GO:0051164,1,0.988662939,0,1,L-xylitol metabolic process,BP,1
GO:0051176,1,0.961707499,0,4,positive regulation of sulfur metabolic process,BP,1
GO:0051177,1,0.979202234,0,2,meiotic sister chromatid cohesion,BP,1
GO:0051180,1,0.776724996,0,23,vitamin transport,BP,1
GO:0051181,1,0.725764655,0,29,cofactor transport,BP,1
GO:0051182,1,0.913740243,0,8,coenzyme transport,BP,1
GO:0051187,1,0.651555607,0,38,cofactor catabolic process,BP,1
GO:0051189,1,0.923442863,0,7,prosthetic group metabolic process,BP,1
GO:0051204,1,0.912794472,0,8,protein insertion into mitochondrial membrane,BP,1
GO:0051205,1,0.824266213,0,17,protein insertion into membrane,BP,1
GO:0051208,1,0.439812231,0,77,sequestering of calcium ion,BP,1
GO:0051209,1,0.459032742,0,73,release of sequestered calcium ion into cytosol,BP,1
GO:0051216,1,0.298315405,0,110,cartilage development,BP,1
GO:0051220,1,0.792362192,0,21,cytoplasmic sequestering of protein,BP,1
GO:0051224,1,0.237420851,0,129,negative regulation of protein transport,BP,1
GO:0051228,1,0.979352887,0,2,mitotic spindle disassembly,BP,1
GO:0051230,1,0.979352887,0,2,spindle disassembly,BP,1
GO:0051231,1,0.955411354,0,4,spindle elongation,BP,1
GO:0051232,1,0.98866317,0,1,meiotic spindle elongation,BP,1
GO:0051238,1,0.917083167,0,8,sequestering of metal ion,BP,1
GO:0051250,1,0.335371854,0,98,negative regulation of lymphocyte activation,BP,1
GO:0051255,1,0.955440542,0,4,spindle midzone assembly,BP,1
GO:0051256,1,0.977453372,0,2,mitotic spindle midzone assembly,BP,1
GO:0051257,1,0.98866404,0,1,meiotic spindle midzone assembly,BP,1
GO:0051261,1,0.461062395,0,74,protein depolymerization,BP,1
GO:0051262,1,0.252924458,0,124,protein tetramerization,BP,1
GO:0051279,1,0.593865321,0,48,regulation of release of sequestered calcium ion into cytosol,BP,1
GO:0051280,1,0.902537347,0,9,negative regulation of release of sequestered calcium ion into cytosol,BP,1
GO:0051281,1,0.78345723,0,23,positive regulation of release of sequestered calcium ion into cytosol,BP,1
GO:0051282,1,0.443633025,0,76,regulation of sequestering of calcium ion,BP,1
GO:0051283,1,0.448633885,0,75,negative regulation of sequestering of calcium ion,BP,1
GO:0051284,1,0.902537347,0,9,positive regulation of sequestering of calcium ion,BP,1
GO:0051289,1,0.397253814,0,83,protein homotetramerization,BP,1
GO:0051290,1,0.747254262,0,27,protein heterotetramerization,BP,1
GO:0051291,1,0.316671321,0,104,protein heterooligomerization,BP,1
GO:0051292,1,0.914311189,0,9,nuclear pore complex assembly,BP,1
GO:0051293,1,0.7222145,0,31,establishment of spindle localization,BP,1
GO:0051294,1,0.756272711,0,26,establishment of spindle orientation,BP,1
GO:0051295,1,0.980170033,0,2,establishment of meiotic spindle localization,BP,1
GO:0051298,1,0.610418657,0,45,centrosome duplication,BP,1
GO:0051300,1,0.979108385,0,2,spindle pole body organization,BP,1
GO:0051303,1,0.615360066,0,44,establishment of chromosome localization,BP,1
GO:0051305,1,0.955556775,0,4,chromosome movement towards spindle pole,BP,1
GO:0051307,1,0.883936929,0,11,meiotic chromosome separation,BP,1
GO:0051309,1,0.988662931,0,1,female meiosis chromosome separation,BP,1
GO:0051310,1,0.685483381,0,34,metaphase plate congression,BP,1
GO:0051311,1,0.977454472,0,2,meiotic metaphase plate congression,BP,1
GO:0051315,1,0.923658623,0,7,attachment of mitotic spindle microtubules to kinetochore,BP,1
GO:0051316,1,0.988662931,0,1,attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation,BP,1
GO:0051339,1,0.832088525,0,18,regulation of lyase activity,BP,1
GO:0051340,1,0.912794868,0,8,regulation of ligase activity,BP,1
GO:0051342,1,0.923268905,0,7,regulation of cyclic-nucleotide phosphodiesterase activity,BP,1
GO:0051343,1,0.955411009,0,4,positive regulation of cyclic-nucleotide phosphodiesterase activity,BP,1
GO:0051344,1,0.966369888,0,3,negative regulation of cyclic-nucleotide phosphodiesterase activity,BP,1
GO:0051349,1,0.893968477,0,11,positive regulation of lyase activity,BP,1
GO:0051350,1,0.920317844,0,8,negative regulation of lyase activity,BP,1
GO:0051351,1,0.923268693,0,7,positive regulation of ligase activity,BP,1
GO:0051352,1,0.988662913,0,1,negative regulation of ligase activity,BP,1
GO:0051354,1,0.825626752,0,17,negative regulation of oxidoreductase activity,BP,1
GO:0051365,1,0.96659436,0,3,cellular response to potassium ion starvation,BP,1
GO:0051382,1,0.927656325,0,7,kinetochore assembly,BP,1
GO:0051383,1,0.910310535,0,9,kinetochore organization,BP,1
GO:0051386,1,0.881870782,0,12,regulation of neurotrophin TRK receptor signaling pathway,BP,1
GO:0051387,1,0.959115115,0,4,negative regulation of neurotrophin TRK receptor signaling pathway,BP,1
GO:0051388,1,0.938696302,0,6,positive regulation of neurotrophin TRK receptor signaling pathway,BP,1
GO:0051391,1,0.988662931,0,1,tRNA acetylation,BP,1
GO:0051410,1,0.977452881,0,2,detoxification of nitrogen compound,BP,1
GO:0051413,1,0.988742968,0,1,response to cortisone,BP,1
GO:0051414,1,0.959666921,0,4,response to cortisol,BP,1
GO:0051415,1,0.949308474,0,5,microtubule nucleation by interphase microtubule organizing center,BP,1
GO:0051418,1,0.927895961,0,7,microtubule nucleation by microtubule organizing center,BP,1
GO:0051438,1,0.652001599,0,38,regulation of ubiquitin-protein transferase activity,BP,1
GO:0051443,1,0.797880578,0,20,positive regulation of ubiquitin-protein transferase activity,BP,1
GO:0051444,1,0.845940473,0,15,negative regulation of ubiquitin-protein transferase activity,BP,1
GO:0051446,1,0.839976531,0,16,positive regulation of meiotic cell cycle,BP,1
GO:0051451,1,0.893868499,0,10,myoblast migration,BP,1
GO:0051452,1,0.726847945,0,28,intracellular pH reduction,BP,1
GO:0051455,1,0.988662931,0,1,attachment of spindle microtubules to kinetochore involved in homologous chromosome segregation,BP,1
GO:0051458,1,0.966397272,0,3,corticotropin secretion,BP,1
GO:0051459,1,0.977453044,0,2,regulation of corticotropin secretion,BP,1
GO:0051461,1,0.988662615,0,1,positive regulation of corticotropin secretion,BP,1
GO:0051462,1,0.988663451,0,1,regulation of cortisol secretion,BP,1
GO:0051463,1,0.988663451,0,1,negative regulation of cortisol secretion,BP,1
GO:0051480,1,0.153545411,0,172,regulation of cytosolic calcium ion concentration,BP,1
GO:0051481,1,0.898411965,0,11,negative regulation of cytosolic calcium ion concentration,BP,1
GO:0051482,1,0.874668406,0,12,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway,BP,1
GO:0051489,1,0.699254373,0,33,regulation of filopodium assembly,BP,1
GO:0051490,1,0.96641281,0,3,negative regulation of filopodium assembly,BP,1
GO:0051491,1,0.797237453,0,21,positive regulation of filopodium assembly,BP,1
GO:0051492,1,0.526417857,0,59,regulation of stress fiber assembly,BP,1
GO:0051496,1,0.666903017,0,37,positive regulation of stress fiber assembly,BP,1
GO:0051497,1,0.858985198,0,14,negative regulation of stress fiber assembly,BP,1
GO:0051503,1,0.863644536,0,13,adenine nucleotide transport,BP,1
GO:0051510,1,0.988662792,0,1,regulation of unidimensional cell growth,BP,1
GO:0051511,1,0.988662792,0,1,negative regulation of unidimensional cell growth,BP,1
GO:0051541,1,0.95765306,0,4,elastin metabolic process,BP,1
GO:0051542,1,0.990268193,0,1,elastin biosynthetic process,BP,1
GO:0051547,1,0.920626617,0,8,regulation of keratinocyte migration,BP,1
GO:0051548,1,0.988662832,0,1,negative regulation of keratinocyte migration,BP,1
GO:0051549,1,0.931189662,0,7,positive regulation of keratinocyte migration,BP,1
GO:0051560,1,0.783358446,0,22,mitochondrial calcium ion homeostasis,BP,1
GO:0051561,1,0.893307053,0,10,positive regulation of mitochondrial calcium ion concentration,BP,1
GO:0051562,1,0.955480071,0,4,negative regulation of mitochondrial calcium ion concentration,BP,1
GO:0051563,1,0.97745634,0,2,smooth endoplasmic reticulum calcium ion homeostasis,BP,1
GO:0051567,1,0.790893811,0,24,histone H3-K9 methylation,BP,1
GO:0051568,1,0.619935152,0,44,histone H3-K4 methylation,BP,1
GO:0051569,1,0.787112528,0,22,regulation of histone H3-K4 methylation,BP,1
GO:0051570,1,0.848160945,0,16,regulation of histone H3-K9 methylation,BP,1
GO:0051571,1,0.871621171,0,13,positive regulation of histone H3-K4 methylation,BP,1
GO:0051572,1,0.947672086,0,5,negative regulation of histone H3-K4 methylation,BP,1
GO:0051573,1,0.911922984,0,9,negative regulation of histone H3-K9 methylation,BP,1
GO:0051574,1,0.947518505,0,5,positive regulation of histone H3-K9 methylation,BP,1
GO:0051580,1,0.895259828,0,10,regulation of neurotransmitter uptake,BP,1
GO:0051581,1,0.966662592,0,3,negative regulation of neurotransmitter uptake,BP,1
GO:0051582,1,0.977453329,0,2,positive regulation of neurotransmitter uptake,BP,1
GO:0051583,1,0.977453218,0,2,dopamine uptake involved in synaptic transmission,BP,1
GO:0051584,1,0.988662931,0,1,regulation of dopamine uptake involved in synaptic transmission,BP,1
GO:0051589,1,0.860287602,0,14,negative regulation of neurotransmitter transport,BP,1
GO:0051590,1,0.820530615,0,18,positive regulation of neurotransmitter transport,BP,1
GO:0051594,1,0.966372364,0,3,detection of glucose,BP,1
GO:0051595,1,0.968375335,0,3,response to methylglyoxal,BP,1
GO:0051596,1,0.977520762,0,2,methylglyoxal catabolic process,BP,1
GO:0051597,1,0.892444731,0,10,response to methylmercury,BP,1
GO:0051598,1,0.988662863,0,1,meiotic recombination checkpoint,BP,1
GO:0051599,1,0.915835667,0,8,response to hydrostatic pressure,BP,1
GO:0051602,1,0.588170923,0,49,response to electrical stimulus,BP,1
GO:0051606,1,0.413568417,0,80,detection of stimulus,BP,1
GO:0051608,1,0.925324141,0,7,histamine transport,BP,1
GO:0051610,1,0.988963062,0,1,serotonin uptake,BP,1
GO:0051611,1,0.988963062,0,1,regulation of serotonin uptake,BP,1
GO:0051612,1,0.988963062,0,1,negative regulation of serotonin uptake,BP,1
GO:0051620,1,0.97745329,0,2,norepinephrine uptake,BP,1
GO:0051621,1,0.988662847,0,1,regulation of norepinephrine uptake,BP,1
GO:0051639,1,0.936452252,0,6,actin filament network formation,BP,1
GO:0051642,1,0.72607308,0,30,centrosome localization,BP,1
GO:0051643,1,0.945338875,0,5,endoplasmic reticulum localization,BP,1
GO:0051645,1,0.864901401,0,13,Golgi localization,BP,1
GO:0051646,1,0.706991721,0,33,mitochondrion localization,BP,1
GO:0051647,1,0.777288212,0,25,nucleus localization,BP,1
GO:0051653,1,0.686585382,0,36,spindle localization,BP,1
GO:0051654,1,0.859193424,0,15,establishment of mitochondrion localization,BP,1
GO:0051657,1,0.900446071,0,10,maintenance of organelle location,BP,1
GO:0051659,1,0.988662931,0,1,maintenance of mitochondrion location,BP,1
GO:0051660,1,0.916368035,0,8,establishment of centrosome localization,BP,1
GO:0051661,1,0.941609132,0,6,maintenance of centrosome location,BP,1
GO:0051664,1,0.977453375,0,2,nuclear pore localization,BP,1
GO:0051665,1,0.968338613,0,3,membrane raft localization,BP,1
GO:0051666,1,0.936165799,0,6,actin cortical patch localization,BP,1
GO:0051668,1,0.291229159,0,115,localization within membrane,BP,1
GO:0051673,1,0.988662923,0,1,membrane disruption in other organism,BP,1
GO:0051683,1,0.923268719,0,7,establishment of Golgi localization,BP,1
GO:0051684,1,0.967273893,0,3,maintenance of Golgi location,BP,1
GO:0051685,1,0.988662931,0,1,maintenance of ER location,BP,1
GO:0051691,1,0.988662919,0,1,cellular oligosaccharide metabolic process,BP,1
GO:0051692,1,0.988662919,0,1,cellular oligosaccharide catabolic process,BP,1
GO:0051693,1,0.797707041,0,21,actin filament capping,BP,1
GO:0051694,1,0.977477184,0,2,pointed-end actin filament capping,BP,1
GO:0051695,1,0.988789446,0,1,actin filament uncapping,BP,1
GO:0051697,1,0.988671005,0,1,protein delipidation,BP,1
GO:0051701,1,0.280535894,0,113,interaction with host,BP,1
GO:0051703,1,0.791112625,0,26,intraspecies interaction between organisms,BP,1
GO:0051705,1,0.699989543,0,37,multi-organism behavior,BP,1
GO:0051708,1,0.988662598,0,1,intracellular protein transport in other organism involved in symbiotic interaction,BP,1
GO:0051709,1,0.933870313,0,6,regulation of killing of cells of other organism,BP,1
GO:0051712,1,0.933870313,0,6,positive regulation of killing of cells of other organism,BP,1
GO:0051715,1,0.977453375,0,2,cytolysis in other organism,BP,1
GO:0051725,1,0.96636969,0,3,protein de-ADP-ribosylation,BP,1
GO:0051728,1,0.988662558,0,1,"cell cycle switching, mitotic to meiotic cell cycle",BP,1
GO:0051729,1,0.988662558,0,1,"germline cell cycle switching, mitotic to meiotic cell cycle",BP,1
GO:0051754,1,0.979202234,0,2,"meiotic sister chromatid cohesion, centromeric",BP,1
GO:0051764,1,0.928475064,0,7,actin crosslink formation,BP,1
GO:0051767,1,0.819638788,0,18,nitric-oxide synthase biosynthetic process,BP,1
GO:0051769,1,0.819638788,0,18,regulation of nitric-oxide synthase biosynthetic process,BP,1
GO:0051770,1,0.848201087,0,15,positive regulation of nitric-oxide synthase biosynthetic process,BP,1
GO:0051771,1,0.955410811,0,4,negative regulation of nitric-oxide synthase biosynthetic process,BP,1
GO:0051775,1,0.905982278,0,9,response to redox state,BP,1
GO:0051780,1,0.988674853,0,1,behavioral response to nutrient,BP,1
GO:0051785,1,0.650607713,0,40,positive regulation of nuclear division,BP,1
GO:0051788,1,0.770792899,0,23,response to misfolded protein,BP,1
GO:0051790,1,0.956155413,0,4,short-chain fatty acid biosynthetic process,BP,1
GO:0051791,1,0.87216656,0,12,medium-chain fatty acid metabolic process,BP,1
GO:0051792,1,0.955461888,0,4,medium-chain fatty acid biosynthetic process,BP,1
GO:0051793,1,0.966369853,0,3,medium-chain fatty acid catabolic process,BP,1
GO:0051794,1,0.988754356,0,1,regulation of timing of catagen,BP,1
GO:0051795,1,0.988754356,0,1,positive regulation of timing of catagen,BP,1
GO:0051797,1,0.902529814,0,9,regulation of hair follicle development,BP,1
GO:0051798,1,0.955499385,0,4,positive regulation of hair follicle development,BP,1
GO:0051799,1,0.977457848,0,2,negative regulation of hair follicle development,BP,1
GO:0051801,1,0.988662931,0,1,cytolysis in other organism involved in symbiotic interaction,BP,1
GO:0051805,1,0.988662831,0,1,evasion or tolerance of immune response of other organism involved in symbiotic interaction,BP,1
GO:0051806,1,0.539299437,0,55,entry into cell of other organism involved in symbiotic interaction,BP,1
GO:0051807,1,0.988662831,0,1,evasion or tolerance of defense response of other organism involved in symbiotic interaction,BP,1
GO:0051808,1,0.988662929,0,1,translocation of peptides or proteins into other organism involved in symbiotic interaction,BP,1
GO:0051818,1,0.892259849,0,10,disruption of cells of other organism involved in symbiotic interaction,BP,1
GO:0051821,1,0.991293742,0,1,dissemination or transmission of organism from other organism involved in symbiotic interaction,BP,1
GO:0051823,1,0.95983147,0,4,regulation of synapse structural plasticity,BP,1
GO:0051828,1,0.539299437,0,55,entry into other organism involved in symbiotic interaction,BP,1
GO:0051832,1,0.968158169,0,3,avoidance of defenses of other organism involved in symbiotic interaction,BP,1
GO:0051834,1,0.968158169,0,3,evasion or tolerance of defenses of other organism involved in symbiotic interaction,BP,1
GO:0051835,1,0.970840913,0,3,positive regulation of synapse structural plasticity,BP,1
GO:0051836,1,0.902439227,0,9,translocation of molecules into other organism involved in symbiotic interaction,BP,1
GO:0051838,1,0.988662931,0,1,cytolysis by host of symbiont cells,BP,1
GO:0051852,1,0.923322636,0,7,disruption by host of symbiont cells,BP,1
GO:0051865,1,0.551769945,0,53,protein autoubiquitination,BP,1
GO:0051866,1,0.988682981,0,1,general adaptation syndrome,BP,1
GO:0051873,1,0.923322636,0,7,killing by host of symbiont cells,BP,1
GO:0051875,1,0.841548992,0,16,pigment granule localization,BP,1
GO:0051881,1,0.488472438,0,64,regulation of mitochondrial membrane potential,BP,1
GO:0051882,1,0.815783481,0,18,mitochondrial depolarization,BP,1
GO:0051883,1,0.892259849,0,10,killing of cells in other organism involved in symbiotic interaction,BP,1
GO:0051884,1,0.988666206,0,1,regulation of timing of anagen,BP,1
GO:0051890,1,0.949389929,0,5,regulation of cardioblast differentiation,BP,1
GO:0051891,1,0.958693863,0,4,positive regulation of cardioblast differentiation,BP,1
GO:0051892,1,0.99029846,0,1,negative regulation of cardioblast differentiation,BP,1
GO:0051895,1,0.854856356,0,15,negative regulation of focal adhesion assembly,BP,1
GO:0051898,1,0.734278713,0,28,negative regulation of protein kinase B signaling,BP,1
GO:0051899,1,0.65809589,0,38,membrane depolarization,BP,1
GO:0051900,1,0.834628518,0,16,regulation of mitochondrial depolarization,BP,1
GO:0051901,1,0.913853312,0,8,positive regulation of mitochondrial depolarization,BP,1
GO:0051902,1,0.966369849,0,3,negative regulation of mitochondrial depolarization,BP,1
GO:0051904,1,0.867157066,0,13,pigment granule transport,BP,1
GO:0051905,1,0.860975276,0,14,establishment of pigment granule localization,BP,1
GO:0051913,1,0.996273998,0,1,regulation of synaptic plasticity by chemical substance,BP,1
GO:0051914,1,0.996273998,0,1,positive regulation of synaptic plasticity by chemical substance,BP,1
GO:0051915,1,0.996273998,0,1,induction of synaptic plasticity by chemical substance,BP,1
GO:0051917,1,0.892421415,0,10,regulation of fibrinolysis,BP,1
GO:0051918,1,0.93408226,0,6,negative regulation of fibrinolysis,BP,1
GO:0051919,1,0.95547148,0,4,positive regulation of fibrinolysis,BP,1
GO:0051923,1,0.894104867,0,10,sulfation,BP,1
GO:0051928,1,0.477316953,0,69,positive regulation of calcium ion transport,BP,1
GO:0051930,1,0.791410535,0,22,regulation of sensory perception of pain,BP,1
GO:0051931,1,0.791410535,0,22,regulation of sensory perception,BP,1
GO:0051932,1,0.788033071,0,22,"synaptic transmission, GABAergic",BP,1
GO:0051933,1,0.980465678,0,2,amino acid neurotransmitter reuptake,BP,1
GO:0051934,1,0.977453218,0,2,catecholamine uptake involved in synaptic transmission,BP,1
GO:0051935,1,0.980465678,0,2,glutamate reuptake,BP,1
GO:0051937,1,0.707800761,0,31,catecholamine transport,BP,1
GO:0051938,1,0.921875969,0,8,L-glutamate import,BP,1
GO:0051939,1,0.989787427,0,1,gamma-aminobutyric acid import,BP,1
GO:0051940,1,0.988662931,0,1,regulation of catecholamine uptake involved in synaptic transmission,BP,1
GO:0051941,1,0.991709211,0,1,regulation of amino acid uptake involved in synaptic transmission,BP,1
GO:0051946,1,0.991709211,0,1,regulation of glutamate uptake involved in transmission of nerve impulse,BP,1
GO:0051952,1,0.621135574,0,43,regulation of amine transport,BP,1
GO:0051953,1,0.863796374,0,13,negative regulation of amine transport,BP,1
GO:0051954,1,0.786580516,0,22,positive regulation of amine transport,BP,1
GO:0051955,1,0.752672878,0,26,regulation of amino acid transport,BP,1
GO:0051956,1,0.924717817,0,7,negative regulation of amino acid transport,BP,1
GO:0051957,1,0.831133167,0,17,positive regulation of amino acid transport,BP,1
GO:0051958,1,0.977456082,0,2,methotrexate transport,BP,1
GO:0051964,1,0.979172569,0,2,negative regulation of synapse assembly,BP,1
GO:0051966,1,0.730985035,0,30,"regulation of synaptic transmission, glutamatergic",BP,1
GO:0051967,1,0.966561616,0,3,"negative regulation of synaptic transmission, glutamatergic",BP,1
GO:0051968,1,0.851305715,0,16,"positive regulation of synaptic transmission, glutamatergic",BP,1
GO:0051969,1,0.924483337,0,7,regulation of transmission of nerve impulse,BP,1
GO:0051970,1,0.988662912,0,1,negative regulation of transmission of nerve impulse,BP,1
GO:0051971,1,0.966369909,0,3,positive regulation of transmission of nerve impulse,BP,1
GO:0051972,1,0.637972487,0,40,regulation of telomerase activity,BP,1
GO:0051973,1,0.723394838,0,29,positive regulation of telomerase activity,BP,1
GO:0051974,1,0.872189914,0,12,negative regulation of telomerase activity,BP,1
GO:0051977,1,0.977452916,0,2,lysophospholipid transport,BP,1
GO:0051984,1,0.793329705,0,21,positive regulation of chromosome segregation,BP,1
GO:0051987,1,0.955786835,0,4,positive regulation of attachment of spindle microtubules to kinetochore,BP,1
GO:0051988,1,0.939473991,0,6,regulation of attachment of spindle microtubules to kinetochore,BP,1
GO:0052027,1,0.988758751,0,1,modulation by symbiont of host signal transduction pathway,BP,1
GO:0052031,1,0.98868615,0,1,modulation by symbiont of host defense response,BP,1
GO:0052040,1,0.944585283,0,5,modulation by symbiont of host programmed cell death,BP,1
GO:0052041,1,0.966370812,0,3,negative regulation by symbiont of host programmed cell death,BP,1
GO:0052042,1,0.966378698,0,3,positive regulation by symbiont of host programmed cell death,BP,1
GO:0052047,1,0.982822751,0,2,interaction with other organism via secreted substance involved in symbiotic interaction,BP,1
GO:0052063,1,0.98868615,0,1,induction by symbiont of defense-related host nitric oxide production,BP,1
GO:0052097,1,0.988823445,0,1,interspecies quorum sensing,BP,1
GO:0052106,1,0.988823445,0,1,quorum sensing involved in interaction with host,BP,1
GO:0052126,1,0.721148646,0,29,movement in host environment,BP,1
GO:0052150,1,0.944585283,0,5,modulation by symbiont of host apoptotic process,BP,1
GO:0052151,1,0.966378698,0,3,positive regulation by symbiont of host apoptotic process,BP,1
GO:0052163,1,0.98868615,0,1,modulation by symbiont of defense-related host nitric oxide production,BP,1
GO:0052173,1,0.935612616,0,6,response to defenses of other organism involved in symbiotic interaction,BP,1
GO:0052192,1,0.721148646,0,29,movement in environment of other organism involved in symbiotic interaction,BP,1
GO:0052199,1,0.98866259,0,1,negative regulation of catalytic activity in other organism involved in symbiotic interaction,BP,1
GO:0052200,1,0.935612616,0,6,response to host defenses,BP,1
GO:0052203,1,0.977452931,0,2,modulation of catalytic activity in other organism involved in symbiotic interaction,BP,1
GO:0052204,1,0.955410552,0,4,negative regulation of molecular function in other organism involved in symbiotic interaction,BP,1
GO:0052213,1,0.988713083,0,1,interaction with symbiont via secreted substance involved in symbiotic interaction,BP,1
GO:0052214,1,0.988662869,0,1,metabolism of substance in other organism involved in symbiotic interaction,BP,1
GO:0052227,1,0.988662869,0,1,catabolism of substance in other organism involved in symbiotic interaction,BP,1
GO:0052229,1,0.988662869,0,1,metabolism of macromolecule in other organism involved in symbiotic interaction,BP,1
GO:0052248,1,0.944585283,0,5,modulation of programmed cell death in other organism involved in symbiotic interaction,BP,1
GO:0052250,1,0.966463412,0,3,modulation of signal transduction in other organism involved in symbiotic interaction,BP,1
GO:0052251,1,0.98868615,0,1,induction by organism of defense response of other organism involved in symbiotic interaction,BP,1
GO:0052255,1,0.98868615,0,1,modulation by organism of defense response of other organism involved in symbiotic interaction,BP,1
GO:0052263,1,0.98868615,0,1,induction by organism of defense-related nitric oxide production in other organism involved in symbiotic interaction,BP,1
GO:0052302,1,0.98868615,0,1,modulation by organism of defense-related nitric oxide production in other organism involved in symbiotic interaction,BP,1
GO:0052314,1,0.988662931,0,1,phytoalexin metabolic process,BP,1
GO:0052330,1,0.966378698,0,3,positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,1
GO:0052345,1,0.98868615,0,1,positive regulation by organism of defense-related nitric oxide production in other organism involved in symbiotic interaction,BP,1
GO:0052347,1,0.98868615,0,1,positive regulation by symbiont of defense-related host nitric oxide production,BP,1
GO:0052360,1,0.988662869,0,1,catabolism by host of symbiont macromolecule,BP,1
GO:0052361,1,0.988662869,0,1,catabolism by organism of macromolecule in other organism involved in symbiotic interaction,BP,1
GO:0052362,1,0.988662869,0,1,catabolism by host of symbiont protein,BP,1
GO:0052363,1,0.988662869,0,1,catabolism by organism of protein in other organism involved in symbiotic interaction,BP,1
GO:0052364,1,0.988662869,0,1,catabolism by host of substance in symbiont,BP,1
GO:0052403,1,0.98866259,0,1,negative regulation by host of symbiont catalytic activity,BP,1
GO:0052405,1,0.955410552,0,4,negative regulation by host of symbiont molecular function,BP,1
GO:0052416,1,0.988662869,0,1,metabolism by host of symbiont macromolecule,BP,1
GO:0052417,1,0.988662869,0,1,metabolism by host of symbiont protein,BP,1
GO:0052418,1,0.988662869,0,1,metabolism by organism of protein in other organism involved in symbiotic interaction,BP,1
GO:0052419,1,0.988662869,0,1,metabolism by host of substance in symbiont,BP,1
GO:0052422,1,0.977452931,0,2,modulation by host of symbiont catalytic activity,BP,1
GO:0052433,1,0.944585283,0,5,modulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,1
GO:0052470,1,0.977453199,0,2,modulation by host of symbiont signal transduction pathway,BP,1
GO:0052490,1,0.966370812,0,3,negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,1
GO:0052501,1,0.966378698,0,3,positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,1
GO:0052509,1,0.98868615,0,1,positive regulation by symbiont of host defense response,BP,1
GO:0052510,1,0.98868615,0,1,positive regulation by organism of defense response of other organism involved in symbiotic interaction,BP,1
GO:0052525,1,0.977453199,0,2,positive regulation by host of symbiont signal transduction pathway,BP,1
GO:0052526,1,0.977453199,0,2,positive regulation by organism of signal transduction in other organism involved in symbiotic interaction,BP,1
GO:0052550,1,0.988662931,0,1,response to defense-related reactive oxygen species production by other organism involved in symbiotic interaction,BP,1
GO:0052551,1,0.977476333,0,2,response to defense-related nitric oxide production by other organism involved in symbiotic interaction,BP,1
GO:0052552,1,0.98868615,0,1,modulation by organism of immune response of other organism involved in symbiotic interaction,BP,1
GO:0052553,1,0.98868615,0,1,modulation by symbiont of host immune response,BP,1
GO:0052555,1,0.98868615,0,1,positive regulation by organism of immune response of other organism involved in symbiotic interaction,BP,1
GO:0052556,1,0.98868615,0,1,positive regulation by symbiont of host immune response,BP,1
GO:0052558,1,0.98868615,0,1,induction by organism of immune response of other organism involved in symbiotic interaction,BP,1
GO:0052559,1,0.98868615,0,1,induction by symbiont of host immune response,BP,1
GO:0052564,1,0.955433474,0,4,response to immune response of other organism involved in symbiotic interaction,BP,1
GO:0052565,1,0.977476333,0,2,response to defense-related host nitric oxide production,BP,1
GO:0052567,1,0.988662931,0,1,response to defense-related host reactive oxygen species production,BP,1
GO:0052572,1,0.955433474,0,4,response to host immune response,BP,1
GO:0052646,1,0.924498338,0,7,alditol phosphate metabolic process,BP,1
GO:0052651,1,0.945103334,0,5,monoacylglycerol catabolic process,BP,1
GO:0052695,1,0.955429277,0,4,cellular glucuronidation,BP,1
GO:0052696,1,0.988665243,0,1,flavonoid glucuronidation,BP,1
GO:0052697,1,0.977455661,0,2,xenobiotic glucuronidation,BP,1
GO:0052746,1,0.97745334,0,2,inositol phosphorylation,BP,1
GO:0052803,1,0.934232047,0,6,imidazole-containing compound metabolic process,BP,1
GO:0052805,1,0.944578351,0,5,imidazole-containing compound catabolic process,BP,1
GO:0055003,1,0.936073975,0,7,cardiac myofibril assembly,BP,1
GO:0055005,1,0.97865176,0,2,ventricular cardiac myofibril assembly,BP,1
GO:0055008,1,0.71225524,0,33,cardiac muscle tissue morphogenesis,BP,1
GO:0055009,1,0.96755473,0,3,atrial cardiac muscle tissue morphogenesis,BP,1
GO:0055010,1,0.769740431,0,26,ventricular cardiac muscle tissue morphogenesis,BP,1
GO:0055011,1,0.988662673,0,1,atrial cardiac muscle cell differentiation,BP,1
GO:0055012,1,0.867877117,0,13,ventricular cardiac muscle cell differentiation,BP,1
GO:0055014,1,0.988662673,0,1,atrial cardiac muscle cell development,BP,1
GO:0055015,1,0.929077605,0,7,ventricular cardiac muscle cell development,BP,1
GO:0055017,1,0.482472358,0,68,cardiac muscle tissue growth,BP,1
GO:0055021,1,0.588528393,0,50,regulation of cardiac muscle tissue growth,BP,1
GO:0055022,1,0.793486975,0,21,negative regulation of cardiac muscle tissue growth,BP,1
GO:0055023,1,0.754215539,0,27,positive regulation of cardiac muscle tissue growth,BP,1
GO:0055025,1,0.689243082,0,35,positive regulation of cardiac muscle tissue development,BP,1
GO:0055048,1,0.988662931,0,1,anastral spindle assembly,BP,1
GO:0055057,1,0.894912073,0,11,neuroblast division,BP,1
GO:0055059,1,0.945847939,0,5,asymmetric neuroblast division,BP,1
GO:0055062,1,0.945354886,0,5,phosphate ion homeostasis,BP,1
GO:0055064,1,0.890654316,0,11,chloride ion homeostasis,BP,1
GO:0055069,1,0.797261253,0,21,zinc ion homeostasis,BP,1
GO:0055070,1,0.866046105,0,13,copper ion homeostasis,BP,1
GO:0055071,1,0.990688607,0,1,manganese ion homeostasis,BP,1
GO:0055072,1,0.496826099,0,63,iron ion homeostasis,BP,1
GO:0055073,1,0.988662931,0,1,cadmium ion homeostasis,BP,1
GO:0055074,1,0.075543149,0,235,calcium ion homeostasis,BP,1
GO:0055075,1,0.87117792,0,13,potassium ion homeostasis,BP,1
GO:0055076,1,0.345632011,0,96,transition metal ion homeostasis,BP,1
GO:0055081,1,0.629906343,0,42,anion homeostasis,BP,1
GO:0055083,1,0.841940537,0,16,monovalent inorganic anion homeostasis,BP,1
GO:0055089,1,0.8728513,0,12,fatty acid homeostasis,BP,1
GO:0055091,1,0.896318737,0,10,phospholipid homeostasis,BP,1
GO:0055094,1,0.755726342,0,26,response to lipoprotein particle,BP,1
GO:0055095,1,0.988828748,0,1,lipoprotein particle mediated signaling,BP,1
GO:0055096,1,0.988828748,0,1,low-density lipoprotein particle mediated signaling,BP,1
GO:0055107,1,0.977453375,0,2,Golgi to secretory granule transport,BP,1
GO:0055108,1,0.977984594,0,2,Golgi to transport vesicle transport,BP,1
GO:0055113,1,0.988662931,0,1,epiboly involved in gastrulation with mouth forming second,BP,1
GO:0055117,1,0.633365674,0,42,regulation of cardiac muscle contraction,BP,1
GO:0055118,1,0.966391396,0,3,negative regulation of cardiac muscle contraction,BP,1
GO:0055119,1,0.880744757,0,12,relaxation of cardiac muscle,BP,1
GO:0055129,1,0.966369903,0,3,L-proline biosynthetic process,BP,1
GO:0055130,1,0.988662915,0,1,D-alanine catabolic process,BP,1
GO:0060003,1,0.970661235,0,3,copper ion export,BP,1
GO:0060004,1,0.913303772,0,8,reflex,BP,1
GO:0060005,1,0.988662928,0,1,vestibular reflex,BP,1
GO:0060008,1,0.79526687,0,22,Sertoli cell differentiation,BP,1
GO:0060009,1,0.832139399,0,18,Sertoli cell development,BP,1
GO:0060010,1,0.988662933,0,1,Sertoli cell fate commitment,BP,1
GO:0060011,1,0.955930314,0,4,Sertoli cell proliferation,BP,1
GO:0060012,1,0.988924706,0,1,"synaptic transmission, glycinergic",BP,1
GO:0060013,1,0.966558376,0,3,righting reflex,BP,1
GO:0060014,1,0.988662948,0,1,granulosa cell differentiation,BP,1
GO:0060017,1,0.980396168,0,2,parathyroid gland development,BP,1
GO:0060018,1,0.978780946,0,2,astrocyte fate commitment,BP,1
GO:0060020,1,0.923308082,0,7,Bergmann glial cell differentiation,BP,1
GO:0060022,1,0.979257375,0,2,hard palate development,BP,1
GO:0060023,1,0.988662931,0,1,soft palate development,BP,1
GO:0060024,1,0.988662832,0,1,rhythmic synaptic transmission,BP,1
GO:0060025,1,0.988662931,0,1,regulation of synaptic activity,BP,1
GO:0060026,1,0.915249324,0,8,convergent extension,BP,1
GO:0060027,1,0.966497128,0,3,convergent extension involved in gastrulation,BP,1
GO:0060028,1,0.966504841,0,3,convergent extension involved in axis elongation,BP,1
GO:0060029,1,0.977633572,0,2,convergent extension involved in organogenesis,BP,1
GO:0060033,1,0.947032113,0,5,anatomical structure regression,BP,1
GO:0060034,1,0.989569383,0,1,notochord cell differentiation,BP,1
GO:0060035,1,0.989569383,0,1,notochord cell development,BP,1
GO:0060038,1,0.677642493,0,36,cardiac muscle cell proliferation,BP,1
GO:0060039,1,0.853709989,0,16,pericardium development,BP,1
GO:0060040,1,0.977453305,0,2,retinal bipolar neuron differentiation,BP,1
GO:0060043,1,0.733930191,0,29,regulation of cardiac muscle cell proliferation,BP,1
GO:0060044,1,0.878665972,0,12,negative regulation of cardiac muscle cell proliferation,BP,1
GO:0060045,1,0.852160088,0,15,positive regulation of cardiac muscle cell proliferation,BP,1
GO:0060046,1,0.969314968,0,3,regulation of acrosome reaction,BP,1
GO:0060047,1,0.328066506,0,101,heart contraction,BP,1
GO:0060048,1,0.516739261,0,61,cardiac muscle contraction,BP,1
GO:0060049,1,0.895814949,0,10,regulation of protein glycosylation,BP,1
GO:0060050,1,0.924773023,0,7,positive regulation of protein glycosylation,BP,1
GO:0060051,1,0.968705572,0,3,negative regulation of protein glycosylation,BP,1
GO:0060052,1,0.956641384,0,4,neurofilament cytoskeleton organization,BP,1
GO:0060054,1,0.96637119,0,3,positive regulation of epithelial cell proliferation involved in wound healing,BP,1
GO:0060055,1,0.845277588,0,15,angiogenesis involved in wound healing,BP,1
GO:0060056,1,0.894123308,0,10,mammary gland involution,BP,1
GO:0060057,1,0.966370798,0,3,apoptotic process involved in mammary gland involution,BP,1
GO:0060058,1,0.966370798,0,3,positive regulation of apoptotic process involved in mammary gland involution,BP,1
GO:0060059,1,0.945630185,0,6,embryonic retina morphogenesis in camera-type eye,BP,1
GO:0060060,1,0.988662931,0,1,post-embryonic retina morphogenesis in camera-type eye,BP,1
GO:0060061,1,0.977453324,0,2,Spemann organizer formation,BP,1
GO:0060065,1,0.89840003,0,11,uterus development,BP,1
GO:0060066,1,0.978980276,0,2,oviduct development,BP,1
GO:0060068,1,0.911610647,0,9,vagina development,BP,1
GO:0060073,1,0.966455481,0,3,micturition,BP,1
GO:0060074,1,0.854359516,0,15,synapse maturation,BP,1
GO:0060075,1,0.977453186,0,2,regulation of resting membrane potential,BP,1
GO:0060080,1,0.944793364,0,5,inhibitory postsynaptic potential,BP,1
GO:0060081,1,0.923315016,0,7,membrane hyperpolarization,BP,1
GO:0060083,1,0.97753982,0,2,smooth muscle contraction involved in micturition,BP,1
GO:0060087,1,0.94777233,0,5,relaxation of vascular smooth muscle,BP,1
GO:0060088,1,0.89444984,0,11,auditory receptor cell stereocilium organization,BP,1
GO:0060092,1,0.988924706,0,1,"regulation of synaptic transmission, glycinergic",BP,1
GO:0060096,1,0.988662928,0,1,"serotonin secretion, neurotransmission",BP,1
GO:0060099,1,0.892312301,0,11,"regulation of phagocytosis, engulfment",BP,1
GO:0060100,1,0.902552958,0,10,"positive regulation of phagocytosis, engulfment",BP,1
GO:0060101,1,0.988662931,0,1,"negative regulation of phagocytosis, engulfment",BP,1
GO:0060112,1,0.988662889,0,1,generation of ovulation cycle rhythm,BP,1
GO:0060117,1,0.845545856,0,16,auditory receptor cell development,BP,1
GO:0060123,1,0.909810364,0,10,regulation of growth hormone secretion,BP,1
GO:0060124,1,0.938461653,0,6,positive regulation of growth hormone secretion,BP,1
GO:0060125,1,0.974489364,0,3,negative regulation of growth hormone secretion,BP,1
GO:0060126,1,0.98866283,0,1,somatotropin secreting cell differentiation,BP,1
GO:0060128,1,0.988662842,0,1,corticotropin hormone secreting cell differentiation,BP,1
GO:0060129,1,0.977453188,0,2,thyroid-stimulating hormone-secreting cell differentiation,BP,1
GO:0060134,1,0.928529312,0,7,prepulse inhibition,BP,1
GO:0060137,1,0.952265076,0,5,maternal process involved in parturition,BP,1
GO:0060138,1,0.988662931,0,1,fetal process involved in parturition,BP,1
GO:0060139,1,0.966378698,0,3,positive regulation of apoptotic process by virus,BP,1
GO:0060147,1,0.678100802,0,36,regulation of posttranscriptional gene silencing,BP,1
GO:0060148,1,0.79951901,0,21,positive regulation of posttranscriptional gene silencing,BP,1
GO:0060149,1,0.848386279,0,15,negative regulation of posttranscriptional gene silencing,BP,1
GO:0060151,1,0.98088323,0,2,peroxisome localization,BP,1
GO:0060152,1,0.98088323,0,2,microtubule-based peroxisome localization,BP,1
GO:0060154,1,0.966370329,0,3,cellular process regulating host cell cycle in response to virus,BP,1
GO:0060155,1,0.959245076,0,4,platelet dense granule organization,BP,1
GO:0060156,1,0.988882047,0,1,milk ejection reflex,BP,1
GO:0060157,1,0.988662706,0,1,urinary bladder development,BP,1
GO:0060158,1,0.944575253,0,5,phospholipase C-activating dopamine receptor signaling pathway,BP,1
GO:0060159,1,0.934157898,0,6,regulation of dopamine receptor signaling pathway,BP,1
GO:0060160,1,0.988677219,0,1,negative regulation of dopamine receptor signaling pathway,BP,1
GO:0060161,1,0.955699922,0,4,positive regulation of dopamine receptor signaling pathway,BP,1
GO:0060163,1,0.988662898,0,1,subpallium neuron fate commitment,BP,1
GO:0060165,1,0.988662898,0,1,regulation of timing of subpallium neuron differentiation,BP,1
GO:0060166,1,0.977453304,0,2,olfactory pit development,BP,1
GO:0060167,1,0.977453284,0,2,regulation of adenosine receptor signaling pathway,BP,1
GO:0060168,1,0.988662888,0,1,positive regulation of adenosine receptor signaling pathway,BP,1
GO:0060169,1,0.988662881,0,1,negative regulation of adenosine receptor signaling pathway,BP,1
GO:0060174,1,0.953309383,0,5,limb bud formation,BP,1
GO:0060177,1,0.988662931,0,1,regulation of angiotensin metabolic process,BP,1
GO:0060178,1,0.966369908,0,3,regulation of exocyst localization,BP,1
GO:0060179,1,0.926021028,0,7,male mating behavior,BP,1
GO:0060180,1,0.948487728,0,5,female mating behavior,BP,1
GO:0060183,1,0.98932281,0,1,apelin receptor signaling pathway,BP,1
GO:0060184,1,0.988662558,0,1,cell cycle switching,BP,1
GO:0060193,1,0.678765678,0,35,positive regulation of lipase activity,BP,1
GO:0060211,1,0.865099372,0,14,regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,1
GO:0060212,1,0.966369909,0,3,negative regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,1
GO:0060213,1,0.885074091,0,12,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,1
GO:0060214,1,0.967556867,0,3,endocardium formation,BP,1
GO:0060217,1,0.990005605,0,1,hemangioblast cell differentiation,BP,1
GO:0060218,1,0.858033448,0,14,hematopoietic stem cell differentiation,BP,1
GO:0060219,1,0.924110511,0,7,camera-type eye photoreceptor cell differentiation,BP,1
GO:0060220,1,0.988663811,0,1,camera-type eye photoreceptor cell fate commitment,BP,1
GO:0060221,1,0.977453305,0,2,retinal rod cell differentiation,BP,1
GO:0060231,1,0.934742054,0,6,mesenchymal to epithelial transition,BP,1
GO:0060232,1,0.991281997,0,1,delamination,BP,1
GO:0060234,1,0.991281997,0,1,neuroblast delamination,BP,1
GO:0060235,1,0.973342382,0,3,lens induction in camera-type eye,BP,1
GO:0060242,1,0.944596202,0,5,contact inhibition,BP,1
GO:0060244,1,0.977470479,0,2,negative regulation of cell proliferation involved in contact inhibition,BP,1
GO:0060245,1,0.988667479,0,1,detection of cell density,BP,1
GO:0060246,1,0.988667479,0,1,detection of cell density by contact stimulus,BP,1
GO:0060248,1,0.988667479,0,1,detection of cell density by contact stimulus involved in contact inhibition,BP,1
GO:0060252,1,0.835951027,0,17,positive regulation of glial cell proliferation,BP,1
GO:0060259,1,0.90936316,0,9,regulation of feeding behavior,BP,1
GO:0060260,1,0.749234921,0,26,regulation of transcription initiation from RNA polymerase II promoter,BP,1
GO:0060261,1,0.801450213,0,20,positive regulation of transcription initiation from RNA polymerase II promoter,BP,1
GO:0060263,1,0.884497095,0,11,regulation of respiratory burst,BP,1
GO:0060264,1,0.955453336,0,4,regulation of respiratory burst involved in inflammatory response,BP,1
GO:0060265,1,0.988662929,0,1,positive regulation of respiratory burst involved in inflammatory response,BP,1
GO:0060266,1,0.966412601,0,3,negative regulation of respiratory burst involved in inflammatory response,BP,1
GO:0060267,1,0.957990187,0,4,positive regulation of respiratory burst,BP,1
GO:0060268,1,0.944617254,0,5,negative regulation of respiratory burst,BP,1
GO:0060272,1,0.966373051,0,3,embryonic skeletal joint morphogenesis,BP,1
GO:0060278,1,0.966383248,0,3,regulation of ovulation,BP,1
GO:0060279,1,0.966383248,0,3,positive regulation of ovulation,BP,1
GO:0060281,1,0.833626077,0,16,regulation of oocyte development,BP,1
GO:0060282,1,0.933864948,0,6,positive regulation of oocyte development,BP,1
GO:0060283,1,0.934338481,0,6,negative regulation of oocyte development,BP,1
GO:0060285,1,0.924155515,0,7,cilium-dependent cell motility,BP,1
GO:0060287,1,0.980749135,0,2,epithelial cilium movement involved in determination of left/right asymmetry,BP,1
GO:0060290,1,0.947061486,0,5,transdifferentiation,BP,1
GO:0060291,1,0.585523401,0,50,long-term synaptic potentiation,BP,1
GO:0060292,1,0.836117507,0,17,long-term synaptic depression,BP,1
GO:0060294,1,0.934758626,0,6,cilium movement involved in cell motility,BP,1
GO:0060295,1,0.945482597,0,5,regulation of cilium movement involved in cell motility,BP,1
GO:0060296,1,0.945482597,0,5,regulation of cilium beat frequency involved in ciliary motility,BP,1
GO:0060297,1,0.932000713,0,7,regulation of sarcomere organization,BP,1
GO:0060298,1,0.96755473,0,3,positive regulation of sarcomere organization,BP,1
GO:0060299,1,0.98958645,0,1,negative regulation of sarcomere organization,BP,1
GO:0060300,1,0.989402137,0,1,regulation of cytokine activity,BP,1
GO:0060304,1,0.951102756,0,5,regulation of phosphatidylinositol dephosphorylation,BP,1
GO:0060305,1,0.988662918,0,1,regulation of cell diameter,BP,1
GO:0060306,1,0.868914047,0,14,regulation of membrane repolarization,BP,1
GO:0060307,1,0.924624586,0,7,regulation of ventricular cardiac muscle cell membrane repolarization,BP,1
GO:0060309,1,0.977452785,0,2,elastin catabolic process,BP,1
GO:0060310,1,0.988662611,0,1,regulation of elastin catabolic process,BP,1
GO:0060311,1,0.988662611,0,1,negative regulation of elastin catabolic process,BP,1
GO:0060312,1,0.914627493,0,8,regulation of blood vessel remodeling,BP,1
GO:0060313,1,0.977453058,0,2,negative regulation of blood vessel remodeling,BP,1
GO:0060314,1,0.87706789,0,12,regulation of ryanodine-sensitive calcium-release channel activity,BP,1
GO:0060315,1,0.933861563,0,6,negative regulation of ryanodine-sensitive calcium-release channel activity,BP,1
GO:0060316,1,0.960882869,0,4,positive regulation of ryanodine-sensitive calcium-release channel activity,BP,1
GO:0060317,1,0.810429337,0,20,cardiac epithelial to mesenchymal transition,BP,1
GO:0060318,1,0.948259383,0,5,definitive erythrocyte differentiation,BP,1
GO:0060327,1,0.977707738,0,2,cytoplasmic actin-based contraction involved in cell motility,BP,1
GO:0060330,1,0.874973854,0,12,regulation of response to interferon-gamma,BP,1
GO:0060331,1,0.944575536,0,5,negative regulation of response to interferon-gamma,BP,1
GO:0060332,1,0.947721128,0,5,positive regulation of response to interferon-gamma,BP,1
GO:0060333,1,0.827465002,0,17,interferon-gamma-mediated signaling pathway,BP,1
GO:0060334,1,0.874973854,0,12,regulation of interferon-gamma-mediated signaling pathway,BP,1
GO:0060335,1,0.947721128,0,5,positive regulation of interferon-gamma-mediated signaling pathway,BP,1
GO:0060336,1,0.944575536,0,5,negative regulation of interferon-gamma-mediated signaling pathway,BP,1
GO:0060337,1,0.714790968,0,30,type I interferon signaling pathway,BP,1
GO:0060338,1,0.80892682,0,19,regulation of type I interferon-mediated signaling pathway,BP,1
GO:0060339,1,0.904284241,0,9,negative regulation of type I interferon-mediated signaling pathway,BP,1
GO:0060340,1,0.904894077,0,9,positive regulation of type I interferon-mediated signaling pathway,BP,1
GO:0060347,1,0.889491385,0,11,heart trabecula formation,BP,1
GO:0060349,1,0.492579452,0,65,bone morphogenesis,BP,1
GO:0060350,1,0.62691533,0,43,endochondral bone morphogenesis,BP,1
GO:0060351,1,0.753290963,0,26,cartilage development involved in endochondral bone morphogenesis,BP,1
GO:0060352,1,0.921085761,0,8,cell adhesion molecule production,BP,1
GO:0060353,1,0.940222424,0,6,regulation of cell adhesion molecule production,BP,1
GO:0060354,1,0.988662931,0,1,negative regulation of cell adhesion molecule production,BP,1
GO:0060355,1,0.951008382,0,5,positive regulation of cell adhesion molecule production,BP,1
GO:0060359,1,0.356005114,0,94,response to ammonium ion,BP,1
GO:0060363,1,0.924787597,0,7,cranial suture morphogenesis,BP,1
GO:0060364,1,0.96648583,0,3,frontal suture morphogenesis,BP,1
GO:0060365,1,0.990163438,0,1,coronal suture morphogenesis,BP,1
GO:0060368,1,0.874628249,0,12,regulation of Fc receptor mediated stimulatory signaling pathway,BP,1
GO:0060369,1,0.936531115,0,6,positive regulation of Fc receptor mediated stimulatory signaling pathway,BP,1
GO:0060370,1,0.988662931,0,1,susceptibility to T cell mediated cytotoxicity,BP,1
GO:0060371,1,0.977669995,0,2,regulation of atrial cardiac muscle cell membrane depolarization,BP,1
GO:0060372,1,0.99377117,0,1,regulation of atrial cardiac muscle cell membrane repolarization,BP,1
GO:0060373,1,0.977670026,0,2,regulation of ventricular cardiac muscle cell membrane depolarization,BP,1
GO:0060374,1,0.958174531,0,4,mast cell differentiation,BP,1
GO:0060375,1,0.968313343,0,3,regulation of mast cell differentiation,BP,1
GO:0060376,1,0.989307295,0,1,positive regulation of mast cell differentiation,BP,1
GO:0060377,1,0.988662931,0,1,negative regulation of mast cell differentiation,BP,1
GO:0060379,1,0.943917356,0,6,cardiac muscle cell myoblast differentiation,BP,1
GO:0060380,1,0.988662878,0,1,regulation of single-stranded telomeric DNA binding,BP,1
GO:0060381,1,0.988662878,0,1,positive regulation of single-stranded telomeric DNA binding,BP,1
GO:0060383,1,0.988662931,0,1,positive regulation of DNA strand elongation,BP,1
GO:0060384,1,0.895020918,0,11,innervation,BP,1
GO:0060385,1,0.967527504,0,3,axonogenesis involved in innervation,BP,1
GO:0060390,1,0.830988926,0,17,regulation of SMAD protein signal transduction,BP,1
GO:0060391,1,0.895847566,0,10,positive regulation of SMAD protein signal transduction,BP,1
GO:0060392,1,0.955561764,0,4,negative regulation of SMAD protein signal transduction,BP,1
GO:0060394,1,0.895467684,0,10,negative regulation of pathway-restricted SMAD protein phosphorylation,BP,1
GO:0060397,1,0.947507079,0,5,JAK-STAT cascade involved in growth hormone signaling pathway,BP,1
GO:0060399,1,0.967128562,0,3,positive regulation of growth hormone receptor signaling pathway,BP,1
GO:0060401,1,0.341276563,0,99,cytosolic calcium ion transport,BP,1
GO:0060402,1,0.390917539,0,87,calcium ion transport into cytosol,BP,1
GO:0060405,1,0.955650606,0,4,regulation of penile erection,BP,1
GO:0060406,1,0.966612163,0,3,positive regulation of penile erection,BP,1
GO:0060407,1,0.988662881,0,1,negative regulation of penile erection,BP,1
GO:0060408,1,0.988662764,0,1,regulation of acetylcholine metabolic process,BP,1
GO:0060409,1,0.988662764,0,1,positive regulation of acetylcholine metabolic process,BP,1
GO:0060413,1,0.908027405,0,9,atrial septum morphogenesis,BP,1
GO:0060414,1,0.973300605,0,3,aorta smooth muscle tissue morphogenesis,BP,1
GO:0060415,1,0.68807936,0,37,muscle tissue morphogenesis,BP,1
GO:0060421,1,0.741390805,0,29,positive regulation of heart growth,BP,1
GO:0060423,1,0.988666206,0,1,foregut regionalization,BP,1
GO:0060424,1,0.988666206,0,1,lung field specification,BP,1
GO:0060425,1,0.643052803,0,41,lung morphogenesis,BP,1
GO:0060427,1,0.988664179,0,1,lung connective tissue development,BP,1
GO:0060430,1,0.902901455,0,9,lung saccule development,BP,1
GO:0060431,1,0.966372941,0,3,primary lung bud formation,BP,1
GO:0060433,1,0.92478614,0,7,bronchus development,BP,1
GO:0060434,1,0.977453375,0,2,bronchus morphogenesis,BP,1
GO:0060435,1,0.988662833,0,1,bronchiole development,BP,1
GO:0060437,1,0.95082078,0,5,lung growth,BP,1
GO:0060438,1,0.865315878,0,13,trachea development,BP,1
GO:0060439,1,0.92545327,0,7,trachea morphogenesis,BP,1
GO:0060440,1,0.933865065,0,6,trachea formation,BP,1
GO:0060441,1,0.793106011,0,22,epithelial tube branching involved in lung morphogenesis,BP,1
GO:0060442,1,0.908278018,0,9,branching involved in prostate gland morphogenesis,BP,1
GO:0060443,1,0.688949944,0,35,mammary gland morphogenesis,BP,1
GO:0060444,1,0.829089823,0,18,branching involved in mammary gland duct morphogenesis,BP,1
GO:0060445,1,0.829701596,0,18,branching involved in salivary gland morphogenesis,BP,1
GO:0060447,1,0.992021409,0,1,bud outgrowth involved in lung branching,BP,1
GO:0060448,1,0.988662874,0,1,dichotomous subdivision of terminal units involved in lung branching,BP,1
GO:0060449,1,0.9460094,0,5,bud elongation involved in lung branching,BP,1
GO:0060450,1,0.988662931,0,1,positive regulation of hindgut contraction,BP,1
GO:0060452,1,0.9355159,0,6,positive regulation of cardiac muscle contraction,BP,1
GO:0060453,1,0.956938152,0,4,regulation of gastric acid secretion,BP,1
GO:0060454,1,0.988750447,0,1,positive regulation of gastric acid secretion,BP,1
GO:0060455,1,0.977453195,0,2,negative regulation of gastric acid secretion,BP,1
GO:0060456,1,0.923526736,0,7,positive regulation of digestive system process,BP,1
GO:0060457,1,0.900031125,0,10,negative regulation of digestive system process,BP,1
GO:0060458,1,0.988662931,0,1,right lung development,BP,1
GO:0060461,1,0.988662931,0,1,right lung morphogenesis,BP,1
GO:0060462,1,0.928971996,0,7,lung lobe development,BP,1
GO:0060463,1,0.928971996,0,7,lung lobe morphogenesis,BP,1
GO:0060464,1,0.989016853,0,1,lung lobe formation,BP,1
GO:0060465,1,0.988662931,0,1,pharynx development,BP,1
GO:0060466,1,0.991140072,0,1,activation of meiosis involved in egg activation,BP,1
GO:0060467,1,0.988662924,0,1,negative regulation of fertilization,BP,1
GO:0060468,1,0.988662924,0,1,prevention of polyspermy,BP,1
GO:0060478,1,0.977980001,0,2,acrosomal vesicle exocytosis,BP,1
GO:0060480,1,0.977886837,0,2,lung goblet cell differentiation,BP,1
GO:0060481,1,0.966798495,0,3,lobar bronchus epithelium development,BP,1
GO:0060482,1,0.966798495,0,3,lobar bronchus development,BP,1
GO:0060484,1,0.956875897,0,4,lung-associated mesenchyme development,BP,1
GO:0060486,1,0.956497242,0,4,Clara cell differentiation,BP,1
GO:0060491,1,0.239400363,0,131,regulation of cell projection assembly,BP,1
GO:0060492,1,0.988666206,0,1,lung induction,BP,1
GO:0060501,1,0.967836637,0,3,positive regulation of epithelial cell proliferation involved in lung morphogenesis,BP,1
GO:0060502,1,0.924670948,0,7,epithelial cell proliferation involved in lung morphogenesis,BP,1
GO:0060510,1,0.933863306,0,6,type II pneumocyte differentiation,BP,1
GO:0060512,1,0.825356458,0,18,prostate gland morphogenesis,BP,1
GO:0060513,1,0.988662931,0,1,prostatic bud formation,BP,1
GO:0060516,1,0.988662931,0,1,primary prostatic bud elongation,BP,1
GO:0060517,1,0.988662931,0,1,epithelial cell proliferation involved in prostatic bud elongation,BP,1
GO:0060523,1,0.978936843,0,2,prostate epithelial cord elongation,BP,1
GO:0060525,1,0.912858766,0,9,prostate glandular acinus development,BP,1
GO:0060526,1,0.949663987,0,5,prostate glandular acinus morphogenesis,BP,1
GO:0060527,1,0.949663987,0,5,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,BP,1
GO:0060528,1,0.96125967,0,4,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,BP,1
GO:0060529,1,0.990163438,0,1,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,BP,1
GO:0060532,1,0.978624806,0,2,bronchus cartilage development,BP,1
GO:0060534,1,0.948018577,0,5,trachea cartilage development,BP,1
GO:0060535,1,0.990997407,0,1,trachea cartilage morphogenesis,BP,1
GO:0060536,1,0.898168481,0,10,cartilage morphogenesis,BP,1
GO:0060539,1,0.94673495,0,5,diaphragm development,BP,1
GO:0060542,1,0.988662931,0,1,regulation of strand invasion,BP,1
GO:0060544,1,0.818889767,0,18,regulation of necroptotic process,BP,1
GO:0060545,1,0.979120985,0,2,positive regulation of necroptotic process,BP,1
GO:0060546,1,0.855464613,0,14,negative regulation of necroptotic process,BP,1
GO:0060547,1,0.826676585,0,17,negative regulation of necrotic cell death,BP,1
GO:0060556,1,0.95541104,0,4,regulation of vitamin D biosynthetic process,BP,1
GO:0060557,1,0.988662861,0,1,positive regulation of vitamin D biosynthetic process,BP,1
GO:0060558,1,0.977453306,0,2,regulation of calcidiol 1-monooxygenase activity,BP,1
GO:0060559,1,0.988662861,0,1,positive regulation of calcidiol 1-monooxygenase activity,BP,1
GO:0060561,1,0.803880118,0,20,apoptotic process involved in morphogenesis,BP,1
GO:0060566,1,0.988662931,0,1,"positive regulation of DNA-templated transcription, termination",BP,1
GO:0060567,1,0.991709211,0,1,"negative regulation of DNA-templated transcription, termination",BP,1
GO:0060571,1,0.881402652,0,12,morphogenesis of an epithelial fold,BP,1
GO:0060572,1,0.946012718,0,5,morphogenesis of an epithelial bud,BP,1
GO:0060579,1,0.97788919,0,2,ventral spinal cord interneuron fate commitment,BP,1
GO:0060581,1,0.97788919,0,2,cell fate commitment involved in pattern specification,BP,1
GO:0060584,1,0.98918315,0,1,regulation of prostaglandin-endoperoxide synthase activity,BP,1
GO:0060585,1,0.98918315,0,1,positive regulation of prostaglandin-endoperoxide synthase activity,BP,1
GO:0060586,1,0.914135449,0,8,multicellular organismal iron ion homeostasis,BP,1
GO:0060591,1,0.977453377,0,2,chondroblast differentiation,BP,1
GO:0060592,1,0.970122931,0,3,mammary gland formation,BP,1
GO:0060594,1,0.990163438,0,1,mammary gland specification,BP,1
GO:0060595,1,0.990163438,0,1,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,BP,1
GO:0060596,1,0.979761992,0,2,mammary placode formation,BP,1
GO:0060600,1,0.950570845,0,5,dichotomous subdivision of an epithelial terminal unit,BP,1
GO:0060601,1,0.978937003,0,2,lateral sprouting from an epithelium,BP,1
GO:0060602,1,0.879104392,0,12,branch elongation of an epithelium,BP,1
GO:0060603,1,0.788269235,0,23,mammary gland duct morphogenesis,BP,1
GO:0060605,1,0.957416534,0,4,tube lumen cavitation,BP,1
GO:0060611,1,0.989447732,0,1,mammary gland fat development,BP,1
GO:0060613,1,0.949267021,0,5,fat pad development,BP,1
GO:0060615,1,0.990163438,0,1,mammary gland bud formation,BP,1
GO:0060618,1,0.988664179,0,1,nipple development,BP,1
GO:0060620,1,0.931543884,0,7,regulation of cholesterol import,BP,1
GO:0060621,1,0.977452879,0,2,negative regulation of cholesterol import,BP,1
GO:0060623,1,0.977453362,0,2,regulation of chromosome condensation,BP,1
GO:0060628,1,0.864143422,0,13,regulation of ER to Golgi vesicle-mediated transport,BP,1
GO:0060631,1,0.968723017,0,3,regulation of meiosis I,BP,1
GO:0060632,1,0.838575663,0,16,regulation of microtubule-based movement,BP,1
GO:0060633,1,0.956389785,0,4,negative regulation of transcription initiation from RNA polymerase II promoter,BP,1
GO:0060638,1,0.967666953,0,3,mesenchymal-epithelial cell signaling,BP,1
GO:0060644,1,0.885001108,0,11,mammary gland epithelial cell differentiation,BP,1
GO:0060648,1,0.990163438,0,1,mammary gland bud morphogenesis,BP,1
GO:0060658,1,0.988664179,0,1,nipple morphogenesis,BP,1
GO:0060661,1,0.988662716,0,1,submandibular salivary gland formation,BP,1
GO:0060662,1,0.957416534,0,4,salivary gland cavitation,BP,1
GO:0060664,1,0.990163438,0,1,epithelial cell proliferation involved in salivary gland morphogenesis,BP,1
GO:0060665,1,0.967666953,0,3,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,BP,1
GO:0060666,1,0.961474613,0,4,dichotomous subdivision of terminal units involved in salivary gland branching,BP,1
GO:0060667,1,0.990163438,0,1,branch elongation involved in salivary gland morphogenesis,BP,1
GO:0060671,1,0.968450113,0,3,epithelial cell differentiation involved in embryonic placenta development,BP,1
GO:0060672,1,0.968450113,0,3,epithelial cell morphogenesis involved in placental branching,BP,1
GO:0060676,1,0.989852427,0,1,ureteric bud formation,BP,1
GO:0060681,1,0.977453259,0,2,branch elongation involved in ureteric bud branching,BP,1
GO:0060682,1,0.988692257,0,1,primary ureteric bud growth,BP,1
GO:0060683,1,0.988662821,0,1,regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling,BP,1
GO:0060684,1,0.966374314,0,3,epithelial-mesenchymal cell signaling,BP,1
GO:0060685,1,0.988662931,0,1,regulation of prostatic bud formation,BP,1
GO:0060686,1,0.988662931,0,1,negative regulation of prostatic bud formation,BP,1
GO:0060687,1,0.94600955,0,5,regulation of branching involved in prostate gland morphogenesis,BP,1
GO:0060689,1,0.957542051,0,4,cell differentiation involved in salivary gland development,BP,1
GO:0060690,1,0.979362393,0,2,epithelial cell differentiation involved in salivary gland development,BP,1
GO:0060691,1,0.988662928,0,1,epithelial cell maturation involved in salivary gland development,BP,1
GO:0060693,1,0.927016217,0,7,regulation of branching involved in salivary gland morphogenesis,BP,1
GO:0060694,1,0.988662429,0,1,regulation of cholesterol transporter activity,BP,1
GO:0060695,1,0.988662429,0,1,negative regulation of cholesterol transporter activity,BP,1
GO:0060696,1,0.93407732,0,6,regulation of phospholipid catabolic process,BP,1
GO:0060697,1,0.977496347,0,2,positive regulation of phospholipid catabolic process,BP,1
GO:0060701,1,0.977934015,0,2,negative regulation of ribonuclease activity,BP,1
GO:0060702,1,0.977934015,0,2,negative regulation of endoribonuclease activity,BP,1
GO:0060709,1,0.988662914,0,1,glycogen cell differentiation involved in embryonic placenta development,BP,1
GO:0060710,1,0.924821057,0,7,chorio-allantoic fusion,BP,1
GO:0060715,1,0.977461931,0,2,syncytiotrophoblast cell differentiation involved in labyrinthine layer development,BP,1
GO:0060717,1,0.936435303,0,6,chorion development,BP,1
GO:0060718,1,0.968457606,0,3,chorionic trophoblast cell differentiation,BP,1
GO:0060729,1,0.955925874,0,4,intestinal epithelial structure maintenance,BP,1
GO:0060730,1,0.988823445,0,1,regulation of intestinal epithelial structure maintenance,BP,1
GO:0060731,1,0.988823445,0,1,positive regulation of intestinal epithelial structure maintenance,BP,1
GO:0060732,1,0.934523556,0,6,positive regulation of inositol phosphate biosynthetic process,BP,1
GO:0060733,1,0.977452977,0,2,regulation of eIF2 alpha phosphorylation by amino acid starvation,BP,1
GO:0060734,1,0.979087739,0,2,regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,1
GO:0060735,1,0.988662853,0,1,regulation of eIF2 alpha phosphorylation by dsRNA,BP,1
GO:0060736,1,0.914181293,0,8,prostate gland growth,BP,1
GO:0060737,1,0.967836689,0,3,prostate gland morphogenetic growth,BP,1
GO:0060738,1,0.988662999,0,1,epithelial-mesenchymal signaling involved in prostate gland development,BP,1
GO:0060740,1,0.834834638,0,17,prostate gland epithelium morphogenesis,BP,1
GO:0060741,1,0.955411167,0,4,prostate gland stromal morphogenesis,BP,1
GO:0060742,1,0.909941352,0,9,epithelial cell differentiation involved in prostate gland development,BP,1
GO:0060743,1,0.977453581,0,2,epithelial cell maturation involved in prostate gland development,BP,1
GO:0060744,1,0.958401177,0,4,mammary gland branching involved in thelarche,BP,1
GO:0060745,1,0.969393821,0,3,mammary gland branching involved in pregnancy,BP,1
GO:0060746,1,0.921648413,0,8,parental behavior,BP,1
GO:0060748,1,0.98866283,0,1,tertiary branching involved in mammary gland duct morphogenesis,BP,1
GO:0060750,1,0.980511791,0,2,epithelial cell proliferation involved in mammary gland duct elongation,BP,1
GO:0060751,1,0.969393882,0,3,branch elongation involved in mammary gland duct branching,BP,1
GO:0060752,1,0.979019822,0,2,intestinal phytosterol absorption,BP,1
GO:0060761,1,0.67656971,0,35,negative regulation of response to cytokine stimulus,BP,1
GO:0060762,1,0.967298384,0,3,regulation of branching involved in mammary gland duct morphogenesis,BP,1
GO:0060763,1,0.963205267,0,4,mammary duct terminal end bud growth,BP,1
GO:0060764,1,0.990994118,0,1,cell-cell signaling involved in mammary gland development,BP,1
GO:0060765,1,0.777701522,0,23,regulation of androgen receptor signaling pathway,BP,1
GO:0060766,1,0.871392402,0,13,negative regulation of androgen receptor signaling pathway,BP,1
GO:0060767,1,0.923747515,0,8,epithelial cell proliferation involved in prostate gland development,BP,1
GO:0060768,1,0.934345987,0,7,regulation of epithelial cell proliferation involved in prostate gland development,BP,1
GO:0060769,1,0.988666206,0,1,positive regulation of epithelial cell proliferation involved in prostate gland development,BP,1
GO:0060770,1,0.950086782,0,5,negative regulation of epithelial cell proliferation involved in prostate gland development,BP,1
GO:0060784,1,0.988662931,0,1,regulation of cell proliferation involved in tissue homeostasis,BP,1
GO:0060785,1,0.988662662,0,1,regulation of apoptosis involved in tissue homeostasis,BP,1
GO:0060788,1,0.909204023,0,9,ectodermal placode formation,BP,1
GO:0060789,1,0.955414361,0,4,hair follicle placode formation,BP,1
GO:0060795,1,0.855876127,0,14,cell fate commitment involved in formation of primary germ layer,BP,1
GO:0060796,1,0.988665047,0,1,regulation of transcription involved in primary germ layer cell fate commitment,BP,1
GO:0060800,1,0.968813996,0,3,regulation of cell differentiation involved in embryonic placenta development,BP,1
GO:0060804,1,0.988662842,0,1,positive regulation of Wnt signaling pathway by BMP signaling pathway,BP,1
GO:0060806,1,0.988662912,0,1,negative regulation of cell differentiation involved in embryonic placenta development,BP,1
GO:0060807,1,0.988665047,0,1,regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification,BP,1
GO:0060816,1,0.97745348,0,2,random inactivation of X chromosome,BP,1
GO:0060819,1,0.966369464,0,3,inactivation of X chromosome by genetic imprinting,BP,1
GO:0060820,1,0.988662931,0,1,inactivation of X chromosome by heterochromatin assembly,BP,1
GO:0060821,1,0.978860649,0,2,inactivation of X chromosome by DNA methylation,BP,1
GO:0060825,1,0.978040212,0,2,fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,1
GO:0060830,1,0.966369483,0,3,ciliary receptor clustering involved in smoothened signaling pathway,BP,1
GO:0060831,1,0.914136103,0,8,smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,1
GO:0060836,1,0.946823788,0,5,lymphatic endothelial cell differentiation,BP,1
GO:0060838,1,0.978651738,0,2,lymphatic endothelial cell fate commitment,BP,1
GO:0060843,1,0.994713354,0,1,venous endothelial cell differentiation,BP,1
GO:0060849,1,0.978651738,0,2,regulation of transcription involved in lymphatic endothelial cell fate commitment,BP,1
GO:0060854,1,0.988662931,0,1,branching involved in lymph vessel morphogenesis,BP,1
GO:0060856,1,0.894778469,0,10,establishment of blood-brain barrier,BP,1
GO:0060857,1,0.977455882,0,2,establishment of glial blood-brain barrier,BP,1
GO:0060872,1,0.973049494,0,3,semicircular canal development,BP,1
GO:0060887,1,0.988662931,0,1,limb epidermis development,BP,1
GO:0060896,1,0.936010313,0,6,neural plate pattern specification,BP,1
GO:0060897,1,0.956215608,0,4,neural plate regionalization,BP,1
GO:0060900,1,0.942698776,0,6,embryonic camera-type eye formation,BP,1
GO:0060903,1,0.968723017,0,3,positive regulation of meiosis I,BP,1
GO:0060907,1,0.957573048,0,4,positive regulation of macrophage cytokine production,BP,1
GO:0060911,1,0.956498253,0,4,cardiac cell fate commitment,BP,1
GO:0060912,1,0.988665047,0,1,cardiac cell fate specification,BP,1
GO:0060913,1,0.988665047,0,1,cardiac cell fate determination,BP,1
GO:0060915,1,0.990163438,0,1,mesenchymal cell differentiation involved in lung development,BP,1
GO:0060916,1,0.958107194,0,4,mesenchymal cell proliferation involved in lung development,BP,1
GO:0060920,1,0.969040185,0,3,cardiac pacemaker cell differentiation,BP,1
GO:0060921,1,0.977454085,0,2,sinoatrial node cell differentiation,BP,1
GO:0060922,1,0.991393591,0,1,atrioventricular node cell differentiation,BP,1
GO:0060923,1,0.967467335,0,3,cardiac muscle cell fate commitment,BP,1
GO:0060926,1,0.969040185,0,3,cardiac pacemaker cell development,BP,1
GO:0060928,1,0.991393591,0,1,atrioventricular node cell development,BP,1
GO:0060931,1,0.977454085,0,2,sinoatrial node cell development,BP,1
GO:0060932,1,0.988663335,0,1,His-Purkinje system cell differentiation,BP,1
GO:0060935,1,0.967341066,0,3,cardiac fibroblast cell differentiation,BP,1
GO:0060936,1,0.967341066,0,3,cardiac fibroblast cell development,BP,1
GO:0060938,1,0.967341066,0,3,epicardium-derived cardiac fibroblast cell differentiation,BP,1
GO:0060939,1,0.967341066,0,3,epicardium-derived cardiac fibroblast cell development,BP,1
GO:0060940,1,0.97745316,0,2,epithelial to mesenchymal transition involved in cardiac fibroblast development,BP,1
GO:0060945,1,0.988814689,0,1,cardiac neuron differentiation,BP,1
GO:0060956,1,0.929215609,0,7,endocardial cell differentiation,BP,1
GO:0060957,1,0.988662927,0,1,endocardial cell fate commitment,BP,1
GO:0060964,1,0.699483199,0,33,regulation of gene silencing by miRNA,BP,1
GO:0060965,1,0.867054153,0,13,negative regulation of gene silencing by miRNA,BP,1
GO:0060966,1,0.678100802,0,36,regulation of gene silencing by RNA,BP,1
GO:0060967,1,0.848386279,0,15,negative regulation of gene silencing by RNA,BP,1
GO:0060968,1,0.541791149,0,57,regulation of gene silencing,BP,1
GO:0060969,1,0.795925267,0,21,negative regulation of gene silencing,BP,1
GO:0060971,1,0.958057816,0,4,embryonic heart tube left/right pattern formation,BP,1
GO:0060973,1,0.918584873,0,9,cell migration involved in heart development,BP,1
GO:0060979,1,0.973262184,0,3,vasculogenesis involved in coronary vascular morphogenesis,BP,1
GO:0060981,1,0.991301209,0,1,cell migration involved in coronary angiogenesis,BP,1
GO:0060988,1,0.977458117,0,2,lipid tube assembly,BP,1
GO:0060994,1,0.989057544,0,1,regulation of transcription from RNA polymerase II promoter involved in kidney development,BP,1
GO:0060995,1,0.98919176,0,1,cell-cell signaling involved in kidney development,BP,1
GO:0061000,1,0.895413949,0,10,negative regulation of dendritic spine development,BP,1
GO:0061002,1,0.944612988,0,5,negative regulation of dendritic spine morphogenesis,BP,1
GO:0061004,1,0.988665305,0,1,pattern specification involved in kidney development,BP,1
GO:0061010,1,0.972325385,0,3,gall bladder development,BP,1
GO:0061011,1,0.988662913,0,1,hepatic duct development,BP,1
GO:0061015,1,0.977453162,0,2,snRNA import into nucleus,BP,1
GO:0061017,1,0.977453349,0,2,hepatoblast differentiation,BP,1
GO:0061025,1,0.338235091,0,97,membrane fusion,BP,1
GO:0061028,1,0.680412983,0,36,establishment of endothelial barrier,BP,1
GO:0061029,1,0.91005998,0,9,eyelid development in camera-type eye,BP,1
GO:0061030,1,0.967067156,0,3,epithelial cell differentiation involved in mammary gland alveolus development,BP,1
GO:0061031,1,0.96783861,0,3,endodermal digestive tract morphogenesis,BP,1
GO:0061032,1,0.988662368,0,1,visceral serous pericardium development,BP,1
GO:0061033,1,0.988701948,0,1,secretion by lung epithelial cell involved in lung growth,BP,1
GO:0061034,1,0.978366506,0,2,olfactory bulb mitral cell layer development,BP,1
GO:0061035,1,0.622269893,0,43,regulation of cartilage development,BP,1
GO:0061036,1,0.789615805,0,21,positive regulation of cartilage development,BP,1
GO:0061037,1,0.849442442,0,15,negative regulation of cartilage development,BP,1
GO:0061038,1,0.982618764,0,3,uterus morphogenesis,BP,1
GO:0061040,1,0.988662926,0,1,female gonad morphogenesis,BP,1
GO:0061042,1,0.923535957,0,7,vascular wound healing,BP,1
GO:0061043,1,0.95562937,0,4,regulation of vascular wound healing,BP,1
GO:0061044,1,0.988845897,0,1,negative regulation of vascular wound healing,BP,1
GO:0061046,1,0.970080489,0,3,regulation of branching involved in lung morphogenesis,BP,1
GO:0061047,1,0.981206171,0,2,positive regulation of branching involved in lung morphogenesis,BP,1
GO:0061049,1,0.721178839,0,31,cell growth involved in cardiac muscle cell development,BP,1
GO:0061050,1,0.793212665,0,22,regulation of cell growth involved in cardiac muscle cell development,BP,1
GO:0061051,1,0.885201601,0,12,positive regulation of cell growth involved in cardiac muscle cell development,BP,1
GO:0061052,1,0.903154016,0,9,negative regulation of cell growth involved in cardiac muscle cell development,BP,1
GO:0061054,1,0.98866283,0,1,dermatome development,BP,1
GO:0061072,1,0.963047495,0,4,iris morphogenesis,BP,1
GO:0061073,1,0.963161473,0,4,ciliary body morphogenesis,BP,1
GO:0061074,1,0.989103737,0,1,regulation of neural retina development,BP,1
GO:0061083,1,0.94457698,0,5,regulation of protein refolding,BP,1
GO:0061084,1,0.955412487,0,4,negative regulation of protein refolding,BP,1
GO:0061085,1,0.917869725,0,8,regulation of histone H3-K27 methylation,BP,1
GO:0061086,1,0.955429814,0,4,negative regulation of histone H3-K27 methylation,BP,1
GO:0061087,1,0.93905273,0,6,positive regulation of histone H3-K27 methylation,BP,1
GO:0061088,1,0.970907954,0,3,regulation of sequestering of zinc ion,BP,1
GO:0061091,1,0.989644972,0,1,regulation of phospholipid translocation,BP,1
GO:0061092,1,0.989644972,0,1,positive regulation of phospholipid translocation,BP,1
GO:0061097,1,0.533642929,0,58,regulation of protein tyrosine kinase activity,BP,1
GO:0061098,1,0.723805897,0,31,positive regulation of protein tyrosine kinase activity,BP,1
GO:0061099,1,0.772361023,0,23,negative regulation of protein tyrosine kinase activity,BP,1
GO:0061100,1,0.988662898,0,1,lung neuroendocrine cell differentiation,BP,1
GO:0061103,1,0.988662898,0,1,carotid body glomus cell differentiation,BP,1
GO:0061104,1,0.988662898,0,1,adrenal chromaffin cell differentiation,BP,1
GO:0061107,1,0.97745336,0,2,seminal vesicle development,BP,1
GO:0061108,1,0.988662931,0,1,seminal vesicle epithelium development,BP,1
GO:0061110,1,0.966956109,0,3,dense core granule biogenesis,BP,1
GO:0061113,1,0.956586832,0,4,pancreas morphogenesis,BP,1
GO:0061114,1,0.989874949,0,1,branching involved in pancreas morphogenesis,BP,1
GO:0061117,1,0.793486975,0,21,negative regulation of heart growth,BP,1
GO:0061140,1,0.902840918,0,9,lung secretory cell differentiation,BP,1
GO:0061141,1,0.988663082,0,1,lung ciliated cell differentiation,BP,1
GO:0061144,1,0.966863413,0,3,alveolar secondary septum development,BP,1
GO:0061145,1,0.978624806,0,2,lung smooth muscle development,BP,1
GO:0061154,1,0.86795003,0,13,endothelial tube morphogenesis,BP,1
GO:0061156,1,0.969152623,0,4,pulmonary artery morphogenesis,BP,1
GO:0061162,1,0.849667351,0,16,establishment of monopolar cell polarity,BP,1
GO:0061163,1,0.988662931,0,1,endoplasmic reticulum polarization,BP,1
GO:0061179,1,0.90745336,0,9,negative regulation of insulin secretion involved in cellular response to glucose stimulus,BP,1
GO:0061180,1,0.613423367,0,46,mammary gland epithelium development,BP,1
GO:0061181,1,0.988929619,0,1,regulation of chondrocyte development,BP,1
GO:0061183,1,0.98866283,0,1,regulation of dermatome development,BP,1
GO:0061184,1,0.98866283,0,1,positive regulation of dermatome development,BP,1
GO:0061187,1,0.96830064,0,3,regulation of chromatin silencing at rDNA,BP,1
GO:0061188,1,0.979406072,0,2,negative regulation of chromatin silencing at rDNA,BP,1
GO:0061196,1,0.96637321,0,3,fungiform papilla development,BP,1
GO:0061197,1,0.96637321,0,3,fungiform papilla morphogenesis,BP,1
GO:0061198,1,0.96637321,0,3,fungiform papilla formation,BP,1
GO:0061205,1,0.977453276,0,2,paramesonephric duct development,BP,1
GO:0061206,1,0.988662923,0,1,mesonephros morphogenesis,BP,1
GO:0061209,1,0.988662842,0,1,cell proliferation involved in mesonephros development,BP,1
GO:0061215,1,0.988662923,0,1,mesonephric nephron development,BP,1
GO:0061218,1,0.988662923,0,1,negative regulation of mesonephros development,BP,1
GO:0061228,1,0.988662923,0,1,mesonephric nephron morphogenesis,BP,1
GO:0061235,1,0.988662923,0,1,mesenchymal stem cell maintenance involved in mesonephric nephron morphogenesis,BP,1
GO:0061245,1,0.704107765,0,34,establishment or maintenance of bipolar cell polarity,BP,1
GO:0061289,1,0.98919176,0,1,Wnt signaling pathway involved in kidney development,BP,1
GO:0061290,1,0.98919176,0,1,canonical Wnt signaling pathway involved in metanephric kidney development,BP,1
GO:0061295,1,0.988662923,0,1,regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis,BP,1
GO:0061296,1,0.988662923,0,1,negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis,BP,1
GO:0061300,1,0.988662929,0,1,cerebellum vasculature development,BP,1
GO:0061301,1,0.988662929,0,1,cerebellum vasculature morphogenesis,BP,1
GO:0061302,1,0.944844959,0,5,smooth muscle cell-matrix adhesion,BP,1
GO:0061303,1,0.989150195,0,1,cornea development in camera-type eye,BP,1
GO:0061310,1,0.990997407,0,1,canonical Wnt signaling pathway involved in cardiac neural crest cell differentiation involved in heart development,BP,1
GO:0061311,1,0.863512985,0,14,cell surface receptor signaling pathway involved in heart development,BP,1
GO:0061312,1,0.988662927,0,1,BMP signaling pathway involved in heart development,BP,1
GO:0061314,1,0.95354809,0,5,Notch signaling involved in heart development,BP,1
GO:0061316,1,0.969754979,0,3,canonical Wnt signaling pathway involved in heart development,BP,1
GO:0061317,1,0.98978507,0,1,canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,1
GO:0061318,1,0.870363784,0,14,renal filtration cell differentiation,BP,1
GO:0061324,1,0.979764838,0,2,canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,BP,1
GO:0061325,1,0.968654817,0,3,cell proliferation involved in outflow tract morphogenesis,BP,1
GO:0061337,1,0.77023726,0,24,cardiac conduction,BP,1
GO:0061339,1,0.849667351,0,16,establishment or maintenance of monopolar cell polarity,BP,1
GO:0061341,1,0.990997407,0,1,non-canonical Wnt signaling pathway involved in heart development,BP,1
GO:0061343,1,0.966459284,0,3,cell adhesion involved in heart morphogenesis,BP,1
GO:0061346,1,0.990997407,0,1,planar cell polarity pathway involved in heart morphogenesis,BP,1
GO:0061347,1,0.990997407,0,1,planar cell polarity pathway involved in outflow tract morphogenesis,BP,1
GO:0061348,1,0.990997407,0,1,planar cell polarity pathway involved in ventricular septum morphogenesis,BP,1
GO:0061349,1,0.990997407,0,1,planar cell polarity pathway involved in cardiac right atrium morphogenesis,BP,1
GO:0061350,1,0.990997407,0,1,planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,BP,1
GO:0061354,1,0.990997407,0,1,planar cell polarity pathway involved in pericardium morphogenesis,BP,1
GO:0061355,1,0.968424784,0,3,Wnt protein secretion,BP,1
GO:0061356,1,0.968424784,0,3,regulation of Wnt protein secretion,BP,1
GO:0061357,1,0.968424784,0,3,positive regulation of Wnt protein secretion,BP,1
GO:0061364,1,0.994495178,0,1,apoptotic process involved in luteolysis,BP,1
GO:0061365,1,0.912794015,0,8,positive regulation of triglyceride lipase activity,BP,1
GO:0061366,1,0.972696676,0,3,behavioral response to chemical pain,BP,1
GO:0061368,1,0.972696676,0,3,behavioral response to formalin induced pain,BP,1
GO:0061369,1,0.98866283,0,1,negative regulation of testicular blood vessel morphogenesis,BP,1
GO:0061370,1,0.977453231,0,2,testosterone biosynthetic process,BP,1
GO:0061373,1,0.989332177,0,1,mammillary axonal complex development,BP,1
GO:0061384,1,0.742394481,0,29,heart trabecula morphogenesis,BP,1
GO:0061386,1,0.988662931,0,1,closure of optic fissure,BP,1
GO:0061396,1,0.977454881,0,2,regulation of transcription from RNA polymerase II promoter in response to copper ion,BP,1
GO:0061402,1,0.9774868,0,2,positive regulation of transcription from RNA polymerase II promoter in response to acidic pH,BP,1
GO:0061408,1,0.966377297,0,3,positive regulation of transcription from RNA polymerase II promoter in response to heat stress,BP,1
GO:0061428,1,0.955478667,0,4,negative regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,1
GO:0061431,1,0.990320531,0,1,cellular response to methionine,BP,1
GO:0061433,1,0.988662931,0,1,cellular response to caloric restriction,BP,1
GO:0061436,1,0.916474541,0,8,establishment of skin barrier,BP,1
GO:0061438,1,0.945599644,0,6,renal system vasculature morphogenesis,BP,1
GO:0061439,1,0.945599644,0,6,kidney vasculature morphogenesis,BP,1
GO:0061441,1,0.978329475,0,2,renal artery morphogenesis,BP,1
GO:0061443,1,0.980282159,0,2,endocardial cushion cell differentiation,BP,1
GO:0061444,1,0.991523901,0,1,endocardial cushion cell development,BP,1
GO:0061445,1,0.988662927,0,1,endocardial cushion cell fate commitment,BP,1
GO:0061450,1,0.896977207,0,10,trophoblast cell migration,BP,1
GO:0061462,1,0.729311378,0,29,protein localization to lysosome,BP,1
GO:0061470,1,0.978440631,0,2,T follicular helper cell differentiation,BP,1
GO:0061476,1,0.933863022,0,6,response to anticoagulant,BP,1
GO:0061481,1,0.988662662,0,1,response to TNF agonist,BP,1
GO:0061484,1,0.923879323,0,7,hematopoietic stem cell homeostasis,BP,1
GO:0061485,1,0.993360016,0,1,memory T cell proliferation,BP,1
GO:0061502,1,0.973631643,0,3,early endosome to recycling endosome transport,BP,1
GO:0061511,1,0.935516917,0,6,centriole elongation,BP,1
GO:0061512,1,0.686831885,0,34,protein localization to cilium,BP,1
GO:0061517,1,0.935478329,0,6,macrophage proliferation,BP,1
GO:0061518,1,0.935478329,0,6,microglial cell proliferation,BP,1
GO:0061519,1,0.989453211,0,1,macrophage homeostasis,BP,1
GO:0061525,1,0.966369909,0,3,hindgut development,BP,1
GO:0061526,1,0.977465005,0,2,acetylcholine secretion,BP,1
GO:0061528,1,0.988662924,0,1,aspartate secretion,BP,1
GO:0061534,1,0.983305955,0,2,"gamma-aminobutyric acid secretion, neurotransmission",BP,1
GO:0061535,1,0.939962026,0,6,"glutamate secretion, neurotransmission",BP,1
GO:0061536,1,0.988924706,0,1,glycine secretion,BP,1
GO:0061537,1,0.988924706,0,1,"glycine secretion, neurotransmission",BP,1
GO:0061548,1,0.914453232,0,8,ganglion development,BP,1
GO:0061549,1,0.9462909,0,5,sympathetic ganglion development,BP,1
GO:0061550,1,0.967618029,0,3,cranial ganglion development,BP,1
GO:0061551,1,0.978712453,0,2,trigeminal ganglion development,BP,1
GO:0061552,1,0.978712453,0,2,ganglion morphogenesis,BP,1
GO:0061572,1,0.289688928,0,114,actin filament bundle organization,BP,1
GO:0061573,1,0.988662931,0,1,actin filament bundle retrograde transport,BP,1
GO:0061577,1,0.949517659,0,5,calcium ion transmembrane transport via high voltage-gated calcium channel,BP,1
GO:0061580,1,0.988662929,0,1,colon epithelial cell migration,BP,1
GO:0061582,1,0.977453887,0,2,intestinal epithelial cell migration,BP,1
GO:0061588,1,0.991229526,0,1,calcium activated phospholipid scrambling,BP,1
GO:0061589,1,0.991229526,0,1,calcium activated phosphatidylserine scrambling,BP,1
GO:0061590,1,0.991229526,0,1,calcium activated phosphatidylcholine scrambling,BP,1
GO:0061591,1,0.991229526,0,1,calcium activated galactosylceramide scrambling,BP,1
GO:0061611,1,0.988662881,0,1,mannose to fructose-6-phosphate metabolic process,BP,1
GO:0061615,1,0.923429859,0,7,glycolytic process through fructose-6-phosphate,BP,1
GO:0061620,1,0.923429859,0,7,glycolytic process through glucose-6-phosphate,BP,1
GO:0061621,1,0.944740268,0,5,canonical glycolysis,BP,1
GO:0061622,1,0.966428605,0,3,glycolytic process through glucose-1-phosphate,BP,1
GO:0061623,1,0.977453239,0,2,glycolytic process from galactose,BP,1
GO:0061635,1,0.872215749,0,12,regulation of protein complex stability,BP,1
GO:0061640,1,0.494308173,0,66,cytoskeleton-dependent cytokinesis,BP,1
GO:0061641,1,0.95546023,0,4,CENP-A containing chromatin organization,BP,1
GO:0061642,1,0.995230873,0,2,chemoattraction of axon,BP,1
GO:0061643,1,0.988662921,0,1,chemorepulsion of axon,BP,1
GO:0061646,1,0.977453375,0,2,positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization,BP,1
GO:0061647,1,0.730837716,0,31,histone H3-K9 modification,BP,1
GO:0061668,1,0.924092065,0,7,mitochondrial ribosome assembly,BP,1
GO:0061670,1,0.988662876,0,1,evoked neurotransmitter secretion,BP,1
GO:0061682,1,0.988662915,0,1,seminal vesicle morphogenesis,BP,1
GO:0061684,1,0.862272057,0,13,chaperone-mediated autophagy,BP,1
GO:0061687,1,0.935384675,0,6,detoxification of inorganic compound,BP,1
GO:0061698,1,0.988662869,0,1,protein deglutarylation,BP,1
GO:0061699,1,0.988662869,0,1,peptidyl-lysine deglutarylation,BP,1
GO:0061709,1,0.99308169,0,1,reticulophagy,BP,1
GO:0061715,1,0.988662839,0,1,miRNA 2'-O-methylation,BP,1
GO:0061718,1,0.944740268,0,5,glucose catabolic process to pyruvate,BP,1
GO:0061723,1,0.98182243,0,2,glycophagy,BP,1
GO:0061725,1,0.98866287,0,1,cytosolic lipolysis,BP,1
GO:0061726,1,0.526299703,0,59,mitochondrion disassembly,BP,1
GO:0061727,1,0.977520762,0,2,methylglyoxal catabolic process to lactate,BP,1
GO:0061732,1,0.966443107,0,3,mitochondrial acetyl-CoA biosynthetic process from pyruvate,BP,1
GO:0061734,1,0.94601752,0,5,parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,1
GO:0061736,1,0.988662931,0,1,engulfment of target by autophagosome,BP,1
GO:0061738,1,0.955485902,0,4,late endosomal microautophagy,BP,1
GO:0061739,1,0.955534902,0,4,protein lipidation involved in autophagosome assembly,BP,1
GO:0061740,1,0.966369903,0,3,protein targeting to lysosome involved in chaperone-mediated autophagy,BP,1
GO:0061741,1,0.944640298,0,5,chaperone-mediated protein transport involved in chaperone-mediated autophagy,BP,1
GO:0061744,1,0.940675033,0,6,motor behavior,BP,1
GO:0061753,1,0.988662931,0,1,substrate localization to autophagosome,BP,1
GO:0061756,1,0.781694151,0,23,leukocyte adhesion to vascular endothelial cell,BP,1
GO:0061757,1,0.988666488,0,1,leukocyte adhesion to arterial endothelial cell,BP,1
GO:0061760,1,0.977453028,0,2,antifungal innate immune response,BP,1
GO:0061762,1,0.929587959,0,7,CAMKK-AMPK signaling cascade,BP,1
GO:0061763,1,0.988662931,0,1,multivesicular body-lysosome fusion,BP,1
GO:0061767,1,0.99049225,0,1,negative regulation of lung blood pressure,BP,1
GO:0061771,1,0.94474318,0,5,response to caloric restriction,BP,1
GO:0061772,1,0.988943913,0,1,drug transport across blood-nerve barrier,BP,1
GO:0061789,1,0.978686486,0,2,dense core granule priming,BP,1
GO:0061792,1,0.980326354,0,2,secretory granule maturation,BP,1
GO:0061817,1,0.956183051,0,4,endoplasmic reticulum-plasma membrane tethering,BP,1
GO:0061819,1,0.966369721,0,3,telomeric DNA-containing double minutes formation,BP,1
GO:0061820,1,0.92533394,0,7,telomeric D-loop disassembly,BP,1
GO:0061833,1,0.966398579,0,3,protein localization to tricellular tight junction,BP,1
GO:0061842,1,0.717820546,0,31,microtubule organizing center localization,BP,1
GO:0061843,1,0.988662931,0,1,Sertoli cell barrier remodeling,BP,1
GO:0061844,1,0.824111521,0,17,antimicrobial humoral immune response mediated by antimicrobial peptide,BP,1
GO:0061847,1,0.967465721,0,3,response to cholecystokinin,BP,1
GO:0061853,1,0.990446389,0,1,regulation of neuroblast migration,BP,1
GO:0061855,1,0.990446389,0,1,negative regulation of neuroblast migration,BP,1
GO:0061857,1,0.977722671,0,2,endoplasmic reticulum stress-induced pre-emptive quality control,BP,1
GO:0061868,1,0.980798633,0,2,hepatic stellate cell migration,BP,1
GO:0061869,1,0.980798633,0,2,regulation of hepatic stellate cell migration,BP,1
GO:0061870,1,0.980798633,0,2,positive regulation of hepatic stellate cell migration,BP,1
GO:0061872,1,0.97775013,0,2,hepatic stellate cell contraction,BP,1
GO:0061873,1,0.97775013,0,2,regulation of hepatic stellate cell contraction,BP,1
GO:0061874,1,0.988662931,0,1,positive regulation of hepatic stellate cell contraction,BP,1
GO:0061875,1,0.988963062,0,1,negative regulation of hepatic stellate cell contraction,BP,1
GO:0061884,1,0.978086421,0,2,regulation of mini excitatory postsynaptic potential,BP,1
GO:0061885,1,0.978086421,0,2,positive regulation of mini excitatory postsynaptic potential,BP,1
GO:0061890,1,0.977456206,0,2,positive regulation of astrocyte activation,BP,1
GO:0061921,1,0.988662931,0,1,peptidyl-lysine propionylation,BP,1
GO:0061944,1,0.988662764,0,1,negative regulation of protein K48-linked ubiquitination,BP,1
GO:0061945,1,0.966467936,0,3,regulation of protein K48-linked ubiquitination,BP,1
GO:0061951,1,0.546118186,0,56,establishment of protein localization to plasma membrane,BP,1
GO:0061952,1,0.872188906,0,12,midbody abscission,BP,1
GO:0061959,1,0.988662931,0,1,response to (R)-carnitine,BP,1
GO:0061982,1,0.615279223,0,44,meiosis I cell cycle process,BP,1
GO:0061983,1,0.979202234,0,2,meiosis II cell cycle process,BP,1
GO:0061984,1,0.988662931,0,1,catabolite repression,BP,1
GO:0061986,1,0.988663177,0,1,negative regulation of transcription by glucose,BP,1
GO:0061987,1,0.988663177,0,1,negative regulation of transcription from RNA polymerase II promoter by glucose,BP,1
GO:0062009,1,0.890255907,0,11,secondary palate development,BP,1
GO:0062025,1,0.988662931,0,1,regulation of SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,1
GO:0062026,1,0.988662931,0,1,negative regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process,BP,1
GO:0062028,1,0.955443664,0,4,regulation of stress granule assembly,BP,1
GO:0062029,1,0.988662929,0,1,positive regulation of stress granule assembly,BP,1
GO:0062030,1,0.988662853,0,1,negative regulation of stress granule assembly,BP,1
GO:0062033,1,0.868662768,0,13,positive regulation of mitotic sister chromatid segregation,BP,1
GO:0062042,1,0.934504075,0,7,regulation of cardiac epithelial to mesenchymal transition,BP,1
GO:0062043,1,0.934504075,0,7,positive regulation of cardiac epithelial to mesenchymal transition,BP,1
GO:0062044,1,0.988754356,0,1,negative regulation of cardiac epithelial to mesenchymal transition,BP,1
GO:0065001,1,0.977689949,0,2,specification of axis polarity,BP,1
GO:0065002,1,0.57581264,0,49,intracellular protein transmembrane transport,BP,1
GO:0065004,1,0.329268576,0,101,protein-DNA complex assembly,BP,1
GO:0065005,1,0.803639534,0,20,protein-lipid complex assembly,BP,1
GO:0070050,1,0.804220554,0,20,neuron cellular homeostasis,BP,1
GO:0070054,1,0.988662931,0,1,"mRNA splicing, via endonucleolytic cleavage and ligation",BP,1
GO:0070060,1,0.988662931,0,1,'de novo' actin filament nucleation,BP,1
GO:0070070,1,0.944576112,0,5,proton-transporting V-type ATPase complex assembly,BP,1
GO:0070071,1,0.872229465,0,12,proton-transporting two-sector ATPase complex assembly,BP,1
GO:0070072,1,0.944576112,0,5,vacuolar proton-transporting V-type ATPase complex assembly,BP,1
GO:0070076,1,0.770394577,0,24,histone lysine demethylation,BP,1
GO:0070077,1,0.988662894,0,1,histone arginine demethylation,BP,1
GO:0070078,1,0.988662894,0,1,histone H3-R2 demethylation,BP,1
GO:0070079,1,0.988662894,0,1,histone H4-R3 demethylation,BP,1
GO:0070084,1,0.96640078,0,3,protein initiator methionine removal,BP,1
GO:0070086,1,0.968408208,0,3,ubiquitin-dependent endocytosis,BP,1
GO:0070091,1,0.968910351,0,3,glucagon secretion,BP,1
GO:0070092,1,0.968910351,0,3,regulation of glucagon secretion,BP,1
GO:0070093,1,0.988662915,0,1,negative regulation of glucagon secretion,BP,1
GO:0070094,1,0.980022736,0,2,positive regulation of glucagon secretion,BP,1
GO:0070096,1,0.98866274,0,1,mitochondrial outer membrane translocase complex assembly,BP,1
GO:0070098,1,0.749345082,0,26,chemokine-mediated signaling pathway,BP,1
GO:0070099,1,0.978153205,0,2,regulation of chemokine-mediated signaling pathway,BP,1
GO:0070100,1,0.978153205,0,2,negative regulation of chemokine-mediated signaling pathway,BP,1
GO:0070102,1,0.886003872,0,11,interleukin-6-mediated signaling pathway,BP,1
GO:0070103,1,0.977621565,0,2,regulation of interleukin-6-mediated signaling pathway,BP,1
GO:0070104,1,0.977621565,0,2,negative regulation of interleukin-6-mediated signaling pathway,BP,1
GO:0070106,1,0.977621377,0,2,interleukin-27-mediated signaling pathway,BP,1
GO:0070120,1,0.945165409,0,5,ciliary neurotrophic factor-mediated signaling pathway,BP,1
GO:0070121,1,0.988902196,0,1,Kupffer's vesicle development,BP,1
GO:0070124,1,0.977453845,0,2,mitochondrial translational initiation,BP,1
GO:0070125,1,0.955438546,0,4,mitochondrial translational elongation,BP,1
GO:0070126,1,0.966369817,0,3,mitochondrial translational termination,BP,1
GO:0070127,1,0.934218707,0,6,tRNA aminoacylation for mitochondrial protein translation,BP,1
GO:0070129,1,0.752797474,0,25,regulation of mitochondrial translation,BP,1
GO:0070130,1,0.988662931,0,1,negative regulation of mitochondrial translation,BP,1
GO:0070131,1,0.814343915,0,18,positive regulation of mitochondrial translation,BP,1
GO:0070141,1,0.95745414,0,4,response to UV-A,BP,1
GO:0070142,1,0.895500639,0,10,synaptic vesicle budding,BP,1
GO:0070143,1,0.989039028,0,1,mitochondrial alanyl-tRNA aminoacylation,BP,1
GO:0070145,1,0.988664263,0,1,mitochondrial asparaginyl-tRNA aminoacylation,BP,1
GO:0070150,1,0.988662931,0,1,mitochondrial glycyl-tRNA aminoacylation,BP,1
GO:0070162,1,0.955411058,0,4,adiponectin secretion,BP,1
GO:0070163,1,0.955411058,0,4,regulation of adiponectin secretion,BP,1
GO:0070164,1,0.955411058,0,4,negative regulation of adiponectin secretion,BP,1
GO:0070166,1,0.903378113,0,9,enamel mineralization,BP,1
GO:0070169,1,0.734273267,0,28,positive regulation of biomineral tissue development,BP,1
GO:0070170,1,0.966369883,0,3,regulation of tooth mineralization,BP,1
GO:0070171,1,0.977453348,0,2,negative regulation of tooth mineralization,BP,1
GO:0070173,1,0.988662931,0,1,regulation of enamel mineralization,BP,1
GO:0070178,1,0.977453359,0,2,D-serine metabolic process,BP,1
GO:0070179,1,0.988662931,0,1,D-serine biosynthetic process,BP,1
GO:0070183,1,0.988662931,0,1,mitochondrial tryptophanyl-tRNA aminoacylation,BP,1
GO:0070184,1,0.988662909,0,1,mitochondrial tyrosyl-tRNA aminoacylation,BP,1
GO:0070189,1,0.902441223,0,9,kynurenine metabolic process,BP,1
GO:0070192,1,0.778582032,0,24,chromosome organization involved in meiotic cell cycle,BP,1
GO:0070193,1,0.915593281,0,8,synaptonemal complex organization,BP,1
GO:0070197,1,0.988662931,0,1,meiotic attachment of telomere to nuclear envelope,BP,1
GO:0070198,1,0.743840248,0,27,"protein localization to chromosome, telomeric region",BP,1
GO:0070199,1,0.796291393,0,20,establishment of protein localization to chromosome,BP,1
GO:0070200,1,0.84308074,0,15,establishment of protein localization to telomere,BP,1
GO:0070202,1,0.872085526,0,12,regulation of establishment of protein localization to chromosome,BP,1
GO:0070203,1,0.88209589,0,11,regulation of establishment of protein localization to telomere,BP,1
GO:0070208,1,0.849004398,0,15,protein heterotrimerization,BP,1
GO:0070212,1,0.928524543,0,7,protein poly-ADP-ribosylation,BP,1
GO:0070213,1,0.898451128,0,10,protein auto-ADP-ribosylation,BP,1
GO:0070221,1,0.988662931,0,1,"sulfide oxidation, using sulfide:quinone oxidoreductase",BP,1
GO:0070230,1,0.847050291,0,15,positive regulation of lymphocyte apoptotic process,BP,1
GO:0070234,1,0.896265786,0,10,positive regulation of T cell apoptotic process,BP,1
GO:0070237,1,0.978010077,0,2,positive regulation of activation-induced cell death of T cells,BP,1
GO:0070238,1,0.988662892,0,1,activated T cell autonomous cell death,BP,1
GO:0070239,1,0.988662892,0,1,regulation of activated T cell autonomous cell death,BP,1
GO:0070241,1,0.988662892,0,1,positive regulation of activated T cell autonomous cell death,BP,1
GO:0070245,1,0.977453343,0,2,positive regulation of thymocyte apoptotic process,BP,1
GO:0070252,1,0.64340191,0,41,actin-mediated cell contraction,BP,1
GO:0070253,1,0.980022471,0,2,somatostatin secretion,BP,1
GO:0070254,1,0.893669516,0,10,mucus secretion,BP,1
GO:0070255,1,0.903926144,0,9,regulation of mucus secretion,BP,1
GO:0070256,1,0.977453176,0,2,negative regulation of mucus secretion,BP,1
GO:0070257,1,0.924790121,0,7,positive regulation of mucus secretion,BP,1
GO:0070265,1,0.596474666,0,46,necrotic cell death,BP,1
GO:0070266,1,0.716229674,0,30,necroptotic process,BP,1
GO:0070267,1,0.988720157,0,1,oncosis,BP,1
GO:0070268,1,0.988662931,0,1,cornification,BP,1
GO:0070269,1,0.935223229,0,6,pyroptosis,BP,1
GO:0070276,1,0.989129008,0,1,halogen metabolic process,BP,1
GO:0070278,1,0.897822706,0,10,extracellular matrix constituent secretion,BP,1
GO:0070291,1,0.955416115,0,4,N-acylethanolamine metabolic process,BP,1
GO:0070292,1,0.988662931,0,1,N-acylphosphatidylethanolamine metabolic process,BP,1
GO:0070293,1,0.903005298,0,9,renal absorption,BP,1
GO:0070294,1,0.98866317,0,1,renal sodium ion absorption,BP,1
GO:0070295,1,0.977481379,0,2,renal water absorption,BP,1
GO:0070296,1,0.844501104,0,16,sarcoplasmic reticulum calcium ion transport,BP,1
GO:0070305,1,0.960196453,0,4,response to cGMP,BP,1
GO:0070306,1,0.820893939,0,19,lens fiber cell differentiation,BP,1
GO:0070307,1,0.912148073,0,9,lens fiber cell development,BP,1
GO:0070309,1,0.968442008,0,3,lens fiber cell morphogenesis,BP,1
GO:0070314,1,0.946989994,0,5,G1 to G0 transition,BP,1
GO:0070315,1,0.988662931,0,1,G1 to G0 transition involved in cell differentiation,BP,1
GO:0070316,1,0.929882765,0,7,regulation of G0 to G1 transition,BP,1
GO:0070317,1,0.959251161,0,4,negative regulation of G0 to G1 transition,BP,1
GO:0070318,1,0.969394078,0,3,positive regulation of G0 to G1 transition,BP,1
GO:0070327,1,0.933871903,0,6,thyroid hormone transport,BP,1
GO:0070329,1,0.991151969,0,1,tRNA seleno-modification,BP,1
GO:0070339,1,0.955492805,0,4,response to bacterial lipopeptide,BP,1
GO:0070340,1,0.966452548,0,3,detection of bacterial lipopeptide,BP,1
GO:0070341,1,0.926525995,0,7,fat cell proliferation,BP,1
GO:0070343,1,0.98866291,0,1,white fat cell proliferation,BP,1
GO:0070344,1,0.926525995,0,7,regulation of fat cell proliferation,BP,1
GO:0070345,1,0.95878125,0,4,negative regulation of fat cell proliferation,BP,1
GO:0070346,1,0.977452682,0,2,positive regulation of fat cell proliferation,BP,1
GO:0070350,1,0.98866291,0,1,regulation of white fat cell proliferation,BP,1
GO:0070358,1,0.968149351,0,3,actin polymerization-dependent cell motility,BP,1
GO:0070365,1,0.874576593,0,12,hepatocyte differentiation,BP,1
GO:0070366,1,0.977504867,0,2,regulation of hepatocyte differentiation,BP,1
GO:0070367,1,0.988715041,0,1,negative regulation of hepatocyte differentiation,BP,1
GO:0070368,1,0.988662899,0,1,positive regulation of hepatocyte differentiation,BP,1
GO:0070375,1,0.977453375,0,2,ERK5 cascade,BP,1
GO:0070383,1,0.97745324,0,2,DNA cytosine deamination,BP,1
GO:0070384,1,0.966448117,0,3,Harderian gland development,BP,1
GO:0070391,1,0.924073086,0,7,response to lipoteichoic acid,BP,1
GO:0070407,1,0.988794895,0,1,oxidation-dependent protein catabolic process,BP,1
GO:0070408,1,0.990209779,0,1,carbamoyl phosphate metabolic process,BP,1
GO:0070409,1,0.990209779,0,1,carbamoyl phosphate biosynthetic process,BP,1
GO:0070413,1,0.988662931,0,1,trehalose metabolism in response to stress,BP,1
GO:0070425,1,0.988662931,0,1,negative regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,1
GO:0070427,1,0.955770636,0,4,nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,1
GO:0070428,1,0.977821135,0,2,regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,1
GO:0070430,1,0.989034876,0,1,positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,1
GO:0070433,1,0.988662931,0,1,negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,1
GO:0070444,1,0.944261777,0,6,oligodendrocyte progenitor proliferation,BP,1
GO:0070445,1,0.944261777,0,6,regulation of oligodendrocyte progenitor proliferation,BP,1
GO:0070446,1,0.988662931,0,1,negative regulation of oligodendrocyte progenitor proliferation,BP,1
GO:0070447,1,0.975657637,0,3,positive regulation of oligodendrocyte progenitor proliferation,BP,1
GO:0070453,1,0.977453185,0,2,regulation of heme biosynthetic process,BP,1
GO:0070458,1,0.977452881,0,2,cellular detoxification of nitrogen compound,BP,1
GO:0070459,1,0.945790664,0,5,prolactin secretion,BP,1
GO:0070471,1,0.944577512,0,5,uterine smooth muscle contraction,BP,1
GO:0070472,1,0.955413026,0,4,regulation of uterine smooth muscle contraction,BP,1
GO:0070474,1,0.96637183,0,3,positive regulation of uterine smooth muscle contraction,BP,1
GO:0070475,1,0.912795218,0,8,rRNA base methylation,BP,1
GO:0070476,1,0.977453375,0,2,rRNA (guanine-N7)-methylation,BP,1
GO:0070478,1,0.989465302,0,1,"nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay",BP,1
GO:0070481,1,0.988662896,0,1,"nuclear-transcribed mRNA catabolic process, non-stop decay",BP,1
GO:0070483,1,0.977480254,0,2,detection of hypoxia,BP,1
GO:0070486,1,0.905605218,0,9,leukocyte aggregation,BP,1
GO:0070487,1,0.96740833,0,3,monocyte aggregation,BP,1
GO:0070488,1,0.977452391,0,2,neutrophil aggregation,BP,1
GO:0070489,1,0.977453375,0,2,T cell aggregation,BP,1
GO:0070493,1,0.935391147,0,6,thrombin-activated receptor signaling pathway,BP,1
GO:0070494,1,0.978737319,0,2,regulation of thrombin-activated receptor signaling pathway,BP,1
GO:0070495,1,0.978737319,0,2,negative regulation of thrombin-activated receptor signaling pathway,BP,1
GO:0070498,1,0.828775868,0,17,interleukin-1-mediated signaling pathway,BP,1
GO:0070508,1,0.882256863,0,12,cholesterol import,BP,1
GO:0070510,1,0.991551022,0,1,regulation of histone H4-K20 methylation,BP,1
GO:0070512,1,0.991551022,0,1,positive regulation of histone H4-K20 methylation,BP,1
GO:0070525,1,0.902438528,0,9,tRNA threonylcarbamoyladenosine metabolic process,BP,1
GO:0070527,1,0.71096363,0,31,platelet aggregation,BP,1
GO:0070534,1,0.649644432,0,39,protein K63-linked ubiquitination,BP,1
GO:0070535,1,0.948900772,0,5,histone H2A K63-linked ubiquitination,BP,1
GO:0070536,1,0.757985932,0,25,protein K63-linked deubiquitination,BP,1
GO:0070537,1,0.966498156,0,3,histone H2A K63-linked deubiquitination,BP,1
GO:0070541,1,0.944702536,0,5,response to platinum ion,BP,1
GO:0070543,1,0.977453147,0,2,response to linoleic acid,BP,1
GO:0070544,1,0.906026802,0,9,histone H3-K36 demethylation,BP,1
GO:0070560,1,0.977453362,0,2,protein secretion by platelet,BP,1
GO:0070561,1,0.936818432,0,6,vitamin D receptor signaling pathway,BP,1
GO:0070562,1,0.947565723,0,5,regulation of vitamin D receptor signaling pathway,BP,1
GO:0070563,1,0.977453375,0,2,negative regulation of vitamin D receptor signaling pathway,BP,1
GO:0070564,1,0.988664021,0,1,positive regulation of vitamin D receptor signaling pathway,BP,1
GO:0070571,1,0.885457825,0,12,negative regulation of neuron projection regeneration,BP,1
GO:0070574,1,0.957001779,0,4,cadmium ion transmembrane transport,BP,1
GO:0070584,1,0.782147577,0,22,mitochondrion morphogenesis,BP,1
GO:0070585,1,0.398255975,0,81,protein localization to mitochondrion,BP,1
GO:0070586,1,0.906691258,0,9,cell-cell adhesion involved in gastrulation,BP,1
GO:0070587,1,0.917079425,0,8,regulation of cell-cell adhesion involved in gastrulation,BP,1
GO:0070588,1,0.203796973,0,147,calcium ion transmembrane transport,BP,1
GO:0070589,1,0.988662881,0,1,cellular component macromolecule biosynthetic process,BP,1
GO:0070593,1,0.949099264,0,5,dendrite self-avoidance,BP,1
GO:0070601,1,0.914679102,0,8,centromeric sister chromatid cohesion,BP,1
GO:0070602,1,0.966633833,0,3,regulation of centromeric sister chromatid cohesion,BP,1
GO:0070613,1,0.498748568,0,63,regulation of protein processing,BP,1
GO:0070625,1,0.977452765,0,2,zymogen granule exocytosis,BP,1
GO:0070627,1,0.988662715,0,1,ferrous iron import,BP,1
GO:0070634,1,0.981098951,0,2,transepithelial ammonium transport,BP,1
GO:0070637,1,0.988662931,0,1,pyridine nucleoside metabolic process,BP,1
GO:0070638,1,0.988662931,0,1,pyridine nucleoside catabolic process,BP,1
GO:0070640,1,0.955650611,0,4,vitamin D3 metabolic process,BP,1
GO:0070649,1,0.991410495,0,1,formin-nucleated actin cable assembly,BP,1
GO:0070650,1,0.971069804,0,3,actin filament bundle distribution,BP,1
GO:0070651,1,0.988662896,0,1,nonfunctional rRNA decay,BP,1
GO:0070662,1,0.958999887,0,4,mast cell proliferation,BP,1
GO:0070664,1,0.545116804,0,55,negative regulation of leukocyte proliferation,BP,1
GO:0070666,1,0.958999887,0,4,regulation of mast cell proliferation,BP,1
GO:0070667,1,0.977945664,0,2,negative regulation of mast cell proliferation,BP,1
GO:0070668,1,0.969934371,0,3,positive regulation of mast cell proliferation,BP,1
GO:0070669,1,0.936749536,0,6,response to interleukin-2,BP,1
GO:0070670,1,0.712556952,0,30,response to interleukin-4,BP,1
GO:0070671,1,0.938123723,0,6,response to interleukin-12,BP,1
GO:0070672,1,0.917026152,0,8,response to interleukin-15,BP,1
GO:0070673,1,0.935613506,0,6,response to interleukin-18,BP,1
GO:0070676,1,0.988662856,0,1,intralumenal vesicle formation,BP,1
GO:0070681,1,0.966369908,0,3,glutaminyl-tRNAGln biosynthesis via transamidation,BP,1
GO:0070682,1,0.966369206,0,3,proteasome regulatory particle assembly,BP,1
GO:0070715,1,0.988823445,0,1,sodium-dependent organic cation transport,BP,1
GO:0070716,1,0.988662931,0,1,mismatch repair involved in maintenance of fidelity involved in DNA-dependent DNA replication,BP,1
GO:0070734,1,0.841126846,0,16,histone H3-K27 methylation,BP,1
GO:0070741,1,0.707513524,0,31,response to interleukin-6,BP,1
GO:0070777,1,0.977496789,0,2,D-aspartate transport,BP,1
GO:0070778,1,0.944823765,0,5,L-aspartate transmembrane transport,BP,1
GO:0070779,1,0.977496789,0,2,D-aspartate import across plasma membrane,BP,1
GO:0070781,1,0.977453348,0,2,response to biotin,BP,1
GO:0070782,1,0.955510156,0,4,phosphatidylserine exposure on apoptotic cell surface,BP,1
GO:0070813,1,0.949227108,0,5,hydrogen sulfide metabolic process,BP,1
GO:0070814,1,0.971128033,0,3,hydrogen sulfide biosynthetic process,BP,1
GO:0070816,1,0.896544565,0,10,phosphorylation of RNA polymerase II C-terminal domain,BP,1
GO:0070827,1,0.956704403,0,4,chromatin maintenance,BP,1
GO:0070828,1,0.841584716,0,16,heterochromatin organization,BP,1
GO:0070829,1,0.978776249,0,2,heterochromatin maintenance,BP,1
GO:0070830,1,0.678021783,0,36,bicellular tight junction assembly,BP,1
GO:0070831,1,0.90247936,0,10,basement membrane assembly,BP,1
GO:0070836,1,0.966639344,0,3,caveola assembly,BP,1
GO:0070837,1,0.966401109,0,3,dehydroascorbic acid transport,BP,1
GO:0070839,1,0.988662931,0,1,divalent metal ion export,BP,1
GO:0070842,1,0.945341172,0,5,aggresome assembly,BP,1
GO:0070843,1,0.988662931,0,1,misfolded protein transport,BP,1
GO:0070844,1,0.988662931,0,1,polyubiquitinated protein transport,BP,1
GO:0070845,1,0.988662931,0,1,polyubiquitinated misfolded protein transport,BP,1
GO:0070846,1,0.988662931,0,1,Hsp90 deacetylation,BP,1
GO:0070858,1,0.97865176,0,2,negative regulation of bile acid biosynthetic process,BP,1
GO:0070861,1,0.80959566,0,19,regulation of protein exit from endoplasmic reticulum,BP,1
GO:0070862,1,0.91282741,0,8,negative regulation of protein exit from endoplasmic reticulum,BP,1
GO:0070863,1,0.893727332,0,10,positive regulation of protein exit from endoplasmic reticulum,BP,1
GO:0070868,1,0.95885499,0,4,heterochromatin organization involved in chromatin silencing,BP,1
GO:0070869,1,0.980976312,0,2,heterochromatin assembly involved in chromatin silencing,BP,1
GO:0070874,1,0.946767961,0,5,negative regulation of glycogen metabolic process,BP,1
GO:0070884,1,0.756722337,0,27,regulation of calcineurin-NFAT signaling cascade,BP,1
GO:0070885,1,0.900884118,0,10,negative regulation of calcineurin-NFAT signaling cascade,BP,1
GO:0070886,1,0.851944469,0,15,positive regulation of calcineurin-NFAT signaling cascade,BP,1
GO:0070889,1,0.966382771,0,3,platelet alpha granule organization,BP,1
GO:0070897,1,0.658583432,0,38,transcription preinitiation complex assembly,BP,1
GO:0070898,1,0.929966712,0,7,RNA polymerase III preinitiation complex assembly,BP,1
GO:0070899,1,0.988662684,0,1,mitochondrial tRNA wobble uridine modification,BP,1
GO:0070900,1,0.955410699,0,4,mitochondrial tRNA modification,BP,1
GO:0070901,1,0.977453184,0,2,mitochondrial tRNA methylation,BP,1
GO:0070904,1,0.977638879,0,2,transepithelial L-ascorbic acid transport,BP,1
GO:0070914,1,0.893614995,0,10,UV-damage excision repair,BP,1
GO:0070920,1,0.812413733,0,19,regulation of production of small RNA involved in gene silencing by RNA,BP,1
GO:0070922,1,0.914612866,0,8,small RNA loading onto RISC,BP,1
GO:0070926,1,0.990349512,0,1,regulation of ATP:ADP antiporter activity,BP,1
GO:0070933,1,0.887442668,0,11,histone H4 deacetylation,BP,1
GO:0070934,1,0.957073671,0,4,CRD-mediated mRNA stabilization,BP,1
GO:0070935,1,0.862356108,0,13,3'-UTR-mediated mRNA stabilization,BP,1
GO:0070936,1,0.588141003,0,48,protein K48-linked ubiquitination,BP,1
GO:0070940,1,0.955983829,0,4,dephosphorylation of RNA polymerase II C-terminal domain,BP,1
GO:0070942,1,0.933916853,0,6,neutrophil mediated cytotoxicity,BP,1
GO:0070943,1,0.944631099,0,5,neutrophil mediated killing of symbiont cell,BP,1
GO:0070944,1,0.966426892,0,3,neutrophil mediated killing of bacterium,BP,1
GO:0070945,1,0.977453375,0,2,neutrophil mediated killing of gram-negative bacterium,BP,1
GO:0070946,1,0.988721218,0,1,neutrophil mediated killing of gram-positive bacterium,BP,1
GO:0070947,1,0.966426643,0,3,neutrophil mediated killing of fungus,BP,1
GO:0070948,1,0.966369612,0,3,regulation of neutrophil mediated cytotoxicity,BP,1
GO:0070949,1,0.977453123,0,2,regulation of neutrophil mediated killing of symbiont cell,BP,1
GO:0070953,1,0.977453123,0,2,regulation of neutrophil mediated killing of fungus,BP,1
GO:0070960,1,0.977453123,0,2,positive regulation of neutrophil mediated cytotoxicity,BP,1
GO:0070961,1,0.977453123,0,2,positive regulation of neutrophil mediated killing of symbiont cell,BP,1
GO:0070965,1,0.977453123,0,2,positive regulation of neutrophil mediated killing of fungus,BP,1
GO:0070966,1,0.955989708,0,4,"nuclear-transcribed mRNA catabolic process, no-go decay",BP,1
GO:0070970,1,0.938467047,0,6,interleukin-2 secretion,BP,1
GO:0070972,1,0.581612507,0,49,protein localization to endoplasmic reticulum,BP,1
GO:0070973,1,0.9246748,0,7,protein localization to endoplasmic reticulum exit site,BP,1
GO:0070977,1,0.888092573,0,12,bone maturation,BP,1
GO:0070979,1,0.775429954,0,23,protein K11-linked ubiquitination,BP,1
GO:0070981,1,0.988662931,0,1,L-asparagine biosynthetic process,BP,1
GO:0070982,1,0.988662931,0,1,L-asparagine metabolic process,BP,1
GO:0070988,1,0.576917119,0,50,demethylation,BP,1
GO:0070989,1,0.8427062,0,15,oxidative demethylation,BP,1
GO:0070994,1,0.988662703,0,1,detection of oxidative stress,BP,1
GO:0070995,1,0.945020579,0,5,NADPH oxidation,BP,1
GO:0071000,1,0.949282066,0,5,response to magnetism,BP,1
GO:0071025,1,0.844967324,0,15,RNA surveillance,BP,1
GO:0071026,1,0.988662931,0,1,cytoplasmic RNA surveillance,BP,1
GO:0071027,1,0.864480942,0,13,nuclear RNA surveillance,BP,1
GO:0071028,1,0.864480942,0,13,nuclear mRNA surveillance,BP,1
GO:0071029,1,0.933861551,0,6,nuclear ncRNA surveillance,BP,1
GO:0071030,1,0.980073569,0,2,nuclear mRNA surveillance of spliceosomal pre-mRNA splicing,BP,1
GO:0071031,1,0.977453088,0,2,nuclear mRNA surveillance of mRNA 3'-end processing,BP,1
GO:0071033,1,0.947108108,0,5,nuclear retention of pre-mRNA at the site of transcription,BP,1
GO:0071034,1,0.955610591,0,4,CUT catabolic process,BP,1
GO:0071035,1,0.933861551,0,6,nuclear polyadenylation-dependent rRNA catabolic process,BP,1
GO:0071036,1,0.988662931,0,1,nuclear polyadenylation-dependent snoRNA catabolic process,BP,1
GO:0071037,1,0.988662931,0,1,nuclear polyadenylation-dependent snRNA catabolic process,BP,1
GO:0071038,1,0.933861551,0,6,nuclear polyadenylation-dependent tRNA catabolic process,BP,1
GO:0071039,1,0.988662931,0,1,nuclear polyadenylation-dependent CUT catabolic process,BP,1
GO:0071040,1,0.988662931,0,1,nuclear polyadenylation-dependent antisense transcript catabolic process,BP,1
GO:0071041,1,0.988662931,0,1,antisense RNA transcript catabolic process,BP,1
GO:0071042,1,0.955880095,0,4,nuclear polyadenylation-dependent mRNA catabolic process,BP,1
GO:0071043,1,0.955610591,0,4,CUT metabolic process,BP,1
GO:0071044,1,0.887805108,0,11,histone mRNA catabolic process,BP,1
GO:0071045,1,0.988662918,0,1,nuclear histone mRNA catabolic process,BP,1
GO:0071046,1,0.933861551,0,6,nuclear polyadenylation-dependent ncRNA catabolic process,BP,1
GO:0071047,1,0.955880095,0,4,polyadenylation-dependent mRNA catabolic process,BP,1
GO:0071048,1,0.980073569,0,2,nuclear retention of unspliced pre-mRNA at the site of transcription,BP,1
GO:0071049,1,0.977453088,0,2,nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription,BP,1
GO:0071050,1,0.977453375,0,2,snoRNA polyadenylation,BP,1
GO:0071051,1,0.923268457,0,7,polyadenylation-dependent snoRNA 3'-end processing,BP,1
GO:0071071,1,0.884354675,0,11,regulation of phospholipid biosynthetic process,BP,1
GO:0071072,1,0.967247841,0,3,negative regulation of phospholipid biosynthetic process,BP,1
GO:0071073,1,0.935423931,0,6,positive regulation of phospholipid biosynthetic process,BP,1
GO:0071076,1,0.955411126,0,4,RNA 3' uridylation,BP,1
GO:0071104,1,0.989379644,0,1,response to interleukin-9,BP,1
GO:0071105,1,0.97948377,0,2,response to interleukin-11,BP,1
GO:0071106,1,0.977523718,0,2,"adenosine 3',5'-bisphosphate transmembrane transport",BP,1
GO:0071107,1,0.878337953,0,12,response to parathyroid hormone,BP,1
GO:0071108,1,0.766232507,0,25,protein K48-linked deubiquitination,BP,1
GO:0071109,1,0.988662904,0,1,superior temporal gyrus development,BP,1
GO:0071110,1,0.988662931,0,1,histone biotinylation,BP,1
GO:0071139,1,0.990070832,0,1,resolution of recombination intermediates,BP,1
GO:0071140,1,0.990070832,0,1,resolution of mitotic recombination intermediates,BP,1
GO:0071169,1,0.955411019,0,4,establishment of protein localization to chromatin,BP,1
GO:0071170,1,0.988662931,0,1,site-specific DNA replication termination,BP,1
GO:0071171,1,0.988662931,0,1,site-specific DNA replication termination at RTS1 barrier,BP,1
GO:0071211,1,0.95541112,0,4,protein targeting to vacuole involved in autophagy,BP,1
GO:0071215,1,0.988662911,0,1,cellular response to abscisic acid stimulus,BP,1
GO:0071218,1,0.788606744,0,21,cellular response to misfolded protein,BP,1
GO:0071220,1,0.955492805,0,4,cellular response to bacterial lipoprotein,BP,1
GO:0071221,1,0.955492805,0,4,cellular response to bacterial lipopeptide,BP,1
GO:0071223,1,0.924073086,0,7,cellular response to lipoteichoic acid,BP,1
GO:0071224,1,0.945102898,0,5,cellular response to peptidoglycan,BP,1
GO:0071225,1,0.926611805,0,7,cellular response to muramyl dipeptide,BP,1
GO:0071226,1,0.991228453,0,1,cellular response to molecule of fungal origin,BP,1
GO:0071228,1,0.988716039,0,1,cellular response to tumor cell,BP,1
GO:0071231,1,0.988662831,0,1,cellular response to folic acid,BP,1
GO:0071234,1,0.988672927,0,1,cellular response to phenylalanine,BP,1
GO:0071242,1,0.651267446,0,39,cellular response to ammonium ion,BP,1
GO:0071243,1,0.794445032,0,21,cellular response to arsenic-containing substance,BP,1
GO:0071245,1,0.978649299,0,2,cellular response to carbon monoxide,BP,1
GO:0071247,1,0.977453195,0,2,cellular response to chromate,BP,1
GO:0071250,1,0.989376448,0,1,cellular response to nitrite,BP,1
GO:0071258,1,0.977981092,0,2,cellular response to gravity,BP,1
GO:0071259,1,0.977454496,0,2,cellular response to magnetism,BP,1
GO:0071260,1,0.416435427,0,79,cellular response to mechanical stimulus,BP,1
GO:0071262,1,0.977452977,0,2,regulation of translational initiation in response to starvation,BP,1
GO:0071264,1,0.977452977,0,2,positive regulation of translational initiation in response to starvation,BP,1
GO:0071275,1,0.97745333,0,2,cellular response to aluminum ion,BP,1
GO:0071276,1,0.75471664,0,25,cellular response to cadmium ion,BP,1
GO:0071279,1,0.93606378,0,6,cellular response to cobalt ion,BP,1
GO:0071280,1,0.837821674,0,16,cellular response to copper ion,BP,1
GO:0071281,1,0.885493908,0,11,cellular response to iron ion,BP,1
GO:0071282,1,0.97772335,0,2,cellular response to iron(II) ion,BP,1
GO:0071283,1,0.977803735,0,2,cellular response to iron(III) ion,BP,1
GO:0071284,1,0.938366419,0,6,cellular response to lead ion,BP,1
GO:0071285,1,0.837615502,0,16,cellular response to lithium ion,BP,1
GO:0071286,1,0.944889409,0,6,cellular response to magnesium ion,BP,1
GO:0071287,1,0.84833563,0,15,cellular response to manganese ion,BP,1
GO:0071288,1,0.971657403,0,3,cellular response to mercury ion,BP,1
GO:0071294,1,0.913321482,0,8,cellular response to zinc ion,BP,1
GO:0071295,1,0.76356149,0,25,cellular response to vitamin,BP,1
GO:0071298,1,0.989302151,0,1,cellular response to L-ascorbic acid,BP,1
GO:0071301,1,0.988751502,0,1,cellular response to vitamin B1,BP,1
GO:0071305,1,0.833335132,0,17,cellular response to vitamin D,BP,1
GO:0071306,1,0.96944189,0,3,cellular response to vitamin E,BP,1
GO:0071307,1,0.977470433,0,2,cellular response to vitamin K,BP,1
GO:0071312,1,0.763595099,0,24,cellular response to alkaloid,BP,1
GO:0071313,1,0.955448803,0,4,cellular response to caffeine,BP,1
GO:0071314,1,0.9890056,0,1,cellular response to cocaine,BP,1
GO:0071315,1,0.944949051,0,5,cellular response to morphine,BP,1
GO:0071316,1,0.934071236,0,6,cellular response to nicotine,BP,1
GO:0071317,1,0.923634063,0,7,cellular response to isoquinoline alkaloid,BP,1
GO:0071318,1,0.896983067,0,10,cellular response to ATP,BP,1
GO:0071321,1,0.971209728,0,3,cellular response to cGMP,BP,1
GO:0071324,1,0.988662931,0,1,cellular response to disaccharide stimulus,BP,1
GO:0071329,1,0.988662931,0,1,cellular response to sucrose stimulus,BP,1
GO:0071335,1,0.977453375,0,2,hair follicle cell proliferation,BP,1
GO:0071336,1,0.988662931,0,1,regulation of hair follicle cell proliferation,BP,1
GO:0071340,1,0.881349069,0,12,skeletal muscle acetylcholine-gated channel clustering,BP,1
GO:0071348,1,0.97948377,0,2,cellular response to interleukin-11,BP,1
GO:0071349,1,0.959426797,0,4,cellular response to interleukin-12,BP,1
GO:0071350,1,0.936202502,0,6,cellular response to interleukin-15,BP,1
GO:0071351,1,0.966715577,0,3,cellular response to interleukin-18,BP,1
GO:0071352,1,0.947474263,0,5,cellular response to interleukin-2,BP,1
GO:0071353,1,0.737398852,0,27,cellular response to interleukin-4,BP,1
GO:0071354,1,0.72385348,0,29,cellular response to interleukin-6,BP,1
GO:0071355,1,0.989379644,0,1,cellular response to interleukin-9,BP,1
GO:0071357,1,0.706680605,0,31,cellular response to type I interferon,BP,1
GO:0071359,1,0.803217823,0,20,cellular response to dsRNA,BP,1
GO:0071360,1,0.849152291,0,15,cellular response to exogenous dsRNA,BP,1
GO:0071361,1,0.873593829,0,13,cellular response to ethanol,BP,1
GO:0071362,1,0.894698361,0,10,cellular response to ether,BP,1
GO:0071371,1,0.811112899,0,19,cellular response to gonadotropin stimulus,BP,1
GO:0071372,1,0.858688671,0,14,cellular response to follicle-stimulating hormone stimulus,BP,1
GO:0071373,1,0.977468813,0,2,cellular response to luteinizing hormone stimulus,BP,1
GO:0071374,1,0.906982798,0,9,cellular response to parathyroid hormone stimulus,BP,1
GO:0071376,1,0.977484007,0,2,cellular response to corticotropin-releasing hormone stimulus,BP,1
GO:0071377,1,0.904053134,0,9,cellular response to glucagon stimulus,BP,1
GO:0071386,1,0.967785579,0,3,cellular response to corticosterone stimulus,BP,1
GO:0071387,1,0.988691255,0,1,cellular response to cortisol stimulus,BP,1
GO:0071389,1,0.924793122,0,7,cellular response to mineralocorticoid stimulus,BP,1
GO:0071391,1,0.872605944,0,12,cellular response to estrogen stimulus,BP,1
GO:0071392,1,0.715481232,0,30,cellular response to estradiol stimulus,BP,1
GO:0071393,1,0.966369511,0,3,cellular response to progesterone stimulus,BP,1
GO:0071394,1,0.884635898,0,11,cellular response to testosterone stimulus,BP,1
GO:0071400,1,0.967883489,0,3,cellular response to oleic acid,BP,1
GO:0071401,1,0.988936004,0,1,cellular response to triglyceride,BP,1
GO:0071402,1,0.731545785,0,29,cellular response to lipoprotein particle stimulus,BP,1
GO:0071403,1,0.958093047,0,4,cellular response to high density lipoprotein particle stimulus,BP,1
GO:0071404,1,0.825806102,0,18,cellular response to low-density lipoprotein particle stimulus,BP,1
GO:0071415,1,0.925136232,0,7,cellular response to purine-containing compound,BP,1
GO:0071418,1,0.966369834,0,3,cellular response to amine stimulus,BP,1
GO:0071420,1,0.978488842,0,2,cellular response to histamine,BP,1
GO:0071421,1,0.949543273,0,5,manganese ion transmembrane transport,BP,1
GO:0071422,1,0.944823132,0,5,succinate transmembrane transport,BP,1
GO:0071423,1,0.966369875,0,3,malate transmembrane transport,BP,1
GO:0071425,1,0.827597789,0,17,hematopoietic stem cell proliferation,BP,1
GO:0071428,1,0.853513514,0,14,rRNA-containing ribonucleoprotein complex export from nucleus,BP,1
GO:0071431,1,0.967414547,0,3,tRNA-containing ribonucleoprotein complex export from nucleus,BP,1
GO:0071435,1,0.980285658,0,2,potassium ion export,BP,1
GO:0071440,1,0.977453098,0,2,regulation of histone H3-K14 acetylation,BP,1
GO:0071442,1,0.988662651,0,1,positive regulation of histone H3-K14 acetylation,BP,1
GO:0071447,1,0.926940617,0,7,cellular response to hydroperoxide,BP,1
GO:0071448,1,0.988662523,0,1,cellular response to alkyl hydroperoxide,BP,1
GO:0071449,1,0.988662703,0,1,cellular response to lipid hydroperoxide,BP,1
GO:0071450,1,0.78945943,0,21,cellular response to oxygen radical,BP,1
GO:0071451,1,0.78945943,0,21,cellular response to superoxide,BP,1
GO:0071454,1,0.977462037,0,2,cellular response to anoxia,BP,1
GO:0071455,1,0.90418711,0,9,cellular response to hyperoxia,BP,1
GO:0071459,1,0.874269742,0,12,"protein localization to chromosome, centromeric region",BP,1
GO:0071460,1,0.988662638,0,1,cellular response to cell-matrix adhesion,BP,1
GO:0071461,1,0.957640797,0,4,cellular response to redox state,BP,1
GO:0071462,1,0.934082461,0,6,cellular response to water stimulus,BP,1
GO:0071464,1,0.955421709,0,4,cellular response to hydrostatic pressure,BP,1
GO:0071467,1,0.846665084,0,15,cellular response to pH,BP,1
GO:0071468,1,0.904182085,0,9,cellular response to acidic pH,BP,1
GO:0071469,1,0.990895021,0,1,cellular response to alkaline pH,BP,1
GO:0071470,1,0.713515291,0,31,cellular response to osmotic stress,BP,1
GO:0071472,1,0.885434375,0,11,cellular response to salt stress,BP,1
GO:0071474,1,0.834687706,0,16,cellular hyperosmotic response,BP,1
GO:0071475,1,0.913069425,0,8,cellular hyperosmotic salinity response,BP,1
GO:0071476,1,0.953150268,0,5,cellular hypotonic response,BP,1
GO:0071477,1,0.992061117,0,1,cellular hypotonic salinity response,BP,1
GO:0071484,1,0.977453375,0,2,cellular response to light intensity,BP,1
GO:0071485,1,0.988662931,0,1,cellular response to absence of light,BP,1
GO:0071486,1,0.988662931,0,1,cellular response to high light intensity,BP,1
GO:0071492,1,0.988662866,0,1,cellular response to UV-A,BP,1
GO:0071494,1,0.944906508,0,5,cellular response to UV-C,BP,1
GO:0071497,1,0.988662931,0,1,cellular response to freezing,BP,1
GO:0071500,1,0.950707358,0,5,cellular response to nitrosative stress,BP,1
GO:0071501,1,0.905683415,0,9,cellular response to sterol depletion,BP,1
GO:0071502,1,0.979231683,0,2,cellular response to temperature stimulus,BP,1
GO:0071503,1,0.955411099,0,4,response to heparin,BP,1
GO:0071504,1,0.966369882,0,3,cellular response to heparin,BP,1
GO:0071505,1,0.988662903,0,1,response to mycophenolic acid,BP,1
GO:0071506,1,0.988662903,0,1,cellular response to mycophenolic acid,BP,1
GO:0071514,1,0.798193062,0,21,genetic imprinting,BP,1
GO:0071515,1,0.988662931,0,1,genetic imprinting at mating-type locus,BP,1
GO:0071516,1,0.988662931,0,1,establishment of imprinting at mating-type locus,BP,1
GO:0071526,1,0.780193065,0,26,semaphorin-plexin signaling pathway,BP,1
GO:0071527,1,0.988662368,0,1,semaphorin-plexin signaling pathway involved in outflow tract morphogenesis,BP,1
GO:0071528,1,0.98920429,0,1,tRNA re-export from nucleus,BP,1
GO:0071529,1,0.97745942,0,2,cementum mineralization,BP,1
GO:0071539,1,0.779066629,0,24,protein localization to centrosome,BP,1
GO:0071543,1,0.977565651,0,2,diphosphoinositol polyphosphate metabolic process,BP,1
GO:0071544,1,0.988662931,0,1,diphosphoinositol polyphosphate catabolic process,BP,1
GO:0071545,1,0.860455784,0,14,inositol phosphate catabolic process,BP,1
GO:0071550,1,0.988704879,0,1,death-inducing signaling complex assembly,BP,1
GO:0071554,1,0.967049789,0,3,cell wall organization or biogenesis,BP,1
GO:0071557,1,0.946363322,0,5,histone H3-K27 demethylation,BP,1
GO:0071569,1,0.93386165,0,6,protein ufmylation,BP,1
GO:0071573,1,0.988662931,0,1,shelterin complex assembly,BP,1
GO:0071577,1,0.826275339,0,18,zinc ion transmembrane transport,BP,1
GO:0071578,1,0.927460385,0,7,zinc ion import across plasma membrane,BP,1
GO:0071579,1,0.971616017,0,3,regulation of zinc ion transport,BP,1
GO:0071580,1,0.982758674,0,2,regulation of zinc ion transmembrane transport,BP,1
GO:0071581,1,0.988669595,0,1,regulation of zinc ion transmembrane import,BP,1
GO:0071582,1,0.982758674,0,2,negative regulation of zinc ion transport,BP,1
GO:0071583,1,0.982758674,0,2,negative regulation of zinc ion transmembrane transport,BP,1
GO:0071584,1,0.988669595,0,1,negative regulation of zinc ion transmembrane import,BP,1
GO:0071585,1,0.988669595,0,1,detoxification of cadmium ion,BP,1
GO:0071586,1,0.977453494,0,2,CAAX-box protein processing,BP,1
GO:0071593,1,0.957733117,0,4,lymphocyte aggregation,BP,1
GO:0071594,1,0.988662931,0,1,thymocyte aggregation,BP,1
GO:0071596,1,0.977453375,0,2,ubiquitin-dependent protein catabolic process via the N-end rule pathway,BP,1
GO:0071599,1,0.968071112,0,3,otic vesicle development,BP,1
GO:0071600,1,0.978937003,0,2,otic vesicle morphogenesis,BP,1
GO:0071602,1,0.988662931,0,1,phytosphingosine biosynthetic process,BP,1
GO:0071603,1,0.977453375,0,2,endothelial cell-cell adhesion,BP,1
GO:0071604,1,0.758652683,0,25,transforming growth factor beta production,BP,1
GO:0071605,1,0.873701358,0,12,monocyte chemotactic protein-1 production,BP,1
GO:0071608,1,0.967755406,0,3,macrophage inflammatory protein-1 alpha production,BP,1
GO:0071609,1,0.947068168,0,5,chemokine (C-C motif) ligand 5 production,BP,1
GO:0071612,1,0.988662931,0,1,IP-10 production,BP,1
GO:0071613,1,0.988662386,0,1,granzyme B production,BP,1
GO:0071615,1,0.988662908,0,1,oxidative deethylation,BP,1
GO:0071616,1,0.771059152,0,24,acyl-CoA biosynthetic process,BP,1
GO:0071619,1,0.988678072,0,1,phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,1
GO:0071622,1,0.692555562,0,33,regulation of granulocyte chemotaxis,BP,1
GO:0071623,1,0.988662931,0,1,negative regulation of granulocyte chemotaxis,BP,1
GO:0071624,1,0.810902525,0,19,positive regulation of granulocyte chemotaxis,BP,1
GO:0071625,1,0.948967131,0,6,vocalization behavior,BP,1
GO:0071626,1,0.98866287,0,1,mastication,BP,1
GO:0071629,1,0.988662873,0,1,cytoplasm protein quality control by the ubiquitin-proteasome system,BP,1
GO:0071630,1,0.978868043,0,2,nuclear protein quality control by the ubiquitin-proteasome system,BP,1
GO:0071634,1,0.776188211,0,23,regulation of transforming growth factor beta production,BP,1
GO:0071635,1,0.915278703,0,8,negative regulation of transforming growth factor beta production,BP,1
GO:0071636,1,0.895264663,0,10,positive regulation of transforming growth factor beta production,BP,1
GO:0071637,1,0.873701358,0,12,regulation of monocyte chemotactic protein-1 production,BP,1
GO:0071638,1,0.945848401,0,5,negative regulation of monocyte chemotactic protein-1 production,BP,1
GO:0071639,1,0.923755045,0,7,positive regulation of monocyte chemotactic protein-1 production,BP,1
GO:0071640,1,0.978339805,0,2,regulation of macrophage inflammatory protein 1 alpha production,BP,1
GO:0071641,1,0.989559177,0,1,negative regulation of macrophage inflammatory protein 1 alpha production,BP,1
GO:0071642,1,0.988663199,0,1,positive regulation of macrophage inflammatory protein 1 alpha production,BP,1
GO:0071649,1,0.957932022,0,4,regulation of chemokine (C-C motif) ligand 5 production,BP,1
GO:0071650,1,0.968919489,0,3,negative regulation of chemokine (C-C motif) ligand 5 production,BP,1
GO:0071651,1,0.977803316,0,2,positive regulation of chemokine (C-C motif) ligand 5 production,BP,1
GO:0071658,1,0.988662931,0,1,regulation of IP-10 production,BP,1
GO:0071660,1,0.988662931,0,1,positive regulation of IP-10 production,BP,1
GO:0071661,1,0.988662386,0,1,regulation of granzyme B production,BP,1
GO:0071663,1,0.988662386,0,1,positive regulation of granzyme B production,BP,1
GO:0071670,1,0.91543406,0,8,smooth muscle cell chemotaxis,BP,1
GO:0071671,1,0.934067712,0,6,regulation of smooth muscle cell chemotaxis,BP,1
GO:0071672,1,0.966369269,0,3,negative regulation of smooth muscle cell chemotaxis,BP,1
GO:0071673,1,0.955621776,0,4,positive regulation of smooth muscle cell chemotaxis,BP,1
GO:0071677,1,0.854827389,0,14,positive regulation of mononuclear cell migration,BP,1
GO:0071680,1,0.949889963,0,5,response to indole-3-methanol,BP,1
GO:0071681,1,0.949889963,0,5,cellular response to indole-3-methanol,BP,1
GO:0071684,1,0.817700205,0,19,organism emergence from protective structure,BP,1
GO:0071692,1,0.953290728,0,5,protein localization to extracellular region,BP,1
GO:0071693,1,0.988662928,0,1,protein transport within extracellular region,BP,1
GO:0071694,1,0.964225392,0,4,maintenance of protein location in extracellular region,BP,1
GO:0071696,1,0.899694725,0,10,ectodermal placode development,BP,1
GO:0071697,1,0.909204023,0,9,ectodermal placode morphogenesis,BP,1
GO:0071698,1,0.988683913,0,1,olfactory placode development,BP,1
GO:0071699,1,0.988683913,0,1,olfactory placode morphogenesis,BP,1
GO:0071701,1,0.988662931,0,1,regulation of MAPK export from nucleus,BP,1
GO:0071707,1,0.988662817,0,1,immunoglobulin heavy chain V-D-J recombination,BP,1
GO:0071709,1,0.803603365,0,21,membrane assembly,BP,1
GO:0071711,1,0.827547268,0,18,basement membrane organization,BP,1
GO:0071712,1,0.892550943,0,10,ER-associated misfolded protein catabolic process,BP,1
GO:0071718,1,0.989491854,0,1,sodium-independent icosanoid transport,BP,1
GO:0071724,1,0.966433799,0,3,response to diacyl bacterial lipopeptide,BP,1
GO:0071725,1,0.966411296,0,3,response to triacyl bacterial lipopeptide,BP,1
GO:0071726,1,0.966433799,0,3,cellular response to diacyl bacterial lipopeptide,BP,1
GO:0071727,1,0.966411296,0,3,cellular response to triacyl bacterial lipopeptide,BP,1
GO:0071731,1,0.780442283,0,22,response to nitric oxide,BP,1
GO:0071732,1,0.825813402,0,17,cellular response to nitric oxide,BP,1
GO:0071733,1,0.977453342,0,2,transcriptional activation by promoter-enhancer looping,BP,1
GO:0071763,1,0.944810065,0,5,nuclear membrane organization,BP,1
GO:0071765,1,0.988662931,0,1,nuclear inner membrane organization,BP,1
GO:0071786,1,0.846309415,0,15,endoplasmic reticulum tubular network organization,BP,1
GO:0071787,1,0.957536299,0,4,endoplasmic reticulum tubular network formation,BP,1
GO:0071788,1,0.988662931,0,1,endoplasmic reticulum tubular network maintenance,BP,1
GO:0071798,1,0.988722293,0,1,response to prostaglandin D,BP,1
GO:0071799,1,0.988722293,0,1,cellular response to prostaglandin D stimulus,BP,1
GO:0071800,1,0.845893662,0,15,podosome assembly,BP,1
GO:0071801,1,0.874069009,0,12,regulation of podosome assembly,BP,1
GO:0071802,1,0.989964023,0,1,negative regulation of podosome assembly,BP,1
GO:0071803,1,0.903310164,0,9,positive regulation of podosome assembly,BP,1
GO:0071804,1,0.5004095,0,66,cellular potassium ion transport,BP,1
GO:0071805,1,0.5004095,0,66,potassium ion transmembrane transport,BP,1
GO:0071806,1,0.519435093,0,58,protein transmembrane transport,BP,1
GO:0071812,1,0.988662931,0,1,positive regulation of fever generation by positive regulation of prostaglandin secretion,BP,1
GO:0071816,1,0.933861967,0,6,tail-anchored membrane protein insertion into ER membrane,BP,1
GO:0071824,1,0.238291365,0,131,protein-DNA complex subunit organization,BP,1
GO:0071825,1,0.740377707,0,28,protein-lipid complex subunit organization,BP,1
GO:0071827,1,0.757490526,0,26,plasma lipoprotein particle organization,BP,1
GO:0071830,1,0.93386102,0,6,triglyceride-rich lipoprotein particle clearance,BP,1
GO:0071831,1,0.988662786,0,1,intermediate-density lipoprotein particle clearance,BP,1
GO:0071838,1,0.936100465,0,6,cell proliferation in bone marrow,BP,1
GO:0071839,1,0.955473172,0,4,apoptotic process in bone marrow,BP,1
GO:0071846,1,0.977452898,0,2,actin filament debranching,BP,1
GO:0071847,1,0.968083128,0,3,TNFSF11-mediated signaling pathway,BP,1
GO:0071848,1,0.988662931,0,1,positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling,BP,1
GO:0071852,1,0.988663984,0,1,fungal-type cell wall organization or biogenesis,BP,1
GO:0071863,1,0.926887609,0,7,regulation of cell proliferation in bone marrow,BP,1
GO:0071864,1,0.937522009,0,6,positive regulation of cell proliferation in bone marrow,BP,1
GO:0071865,1,0.956922626,0,4,regulation of apoptotic process in bone marrow,BP,1
GO:0071866,1,0.956922626,0,4,negative regulation of apoptotic process in bone marrow,BP,1
GO:0071871,1,0.860283716,0,14,response to epinephrine,BP,1
GO:0071872,1,0.890250409,0,11,cellular response to epinephrine stimulus,BP,1
GO:0071873,1,0.955414042,0,4,response to norepinephrine,BP,1
GO:0071874,1,0.966372886,0,3,cellular response to norepinephrine stimulus,BP,1
GO:0071875,1,0.863121746,0,14,adrenergic receptor signaling pathway,BP,1
GO:0071877,1,0.988662591,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,1
GO:0071878,1,0.956663329,0,4,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,1
GO:0071879,1,0.977750094,0,2,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,1
GO:0071880,1,0.883051506,0,12,adenylate cyclase-activating adrenergic receptor signaling pathway,BP,1
GO:0071881,1,0.988662591,0,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,1
GO:0071888,1,0.924300521,0,7,macrophage apoptotic process,BP,1
GO:0071894,1,0.977453375,0,2,histone H2B conserved C-terminal lysine ubiquitination,BP,1
GO:0071895,1,0.966676468,0,3,odontoblast differentiation,BP,1
GO:0071896,1,0.970495516,0,3,protein localization to adherens junction,BP,1
GO:0071898,1,0.988662898,0,1,regulation of estrogen receptor binding,BP,1
GO:0071899,1,0.988662898,0,1,negative regulation of estrogen receptor binding,BP,1
GO:0071907,1,0.977453375,0,2,determination of digestive tract left/right asymmetry,BP,1
GO:0071908,1,0.988662931,0,1,determination of intestine left/right asymmetry,BP,1
GO:0071909,1,0.988662931,0,1,determination of stomach left/right asymmetry,BP,1
GO:0071910,1,0.977453375,0,2,determination of liver left/right asymmetry,BP,1
GO:0071918,1,0.97745331,0,2,urea transmembrane transport,BP,1
GO:0071921,1,0.952219652,0,5,cohesin loading,BP,1
GO:0071922,1,0.968224127,0,3,regulation of cohesin loading,BP,1
GO:0071926,1,0.966500355,0,3,endocannabinoid signaling pathway,BP,1
GO:0071929,1,0.977453375,0,2,alpha-tubulin acetylation,BP,1
GO:0071930,1,0.99055958,0,1,negative regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,1
GO:0071931,1,0.988662931,0,1,positive regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,1
GO:0071934,1,0.977703954,0,2,thiamine transmembrane transport,BP,1
GO:0071938,1,0.977460449,0,2,vitamin A transport,BP,1
GO:0071939,1,0.977460449,0,2,vitamin A import,BP,1
GO:0071941,1,0.899713976,0,10,nitrogen cycle metabolic process,BP,1
GO:0071947,1,0.976728572,0,3,protein deubiquitination involved in ubiquitin-dependent protein catabolic process,BP,1
GO:0071951,1,0.98866288,0,1,conversion of methionyl-tRNA to N-formyl-methionyl-tRNA,BP,1
GO:0071955,1,0.98306179,0,2,recycling endosome to Golgi transport,BP,1
GO:0071960,1,0.988662931,0,1,"maintenance of mitotic sister chromatid cohesion, centromeric",BP,1
GO:0071962,1,0.95541109,0,4,"mitotic sister chromatid cohesion, centromeric",BP,1
GO:0071963,1,0.955431853,0,4,establishment or maintenance of cell polarity regulating cell shape,BP,1
GO:0071964,1,0.988662792,0,1,establishment of cell polarity regulating cell shape,BP,1
GO:0071966,1,0.988663984,0,1,fungal-type cell wall polysaccharide metabolic process,BP,1
GO:0071971,1,0.934160084,0,6,extracellular exosome assembly,BP,1
GO:0071976,1,0.989012815,0,1,cell gliding,BP,1
GO:0071985,1,0.738003468,0,27,multivesicular body sorting pathway,BP,1
GO:0071988,1,0.988662931,0,1,protein localization to spindle pole body,BP,1
GO:0072007,1,0.972284945,0,3,mesangial cell differentiation,BP,1
GO:0072008,1,0.972284945,0,3,glomerular mesangial cell differentiation,BP,1
GO:0072010,1,0.870363784,0,14,glomerular epithelium development,BP,1
GO:0072015,1,0.919043563,0,9,glomerular visceral epithelial cell development,BP,1
GO:0072017,1,0.964041945,0,4,distal tubule development,BP,1
GO:0072019,1,0.977481371,0,2,proximal convoluted tubule development,BP,1
GO:0072020,1,0.988691255,0,1,proximal straight tubule development,BP,1
GO:0072021,1,0.977453375,0,2,ascending thin limb development,BP,1
GO:0072022,1,0.988691255,0,1,descending thin limb development,BP,1
GO:0072032,1,0.988691255,0,1,proximal convoluted tubule segment 2 development,BP,1
GO:0072034,1,0.977453276,0,2,renal vesicle induction,BP,1
GO:0072036,1,0.988667479,0,1,mesenchymal to epithelial transition involved in renal vesicle formation,BP,1
GO:0072038,1,0.96727276,0,3,mesenchymal stem cell maintenance involved in nephron morphogenesis,BP,1
GO:0072039,1,0.977453367,0,2,regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,1
GO:0072040,1,0.977453367,0,2,negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,1
GO:0072044,1,0.954464284,0,5,collecting duct development,BP,1
GO:0072047,1,0.988665305,0,1,proximal/distal pattern formation involved in nephron development,BP,1
GO:0072048,1,0.988665305,0,1,renal system pattern specification,BP,1
GO:0072053,1,0.988666206,0,1,renal inner medulla development,BP,1
GO:0072054,1,0.988666206,0,1,renal outer medulla development,BP,1
GO:0072055,1,0.988662931,0,1,renal cortex development,BP,1
GO:0072059,1,0.988662931,0,1,cortical collecting duct development,BP,1
GO:0072061,1,0.977502663,0,2,inner medullary collecting duct development,BP,1
GO:0072074,1,0.936356131,0,6,kidney mesenchyme development,BP,1
GO:0072075,1,0.936356131,0,6,metanephric mesenchyme development,BP,1
GO:0072076,1,0.97745337,0,2,nephrogenic mesenchyme development,BP,1
GO:0072079,1,0.945717898,0,5,nephron tubule formation,BP,1
GO:0072081,1,0.988665305,0,1,specification of nephron tubule identity,BP,1
GO:0072086,1,0.988665305,0,1,specification of loop of Henle identity,BP,1
GO:0072095,1,0.988662923,0,1,regulation of branch elongation involved in ureteric bud branching,BP,1
GO:0072102,1,0.927023513,0,8,glomerulus morphogenesis,BP,1
GO:0072103,1,0.96655096,0,4,glomerulus vasculature morphogenesis,BP,1
GO:0072104,1,0.96655096,0,4,glomerular capillary formation,BP,1
GO:0072109,1,0.900061398,0,10,glomerular mesangium development,BP,1
GO:0072110,1,0.925733802,0,7,glomerular mesangial cell proliferation,BP,1
GO:0072111,1,0.885842321,0,11,cell proliferation involved in kidney development,BP,1
GO:0072112,1,0.870363784,0,14,glomerular visceral epithelial cell differentiation,BP,1
GO:0072114,1,0.977689941,0,2,pronephros morphogenesis,BP,1
GO:0072124,1,0.933861705,0,6,regulation of glomerular mesangial cell proliferation,BP,1
GO:0072125,1,0.988662931,0,1,negative regulation of glomerular mesangial cell proliferation,BP,1
GO:0072126,1,0.944575276,0,5,positive regulation of glomerular mesangial cell proliferation,BP,1
GO:0072131,1,0.966370933,0,3,kidney mesenchyme morphogenesis,BP,1
GO:0072132,1,0.712505581,0,33,mesenchyme morphogenesis,BP,1
GO:0072133,1,0.966370933,0,3,metanephric mesenchyme morphogenesis,BP,1
GO:0072134,1,0.97745337,0,2,nephrogenic mesenchyme morphogenesis,BP,1
GO:0072135,1,0.988662931,0,1,kidney mesenchymal cell proliferation,BP,1
GO:0072136,1,0.988662931,0,1,metanephric mesenchymal cell proliferation involved in metanephros development,BP,1
GO:0072137,1,0.984211813,0,2,condensed mesenchymal cell proliferation,BP,1
GO:0072138,1,0.988662842,0,1,mesenchymal cell proliferation involved in ureteric bud development,BP,1
GO:0072139,1,0.978106342,0,2,glomerular parietal epithelial cell differentiation,BP,1
GO:0072143,1,0.972284945,0,3,mesangial cell development,BP,1
GO:0072144,1,0.972284945,0,3,glomerular mesangial cell development,BP,1
GO:0072156,1,0.988662931,0,1,distal tubule morphogenesis,BP,1
GO:0072158,1,0.988662781,0,1,proximal tubule morphogenesis,BP,1
GO:0072160,1,0.915143789,0,8,nephron tubule epithelial cell differentiation,BP,1
GO:0072161,1,0.988662833,0,1,mesenchymal cell differentiation involved in kidney development,BP,1
GO:0072162,1,0.988662833,0,1,metanephric mesenchymal cell differentiation,BP,1
GO:0072172,1,0.978629483,0,2,mesonephric tubule formation,BP,1
GO:0072174,1,0.977453276,0,2,metanephric tubule formation,BP,1
GO:0072176,1,0.926870733,0,7,nephric duct development,BP,1
GO:0072177,1,0.955411119,0,4,mesonephric duct development,BP,1
GO:0072178,1,0.959137192,0,4,nephric duct morphogenesis,BP,1
GO:0072179,1,0.988662923,0,1,nephric duct formation,BP,1
GO:0072180,1,0.988662923,0,1,mesonephric duct morphogenesis,BP,1
GO:0072181,1,0.988662923,0,1,mesonephric duct formation,BP,1
GO:0072182,1,0.934489172,0,6,regulation of nephron tubule epithelial cell differentiation,BP,1
GO:0072185,1,0.988663984,0,1,metanephric cap development,BP,1
GO:0072186,1,0.988663984,0,1,metanephric cap morphogenesis,BP,1
GO:0072189,1,0.933967136,0,6,ureter development,BP,1
GO:0072190,1,0.988662931,0,1,ureter urothelium development,BP,1
GO:0072191,1,0.988662931,0,1,ureter smooth muscle development,BP,1
GO:0072193,1,0.988662931,0,1,ureter smooth muscle cell differentiation,BP,1
GO:0072194,1,0.988662931,0,1,kidney smooth muscle tissue development,BP,1
GO:0072197,1,0.966478615,0,3,ureter morphogenesis,BP,1
GO:0072201,1,0.946000587,0,5,negative regulation of mesenchymal cell proliferation,BP,1
GO:0072202,1,0.885947764,0,11,cell differentiation involved in metanephros development,BP,1
GO:0072203,1,0.948477931,0,5,cell proliferation involved in metanephros development,BP,1
GO:0072204,1,0.98919176,0,1,cell-cell signaling involved in metanephros development,BP,1
GO:0072205,1,0.970495455,0,3,metanephric collecting duct development,BP,1
GO:0072208,1,0.988662931,0,1,metanephric smooth muscle tissue development,BP,1
GO:0072214,1,0.988662931,0,1,metanephric cortex development,BP,1
GO:0072215,1,0.885262172,0,11,regulation of metanephros development,BP,1
GO:0072216,1,0.947097838,0,5,positive regulation of metanephros development,BP,1
GO:0072217,1,0.956306767,0,4,negative regulation of metanephros development,BP,1
GO:0072218,1,0.977453375,0,2,metanephric ascending thin limb development,BP,1
GO:0072219,1,0.988662931,0,1,metanephric cortical collecting duct development,BP,1
GO:0072220,1,0.988691255,0,1,metanephric descending thin limb development,BP,1
GO:0072223,1,0.98006195,0,2,metanephric glomerular mesangium development,BP,1
GO:0072224,1,0.911475628,0,9,metanephric glomerulus development,BP,1
GO:0072229,1,0.977481371,0,2,metanephric proximal convoluted tubule development,BP,1
GO:0072230,1,0.988691255,0,1,metanephric proximal straight tubule development,BP,1
GO:0072232,1,0.988691255,0,1,metanephric proximal convoluted tubule segment 2 development,BP,1
GO:0072235,1,0.977453375,0,2,metanephric distal tubule development,BP,1
GO:0072236,1,0.9663976,0,3,metanephric loop of Henle development,BP,1
GO:0072237,1,0.96639759,0,3,metanephric proximal tubule development,BP,1
GO:0072239,1,0.950758317,0,5,metanephric glomerulus vasculature development,BP,1
GO:0072244,1,0.969176844,0,3,metanephric glomerular epithelium development,BP,1
GO:0072248,1,0.969176844,0,3,metanephric glomerular visceral epithelial cell differentiation,BP,1
GO:0072249,1,0.969176844,0,3,metanephric glomerular visceral epithelial cell development,BP,1
GO:0072257,1,0.96636985,0,3,metanephric nephron tubule epithelial cell differentiation,BP,1
GO:0072262,1,0.98006195,0,2,metanephric glomerular mesangial cell proliferation involved in metanephros development,BP,1
GO:0072268,1,0.988665305,0,1,pattern specification involved in metanephros development,BP,1
GO:0072272,1,0.988665305,0,1,proximal/distal pattern formation involved in metanephric nephron development,BP,1
GO:0072274,1,0.991534341,0,1,metanephric glomerular basement membrane development,BP,1
GO:0072275,1,0.972666252,0,3,metanephric glomerulus morphogenesis,BP,1
GO:0072276,1,0.972666252,0,3,metanephric glomerulus vasculature morphogenesis,BP,1
GO:0072277,1,0.972666252,0,3,metanephric glomerular capillary formation,BP,1
GO:0072278,1,0.991301209,0,1,metanephric comma-shaped body morphogenesis,BP,1
GO:0072284,1,0.980061977,0,2,metanephric S-shaped body morphogenesis,BP,1
GO:0072285,1,0.988667479,0,1,mesenchymal to epithelial transition involved in metanephric renal vesicle formation,BP,1
GO:0072287,1,0.988662931,0,1,metanephric distal tubule morphogenesis,BP,1
GO:0072289,1,0.988662931,0,1,metanephric nephron tubule formation,BP,1
GO:0072298,1,0.977453122,0,2,regulation of metanephric glomerulus development,BP,1
GO:0072300,1,0.977453122,0,2,positive regulation of metanephric glomerulus development,BP,1
GO:0072301,1,0.988662903,0,1,regulation of metanephric glomerular mesangial cell proliferation,BP,1
GO:0072303,1,0.988662903,0,1,positive regulation of glomerular metanephric mesangial cell proliferation,BP,1
GO:0072307,1,0.96636985,0,3,regulation of metanephric nephron tubule epithelial cell differentiation,BP,1
GO:0072309,1,0.98958645,0,1,mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis,BP,1
GO:0072310,1,0.919043563,0,9,glomerular epithelial cell development,BP,1
GO:0072311,1,0.870363784,0,14,glomerular epithelial cell differentiation,BP,1
GO:0072312,1,0.969176844,0,3,metanephric glomerular epithelial cell differentiation,BP,1
GO:0072313,1,0.969176844,0,3,metanephric glomerular epithelial cell development,BP,1
GO:0072318,1,0.938400388,0,6,clathrin coat disassembly,BP,1
GO:0072319,1,0.927756231,0,7,vesicle uncoating,BP,1
GO:0072321,1,0.882135316,0,11,chaperone-mediated protein transport,BP,1
GO:0072334,1,0.9774533,0,2,UDP-galactose transmembrane transport,BP,1
GO:0072337,1,0.853127266,0,15,modified amino acid transport,BP,1
GO:0072338,1,0.988662911,0,1,cellular lactam metabolic process,BP,1
GO:0072343,1,0.988662928,0,1,pancreatic stellate cell proliferation,BP,1
GO:0072344,1,0.955536034,0,4,rescue of stalled ribosome,BP,1
GO:0072347,1,0.491108692,0,65,response to anesthetic,BP,1
GO:0072350,1,0.705134236,0,31,tricarboxylic acid metabolic process,BP,1
GO:0072355,1,0.98866293,0,1,histone H3-T3 phosphorylation,BP,1
GO:0072356,1,0.988662931,0,1,chromosome passenger complex localization to kinetochore,BP,1
GO:0072361,1,0.966369904,0,3,regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter,BP,1
GO:0072362,1,0.988662931,0,1,regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter,BP,1
GO:0072363,1,0.977453369,0,2,regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter,BP,1
GO:0072364,1,0.982959919,0,2,regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter,BP,1
GO:0072365,1,0.994232119,0,1,regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter,BP,1
GO:0072366,1,0.988662931,0,1,regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter,BP,1
GO:0072367,1,0.957590936,0,4,regulation of lipid transport by regulation of transcription from RNA polymerase II promoter,BP,1
GO:0072368,1,0.979662545,0,2,regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter,BP,1
GO:0072369,1,0.977473855,0,2,regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter,BP,1
GO:0072376,1,0.557092477,0,53,protein activation cascade,BP,1
GO:0072377,1,0.988662951,0,1,"blood coagulation, common pathway",BP,1
GO:0072378,1,0.910600904,0,9,"blood coagulation, fibrin clot formation",BP,1
GO:0072382,1,0.996710886,0,1,minus-end-directed vesicle transport along microtubule,BP,1
GO:0072383,1,0.975189954,0,3,plus-end-directed vesicle transport along microtubule,BP,1
GO:0072384,1,0.551937577,0,57,organelle transport along microtubule,BP,1
GO:0072385,1,0.976900788,0,3,minus-end-directed organelle transport along microtubule,BP,1
GO:0072386,1,0.975189954,0,3,plus-end-directed organelle transport along microtubule,BP,1
GO:0072387,1,0.977810619,0,2,flavin adenine dinucleotide metabolic process,BP,1
GO:0072388,1,0.988751856,0,1,flavin adenine dinucleotide biosynthetic process,BP,1
GO:0072389,1,0.988935291,0,1,flavin adenine dinucleotide catabolic process,BP,1
GO:0072393,1,0.90995417,0,9,microtubule anchoring at microtubule organizing center,BP,1
GO:0072394,1,0.988662749,0,1,detection of stimulus involved in cell cycle checkpoint,BP,1
GO:0072396,1,0.934557716,0,6,response to cell cycle checkpoint signaling,BP,1
GO:0072402,1,0.934557716,0,6,response to DNA integrity checkpoint signaling,BP,1
GO:0072421,1,0.988662749,0,1,detection of DNA damage stimulus involved in DNA damage checkpoint,BP,1
GO:0072423,1,0.934557716,0,6,response to DNA damage checkpoint signaling,BP,1
GO:0072425,1,0.900840534,0,10,signal transduction involved in G2 DNA damage checkpoint,BP,1
GO:0072429,1,0.966369908,0,3,response to intra-S DNA damage checkpoint signaling,BP,1
GO:0072434,1,0.983797226,0,2,signal transduction involved in mitotic G2 DNA damage checkpoint,BP,1
GO:0072488,1,0.905980333,0,9,ammonium transmembrane transport,BP,1
GO:0072497,1,0.928570615,0,7,mesenchymal stem cell differentiation,BP,1
GO:0072498,1,0.945048812,0,5,embryonic skeletal joint development,BP,1
GO:0072501,1,0.955969757,0,4,cellular divalent inorganic anion homeostasis,BP,1
GO:0072502,1,0.955969757,0,4,cellular trivalent inorganic anion homeostasis,BP,1
GO:0072503,1,0.064771465,0,249,cellular divalent inorganic cation homeostasis,BP,1
GO:0072505,1,0.945354886,0,5,divalent inorganic anion homeostasis,BP,1
GO:0072506,1,0.945354886,0,5,trivalent inorganic anion homeostasis,BP,1
GO:0072507,1,0.056815351,0,261,divalent inorganic cation homeostasis,BP,1
GO:0072512,1,0.89303363,0,11,trivalent inorganic cation transport,BP,1
GO:0072520,1,0.89935162,0,10,seminiferous tubule development,BP,1
GO:0072523,1,0.692877798,0,33,purine-containing compound catabolic process,BP,1
GO:0072526,1,0.945048168,0,5,pyridine-containing compound catabolic process,BP,1
GO:0072529,1,0.853774488,0,14,pyrimidine-containing compound catabolic process,BP,1
GO:0072530,1,0.934020543,0,6,purine-containing compound transmembrane transport,BP,1
GO:0072531,1,0.944818638,0,5,pyrimidine-containing compound transmembrane transport,BP,1
GO:0072540,1,0.97904926,0,2,T-helper 17 cell lineage commitment,BP,1
GO:0072553,1,0.955673021,0,4,terminal button organization,BP,1
GO:0072554,1,0.97899923,0,2,blood vessel lumenization,BP,1
GO:0072566,1,0.988662958,0,1,chemokine (C-X-C motif) ligand 1 production,BP,1
GO:0072574,1,0.803512739,0,21,hepatocyte proliferation,BP,1
GO:0072575,1,0.803512739,0,21,epithelial cell proliferation involved in liver morphogenesis,BP,1
GO:0072576,1,0.78647305,0,23,liver morphogenesis,BP,1
GO:0072578,1,0.951100788,0,6,neurotransmitter-gated ion channel clustering,BP,1
GO:0072579,1,0.988676702,0,1,glycine receptor clustering,BP,1
GO:0072584,1,0.905607787,0,9,caveolin-mediated endocytosis,BP,1
GO:0072592,1,0.977453373,0,2,oxygen metabolic process,BP,1
GO:0072599,1,0.728645881,0,29,establishment of protein localization to endoplasmic reticulum,BP,1
GO:0072602,1,0.967271594,0,4,interleukin-4 secretion,BP,1
GO:0072603,1,0.94684422,0,5,interleukin-5 secretion,BP,1
GO:0072604,1,0.729743239,0,28,interleukin-6 secretion,BP,1
GO:0072606,1,0.825591663,0,17,interleukin-8 secretion,BP,1
GO:0072607,1,0.988689163,0,1,interleukin-9 secretion,BP,1
GO:0072608,1,0.903794273,0,9,interleukin-10 secretion,BP,1
GO:0072610,1,0.913217699,0,8,interleukin-12 secretion,BP,1
GO:0072611,1,0.925490852,0,7,interleukin-13 secretion,BP,1
GO:0072616,1,0.988721486,0,1,interleukin-18 secretion,BP,1
GO:0072619,1,0.977479569,0,2,interleukin-21 secretion,BP,1
GO:0072641,1,0.919664504,0,8,type I interferon secretion,BP,1
GO:0072642,1,0.919664504,0,8,interferon-alpha secretion,BP,1
GO:0072643,1,0.912824222,0,8,interferon-gamma secretion,BP,1
GO:0072655,1,0.412210345,0,78,establishment of protein localization to mitochondrion,BP,1
GO:0072656,1,0.945210872,0,5,maintenance of protein location in mitochondrion,BP,1
GO:0072662,1,0.846502513,0,15,protein localization to peroxisome,BP,1
GO:0072663,1,0.846502513,0,15,establishment of protein localization to peroxisome,BP,1
GO:0072665,1,0.604669873,0,47,protein localization to vacuole,BP,1
GO:0072666,1,0.705658793,0,33,establishment of protein localization to vacuole,BP,1
GO:0072671,1,0.988701136,0,1,mitochondria-associated ubiquitin-dependent protein catabolic process,BP,1
GO:0072672,1,0.903592503,0,9,neutrophil extravasation,BP,1
GO:0072673,1,0.854513399,0,15,lamellipodium morphogenesis,BP,1
GO:0072674,1,0.946932843,0,5,multinuclear osteoclast differentiation,BP,1
GO:0072675,1,0.957795158,0,4,osteoclast fusion,BP,1
GO:0072676,1,0.52707784,0,58,lymphocyte migration,BP,1
GO:0072677,1,0.902598473,0,9,eosinophil migration,BP,1
GO:0072678,1,0.64479718,0,40,T cell migration,BP,1
GO:0072679,1,0.988662386,0,1,thymocyte migration,BP,1
GO:0072683,1,0.903615236,0,9,T cell extravasation,BP,1
GO:0072684,1,0.988781557,0,1,"mitochondrial tRNA 3'-trailer cleavage, endonucleolytic",BP,1
GO:0072695,1,0.966369914,0,3,regulation of DNA recombination at telomere,BP,1
GO:0072697,1,0.923749913,0,7,protein localization to cell cortex,BP,1
GO:0072698,1,0.660176601,0,39,protein localization to microtubule cytoskeleton,BP,1
GO:0072702,1,0.977453188,0,2,response to methyl methanesulfonate,BP,1
GO:0072703,1,0.977453188,0,2,cellular response to methyl methanesulfonate,BP,1
GO:0072704,1,0.978717573,0,2,response to mercaptoethanol,BP,1
GO:0072705,1,0.978717573,0,2,cellular response to mercaptoethanol,BP,1
GO:0072708,1,0.955412959,0,4,response to sorbitol,BP,1
GO:0072709,1,0.966371763,0,3,cellular response to sorbitol,BP,1
GO:0072710,1,0.90266513,0,10,response to hydroxyurea,BP,1
GO:0072711,1,0.91302364,0,9,cellular response to hydroxyurea,BP,1
GO:0072714,1,0.988662931,0,1,response to selenite ion,BP,1
GO:0072715,1,0.988662931,0,1,cellular response to selenite ion,BP,1
GO:0072716,1,0.944659754,0,5,response to actinomycin D,BP,1
GO:0072717,1,0.955496202,0,4,cellular response to actinomycin D,BP,1
GO:0072718,1,0.93465162,0,6,response to cisplatin,BP,1
GO:0072719,1,0.967182391,0,3,cellular response to cisplatin,BP,1
GO:0072720,1,0.988662931,0,1,response to dithiothreitol,BP,1
GO:0072732,1,0.988662931,0,1,cellular response to calcium ion starvation,BP,1
GO:0072733,1,0.955420481,0,4,response to staurosporine,BP,1
GO:0072734,1,0.955420481,0,4,cellular response to staurosporine,BP,1
GO:0072737,1,0.977468341,0,2,response to diamide,BP,1
GO:0072738,1,0.977468341,0,2,cellular response to diamide,BP,1
GO:0072739,1,0.988662931,0,1,response to anisomycin,BP,1
GO:0072749,1,0.988662847,0,1,cellular response to cytochalasin B,BP,1
GO:0072750,1,0.97745301,0,2,cellular response to leptomycin B,BP,1
GO:0072752,1,0.955431106,0,4,cellular response to rapamycin,BP,1
GO:0072755,1,0.988662931,0,1,cellular response to benomyl,BP,1
GO:0072757,1,0.969476812,0,3,cellular response to camptothecin,BP,1
GO:0075044,1,0.946602702,0,5,autophagy of host cells involved in interaction with symbiont,BP,1
GO:0075071,1,0.946602702,0,5,autophagy involved in symbiotic interaction,BP,1
GO:0075136,1,0.935612616,0,6,response to host,BP,1
GO:0075205,1,0.977453199,0,2,modulation by host of symbiont cAMP-mediated signal transduction,BP,1
GO:0075206,1,0.977453199,0,2,positive regulation by host of symbiont cAMP-mediated signal transduction,BP,1
GO:0075506,1,0.977453275,0,2,entry of viral genome into host nucleus through nuclear pore complex via importin,BP,1
GO:0075509,1,0.959375865,0,4,endocytosis involved in viral entry into host cell,BP,1
GO:0075512,1,0.992599401,0,1,clathrin-dependent endocytosis of virus by host cell,BP,1
GO:0075522,1,0.892240979,0,10,IRES-dependent viral translational initiation,BP,1
GO:0075525,1,0.944575437,0,5,viral translational termination-reinitiation,BP,1
GO:0075732,1,0.977453275,0,2,viral penetration into host nucleus,BP,1
GO:0075733,1,0.945834139,0,5,intracellular transport of virus,BP,1
GO:0080009,1,0.867219976,0,13,mRNA methylation,BP,1
GO:0080033,1,0.989376448,0,1,response to nitrite,BP,1
GO:0080053,1,0.988672927,0,1,response to phenylalanine,BP,1
GO:0080111,1,0.869099782,0,13,DNA demethylation,BP,1
GO:0080120,1,0.977453494,0,2,CAAX-box protein maturation,BP,1
GO:0080121,1,0.977523718,0,2,AMP transport,BP,1
GO:0080129,1,0.988662808,0,1,proteasome core complex assembly,BP,1
GO:0080144,1,0.966371803,0,3,amino acid homeostasis,BP,1
GO:0080154,1,0.93799596,0,6,regulation of fertilization,BP,1
GO:0080164,1,0.988662931,0,1,regulation of nitric oxide metabolic process,BP,1
GO:0080171,1,0.559873124,0,52,lytic vacuole organization,BP,1
GO:0080182,1,0.859028528,0,14,histone H3-K4 trimethylation,BP,1
GO:0080184,1,0.935074101,0,6,response to phenylpropanoid,BP,1
GO:0085018,1,0.988691255,0,1,maintenance of symbiont-containing vacuole by host,BP,1
GO:0085020,1,0.958621171,0,4,protein K6-linked ubiquitination,BP,1
GO:0085029,1,0.828727096,0,18,extracellular matrix assembly,BP,1
GO:0085032,1,0.988758751,0,1,modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade,BP,1
GO:0086001,1,0.770809563,0,25,cardiac muscle cell action potential,BP,1
GO:0086002,1,0.842923725,0,16,cardiac muscle cell action potential involved in contraction,BP,1
GO:0086003,1,0.742715969,0,28,cardiac muscle cell contraction,BP,1
GO:0086004,1,0.789576018,0,22,regulation of cardiac muscle cell contraction,BP,1
GO:0086005,1,0.876472385,0,12,ventricular cardiac muscle cell action potential,BP,1
GO:0086009,1,0.820736483,0,19,membrane repolarization,BP,1
GO:0086010,1,0.923779962,0,8,membrane depolarization during action potential,BP,1
GO:0086011,1,0.950074737,0,5,membrane repolarization during action potential,BP,1
GO:0086012,1,0.945098276,0,6,membrane depolarization during cardiac muscle cell action potential,BP,1
GO:0086013,1,0.960961169,0,4,membrane repolarization during cardiac muscle cell action potential,BP,1
GO:0086014,1,0.969088468,0,3,atrial cardiac muscle cell action potential,BP,1
GO:0086015,1,0.99377117,0,1,SA node cell action potential,BP,1
GO:0086016,1,0.978762138,0,2,AV node cell action potential,BP,1
GO:0086017,1,0.978762124,0,2,Purkinje myocyte action potential,BP,1
GO:0086018,1,0.99377117,0,1,SA node cell to atrial cardiac muscle cell signaling,BP,1
GO:0086019,1,0.930653287,0,7,cell-cell signaling involved in cardiac conduction,BP,1
GO:0086023,1,0.942178236,0,6,adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,1
GO:0086024,1,0.988662633,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate,BP,1
GO:0086026,1,0.969088468,0,3,atrial cardiac muscle cell to AV node cell signaling,BP,1
GO:0086027,1,0.978762138,0,2,AV node cell to bundle of His cell signaling,BP,1
GO:0086028,1,0.978761893,0,2,bundle of His cell to Purkinje myocyte signaling,BP,1
GO:0086029,1,0.978762124,0,2,Purkinje myocyte to ventricular cardiac muscle cell signaling,BP,1
GO:0086036,1,0.950278739,0,5,regulation of cardiac muscle cell membrane potential,BP,1
GO:0086042,1,0.946490228,0,5,cardiac muscle cell-cardiac muscle cell adhesion,BP,1
GO:0086043,1,0.978761893,0,2,bundle of His cell action potential,BP,1
GO:0086045,1,0.9899866,0,1,membrane depolarization during AV node cell action potential,BP,1
GO:0086046,1,0.99377117,0,1,membrane depolarization during SA node cell action potential,BP,1
GO:0086047,1,0.978762124,0,2,membrane depolarization during Purkinje myocyte cell action potential,BP,1
GO:0086048,1,0.9899866,0,1,membrane depolarization during bundle of His cell action potential,BP,1
GO:0086064,1,0.955426106,0,4,cell communication by electrical coupling involved in cardiac conduction,BP,1
GO:0086065,1,0.851187881,0,15,cell communication involved in cardiac conduction,BP,1
GO:0086066,1,0.969088468,0,3,atrial cardiac muscle cell to AV node cell communication,BP,1
GO:0086067,1,0.978762138,0,2,AV node cell to bundle of His cell communication,BP,1
GO:0086068,1,0.978762124,0,2,Purkinje myocyte to ventricular cardiac muscle cell communication,BP,1
GO:0086069,1,0.937008255,0,6,bundle of His cell to Purkinje myocyte communication,BP,1
GO:0086070,1,0.99377117,0,1,SA node cell to atrial cardiac muscle cell communication,BP,1
GO:0086072,1,0.988662915,0,1,AV node cell-bundle of His cell adhesion involved in cell communication,BP,1
GO:0086073,1,0.957347522,0,4,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,BP,1
GO:0086091,1,0.900632818,0,10,regulation of heart rate by cardiac conduction,BP,1
GO:0086092,1,0.990396893,0,1,regulation of the force of heart contraction by cardiac conduction,BP,1
GO:0086096,1,0.988662591,0,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,1
GO:0086097,1,0.977578553,0,2,phospholipase C-activating angiotensin-activated signaling pathway,BP,1
GO:0086098,1,0.977465208,0,2,angiotensin-activated signaling pathway involved in heart process,BP,1
GO:0086100,1,0.968093035,0,3,endothelin receptor signaling pathway,BP,1
GO:0086103,1,0.910488558,0,9,G protein-coupled receptor signaling pathway involved in heart process,BP,1
GO:0089709,1,0.955462733,0,4,L-histidine transmembrane transport,BP,1
GO:0089718,1,0.864892006,0,13,amino acid import across plasma membrane,BP,1
GO:0090009,1,0.948553155,0,5,primitive streak formation,BP,1
GO:0090022,1,0.783999884,0,22,regulation of neutrophil chemotaxis,BP,1
GO:0090023,1,0.810902525,0,19,positive regulation of neutrophil chemotaxis,BP,1
GO:0090024,1,0.988662931,0,1,negative regulation of neutrophil chemotaxis,BP,1
GO:0090026,1,0.894759127,0,10,positive regulation of monocyte chemotaxis,BP,1
GO:0090030,1,0.857098191,0,14,regulation of steroid hormone biosynthetic process,BP,1
GO:0090031,1,0.934066671,0,6,positive regulation of steroid hormone biosynthetic process,BP,1
GO:0090032,1,0.945884259,0,5,negative regulation of steroid hormone biosynthetic process,BP,1
GO:0090034,1,0.977453293,0,2,regulation of chaperone-mediated protein complex assembly,BP,1
GO:0090035,1,0.977453293,0,2,positive regulation of chaperone-mediated protein complex assembly,BP,1
GO:0090038,1,0.96645209,0,3,negative regulation of protein kinase C signaling,BP,1
GO:0090042,1,0.883575796,0,12,tubulin deacetylation,BP,1
GO:0090043,1,0.89371699,0,11,regulation of tubulin deacetylation,BP,1
GO:0090044,1,0.977453365,0,2,positive regulation of tubulin deacetylation,BP,1
GO:0090051,1,0.841609751,0,16,negative regulation of cell migration involved in sprouting angiogenesis,BP,1
GO:0090065,1,0.977864509,0,2,regulation of production of siRNA involved in RNA interference,BP,1
GO:0090069,1,0.853964269,0,14,regulation of ribosome biogenesis,BP,1
GO:0090070,1,0.902895207,0,9,positive regulation of ribosome biogenesis,BP,1
GO:0090071,1,0.966370309,0,3,negative regulation of ribosome biogenesis,BP,1
GO:0090073,1,0.902439512,0,9,positive regulation of protein homodimerization activity,BP,1
GO:0090074,1,0.967286468,0,3,negative regulation of protein homodimerization activity,BP,1
GO:0090075,1,0.799070921,0,21,relaxation of muscle,BP,1
GO:0090077,1,0.823197968,0,18,foam cell differentiation,BP,1
GO:0090080,1,0.966641388,0,3,positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,BP,1
GO:0090085,1,0.863815059,0,13,regulation of protein deubiquitination,BP,1
GO:0090086,1,0.955410706,0,4,negative regulation of protein deubiquitination,BP,1
GO:0090091,1,0.958784255,0,4,positive regulation of extracellular matrix disassembly,BP,1
GO:0090094,1,0.988663984,0,1,metanephric cap mesenchymal cell proliferation involved in metanephros development,BP,1
GO:0090095,1,0.988663984,0,1,regulation of metanephric cap mesenchymal cell proliferation,BP,1
GO:0090096,1,0.988663984,0,1,positive regulation of metanephric cap mesenchymal cell proliferation,BP,1
GO:0090103,1,0.902783849,0,9,cochlea morphogenesis,BP,1
GO:0090104,1,0.988831442,0,1,pancreatic epsilon cell differentiation,BP,1
GO:0090107,1,0.977453313,0,2,regulation of high-density lipoprotein particle assembly,BP,1
GO:0090108,1,0.98866293,0,1,positive regulation of high-density lipoprotein particle assembly,BP,1
GO:0090110,1,0.878463452,0,12,cargo loading into COPII-coated vesicle,BP,1
GO:0090113,1,0.977453258,0,2,regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis,BP,1
GO:0090114,1,0.777046476,0,23,COPII-coated vesicle budding,BP,1
GO:0090116,1,0.971443366,0,3,C-5 methylation of cytosine,BP,1
GO:0090118,1,0.947663016,0,5,receptor-mediated endocytosis involved in cholesterol transport,BP,1
GO:0090128,1,0.903210251,0,10,regulation of synapse maturation,BP,1
GO:0090129,1,0.944492973,0,6,positive regulation of synapse maturation,BP,1
GO:0090131,1,0.966369815,0,3,mesenchyme migration,BP,1
GO:0090135,1,0.977453158,0,2,actin filament branching,BP,1
GO:0090136,1,0.897278198,0,10,epithelial cell-cell adhesion,BP,1
GO:0090138,1,0.98866293,0,1,regulation of actin cytoskeleton organization by cell-cell adhesion,BP,1
GO:0090140,1,0.774010763,0,23,regulation of mitochondrial fission,BP,1
GO:0090141,1,0.844463788,0,15,positive regulation of mitochondrial fission,BP,1
GO:0090148,1,0.904932033,0,9,membrane fission,BP,1
GO:0090149,1,0.977576024,0,2,mitochondrial membrane fission,BP,1
GO:0090150,1,0.13683905,0,178,establishment of protein localization to membrane,BP,1
GO:0090151,1,0.834619333,0,16,establishment of protein localization to mitochondrial membrane,BP,1
GO:0090152,1,0.988665551,0,1,establishment of protein localization to mitochondrial membrane involved in mitochondrial fission,BP,1
GO:0090153,1,0.904722941,0,9,regulation of sphingolipid biosynthetic process,BP,1
GO:0090154,1,0.946963735,0,5,positive regulation of sphingolipid biosynthetic process,BP,1
GO:0090155,1,0.96637127,0,3,negative regulation of sphingolipid biosynthetic process,BP,1
GO:0090156,1,0.957191805,0,4,cellular sphingolipid homeostasis,BP,1
GO:0090158,1,0.935601076,0,6,endoplasmic reticulum membrane organization,BP,1
GO:0090160,1,0.929011766,0,7,Golgi to lysosome transport,BP,1
GO:0090161,1,0.887406152,0,11,Golgi ribbon formation,BP,1
GO:0090164,1,0.977466007,0,2,asymmetric Golgi ribbon formation,BP,1
GO:0090166,1,0.946012834,0,5,Golgi disassembly,BP,1
GO:0090168,1,0.956281755,0,4,Golgi reassembly,BP,1
GO:0090170,1,0.955411035,0,4,regulation of Golgi inheritance,BP,1
GO:0090171,1,0.948651523,0,5,chondrocyte morphogenesis,BP,1
GO:0090174,1,0.449880267,0,72,organelle membrane fusion,BP,1
GO:0090176,1,0.989486303,0,1,microtubule cytoskeleton organization involved in establishment of planar polarity,BP,1
GO:0090177,1,0.929110913,0,7,establishment of planar polarity involved in neural tube closure,BP,1
GO:0090178,1,0.929110913,0,7,regulation of establishment of planar polarity involved in neural tube closure,BP,1
GO:0090179,1,0.937646324,0,6,planar cell polarity pathway involved in neural tube closure,BP,1
GO:0090181,1,0.73530152,0,28,regulation of cholesterol metabolic process,BP,1
GO:0090182,1,0.966392731,0,3,regulation of secretion of lysosomal enzymes,BP,1
GO:0090185,1,0.934865111,0,6,negative regulation of kidney development,BP,1
GO:0090186,1,0.951337963,0,5,regulation of pancreatic juice secretion,BP,1
GO:0090187,1,0.977452807,0,2,positive regulation of pancreatic juice secretion,BP,1
GO:0090188,1,0.973287571,0,3,negative regulation of pancreatic juice secretion,BP,1
GO:0090192,1,0.923268474,0,7,regulation of glomerulus development,BP,1
GO:0090193,1,0.933861489,0,6,positive regulation of glomerulus development,BP,1
GO:0090194,1,0.988662931,0,1,negative regulation of glomerulus development,BP,1
GO:0090195,1,0.89078986,0,11,chemokine secretion,BP,1
GO:0090196,1,0.901012946,0,10,regulation of chemokine secretion,BP,1
GO:0090197,1,0.901012946,0,10,positive regulation of chemokine secretion,BP,1
GO:0090199,1,0.641845286,0,39,regulation of release of cytochrome c from mitochondria,BP,1
GO:0090200,1,0.778120939,0,22,positive regulation of release of cytochrome c from mitochondria,BP,1
GO:0090201,1,0.81581486,0,18,negative regulation of release of cytochrome c from mitochondria,BP,1
GO:0090202,1,0.977453342,0,2,gene looping,BP,1
GO:0090204,1,0.96636978,0,3,protein localization to nuclear pore,BP,1
GO:0090205,1,0.913878653,0,8,positive regulation of cholesterol metabolic process,BP,1
GO:0090206,1,0.95587773,0,4,negative regulation of cholesterol metabolic process,BP,1
GO:0090207,1,0.648361699,0,39,regulation of triglyceride metabolic process,BP,1
GO:0090208,1,0.752322476,0,25,positive regulation of triglyceride metabolic process,BP,1
GO:0090209,1,0.904871215,0,9,negative regulation of triglyceride metabolic process,BP,1
GO:0090210,1,0.967353949,0,3,regulation of establishment of blood-brain barrier,BP,1
GO:0090212,1,0.977539907,0,2,negative regulation of establishment of blood-brain barrier,BP,1
GO:0090215,1,0.989258499,0,1,regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity,BP,1
GO:0090216,1,0.989258499,0,1,positive regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity,BP,1
GO:0090218,1,0.767014919,0,25,positive regulation of lipid kinase activity,BP,1
GO:0090219,1,0.959043266,0,4,negative regulation of lipid kinase activity,BP,1
GO:0090220,1,0.939926256,0,6,chromosome localization to nuclear envelope involved in homologous chromosome segregation,BP,1
GO:0090222,1,0.977453375,0,2,centrosome-templated microtubule nucleation,BP,1
GO:0090226,1,0.988662667,0,1,regulation of microtubule nucleation by Ran protein signal transduction,BP,1
GO:0090230,1,0.956711087,0,4,regulation of centromere complex assembly,BP,1
GO:0090232,1,0.950447825,0,5,positive regulation of spindle checkpoint,BP,1
GO:0090234,1,0.967684675,0,3,regulation of kinetochore assembly,BP,1
GO:0090235,1,0.941864914,0,6,regulation of metaphase plate congression,BP,1
GO:0090239,1,0.905198412,0,9,regulation of histone H4 acetylation,BP,1
GO:0090240,1,0.969193315,0,3,positive regulation of histone H4 acetylation,BP,1
GO:0090241,1,0.944583755,0,5,negative regulation of histone H4 acetylation,BP,1
GO:0090244,1,0.979761592,0,2,Wnt signaling pathway involved in somitogenesis,BP,1
GO:0090245,1,0.960031031,0,4,axis elongation involved in somitogenesis,BP,1
GO:0090246,1,0.988662931,0,1,convergent extension involved in somitogenesis,BP,1
GO:0090247,1,0.991102132,0,1,cell motility involved in somitogenic axis elongation,BP,1
GO:0090249,1,0.991102132,0,1,regulation of cell motility involved in somitogenic axis elongation,BP,1
GO:0090257,1,0.194429362,0,150,regulation of muscle system process,BP,1
GO:0090258,1,0.958595195,0,4,negative regulation of mitochondrial fission,BP,1
GO:0090261,1,0.944585587,0,5,positive regulation of inclusion body assembly,BP,1
GO:0090267,1,0.950447825,0,5,positive regulation of mitotic cell cycle spindle assembly checkpoint,BP,1
GO:0090269,1,0.946383598,0,5,fibroblast growth factor production,BP,1
GO:0090270,1,0.946383598,0,5,regulation of fibroblast growth factor production,BP,1
GO:0090271,1,0.967976454,0,3,positive regulation of fibroblast growth factor production,BP,1
GO:0090272,1,0.977698531,0,2,negative regulation of fibroblast growth factor production,BP,1
GO:0090273,1,0.980022471,0,2,regulation of somatostatin secretion,BP,1
GO:0090274,1,0.988662504,0,1,positive regulation of somatostatin secretion,BP,1
GO:0090275,1,0.980022471,0,2,negative regulation of somatostatin secretion,BP,1
GO:0090278,1,0.694079228,0,34,negative regulation of peptide hormone secretion,BP,1
GO:0090280,1,0.926613449,0,7,positive regulation of calcium ion import,BP,1
GO:0090283,1,0.968705572,0,3,regulation of protein glycosylation in Golgi,BP,1
GO:0090284,1,0.988662931,0,1,positive regulation of protein glycosylation in Golgi,BP,1
GO:0090285,1,0.979815612,0,2,negative regulation of protein glycosylation in Golgi,BP,1
GO:0090286,1,0.967494627,0,3,cytoskeletal anchoring at nuclear membrane,BP,1
GO:0090289,1,0.977453349,0,2,regulation of osteoclast proliferation,BP,1
GO:0090290,1,0.977453349,0,2,positive regulation of osteoclast proliferation,BP,1
GO:0090292,1,0.977453375,0,2,nuclear matrix anchoring at nuclear membrane,BP,1
GO:0090293,1,0.988662931,0,1,nitrogen catabolite regulation of transcription,BP,1
GO:0090295,1,0.988662931,0,1,nitrogen catabolite repression of transcription,BP,1
GO:0090296,1,0.967254579,0,3,regulation of mitochondrial DNA replication,BP,1
GO:0090297,1,0.988662824,0,1,positive regulation of mitochondrial DNA replication,BP,1
GO:0090298,1,0.978348217,0,2,negative regulation of mitochondrial DNA replication,BP,1
GO:0090299,1,0.98866288,0,1,regulation of neural crest formation,BP,1
GO:0090301,1,0.98866288,0,1,negative regulation of neural crest formation,BP,1
GO:0090306,1,0.941437804,0,6,spindle assembly involved in meiosis,BP,1
GO:0090308,1,0.897316384,0,10,regulation of methylation-dependent chromatin silencing,BP,1
GO:0090309,1,0.907614079,0,9,positive regulation of methylation-dependent chromatin silencing,BP,1
GO:0090310,1,0.988662849,0,1,negative regulation of methylation-dependent chromatin silencing,BP,1
GO:0090313,1,0.732432071,0,28,regulation of protein targeting to membrane,BP,1
GO:0090314,1,0.773495086,0,23,positive regulation of protein targeting to membrane,BP,1
GO:0090315,1,0.947018711,0,5,negative regulation of protein targeting to membrane,BP,1
GO:0090316,1,0.310199041,0,106,positive regulation of intracellular protein transport,BP,1
GO:0090317,1,0.700254133,0,32,negative regulation of intracellular protein transport,BP,1
GO:0090322,1,0.731614777,0,28,regulation of superoxide metabolic process,BP,1
GO:0090324,1,0.934965313,0,6,negative regulation of oxidative phosphorylation,BP,1
GO:0090325,1,0.966674472,0,3,regulation of locomotion involved in locomotory behavior,BP,1
GO:0090326,1,0.988933867,0,1,positive regulation of locomotion involved in locomotory behavior,BP,1
GO:0090327,1,0.977493504,0,2,negative regulation of locomotion involved in locomotory behavior,BP,1
GO:0090330,1,0.846576321,0,15,regulation of platelet aggregation,BP,1
GO:0090331,1,0.893305208,0,10,negative regulation of platelet aggregation,BP,1
GO:0090335,1,0.90839933,0,9,regulation of brown fat cell differentiation,BP,1
GO:0090336,1,0.934738735,0,6,positive regulation of brown fat cell differentiation,BP,1
GO:0090340,1,0.98866293,0,1,positive regulation of secretion of lysosomal enzymes,BP,1
GO:0090341,1,0.977476458,0,2,negative regulation of secretion of lysosomal enzymes,BP,1
GO:0090343,1,0.923445979,0,7,positive regulation of cell aging,BP,1
GO:0090345,1,0.9774615,0,2,cellular organohalogen metabolic process,BP,1
GO:0090346,1,0.9774615,0,2,cellular organofluorine metabolic process,BP,1
GO:0090347,1,0.988662931,0,1,regulation of cellular organohalogen metabolic process,BP,1
GO:0090348,1,0.988662931,0,1,regulation of cellular organofluorine metabolic process,BP,1
GO:0090349,1,0.988662931,0,1,negative regulation of cellular organohalogen metabolic process,BP,1
GO:0090350,1,0.988662931,0,1,negative regulation of cellular organofluorine metabolic process,BP,1
GO:0090360,1,0.988662931,0,1,platelet-derived growth factor production,BP,1
GO:0090361,1,0.988662931,0,1,regulation of platelet-derived growth factor production,BP,1
GO:0090365,1,0.95541093,0,4,regulation of mRNA modification,BP,1
GO:0090366,1,0.988662849,0,1,positive regulation of mRNA modification,BP,1
GO:0090367,1,0.966369791,0,3,negative regulation of mRNA modification,BP,1
GO:0090370,1,0.970440612,0,3,negative regulation of cholesterol efflux,BP,1
GO:0090381,1,0.994495178,0,1,regulation of heart induction,BP,1
GO:0090382,1,0.818478916,0,18,phagosome maturation,BP,1
GO:0090383,1,0.93387556,0,6,phagosome acidification,BP,1
GO:0090385,1,0.933861952,0,6,phagosome-lysosome fusion,BP,1
GO:0090386,1,0.977453079,0,2,phagosome maturation involved in apoptotic cell clearance,BP,1
GO:0090387,1,0.977453079,0,2,phagolysosome assembly involved in apoptotic cell clearance,BP,1
GO:0090389,1,0.988662931,0,1,phagosome-lysosome fusion involved in apoptotic cell clearance,BP,1
GO:0090394,1,0.945449415,0,5,negative regulation of excitatory postsynaptic potential,BP,1
GO:0090400,1,0.947893964,0,5,stress-induced premature senescence,BP,1
GO:0090402,1,0.988662374,0,1,oncogene-induced cell senescence,BP,1
GO:0090403,1,0.969316104,0,3,oxidative stress-induced premature senescence,BP,1
GO:0090410,1,0.988662931,0,1,malonate catabolic process,BP,1
GO:0090420,1,0.977453285,0,2,naphthalene-containing compound metabolic process,BP,1
GO:0090425,1,0.989874949,0,1,acinar cell differentiation,BP,1
GO:0090427,1,0.991140072,0,1,activation of meiosis,BP,1
GO:0090429,1,0.988662749,0,1,detection of endogenous biotic stimulus,BP,1
GO:0090435,1,0.90381264,0,9,protein localization to nuclear envelope,BP,1
GO:0090461,1,0.988662896,0,1,glutamate homeostasis,BP,1
GO:0090472,1,0.990048323,0,1,dibasic protein processing,BP,1
GO:0090480,1,0.988822398,0,1,purine nucleotide-sugar transmembrane transport,BP,1
GO:0090481,1,0.872665736,0,12,pyrimidine nucleotide-sugar transmembrane transport,BP,1
GO:0090493,1,0.946730903,0,5,catecholamine uptake,BP,1
GO:0090494,1,0.957591002,0,4,dopamine uptake,BP,1
GO:0090500,1,0.977453332,0,2,endocardial cushion to mesenchymal transition,BP,1
GO:0090501,1,0.283098269,0,112,RNA phosphodiester bond hydrolysis,BP,1
GO:0090502,1,0.525752292,0,57,"RNA phosphodiester bond hydrolysis, endonucleolytic",BP,1
GO:0090503,1,0.689097948,0,33,"RNA phosphodiester bond hydrolysis, exonucleolytic",BP,1
GO:0090504,1,0.774698702,0,25,epiboly,BP,1
GO:0090505,1,0.783599681,0,24,epiboly involved in wound healing,BP,1
GO:0090520,1,0.915917518,0,8,sphingolipid mediated signaling pathway,BP,1
GO:0090521,1,0.968727972,0,3,glomerular visceral epithelial cell migration,BP,1
GO:0090522,1,0.989200423,0,1,vesicle tethering involved in exocytosis,BP,1
GO:0090527,1,0.925043175,0,7,actin filament reorganization,BP,1
GO:0090529,1,0.988662892,0,1,cell septum assembly,BP,1
GO:0090557,1,0.893208514,0,11,establishment of endothelial intestinal barrier,BP,1
GO:0090579,1,0.977453342,0,2,dsDNA loop formation,BP,1
GO:0090594,1,0.894092415,0,10,inflammatory response to wounding,BP,1
GO:0090611,1,0.955485879,0,4,ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway,BP,1
GO:0090615,1,0.977933325,0,2,mitochondrial mRNA processing,BP,1
GO:0090616,1,0.989148338,0,1,mitochondrial mRNA 3'-end processing,BP,1
GO:0090618,1,0.99059367,0,1,DNA clamp unloading,BP,1
GO:0090625,1,0.988662931,0,1,mRNA cleavage involved in gene silencing by siRNA,BP,1
GO:0090630,1,0.508589464,0,62,activation of GTPase activity,BP,1
GO:0090634,1,0.988662497,0,1,microglial cell mediated cytotoxicity,BP,1
GO:0090646,1,0.902439214,0,9,mitochondrial tRNA processing,BP,1
GO:0090647,1,0.955414031,0,4,modulation of age-related behavioral decline,BP,1
GO:0090648,1,0.988662931,0,1,response to environmental enrichment,BP,1
GO:0090649,1,0.904105244,0,9,response to oxygen-glucose deprivation,BP,1
GO:0090650,1,0.904105244,0,9,cellular response to oxygen-glucose deprivation,BP,1
GO:0090656,1,0.923308215,0,7,t-circle formation,BP,1
GO:0090657,1,0.914836888,0,8,telomeric loop disassembly,BP,1
GO:0090659,1,0.791127591,0,22,walking behavior,BP,1
GO:0090666,1,0.944575632,0,5,scaRNA localization to Cajal body,BP,1
GO:0090667,1,0.98993788,0,1,cell chemotaxis to vascular endothelial growth factor,BP,1
GO:0090668,1,0.98993788,0,1,endothelial cell chemotaxis to vascular endothelial growth factor,BP,1
GO:0090669,1,0.958262084,0,4,telomerase RNA stabilization,BP,1
GO:0090670,1,0.923269035,0,7,RNA localization to Cajal body,BP,1
GO:0090671,1,0.923269035,0,7,telomerase RNA localization to Cajal body,BP,1
GO:0090672,1,0.923269035,0,7,telomerase RNA localization,BP,1
GO:0090673,1,0.993746019,0,1,endothelial cell-matrix adhesion,BP,1
GO:0090677,1,0.980295581,0,2,reversible differentiation,BP,1
GO:0090679,1,0.980295581,0,2,cell differentiation involved in phenotypic switching,BP,1
GO:0090685,1,0.923269035,0,7,RNA localization to nucleus,BP,1
GO:0090713,1,0.967297035,0,3,immunological memory process,BP,1
GO:0090715,1,0.978391123,0,2,immunological memory formation process,BP,1
GO:0090716,1,0.988662856,0,1,adaptive immune memory response,BP,1
GO:0090731,1,0.988662786,0,1,cellular response to very-low-density lipoprotein particle stimulus,BP,1
GO:0090735,1,0.977453373,0,2,DNA repair complex assembly,BP,1
GO:0090737,1,0.923308215,0,7,telomere maintenance via telomere trimming,BP,1
GO:0093001,1,0.988723108,0,1,glycolysis from storage polysaccharide through glucose-1-phosphate,BP,1
GO:0095500,1,0.908793559,0,9,acetylcholine receptor signaling pathway,BP,1
GO:0097006,1,0.58430258,0,49,regulation of plasma lipoprotein particle levels,BP,1
GO:0097010,1,0.967047347,0,3,eukaryotic translation initiation factor 4F complex assembly,BP,1
GO:0097017,1,0.966399824,0,3,renal protein absorption,BP,1
GO:0097018,1,0.977470611,0,2,renal albumin absorption,BP,1
GO:0097021,1,0.993212474,0,1,lymphocyte migration into lymphoid organs,BP,1
GO:0097022,1,0.993212474,0,1,lymphocyte migration into lymph node,BP,1
GO:0097026,1,0.981183785,0,2,dendritic cell dendrite assembly,BP,1
GO:0097028,1,0.775696702,0,23,dendritic cell differentiation,BP,1
GO:0097029,1,0.988662607,0,1,mature conventional dendritic cell differentiation,BP,1
GO:0097035,1,0.709773456,0,32,regulation of membrane lipid distribution,BP,1
GO:0097036,1,0.988662807,0,1,regulation of plasma membrane sterol distribution,BP,1
GO:0097037,1,0.988924706,0,1,heme export,BP,1
GO:0097039,1,0.955844898,0,4,protein linear polyubiquitination,BP,1
GO:0097045,1,0.991229526,0,1,phosphatidylserine exposure on blood platelet,BP,1
GO:0097048,1,0.907002591,0,9,dendritic cell apoptotic process,BP,1
GO:0097049,1,0.926710475,0,7,motor neuron apoptotic process,BP,1
GO:0097050,1,0.883628981,0,11,type B pancreatic cell apoptotic process,BP,1
GO:0097051,1,0.967655574,0,3,establishment of protein localization to endoplasmic reticulum membrane,BP,1
GO:0097052,1,0.933864067,0,6,L-kynurenine metabolic process,BP,1
GO:0097053,1,0.977453367,0,2,L-kynurenine catabolic process,BP,1
GO:0097056,1,0.977453375,0,2,selenocysteinyl-tRNA(Sec) biosynthetic process,BP,1
GO:0097062,1,0.840812611,0,16,dendritic spine maintenance,BP,1
GO:0097064,1,0.92475931,0,7,ncRNA export from nucleus,BP,1
GO:0097065,1,0.936505951,0,6,anterior head development,BP,1
GO:0097067,1,0.864043834,0,14,cellular response to thyroid hormone stimulus,BP,1
GO:0097068,1,0.902600158,0,9,response to thyroxine,BP,1
GO:0097069,1,0.977628113,0,2,cellular response to thyroxine stimulus,BP,1
GO:0097070,1,0.988662931,0,1,ductus arteriosus closure,BP,1
GO:0097086,1,0.988965311,0,1,amniotic stem cell differentiation,BP,1
GO:0097089,1,0.977509335,0,2,methyl-branched fatty acid metabolic process,BP,1
GO:0097090,1,0.960179935,0,4,presynaptic membrane organization,BP,1
GO:0097091,1,0.935274595,0,6,synaptic vesicle clustering,BP,1
GO:0097094,1,0.864595863,0,13,craniofacial suture morphogenesis,BP,1
GO:0097104,1,0.976287337,0,3,postsynaptic membrane assembly,BP,1
GO:0097105,1,0.971193122,0,3,presynaptic membrane assembly,BP,1
GO:0097106,1,0.802405368,0,22,postsynaptic density organization,BP,1
GO:0097107,1,0.930167952,0,8,postsynaptic density assembly,BP,1
GO:0097111,1,0.977453365,0,2,endoplasmic reticulum-Golgi intermediate compartment organization,BP,1
GO:0097112,1,0.988676702,0,1,gamma-aminobutyric acid receptor clustering,BP,1
GO:0097113,1,0.965771023,0,4,AMPA glutamate receptor clustering,BP,1
GO:0097114,1,0.978138975,0,3,NMDA glutamate receptor clustering,BP,1
GO:0097116,1,0.992351914,0,1,gephyrin clustering involved in postsynaptic density assembly,BP,1
GO:0097117,1,0.993236819,0,1,guanylate kinase-associated protein clustering,BP,1
GO:0097118,1,0.982580065,0,2,neuroligin clustering involved in postsynaptic membrane assembly,BP,1
GO:0097119,1,0.946897105,0,6,postsynaptic density protein 95 clustering,BP,1
GO:0097120,1,0.690788292,0,34,receptor localization to synapse,BP,1
GO:0097151,1,0.988662924,0,1,positive regulation of inhibitory postsynaptic potential,BP,1
GO:0097152,1,0.94525757,0,5,mesenchymal cell apoptotic process,BP,1
GO:0097154,1,0.944996182,0,5,GABAergic neuron differentiation,BP,1
GO:0097155,1,0.9700872,0,3,fasciculation of sensory neuron axon,BP,1
GO:0097156,1,0.981212958,0,2,fasciculation of motor neuron axon,BP,1
GO:0097164,1,0.269954787,0,116,ammonium ion metabolic process,BP,1
GO:0097168,1,0.988662931,0,1,mesenchymal stem cell proliferation,BP,1
GO:0097176,1,0.977453365,0,2,epoxide metabolic process,BP,1
GO:0097178,1,0.702887166,0,32,ruffle assembly,BP,1
GO:0097184,1,0.989996103,0,1,response to azide,BP,1
GO:0097186,1,0.865850529,0,13,amelogenesis,BP,1
GO:0097187,1,0.94704531,0,5,dentinogenesis,BP,1
GO:0097188,1,0.988677323,0,1,dentin mineralization,BP,1
GO:0097195,1,0.988662922,0,1,pilomotor reflex,BP,1
GO:0097198,1,0.964533051,0,4,histone H3-K36 trimethylation,BP,1
GO:0097202,1,0.865264424,0,13,activation of cysteine-type endopeptidase activity,BP,1
GO:0097205,1,0.835148564,0,17,renal filtration,BP,1
GO:0097210,1,0.977452921,0,2,response to gonadotropin-releasing hormone,BP,1
GO:0097211,1,0.977452921,0,2,cellular response to gonadotropin-releasing hormone,BP,1
GO:0097212,1,0.966369677,0,3,lysosomal membrane organization,BP,1
GO:0097213,1,0.977453368,0,2,regulation of lysosomal membrane permeability,BP,1
GO:0097214,1,0.988662931,0,1,positive regulation of lysosomal membrane permeability,BP,1
GO:0097222,1,0.989148338,0,1,mitochondrial mRNA polyadenylation,BP,1
GO:0097238,1,0.977453157,0,2,cellular response to methylglyoxal,BP,1
GO:0097240,1,0.988662931,0,1,chromosome attachment to the nuclear envelope,BP,1
GO:0097241,1,0.988680592,0,1,hematopoietic stem cell migration to bone marrow,BP,1
GO:0097242,1,0.794510395,0,23,amyloid-beta clearance,BP,1
GO:0097250,1,0.977452908,0,2,mitochondrial respiratory chain supercomplex assembly,BP,1
GO:0097252,1,0.949240926,0,5,oligodendrocyte apoptotic process,BP,1
GO:0097264,1,0.945310217,0,5,self proteolysis,BP,1
GO:0097272,1,0.988662903,0,1,ammonia homeostasis,BP,1
GO:0097274,1,0.988924009,0,1,urea homeostasis,BP,1
GO:0097278,1,0.905402367,0,9,complement-dependent cytotoxicity,BP,1
GO:0097281,1,0.988662749,0,1,immune complex formation,BP,1
GO:0097283,1,0.955464683,0,4,keratinocyte apoptotic process,BP,1
GO:0097284,1,0.839350473,0,16,hepatocyte apoptotic process,BP,1
GO:0097286,1,0.934068893,0,6,iron ion import,BP,1
GO:0097291,1,0.988662899,0,1,renal phosphate ion absorption,BP,1
GO:0097296,1,0.968917999,0,3,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,1
GO:0097298,1,0.988921921,0,1,regulation of nucleus size,BP,1
GO:0097300,1,0.65361106,0,38,programmed necrotic cell death,BP,1
GO:0097309,1,0.977453375,0,2,cap1 mRNA methylation,BP,1
GO:0097310,1,0.988662931,0,1,cap2 mRNA methylation,BP,1
GO:0097320,1,0.82553972,0,17,plasma membrane tubulation,BP,1
GO:0097324,1,0.978975057,0,2,melanocyte migration,BP,1
GO:0097325,1,0.988757271,0,1,melanocyte proliferation,BP,1
GO:0097326,1,0.989532094,0,1,melanocyte adhesion,BP,1
GO:0097329,1,0.862383774,0,14,response to antimetabolite,BP,1
GO:0097332,1,0.955787153,0,4,response to antipsychotic drug,BP,1
GO:0097338,1,0.966750567,0,3,response to clozapine,BP,1
GO:0097340,1,0.946290873,0,5,inhibition of cysteine-type endopeptidase activity,BP,1
GO:0097341,1,0.946290873,0,5,zymogen inhibition,BP,1
GO:0097343,1,0.948169663,0,5,ripoptosome assembly,BP,1
GO:0097350,1,0.95560716,0,4,neutrophil clearance,BP,1
GO:0097352,1,0.741360338,0,27,autophagosome maturation,BP,1
GO:0097354,1,0.917419807,0,8,prenylation,BP,1
GO:0097355,1,0.97858505,0,2,protein localization to heterochromatin,BP,1
GO:0097359,1,0.988662931,0,1,UDP-glucosylation,BP,1
GO:0097360,1,0.966369841,0,3,chorionic trophoblast cell proliferation,BP,1
GO:0097366,1,0.601303066,0,45,response to bronchodilator,BP,1
GO:0097368,1,0.933077394,0,7,establishment of Sertoli cell barrier,BP,1
GO:0097374,1,0.978712453,0,2,sensory neuron axon guidance,BP,1
GO:0097384,1,0.913017453,0,8,cellular lipid biosynthetic process,BP,1
GO:0097393,1,0.995326928,0,1,telomeric repeat-containing RNA transcription,BP,1
GO:0097394,1,0.995326928,0,1,telomeric repeat-containing RNA transcription by RNA polymerase II,BP,1
GO:0097396,1,0.98890353,0,1,response to interleukin-17,BP,1
GO:0097398,1,0.98890353,0,1,cellular response to interleukin-17,BP,1
GO:0097400,1,0.98890353,0,1,interleukin-17-mediated signaling pathway,BP,1
GO:0097401,1,0.978307001,0,2,synaptic vesicle lumen acidification,BP,1
GO:0097402,1,0.973496093,0,3,neuroblast migration,BP,1
GO:0097403,1,0.988699351,0,1,cellular response to raffinose,BP,1
GO:0097411,1,0.934602073,0,6,hypoxia-inducible factor-1alpha signaling pathway,BP,1
GO:0097428,1,0.862167541,0,13,protein maturation by iron-sulfur cluster transfer,BP,1
GO:0097466,1,0.955411125,0,4,ubiquitin-dependent glycoprotein ERAD pathway,BP,1
GO:0097468,1,0.853866872,0,14,programmed cell death in response to reactive oxygen species,BP,1
GO:0097473,1,0.988662931,0,1,retinal rod cell apoptotic process,BP,1
GO:0097474,1,0.988662899,0,1,retinal cone cell apoptotic process,BP,1
GO:0097476,1,0.984800309,0,2,spinal cord motor neuron migration,BP,1
GO:0097477,1,0.984800309,0,2,lateral motor column neuron migration,BP,1
GO:0097484,1,0.813322606,0,19,dendrite extension,BP,1
GO:0097490,1,0.968121257,0,3,sympathetic neuron projection extension,BP,1
GO:0097491,1,0.968121257,0,3,sympathetic neuron projection guidance,BP,1
GO:0097494,1,0.970456458,0,3,regulation of vesicle size,BP,1
GO:0097498,1,0.980218583,0,2,endothelial tube lumen extension,BP,1
GO:0097499,1,0.945122651,0,5,protein localization to non-motile cilium,BP,1
GO:0097500,1,0.989220842,0,1,receptor localization to non-motile cilium,BP,1
GO:0097501,1,0.935403548,0,6,stress response to metal ion,BP,1
GO:0097503,1,0.88293732,0,11,sialylation,BP,1
GO:0097510,1,0.988662928,0,1,"base-excision repair, AP site formation via deaminated base removal",BP,1
GO:0097527,1,0.957451192,0,4,necroptotic signaling pathway,BP,1
GO:0097549,1,0.95885499,0,4,chromatin organization involved in negative regulation of transcription,BP,1
GO:0097551,1,0.988662931,0,1,mitochondrial double-strand break repair,BP,1
GO:0097552,1,0.988662931,0,1,mitochondrial double-strand break repair via homologous recombination,BP,1
GO:0097553,1,0.438440014,0,77,calcium ion transmembrane import into cytosol,BP,1
GO:0097576,1,0.977483385,0,2,vacuole fusion,BP,1
GO:0097577,1,0.955410639,0,4,sequestering of iron ion,BP,1
GO:0097581,1,0.481985583,0,67,lamellipodium organization,BP,1
GO:0097623,1,0.980285658,0,2,potassium ion export across plasma membrane,BP,1
GO:0097638,1,0.977466248,0,2,L-arginine import across plasma membrane,BP,1
GO:0097639,1,0.977466248,0,2,L-lysine import across plasma membrane,BP,1
GO:0097640,1,0.988675951,0,1,L-ornithine import across plasma membrane,BP,1
GO:0097646,1,0.955410507,0,4,calcitonin family receptor signaling pathway,BP,1
GO:0097647,1,0.966369283,0,3,amylin receptor signaling pathway,BP,1
GO:0097676,1,0.978029253,0,3,histone H3-K36 dimethylation,BP,1
GO:0097680,1,0.956619143,0,4,double-strand break repair via classical nonhomologous end joining,BP,1
GO:0097681,1,0.989565978,0,1,double-strand break repair via alternative nonhomologous end joining,BP,1
GO:0097688,1,0.965771023,0,4,glutamate receptor clustering,BP,1
GO:0097692,1,0.988662931,0,1,histone H3-K4 monomethylation,BP,1
GO:0097694,1,0.972642397,0,3,establishment of RNA localization to telomere,BP,1
GO:0097698,1,0.988662831,0,1,telomere maintenance via base-excision repair,BP,1
GO:0097699,1,0.989994916,0,1,vascular endothelial cell response to fluid shear stress,BP,1
GO:0097707,1,0.988662718,0,1,ferroptosis,BP,1
GO:0097709,1,0.89639784,0,10,connective tissue replacement,BP,1
GO:0097712,1,0.988662931,0,1,"vesicle targeting, trans-Golgi to periciliary membrane compartment",BP,1
GO:0097720,1,0.701045804,0,34,calcineurin-mediated signaling,BP,1
GO:0097724,1,0.988662731,0,1,sperm flagellum movement,BP,1
GO:0097734,1,0.810601721,0,19,extracellular exosome biogenesis,BP,1
GO:0097742,1,0.988662931,0,1,de novo centriole assembly,BP,1
GO:0097744,1,0.988663029,0,1,urate salt excretion,BP,1
GO:0097745,1,0.96636969,0,3,mitochondrial tRNA 5'-end processing,BP,1
GO:0097749,1,0.966933445,0,3,membrane tubulation,BP,1
GO:0097750,1,0.977891872,0,2,endosome membrane tubulation,BP,1
GO:0097752,1,0.977992479,0,2,regulation of DNA stability,BP,1
GO:0097753,1,0.988662931,0,1,membrane bending,BP,1
GO:0097756,1,0.540437614,0,56,negative regulation of blood vessel diameter,BP,1
GO:0098501,1,0.956606655,0,4,polynucleotide dephosphorylation,BP,1
GO:0098502,1,0.98866292,0,1,DNA dephosphorylation,BP,1
GO:0098503,1,0.98866292,0,1,DNA 3' dephosphorylation,BP,1
GO:0098504,1,0.98866292,0,1,DNA 3' dephosphorylation involved in DNA repair,BP,1
GO:0098506,1,0.98866292,0,1,polynucleotide 3' dephosphorylation,BP,1
GO:0098507,1,0.967579052,0,3,polynucleotide 5' dephosphorylation,BP,1
GO:0098528,1,0.988703396,0,1,skeletal muscle fiber differentiation,BP,1
GO:0098529,1,0.988662928,0,1,"neuromuscular junction development, skeletal muscle fiber",BP,1
GO:0098530,1,0.988662931,0,1,positive regulation of strand invasion,BP,1
GO:0098532,1,0.937861146,0,6,histone H3-K27 trimethylation,BP,1
GO:0098534,1,0.772297608,0,24,centriole assembly,BP,1
GO:0098535,1,0.988662931,0,1,de novo centriole assembly involved in multi-ciliated epithelial cell differentiation,BP,1
GO:0098543,1,0.894773813,0,10,detection of other organism,BP,1
GO:0098581,1,0.857461906,0,14,detection of external biotic stimulus,BP,1
GO:0098582,1,0.988663191,0,1,innate vocalization behavior,BP,1
GO:0098583,1,0.98866287,0,1,learned vocalization behavior,BP,1
GO:0098586,1,0.650788578,0,40,cellular response to virus,BP,1
GO:0098596,1,0.981130579,0,3,imitative learning,BP,1
GO:0098597,1,0.964749051,0,5,observational learning,BP,1
GO:0098598,1,0.970005681,0,4,learned vocalization behavior or vocal learning,BP,1
GO:0098659,1,0.70104189,0,33,inorganic cation import across plasma membrane,BP,1
GO:0098679,1,0.966369904,0,3,regulation of carbohydrate catabolic process by regulation of transcription from RNA polymerase II promoter,BP,1
GO:0098696,1,0.887276247,0,11,regulation of neurotransmitter receptor localization to postsynaptic specialization membrane,BP,1
GO:0098698,1,0.919616484,0,9,postsynaptic specialization assembly,BP,1
GO:0098700,1,0.977694581,0,2,neurotransmitter loading into synaptic vesicle,BP,1
GO:0098703,1,0.935561764,0,6,calcium ion import across plasma membrane,BP,1
GO:0098704,1,0.988662985,0,1,carbohydrate import across plasma membrane,BP,1
GO:0098705,1,0.978888634,0,2,copper ion import across plasma membrane,BP,1
GO:0098706,1,0.977670096,0,2,ferric iron import across cell outer membrane,BP,1
GO:0098707,1,0.988662715,0,1,ferrous iron import across plasma membrane,BP,1
GO:0098711,1,0.977453113,0,2,iron ion import across plasma membrane,BP,1
GO:0098712,1,0.926115221,0,7,L-glutamate import across plasma membrane,BP,1
GO:0098713,1,0.988662931,0,1,leucine import across plasma membrane,BP,1
GO:0098719,1,0.958368951,0,4,sodium ion import across plasma membrane,BP,1
GO:0098722,1,0.914952549,0,8,asymmetric stem cell division,BP,1
GO:0098728,1,0.967350082,0,3,germline stem cell asymmetric division,BP,1
GO:0098734,1,0.892459775,0,10,macromolecule depalmitoylation,BP,1
GO:0098735,1,0.979465104,0,2,positive regulation of the force of heart contraction,BP,1
GO:0098736,1,0.989736892,0,1,negative regulation of the force of heart contraction,BP,1
GO:0098739,1,0.577624041,0,51,import across plasma membrane,BP,1
GO:0098742,1,0.389393655,0,89,cell-cell adhesion via plasma-membrane adhesion molecules,BP,1
GO:0098743,1,0.924714168,0,7,cell aggregation,BP,1
GO:0098749,1,0.967758893,0,3,cerebellar neuron development,BP,1
GO:0098751,1,0.733374129,0,29,bone cell development,BP,1
GO:0098758,1,0.988662903,0,1,response to interleukin-8,BP,1
GO:0098759,1,0.988662903,0,1,cellular response to interleukin-8,BP,1
GO:0098760,1,0.824938968,0,17,response to interleukin-7,BP,1
GO:0098761,1,0.824938968,0,17,cellular response to interleukin-7,BP,1
GO:0098779,1,0.914188362,0,8,positive regulation of mitophagy in response to mitochondrial depolarization,BP,1
GO:0098780,1,0.800501431,0,20,response to mitochondrial depolarisation,BP,1
GO:0098781,1,0.692380578,0,34,ncRNA transcription,BP,1
GO:0098787,1,0.88681211,0,11,mRNA cleavage involved in mRNA processing,BP,1
GO:0098789,1,0.896990146,0,10,pre-mRNA cleavage required for polyadenylation,BP,1
GO:0098792,1,0.886280704,0,11,xenophagy,BP,1
GO:0098795,1,0.978271875,0,2,mRNA cleavage involved in gene silencing,BP,1
GO:0098801,1,0.798512764,0,20,regulation of renal system process,BP,1
GO:0098810,1,0.90652765,0,9,neurotransmitter reuptake,BP,1
GO:0098814,1,0.988665977,0,1,spontaneous synaptic transmission,BP,1
GO:0098816,1,0.978086421,0,2,mini excitatory postsynaptic potential,BP,1
GO:0098822,1,0.988662931,0,1,peptidyl-cysteine modification to L-cysteine persulfide,BP,1
GO:0098828,1,0.977493585,0,2,modulation of inhibitory postsynaptic potential,BP,1
GO:0098838,1,0.964174565,0,4,folate transmembrane transport,BP,1
GO:0098840,1,0.883628261,0,11,protein transport along microtubule,BP,1
GO:0098856,1,0.874303454,0,12,intestinal lipid absorption,BP,1
GO:0098868,1,0.779702716,0,23,bone growth,BP,1
GO:0098870,1,0.961636248,0,4,action potential propagation,BP,1
GO:0098876,1,0.399439395,0,84,vesicle-mediated transport to the plasma membrane,BP,1
GO:0098877,1,0.865326874,0,13,neurotransmitter receptor transport to plasma membrane,BP,1
GO:0098880,1,0.901576435,0,10,maintenance of postsynaptic specialization structure,BP,1
GO:0098881,1,0.955410825,0,4,exocytic insertion of neurotransmitter receptor to plasma membrane,BP,1
GO:0098883,1,0.928873988,0,7,synapse pruning,BP,1
GO:0098884,1,0.786816618,0,22,postsynaptic neurotransmitter receptor internalization,BP,1
GO:0098885,1,0.877351167,0,13,modification of postsynaptic actin cytoskeleton,BP,1
GO:0098886,1,0.988700735,0,1,modification of dendritic spine,BP,1
GO:0098887,1,0.923671897,0,7,"neurotransmitter receptor transport, endosome to postsynaptic membrane",BP,1
GO:0098900,1,0.758507724,0,26,regulation of action potential,BP,1
GO:0098901,1,0.847451199,0,16,regulation of cardiac muscle cell action potential,BP,1
GO:0098902,1,0.96064688,0,4,regulation of membrane depolarization during action potential,BP,1
GO:0098903,1,0.971994896,0,3,regulation of membrane repolarization during action potential,BP,1
GO:0098904,1,0.988662915,0,1,regulation of AV node cell action potential,BP,1
GO:0098905,1,0.988662667,0,1,regulation of bundle of His cell action potential,BP,1
GO:0098908,1,0.956664207,0,4,regulation of neuronal action potential,BP,1
GO:0098909,1,0.95768452,0,4,regulation of cardiac muscle cell action potential involved in regulation of contraction,BP,1
GO:0098910,1,0.9899866,0,1,regulation of atrial cardiac muscle cell action potential,BP,1
GO:0098911,1,0.916162228,0,8,regulation of ventricular cardiac muscle cell action potential,BP,1
GO:0098914,1,0.988662925,0,1,membrane repolarization during atrial cardiac muscle cell action potential,BP,1
GO:0098915,1,0.977747155,0,2,membrane repolarization during ventricular cardiac muscle cell action potential,BP,1
GO:0098917,1,0.906493736,0,9,retrograde trans-synaptic signaling,BP,1
GO:0098920,1,0.957935003,0,4,retrograde trans-synaptic signaling by lipid,BP,1
GO:0098921,1,0.957935003,0,4,retrograde trans-synaptic signaling by endocannabinoid,BP,1
GO:0098923,1,0.97775013,0,2,retrograde trans-synaptic signaling by soluble gas,BP,1
GO:0098924,1,0.97775013,0,2,retrograde trans-synaptic signaling by nitric oxide,BP,1
GO:0098925,1,0.988662931,0,1,"retrograde trans-synaptic signaling by nitric oxide, modulating synaptic transmission",BP,1
GO:0098926,1,0.880590441,0,12,postsynaptic signal transduction,BP,1
GO:0098927,1,0.670187147,0,38,vesicle-mediated transport between endosomal compartments,BP,1
GO:0098928,1,0.988669532,0,1,presynaptic signal transduction,BP,1
GO:0098930,1,0.652242194,0,41,axonal transport,BP,1
GO:0098935,1,0.926928461,0,7,dendritic transport,BP,1
GO:0098937,1,0.980741183,0,2,anterograde dendritic transport,BP,1
GO:0098939,1,0.980727862,0,2,dendritic transport of mitochondrion,BP,1
GO:0098942,1,0.967858082,0,3,retrograde trans-synaptic signaling by trans-synaptic protein complex,BP,1
GO:0098943,1,0.990637843,0,1,"neurotransmitter receptor transport, postsynaptic endosome to lysosome",BP,1
GO:0098953,1,0.988676702,0,1,receptor diffusion trapping,BP,1
GO:0098957,1,0.980713895,0,2,anterograde axonal transport of mitochondrion,BP,1
GO:0098958,1,0.988662887,0,1,retrograde axonal transport of mitochondrion,BP,1
GO:0098961,1,0.955967146,0,4,dendritic transport of ribonucleoprotein complex,BP,1
GO:0098962,1,0.945395514,0,5,regulation of postsynaptic neurotransmitter receptor activity,BP,1
GO:0098963,1,0.955967146,0,4,dendritic transport of messenger ribonucleoprotein complex,BP,1
GO:0098967,1,0.955410825,0,4,exocytic insertion of neurotransmitter receptor to postsynaptic membrane,BP,1
GO:0098968,1,0.977453375,0,2,neurotransmitter receptor transport postsynaptic membrane to endosome,BP,1
GO:0098969,1,0.872446085,0,12,neurotransmitter receptor transport to postsynaptic membrane,BP,1
GO:0098970,1,0.988676702,0,1,postsynaptic neurotransmitter receptor diffusion trapping,BP,1
GO:0098972,1,0.991960544,0,1,anterograde dendritic transport of mitochondrion,BP,1
GO:0098974,1,0.87362667,0,13,postsynaptic actin cytoskeleton organization,BP,1
GO:0098976,1,0.991694836,0,1,excitatory chemical synaptic transmission,BP,1
GO:0098989,1,0.994438131,0,1,NMDA selective glutamate receptor signaling pathway,BP,1
GO:0099004,1,0.929587959,0,7,calmodulin dependent kinase signaling pathway,BP,1
GO:0099010,1,0.813456358,0,20,modification of postsynaptic structure,BP,1
GO:0099011,1,0.958666697,0,4,neuronal dense core vesicle exocytosis,BP,1
GO:0099022,1,0.925247515,0,7,vesicle tethering,BP,1
GO:0099024,1,0.594357678,0,48,plasma membrane invagination,BP,1
GO:0099041,1,0.9569377,0,4,vesicle tethering to Golgi,BP,1
GO:0099044,1,0.977453216,0,2,vesicle tethering to endoplasmic reticulum,BP,1
GO:0099054,1,0.814581251,0,19,presynapse assembly,BP,1
GO:0099068,1,0.904720355,0,11,postsynapse assembly,BP,1
GO:0099072,1,0.539371136,0,56,regulation of postsynaptic membrane neurotransmitter receptor levels,BP,1
GO:0099074,1,0.977721141,0,2,mitochondrion to lysosome transport,BP,1
GO:0099075,1,0.977721141,0,2,mitochondrion-derived vesicle mediated transport,BP,1
GO:0099084,1,0.793292485,0,23,postsynaptic specialization organization,BP,1
GO:0099087,1,0.988662931,0,1,anterograde axonal transport of messenger ribonucleoprotein complex,BP,1
GO:0099088,1,0.988662931,0,1,axonal transport of messenger ribonucleoprotein complex,BP,1
GO:0099093,1,0.977473855,0,2,calcium export from the mitochondrion,BP,1
GO:0099098,1,0.988779002,0,1,microtubule polymerization based movement,BP,1
GO:0099116,1,0.852735572,0,14,tRNA 5'-end processing,BP,1
GO:0099118,1,0.883628261,0,11,microtubule-based protein transport,BP,1
GO:0099140,1,0.9901699,0,1,presynaptic actin cytoskeleton organization,BP,1
GO:0099149,1,0.839560567,0,16,regulation of postsynaptic neurotransmitter receptor internalization,BP,1
GO:0099150,1,0.950815129,0,5,regulation of postsynaptic specialization assembly,BP,1
GO:0099151,1,0.961721629,0,4,regulation of postsynaptic density assembly,BP,1
GO:0099152,1,0.977611012,0,2,"regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane",BP,1
GO:0099158,1,0.988822398,0,1,regulation of recycling endosome localization within postsynapse,BP,1
GO:0099159,1,0.890167359,0,12,regulation of modification of postsynaptic structure,BP,1
GO:0099161,1,0.989237578,0,1,regulation of presynaptic dense core granule exocytosis,BP,1
GO:0099163,1,0.966663325,0,3,synaptic signaling by nitric oxide,BP,1
GO:0099170,1,0.843409944,0,16,postsynaptic modulation of chemical synaptic transmission,BP,1
GO:0099172,1,0.761992028,0,25,presynapse organization,BP,1
GO:0099174,1,0.867851646,0,13,regulation of presynapse organization,BP,1
GO:0099178,1,0.968791812,0,3,regulation of retrograde trans-synaptic signaling by endocanabinoid,BP,1
GO:0099179,1,0.968187916,0,3,regulation of synaptic membrane adhesion,BP,1
GO:0099180,1,0.97745336,0,2,zinc ion import into synaptic vesicle,BP,1
GO:0099183,1,0.968095967,0,3,"trans-synaptic signaling by BDNF, modulating synaptic transmission",BP,1
GO:0099187,1,0.9901699,0,1,presynaptic cytoskeleton organization,BP,1
GO:0099188,1,0.87362667,0,13,postsynaptic cytoskeleton organization,BP,1
GO:0099191,1,0.968095967,0,3,trans-synaptic signaling by BDNF,BP,1
GO:0099403,1,0.985625143,0,2,"maintenance of mitotic sister chromatid cohesion, telomeric",BP,1
GO:0099404,1,0.985625143,0,2,"mitotic sister chromatid cohesion, telomeric",BP,1
GO:0099500,1,0.903238519,0,9,vesicle fusion to plasma membrane,BP,1
GO:0099509,1,0.929543741,0,7,regulation of presynaptic cytosolic calcium ion concentration,BP,1
GO:0099514,1,0.840320466,0,16,synaptic vesicle cytoskeletal transport,BP,1
GO:0099515,1,0.935549424,0,6,actin filament-based transport,BP,1
GO:0099517,1,0.840320466,0,16,synaptic vesicle transport along microtubule,BP,1
GO:0099518,1,0.668834339,0,39,vesicle cytoskeletal trafficking,BP,1
GO:0099519,1,0.95184242,0,5,dense core granule cytoskeletal transport,BP,1
GO:0099525,1,0.958666697,0,4,presynaptic dense core vesicle exocytosis,BP,1
GO:0099526,1,0.988669532,0,1,presynapse to nucleus signaling pathway,BP,1
GO:0099527,1,0.880590441,0,12,postsynapse to nucleus signaling pathway,BP,1
GO:0099532,1,0.915342322,0,8,synaptic vesicle endosomal processing,BP,1
GO:0099533,1,0.982504041,0,2,positive regulation of presynaptic cytosolic calcium concentration,BP,1
GO:0099538,1,0.990364555,0,1,synaptic signaling via neuropeptide,BP,1
GO:0099540,1,0.990364555,0,1,trans-synaptic signaling by neuropeptide,BP,1
GO:0099541,1,0.936648224,0,6,trans-synaptic signaling by lipid,BP,1
GO:0099542,1,0.936648224,0,6,trans-synaptic signaling by endocannabinoid,BP,1
GO:0099543,1,0.966663325,0,3,trans-synaptic signaling by soluble gas,BP,1
GO:0099545,1,0.935305798,0,6,trans-synaptic signaling by trans-synaptic complex,BP,1
GO:0099546,1,0.988676499,0,1,"protein catabolic process, modulating synaptic transmission",BP,1
GO:0099547,1,0.941813241,0,6,"regulation of translation at synapse, modulating synaptic transmission",BP,1
GO:0099548,1,0.966663325,0,3,trans-synaptic signaling by nitric oxide,BP,1
GO:0099550,1,0.914740253,0,8,"trans-synaptic signaling, modulating synaptic transmission",BP,1
GO:0099551,1,0.990364555,0,1,"trans-synaptic signaling by neuropeptide, modulating synaptic transmission",BP,1
GO:0099552,1,0.977786028,0,2,"trans-synaptic signaling by lipid, modulating synaptic transmission",BP,1
GO:0099553,1,0.977786028,0,2,"trans-synaptic signaling by endocannabinoid, modulating synaptic transmission",BP,1
GO:0099554,1,0.977453375,0,2,"trans-synaptic signaling by soluble gas, modulating synaptic transmission",BP,1
GO:0099555,1,0.977453375,0,2,"trans-synaptic signaling by nitric oxide, modulating synaptic transmission",BP,1
GO:0099557,1,0.988665688,0,1,"trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission",BP,1
GO:0099558,1,0.881802492,0,12,maintenance of synapse structure,BP,1
GO:0099560,1,0.835591897,0,17,synaptic membrane adhesion,BP,1
GO:0099561,1,0.9893542,0,1,synaptic membrane adhesion to extracellular matrix,BP,1
GO:0099562,1,0.943467282,0,6,maintenance of postsynaptic density structure,BP,1
GO:0099563,1,0.763712034,0,26,modification of synaptic structure,BP,1
GO:0099564,1,0.988662925,0,1,"modification of synaptic structure, modulating synaptic transmission",BP,1
GO:0099566,1,0.976650224,0,3,regulation of postsynaptic cytosolic calcium ion concentration,BP,1
GO:0099576,1,0.929527015,0,7,"regulation of protein catabolic process at postsynapse, modulating synaptic transmission",BP,1
GO:0099577,1,0.978735132,0,2,"regulation of translation at presynapse, modulating synaptic transmission",BP,1
GO:0099578,1,0.958166168,0,4,"regulation of translation at postsynapse, modulating synaptic transmission",BP,1
GO:0099587,1,0.70104189,0,33,inorganic ion import across plasma membrane,BP,1
GO:0099588,1,0.988700735,0,1,positive regulation of postsynaptic cytosolic calcium concentration,BP,1
GO:0099590,1,0.786816618,0,22,neurotransmitter receptor internalization,BP,1
GO:0099601,1,0.805994961,0,21,regulation of neurotransmitter receptor activity,BP,1
GO:0099612,1,0.99340307,0,1,protein localization to axon,BP,1
GO:0099622,1,0.892832218,0,11,cardiac muscle cell membrane repolarization,BP,1
GO:0099623,1,0.913442038,0,9,regulation of cardiac muscle cell membrane repolarization,BP,1
GO:0099624,1,0.982504149,0,2,atrial cardiac muscle cell membrane repolarization,BP,1
GO:0099625,1,0.914135498,0,8,ventricular cardiac muscle cell membrane repolarization,BP,1
GO:0099628,1,0.988676702,0,1,neurotransmitter receptor diffusion trapping,BP,1
GO:0099632,1,0.857216203,0,14,protein transport within plasma membrane,BP,1
GO:0099633,1,0.848128392,0,15,protein localization to postsynaptic specialization membrane,BP,1
GO:0099637,1,0.857216203,0,14,neurotransmitter receptor transport,BP,1
GO:0099638,1,0.888062344,0,11,endosome to plasma membrane protein transport,BP,1
GO:0099639,1,0.916138112,0,8,"neurotransmitter receptor transport, endosome to plasma membrane",BP,1
GO:0099640,1,0.904027295,0,9,axo-dendritic protein transport,BP,1
GO:0099641,1,0.956533684,0,4,anterograde axonal protein transport,BP,1
GO:0099645,1,0.848128392,0,15,neurotransmitter receptor localization to postsynaptic specialization membrane,BP,1
GO:0099703,1,0.982504041,0,2,induction of synaptic vesicle exocytosis by positive regulation of presynaptic cytosolic calcium ion concentration,BP,1
GO:0101023,1,0.865320616,0,14,vascular endothelial cell proliferation,BP,1
GO:0101030,1,0.966387724,0,3,tRNA-guanine transglycosylation,BP,1
GO:0106001,1,0.977577143,0,2,intestinal hexose absorption,BP,1
GO:0106004,1,0.977453374,0,2,tRNA (guanine-N7)-methylation,BP,1
GO:0106005,1,0.977453375,0,2,RNA 5'-cap (guanine-N7)-methylation,BP,1
GO:0106014,1,0.966369422,0,3,regulation of inflammatory response to wounding,BP,1
GO:0106015,1,0.977452882,0,2,negative regulation of inflammatory response to wounding,BP,1
GO:0106016,1,0.966369422,0,3,positive regulation of inflammatory response to wounding,BP,1
GO:0106020,1,0.977980054,0,2,regulation of vesicle docking,BP,1
GO:0106022,1,0.989195603,0,1,positive regulation of vesicle docking,BP,1
GO:0106030,1,0.88526736,0,12,neuron projection fasciculation,BP,1
GO:0106034,1,0.988662701,0,1,protein maturation by [2Fe-2S] cluster transfer,BP,1
GO:0106035,1,0.944575635,0,5,protein maturation by [4Fe-4S] cluster transfer,BP,1
GO:0106044,1,0.988662773,0,1,guanine deglycation,BP,1
GO:0106045,1,0.988662773,0,1,"guanine deglycation, methylglyoxal removal",BP,1
GO:0106046,1,0.988662773,0,1,"guanine deglycation, glyoxal removal",BP,1
GO:0106047,1,0.988662953,0,1,polyamine deacetylation,BP,1
GO:0106048,1,0.988662953,0,1,spermidine deacetylation,BP,1
GO:0106049,1,0.924748203,0,7,regulation of cellular response to osmotic stress,BP,1
GO:0106056,1,0.756722337,0,27,regulation of calcineurin-mediated signaling,BP,1
GO:0106057,1,0.900884118,0,10,negative regulation of calcineurin-mediated signaling,BP,1
GO:0106058,1,0.851944469,0,15,positive regulation of calcineurin-mediated signaling,BP,1
GO:0106064,1,0.988662836,0,1,regulation of cobalamin metabolic process,BP,1
GO:0106070,1,0.89364298,0,10,regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway,BP,1
GO:0106071,1,0.977750094,0,2,positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway,BP,1
GO:0106072,1,0.913993726,0,8,negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway,BP,1
GO:0106074,1,0.864303135,0,13,aminoacyl-tRNA metabolism involved in translational fidelity,BP,1
GO:0106077,1,0.95547445,0,4,histone succinylation,BP,1
GO:0106088,1,0.989761535,0,1,regulation of cell adhesion involved in sprouting angiogenesis,BP,1
GO:0106089,1,0.989761535,0,1,negative regulation of cell adhesion involved in sprouting angiogenesis,BP,1
GO:0106091,1,0.988662435,0,1,glial cell projection elongation,BP,1
GO:0106096,1,0.991301209,0,1,response to ceramide,BP,1
GO:0106101,1,0.988662831,0,1,ER-dependent peroxisome localization,BP,1
GO:0106104,1,0.976847824,0,3,regulation of glutamate receptor clustering,BP,1
GO:0106118,1,0.824109316,0,18,regulation of sterol biosynthetic process,BP,1
GO:0106119,1,0.95587773,0,4,negative reguation of sterol biosynthetic process,BP,1
GO:0106120,1,0.913878653,0,8,positive regulation of sterol biosynthetic process,BP,1
GO:0106134,1,0.9899866,0,1,positive regulation of cardiac muscle cell contraction,BP,1
GO:0106135,1,0.988667727,0,1,negative regulation of cardiac muscle cell contraction,BP,1
GO:0110008,1,0.988662931,0,1,ncRNA deadenylation,BP,1
GO:0110009,1,0.991410495,0,1,formin-nucleated actin cable organization,BP,1
GO:0110011,1,0.947307024,0,5,regulation of basement membrane organization,BP,1
GO:0110017,1,0.977453073,0,2,cap-independent translational initiation of linear mRNA,BP,1
GO:0110020,1,0.484852064,0,67,regulation of actomyosin structure organization,BP,1
GO:0110021,1,0.966443075,0,3,cardiac muscle myoblast proliferation,BP,1
GO:0110022,1,0.966443075,0,3,regulation of cardiac muscle myoblast proliferation,BP,1
GO:0110024,1,0.966443075,0,3,positive regulation of cardiac muscle myoblast proliferation,BP,1
GO:0110025,1,0.977453375,0,2,DNA strand resection involved in replication fork processing,BP,1
GO:0110028,1,0.988662931,0,1,positive regulation of mitotic spindle organization,BP,1
GO:0110030,1,0.966882426,0,3,regulation of G2/MI transition of meiotic cell cycle,BP,1
GO:0110032,1,0.966882426,0,3,positive regulation of G2/MI transition of meiotic cell cycle,BP,1
GO:0110057,1,0.990862907,0,1,regulation of blood vessel endothelial cell differentiation,BP,1
GO:0110059,1,0.990862907,0,1,negative regulation of blood vessel endothelial cell differentiation,BP,1
GO:0110061,1,0.980670683,0,2,regulation of angiotensin-activated signaling pathway,BP,1
GO:0110075,1,0.988662718,0,1,regulation of ferroptosis,BP,1
GO:0110076,1,0.988662718,0,1,negative regulation of ferroptosis,BP,1
GO:0110088,1,0.977627166,0,2,hippocampal neuron apoptotic process,BP,1
GO:0110089,1,0.977627166,0,2,regulation of hippocampal neuron apoptotic process,BP,1
GO:0110090,1,0.988662497,0,1,positive regulation of hippocampal neuron apoptotic process,BP,1
GO:0110091,1,0.988839133,0,1,negative regulation of hippocampal neuron apoptotic process,BP,1
GO:0110095,1,0.944575137,0,5,cellular detoxification of aldehyde,BP,1
GO:0110096,1,0.91296372,0,8,cellular response to aldehyde,BP,1
GO:0110097,1,0.988662913,0,1,regulation of calcium import into the mitochondrion,BP,1
GO:0110104,1,0.95986016,0,4,mRNA alternative polyadenylation,BP,1
GO:0110111,1,0.827684365,0,18,negative regulation of animal organ morphogenesis,BP,1
GO:0110112,1,0.977496293,0,2,regulation of lipid transporter activity,BP,1
GO:0110113,1,0.988706839,0,1,positive regulation of lipid transporter activity,BP,1
GO:0110114,1,0.988662429,0,1,negative regulation of lipid transporter activity,BP,1
GO:0120012,1,0.988662931,0,1,intermembrane sphingolipid transfer,BP,1
GO:0120032,1,0.244933837,0,129,regulation of plasma membrane bounded cell projection assembly,BP,1
GO:0120033,1,0.82844967,0,17,negative regulation of plasma membrane bounded cell projection assembly,BP,1
GO:0120034,1,0.439524034,0,76,positive regulation of plasma membrane bounded cell projection assembly,BP,1
GO:0120045,1,0.988662931,0,1,stereocilium maintenance,BP,1
GO:0120049,1,0.988662931,0,1,snRNA (adenine-N6)-methylation,BP,1
GO:0120063,1,0.989532094,0,1,stomach smooth muscle contraction,BP,1
GO:0120064,1,0.989532094,0,1,stomach pylorus smooth muscle contraction,BP,1
GO:0120065,1,0.989532094,0,1,pyloric antrum smooth muscle contraction,BP,1
GO:0120071,1,0.989532094,0,1,regulation of pyloric antrum smooth muscle contraction,BP,1
GO:0120072,1,0.989532094,0,1,positive regulation of pyloric antrum smooth muscle contraction,BP,1
GO:0120077,1,0.98036168,0,2,angiogenic sprout fusion,BP,1
GO:0120078,1,0.98036168,0,2,cell adhesion involved in sprouting angiogenesis,BP,1
GO:0120093,1,0.988663037,0,1,regulation of peptidyl-lysine crotonylation,BP,1
GO:0120094,1,0.988663037,0,1,negative regulation of peptidyl-lysine crotonylation,BP,1
GO:0120117,1,0.989012815,0,1,T cell meandering migration,BP,1
GO:0120127,1,0.977532148,0,2,response to zinc ion starvation,BP,1
GO:0120158,1,0.977476476,0,2,positive regulation of collagen catabolic process,BP,1
GO:0120179,1,0.98999254,0,1,adherens junction disassembly,BP,1
GO:0120180,1,0.98999254,0,1,cell-substrate adherens junction disassembly,BP,1
GO:0120181,1,0.98999254,0,1,focal adhesion disassembly,BP,1
GO:0120182,1,0.98999254,0,1,regulation of focal adhesion disassembly,BP,1
GO:0120183,1,0.98999254,0,1,positive regulation of focal adhesion disassembly,BP,1
GO:0120192,1,0.670311206,0,37,tight junction assembly,BP,1
GO:0120193,1,0.650847756,0,40,tight junction organization,BP,1
GO:0140018,1,0.989071257,0,1,regulation of cytoplasmic translational fidelity,BP,1
GO:0140029,1,0.552820513,0,54,exocytic process,BP,1
GO:0140039,1,0.988814689,0,1,cell-cell adhesion in response to extracellular stimulus,BP,1
GO:0140041,1,0.988662773,0,1,cellular detoxification of methylglyoxal,BP,1
GO:0140042,1,0.98866287,0,1,lipid droplet formation,BP,1
GO:0140052,1,0.925764033,0,7,cellular response to oxidised low-density lipoprotein particle stimulus,BP,1
GO:0140053,1,0.379303462,0,85,mitochondrial gene expression,BP,1
GO:0140056,1,0.569199869,0,51,organelle localization by membrane tethering,BP,1
GO:0140058,1,0.867926778,0,14,neuron projection arborization,BP,1
GO:0140059,1,0.946763528,0,5,dendrite arborization,BP,1
GO:0140066,1,0.97745348,0,2,peptidyl-lysine crotonylation,BP,1
GO:0140067,1,0.988662931,0,1,peptidyl-lysine butyrylation,BP,1
GO:0140074,1,0.990631058,0,1,cardiac endothelial to mesenchymal transition,BP,1
GO:0140075,1,0.997726229,0,1,regulation of lipoprotein transport,BP,1
GO:0140077,1,0.997726229,0,1,positive regulation of lipoprotein transport,BP,1
GO:0140112,1,0.792294829,0,21,extracellular vesicle biogenesis,BP,1
GO:0140115,1,0.912978288,0,9,export across plasma membrane,BP,1
GO:0140131,1,0.879450168,0,12,positive regulation of lymphocyte chemotaxis,BP,1
GO:0140192,1,0.956953907,0,4,regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,1
GO:0140193,1,0.988662591,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,1
GO:0140194,1,0.988662591,0,1,negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,1
GO:0140196,1,0.988963062,0,1,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,1
GO:0140199,1,0.967636447,0,3,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,1
GO:0140200,1,0.988662633,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in regulation of heart rate,BP,1
GO:0140212,1,0.979069,0,2,regulation of long-chain fatty acid import into cell,BP,1
GO:0140214,1,0.988662571,0,1,positive regulation of long-chain fatty acid import into cell,BP,1
GO:0140238,1,0.615583224,0,44,presynaptic endocytosis,BP,1
GO:0140239,1,0.786816618,0,22,postsynaptic endocytosis,BP,1
GO:0140243,1,0.941813241,0,6,regulation of translation at synapse,BP,1
GO:0140244,1,0.978735132,0,2,regulation of translation at presynapse,BP,1
GO:0140245,1,0.958166168,0,4,regulation of translation at postsynapse,BP,1
GO:0140246,1,0.988676499,0,1,protein catabolic process at synapse,BP,1
GO:0150003,1,0.988665977,0,1,regulation of spontaneous synaptic transmission,BP,1
GO:0150007,1,0.988662931,0,1,clathrin-dependent synaptic vesicle endocytosis,BP,1
GO:0150011,1,0.938534758,0,6,regulation of neuron projection arborization,BP,1
GO:0150012,1,0.955544648,0,4,positive regulation of neuron projection arborization,BP,1
GO:0150018,1,0.979716919,0,2,basal dendrite development,BP,1
GO:0150019,1,0.979716919,0,2,basal dendrite morphogenesis,BP,1
GO:0150020,1,0.979716919,0,2,basal dendrite arborization,BP,1
GO:0150031,1,0.979078551,0,2,regulation of protein localization to lysosome,BP,1
GO:0150032,1,0.988662931,0,1,positive regulation of protein localization to lysosome,BP,1
GO:0150033,1,0.990306596,0,1,negative regulation of protein localization to lysosome,BP,1
GO:0150052,1,0.950815129,0,5,regulation of postsynapse assembly,BP,1
GO:0150062,1,0.979763578,0,2,complement-mediated synapse pruning,BP,1
GO:0150064,1,0.979763578,0,2,vertebrate eye-specific patterning,BP,1
GO:0150066,1,0.977457635,0,2,negative regulation of deacetylase activity,BP,1
GO:0150078,1,0.944577992,0,5,positive regulation of neuroinflammatory response,BP,1
GO:0150093,1,0.934698854,0,7,amyloid-beta clearance by transcytosis,BP,1
GO:0150094,1,0.962965229,0,5,amyloid-beta clearance by cellular catabolic process,BP,1
GO:1900003,1,0.98866291,0,1,regulation of serine-type endopeptidase activity,BP,1
GO:1900004,1,0.98866291,0,1,negative regulation of serine-type endopeptidase activity,BP,1
GO:1900016,1,0.896123036,0,10,negative regulation of cytokine production involved in inflammatory response,BP,1
GO:1900017,1,0.863867311,0,13,positive regulation of cytokine production involved in inflammatory response,BP,1
GO:1900019,1,0.936006949,0,6,regulation of protein kinase C activity,BP,1
GO:1900020,1,0.936006949,0,6,positive regulation of protein kinase C activity,BP,1
GO:1900022,1,0.988662924,0,1,regulation of D-erythro-sphingosine kinase activity,BP,1
GO:1900024,1,0.632541857,0,43,regulation of substrate adhesion-dependent cell spreading,BP,1
GO:1900025,1,0.896028213,0,10,negative regulation of substrate adhesion-dependent cell spreading,BP,1
GO:1900026,1,0.720813218,0,31,positive regulation of substrate adhesion-dependent cell spreading,BP,1
GO:1900027,1,0.795231732,0,21,regulation of ruffle assembly,BP,1
GO:1900028,1,0.968776869,0,3,negative regulation of ruffle assembly,BP,1
GO:1900029,1,0.89787665,0,10,positive regulation of ruffle assembly,BP,1
GO:1900034,1,0.957726579,0,4,regulation of cellular response to heat,BP,1
GO:1900036,1,0.988662931,0,1,positive regulation of cellular response to heat,BP,1
GO:1900037,1,0.859277662,0,14,regulation of cellular response to hypoxia,BP,1
GO:1900038,1,0.906258021,0,9,negative regulation of cellular response to hypoxia,BP,1
GO:1900039,1,0.988662768,0,1,positive regulation of cellular response to hypoxia,BP,1
GO:1900040,1,0.960087268,0,4,regulation of interleukin-2 secretion,BP,1
GO:1900041,1,0.977577182,0,2,negative regulation of interleukin-2 secretion,BP,1
GO:1900042,1,0.982112138,0,2,positive regulation of interleukin-2 secretion,BP,1
GO:1900044,1,0.907130592,0,9,regulation of protein K63-linked ubiquitination,BP,1
GO:1900045,1,0.938125873,0,6,negative regulation of protein K63-linked ubiquitination,BP,1
GO:1900046,1,0.505501875,0,61,regulation of hemostasis,BP,1
GO:1900047,1,0.65206955,0,38,negative regulation of hemostasis,BP,1
GO:1900048,1,0.79133605,0,21,positive regulation of hemostasis,BP,1
GO:1900052,1,0.988662775,0,1,regulation of retinoic acid biosynthetic process,BP,1
GO:1900054,1,0.988662775,0,1,positive regulation of retinoic acid biosynthetic process,BP,1
GO:1900060,1,0.977452801,0,2,negative regulation of ceramide biosynthetic process,BP,1
GO:1900062,1,0.988670111,0,1,regulation of replicative cell aging,BP,1
GO:1900063,1,0.96638259,0,3,regulation of peroxisome organization,BP,1
GO:1900069,1,0.955683515,0,4,regulation of cellular hyperosmotic salinity response,BP,1
GO:1900081,1,0.989736892,0,1,regulation of arginine catabolic process,BP,1
GO:1900082,1,0.989736892,0,1,negative regulation of arginine catabolic process,BP,1
GO:1900085,1,0.988674899,0,1,negative regulation of peptidyl-tyrosine autophosphorylation,BP,1
GO:1900087,1,0.747696988,0,28,positive regulation of G1/S transition of mitotic cell cycle,BP,1
GO:1900094,1,0.977453375,0,2,regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry,BP,1
GO:1900095,1,0.988662931,0,1,regulation of dosage compensation by inactivation of X chromosome,BP,1
GO:1900098,1,0.988662928,0,1,regulation of plasma cell differentiation,BP,1
GO:1900100,1,0.988662928,0,1,positive regulation of plasma cell differentiation,BP,1
GO:1900103,1,0.902702151,0,9,positive regulation of endoplasmic reticulum unfolded protein response,BP,1
GO:1900104,1,0.977453315,0,2,regulation of hyaluranon cable assembly,BP,1
GO:1900106,1,0.977453315,0,2,positive regulation of hyaluranon cable assembly,BP,1
GO:1900107,1,0.977502725,0,2,regulation of nodal signaling pathway,BP,1
GO:1900108,1,0.988712842,0,1,negative regulation of nodal signaling pathway,BP,1
GO:1900109,1,0.988662854,0,1,regulation of histone H3-K9 dimethylation,BP,1
GO:1900110,1,0.988662854,0,1,negative regulation of histone H3-K9 dimethylation,BP,1
GO:1900112,1,0.920725754,0,8,regulation of histone H3-K9 trimethylation,BP,1
GO:1900113,1,0.956934546,0,4,negative regulation of histone H3-K9 trimethylation,BP,1
GO:1900114,1,0.977641696,0,2,positive regulation of histone H3-K9 trimethylation,BP,1
GO:1900115,1,0.94318406,0,6,extracellular regulation of signal transduction,BP,1
GO:1900116,1,0.94318406,0,6,extracellular negative regulation of signal transduction,BP,1
GO:1900117,1,0.799871202,0,20,regulation of execution phase of apoptosis,BP,1
GO:1900118,1,0.923611986,0,7,negative regulation of execution phase of apoptosis,BP,1
GO:1900119,1,0.883390576,0,11,positive regulation of execution phase of apoptosis,BP,1
GO:1900120,1,0.879566373,0,12,regulation of receptor binding,BP,1
GO:1900121,1,0.927270742,0,7,negative regulation of receptor binding,BP,1
GO:1900122,1,0.947874915,0,5,positive regulation of receptor binding,BP,1
GO:1900125,1,0.941337737,0,6,regulation of hyaluronan biosynthetic process,BP,1
GO:1900126,1,0.961241157,0,4,negative regulation of hyaluronan biosynthetic process,BP,1
GO:1900127,1,0.979300527,0,2,positive regulation of hyaluronan biosynthetic process,BP,1
GO:1900133,1,0.977862224,0,2,regulation of renin secretion into blood stream,BP,1
GO:1900134,1,0.988982061,0,1,negative regulation of renin secretion into blood stream,BP,1
GO:1900135,1,0.988757271,0,1,positive regulation of renin secretion into blood stream,BP,1
GO:1900138,1,0.98866288,0,1,negative regulation of phospholipase A2 activity,BP,1
GO:1900139,1,0.988662931,0,1,negative regulation of arachidonic acid secretion,BP,1
GO:1900141,1,0.96969485,0,3,regulation of oligodendrocyte apoptotic process,BP,1
GO:1900142,1,0.977470828,0,2,negative regulation of oligodendrocyte apoptotic process,BP,1
GO:1900143,1,0.992046245,0,1,positive regulation of oligodendrocyte apoptotic process,BP,1
GO:1900145,1,0.988662931,0,1,regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,1
GO:1900147,1,0.953029926,0,5,regulation of Schwann cell migration,BP,1
GO:1900148,1,0.977463259,0,2,negative regulation of Schwann cell migration,BP,1
GO:1900149,1,0.986189575,0,2,positive regulation of Schwann cell migration,BP,1
GO:1900150,1,0.966369651,0,3,regulation of defense response to fungus,BP,1
GO:1900152,1,0.966369909,0,3,"negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",BP,1
GO:1900157,1,0.991451586,0,1,regulation of bone mineralization involved in bone maturation,BP,1
GO:1900159,1,0.991451586,0,1,positive regulation of bone mineralization involved in bone maturation,BP,1
GO:1900161,1,0.988706839,0,1,regulation of phospholipid scramblase activity,BP,1
GO:1900163,1,0.988706839,0,1,positive regulation of phospholipid scramblase activity,BP,1
GO:1900164,1,0.977453375,0,2,nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,1
GO:1900165,1,0.944683069,0,5,negative regulation of interleukin-6 secretion,BP,1
GO:1900169,1,0.976944067,0,3,regulation of glucocorticoid mediated signaling pathway,BP,1
GO:1900170,1,0.98101015,0,2,negative regulation of glucocorticoid mediated signaling pathway,BP,1
GO:1900175,1,0.988662931,0,1,regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,1
GO:1900181,1,0.845973595,0,16,negative regulation of protein localization to nucleus,BP,1
GO:1900186,1,0.966802474,0,3,negative regulation of clathrin-dependent endocytosis,BP,1
GO:1900193,1,0.843198458,0,15,regulation of oocyte maturation,BP,1
GO:1900194,1,0.945057487,0,5,negative regulation of oocyte maturation,BP,1
GO:1900195,1,0.933864948,0,6,positive regulation of oocyte maturation,BP,1
GO:1900200,1,0.988662923,0,1,mesenchymal cell apoptotic process involved in metanephros development,BP,1
GO:1900208,1,0.977453265,0,2,regulation of cardiolipin metabolic process,BP,1
GO:1900210,1,0.977453265,0,2,positive regulation of cardiolipin metabolic process,BP,1
GO:1900211,1,0.988662923,0,1,regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,1
GO:1900212,1,0.988662923,0,1,negative regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,1
GO:1900220,1,0.994239697,0,1,semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis,BP,1
GO:1900221,1,0.909906414,0,9,regulation of amyloid-beta clearance,BP,1
GO:1900222,1,0.958101635,0,4,negative regulation of amyloid-beta clearance,BP,1
GO:1900223,1,0.982769254,0,2,positive regulation of amyloid-beta clearance,BP,1
GO:1900224,1,0.988662931,0,1,positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,1
GO:1900225,1,0.913276496,0,8,regulation of NLRP3 inflammasome complex assembly,BP,1
GO:1900226,1,0.977453375,0,2,negative regulation of NLRP3 inflammasome complex assembly,BP,1
GO:1900227,1,0.945073553,0,5,positive regulation of NLRP3 inflammasome complex assembly,BP,1
GO:1900234,1,0.978230538,0,2,regulation of Kit signaling pathway,BP,1
GO:1900235,1,0.978230538,0,2,negative regulation of Kit signaling pathway,BP,1
GO:1900238,1,0.980061868,0,2,regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,1
GO:1900239,1,0.980295581,0,2,regulation of phenotypic switching,BP,1
GO:1900240,1,0.991537471,0,1,negative regulation of phenotypic switching,BP,1
GO:1900241,1,0.988662931,0,1,positive regulation of phenotypic switching,BP,1
GO:1900242,1,0.798589094,0,20,regulation of synaptic vesicle endocytosis,BP,1
GO:1900244,1,0.882338634,0,11,positive regulation of synaptic vesicle endocytosis,BP,1
GO:1900245,1,0.983993415,0,2,positive regulation of MDA-5 signaling pathway,BP,1
GO:1900246,1,0.956568459,0,5,positive regulation of RIG-I signaling pathway,BP,1
GO:1900247,1,0.923927629,0,7,regulation of cytoplasmic translational elongation,BP,1
GO:1900248,1,0.988662931,0,1,negative regulation of cytoplasmic translational elongation,BP,1
GO:1900259,1,0.98866293,0,1,regulation of RNA-directed 5'-3' RNA polymerase activity,BP,1
GO:1900260,1,0.98866293,0,1,negative regulation of RNA-directed 5'-3' RNA polymerase activity,BP,1
GO:1900262,1,0.933871122,0,6,regulation of DNA-directed DNA polymerase activity,BP,1
GO:1900264,1,0.933871122,0,6,positive regulation of DNA-directed DNA polymerase activity,BP,1
GO:1900271,1,0.730855237,0,30,regulation of long-term synaptic potentiation,BP,1
GO:1900272,1,0.916190786,0,8,negative regulation of long-term synaptic potentiation,BP,1
GO:1900273,1,0.839589187,0,17,positive regulation of long-term synaptic potentiation,BP,1
GO:1900274,1,0.871182595,0,13,regulation of phospholipase C activity,BP,1
GO:1900363,1,0.859140792,0,14,regulation of mRNA polyadenylation,BP,1
GO:1900364,1,0.926264628,0,7,negative regulation of mRNA polyadenylation,BP,1
GO:1900365,1,0.966376241,0,3,positive regulation of mRNA polyadenylation,BP,1
GO:1900368,1,0.958522647,0,4,regulation of RNA interference,BP,1
GO:1900369,1,0.978494069,0,2,negative regulation of RNA interference,BP,1
GO:1900370,1,0.990827365,0,1,positive regulation of RNA interference,BP,1
GO:1900376,1,0.963591675,0,4,regulation of secondary metabolite biosynthetic process,BP,1
GO:1900377,1,0.992257257,0,1,negative regulation of secondary metabolite biosynthetic process,BP,1
GO:1900378,1,0.971112512,0,3,positive regulation of secondary metabolite biosynthetic process,BP,1
GO:1900387,1,0.988662931,0,1,negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter,BP,1
GO:1900390,1,0.988662715,0,1,regulation of iron ion import,BP,1
GO:1900407,1,0.476050679,0,66,regulation of cellular response to oxidative stress,BP,1
GO:1900408,1,0.637619936,0,40,negative regulation of cellular response to oxidative stress,BP,1
GO:1900409,1,0.837213429,0,16,positive regulation of cellular response to oxidative stress,BP,1
GO:1900424,1,0.904640046,0,9,regulation of defense response to bacterium,BP,1
GO:1900425,1,0.979319685,0,2,negative regulation of defense response to bacterium,BP,1
GO:1900426,1,0.945072281,0,5,positive regulation of defense response to bacterium,BP,1
GO:1900449,1,0.832632258,0,18,regulation of glutamate receptor signaling pathway,BP,1
GO:1900450,1,0.977627438,0,2,negative regulation of glutamate receptor signaling pathway,BP,1
GO:1900451,1,0.934670382,0,7,positive regulation of glutamate receptor signaling pathway,BP,1
GO:1900452,1,0.941667301,0,6,regulation of long-term synaptic depression,BP,1
GO:1900453,1,0.978734982,0,2,negative regulation of long-term synaptic depression,BP,1
GO:1900454,1,0.979795135,0,2,positive regulation of long-term synaptic depression,BP,1
GO:1900477,1,0.988662931,0,1,negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter,BP,1
GO:1900483,1,0.988662579,0,1,regulation of protein targeting to vacuolar membrane,BP,1
GO:1900533,1,0.977453331,0,2,palmitic acid metabolic process,BP,1
GO:1900535,1,0.977453331,0,2,palmitic acid biosynthetic process,BP,1
GO:1900619,1,0.966370559,0,3,acetate ester metabolic process,BP,1
GO:1900620,1,0.988663763,0,1,acetate ester biosynthetic process,BP,1
GO:1900623,1,0.989725185,0,1,regulation of monocyte aggregation,BP,1
GO:1900625,1,0.989725185,0,1,positive regulation of monocyte aggregation,BP,1
GO:1900673,1,0.98866293,0,1,olefin metabolic process,BP,1
GO:1900719,1,0.990446389,0,1,regulation of uterine smooth muscle relaxation,BP,1
GO:1900721,1,0.990446389,0,1,positive regulation of uterine smooth muscle relaxation,BP,1
GO:1900729,1,0.988662931,0,1,regulation of adenylate cyclase-inhibiting opioid receptor signaling pathway,BP,1
GO:1900731,1,0.988662931,0,1,positive regulation of adenylate cyclase-inhibiting opioid receptor signaling pathway,BP,1
GO:1900736,1,0.988662931,0,1,regulation of phospholipase C-activating G protein-coupled receptor signaling pathway,BP,1
GO:1900738,1,0.988662931,0,1,positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway,BP,1
GO:1900739,1,0.988662926,0,1,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,1
GO:1900740,1,0.988662926,0,1,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,1
GO:1900747,1,0.929038123,0,7,negative regulation of vascular endothelial growth factor signaling pathway,BP,1
GO:1900748,1,0.967241789,0,3,positive regulation of vascular endothelial growth factor signaling pathway,BP,1
GO:1900753,1,0.989270572,0,1,doxorubicin transport,BP,1
GO:1900756,1,0.977466395,0,2,protein processing in phagocytic vesicle,BP,1
GO:1900825,1,0.971665237,0,3,regulation of membrane depolarization during cardiac muscle cell action potential,BP,1
GO:1900827,1,0.99340307,0,1,positive regulation of membrane depolarization during cardiac muscle cell action potential,BP,1
GO:1900864,1,0.955410699,0,4,mitochondrial RNA modification,BP,1
GO:1900923,1,0.988662591,0,1,regulation of glycine import across plasma membrane,BP,1
GO:1900924,1,0.988662591,0,1,negative regulation of glycine import across plasma membrane,BP,1
GO:1901000,1,0.955683515,0,4,regulation of response to salt stress,BP,1
GO:1901003,1,0.955411121,0,4,negative regulation of fermentation,BP,1
GO:1901004,1,0.988662838,0,1,ubiquinone-6 metabolic process,BP,1
GO:1901006,1,0.988662838,0,1,ubiquinone-6 biosynthetic process,BP,1
GO:1901016,1,0.760543602,0,27,regulation of potassium ion transmembrane transporter activity,BP,1
GO:1901017,1,0.906241665,0,10,negative regulation of potassium ion transmembrane transporter activity,BP,1
GO:1901018,1,0.910611425,0,9,positive regulation of potassium ion transmembrane transporter activity,BP,1
GO:1901019,1,0.681361072,0,36,regulation of calcium ion transmembrane transporter activity,BP,1
GO:1901020,1,0.868484463,0,13,negative regulation of calcium ion transmembrane transporter activity,BP,1
GO:1901021,1,0.828534277,0,18,positive regulation of calcium ion transmembrane transporter activity,BP,1
GO:1901026,1,0.948169663,0,5,ripoptosome assembly involved in necroptotic process,BP,1
GO:1901030,1,0.924663238,0,7,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,1
GO:1901032,1,0.815686407,0,18,negative regulation of response to reactive oxygen species,BP,1
GO:1901033,1,0.91444296,0,8,positive regulation of response to reactive oxygen species,BP,1
GO:1901052,1,0.977550156,0,2,sarcosine metabolic process,BP,1
GO:1901053,1,0.988761,0,1,sarcosine catabolic process,BP,1
GO:1901068,1,0.687192859,0,33,guanosine-containing compound metabolic process,BP,1
GO:1901069,1,0.966369747,0,3,guanosine-containing compound catabolic process,BP,1
GO:1901070,1,0.87207143,0,12,guanosine-containing compound biosynthetic process,BP,1
GO:1901073,1,0.966444567,0,3,glucosamine-containing compound biosynthetic process,BP,1
GO:1901074,1,0.992425622,0,1,regulation of engulfment of apoptotic cell,BP,1
GO:1901076,1,0.992425622,0,1,positive regulation of engulfment of apoptotic cell,BP,1
GO:1901077,1,0.899136722,0,10,regulation of relaxation of muscle,BP,1
GO:1901078,1,0.966585635,0,3,negative regulation of relaxation of muscle,BP,1
GO:1901079,1,0.968116872,0,3,positive regulation of relaxation of muscle,BP,1
GO:1901080,1,0.979216772,0,2,regulation of relaxation of smooth muscle,BP,1
GO:1901082,1,0.979216772,0,2,positive regulation of relaxation of smooth muscle,BP,1
GO:1901086,1,0.988662911,0,1,benzylpenicillin metabolic process,BP,1
GO:1901090,1,0.977705348,0,2,regulation of protein tetramerization,BP,1
GO:1901091,1,0.977705348,0,2,negative regulation of protein tetramerization,BP,1
GO:1901093,1,0.977705348,0,2,regulation of protein homotetramerization,BP,1
GO:1901094,1,0.977705348,0,2,negative regulation of protein homotetramerization,BP,1
GO:1901096,1,0.917602445,0,8,regulation of autophagosome maturation,BP,1
GO:1901097,1,0.95571589,0,4,negative regulation of autophagosome maturation,BP,1
GO:1901098,1,0.960132115,0,4,positive regulation of autophagosome maturation,BP,1
GO:1901142,1,0.935641009,0,6,insulin metabolic process,BP,1
GO:1901143,1,0.979314703,0,2,insulin catabolic process,BP,1
GO:1901145,1,0.977453367,0,2,mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,1
GO:1901146,1,0.988662923,0,1,mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis,BP,1
GO:1901160,1,0.907637398,0,9,primary amino compound metabolic process,BP,1
GO:1901162,1,0.977453375,0,2,primary amino compound biosynthetic process,BP,1
GO:1901163,1,0.904353755,0,9,regulation of trophoblast cell migration,BP,1
GO:1901164,1,0.955410698,0,4,negative regulation of trophoblast cell migration,BP,1
GO:1901165,1,0.946579184,0,5,positive regulation of trophoblast cell migration,BP,1
GO:1901166,1,0.962352629,0,4,neural crest cell migration involved in autonomic nervous system development,BP,1
GO:1901184,1,0.596291455,0,48,regulation of ERBB signaling pathway,BP,1
GO:1901185,1,0.787117607,0,22,negative regulation of ERBB signaling pathway,BP,1
GO:1901186,1,0.838814696,0,17,positive regulation of ERBB signaling pathway,BP,1
GO:1901187,1,0.981440259,0,2,regulation of ephrin receptor signaling pathway,BP,1
GO:1901189,1,0.98978507,0,1,positive regulation of ephrin receptor signaling pathway,BP,1
GO:1901193,1,0.988662574,0,1,regulation of formation of translation preinitiation complex,BP,1
GO:1901194,1,0.988662574,0,1,negative regulation of formation of translation preinitiation complex,BP,1
GO:1901201,1,0.942510683,0,6,regulation of extracellular matrix assembly,BP,1
GO:1901202,1,0.989039028,0,1,negative regulation of extracellular matrix assembly,BP,1
GO:1901203,1,0.969015094,0,3,positive regulation of extracellular matrix assembly,BP,1
GO:1901213,1,0.952577629,0,5,regulation of transcription from RNA polymerase II promoter involved in heart development,BP,1
GO:1901216,1,0.352660598,0,95,positive regulation of neuron death,BP,1
GO:1901219,1,0.990997407,0,1,regulation of cardiac chamber morphogenesis,BP,1
GO:1901220,1,0.990997407,0,1,negative regulation of cardiac chamber morphogenesis,BP,1
GO:1901222,1,0.428928329,0,77,regulation of NIK/NF-kappaB signaling,BP,1
GO:1901223,1,0.815602787,0,18,negative regulation of NIK/NF-kappaB signaling,BP,1
GO:1901224,1,0.556458996,0,54,positive regulation of NIK/NF-kappaB signaling,BP,1
GO:1901227,1,0.9886627,0,1,negative regulation of transcription from RNA polymerase II promoter involved in heart development,BP,1
GO:1901228,1,0.978624577,0,2,positive regulation of transcription from RNA polymerase II promoter involved in heart development,BP,1
GO:1901229,1,0.98866291,0,1,regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,1
GO:1901231,1,0.98866291,0,1,positive regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,1
GO:1901232,1,0.98866291,0,1,regulation of convergent extension involved in axis elongation,BP,1
GO:1901233,1,0.98866291,0,1,negative regulation of convergent extension involved in axis elongation,BP,1
GO:1901249,1,0.977886837,0,2,regulation of lung goblet cell differentiation,BP,1
GO:1901250,1,0.977886837,0,2,negative regulation of lung goblet cell differentiation,BP,1
GO:1901252,1,0.967657317,0,3,regulation of intracellular transport of viral material,BP,1
GO:1901253,1,0.977473646,0,2,negative regulation of intracellular transport of viral material,BP,1
GO:1901254,1,0.98995927,0,1,positive regulation of intracellular transport of viral material,BP,1
GO:1901255,1,0.988662829,0,1,nucleotide-excision repair involved in interstrand cross-link repair,BP,1
GO:1901256,1,0.988663191,0,1,regulation of macrophage colony-stimulating factor production,BP,1
GO:1901291,1,0.988662798,0,1,negative regulation of double-strand break repair via single-strand annealing,BP,1
GO:1901295,1,0.98978507,0,1,regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,1
GO:1901297,1,0.98978507,0,1,positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,1
GO:1901298,1,0.873584391,0,12,regulation of hydrogen peroxide-mediated programmed cell death,BP,1
GO:1901299,1,0.914294795,0,8,negative regulation of hydrogen peroxide-mediated programmed cell death,BP,1
GO:1901300,1,0.955504624,0,4,positive regulation of hydrogen peroxide-mediated programmed cell death,BP,1
GO:1901301,1,0.979673153,0,2,regulation of cargo loading into COPII-coated vesicle,BP,1
GO:1901303,1,0.988669224,0,1,negative regulation of cargo loading into COPII-coated vesicle,BP,1
GO:1901304,1,0.988662931,0,1,regulation of spermidine biosynthetic process,BP,1
GO:1901307,1,0.988662931,0,1,positive regulation of spermidine biosynthetic process,BP,1
GO:1901314,1,0.970738099,0,3,regulation of histone H2A K63-linked ubiquitination,BP,1
GO:1901315,1,0.970738099,0,3,negative regulation of histone H2A K63-linked ubiquitination,BP,1
GO:1901317,1,0.977453313,0,2,regulation of flagellated sperm motility,BP,1
GO:1901318,1,0.988662913,0,1,negative regulation of flagellated sperm motility,BP,1
GO:1901321,1,0.994495178,0,1,positive regulation of heart induction,BP,1
GO:1901328,1,0.988662847,0,1,response to cytochalasin B,BP,1
GO:1901329,1,0.97763428,0,2,regulation of odontoblast differentiation,BP,1
GO:1901331,1,0.988845897,0,1,positive regulation of odontoblast differentiation,BP,1
GO:1901337,1,0.977890105,0,2,thioester transport,BP,1
GO:1901339,1,0.897192593,0,10,regulation of store-operated calcium channel activity,BP,1
GO:1901340,1,0.988662937,0,1,negative regulation of store-operated calcium channel activity,BP,1
GO:1901341,1,0.947406036,0,5,positive regulation of store-operated calcium channel activity,BP,1
GO:1901344,1,0.97745301,0,2,response to leptomycin B,BP,1
GO:1901355,1,0.94459539,0,5,response to rapamycin,BP,1
GO:1901367,1,0.988662955,0,1,response to L-cysteine,BP,1
GO:1901373,1,0.98868351,0,1,lipid hydroperoxide transport,BP,1
GO:1901374,1,0.955422261,0,4,acetate ester transport,BP,1
GO:1901376,1,0.966371257,0,3,organic heteropentacyclic compound metabolic process,BP,1
GO:1901377,1,0.966371257,0,3,organic heteropentacyclic compound catabolic process,BP,1
GO:1901379,1,0.702962401,0,35,regulation of potassium ion transmembrane transport,BP,1
GO:1901380,1,0.88579727,0,12,negative regulation of potassium ion transmembrane transport,BP,1
GO:1901381,1,0.891198704,0,12,positive regulation of potassium ion transmembrane transport,BP,1
GO:1901382,1,0.966369841,0,3,regulation of chorionic trophoblast cell proliferation,BP,1
GO:1901383,1,0.988662928,0,1,negative regulation of chorionic trophoblast cell proliferation,BP,1
GO:1901385,1,0.866589956,0,13,regulation of voltage-gated calcium channel activity,BP,1
GO:1901386,1,0.960090946,0,4,negative regulation of voltage-gated calcium channel activity,BP,1
GO:1901387,1,0.966369886,0,3,positive regulation of voltage-gated calcium channel activity,BP,1
GO:1901388,1,0.949288116,0,5,regulation of transforming growth factor beta activation,BP,1
GO:1901389,1,0.988665653,0,1,negative regulation of transforming growth factor beta activation,BP,1
GO:1901390,1,0.990048323,0,1,positive regulation of transforming growth factor beta activation,BP,1
GO:1901392,1,0.990048323,0,1,regulation of transforming growth factor beta1 activation,BP,1
GO:1901394,1,0.990048323,0,1,positive regulation of transforming growth factor beta1 activation,BP,1
GO:1901398,1,0.988662931,0,1,regulation of transforming growth factor beta3 activation,BP,1
GO:1901401,1,0.966369628,0,3,regulation of tetrapyrrole metabolic process,BP,1
GO:1901407,1,0.971041928,0,3,regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,1
GO:1901409,1,0.988678072,0,1,positive regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,1
GO:1901419,1,0.988662911,0,1,regulation of response to alcohol,BP,1
GO:1901421,1,0.988662911,0,1,positive regulation of response to alcohol,BP,1
GO:1901423,1,0.933861299,0,6,response to benzene,BP,1
GO:1901463,1,0.977453185,0,2,regulation of tetrapyrrole biosynthetic process,BP,1
GO:1901475,1,0.955411141,0,4,pyruvate transmembrane transport,BP,1
GO:1901483,1,0.968629346,0,3,regulation of transcription factor catabolic process,BP,1
GO:1901485,1,0.968629346,0,3,positive regulation of transcription factor catabolic process,BP,1
GO:1901491,1,0.989569383,0,1,negative regulation of lymphangiogenesis,BP,1
GO:1901503,1,0.933861377,0,6,ether biosynthetic process,BP,1
GO:1901509,1,0.957070512,0,4,regulation of endothelial tube morphogenesis,BP,1
GO:1901523,1,0.977453189,0,2,icosanoid catabolic process,BP,1
GO:1901524,1,0.852021037,0,15,regulation of mitophagy,BP,1
GO:1901525,1,0.934241399,0,6,negative regulation of mitophagy,BP,1
GO:1901526,1,0.912038121,0,9,positive regulation of mitophagy,BP,1
GO:1901529,1,0.989013621,0,1,positive regulation of anion channel activity,BP,1
GO:1901534,1,0.960451502,0,4,positive regulation of hematopoietic progenitor cell differentiation,BP,1
GO:1901535,1,0.963000108,0,4,regulation of DNA demethylation,BP,1
GO:1901536,1,0.988800972,0,1,negative regulation of DNA demethylation,BP,1
GO:1901537,1,0.973909242,0,3,positive regulation of DNA demethylation,BP,1
GO:1901538,1,0.949668194,0,5,changes to DNA methylation involved in embryo development,BP,1
GO:1901545,1,0.988699351,0,1,response to raffinose,BP,1
GO:1901550,1,0.89004548,0,11,regulation of endothelial cell development,BP,1
GO:1901551,1,0.988662931,0,1,negative regulation of endothelial cell development,BP,1
GO:1901552,1,0.949439045,0,5,positive regulation of endothelial cell development,BP,1
GO:1901555,1,0.988662931,0,1,response to paclitaxel,BP,1
GO:1901556,1,0.989692508,0,1,response to candesartan,BP,1
GO:1901557,1,0.989644972,0,1,response to fenofibrate,BP,1
GO:1901558,1,0.978471368,0,2,response to metformin,BP,1
GO:1901561,1,0.988662931,0,1,response to benomyl,BP,1
GO:1901563,1,0.958483062,0,4,response to camptothecin,BP,1
GO:1901569,1,0.923681514,0,7,fatty acid derivative catabolic process,BP,1
GO:1901580,1,0.995326928,0,1,regulation of telomeric RNA transcription from RNA pol II promoter,BP,1
GO:1901581,1,0.995326928,0,1,negative regulation of telomeric RNA transcription from RNA pol II promoter,BP,1
GO:1901582,1,0.995326928,0,1,positive regulation of telomeric RNA transcription from RNA pol II promoter,BP,1
GO:1901585,1,0.97745337,0,2,regulation of acid-sensing ion channel activity,BP,1
GO:1901586,1,0.988662931,0,1,negative regulation of acid-sensing ion channel activity,BP,1
GO:1901594,1,0.988750447,0,1,response to capsazepine,BP,1
GO:1901608,1,0.969297752,0,3,regulation of vesicle transport along microtubule,BP,1
GO:1901610,1,0.969297752,0,3,positive regulation of vesicle transport along microtubule,BP,1
GO:1901616,1,0.619142792,0,43,organic hydroxy compound catabolic process,BP,1
GO:1901620,1,0.93387298,0,6,regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,1
GO:1901621,1,0.955412149,0,4,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,1
GO:1901622,1,0.988662931,0,1,positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,1
GO:1901623,1,0.859601264,0,14,regulation of lymphocyte chemotaxis,BP,1
GO:1901626,1,0.868232721,0,14,regulation of postsynaptic membrane organization,BP,1
GO:1901628,1,0.944332162,0,6,positive regulation of postsynaptic membrane organization,BP,1
GO:1901629,1,0.982331416,0,2,regulation of presynaptic membrane organization,BP,1
GO:1901630,1,0.988662786,0,1,negative regulation of presynaptic membrane organization,BP,1
GO:1901631,1,0.993596612,0,1,positive regulation of presynaptic membrane organization,BP,1
GO:1901639,1,0.988662841,0,1,XDP catabolic process,BP,1
GO:1901642,1,0.955504455,0,4,nucleoside transmembrane transport,BP,1
GO:1901656,1,0.978054182,0,2,glycoside transport,BP,1
GO:1901658,1,0.771649925,0,23,glycosyl compound catabolic process,BP,1
GO:1901660,1,0.936174623,0,6,calcium ion export,BP,1
GO:1901661,1,0.761597514,0,24,quinone metabolic process,BP,1
GO:1901662,1,0.988662743,0,1,quinone catabolic process,BP,1
GO:1901663,1,0.83325298,0,16,quinone biosynthetic process,BP,1
GO:1901664,1,0.968357824,0,3,regulation of NAD+ ADP-ribosyltransferase activity,BP,1
GO:1901666,1,0.968357824,0,3,positive regulation of NAD+ ADP-ribosyltransferase activity,BP,1
GO:1901668,1,0.966369736,0,3,regulation of superoxide dismutase activity,BP,1
GO:1901671,1,0.9774532,0,2,positive regulation of superoxide dismutase activity,BP,1
GO:1901674,1,0.979481837,0,2,regulation of histone H3-K27 acetylation,BP,1
GO:1901675,1,0.990714469,0,1,negative regulation of histone H3-K27 acetylation,BP,1
GO:1901678,1,0.921495724,0,8,iron coordination entity transport,BP,1
GO:1901679,1,0.933931025,0,6,nucleotide transmembrane transport,BP,1
GO:1901685,1,0.988662669,0,1,glutathione derivative metabolic process,BP,1
GO:1901687,1,0.988662669,0,1,glutathione derivative biosynthetic process,BP,1
GO:1901722,1,0.912920337,0,8,regulation of cell proliferation involved in kidney development,BP,1
GO:1901723,1,0.977586605,0,2,negative regulation of cell proliferation involved in kidney development,BP,1
GO:1901724,1,0.933862699,0,6,positive regulation of cell proliferation involved in kidney development,BP,1
GO:1901726,1,0.977457635,0,2,negative regulation of histone deacetylase activity,BP,1
GO:1901731,1,0.988662931,0,1,positive regulation of platelet aggregation,BP,1
GO:1901738,1,0.988662925,0,1,regulation of vitamin A metabolic process,BP,1
GO:1901740,1,0.977453243,0,2,negative regulation of myoblast fusion,BP,1
GO:1901748,1,0.988662931,0,1,leukotriene D4 metabolic process,BP,1
GO:1901750,1,0.988662931,0,1,leukotriene D4 biosynthetic process,BP,1
GO:1901787,1,0.988662699,0,1,benzoyl-CoA metabolic process,BP,1
GO:1901798,1,0.81304428,0,19,positive regulation of signal transduction by p53 class mediator,BP,1
GO:1901799,1,0.62401375,0,42,negative regulation of proteasomal protein catabolic process,BP,1
GO:1901804,1,0.988662931,0,1,beta-glucoside metabolic process,BP,1
GO:1901805,1,0.988662931,0,1,beta-glucoside catabolic process,BP,1
GO:1901810,1,0.988662931,0,1,beta-carotene metabolic process,BP,1
GO:1901834,1,0.988662927,0,1,regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,1
GO:1901835,1,0.988662927,0,1,positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,1
GO:1901836,1,0.889601013,0,11,regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,1
GO:1901837,1,0.966369782,0,3,negative regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,1
GO:1901838,1,0.920580496,0,8,positive regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,1
GO:1901841,1,0.937417541,0,6,regulation of high voltage-gated calcium channel activity,BP,1
GO:1901842,1,0.992203716,0,1,negative regulation of high voltage-gated calcium channel activity,BP,1
GO:1901843,1,0.988662931,0,1,positive regulation of high voltage-gated calcium channel activity,BP,1
GO:1901844,1,0.955426106,0,4,regulation of cell communication by electrical coupling involved in cardiac conduction,BP,1
GO:1901856,1,0.966501913,0,3,negative regulation of cellular respiration,BP,1
GO:1901857,1,0.924132226,0,7,positive regulation of cellular respiration,BP,1
GO:1901858,1,0.956416211,0,4,regulation of mitochondrial DNA metabolic process,BP,1
GO:1901859,1,0.967386535,0,3,negative regulation of mitochondrial DNA metabolic process,BP,1
GO:1901860,1,0.988662824,0,1,positive regulation of mitochondrial DNA metabolic process,BP,1
GO:1901873,1,0.977586605,0,2,regulation of post-translational protein modification,BP,1
GO:1901874,1,0.977586605,0,2,negative regulation of post-translational protein modification,BP,1
GO:1901879,1,0.550551172,0,58,regulation of protein depolymerization,BP,1
GO:1901880,1,0.618735105,0,47,negative regulation of protein depolymerization,BP,1
GO:1901881,1,0.889958336,0,11,positive regulation of protein depolymerization,BP,1
GO:1901889,1,0.81984979,0,19,negative regulation of cell junction assembly,BP,1
GO:1901894,1,0.977453228,0,2,regulation of calcium-transporting ATPase activity,BP,1
GO:1901896,1,0.977453228,0,2,positive regulation of calcium-transporting ATPase activity,BP,1
GO:1901897,1,0.939424868,0,6,regulation of relaxation of cardiac muscle,BP,1
GO:1901898,1,0.977671617,0,2,negative regulation of relaxation of cardiac muscle,BP,1
GO:1901899,1,0.988666406,0,1,positive regulation of relaxation of cardiac muscle,BP,1
GO:1901906,1,0.977565651,0,2,diadenosine pentaphosphate metabolic process,BP,1
GO:1901907,1,0.977565651,0,2,diadenosine pentaphosphate catabolic process,BP,1
GO:1901908,1,0.977565651,0,2,diadenosine hexaphosphate metabolic process,BP,1
GO:1901909,1,0.977565651,0,2,diadenosine hexaphosphate catabolic process,BP,1
GO:1901910,1,0.977565651,0,2,adenosine 5'-(hexahydrogen pentaphosphate) metabolic process,BP,1
GO:1901911,1,0.977565651,0,2,adenosine 5'-(hexahydrogen pentaphosphate) catabolic process,BP,1
GO:1901917,1,0.988666206,0,1,regulation of exoribonuclease activity,BP,1
GO:1901919,1,0.988666206,0,1,positive regulation of exoribonuclease activity,BP,1
GO:1901950,1,0.95184242,0,5,dense core granule transport,BP,1
GO:1901951,1,0.980414529,0,2,regulation of anterograde dense core granule transport,BP,1
GO:1901953,1,0.980414529,0,2,positive regulation of anterograde dense core granule transport,BP,1
GO:1901954,1,0.988662923,0,1,regulation of retrograde dense core granule transport,BP,1
GO:1901956,1,0.988662923,0,1,positive regulation of retrograde dense core granule transport,BP,1
GO:1901963,1,0.979764838,0,2,regulation of cell proliferation involved in outflow tract morphogenesis,BP,1
GO:1901970,1,0.937467474,0,6,positive regulation of mitotic sister chromatid separation,BP,1
GO:1901978,1,0.930149268,0,7,positive regulation of cell cycle checkpoint,BP,1
GO:1901979,1,0.980505121,0,2,regulation of inward rectifier potassium channel activity,BP,1
GO:1901984,1,0.80109529,0,20,negative regulation of protein acetylation,BP,1
GO:1901986,1,0.988662931,0,1,response to ketamine,BP,1
GO:1901989,1,0.542465307,0,57,positive regulation of cell cycle phase transition,BP,1
GO:1901992,1,0.581014739,0,51,positive regulation of mitotic cell cycle phase transition,BP,1
GO:1901993,1,0.955917877,0,4,regulation of meiotic cell cycle phase transition,BP,1
GO:1901994,1,0.988662931,0,1,negative regulation of meiotic cell cycle phase transition,BP,1
GO:1901995,1,0.966882426,0,3,positive regulation of meiotic cell cycle phase transition,BP,1
GO:1901998,1,0.663706128,0,37,toxin transport,BP,1
GO:1901999,1,0.988662876,0,1,homogentisate metabolic process,BP,1
GO:1902000,1,0.988662876,0,1,homogentisate catabolic process,BP,1
GO:1902001,1,0.93723125,0,6,fatty acid transmembrane transport,BP,1
GO:1902003,1,0.806764882,0,20,regulation of amyloid-beta formation,BP,1
GO:1902004,1,0.886787659,0,11,positive regulation of amyloid-beta formation,BP,1
GO:1902017,1,0.631639363,0,42,regulation of cilium assembly,BP,1
GO:1902018,1,0.91575351,0,8,negative regulation of cilium assembly,BP,1
GO:1902019,1,0.945482597,0,5,regulation of cilium-dependent cell motility,BP,1
GO:1902022,1,0.955423708,0,4,L-lysine transport,BP,1
GO:1902023,1,0.933874315,0,6,L-arginine transport,BP,1
GO:1902031,1,0.944861281,0,5,regulation of NADP metabolic process,BP,1
GO:1902033,1,0.925667217,0,7,regulation of hematopoietic stem cell proliferation,BP,1
GO:1902035,1,0.947028809,0,5,positive regulation of hematopoietic stem cell proliferation,BP,1
GO:1902036,1,0.923279525,0,7,regulation of hematopoietic stem cell differentiation,BP,1
GO:1902037,1,0.966371456,0,3,negative regulation of hematopoietic stem cell differentiation,BP,1
GO:1902041,1,0.663815545,0,37,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,1
GO:1902042,1,0.783986482,0,22,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,1
GO:1902043,1,0.884309057,0,11,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,1
GO:1902044,1,0.977453356,0,2,regulation of Fas signaling pathway,BP,1
GO:1902045,1,0.988662931,0,1,negative regulation of Fas signaling pathway,BP,1
GO:1902047,1,0.957564087,0,4,polyamine transmembrane transport,BP,1
GO:1902064,1,0.991612308,0,1,regulation of transcription from RNA polymerase II promoter involved in spermatogenesis,BP,1
GO:1902065,1,0.853798754,0,14,response to L-glutamate,BP,1
GO:1902068,1,0.988662931,0,1,regulation of sphingolipid mediated signaling pathway,BP,1
GO:1902071,1,0.966437899,0,3,regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,1
GO:1902072,1,0.9775223,0,2,negative regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,1
GO:1902073,1,0.988662768,0,1,positive regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,1
GO:1902074,1,0.819023343,0,18,response to salt,BP,1
GO:1902075,1,0.924510526,0,7,cellular response to salt,BP,1
GO:1902076,1,0.996093455,0,1,regulation of lateral motor column neuron migration,BP,1
GO:1902078,1,0.996093455,0,1,positive regulation of lateral motor column neuron migration,BP,1
GO:1902080,1,0.988666406,0,1,regulation of calcium ion import into sarcoplasmic reticulum,BP,1
GO:1902081,1,0.988666406,0,1,negative regulation of calcium ion import into sarcoplasmic reticulum,BP,1
GO:1902083,1,0.946194948,0,5,negative regulation of peptidyl-cysteine S-nitrosylation,BP,1
GO:1902101,1,0.937467474,0,6,positive regulation of metaphase/anaphase transition of cell cycle,BP,1
GO:1902102,1,0.988662931,0,1,regulation of metaphase/anaphase transition of meiotic cell cycle,BP,1
GO:1902103,1,0.988662931,0,1,negative regulation of metaphase/anaphase transition of meiotic cell cycle,BP,1
GO:1902106,1,0.509898982,0,61,negative regulation of leukocyte differentiation,BP,1
GO:1902109,1,0.966369802,0,3,negative regulation of mitochondrial membrane permeability involved in apoptotic process,BP,1
GO:1902116,1,0.725056987,0,29,negative regulation of organelle assembly,BP,1
GO:1902117,1,0.519625072,0,60,positive regulation of organelle assembly,BP,1
GO:1902145,1,0.988662931,0,1,regulation of response to cell cycle checkpoint signaling,BP,1
GO:1902151,1,0.988662931,0,1,regulation of response to DNA integrity checkpoint signaling,BP,1
GO:1902153,1,0.988662931,0,1,regulation of response to DNA damage checkpoint signaling,BP,1
GO:1902162,1,0.966372542,0,3,"regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",BP,1
GO:1902163,1,0.988662931,0,1,"negative regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",BP,1
GO:1902164,1,0.977456038,0,2,"positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",BP,1
GO:1902167,1,0.977487919,0,2,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,1
GO:1902170,1,0.798603307,0,20,cellular response to reactive nitrogen species,BP,1
GO:1902172,1,0.955464683,0,4,regulation of keratinocyte apoptotic process,BP,1
GO:1902174,1,0.97747215,0,2,positive regulation of keratinocyte apoptotic process,BP,1
GO:1902175,1,0.797593282,0,20,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,1
GO:1902176,1,0.862921725,0,13,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,1
GO:1902177,1,0.945157048,0,5,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,1
GO:1902178,1,0.988930324,0,1,fibroblast growth factor receptor apoptotic signaling pathway,BP,1
GO:1902186,1,0.737824138,0,27,regulation of viral release from host cell,BP,1
GO:1902187,1,0.853848824,0,14,negative regulation of viral release from host cell,BP,1
GO:1902188,1,0.854458959,0,14,positive regulation of viral release from host cell,BP,1
GO:1902202,1,0.957070446,0,4,regulation of hepatocyte growth factor receptor signaling pathway,BP,1
GO:1902203,1,0.99037958,0,1,negative regulation of hepatocyte growth factor receptor signaling pathway,BP,1
GO:1902204,1,0.988662931,0,1,positive regulation of hepatocyte growth factor receptor signaling pathway,BP,1
GO:1902205,1,0.988662894,0,1,regulation of interleukin-2-mediated signaling pathway,BP,1
GO:1902206,1,0.988662894,0,1,negative regulation of interleukin-2-mediated signaling pathway,BP,1
GO:1902211,1,0.988662931,0,1,regulation of prolactin signaling pathway,BP,1
GO:1902213,1,0.988662931,0,1,positive regulation of prolactin signaling pathway,BP,1
GO:1902214,1,0.966369867,0,3,regulation of interleukin-4-mediated signaling pathway,BP,1
GO:1902215,1,0.988662894,0,1,negative regulation of interleukin-4-mediated signaling pathway,BP,1
GO:1902216,1,0.97745337,0,2,positive regulation of interleukin-4-mediated signaling pathway,BP,1
GO:1902218,1,0.967641716,0,3,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,1
GO:1902219,1,0.978739832,0,2,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,1
GO:1902220,1,0.988662749,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,1
GO:1902224,1,0.923269681,0,7,ketone body metabolic process,BP,1
GO:1902226,1,0.978229311,0,2,regulation of macrophage colony-stimulating factor signaling pathway,BP,1
GO:1902227,1,0.988662894,0,1,negative regulation of macrophage colony-stimulating factor signaling pathway,BP,1
GO:1902228,1,0.989447732,0,1,positive regulation of macrophage colony-stimulating factor signaling pathway,BP,1
GO:1902231,1,0.902478648,0,9,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,1
GO:1902232,1,0.988662894,0,1,regulation of positive thymic T cell selection,BP,1
GO:1902233,1,0.988662894,0,1,negative regulation of positive thymic T cell selection,BP,1
GO:1902237,1,0.924835986,0,7,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,1
GO:1902255,1,0.933894174,0,6,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,1
GO:1902256,1,0.988754356,0,1,regulation of apoptotic process involved in outflow tract morphogenesis,BP,1
GO:1902259,1,0.954542135,0,5,regulation of delayed rectifier potassium channel activity,BP,1
GO:1902260,1,0.982140065,0,2,negative regulation of delayed rectifier potassium channel activity,BP,1
GO:1902261,1,0.983050599,0,2,positive regulation of delayed rectifier potassium channel activity,BP,1
GO:1902262,1,0.957664133,0,4,apoptotic process involved in blood vessel morphogenesis,BP,1
GO:1902263,1,0.972284095,0,3,apoptotic process involved in embryonic digit morphogenesis,BP,1
GO:1902267,1,0.967719509,0,3,regulation of polyamine transmembrane transport,BP,1
GO:1902268,1,0.977453211,0,2,negative regulation of polyamine transmembrane transport,BP,1
GO:1902269,1,0.99004358,0,1,positive regulation of polyamine transmembrane transport,BP,1
GO:1902276,1,0.979939468,0,2,regulation of pancreatic amylase secretion,BP,1
GO:1902277,1,0.991177882,0,1,negative regulation of pancreatic amylase secretion,BP,1
GO:1902278,1,0.988662358,0,1,positive regulation of pancreatic amylase secretion,BP,1
GO:1902283,1,0.989642663,0,1,negative regulation of primary amine oxidase activity,BP,1
GO:1902285,1,0.931788641,0,8,semaphorin-plexin signaling pathway involved in neuron projection guidance,BP,1
GO:1902287,1,0.94210972,0,7,semaphorin-plexin signaling pathway involved in axon guidance,BP,1
GO:1902292,1,0.958527852,0,4,cell cycle DNA replication initiation,BP,1
GO:1902294,1,0.988662931,0,1,cell cycle DNA replication termination,BP,1
GO:1902299,1,0.934637142,0,6,pre-replicative complex assembly involved in cell cycle DNA replication,BP,1
GO:1902302,1,0.980285658,0,2,regulation of potassium ion export,BP,1
GO:1902304,1,0.991229526,0,1,positive regulation of potassium ion export,BP,1
GO:1902305,1,0.68050473,0,36,regulation of sodium ion transmembrane transport,BP,1
GO:1902306,1,0.902355193,0,10,negative regulation of sodium ion transmembrane transport,BP,1
GO:1902307,1,0.853256092,0,15,positive regulation of sodium ion transmembrane transport,BP,1
GO:1902308,1,0.967268305,0,3,regulation of peptidyl-serine dephosphorylation,BP,1
GO:1902309,1,0.978361992,0,2,negative regulation of peptidyl-serine dephosphorylation,BP,1
GO:1902310,1,0.988662931,0,1,positive regulation of peptidyl-serine dephosphorylation,BP,1
GO:1902311,1,0.988690926,0,1,regulation of copper ion transmembrane transport,BP,1
GO:1902315,1,0.958527852,0,4,nuclear cell cycle DNA replication initiation,BP,1
GO:1902317,1,0.988662931,0,1,nuclear DNA replication termination,BP,1
GO:1902337,1,0.898744694,0,10,regulation of apoptotic process involved in morphogenesis,BP,1
GO:1902338,1,0.967341271,0,3,negative regulation of apoptotic process involved in morphogenesis,BP,1
GO:1902339,1,0.939678192,0,6,positive regulation of apoptotic process involved in morphogenesis,BP,1
GO:1902340,1,0.988662918,0,1,negative regulation of chromosome condensation,BP,1
GO:1902356,1,0.966369875,0,3,oxaloacetate(2-) transmembrane transport,BP,1
GO:1902359,1,0.988679996,0,1,Notch signaling pathway involved in somitogenesis,BP,1
GO:1902363,1,0.988662931,0,1,regulation of protein localization to spindle pole body,BP,1
GO:1902365,1,0.988662931,0,1,positive regulation of protein localization to spindle pole body,BP,1
GO:1902366,1,0.988679996,0,1,regulation of Notch signaling pathway involved in somitogenesis,BP,1
GO:1902367,1,0.988679996,0,1,negative regulation of Notch signaling pathway involved in somitogenesis,BP,1
GO:1902378,1,0.989548998,0,1,VEGF-activated neuropilin signaling pathway involved in axon guidance,BP,1
GO:1902389,1,0.933861978,0,6,ceramide 1-phosphate transport,BP,1
GO:1902396,1,0.983765656,0,2,protein localization to bicellular tight junction,BP,1
GO:1902410,1,0.826185038,0,17,mitotic cytokinetic process,BP,1
GO:1902412,1,0.958415905,0,4,regulation of mitotic cytokinesis,BP,1
GO:1902414,1,0.871476316,0,13,protein localization to cell junction,BP,1
GO:1902415,1,0.914382496,0,8,regulation of mRNA binding,BP,1
GO:1902416,1,0.935252241,0,6,positive regulation of mRNA binding,BP,1
GO:1902423,1,0.977837682,0,2,regulation of attachment of mitotic spindle microtubules to kinetochore,BP,1
GO:1902425,1,0.977837682,0,2,positive regulation of attachment of mitotic spindle microtubules to kinetochore,BP,1
GO:1902430,1,0.899521381,0,10,negative regulation of amyloid-beta formation,BP,1
GO:1902435,1,0.977453476,0,2,regulation of male mating behavior,BP,1
GO:1902437,1,0.977453476,0,2,positive regulation of male mating behavior,BP,1
GO:1902442,1,0.979242493,0,2,regulation of ripoptosome assembly involved in necroptotic process,BP,1
GO:1902443,1,0.979242493,0,2,negative regulation of ripoptosome assembly involved in necroptotic process,BP,1
GO:1902445,1,0.966369301,0,3,regulation of mitochondrial membrane permeability involved in programmed necrotic cell death,BP,1
GO:1902455,1,0.955452879,0,4,negative regulation of stem cell population maintenance,BP,1
GO:1902459,1,0.915469965,0,8,positive regulation of stem cell population maintenance,BP,1
GO:1902460,1,0.988662931,0,1,regulation of mesenchymal stem cell proliferation,BP,1
GO:1902462,1,0.988662931,0,1,positive regulation of mesenchymal stem cell proliferation,BP,1
GO:1902463,1,0.955410699,0,4,protein localization to cell leading edge,BP,1
GO:1902464,1,0.991451586,0,1,regulation of histone H3-K27 trimethylation,BP,1
GO:1902466,1,0.991451586,0,1,positive regulation of histone H3-K27 trimethylation,BP,1
GO:1902473,1,0.840338949,0,16,regulation of protein localization to synapse,BP,1
GO:1902474,1,0.97995736,0,2,positive regulation of protein localization to synapse,BP,1
GO:1902475,1,0.706893326,0,31,L-alpha-amino acid transmembrane transport,BP,1
GO:1902477,1,0.988663778,0,1,"regulation of defense response to bacterium, incompatible interaction",BP,1
GO:1902488,1,0.982938885,0,2,cholangiocyte apoptotic process,BP,1
GO:1902498,1,0.955453356,0,4,regulation of protein autoubiquitination,BP,1
GO:1902499,1,0.977496571,0,2,positive regulation of protein autoubiquitination,BP,1
GO:1902504,1,0.988662931,0,1,regulation of signal transduction involved in mitotic G2 DNA damage checkpoint,BP,1
GO:1902510,1,0.895276396,0,10,regulation of apoptotic DNA fragmentation,BP,1
GO:1902511,1,0.966727884,0,3,negative regulation of apoptotic DNA fragmentation,BP,1
GO:1902512,1,0.955418207,0,4,positive regulation of apoptotic DNA fragmentation,BP,1
GO:1902513,1,0.947549234,0,5,regulation of organelle transport along microtubule,BP,1
GO:1902514,1,0.949517659,0,5,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,1
GO:1902523,1,0.978067399,0,2,positive regulation of protein K63-linked ubiquitination,BP,1
GO:1902524,1,0.977552683,0,2,positive regulation of protein K48-linked ubiquitination,BP,1
GO:1902525,1,0.934751838,0,6,regulation of protein monoubiquitination,BP,1
GO:1902527,1,0.944671511,0,5,positive regulation of protein monoubiquitination,BP,1
GO:1902528,1,0.988672845,0,1,regulation of protein linear polyubiquitination,BP,1
GO:1902530,1,0.988672845,0,1,positive regulation of protein linear polyubiquitination,BP,1
GO:1902544,1,0.977540684,0,2,regulation of DNA N-glycosylase activity,BP,1
GO:1902546,1,0.988662662,0,1,positive regulation of DNA N-glycosylase activity,BP,1
GO:1902548,1,0.920095141,0,8,negative regulation of cellular response to vascular endothelial growth factor stimulus,BP,1
GO:1902559,1,0.977453375,0,2,3'-phospho-5'-adenylyl sulfate transmembrane transport,BP,1
GO:1902563,1,0.936851216,0,6,regulation of neutrophil activation,BP,1
GO:1902564,1,0.966369909,0,3,negative regulation of neutrophil activation,BP,1
GO:1902565,1,0.978042744,0,2,positive regulation of neutrophil activation,BP,1
GO:1902566,1,0.977453187,0,2,regulation of eosinophil activation,BP,1
GO:1902567,1,0.988662931,0,1,negative regulation of eosinophil activation,BP,1
GO:1902568,1,0.98866274,0,1,positive regulation of eosinophil activation,BP,1
GO:1902569,1,0.977453334,0,2,negative regulation of activation of Janus kinase activity,BP,1
GO:1902570,1,0.857252347,0,14,protein localization to nucleolus,BP,1
GO:1902571,1,0.98866291,0,1,regulation of serine-type peptidase activity,BP,1
GO:1902572,1,0.98866291,0,1,negative regulation of serine-type peptidase activity,BP,1
GO:1902579,1,0.791222253,0,21,multi-organism localization,BP,1
GO:1902581,1,0.966369484,0,3,multi-organism cellular localization,BP,1
GO:1902583,1,0.966369484,0,3,multi-organism intracellular transport,BP,1
GO:1902594,1,0.977453275,0,2,multi-organism nuclear import,BP,1
GO:1902595,1,0.988662931,0,1,regulation of DNA replication origin binding,BP,1
GO:1902600,1,0.376393012,0,87,proton transmembrane transport,BP,1
GO:1902603,1,0.977612078,0,2,carnitine transmembrane transport,BP,1
GO:1902605,1,0.988664351,0,1,heterotrimeric G-protein complex assembly,BP,1
GO:1902616,1,0.977453375,0,2,acyl carnitine transmembrane transport,BP,1
GO:1902617,1,0.897292864,0,10,response to fluoride,BP,1
GO:1902618,1,0.983017309,0,2,cellular response to fluoride,BP,1
GO:1902622,1,0.709599021,0,31,regulation of neutrophil migration,BP,1
GO:1902623,1,0.977453357,0,2,negative regulation of neutrophil migration,BP,1
GO:1902624,1,0.75093789,0,26,positive regulation of neutrophil migration,BP,1
GO:1902626,1,0.966369489,0,3,assembly of large subunit precursor of preribosome,BP,1
GO:1902629,1,0.988662853,0,1,regulation of mRNA stability involved in cellular response to UV,BP,1
GO:1902630,1,0.988662931,0,1,regulation of membrane hyperpolarization,BP,1
GO:1902631,1,0.988662931,0,1,negative regulation of membrane hyperpolarization,BP,1
GO:1902644,1,0.863328535,0,13,tertiary alcohol metabolic process,BP,1
GO:1902645,1,0.92451,0,7,tertiary alcohol biosynthetic process,BP,1
GO:1902656,1,0.935561764,0,6,calcium ion import into cytosol,BP,1
GO:1902659,1,0.980278989,0,2,regulation of glucose mediated signaling pathway,BP,1
GO:1902661,1,0.980278989,0,2,positive regulation of glucose mediated signaling pathway,BP,1
GO:1902668,1,0.860629627,0,15,negative regulation of axon guidance,BP,1
GO:1902683,1,0.828709224,0,17,regulation of receptor localization to synapse,BP,1
GO:1902685,1,0.966409249,0,3,positive regulation of receptor localization to synapse,BP,1
GO:1902688,1,0.966369904,0,3,regulation of NAD metabolic process,BP,1
GO:1902689,1,0.966369904,0,3,negative regulation of NAD metabolic process,BP,1
GO:1902691,1,0.988662999,0,1,respiratory basal cell differentiation,BP,1
GO:1902713,1,0.955427579,0,4,regulation of interferon-gamma secretion,BP,1
GO:1902714,1,0.966386669,0,3,negative regulation of interferon-gamma secretion,BP,1
GO:1902715,1,0.977453214,0,2,positive regulation of interferon-gamma secretion,BP,1
GO:1902721,1,0.988662887,0,1,negative regulation of prolactin secretion,BP,1
GO:1902722,1,0.978710451,0,2,positive regulation of prolactin secretion,BP,1
GO:1902723,1,0.977466873,0,2,negative regulation of skeletal muscle satellite cell proliferation,BP,1
GO:1902724,1,0.979791831,0,2,positive regulation of skeletal muscle satellite cell proliferation,BP,1
GO:1902725,1,0.988663015,0,1,negative regulation of satellite cell differentiation,BP,1
GO:1902728,1,0.979791831,0,2,positive regulation of growth factor dependent skeletal muscle satellite cell proliferation,BP,1
GO:1902730,1,0.966373111,0,3,positive regulation of proteoglycan biosynthetic process,BP,1
GO:1902731,1,0.978057179,0,2,negative regulation of chondrocyte proliferation,BP,1
GO:1902732,1,0.988662916,0,1,positive regulation of chondrocyte proliferation,BP,1
GO:1902739,1,0.919664504,0,8,regulation of interferon-alpha secretion,BP,1
GO:1902741,1,0.919664504,0,8,positive regulation of interferon-alpha secretion,BP,1
GO:1902742,1,0.763817561,0,25,apoptotic process involved in development,BP,1
GO:1902743,1,0.699086209,0,33,regulation of lamellipodium organization,BP,1
GO:1902744,1,0.946880798,0,5,negative regulation of lamellipodium organization,BP,1
GO:1902745,1,0.789148195,0,22,positive regulation of lamellipodium organization,BP,1
GO:1902746,1,0.967024177,0,3,regulation of lens fiber cell differentiation,BP,1
GO:1902748,1,0.989332177,0,1,positive regulation of lens fiber cell differentiation,BP,1
GO:1902751,1,0.839712723,0,16,positive regulation of cell cycle G2/M phase transition,BP,1
GO:1902766,1,0.977452899,0,2,skeletal muscle satellite cell migration,BP,1
GO:1902767,1,0.968093358,0,3,isoprenoid biosynthetic process via mevalonate,BP,1
GO:1902774,1,0.946305332,0,5,late endosome to lysosome transport,BP,1
GO:1902775,1,0.967229742,0,3,mitochondrial large ribosomal subunit assembly,BP,1
GO:1902804,1,0.956670883,0,4,negative regulation of synaptic vesicle transport,BP,1
GO:1902805,1,0.941547295,0,6,positive regulation of synaptic vesicle transport,BP,1
GO:1902808,1,0.69818509,0,34,positive regulation of cell cycle G1/S phase transition,BP,1
GO:1902809,1,0.988703396,0,1,regulation of skeletal muscle fiber differentiation,BP,1
GO:1902816,1,0.956758307,0,4,regulation of protein localization to microtubule,BP,1
GO:1902817,1,0.956758307,0,4,negative regulation of protein localization to microtubule,BP,1
GO:1902822,1,0.977721036,0,2,regulation of late endosome to lysosome transport,BP,1
GO:1902823,1,0.988933867,0,1,negative regulation of late endosome to lysosome transport,BP,1
GO:1902824,1,0.988662702,0,1,positive regulation of late endosome to lysosome transport,BP,1
GO:1902846,1,0.988662931,0,1,positive regulation of mitotic spindle elongation,BP,1
GO:1902847,1,0.988662929,0,1,regulation of neuronal signal transduction,BP,1
GO:1902855,1,0.884638851,0,12,regulation of non-motile cilium assembly,BP,1
GO:1902856,1,0.980615417,0,2,negative regulation of non-motile cilium assembly,BP,1
GO:1902857,1,0.912479818,0,9,positive regulation of non-motile cilium assembly,BP,1
GO:1902858,1,0.988662922,0,1,propionyl-CoA metabolic process,BP,1
GO:1902860,1,0.988662922,0,1,propionyl-CoA biosynthetic process,BP,1
GO:1902866,1,0.989103737,0,1,regulation of retina development in camera-type eye,BP,1
GO:1902883,1,0.630365277,0,41,negative regulation of response to oxidative stress,BP,1
GO:1902884,1,0.809030124,0,19,positive regulation of response to oxidative stress,BP,1
GO:1902889,1,0.98905161,0,1,protein localization to spindle microtubule,BP,1
GO:1902895,1,0.749119692,0,27,positive regulation of pri-miRNA transcription by RNA polymerase II,BP,1
GO:1902896,1,0.977577143,0,2,terminal web assembly,BP,1
GO:1902897,1,0.957941165,0,4,regulation of postsynaptic density protein 95 clustering,BP,1
GO:1902902,1,0.882389795,0,11,negative regulation of autophagosome assembly,BP,1
GO:1902913,1,0.988845897,0,1,positive regulation of neuroepithelial cell differentiation,BP,1
GO:1902914,1,0.812610208,0,19,regulation of protein polyubiquitination,BP,1
GO:1902915,1,0.920249428,0,8,negative regulation of protein polyubiquitination,BP,1
GO:1902916,1,0.893241464,0,10,positive regulation of protein polyubiquitination,BP,1
GO:1902930,1,0.665558826,0,37,regulation of alcohol biosynthetic process,BP,1
GO:1902931,1,0.893836108,0,10,negative regulation of alcohol biosynthetic process,BP,1
GO:1902932,1,0.81604567,0,18,positive regulation of alcohol biosynthetic process,BP,1
GO:1902938,1,0.988662938,0,1,regulation of intracellular calcium activated chloride channel activity,BP,1
GO:1902941,1,0.989013621,0,1,regulation of voltage-gated chloride channel activity,BP,1
GO:1902943,1,0.989013621,0,1,positive regulation of voltage-gated chloride channel activity,BP,1
GO:1902947,1,0.925492395,0,7,regulation of tau-protein kinase activity,BP,1
GO:1902948,1,0.99055958,0,1,negative regulation of tau-protein kinase activity,BP,1
GO:1902949,1,0.955860282,0,4,positive regulation of tau-protein kinase activity,BP,1
GO:1902950,1,0.903677393,0,9,regulation of dendritic spine maintenance,BP,1
GO:1902951,1,0.966369778,0,3,negative regulation of dendritic spine maintenance,BP,1
GO:1902952,1,0.978525545,0,2,positive regulation of dendritic spine maintenance,BP,1
GO:1902953,1,0.966369598,0,3,positive regulation of ER to Golgi vesicle-mediated transport,BP,1
GO:1902954,1,0.993540855,0,1,regulation of early endosome to recycling endosome transport,BP,1
GO:1902956,1,0.955410365,0,4,"regulation of mitochondrial electron transport, NADH to ubiquinone",BP,1
GO:1902957,1,0.988662643,0,1,"negative regulation of mitochondrial electron transport, NADH to ubiquinone",BP,1
GO:1902958,1,0.966369422,0,3,"positive regulation of mitochondrial electron transport, NADH to ubiquinone",BP,1
GO:1902959,1,0.939251264,0,6,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,1
GO:1902960,1,0.988667727,0,1,negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,1
GO:1902961,1,0.950021561,0,5,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,1
GO:1902962,1,0.988662931,0,1,regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,1
GO:1902963,1,0.988662931,0,1,negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,1
GO:1902975,1,0.958527852,0,4,mitotic DNA replication initiation,BP,1
GO:1902979,1,0.988662931,0,1,mitotic DNA replication termination,BP,1
GO:1902988,1,0.988662929,0,1,neurofibrillary tangle assembly,BP,1
GO:1902990,1,0.977453259,0,2,mitotic telomere maintenance via semi-conservative replication,BP,1
GO:1902991,1,0.771196043,0,24,regulation of amyloid precursor protein catabolic process,BP,1
GO:1902992,1,0.879247698,0,12,negative regulation of amyloid precursor protein catabolic process,BP,1
GO:1902993,1,0.868005383,0,13,positive regulation of amyloid precursor protein catabolic process,BP,1
GO:1902994,1,0.970048282,0,3,regulation of phospholipid efflux,BP,1
GO:1902995,1,0.970048282,0,3,positive regulation of phospholipid efflux,BP,1
GO:1902996,1,0.988662929,0,1,regulation of neurofibrillary tangle assembly,BP,1
GO:1902998,1,0.988662929,0,1,positive regulation of neurofibrillary tangle assembly,BP,1
GO:1903000,1,0.988662786,0,1,regulation of lipid transport across blood brain barrier,BP,1
GO:1903002,1,0.988662786,0,1,positive regulation of lipid transport across blood brain barrier,BP,1
GO:1903003,1,0.925011477,0,7,positive regulation of protein deubiquitination,BP,1
GO:1903004,1,0.977722671,0,2,regulation of protein K63-linked deubiquitination,BP,1
GO:1903006,1,0.977722671,0,2,positive regulation of protein K63-linked deubiquitination,BP,1
GO:1903007,1,0.988935291,0,1,positive regulation of Lys63-specific deubiquitinase activity,BP,1
GO:1903008,1,0.434891866,0,76,organelle disassembly,BP,1
GO:1903010,1,0.885910537,0,12,regulation of bone development,BP,1
GO:1903011,1,0.962669095,0,4,negative regulation of bone development,BP,1
GO:1903012,1,0.969095754,0,3,positive regulation of bone development,BP,1
GO:1903015,1,0.98866259,0,1,regulation of exo-alpha-sialidase activity,BP,1
GO:1903016,1,0.98866259,0,1,negative regulation of exo-alpha-sialidase activity,BP,1
GO:1903018,1,0.703732381,0,32,regulation of glycoprotein metabolic process,BP,1
GO:1903019,1,0.868272216,0,13,negative regulation of glycoprotein metabolic process,BP,1
GO:1903020,1,0.810689942,0,19,positive regulation of glycoprotein metabolic process,BP,1
GO:1903025,1,0.918367531,0,8,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,1
GO:1903026,1,0.955410489,0,4,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,1
GO:1903027,1,0.988662931,0,1,regulation of opsonization,BP,1
GO:1903028,1,0.988662931,0,1,positive regulation of opsonization,BP,1
GO:1903031,1,0.977454605,0,2,regulation of microtubule plus-end binding,BP,1
GO:1903033,1,0.977454605,0,2,positive regulation of microtubule plus-end binding,BP,1
GO:1903038,1,0.395268519,0,83,negative regulation of leukocyte cell-cell adhesion,BP,1
GO:1903044,1,0.927795093,0,7,protein localization to membrane raft,BP,1
GO:1903051,1,0.530147226,0,57,negative regulation of proteolysis involved in cellular protein catabolic process,BP,1
GO:1903053,1,0.741256636,0,28,regulation of extracellular matrix organization,BP,1
GO:1903054,1,0.921449611,0,8,negative regulation of extracellular matrix organization,BP,1
GO:1903055,1,0.849630691,0,15,positive regulation of extracellular matrix organization,BP,1
GO:1903056,1,0.989332177,0,1,regulation of melanosome organization,BP,1
GO:1903059,1,0.956672247,0,4,regulation of protein lipidation,BP,1
GO:1903061,1,0.956672247,0,4,positive regulation of protein lipidation,BP,1
GO:1903069,1,0.923682401,0,7,regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,1
GO:1903070,1,0.966369818,0,3,negative regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,1
GO:1903071,1,0.944998456,0,5,positive regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,1
GO:1903076,1,0.41163929,0,81,regulation of protein localization to plasma membrane,BP,1
GO:1903077,1,0.802262804,0,20,negative regulation of protein localization to plasma membrane,BP,1
GO:1903078,1,0.641677205,0,41,positive regulation of protein localization to plasma membrane,BP,1
GO:1903087,1,0.990336769,0,1,mitotic spindle pole body duplication,BP,1
GO:1903093,1,0.96636953,0,3,regulation of protein K48-linked deubiquitination,BP,1
GO:1903094,1,0.977452991,0,2,negative regulation of protein K48-linked deubiquitination,BP,1
GO:1903108,1,0.977453305,0,2,regulation of mitochondrial transcription,BP,1
GO:1903109,1,0.977453305,0,2,positive regulation of mitochondrial transcription,BP,1
GO:1903115,1,0.754565124,0,26,regulation of actin filament-based movement,BP,1
GO:1903116,1,0.96766388,0,3,positive regulation of actin filament-based movement,BP,1
GO:1903118,1,0.988662942,0,1,urate homeostasis,BP,1
GO:1903119,1,0.989052455,0,1,protein localization to actin cytoskeleton,BP,1
GO:1903121,1,0.955410869,0,4,regulation of TRAIL-activated apoptotic signaling pathway,BP,1
GO:1903122,1,0.988662773,0,1,negative regulation of TRAIL-activated apoptotic signaling pathway,BP,1
GO:1903123,1,0.988662931,0,1,regulation of thioredoxin peroxidase activity,BP,1
GO:1903124,1,0.988662931,0,1,negative regulation of thioredoxin peroxidase activity,BP,1
GO:1903125,1,0.988662931,0,1,negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation,BP,1
GO:1903140,1,0.89004548,0,11,regulation of establishment of endothelial barrier,BP,1
GO:1903141,1,0.988662931,0,1,negative regulation of establishment of endothelial barrier,BP,1
GO:1903142,1,0.949439045,0,5,positive regulation of establishment of endothelial barrier,BP,1
GO:1903146,1,0.708675812,0,32,regulation of autophagy of mitochondrion,BP,1
GO:1903147,1,0.913165692,0,8,negative regulation of autophagy of mitochondrion,BP,1
GO:1903165,1,0.9665494,0,3,response to polycyclic arene,BP,1
GO:1903166,1,0.98868351,0,1,cellular response to polycyclic arene,BP,1
GO:1903167,1,0.988662773,0,1,regulation of pyrroline-5-carboxylate reductase activity,BP,1
GO:1903168,1,0.988662773,0,1,positive regulation of pyrroline-5-carboxylate reductase activity,BP,1
GO:1903169,1,0.414947538,0,81,regulation of calcium ion transmembrane transport,BP,1
GO:1903170,1,0.801927203,0,20,negative regulation of calcium ion transmembrane transport,BP,1
GO:1903173,1,0.977590221,0,2,fatty alcohol metabolic process,BP,1
GO:1903176,1,0.988662773,0,1,regulation of tyrosine 3-monooxygenase activity,BP,1
GO:1903178,1,0.988662773,0,1,positive regulation of tyrosine 3-monooxygenase activity,BP,1
GO:1903179,1,0.966686808,0,3,regulation of dopamine biosynthetic process,BP,1
GO:1903181,1,0.966686808,0,3,positive regulation of dopamine biosynthetic process,BP,1
GO:1903182,1,0.988662779,0,1,regulation of SUMO transferase activity,BP,1
GO:1903184,1,0.988662773,0,1,L-dopa metabolic process,BP,1
GO:1903185,1,0.988662773,0,1,L-dopa biosynthetic process,BP,1
GO:1903189,1,0.988662773,0,1,glyoxal metabolic process,BP,1
GO:1903195,1,0.988662773,0,1,regulation of L-dopa biosynthetic process,BP,1
GO:1903197,1,0.988662773,0,1,positive regulation of L-dopa biosynthetic process,BP,1
GO:1903198,1,0.988662773,0,1,regulation of L-dopa decarboxylase activity,BP,1
GO:1903200,1,0.988662773,0,1,positive regulation of L-dopa decarboxylase activity,BP,1
GO:1903201,1,0.52755213,0,57,regulation of oxidative stress-induced cell death,BP,1
GO:1903202,1,0.644957406,0,39,negative regulation of oxidative stress-induced cell death,BP,1
GO:1903203,1,0.757920175,0,25,regulation of oxidative stress-induced neuron death,BP,1
GO:1903204,1,0.827669251,0,17,negative regulation of oxidative stress-induced neuron death,BP,1
GO:1903205,1,0.75436143,0,25,regulation of hydrogen peroxide-induced cell death,BP,1
GO:1903206,1,0.815686407,0,18,negative regulation of hydrogen peroxide-induced cell death,BP,1
GO:1903207,1,0.955410849,0,4,regulation of hydrogen peroxide-induced neuron death,BP,1
GO:1903208,1,0.955410849,0,4,negative regulation of hydrogen peroxide-induced neuron death,BP,1
GO:1903209,1,0.846826681,0,15,positive regulation of oxidative stress-induced cell death,BP,1
GO:1903214,1,0.852614469,0,14,regulation of protein targeting to mitochondrion,BP,1
GO:1903215,1,0.955413147,0,4,negative regulation of protein targeting to mitochondrion,BP,1
GO:1903216,1,0.988662917,0,1,regulation of protein processing involved in protein targeting to mitochondrion,BP,1
GO:1903217,1,0.988662917,0,1,negative regulation of protein processing involved in protein targeting to mitochondrion,BP,1
GO:1903223,1,0.926107503,0,7,positive regulation of oxidative stress-induced neuron death,BP,1
GO:1903224,1,0.972510544,0,3,regulation of endodermal cell differentiation,BP,1
GO:1903225,1,0.983663881,0,2,negative regulation of endodermal cell differentiation,BP,1
GO:1903232,1,0.944610395,0,5,melanosome assembly,BP,1
GO:1903233,1,0.978929447,0,2,regulation of calcium ion-dependent exocytosis of neurotransmitter,BP,1
GO:1903236,1,0.945109597,0,5,regulation of leukocyte tethering or rolling,BP,1
GO:1903237,1,0.977536491,0,2,negative regulation of leukocyte tethering or rolling,BP,1
GO:1903238,1,0.966833873,0,3,positive regulation of leukocyte tethering or rolling,BP,1
GO:1903241,1,0.968569327,0,3,U2-type prespliceosome assembly,BP,1
GO:1903242,1,0.926293028,0,7,regulation of cardiac muscle hypertrophy in response to stress,BP,1
GO:1903243,1,0.947666353,0,5,negative regulation of cardiac muscle hypertrophy in response to stress,BP,1
GO:1903244,1,0.988665619,0,1,positive regulation of cardiac muscle hypertrophy in response to stress,BP,1
GO:1903248,1,0.989736892,0,1,regulation of citrulline biosynthetic process,BP,1
GO:1903249,1,0.989736892,0,1,negative regulation of citrulline biosynthetic process,BP,1
GO:1903251,1,0.97745336,0,2,multi-ciliated epithelial cell differentiation,BP,1
GO:1903259,1,0.988662931,0,1,exon-exon junction complex disassembly,BP,1
GO:1903276,1,0.959729783,0,4,regulation of sodium ion export across plasma membrane,BP,1
GO:1903277,1,0.993131088,0,1,negative regulation of sodium ion export across plasma membrane,BP,1
GO:1903278,1,0.966369507,0,3,positive regulation of sodium ion export across plasma membrane,BP,1
GO:1903279,1,0.970398608,0,3,regulation of calcium:sodium antiporter activity,BP,1
GO:1903280,1,0.991045527,0,1,negative regulation of calcium:sodium antiporter activity,BP,1
GO:1903281,1,0.979168014,0,2,positive regulation of calcium:sodium antiporter activity,BP,1
GO:1903285,1,0.989889186,0,1,positive regulation of hydrogen peroxide catabolic process,BP,1
GO:1903286,1,0.960097567,0,4,regulation of potassium ion import,BP,1
GO:1903288,1,0.970817851,0,3,positive regulation of potassium ion import,BP,1
GO:1903292,1,0.977507521,0,2,protein localization to Golgi membrane,BP,1
GO:1903294,1,0.955926015,0,4,"regulation of glutamate secretion, neurotransmission",BP,1
GO:1903296,1,0.955926015,0,4,"positive regulation of glutamate secretion, neurotransmission",BP,1
GO:1903297,1,0.946057059,0,5,regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,1
GO:1903298,1,0.946057059,0,5,negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,1
GO:1903299,1,0.902439274,0,9,regulation of hexokinase activity,BP,1
GO:1903300,1,0.96637015,0,3,negative regulation of hexokinase activity,BP,1
GO:1903301,1,0.923268789,0,7,positive regulation of hexokinase activity,BP,1
GO:1903302,1,0.988663092,0,1,regulation of pyruvate kinase activity,BP,1
GO:1903306,1,0.830545494,0,17,negative regulation of regulated secretory pathway,BP,1
GO:1903307,1,0.736796196,0,28,positive regulation of regulated secretory pathway,BP,1
GO:1903314,1,0.988662931,0,1,regulation of nitrogen cycle metabolic process,BP,1
GO:1903317,1,0.493131599,0,64,regulation of protein maturation,BP,1
GO:1903318,1,0.718368994,0,30,negative regulation of protein maturation,BP,1
GO:1903319,1,0.783211518,0,22,positive regulation of protein maturation,BP,1
GO:1903332,1,0.87206835,0,12,regulation of protein folding,BP,1
GO:1903333,1,0.94457664,0,5,negative regulation of protein folding,BP,1
GO:1903334,1,0.933863932,0,6,positive regulation of protein folding,BP,1
GO:1903335,1,0.966634214,0,3,regulation of vacuolar transport,BP,1
GO:1903336,1,0.988933867,0,1,negative regulation of vacuolar transport,BP,1
GO:1903337,1,0.988662702,0,1,positive regulation of vacuolar transport,BP,1
GO:1903347,1,0.95910009,0,4,negative regulation of bicellular tight junction assembly,BP,1
GO:1903348,1,0.978627705,0,2,positive regulation of bicellular tight junction assembly,BP,1
GO:1903350,1,0.876114912,0,12,response to dopamine,BP,1
GO:1903351,1,0.886171156,0,11,cellular response to dopamine,BP,1
GO:1903352,1,0.966382482,0,3,L-ornithine transmembrane transport,BP,1
GO:1903353,1,0.988662871,0,1,regulation of nucleus organization,BP,1
GO:1903358,1,0.849955024,0,15,regulation of Golgi organization,BP,1
GO:1903361,1,0.93388233,0,6,protein localization to basolateral plasma membrane,BP,1
GO:1903363,1,0.475317537,0,67,negative regulation of cellular protein catabolic process,BP,1
GO:1903365,1,0.950501514,0,5,regulation of fear response,BP,1
GO:1903367,1,0.967952724,0,3,positive regulation of fear response,BP,1
GO:1903371,1,0.945822563,0,5,regulation of endoplasmic reticulum tubular network organization,BP,1
GO:1903373,1,0.956672247,0,4,positive regulation of endoplasmic reticulum tubular network organization,BP,1
GO:1903375,1,0.978712453,0,2,facioacoustic ganglion development,BP,1
GO:1903376,1,0.925043345,0,7,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,1
GO:1903377,1,0.956106531,0,4,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,1
GO:1903378,1,0.978054182,0,2,positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,1
GO:1903381,1,0.990213291,0,1,regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,1
GO:1903382,1,0.990213291,0,1,negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,1
GO:1903383,1,0.977453096,0,2,regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,1
GO:1903384,1,0.977453096,0,2,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,1
GO:1903385,1,0.979730368,0,2,regulation of homophilic cell adhesion,BP,1
GO:1903387,1,0.979730368,0,2,positive regulation of homophilic cell adhesion,BP,1
GO:1903392,1,0.846173837,0,16,negative regulation of adherens junction organization,BP,1
GO:1903400,1,0.955423704,0,4,L-arginine transmembrane transport,BP,1
GO:1903401,1,0.955423708,0,4,L-lysine transmembrane transport,BP,1
GO:1903405,1,0.988662931,0,1,protein localization to nuclear body,BP,1
GO:1903406,1,0.960210268,0,4,regulation of sodium:potassium-exchanging ATPase activity,BP,1
GO:1903407,1,0.981870653,0,2,negative regulation of sodium:potassium-exchanging ATPase activity,BP,1
GO:1903408,1,0.989158588,0,1,positive regulation of sodium:potassium-exchanging ATPase activity,BP,1
GO:1903412,1,0.97842384,0,2,response to bile acid,BP,1
GO:1903413,1,0.97842384,0,2,cellular response to bile acid,BP,1
GO:1903420,1,0.988662931,0,1,protein localization to endoplasmic reticulum tubular network,BP,1
GO:1903421,1,0.764272633,0,24,regulation of synaptic vesicle recycling,BP,1
GO:1903422,1,0.99021095,0,1,negative regulation of synaptic vesicle recycling,BP,1
GO:1903423,1,0.872364122,0,12,positive regulation of synaptic vesicle recycling,BP,1
GO:1903427,1,0.725032083,0,29,negative regulation of reactive oxygen species biosynthetic process,BP,1
GO:1903429,1,0.765209761,0,24,regulation of cell maturation,BP,1
GO:1903430,1,0.923739888,0,7,negative regulation of cell maturation,BP,1
GO:1903431,1,0.887152194,0,11,positive regulation of cell maturation,BP,1
GO:1903433,1,0.977873142,0,2,regulation of constitutive secretory pathway,BP,1
GO:1903434,1,0.989048237,0,1,negative regulation of constitutive secretory pathway,BP,1
GO:1903435,1,0.988702153,0,1,positive regulation of constitutive secretory pathway,BP,1
GO:1903436,1,0.980283667,0,2,regulation of mitotic cytokinetic process,BP,1
GO:1903438,1,0.980283667,0,2,positive regulation of mitotic cytokinetic process,BP,1
GO:1903441,1,0.924309346,0,7,protein localization to ciliary membrane,BP,1
GO:1903445,1,0.966369659,0,3,protein transport from ciliary membrane to plasma membrane,BP,1
GO:1903450,1,0.98886169,0,1,regulation of G1 to G0 transition,BP,1
GO:1903452,1,0.98886169,0,1,positive regulation of G1 to G0 transition,BP,1
GO:1903457,1,0.988662902,0,1,lactate catabolic process,BP,1
GO:1903461,1,0.988840529,0,1,Okazaki fragment processing involved in mitotic DNA replication,BP,1
GO:1903465,1,0.988673601,0,1,positive regulation of mitotic cell cycle DNA replication,BP,1
GO:1903487,1,0.977453358,0,2,regulation of lactation,BP,1
GO:1903489,1,0.977453358,0,2,positive regulation of lactation,BP,1
GO:1903490,1,0.980283667,0,2,positive regulation of mitotic cytokinesis,BP,1
GO:1903509,1,0.484864333,0,64,liposaccharide metabolic process,BP,1
GO:1903513,1,0.753161181,0,25,endoplasmic reticulum to cytosol transport,BP,1
GO:1903514,1,0.862699798,0,14,release of sequestered calcium ion into cytosol by endoplasmic reticulum,BP,1
GO:1903515,1,0.990155795,0,1,calcium ion transport from cytosol to endoplasmic reticulum,BP,1
GO:1903516,1,0.978017649,0,2,regulation of single strand break repair,BP,1
GO:1903518,1,0.978017649,0,2,positive regulation of single strand break repair,BP,1
GO:1903519,1,0.966370798,0,3,regulation of mammary gland involution,BP,1
GO:1903521,1,0.966370798,0,3,positive regulation of mammary gland involution,BP,1
GO:1903522,1,0.280787086,0,115,regulation of blood circulation,BP,1
GO:1903523,1,0.751692886,0,26,negative regulation of blood circulation,BP,1
GO:1903524,1,0.644350309,0,39,positive regulation of blood circulation,BP,1
GO:1903525,1,0.945508817,0,5,regulation of membrane tubulation,BP,1
GO:1903526,1,0.977943177,0,2,negative regulation of membrane tubulation,BP,1
GO:1903527,1,0.966839924,0,3,positive regulation of membrane tubulation,BP,1
GO:1903533,1,0.617131255,0,43,regulation of protein targeting,BP,1
GO:1903537,1,0.87212956,0,12,meiotic cell cycle process involved in oocyte maturation,BP,1
GO:1903538,1,0.87212956,0,12,regulation of meiotic cell cycle process involved in oocyte maturation,BP,1
GO:1903539,1,0.739813101,0,27,protein localization to postsynaptic membrane,BP,1
GO:1903540,1,0.872446085,0,12,establishment of protein localization to postsynaptic membrane,BP,1
GO:1903541,1,0.848418862,0,15,regulation of exosomal secretion,BP,1
GO:1903542,1,0.977529929,0,2,negative regulation of exosomal secretion,BP,1
GO:1903543,1,0.848418862,0,15,positive regulation of exosomal secretion,BP,1
GO:1903544,1,0.969081004,0,3,response to butyrate,BP,1
GO:1903545,1,0.97773091,0,2,cellular response to butyrate,BP,1
GO:1903546,1,0.966384183,0,3,protein localization to photoreceptor outer segment,BP,1
GO:1903551,1,0.934160084,0,6,regulation of extracellular exosome assembly,BP,1
GO:1903553,1,0.955567836,0,4,positive regulation of extracellular exosome assembly,BP,1
GO:1903564,1,0.924566771,0,7,regulation of protein localization to cilium,BP,1
GO:1903565,1,0.977453321,0,2,negative regulation of protein localization to cilium,BP,1
GO:1903566,1,0.956753725,0,4,positive regulation of protein localization to cilium,BP,1
GO:1903567,1,0.977453321,0,2,regulation of protein localization to ciliary membrane,BP,1
GO:1903568,1,0.988662877,0,1,negative regulation of protein localization to ciliary membrane,BP,1
GO:1903569,1,0.988662931,0,1,positive regulation of protein localization to ciliary membrane,BP,1
GO:1903575,1,0.967128488,0,3,cornified envelope assembly,BP,1
GO:1903576,1,0.957299899,0,4,response to L-arginine,BP,1
GO:1903584,1,0.989300097,0,1,regulation of histone deubiquitination,BP,1
GO:1903586,1,0.989300097,0,1,positive regulation of histone deubiquitination,BP,1
GO:1903588,1,0.966800766,0,3,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,1
GO:1903593,1,0.96637431,0,3,regulation of histamine secretion by mast cell,BP,1
GO:1903595,1,0.96637431,0,3,positive regulation of histamine secretion by mast cell,BP,1
GO:1903596,1,0.966381608,0,3,regulation of gap junction assembly,BP,1
GO:1903598,1,0.966381608,0,3,positive regulation of gap junction assembly,BP,1
GO:1903599,1,0.840472877,0,17,positive regulation of autophagy of mitochondrion,BP,1
GO:1903608,1,0.936550313,0,6,protein localization to cytoplasmic stress granule,BP,1
GO:1903609,1,0.980505121,0,2,negative regulation of inward rectifier potassium channel activity,BP,1
GO:1903610,1,0.988662913,0,1,regulation of calcium-dependent ATPase activity,BP,1
GO:1903611,1,0.988662913,0,1,negative regulation of calcium-dependent ATPase activity,BP,1
GO:1903613,1,0.970408384,0,3,regulation of protein tyrosine phosphatase activity,BP,1
GO:1903614,1,0.988663229,0,1,negative regulation of protein tyrosine phosphatase activity,BP,1
GO:1903615,1,0.981537501,0,2,positive regulation of protein tyrosine phosphatase activity,BP,1
GO:1903618,1,0.989079059,0,1,regulation of transdifferentiation,BP,1
GO:1903620,1,0.989079059,0,1,positive regulation of transdifferentiation,BP,1
GO:1903621,1,0.988662929,0,1,protein localization to photoreceptor connecting cilium,BP,1
GO:1903624,1,0.880757653,0,12,regulation of DNA catabolic process,BP,1
GO:1903625,1,0.955765055,0,4,negative regulation of DNA catabolic process,BP,1
GO:1903626,1,0.950714823,0,5,positive regulation of DNA catabolic process,BP,1
GO:1903627,1,0.988662913,0,1,regulation of dUTP diphosphatase activity,BP,1
GO:1903629,1,0.988662913,0,1,positive regulation of dUTP diphosphatase activity,BP,1
GO:1903630,1,0.966369605,0,3,regulation of aminoacyl-tRNA ligase activity,BP,1
GO:1903631,1,0.988662913,0,1,negative regulation of aminoacyl-tRNA ligase activity,BP,1
GO:1903632,1,0.977453086,0,2,positive regulation of aminoacyl-tRNA ligase activity,BP,1
GO:1903633,1,0.988662913,0,1,regulation of leucine-tRNA ligase activity,BP,1
GO:1903634,1,0.988662913,0,1,negative regulation of leucine-tRNA ligase activity,BP,1
GO:1903636,1,0.988662576,0,1,regulation of protein import into mitochondrial outer membrane,BP,1
GO:1903638,1,0.988662576,0,1,positive regulation of protein import into mitochondrial outer membrane,BP,1
GO:1903639,1,0.988662843,0,1,regulation of gastrin-induced gastric acid secretion,BP,1
GO:1903640,1,0.988662843,0,1,negative regulation of gastrin-induced gastric acid secretion,BP,1
GO:1903644,1,0.955410656,0,4,regulation of chaperone-mediated protein folding,BP,1
GO:1903645,1,0.988662576,0,1,negative regulation of chaperone-mediated protein folding,BP,1
GO:1903646,1,0.977453245,0,2,positive regulation of chaperone-mediated protein folding,BP,1
GO:1903649,1,0.788007605,0,22,regulation of cytoplasmic transport,BP,1
GO:1903650,1,0.988662546,0,1,negative regulation of cytoplasmic transport,BP,1
GO:1903651,1,0.889067223,0,11,positive regulation of cytoplasmic transport,BP,1
GO:1903659,1,0.924077991,0,7,regulation of complement-dependent cytotoxicity,BP,1
GO:1903660,1,0.956244846,0,4,negative regulation of complement-dependent cytotoxicity,BP,1
GO:1903661,1,0.977453375,0,2,positive regulation of complement-dependent cytotoxicity,BP,1
GO:1903673,1,0.988662533,0,1,mitotic cleavage furrow formation,BP,1
GO:1903674,1,0.988662901,0,1,regulation of cap-dependent translational initiation,BP,1
GO:1903676,1,0.988662901,0,1,positive regulation of cap-dependent translational initiation,BP,1
GO:1903677,1,0.96639972,0,3,regulation of cap-independent translational initiation,BP,1
GO:1903679,1,0.96639972,0,3,positive regulation of cap-independent translational initiation,BP,1
GO:1903689,1,0.947012628,0,6,"regulation of wound healing, spreading of epidermal cells",BP,1
GO:1903690,1,0.958173501,0,4,"negative regulation of wound healing, spreading of epidermal cells",BP,1
GO:1903691,1,0.988355907,0,2,"positive regulation of wound healing, spreading of epidermal cells",BP,1
GO:1903699,1,0.986505027,0,2,tarsal gland development,BP,1
GO:1903701,1,0.988754356,0,1,substantia propria of cornea development,BP,1
GO:1903704,1,0.989079059,0,1,negative regulation of production of siRNA involved in RNA interference,BP,1
GO:1903709,1,0.995533389,0,1,uterine gland development,BP,1
GO:1903715,1,0.936127903,0,6,regulation of aerobic respiration,BP,1
GO:1903717,1,0.990209779,0,1,response to ammonia,BP,1
GO:1903718,1,0.990209779,0,1,cellular response to ammonia,BP,1
GO:1903719,1,0.945600746,0,5,regulation of I-kappaB phosphorylation,BP,1
GO:1903720,1,0.989559177,0,1,negative regulation of I-kappaB phosphorylation,BP,1
GO:1903721,1,0.955581411,0,4,positive regulation of I-kappaB phosphorylation,BP,1
GO:1903722,1,0.946249326,0,5,regulation of centriole elongation,BP,1
GO:1903723,1,0.988662712,0,1,negative regulation of centriole elongation,BP,1
GO:1903724,1,0.957104076,0,4,positive regulation of centriole elongation,BP,1
GO:1903725,1,0.506158609,0,63,regulation of phospholipid metabolic process,BP,1
GO:1903726,1,0.927597968,0,7,negative regulation of phospholipid metabolic process,BP,1
GO:1903727,1,0.693224061,0,34,positive regulation of phospholipid metabolic process,BP,1
GO:1903729,1,0.883080008,0,11,regulation of plasma membrane organization,BP,1
GO:1903742,1,0.980414537,0,2,regulation of anterograde synaptic vesicle transport,BP,1
GO:1903744,1,0.980414537,0,2,positive regulation of anterograde synaptic vesicle transport,BP,1
GO:1903747,1,0.81661919,0,18,regulation of establishment of protein localization to mitochondrion,BP,1
GO:1903748,1,0.925614109,0,7,negative regulation of establishment of protein localization to mitochondrion,BP,1
GO:1903749,1,0.933861176,0,6,positive regulation of establishment of protein localization to mitochondrion,BP,1
GO:1903750,1,0.955545756,0,4,regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,1
GO:1903751,1,0.955545756,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,1
GO:1903755,1,0.988662779,0,1,positive regulation of SUMO transferase activity,BP,1
GO:1903760,1,0.988960075,0,1,regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,1
GO:1903764,1,0.980285658,0,2,regulation of potassium ion export across plasma membrane,BP,1
GO:1903766,1,0.991229526,0,1,positive regulation of potassium ion export across plasma membrane,BP,1
GO:1903769,1,0.988662726,0,1,negative regulation of cell proliferation in bone marrow,BP,1
GO:1903770,1,0.988662931,0,1,negative regulation of beta-galactosidase activity,BP,1
GO:1903772,1,0.95542464,0,4,regulation of viral budding via host ESCRT complex,BP,1
GO:1903774,1,0.96638386,0,3,positive regulation of viral budding via host ESCRT complex,BP,1
GO:1903775,1,0.977453375,0,2,regulation of DNA double-strand break processing,BP,1
GO:1903778,1,0.977453021,0,2,protein localization to vacuolar membrane,BP,1
GO:1903779,1,0.893409176,0,10,regulation of cardiac conduction,BP,1
GO:1903781,1,0.9899866,0,1,positive regulation of cardiac conduction,BP,1
GO:1903786,1,0.979089306,0,2,regulation of glutathione biosynthetic process,BP,1
GO:1903788,1,0.979089306,0,2,positive regulation of glutathione biosynthetic process,BP,1
GO:1903789,1,0.92611463,0,7,regulation of amino acid transmembrane transport,BP,1
GO:1903792,1,0.826294224,0,18,negative regulation of anion transport,BP,1
GO:1903795,1,0.961114225,0,4,regulation of inorganic anion transmembrane transport,BP,1
GO:1903796,1,0.994210854,0,1,negative regulation of inorganic anion transmembrane transport,BP,1
GO:1903797,1,0.977799536,0,2,positive regulation of inorganic anion transmembrane transport,BP,1
GO:1903798,1,0.82139823,0,18,regulation of production of miRNAs involved in gene silencing by miRNA,BP,1
GO:1903799,1,0.887066827,0,11,negative regulation of production of miRNAs involved in gene silencing by miRNA,BP,1
GO:1903800,1,0.915534623,0,8,positive regulation of production of miRNAs involved in gene silencing by miRNA,BP,1
GO:1903801,1,0.988662931,0,1,L-leucine import across plasma membrane,BP,1
GO:1903803,1,0.988679996,0,1,L-glutamine import across plasma membrane,BP,1
GO:1903804,1,0.988662591,0,1,glycine import across plasma membrane,BP,1
GO:1903817,1,0.962990624,0,4,negative regulation of voltage-gated potassium channel activity,BP,1
GO:1903818,1,0.962616829,0,4,positive regulation of voltage-gated potassium channel activity,BP,1
GO:1903825,1,0.434428461,0,75,organic acid transmembrane transport,BP,1
GO:1903826,1,0.944588071,0,5,arginine transmembrane transport,BP,1
GO:1903828,1,0.387020539,0,86,negative regulation of cellular protein localization,BP,1
GO:1903830,1,0.882539212,0,11,magnesium ion transmembrane transport,BP,1
GO:1903831,1,0.908793559,0,9,signal transduction involved in cellular response to ammonium ion,BP,1
GO:1903837,1,0.98866292,0,1,regulation of mRNA 3'-UTR binding,BP,1
GO:1903839,1,0.98866292,0,1,positive regulation of mRNA 3'-UTR binding,BP,1
GO:1903840,1,0.988663984,0,1,response to arsenite(3-),BP,1
GO:1903841,1,0.988663984,0,1,cellular response to arsenite(3-),BP,1
GO:1903842,1,0.958527155,0,4,response to arsenite ion,BP,1
GO:1903843,1,0.958527155,0,4,cellular response to arsenite ion,BP,1
GO:1903846,1,0.76311016,0,25,positive regulation of cellular response to transforming growth factor beta stimulus,BP,1
GO:1903847,1,0.964924315,0,4,regulation of aorta morphogenesis,BP,1
GO:1903849,1,0.964924315,0,4,positive regulation of aorta morphogenesis,BP,1
GO:1903850,1,0.988662808,0,1,regulation of cristae formation,BP,1
GO:1903852,1,0.988662808,0,1,positive regulation of cristae formation,BP,1
GO:1903859,1,0.866311127,0,13,regulation of dendrite extension,BP,1
GO:1903860,1,0.979273419,0,2,negative regulation of dendrite extension,BP,1
GO:1903861,1,0.874625716,0,12,positive regulation of dendrite extension,BP,1
GO:1903867,1,0.915989686,0,8,extraembryonic membrane development,BP,1
GO:1903874,1,0.988662715,0,1,ferrous iron transmembrane transport,BP,1
GO:1903881,1,0.98890353,0,1,regulation of interleukin-17-mediated signaling pathway,BP,1
GO:1903883,1,0.98890353,0,1,positive regulation of interleukin-17-mediated signaling pathway,BP,1
GO:1903884,1,0.98890353,0,1,regulation of chemokine (C-C motif) ligand 20 production,BP,1
GO:1903886,1,0.98890353,0,1,positive regulation of chemokine (C-C motif) ligand 20 production,BP,1
GO:1903891,1,0.966715598,0,3,regulation of ATF6-mediated unfolded protein response,BP,1
GO:1903892,1,0.977517949,0,2,negative regulation of ATF6-mediated unfolded protein response,BP,1
GO:1903893,1,0.988951203,0,1,positive regulation of ATF6-mediated unfolded protein response,BP,1
GO:1903896,1,0.988662927,0,1,positive regulation of IRE1-mediated unfolded protein response,BP,1
GO:1903897,1,0.933878844,0,6,regulation of PERK-mediated unfolded protein response,BP,1
GO:1903898,1,0.966387374,0,3,negative regulation of PERK-mediated unfolded protein response,BP,1
GO:1903899,1,0.966369809,0,3,positive regulation of PERK-mediated unfolded protein response,BP,1
GO:1903901,1,0.491987962,0,63,negative regulation of viral life cycle,BP,1
GO:1903903,1,0.959990974,0,4,regulation of establishment of T cell polarity,BP,1
GO:1903904,1,0.988662931,0,1,negative regulation of establishment of T cell polarity,BP,1
GO:1903905,1,0.982124951,0,2,positive regulation of establishment of T cell polarity,BP,1
GO:1903906,1,0.988676099,0,1,regulation of plasma membrane raft polarization,BP,1
GO:1903909,1,0.885943582,0,12,regulation of receptor clustering,BP,1
GO:1903911,1,0.933621352,0,7,positive regulation of receptor clustering,BP,1
GO:1903912,1,0.947106123,0,5,negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,1
GO:1903916,1,0.988662931,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,1
GO:1903917,1,0.988662931,0,1,positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,1
GO:1903918,1,0.988662931,0,1,regulation of actin filament severing,BP,1
GO:1903919,1,0.988662931,0,1,negative regulation of actin filament severing,BP,1
GO:1903921,1,0.977466395,0,2,regulation of protein processing in phagocytic vesicle,BP,1
GO:1903923,1,0.977466395,0,2,positive regulation of protein processing in phagocytic vesicle,BP,1
GO:1903927,1,0.989376448,0,1,response to cyanide,BP,1
GO:1903928,1,0.989376448,0,1,cellular response to cyanide,BP,1
GO:1903929,1,0.966604778,0,3,primary palate development,BP,1
GO:1903935,1,0.955442357,0,4,response to sodium arsenite,BP,1
GO:1903936,1,0.955442357,0,4,cellular response to sodium arsenite,BP,1
GO:1903939,1,0.977453375,0,2,regulation of TORC2 signaling,BP,1
GO:1903943,1,0.979328684,0,2,regulation of hepatocyte apoptotic process,BP,1
GO:1903944,1,0.979328684,0,2,negative regulation of hepatocyte apoptotic process,BP,1
GO:1903946,1,0.988667727,0,1,negative regulation of ventricular cardiac muscle cell action potential,BP,1
GO:1903949,1,0.9899866,0,1,positive regulation of atrial cardiac muscle cell action potential,BP,1
GO:1903955,1,0.944574746,0,5,positive regulation of protein targeting to mitochondrion,BP,1
GO:1903959,1,0.790559617,0,22,regulation of anion transmembrane transport,BP,1
GO:1903960,1,0.891752734,0,11,negative regulation of anion transmembrane transport,BP,1
GO:1903961,1,0.934193178,0,6,positive regulation of anion transmembrane transport,BP,1
GO:1903964,1,0.979696384,0,2,monounsaturated fatty acid metabolic process,BP,1
GO:1903966,1,0.979696384,0,2,monounsaturated fatty acid biosynthetic process,BP,1
GO:1903969,1,0.956551987,0,4,regulation of response to macrophage colony-stimulating factor,BP,1
GO:1903970,1,0.988662894,0,1,negative regulation of response to macrophage colony-stimulating factor,BP,1
GO:1903971,1,0.967523788,0,3,positive regulation of response to macrophage colony-stimulating factor,BP,1
GO:1903972,1,0.956551987,0,4,regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,1
GO:1903973,1,0.988662894,0,1,negative regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,1
GO:1903974,1,0.967523788,0,3,positive regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,1
GO:1903975,1,0.900904163,0,10,regulation of glial cell migration,BP,1
GO:1903976,1,0.955420778,0,4,negative regulation of glial cell migration,BP,1
GO:1903977,1,0.964717214,0,4,positive regulation of glial cell migration,BP,1
GO:1903980,1,0.955413891,0,4,positive regulation of microglial cell activation,BP,1
GO:1903984,1,0.966369805,0,3,positive regulation of TRAIL-activated apoptotic signaling pathway,BP,1
GO:1903995,1,0.988662813,0,1,regulation of non-membrane spanning protein tyrosine kinase activity,BP,1
GO:1903996,1,0.988662813,0,1,negative regulation of non-membrane spanning protein tyrosine kinase activity,BP,1
GO:1903998,1,0.961004129,0,4,regulation of eating behavior,BP,1
GO:1903999,1,0.988900204,0,1,negative regulation of eating behavior,BP,1
GO:1904000,1,0.98293847,0,2,positive regulation of eating behavior,BP,1
GO:1904008,1,0.967637255,0,3,response to monosodium glutamate,BP,1
GO:1904009,1,0.97873514,0,2,cellular response to monosodium glutamate,BP,1
GO:1904016,1,0.906321509,0,9,response to Thyroglobulin triiodothyronine,BP,1
GO:1904017,1,0.948488623,0,5,cellular response to Thyroglobulin triiodothyronine,BP,1
GO:1904020,1,0.989105523,0,1,regulation of G protein-coupled receptor internalization,BP,1
GO:1904021,1,0.989105523,0,1,negative regulation of G protein-coupled receptor internalization,BP,1
GO:1904023,1,0.966369904,0,3,regulation of glucose catabolic process to lactate via pyruvate,BP,1
GO:1904024,1,0.966369904,0,3,negative regulation of glucose catabolic process to lactate via pyruvate,BP,1
GO:1904026,1,0.958908133,0,4,regulation of collagen fibril organization,BP,1
GO:1904027,1,0.98953772,0,1,negative regulation of collagen fibril organization,BP,1
GO:1904028,1,0.97932869,0,2,positive regulation of collagen fibril organization,BP,1
GO:1904037,1,0.788757604,0,22,positive regulation of epithelial cell apoptotic process,BP,1
GO:1904041,1,0.988666699,0,1,regulation of cystathionine beta-synthase activity,BP,1
GO:1904042,1,0.988666699,0,1,negative regulation of cystathionine beta-synthase activity,BP,1
GO:1904044,1,0.934573463,0,6,response to aldosterone,BP,1
GO:1904045,1,0.977634283,0,2,cellular response to aldosterone,BP,1
GO:1904046,1,0.968271867,0,3,negative regulation of vascular endothelial growth factor production,BP,1
GO:1904054,1,0.982938894,0,2,regulation of cholangiocyte proliferation,BP,1
GO:1904056,1,0.982938894,0,2,positive regulation of cholangiocyte proliferation,BP,1
GO:1904057,1,0.988662931,0,1,negative regulation of sensory perception of pain,BP,1
GO:1904058,1,0.950851544,0,5,positive regulation of sensory perception of pain,BP,1
GO:1904059,1,0.972026976,0,3,regulation of locomotor rhythm,BP,1
GO:1904060,1,0.988900204,0,1,negative regulation of locomotor rhythm,BP,1
GO:1904062,1,0.172349786,0,163,regulation of cation transmembrane transport,BP,1
GO:1904063,1,0.618460707,0,45,negative regulation of cation transmembrane transport,BP,1
GO:1904064,1,0.457393161,0,74,positive regulation of cation transmembrane transport,BP,1
GO:1904073,1,0.988662922,0,1,regulation of trophectodermal cell proliferation,BP,1
GO:1904075,1,0.988662922,0,1,positive regulation of trophectodermal cell proliferation,BP,1
GO:1904092,1,0.988662931,0,1,regulation of autophagic cell death,BP,1
GO:1904093,1,0.988662931,0,1,negative regulation of autophagic cell death,BP,1
GO:1904098,1,0.966478425,0,3,regulation of protein O-linked glycosylation,BP,1
GO:1904100,1,0.966478425,0,3,positive regulation of protein O-linked glycosylation,BP,1
GO:1904106,1,0.988662931,0,1,protein localization to microvillus,BP,1
GO:1904109,1,0.963972196,0,4,positive regulation of cholesterol import,BP,1
GO:1904113,1,0.988703606,0,1,negative regulation of muscle filament sliding,BP,1
GO:1904124,1,0.978229348,0,2,microglial cell migration,BP,1
GO:1904139,1,0.978229348,0,2,regulation of microglial cell migration,BP,1
GO:1904141,1,0.978229348,0,2,positive regulation of microglial cell migration,BP,1
GO:1904145,1,0.966369961,0,3,negative regulation of meiotic cell cycle process involved in oocyte maturation,BP,1
GO:1904146,1,0.944578556,0,5,positive regulation of meiotic cell cycle process involved in oocyte maturation,BP,1
GO:1904147,1,0.988662929,0,1,response to nonylphenol,BP,1
GO:1904148,1,0.988662929,0,1,cellular response to nonylphenol,BP,1
GO:1904149,1,0.988662497,0,1,regulation of microglial cell mediated cytotoxicity,BP,1
GO:1904151,1,0.988662497,0,1,positive regulation of microglial cell mediated cytotoxicity,BP,1
GO:1904152,1,0.892225606,0,10,"regulation of retrograde protein transport, ER to cytosol",BP,1
GO:1904153,1,0.923295708,0,7,"negative regulation of retrograde protein transport, ER to cytosol",BP,1
GO:1904154,1,0.966369808,0,3,"positive regulation of retrograde protein transport, ER to cytosol",BP,1
GO:1904158,1,0.988663602,0,1,axonemal central apparatus assembly,BP,1
GO:1904161,1,0.977453187,0,2,DNA synthesis involved in UV-damage excision repair,BP,1
GO:1904170,1,0.978021558,0,2,regulation of bleb assembly,BP,1
GO:1904171,1,0.988662931,0,1,negative regulation of bleb assembly,BP,1
GO:1904172,1,0.989237578,0,1,positive regulation of bleb assembly,BP,1
GO:1904177,1,0.956874985,0,4,regulation of adipose tissue development,BP,1
GO:1904178,1,0.988853403,0,1,negative regulation of adipose tissue development,BP,1
GO:1904179,1,0.978762155,0,2,positive regulation of adipose tissue development,BP,1
GO:1904180,1,0.966369849,0,3,negative regulation of membrane depolarization,BP,1
GO:1904181,1,0.898722964,0,10,positive regulation of membrane depolarization,BP,1
GO:1904187,1,0.98873137,0,1,regulation of transformation of host cell by virus,BP,1
GO:1904188,1,0.98873137,0,1,negative regulation of transformation of host cell by virus,BP,1
GO:1904192,1,0.982938885,0,2,regulation of cholangiocyte apoptotic process,BP,1
GO:1904193,1,0.982938885,0,2,negative regulation of cholangiocyte apoptotic process,BP,1
GO:1904195,1,0.994210854,0,1,regulation of granulosa cell proliferation,BP,1
GO:1904197,1,0.994210854,0,1,positive regulation of granulosa cell proliferation,BP,1
GO:1904199,1,0.9899866,0,1,positive regulation of regulation of vascular smooth muscle cell membrane depolarization,BP,1
GO:1904200,1,0.994210854,0,1,iodide transmembrane transport,BP,1
GO:1904201,1,0.994210854,0,1,regulation of iodide transport,BP,1
GO:1904202,1,0.994210854,0,1,negative regulation of iodide transport,BP,1
GO:1904204,1,0.982938878,0,2,regulation of skeletal muscle hypertrophy,BP,1
GO:1904205,1,0.988662915,0,1,negative regulation of skeletal muscle hypertrophy,BP,1
GO:1904206,1,0.994210854,0,1,positive regulation of skeletal muscle hypertrophy,BP,1
GO:1904207,1,0.975171859,0,3,regulation of chemokine (C-C motif) ligand 2 secretion,BP,1
GO:1904209,1,0.975171859,0,3,positive regulation of chemokine (C-C motif) ligand 2 secretion,BP,1
GO:1904210,1,0.988662931,0,1,VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,1
GO:1904211,1,0.977453307,0,2,"membrane protein proteolysis involved in retrograde protein transport, ER to cytosol",BP,1
GO:1904212,1,0.994210854,0,1,regulation of iodide transmembrane transport,BP,1
GO:1904213,1,0.994210854,0,1,negative regulation of iodide transmembrane transport,BP,1
GO:1904217,1,0.977500382,0,2,regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,1
GO:1904219,1,0.977500382,0,2,positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,1
GO:1904220,1,0.977500382,0,2,regulation of serine C-palmitoyltransferase activity,BP,1
GO:1904222,1,0.977500382,0,2,positive regulation of serine C-palmitoyltransferase activity,BP,1
GO:1904226,1,0.988662896,0,1,"regulation of glycogen synthase activity, transferring glucose-1-phosphate",BP,1
GO:1904227,1,0.988662896,0,1,"negative regulation of glycogen synthase activity, transferring glucose-1-phosphate",BP,1
GO:1904229,1,0.988662931,0,1,regulation of succinate dehydrogenase activity,BP,1
GO:1904231,1,0.988662931,0,1,positive regulation of succinate dehydrogenase activity,BP,1
GO:1904232,1,0.977453161,0,2,regulation of aconitate hydratase activity,BP,1
GO:1904234,1,0.977453161,0,2,positive regulation of aconitate hydratase activity,BP,1
GO:1904235,1,0.98284093,0,2,"regulation of substrate-dependent cell migration, cell attachment to substrate",BP,1
GO:1904237,1,0.98284093,0,2,"positive regulation of substrate-dependent cell migration, cell attachment to substrate",BP,1
GO:1904238,1,0.962141141,0,4,pericyte cell differentiation,BP,1
GO:1904239,1,0.988662931,0,1,regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,1
GO:1904240,1,0.988662931,0,1,negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,1
GO:1904245,1,0.977453367,0,2,regulation of polynucleotide adenylyltransferase activity,BP,1
GO:1904246,1,0.988662927,0,1,negative regulation of polynucleotide adenylyltransferase activity,BP,1
GO:1904247,1,0.988662927,0,1,positive regulation of polynucleotide adenylyltransferase activity,BP,1
GO:1904252,1,0.97865176,0,2,negative regulation of bile acid metabolic process,BP,1
GO:1904259,1,0.947307024,0,5,regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,1
GO:1904261,1,0.947307024,0,5,positive regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,1
GO:1904263,1,0.892339215,0,10,positive regulation of TORC1 signaling,BP,1
GO:1904274,1,0.988662931,0,1,tricellular tight junction assembly,BP,1
GO:1904282,1,0.988662883,0,1,regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,1
GO:1904283,1,0.988662883,0,1,negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,1
GO:1904289,1,0.978251081,0,2,regulation of mitotic DNA damage checkpoint,BP,1
GO:1904290,1,0.989469711,0,1,negative regulation of mitotic DNA damage checkpoint,BP,1
GO:1904292,1,0.764229584,0,24,regulation of ERAD pathway,BP,1
GO:1904293,1,0.883625768,0,11,negative regulation of ERAD pathway,BP,1
GO:1904294,1,0.863752427,0,13,positive regulation of ERAD pathway,BP,1
GO:1904298,1,0.989013621,0,1,regulation of transcytosis,BP,1
GO:1904300,1,0.989013621,0,1,positive regulation of transcytosis,BP,1
GO:1904301,1,0.989013621,0,1,regulation of maternal process involved in parturition,BP,1
GO:1904303,1,0.989013621,0,1,positive regulation of maternal process involved in parturition,BP,1
GO:1904304,1,0.967562685,0,3,regulation of gastro-intestinal system smooth muscle contraction,BP,1
GO:1904306,1,0.967562685,0,3,positive regulation of gastro-intestinal system smooth muscle contraction,BP,1
GO:1904307,1,0.988662931,0,1,response to desipramine,BP,1
GO:1904308,1,0.988662931,0,1,cellular response to desipramine,BP,1
GO:1904309,1,0.988662931,0,1,response to cordycepin,BP,1
GO:1904310,1,0.988662931,0,1,cellular response to cordycepin,BP,1
GO:1904311,1,0.988662931,0,1,response to gold(3+),BP,1
GO:1904312,1,0.988662931,0,1,cellular response to gold(3+),BP,1
GO:1904313,1,0.969395122,0,3,response to methamphetamine hydrochloride,BP,1
GO:1904314,1,0.988662931,0,1,cellular response to methamphetamine hydrochloride,BP,1
GO:1904316,1,0.989013621,0,1,response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,1
GO:1904317,1,0.989013621,0,1,cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,1
GO:1904318,1,0.988662843,0,1,regulation of smooth muscle contraction involved in micturition,BP,1
GO:1904320,1,0.988662843,0,1,positive regulation of smooth muscle contraction involved in micturition,BP,1
GO:1904323,1,0.978105744,0,2,regulation of inhibitory G protein-coupled receptor phosphorylation,BP,1
GO:1904325,1,0.978105744,0,2,positive regulation of inhibitory G protein-coupled receptor phosphorylation,BP,1
GO:1904326,1,0.988662843,0,1,"negative regulation of circadian sleep/wake cycle, wakefulness",BP,1
GO:1904327,1,0.988848763,0,1,protein localization to cytosolic proteasome complex,BP,1
GO:1904328,1,0.988662843,0,1,regulation of myofibroblast contraction,BP,1
GO:1904330,1,0.988662843,0,1,positive regulation of myofibroblast contraction,BP,1
GO:1904338,1,0.966369798,0,3,regulation of dopaminergic neuron differentiation,BP,1
GO:1904339,1,0.988662904,0,1,negative regulation of dopaminergic neuron differentiation,BP,1
GO:1904340,1,0.988662844,0,1,positive regulation of dopaminergic neuron differentiation,BP,1
GO:1904341,1,0.978312674,0,2,regulation of colon smooth muscle contraction,BP,1
GO:1904343,1,0.978312674,0,2,positive regulation of colon smooth muscle contraction,BP,1
GO:1904344,1,0.988662843,0,1,regulation of gastric mucosal blood circulation,BP,1
GO:1904346,1,0.988662843,0,1,positive regulation of gastric mucosal blood circulation,BP,1
GO:1904347,1,0.989532094,0,1,regulation of small intestine smooth muscle contraction,BP,1
GO:1904349,1,0.989532094,0,1,positive regulation of small intestine smooth muscle contraction,BP,1
GO:1904350,1,0.941296678,0,7,regulation of protein catabolic process in the vacuole,BP,1
GO:1904351,1,0.977721256,0,2,negative regulation of protein catabolic process in the vacuole,BP,1
GO:1904352,1,0.972962048,0,4,positive regulation of protein catabolic process in the vacuole,BP,1
GO:1904353,1,0.803061194,0,21,regulation of telomere capping,BP,1
GO:1904354,1,0.923597011,0,8,negative regulation of telomere capping,BP,1
GO:1904355,1,0.869570462,0,13,positive regulation of telomere capping,BP,1
GO:1904356,1,0.539373716,0,56,regulation of telomere maintenance via telomere lengthening,BP,1
GO:1904357,1,0.76502047,0,24,negative regulation of telomere maintenance via telomere lengthening,BP,1
GO:1904358,1,0.704128295,0,32,positive regulation of telomere maintenance via telomere lengthening,BP,1
GO:1904370,1,0.989052455,0,1,regulation of protein localization to actin cortical patch,BP,1
GO:1904372,1,0.989052455,0,1,positive regulation of protein localization to actin cortical patch,BP,1
GO:1904373,1,0.967097582,0,3,response to kainic acid,BP,1
GO:1904375,1,0.342523607,0,97,regulation of protein localization to cell periphery,BP,1
GO:1904376,1,0.793151499,0,21,negative regulation of protein localization to cell periphery,BP,1
GO:1904377,1,0.605989753,0,46,positive regulation of protein localization to cell periphery,BP,1
GO:1904378,1,0.977453375,0,2,maintenance of unfolded protein involved in ERAD pathway,BP,1
GO:1904379,1,0.988848763,0,1,protein localization to cytosolic proteasome complex involved in ERAD pathway,BP,1
GO:1904380,1,0.966369908,0,3,endoplasmic reticulum mannose trimming,BP,1
GO:1904382,1,0.955411125,0,4,mannose trimming involved in glycoprotein ERAD pathway,BP,1
GO:1904383,1,0.988662931,0,1,response to sodium phosphate,BP,1
GO:1904386,1,0.892710844,0,10,response to L-phenylalanine derivative,BP,1
GO:1904387,1,0.977628113,0,2,cellular response to L-phenylalanine derivative,BP,1
GO:1904389,1,0.98866286,0,1,rod bipolar cell differentiation,BP,1
GO:1904391,1,0.98866286,0,1,response to ciliary neurotrophic factor,BP,1
GO:1904393,1,0.938524322,0,6,regulation of skeletal muscle acetylcholine-gated channel clustering,BP,1
GO:1904395,1,0.971193149,0,3,positive regulation of skeletal muscle acetylcholine-gated channel clustering,BP,1
GO:1904396,1,0.922973523,0,8,regulation of neuromuscular junction development,BP,1
GO:1904397,1,0.98866286,0,1,negative regulation of neuromuscular junction development,BP,1
GO:1904398,1,0.955105423,0,5,positive regulation of neuromuscular junction development,BP,1
GO:1904400,1,0.955410382,0,4,response to Thyroid stimulating hormone,BP,1
GO:1904401,1,0.966369218,0,3,cellular response to Thyroid stimulating hormone,BP,1
GO:1904404,1,0.981290828,0,2,response to formaldehyde,BP,1
GO:1904406,1,0.875288805,0,12,negative regulation of nitric oxide metabolic process,BP,1
GO:1904409,1,0.988708632,0,1,regulation of secretory granule organization,BP,1
GO:1904411,1,0.988708632,0,1,positive regulation of secretory granule organization,BP,1
GO:1904412,1,0.979998061,0,2,regulation of cardiac ventricle development,BP,1
GO:1904413,1,0.990997407,0,1,negative regulation of cardiac ventricle development,BP,1
GO:1904414,1,0.988901531,0,1,positive regulation of cardiac ventricle development,BP,1
GO:1904415,1,0.9170144,0,8,regulation of xenophagy,BP,1
GO:1904417,1,0.9170144,0,8,positive regulation of xenophagy,BP,1
GO:1904421,1,0.988662786,0,1,response to D-galactosamine,BP,1
GO:1904424,1,0.868038221,0,13,regulation of GTP binding,BP,1
GO:1904426,1,0.98111813,0,2,positive regulation of GTP binding,BP,1
GO:1904427,1,0.66658909,0,38,positive regulation of calcium ion transmembrane transport,BP,1
GO:1904428,1,0.957034836,0,5,negative regulation of tubulin deacetylation,BP,1
GO:1904429,1,0.933876744,0,6,regulation of t-circle formation,BP,1
GO:1904430,1,0.966385249,0,3,negative regulation of t-circle formation,BP,1
GO:1904431,1,0.966369762,0,3,positive regulation of t-circle formation,BP,1
GO:1904432,1,0.977452944,0,2,regulation of ferrous iron binding,BP,1
GO:1904434,1,0.977452944,0,2,positive regulation of ferrous iron binding,BP,1
GO:1904435,1,0.977452944,0,2,regulation of transferrin receptor binding,BP,1
GO:1904437,1,0.977452944,0,2,positive regulation of transferrin receptor binding,BP,1
GO:1904438,1,0.988662715,0,1,regulation of ferrous iron import across plasma membrane,BP,1
GO:1904439,1,0.988662715,0,1,negative regulation of ferrous iron import across plasma membrane,BP,1
GO:1904444,1,0.988662931,0,1,regulation of establishment of Sertoli cell barrier,BP,1
GO:1904445,1,0.988662931,0,1,negative regulation of establishment of Sertoli cell barrier,BP,1
GO:1904447,1,0.964174565,0,4,folate import across plasma membrane,BP,1
GO:1904448,1,0.988662924,0,1,regulation of aspartate secretion,BP,1
GO:1904450,1,0.988662924,0,1,positive regulation of aspartate secretion,BP,1
GO:1904457,1,0.966369909,0,3,positive regulation of neuronal action potential,BP,1
GO:1904464,1,0.98866292,0,1,regulation of matrix metallopeptidase secretion,BP,1
GO:1904465,1,0.98866292,0,1,negative regulation of matrix metallopeptidase secretion,BP,1
GO:1904467,1,0.784430795,0,22,regulation of tumor necrosis factor secretion,BP,1
GO:1904468,1,0.955638825,0,4,negative regulation of tumor necrosis factor secretion,BP,1
GO:1904469,1,0.839549349,0,16,positive regulation of tumor necrosis factor secretion,BP,1
GO:1904475,1,0.959057881,0,4,regulation of Ras GTPase binding,BP,1
GO:1904476,1,0.977453375,0,2,negative regulation of Ras GTPase binding,BP,1
GO:1904477,1,0.992277621,0,1,positive regulation of Ras GTPase binding,BP,1
GO:1904478,1,0.883489194,0,11,regulation of intestinal absorption,BP,1
GO:1904479,1,0.956942104,0,4,negative regulation of intestinal absorption,BP,1
GO:1904480,1,0.988662931,0,1,positive regulation of intestinal absorption,BP,1
GO:1904481,1,0.977453375,0,2,response to tetrahydrofolate,BP,1
GO:1904482,1,0.977453375,0,2,cellular response to tetrahydrofolate,BP,1
GO:1904491,1,0.966369907,0,3,protein localization to ciliary transition zone,BP,1
GO:1904499,1,0.988666206,0,1,regulation of chromatin-mediated maintenance of transcription,BP,1
GO:1904501,1,0.988666206,0,1,positive regulation of chromatin-mediated maintenance of transcription,BP,1
GO:1904505,1,0.95541094,0,4,regulation of telomere maintenance in response to DNA damage,BP,1
GO:1904506,1,0.95541094,0,4,negative regulation of telomere maintenance in response to DNA damage,BP,1
GO:1904515,1,0.977453375,0,2,positive regulation of TORC2 signaling,BP,1
GO:1904526,1,0.916879456,0,8,regulation of microtubule binding,BP,1
GO:1904527,1,0.98179669,0,2,negative regulation of microtubule binding,BP,1
GO:1904528,1,0.944583011,0,5,positive regulation of microtubule binding,BP,1
GO:1904533,1,0.966369909,0,3,regulation of telomeric loop disassembly,BP,1
GO:1904534,1,0.977453375,0,2,negative regulation of telomeric loop disassembly,BP,1
GO:1904535,1,0.988662931,0,1,positive regulation of telomeric loop disassembly,BP,1
GO:1904550,1,0.988662931,0,1,response to arachidonic acid,BP,1
GO:1904562,1,0.991651591,0,1,phosphatidylinositol 5-phosphate metabolic process,BP,1
GO:1904567,1,0.988744294,0,1,response to wortmannin,BP,1
GO:1904568,1,0.988744294,0,1,cellular response to wortmannin,BP,1
GO:1904569,1,0.966668749,0,3,regulation of selenocysteine incorporation,BP,1
GO:1904570,1,0.988662931,0,1,negative regulation of selenocysteine incorporation,BP,1
GO:1904571,1,0.977755615,0,2,positive regulation of selenocysteine incorporation,BP,1
GO:1904572,1,0.988662931,0,1,negative regulation of mRNA binding,BP,1
GO:1904573,1,0.988662931,0,1,regulation of selenocysteine insertion sequence binding,BP,1
GO:1904574,1,0.988662931,0,1,negative regulation of selenocysteine insertion sequence binding,BP,1
GO:1904576,1,0.96636946,0,3,response to tunicamycin,BP,1
GO:1904577,1,0.96636946,0,3,cellular response to tunicamycin,BP,1
GO:1904578,1,0.944588883,0,5,response to thapsigargin,BP,1
GO:1904579,1,0.944588883,0,5,cellular response to thapsigargin,BP,1
GO:1904580,1,0.953912011,0,5,regulation of intracellular mRNA localization,BP,1
GO:1904582,1,0.969289013,0,3,positive regulation of intracellular mRNA localization,BP,1
GO:1904585,1,0.977454416,0,2,response to putrescine,BP,1
GO:1904586,1,0.977454416,0,2,cellular response to putrescine,BP,1
GO:1904587,1,0.902438587,0,9,response to glycoprotein,BP,1
GO:1904588,1,0.955410443,0,4,cellular response to glycoprotein,BP,1
GO:1904589,1,0.590772529,0,48,regulation of protein import,BP,1
GO:1904590,1,0.918676953,0,8,negative regulation of protein import,BP,1
GO:1904591,1,0.672942806,0,36,positive regulation of protein import,BP,1
GO:1904592,1,0.988662931,0,1,positive regulation of protein refolding,BP,1
GO:1904594,1,0.988662931,0,1,regulation of termination of RNA polymerase II transcription,BP,1
GO:1904595,1,0.988662931,0,1,positive regulation of termination of RNA polymerase II transcription,BP,1
GO:1904606,1,0.988833072,0,1,fat cell apoptotic process,BP,1
GO:1904608,1,0.977453383,0,2,response to monosodium L-glutamate,BP,1
GO:1904609,1,0.988662939,0,1,cellular response to monosodium L-glutamate,BP,1
GO:1904612,1,0.946915935,0,5,"response to 2,3,7,8-tetrachlorodibenzodioxine",BP,1
GO:1904613,1,0.978628793,0,2,"cellular response to 2,3,7,8-tetrachlorodibenzodioxine",BP,1
GO:1904619,1,0.988663984,0,1,response to dimethyl sulfoxide,BP,1
GO:1904620,1,0.988663984,0,1,cellular response to dimethyl sulfoxide,BP,1
GO:1904621,1,0.988703606,0,1,regulation of actin-dependent ATPase activity,BP,1
GO:1904622,1,0.988703606,0,1,negative regulation of actin-dependent ATPase activity,BP,1
GO:1904627,1,0.923388332,0,7,response to phorbol 13-acetate 12-myristate,BP,1
GO:1904628,1,0.923388332,0,7,cellular response to phorbol 13-acetate 12-myristate,BP,1
GO:1904629,1,0.988662931,0,1,response to diterpene,BP,1
GO:1904630,1,0.988662931,0,1,cellular response to diterpene,BP,1
GO:1904631,1,0.988662931,0,1,response to glucoside,BP,1
GO:1904632,1,0.988662931,0,1,cellular response to glucoside,BP,1
GO:1904636,1,0.947199867,0,5,response to ionomycin,BP,1
GO:1904637,1,0.947199867,0,5,cellular response to ionomycin,BP,1
GO:1904638,1,0.977634283,0,2,response to resveratrol,BP,1
GO:1904639,1,0.988845897,0,1,cellular response to resveratrol,BP,1
GO:1904640,1,0.968020463,0,3,response to methionine,BP,1
GO:1904643,1,0.977584767,0,2,response to curcumin,BP,1
GO:1904645,1,0.728291876,0,30,response to amyloid-beta,BP,1
GO:1904646,1,0.753387228,0,27,cellular response to amyloid-beta,BP,1
GO:1904647,1,0.981783681,0,2,response to rotenone,BP,1
GO:1904648,1,0.989692508,0,1,cellular response to rotenone,BP,1
GO:1904649,1,0.988833072,0,1,regulation of fat cell apoptotic process,BP,1
GO:1904653,1,0.98871629,0,1,regulation of lung alveolus development,BP,1
GO:1904655,1,0.98871629,0,1,positive regulation of lung alveolus development,BP,1
GO:1904666,1,0.862364081,0,13,regulation of ubiquitin protein ligase activity,BP,1
GO:1904667,1,0.92326773,0,7,negative regulation of ubiquitin protein ligase activity,BP,1
GO:1904668,1,0.944778985,0,5,positive regulation of ubiquitin protein ligase activity,BP,1
GO:1904669,1,0.988670378,0,1,ATP export,BP,1
GO:1904672,1,0.977453367,0,2,regulation of somatic stem cell population maintenance,BP,1
GO:1904673,1,0.977453367,0,2,negative regulation of somatic stem cell population maintenance,BP,1
GO:1904681,1,0.977489794,0,2,response to 3-methylcholanthrene,BP,1
GO:1904682,1,0.98868351,0,1,cellular response to 3-methylcholanthrene,BP,1
GO:1904683,1,0.937464921,0,6,regulation of metalloendopeptidase activity,BP,1
GO:1904684,1,0.967268306,0,3,negative regulation of metalloendopeptidase activity,BP,1
GO:1904685,1,0.969196167,0,3,positive regulation of metalloendopeptidase activity,BP,1
GO:1904688,1,0.955440257,0,4,regulation of cytoplasmic translational initiation,BP,1
GO:1904689,1,0.988662574,0,1,negative regulation of cytoplasmic translational initiation,BP,1
GO:1904690,1,0.96639972,0,3,positive regulation of cytoplasmic translational initiation,BP,1
GO:1904691,1,0.977452956,0,2,negative regulation of type B pancreatic cell proliferation,BP,1
GO:1904692,1,0.988795356,0,1,positive regulation of type B pancreatic cell proliferation,BP,1
GO:1904693,1,0.991913391,0,1,midbrain morphogenesis,BP,1
GO:1904694,1,0.970132852,0,3,negative regulation of vascular smooth muscle contraction,BP,1
GO:1904695,1,0.988662533,0,1,positive regulation of vascular smooth muscle contraction,BP,1
GO:1904700,1,0.977453135,0,2,granulosa cell apoptotic process,BP,1
GO:1904707,1,0.753588134,0,26,positive regulation of vascular smooth muscle cell proliferation,BP,1
GO:1904708,1,0.977453135,0,2,regulation of granulosa cell apoptotic process,BP,1
GO:1904710,1,0.988662749,0,1,positive regulation of granulosa cell apoptotic process,BP,1
GO:1904714,1,0.966416091,0,3,regulation of chaperone-mediated autophagy,BP,1
GO:1904715,1,0.98866386,0,1,negative regulation of chaperone-mediated autophagy,BP,1
GO:1904716,1,0.988667932,0,1,positive regulation of chaperone-mediated autophagy,BP,1
GO:1904717,1,0.976847824,0,3,regulation of AMPA glutamate receptor clustering,BP,1
GO:1904719,1,0.983500302,0,2,positive regulation of AMPA glutamate receptor clustering,BP,1
GO:1904729,1,0.91425784,0,8,regulation of intestinal lipid absorption,BP,1
GO:1904730,1,0.979019822,0,2,negative regulation of intestinal lipid absorption,BP,1
GO:1904731,1,0.988662931,0,1,positive regulation of intestinal lipid absorption,BP,1
GO:1904732,1,0.946113461,0,5,regulation of electron transfer activity,BP,1
GO:1904733,1,0.988662931,0,1,negative regulation of electron transfer activity,BP,1
GO:1904734,1,0.988662435,0,1,positive regulation of electron transfer activity,BP,1
GO:1904735,1,0.988662931,0,1,regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase,BP,1
GO:1904736,1,0.988662931,0,1,negative regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase,BP,1
GO:1904738,1,0.805249028,0,21,vascular associated smooth muscle cell migration,BP,1
GO:1904742,1,0.967924206,0,3,regulation of telomeric DNA binding,BP,1
GO:1904743,1,0.990253032,0,1,negative regulation of telomeric DNA binding,BP,1
GO:1904744,1,0.977453141,0,2,positive regulation of telomeric DNA binding,BP,1
GO:1904746,1,0.967341271,0,3,negative regulation of apoptotic process involved in development,BP,1
GO:1904747,1,0.939678192,0,6,positive regulation of apoptotic process involved in development,BP,1
GO:1904748,1,0.898744694,0,10,regulation of apoptotic process involved in development,BP,1
GO:1904749,1,0.91633998,0,8,regulation of protein localization to nucleolus,BP,1
GO:1904750,1,0.991971547,0,1,negative regulation of protein localization to nucleolus,BP,1
GO:1904751,1,0.944973099,0,5,positive regulation of protein localization to nucleolus,BP,1
GO:1904752,1,0.805249028,0,21,regulation of vascular associated smooth muscle cell migration,BP,1
GO:1904753,1,0.944576918,0,5,negative regulation of vascular associated smooth muscle cell migration,BP,1
GO:1904754,1,0.852559157,0,16,positive regulation of vascular associated smooth muscle cell migration,BP,1
GO:1904760,1,0.957796954,0,4,regulation of myofibroblast differentiation,BP,1
GO:1904761,1,0.968223897,0,3,negative regulation of myofibroblast differentiation,BP,1
GO:1904762,1,0.989233624,0,1,positive regulation of myofibroblast differentiation,BP,1
GO:1904764,1,0.977453375,0,2,chaperone-mediated autophagy translocation complex disassembly,BP,1
GO:1904766,1,0.988662931,0,1,negative regulation of macroautophagy by TORC1 signaling,BP,1
GO:1904772,1,0.978876342,0,2,response to tetrachloromethane,BP,1
GO:1904776,1,0.944947924,0,5,regulation of protein localization to cell cortex,BP,1
GO:1904778,1,0.944947924,0,5,positive regulation of protein localization to cell cortex,BP,1
GO:1904779,1,0.928456118,0,7,regulation of protein localization to centrosome,BP,1
GO:1904780,1,0.966369813,0,3,negative regulation of protein localization to centrosome,BP,1
GO:1904781,1,0.949881522,0,5,positive regulation of protein localization to centrosome,BP,1
GO:1904782,1,0.988662773,0,1,negative regulation of NMDA glutamate receptor activity,BP,1
GO:1904783,1,0.955436531,0,4,positive regulation of NMDA glutamate receptor activity,BP,1
GO:1904784,1,0.988662931,0,1,NLRP1 inflammasome complex assembly,BP,1
GO:1904790,1,0.988662931,0,1,regulation of shelterin complex assembly,BP,1
GO:1904792,1,0.988662931,0,1,positive regulation of shelterin complex assembly,BP,1
GO:1904793,1,0.988666206,0,1,regulation of euchromatin binding,BP,1
GO:1904796,1,0.955417591,0,4,regulation of core promoter binding,BP,1
GO:1904797,1,0.988662884,0,1,negative regulation of core promoter binding,BP,1
GO:1904798,1,0.966376494,0,3,positive regulation of core promoter binding,BP,1
GO:1904803,1,0.988662798,0,1,regulation of translation involved in cellular response to UV,BP,1
GO:1904809,1,0.980414529,0,2,regulation of dense core granule transport,BP,1
GO:1904811,1,0.980414529,0,2,positive regulation of dense core granule transport,BP,1
GO:1904812,1,0.988662931,0,1,rRNA acetylation involved in maturation of SSU-rRNA,BP,1
GO:1904814,1,0.842725625,0,15,"regulation of protein localization to chromosome, telomeric region",BP,1
GO:1904815,1,0.977453375,0,2,"negative regulation of protein localization to chromosome, telomeric region",BP,1
GO:1904816,1,0.862187858,0,13,"positive regulation of protein localization to chromosome, telomeric region",BP,1
GO:1904823,1,0.988662923,0,1,purine nucleobase transmembrane transport,BP,1
GO:1904825,1,0.977454605,0,2,protein localization to microtubule plus-end,BP,1
GO:1904826,1,0.99351408,0,1,regulation of hydrogen sulfide biosynthetic process,BP,1
GO:1904828,1,0.99351408,0,1,positive regulation of hydrogen sulfide biosynthetic process,BP,1
GO:1904833,1,0.9774532,0,2,positive regulation of removal of superoxide radicals,BP,1
GO:1904835,1,0.978712453,0,2,dorsal root ganglion morphogenesis,BP,1
GO:1904837,1,0.988662931,0,1,beta-catenin-TCF complex assembly,BP,1
GO:1904842,1,0.977459769,0,2,response to nitroglycerin,BP,1
GO:1904843,1,0.988669408,0,1,cellular response to nitroglycerin,BP,1
GO:1904844,1,0.966375775,0,3,response to L-glutamine,BP,1
GO:1904845,1,0.966375775,0,3,cellular response to L-glutamine,BP,1
GO:1904847,1,0.966380091,0,3,regulation of cell chemotaxis to fibroblast growth factor,BP,1
GO:1904848,1,0.988662786,0,1,negative regulation of cell chemotaxis to fibroblast growth factor,BP,1
GO:1904849,1,0.988673601,0,1,positive regulation of cell chemotaxis to fibroblast growth factor,BP,1
GO:1904850,1,0.988662931,0,1,negative regulation of establishment of protein localization to telomere,BP,1
GO:1904851,1,0.89222023,0,10,positive regulation of establishment of protein localization to telomere,BP,1
GO:1904861,1,0.902739587,0,11,excitatory synapse assembly,BP,1
GO:1904862,1,0.983172873,0,2,inhibitory synapse assembly,BP,1
GO:1904863,1,0.988662931,0,1,regulation of beta-catenin-TCF complex assembly,BP,1
GO:1904864,1,0.988662931,0,1,negative regulation of beta-catenin-TCF complex assembly,BP,1
GO:1904867,1,0.988662931,0,1,protein localization to Cajal body,BP,1
GO:1904868,1,0.983797226,0,2,telomerase catalytic core complex assembly,BP,1
GO:1904872,1,0.933862056,0,6,regulation of telomerase RNA localization to Cajal body,BP,1
GO:1904874,1,0.955411123,0,4,positive regulation of telomerase RNA localization to Cajal body,BP,1
GO:1904875,1,0.988662931,0,1,regulation of DNA ligase activity,BP,1
GO:1904877,1,0.988662931,0,1,positive regulation of DNA ligase activity,BP,1
GO:1904878,1,0.977514699,0,2,negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,1
GO:1904879,1,0.982504328,0,2,positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,1
GO:1904880,1,0.956540174,0,4,response to hydrogen sulfide,BP,1
GO:1904881,1,0.977453253,0,2,cellular response to hydrogen sulfide,BP,1
GO:1904882,1,0.983797226,0,2,regulation of telomerase catalytic core complex assembly,BP,1
GO:1904884,1,0.983797226,0,2,positive regulation of telomerase catalytic core complex assembly,BP,1
GO:1904887,1,0.988662931,0,1,Wnt signalosome assembly,BP,1
GO:1904888,1,0.697274131,0,34,cranial skeletal system development,BP,1
GO:1904889,1,0.95101393,0,5,regulation of excitatory synapse assembly,BP,1
GO:1904891,1,0.988869573,0,1,positive regulation of excitatory synapse assembly,BP,1
GO:1904907,1,0.985625143,0,2,"regulation of maintenance of mitotic sister chromatid cohesion, telomeric",BP,1
GO:1904908,1,0.985625143,0,2,"negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric",BP,1
GO:1904910,1,0.988662931,0,1,regulation of establishment of RNA localization to telomere,BP,1
GO:1904911,1,0.988662931,0,1,negative regulation of establishment of RNA localization to telomere,BP,1
GO:1904923,1,0.865252326,0,13,regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,1
GO:1904924,1,0.988662911,0,1,negative regulation of mitophagy in response to mitochondrial depolarization,BP,1
GO:1904925,1,0.875184901,0,12,positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,1
GO:1904938,1,0.988662921,0,1,planar cell polarity pathway involved in axon guidance,BP,1
GO:1904948,1,0.944578403,0,5,midbrain dopaminergic neuron differentiation,BP,1
GO:1904950,1,0.227296678,0,133,negative regulation of establishment of protein localization,BP,1
GO:1904953,1,0.988662844,0,1,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,1
GO:1904956,1,0.977453289,0,2,regulation of midbrain dopaminergic neuron differentiation,BP,1
GO:1904958,1,0.988662844,0,1,positive regulation of midbrain dopaminergic neuron differentiation,BP,1
GO:1904959,1,0.956966452,0,4,regulation of cytochrome-c oxidase activity,BP,1
GO:1904960,1,0.988662435,0,1,positive regulation of cytochrome-c oxidase activity,BP,1
GO:1904970,1,0.977453375,0,2,brush border assembly,BP,1
GO:1904971,1,0.989993728,0,1,regulation of viral translation,BP,1
GO:1904973,1,0.989993728,0,1,positive regulation of viral translation,BP,1
GO:1904975,1,0.97827522,0,2,response to bleomycin,BP,1
GO:1904976,1,0.989494077,0,1,cellular response to bleomycin,BP,1
GO:1904977,1,0.988676198,0,1,lymphatic endothelial cell migration,BP,1
GO:1904978,1,0.991838699,0,1,regulation of endosome organization,BP,1
GO:1904980,1,0.991838699,0,1,positive regulation of endosome organization,BP,1
GO:1904983,1,0.988662919,0,1,glycine import into mitochondrion,BP,1
GO:1904984,1,0.988662709,0,1,regulation of quinolinate biosynthetic process,BP,1
GO:1904985,1,0.988662709,0,1,negative regulation of quinolinate biosynthetic process,BP,1
GO:1904990,1,0.988680592,0,1,regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,1
GO:1904992,1,0.988680592,0,1,positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,1
GO:1904994,1,0.862181891,0,14,regulation of leukocyte adhesion to vascular endothelial cell,BP,1
GO:1904995,1,0.966455567,0,3,negative regulation of leukocyte adhesion to vascular endothelial cell,BP,1
GO:1904996,1,0.892134935,0,11,positive regulation of leukocyte adhesion to vascular endothelial cell,BP,1
GO:1904997,1,0.988666488,0,1,regulation of leukocyte adhesion to arterial endothelial cell,BP,1
GO:1904998,1,0.988666488,0,1,negative regulation of leukocyte adhesion to arterial endothelial cell,BP,1
GO:1905005,1,0.947507855,0,5,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,1
GO:1905006,1,0.988754356,0,1,negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,1
GO:1905007,1,0.947507855,0,5,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,1
GO:1905008,1,0.988662931,0,1,regulation of L-lysine import across plasma membrane,BP,1
GO:1905010,1,0.988662931,0,1,positive regulation of L-lysine import across plasma membrane,BP,1
GO:1905015,1,0.988662779,0,1,regulation of isoleucine-tRNA ligase activity,BP,1
GO:1905017,1,0.988662779,0,1,positive regulation of isoleucine-tRNA ligase activity,BP,1
GO:1905018,1,0.988662779,0,1,regulation of methionine-tRNA ligase activity,BP,1
GO:1905020,1,0.988662779,0,1,positive regulation of methionine-tRNA ligase activity,BP,1
GO:1905021,1,0.988662779,0,1,regulation of threonine-tRNA ligase activity,BP,1
GO:1905023,1,0.988662779,0,1,positive regulation of threonine-tRNA ligase activity,BP,1
GO:1905024,1,0.988960075,0,1,regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,1
GO:1905031,1,0.983130457,0,2,regulation of membrane repolarization during cardiac muscle cell action potential,BP,1
GO:1905034,1,0.988662922,0,1,regulation of antifungal innate immune response,BP,1
GO:1905035,1,0.988662922,0,1,negative regulation of antifungal innate immune response,BP,1
GO:1905037,1,0.399312377,0,83,autophagosome organization,BP,1
GO:1905038,1,0.904722941,0,9,regulation of membrane lipid metabolic process,BP,1
GO:1905039,1,0.434428461,0,75,carboxylic acid transmembrane transport,BP,1
GO:1905040,1,0.989548998,0,1,otic placode development,BP,1
GO:1905041,1,0.977677487,0,2,regulation of epithelium regeneration,BP,1
GO:1905042,1,0.988706619,0,1,negative regulation of epithelium regeneration,BP,1
GO:1905043,1,0.988845897,0,1,positive regulation of epithelium regeneration,BP,1
GO:1905044,1,0.988662931,0,1,regulation of Schwann cell proliferation involved in axon regeneration,BP,1
GO:1905045,1,0.988662931,0,1,negative regulation of Schwann cell proliferation involved in axon regeneration,BP,1
GO:1905048,1,0.866226549,0,13,regulation of metallopeptidase activity,BP,1
GO:1905049,1,0.945453621,0,5,negative regulation of metallopeptidase activity,BP,1
GO:1905050,1,0.91623804,0,8,positive regulation of metallopeptidase activity,BP,1
GO:1905051,1,0.978962858,0,2,regulation of base-excision repair,BP,1
GO:1905053,1,0.978962858,0,2,positive regulation of base-excision repair,BP,1
GO:1905062,1,0.988662858,0,1,positive regulation of cardioblast proliferation,BP,1
GO:1905063,1,0.929800873,0,7,regulation of vascular smooth muscle cell differentiation,BP,1
GO:1905064,1,0.961323193,0,4,negative regulation of vascular smooth muscle cell differentiation,BP,1
GO:1905065,1,0.967219628,0,3,positive regulation of vascular smooth muscle cell differentiation,BP,1
GO:1905066,1,0.98978507,0,1,regulation of canonical Wnt signaling pathway involved in heart development,BP,1
GO:1905068,1,0.98978507,0,1,positive regulation of canonical Wnt signaling pathway involved in heart development,BP,1
GO:1905069,1,0.978177891,0,2,allantois development,BP,1
GO:1905071,1,0.971055069,0,3,tight junction disassembly,BP,1
GO:1905073,1,0.971055069,0,3,regulation of tight junction disassembly,BP,1
GO:1905075,1,0.971055069,0,3,positive regulation of tight junction disassembly,BP,1
GO:1905076,1,0.966953495,0,3,regulation of interleukin-17 secretion,BP,1
GO:1905077,1,0.966953495,0,3,negative regulation of interleukin-17 secretion,BP,1
GO:1905089,1,0.988662931,0,1,regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,1
GO:1905090,1,0.988662931,0,1,negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,1
GO:1905097,1,0.896821727,0,10,regulation of guanyl-nucleotide exchange factor activity,BP,1
GO:1905098,1,0.914032813,0,8,negative regulation of guanyl-nucleotide exchange factor activity,BP,1
GO:1905099,1,0.992277621,0,1,positive regulation of guanyl-nucleotide exchange factor activity,BP,1
GO:1905123,1,0.978289494,0,2,regulation of glucosylceramidase activity,BP,1
GO:1905126,1,0.988664199,0,1,regulation of axo-dendritic protein transport,BP,1
GO:1905128,1,0.988664199,0,1,positive regulation of axo-dendritic protein transport,BP,1
GO:1905132,1,0.988662931,0,1,regulation of meiotic chromosome separation,BP,1
GO:1905133,1,0.988662931,0,1,negative regulation of meiotic chromosome separation,BP,1
GO:1905144,1,0.890733216,0,11,response to acetylcholine,BP,1
GO:1905145,1,0.890733216,0,11,cellular response to acetylcholine,BP,1
GO:1905146,1,0.920063302,0,9,lysosomal protein catabolic process,BP,1
GO:1905150,1,0.967133323,0,3,regulation of voltage-gated sodium channel activity,BP,1
GO:1905152,1,0.98877035,0,1,positive regulation of voltage-gated sodium channel activity,BP,1
GO:1905153,1,0.892312301,0,11,regulation of membrane invagination,BP,1
GO:1905154,1,0.988662931,0,1,negative regulation of membrane invagination,BP,1
GO:1905155,1,0.902552958,0,10,positive regulation of membrane invagination,BP,1
GO:1905161,1,0.988662858,0,1,protein localization to phagocytic vesicle,BP,1
GO:1905165,1,0.952094938,0,6,regulation of lysosomal protein catabolic process,BP,1
GO:1905166,1,0.977721256,0,2,negative regulation of lysosomal protein catabolic process,BP,1
GO:1905167,1,0.984120593,0,3,positive regulation of lysosomal protein catabolic process,BP,1
GO:1905169,1,0.988662858,0,1,regulation of protein localization to phagocytic vesicle,BP,1
GO:1905171,1,0.988662858,0,1,positive regulation of protein localization to phagocytic vesicle,BP,1
GO:1905198,1,0.969080517,0,3,manchette assembly,BP,1
GO:1905203,1,0.948027513,0,5,regulation of connective tissue replacement,BP,1
GO:1905204,1,0.989016853,0,1,negative regulation of connective tissue replacement,BP,1
GO:1905205,1,0.958559054,0,4,positive regulation of connective tissue replacement,BP,1
GO:1905206,1,0.935547683,0,6,positive regulation of hydrogen peroxide-induced cell death,BP,1
GO:1905209,1,0.750990198,0,27,positive regulation of cardiocyte differentiation,BP,1
GO:1905215,1,0.988662931,0,1,negative regulation of RNA binding,BP,1
GO:1905216,1,0.924720337,0,7,positive regulation of RNA binding,BP,1
GO:1905217,1,0.97745441,0,2,response to astaxanthin,BP,1
GO:1905218,1,0.98866404,0,1,cellular response to astaxanthin,BP,1
GO:1905222,1,0.988662931,0,1,atrioventricular canal morphogenesis,BP,1
GO:1905223,1,0.991639202,0,1,epicardium morphogenesis,BP,1
GO:1905224,1,0.979056704,0,2,clathrin-coated pit assembly,BP,1
GO:1905225,1,0.977453313,0,2,response to thyrotropin-releasing hormone,BP,1
GO:1905232,1,0.924802967,0,7,cellular response to L-glutamate,BP,1
GO:1905242,1,0.941467198,0,6,"response to 3,3',5-triiodo-L-thyronine",BP,1
GO:1905243,1,0.996710886,0,1,"cellular response to 3,3',5-triiodo-L-thyronine",BP,1
GO:1905244,1,0.854811216,0,16,regulation of modification of synaptic structure,BP,1
GO:1905245,1,0.928597597,0,7,regulation of aspartic-type peptidase activity,BP,1
GO:1905246,1,0.988667727,0,1,negative regulation of aspartic-type peptidase activity,BP,1
GO:1905247,1,0.939246706,0,6,positive regulation of aspartic-type peptidase activity,BP,1
GO:1905258,1,0.977453202,0,2,regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,1
GO:1905259,1,0.977453202,0,2,negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,1
GO:1905267,1,0.977649486,0,2,endonucleolytic cleavage involved in tRNA processing,BP,1
GO:1905268,1,0.648385863,0,40,negative regulation of chromatin organization,BP,1
GO:1905271,1,0.977452981,0,2,"regulation of proton-transporting ATP synthase activity, rotational mechanism",BP,1
GO:1905273,1,0.977452981,0,2,"positive regulation of proton-transporting ATP synthase activity, rotational mechanism",BP,1
GO:1905274,1,0.928741332,0,8,regulation of modification of postsynaptic actin cytoskeleton,BP,1
GO:1905276,1,0.929110913,0,7,regulation of epithelial tube formation,BP,1
GO:1905277,1,0.990997407,0,1,negative regulation of epithelial tube formation,BP,1
GO:1905279,1,0.966369909,0,3,"regulation of retrograde transport, endosome to Golgi",BP,1
GO:1905281,1,0.988662931,0,1,"positive regulation of retrograde transport, endosome to Golgi",BP,1
GO:1905285,1,0.988901531,0,1,fibrous ring of heart morphogenesis,BP,1
GO:1905288,1,0.908179148,0,9,vascular associated smooth muscle cell apoptotic process,BP,1
GO:1905289,1,0.972981066,0,3,regulation of CAMKK-AMPK signaling cascade,BP,1
GO:1905290,1,0.988662931,0,1,negative regulation of CAMKK-AMPK signaling cascade,BP,1
GO:1905292,1,0.979399364,0,2,regulation of neural crest cell differentiation,BP,1
GO:1905294,1,0.979399364,0,2,positive regulation of neural crest cell differentiation,BP,1
GO:1905301,1,0.977589395,0,2,regulation of macropinocytosis,BP,1
GO:1905303,1,0.977589395,0,2,positive regulation of macropinocytosis,BP,1
GO:1905304,1,0.988662926,0,1,regulation of cardiac myofibril assembly,BP,1
GO:1905305,1,0.988662926,0,1,negative regulation of cardiac myofibril assembly,BP,1
GO:1905310,1,0.979399364,0,2,regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,1
GO:1905312,1,0.979399364,0,2,positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,1
GO:1905313,1,0.988662893,0,1,transforming growth factor beta receptor signaling pathway involved in heart development,BP,1
GO:1905314,1,0.811937624,0,21,semi-lunar valve development,BP,1
GO:1905317,1,0.988662931,0,1,inferior endocardial cushion morphogenesis,BP,1
GO:1905319,1,0.988662931,0,1,mesenchymal stem cell migration,BP,1
GO:1905320,1,0.988662931,0,1,regulation of mesenchymal stem cell migration,BP,1
GO:1905322,1,0.988662931,0,1,positive regulation of mesenchymal stem cell migration,BP,1
GO:1905323,1,0.939989536,0,6,telomerase holoenzyme complex assembly,BP,1
GO:1905331,1,0.908039227,0,9,negative regulation of morphogenesis of an epithelium,BP,1
GO:1905333,1,0.988666206,0,1,regulation of gastric motility,BP,1
GO:1905335,1,0.972983172,0,3,regulation of aggrephagy,BP,1
GO:1905337,1,0.972983172,0,3,positive regulation of aggrephagy,BP,1
GO:1905340,1,0.988662931,0,1,regulation of protein localization to kinetochore,BP,1
GO:1905342,1,0.988662931,0,1,positive regulation of protein localization to kinetochore,BP,1
GO:1905344,1,0.977453189,0,2,prostaglandin catabolic process,BP,1
GO:1905349,1,0.988662462,0,1,ciliary transition zone assembly,BP,1
GO:1905355,1,0.988700735,0,1,spine apparatus assembly,BP,1
GO:1905371,1,0.977453348,0,2,ceramide phosphoethanolamine metabolic process,BP,1
GO:1905373,1,0.977453348,0,2,ceramide phosphoethanolamine biosynthetic process,BP,1
GO:1905377,1,0.978372154,0,2,response to D-galactose,BP,1
GO:1905383,1,0.956533684,0,4,protein localization to presynapse,BP,1
GO:1905395,1,0.945470499,0,5,response to flavonoid,BP,1
GO:1905396,1,0.988662928,0,1,cellular response to flavonoid,BP,1
GO:1905397,1,0.988662931,0,1,"activated CD8-positive, alpha-beta T cell apoptotic process",BP,1
GO:1905402,1,0.988662931,0,1,"regulation of activated CD8-positive, alpha-beta T cell apoptotic process",BP,1
GO:1905404,1,0.988662931,0,1,"positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process",BP,1
GO:1905419,1,0.988662731,0,1,sperm flagellum movement involved in flagellated sperm motility,BP,1
GO:1905420,1,0.980295581,0,2,vascular smooth muscle cell differentiation involved in phenotypic switching,BP,1
GO:1905424,1,0.988662844,0,1,regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,1
GO:1905426,1,0.988662844,0,1,positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,1
GO:1905429,1,0.970011676,0,3,response to glycine,BP,1
GO:1905430,1,0.970011676,0,3,cellular response to glycine,BP,1
GO:1905435,1,0.988662931,0,1,regulation of histone H3-K4 trimethylation,BP,1
GO:1905437,1,0.988662931,0,1,positive regulation of histone H3-K4 trimethylation,BP,1
GO:1905443,1,0.978928866,0,2,regulation of clathrin coat assembly,BP,1
GO:1905445,1,0.978928866,0,2,positive regulation of clathrin coat assembly,BP,1
GO:1905446,1,0.955410365,0,4,regulation of mitochondrial ATP synthesis coupled electron transport,BP,1
GO:1905447,1,0.988662643,0,1,negative regulation of mitochondrial ATP synthesis coupled electron transport,BP,1
GO:1905448,1,0.966369422,0,3,positive regulation of mitochondrial ATP synthesis coupled electron transport,BP,1
GO:1905449,1,0.915004922,0,8,regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,1
GO:1905450,1,0.977453375,0,2,negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,1
GO:1905451,1,0.946861686,0,5,positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,1
GO:1905453,1,0.988668638,0,1,regulation of myeloid progenitor cell differentiation,BP,1
GO:1905454,1,0.988668638,0,1,negative regulation of myeloid progenitor cell differentiation,BP,1
GO:1905458,1,0.977762088,0,2,positive regulation of lymphoid progenitor cell differentiation,BP,1
GO:1905459,1,0.908179148,0,9,regulation of vascular associated smooth muscle cell apoptotic process,BP,1
GO:1905460,1,0.980295572,0,2,negative regulation of vascular associated smooth muscle cell apoptotic process,BP,1
GO:1905461,1,0.926445281,0,7,positive regulation of vascular associated smooth muscle cell apoptotic process,BP,1
GO:1905462,1,0.95771852,0,4,regulation of DNA duplex unwinding,BP,1
GO:1905463,1,0.968703558,0,3,negative regulation of DNA duplex unwinding,BP,1
GO:1905464,1,0.988662931,0,1,positive regulation of DNA duplex unwinding,BP,1
GO:1905475,1,0.233079261,0,133,regulation of protein localization to membrane,BP,1
GO:1905476,1,0.751053412,0,26,negative regulation of protein localization to membrane,BP,1
GO:1905477,1,0.458752909,0,72,positive regulation of protein localization to membrane,BP,1
GO:1905483,1,0.996093455,0,1,regulation of motor neuron migration,BP,1
GO:1905485,1,0.996093455,0,1,positive regulation of motor neuron migration,BP,1
GO:1905492,1,0.977453367,0,2,positive regulation of branching morphogenesis of a nerve,BP,1
GO:1905503,1,0.984139741,0,2,regulation of motile cilium assembly,BP,1
GO:1905505,1,0.984139741,0,2,positive regulation of motile cilium assembly,BP,1
GO:1905508,1,0.770216735,0,25,protein localization to microtubule organizing center,BP,1
GO:1905515,1,0.595056455,0,49,non-motile cilium assembly,BP,1
GO:1905516,1,0.970122504,0,3,positive regulation of fertilization,BP,1
GO:1905523,1,0.836118808,0,16,positive regulation of macrophage migration,BP,1
GO:1905524,1,0.988662931,0,1,negative regulation of protein autoubiquitination,BP,1
GO:1905535,1,0.988662931,0,1,regulation of eukaryotic translation initiation factor 4F complex assembly,BP,1
GO:1905537,1,0.988662931,0,1,positive regulation of eukaryotic translation initiation factor 4F complex assembly,BP,1
GO:1905539,1,0.988662795,0,1,regulation of postsynapse to nucleus signaling pathway,BP,1
GO:1905541,1,0.988662931,0,1,regulation of L-arginine import across plasma membrane,BP,1
GO:1905547,1,0.988662916,0,1,regulation of telomeric heterochromatin assembly,BP,1
GO:1905549,1,0.988662916,0,1,positive regulation of telomeric heterochromatin assembly,BP,1
GO:1905550,1,0.979273407,0,2,regulation of protein localization to endoplasmic reticulum,BP,1
GO:1905552,1,0.979273407,0,2,positive regulation of protein localization to endoplasmic reticulum,BP,1
GO:1905553,1,0.966369328,0,3,regulation of blood vessel branching,BP,1
GO:1905555,1,0.97745287,0,2,positive regulation blood vessel branching,BP,1
GO:1905562,1,0.865320616,0,14,regulation of vascular endothelial cell proliferation,BP,1
GO:1905563,1,0.960154226,0,4,negative regulation of vascular endothelial cell proliferation,BP,1
GO:1905564,1,0.90126138,0,10,positive regulation of vascular endothelial cell proliferation,BP,1
GO:1905572,1,0.988663033,0,1,ganglioside GM1 transport to membrane,BP,1
GO:1905578,1,0.990503689,0,1,regulation of ERBB3 signaling pathway,BP,1
GO:1905580,1,0.990503689,0,1,positive regulation of ERBB3 signaling pathway,BP,1
GO:1905581,1,0.977792917,0,2,positive regulation of low-density lipoprotein particle clearance,BP,1
GO:1905584,1,0.977453369,0,2,outer hair cell apoptotic process,BP,1
GO:1905585,1,0.977453369,0,2,regulation of outer hair cell apoptotic process,BP,1
GO:1905587,1,0.977453369,0,2,positive regulation of outer hair cell apoptotic process,BP,1
GO:1905589,1,0.988662931,0,1,positive regulation of L-arginine import across plasma membrane,BP,1
GO:1905595,1,0.97782518,0,2,regulation of low-density lipoprotein particle receptor binding,BP,1
GO:1905596,1,0.989039028,0,1,negative regulation of low-density lipoprotein particle receptor binding,BP,1
GO:1905597,1,0.988662869,0,1,positive regulation of low-density lipoprotein particle receptor binding,BP,1
GO:1905598,1,0.989039028,0,1,negative regulation of low-density lipoprotein receptor activity,BP,1
GO:1905599,1,0.988662869,0,1,positive regulation of low-density lipoprotein receptor activity,BP,1
GO:1905600,1,0.967073441,0,3,regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,1
GO:1905601,1,0.989039028,0,1,negative regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,1
GO:1905602,1,0.977792917,0,2,positive regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,1
GO:1905603,1,0.990446389,0,1,regulation of maintenance of permeability of blood-brain barrier,BP,1
GO:1905604,1,0.990446389,0,1,negative regulation of maintenance of permeability of blood-brain barrier,BP,1
GO:1905606,1,0.887645931,0,11,regulation of presynapse assembly,BP,1
GO:1905609,1,0.988662931,0,1,positive regulation of smooth muscle cell-matrix adhesion,BP,1
GO:1905610,1,0.988662931,0,1,regulation of mRNA cap binding,BP,1
GO:1905612,1,0.988662931,0,1,positive regulation of mRNA cap binding,BP,1
GO:1905616,1,0.977453375,0,2,regulation of miRNA mediated inhibition of translation,BP,1
GO:1905618,1,0.977453375,0,2,positive regulation of miRNA mediated inhibition of translation,BP,1
GO:1905630,1,0.991140072,0,1,response to glyceraldehyde,BP,1
GO:1905631,1,0.991140072,0,1,cellular response to glyceraldehyde,BP,1
GO:1905634,1,0.962107235,0,4,regulation of protein localization to chromatin,BP,1
GO:1905636,1,0.977453355,0,2,positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,1
GO:1905642,1,0.988662931,0,1,negative regulation of DNA methylation,BP,1
GO:1905643,1,0.977454408,0,2,positive regulation of DNA methylation,BP,1
GO:1905651,1,0.944918603,0,6,regulation of artery morphogenesis,BP,1
GO:1905653,1,0.944918603,0,6,positive regulation of artery morphogenesis,BP,1
GO:1905661,1,0.966369757,0,3,regulation of telomerase RNA reverse transcriptase activity,BP,1
GO:1905662,1,0.988662931,0,1,negative regulation of telomerase RNA reverse transcriptase activity,BP,1
GO:1905663,1,0.977453222,0,2,positive regulation of telomerase RNA reverse transcriptase activity,BP,1
GO:1905664,1,0.966369999,0,3,regulation of calcium ion import across plasma membrane,BP,1
GO:1905665,1,0.988663018,0,1,positive regulation of calcium ion import across plasma membrane,BP,1
GO:1905667,1,0.989333221,0,1,negative regulation of protein localization to endosome,BP,1
GO:1905671,1,0.955410943,0,4,regulation of lysosome organization,BP,1
GO:1905672,1,0.988662931,0,1,negative regulation of lysosome organization,BP,1
GO:1905673,1,0.988662931,0,1,positive regulation of lysosome organization,BP,1
GO:1905674,1,0.988662856,0,1,regulation of adaptive immune memory response,BP,1
GO:1905676,1,0.988662856,0,1,positive regulation of adaptive immune memory response,BP,1
GO:1905684,1,0.977453321,0,2,regulation of plasma membrane repair,BP,1
GO:1905693,1,0.988662931,0,1,regulation of phosphatidic acid biosynthetic process,BP,1
GO:1905695,1,0.988662931,0,1,positive regulation of phosphatidic acid biosynthetic process,BP,1
GO:1905696,1,0.978769202,0,2,regulation of polysome binding,BP,1
GO:1905698,1,0.989993728,0,1,positive regulation of polysome binding,BP,1
GO:1905702,1,0.988869573,0,1,regulation of inhibitory synapse assembly,BP,1
GO:1905704,1,0.988869573,0,1,positive regulation of inhibitory synapse assembly,BP,1
GO:1905705,1,0.988662931,0,1,cellular response to paclitaxel,BP,1
GO:1905706,1,0.977453222,0,2,regulation of mitochondrial ATP synthesis coupled proton transport,BP,1
GO:1905709,1,0.913908381,0,8,negative regulation of membrane permeability,BP,1
GO:1905711,1,0.988662929,0,1,response to phosphatidylethanolamine,BP,1
GO:1905719,1,0.977453457,0,2,protein localization to perinuclear region of cytoplasm,BP,1
GO:1905725,1,0.977454605,0,2,protein localization to microtubule end,BP,1
GO:1905747,1,0.98866287,0,1,negative regulation of saliva secretion,BP,1
GO:1905748,1,0.98866287,0,1,hard palate morphogenesis,BP,1
GO:1905749,1,0.96652555,0,3,regulation of endosome to plasma membrane protein transport,BP,1
GO:1905751,1,0.988662704,0,1,positive regulation of endosome to plasma membrane protein transport,BP,1
GO:1905764,1,0.966369721,0,3,regulation of protection from non-homologous end joining at telomere,BP,1
GO:1905765,1,0.966369721,0,3,negative regulation of protection from non-homologous end joining at telomere,BP,1
GO:1905770,1,0.966615674,0,3,regulation of mesodermal cell differentiation,BP,1
GO:1905771,1,0.988665047,0,1,negative regulation of mesodermal cell differentiation,BP,1
GO:1905774,1,0.966684095,0,3,regulation of DNA helicase activity,BP,1
GO:1905775,1,0.977771135,0,2,negative regulation of DNA helicase activity,BP,1
GO:1905776,1,0.988662931,0,1,positive regulation of DNA helicase activity,BP,1
GO:1905777,1,0.966373111,0,3,regulation of exonuclease activity,BP,1
GO:1905778,1,0.977453375,0,2,negative regulation of exonuclease activity,BP,1
GO:1905779,1,0.988666206,0,1,positive regulation of exonuclease activity,BP,1
GO:1905793,1,0.984036813,0,2,protein localization to pericentriolar material,BP,1
GO:1905794,1,0.988662931,0,1,response to puromycin,BP,1
GO:1905795,1,0.988662931,0,1,cellular response to puromycin,BP,1
GO:1905799,1,0.977453142,0,2,regulation of intraciliary retrograde transport,BP,1
GO:1905802,1,0.988663429,0,1,regulation of cellular response to manganese ion,BP,1
GO:1905809,1,0.845019142,0,15,negative regulation of synapse organization,BP,1
GO:1905820,1,0.92683388,0,7,positive regulation of chromosome separation,BP,1
GO:1905832,1,0.974237827,0,3,positive regulation of spindle assembly,BP,1
GO:1905834,1,0.988662931,0,1,response to pyrimidine ribonucleotide,BP,1
GO:1905835,1,0.988662931,0,1,cellular response to pyrimidine ribonucleotide,BP,1
GO:1905836,1,0.988662931,0,1,response to triterpenoid,BP,1
GO:1905837,1,0.988662931,0,1,cellular response to triterpenoid,BP,1
GO:1905838,1,0.977453375,0,2,regulation of telomeric D-loop disassembly,BP,1
GO:1905839,1,0.977453375,0,2,negative regulation of telomeric D-loop disassembly,BP,1
GO:1905843,1,0.99507895,0,1,regulation of cellular response to gamma radiation,BP,1
GO:1905853,1,0.988662786,0,1,regulation of heparan sulfate binding,BP,1
GO:1905855,1,0.988662786,0,1,positive regulation of heparan sulfate binding,BP,1
GO:1905858,1,0.988662786,0,1,regulation of heparan sulfate proteoglycan binding,BP,1
GO:1905860,1,0.988662786,0,1,positive regulation of heparan sulfate proteoglycan binding,BP,1
GO:1905863,1,0.977453333,0,2,invadopodium organization,BP,1
GO:1905867,1,0.96658996,0,3,epididymis development,BP,1
GO:1905868,1,0.977453375,0,2,regulation of 3'-UTR-mediated mRNA stabilization,BP,1
GO:1905870,1,0.977453375,0,2,positive regulation of 3'-UTR-mediated mRNA stabilization,BP,1
GO:1905871,1,0.977453238,0,2,regulation of protein localization to cell leading edge,BP,1
GO:1905872,1,0.988662931,0,1,negative regulation of protein localization to cell leading edge,BP,1
GO:1905873,1,0.988662792,0,1,positive regulation of protein localization to cell leading edge,BP,1
GO:1905874,1,0.910809024,0,9,regulation of postsynaptic density organization,BP,1
GO:1905875,1,0.988662792,0,1,negative regulation of postsynaptic density organization,BP,1
GO:1905877,1,0.988662888,0,1,invadopodium assembly,BP,1
GO:1905878,1,0.988662931,0,1,invadopodium disassembly,BP,1
GO:1905879,1,0.833626077,0,16,regulation of oogenesis,BP,1
GO:1905880,1,0.934338481,0,6,negative regulation of oogenesis,BP,1
GO:1905881,1,0.933864948,0,6,positive regulation of oogenesis,BP,1
GO:1905890,1,0.988662786,0,1,regulation of cellular response to very-low-density lipoprotein particle stimulus,BP,1
GO:1905891,1,0.988662929,0,1,regulation of cellular response to thapsigargin,BP,1
GO:1905892,1,0.988662929,0,1,negative regulation of cellular response to thapsigargin,BP,1
GO:1905894,1,0.988662929,0,1,regulation of cellular response to tunicamycin,BP,1
GO:1905895,1,0.988662929,0,1,negative regulation of cellular response to tunicamycin,BP,1
GO:1905898,1,0.720906101,0,29,positive regulation of response to endoplasmic reticulum stress,BP,1
GO:1905902,1,0.966615674,0,3,regulation of mesoderm formation,BP,1
GO:1905903,1,0.988665047,0,1,negative regulation of mesoderm formation,BP,1
GO:1905906,1,0.923433898,0,7,regulation of amyloid fibril formation,BP,1
GO:1905907,1,0.966539655,0,3,negative regulation of amyloid fibril formation,BP,1
GO:1905908,1,0.97745634,0,2,positive regulation of amyloid fibril formation,BP,1
GO:1905912,1,0.988662924,0,1,regulation of calcium ion export across plasma membrane,BP,1
GO:1905913,1,0.988662924,0,1,negative regulation of calcium ion export across plasma membrane,BP,1
GO:1905915,1,0.980295581,0,2,regulation of cell differentiation involved in phenotypic switching,BP,1
GO:1905916,1,0.991537471,0,1,negative regulation of cell differentiation involved in phenotypic switching,BP,1
GO:1905917,1,0.988662931,0,1,positive regulation of cell differentiation involved in phenotypic switching,BP,1
GO:1905918,1,0.988662889,0,1,regulation of CoA-transferase activity,BP,1
GO:1905920,1,0.988662889,0,1,positive regulation of CoA-transferase activity,BP,1
GO:1905924,1,0.988662888,0,1,regulation of invadopodium assembly,BP,1
GO:1905926,1,0.988662888,0,1,positive regulation of invadopodium assembly,BP,1
GO:1905927,1,0.988662931,0,1,regulation of invadopodium disassembly,BP,1
GO:1905929,1,0.988662931,0,1,positive regulation of invadopodium disassembly,BP,1
GO:1905930,1,0.980295581,0,2,regulation of vascular smooth muscle cell differentiation involved in phenotypic switching,BP,1
GO:1905931,1,0.991537471,0,1,negative regulation of vascular smooth muscle cell differentiation involved in phenotypic switching,BP,1
GO:1905932,1,0.988662931,0,1,positive regulation of vascular smooth muscle cell differentiation involved in phenotypic switching,BP,1
GO:1905936,1,0.95541022,0,4,regulation of germ cell proliferation,BP,1
GO:1905937,1,0.977453041,0,2,negative regulation of germ cell proliferation,BP,1
GO:1905938,1,0.977452783,0,2,positive regulation of germ cell proliferation,BP,1
GO:1905939,1,0.895445535,0,10,regulation of gonad development,BP,1
GO:1905940,1,0.966369805,0,3,negative regulation of gonad development,BP,1
GO:1905941,1,0.945458291,0,5,positive regulation of gonad development,BP,1
GO:1905942,1,0.990503689,0,1,regulation of formation of growth cone in injured axon,BP,1
GO:1905943,1,0.990503689,0,1,negative regulation of formation of growth cone in injured axon,BP,1
GO:1905957,1,0.988662911,0,1,regulation of cellular response to alcohol,BP,1
GO:1905959,1,0.988662911,0,1,positive regulation of cellular response to alcohol,BP,1
GO:1990000,1,0.86595559,0,13,amyloid fibril formation,BP,1
GO:1990001,1,0.955519877,0,4,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,BP,1
GO:1990009,1,0.966507163,0,3,retinal cell apoptotic process,BP,1
GO:1990034,1,0.967690665,0,3,calcium ion export across plasma membrane,BP,1
GO:1990036,1,0.967832941,0,3,calcium ion import into sarcoplasmic reticulum,BP,1
GO:1990046,1,0.988662824,0,1,stress-induced mitochondrial fusion,BP,1
GO:1990048,1,0.962655986,0,4,anterograde neuronal dense core vesicle transport,BP,1
GO:1990049,1,0.95985234,0,4,retrograde neuronal dense core vesicle transport,BP,1
GO:1990074,1,0.966607416,0,3,polyuridylation-dependent mRNA catabolic process,BP,1
GO:1990079,1,0.988686295,0,1,cartilage homeostasis,BP,1
GO:1990086,1,0.977453375,0,2,lens fiber cell apoptotic process,BP,1
GO:1990108,1,0.966628817,0,3,protein linear deubiquitination,BP,1
GO:1990114,1,0.988662834,0,1,RNA polymerase II core complex assembly,BP,1
GO:1990116,1,0.988662931,0,1,ribosome-associated ubiquitin-dependent protein catabolic process,BP,1
GO:1990117,1,0.98866253,0,1,B cell receptor apoptotic signaling pathway,BP,1
GO:1990120,1,0.970869566,0,3,messenger ribonucleoprotein complex assembly,BP,1
GO:1990126,1,0.758054422,0,25,"retrograde transport, endosome to plasma membrane",BP,1
GO:1990141,1,0.988662931,0,1,chromatin silencing at centromere outer repeat region,BP,1
GO:1990144,1,0.924717288,0,7,intrinsic apoptotic signaling pathway in response to hypoxia,BP,1
GO:1990145,1,0.977452598,0,2,maintenance of translational fidelity,BP,1
GO:1990164,1,0.969001328,0,3,histone H2A phosphorylation,BP,1
GO:1990166,1,0.966369909,0,3,protein localization to site of double-strand break,BP,1
GO:1990168,1,0.988662931,0,1,protein K33-linked deubiquitination,BP,1
GO:1990169,1,0.956962162,0,4,stress response to copper ion,BP,1
GO:1990170,1,0.988669595,0,1,stress response to cadmium ion,BP,1
GO:1990172,1,0.992292139,0,1,G protein-coupled receptor catabolic process,BP,1
GO:1990173,1,0.966369879,0,3,protein localization to nucleoplasm,BP,1
GO:1990180,1,0.966370039,0,3,mitochondrial tRNA 3'-end processing,BP,1
GO:1990182,1,0.810601721,0,19,exosomal secretion,BP,1
GO:1990227,1,0.988662931,0,1,paranodal junction maintenance,BP,1
GO:1990245,1,0.988662931,0,1,histone H2A-T120 phosphorylation,BP,1
GO:1990256,1,0.995524327,0,1,signal clustering,BP,1
GO:1990258,1,0.988662821,0,1,histone glutamine methylation,BP,1
GO:1990261,1,0.988662931,0,1,pre-mRNA catabolic process,BP,1
GO:1990264,1,0.967712532,0,3,peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity,BP,1
GO:1990266,1,0.45721864,0,70,neutrophil migration,BP,1
GO:1990267,1,0.977821135,0,2,response to transition metal nanoparticle,BP,1
GO:1990268,1,0.989034876,0,1,response to gold nanoparticle,BP,1
GO:1990280,1,0.98905161,0,1,RNA localization to chromatin,BP,1
GO:1990314,1,0.87723661,0,12,cellular response to insulin-like growth factor stimulus,BP,1
GO:1990349,1,0.977463334,0,2,gap junction-mediated intercellular transport,BP,1
GO:1990375,1,0.98866277,0,1,baculum development,BP,1
GO:1990379,1,0.977453231,0,2,lipid transport across blood brain barrier,BP,1
GO:1990384,1,0.988662795,0,1,hyaloid vascular plexus regression,BP,1
GO:1990386,1,0.988662702,0,1,mitotic cleavage furrow ingression,BP,1
GO:1990390,1,0.988891674,0,1,protein K33-linked ubiquitination,BP,1
GO:1990399,1,0.977677487,0,2,epithelium regeneration,BP,1
GO:1990401,1,0.977454583,0,2,embryonic lung development,BP,1
GO:1990402,1,0.957122193,0,4,embryonic liver development,BP,1
GO:1990403,1,0.864454526,0,13,embryonic brain development,BP,1
GO:1990408,1,0.977453103,0,2,calcitonin gene-related peptide receptor signaling pathway,BP,1
GO:1990410,1,0.966369552,0,3,adrenomedullin receptor signaling pathway,BP,1
GO:1990414,1,0.969476812,0,3,replication-born double-strand break repair via sister chromatid exchange,BP,1
GO:1990416,1,0.896204369,0,10,cellular response to brain-derived neurotrophic factor stimulus,BP,1
GO:1990418,1,0.955412497,0,4,response to insulin-like growth factor stimulus,BP,1
GO:1990428,1,0.977453222,0,2,miRNA transport,BP,1
GO:1990440,1,0.883851153,0,11,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,1
GO:1990441,1,0.944779616,0,5,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,1
GO:1990442,1,0.966369483,0,3,intrinsic apoptotic signaling pathway in response to nitrosative stress,BP,1
GO:1990456,1,0.981793493,0,2,mitochondrion-endoplasmic reticulum membrane tethering,BP,1
GO:1990478,1,0.967458692,0,3,response to ultrasound,BP,1
GO:1990481,1,0.944584853,0,5,mRNA pseudouridine synthesis,BP,1
GO:1990502,1,0.980326354,0,2,dense core granule maturation,BP,1
GO:1990504,1,0.938098737,0,6,dense core granule exocytosis,BP,1
GO:1990511,1,0.989336354,0,1,piRNA biosynthetic process,BP,1
GO:1990519,1,0.988662931,0,1,pyrimidine nucleotide import into mitochondrion,BP,1
GO:1990523,1,0.988662931,0,1,bone regeneration,BP,1
GO:1990535,1,0.930267103,0,7,neuron projection maintenance,BP,1
GO:1990539,1,0.988662985,0,1,fructose import across plasma membrane,BP,1
GO:1990542,1,0.487139805,0,63,mitochondrial transmembrane transport,BP,1
GO:1990546,1,0.988662917,0,1,mitochondrial tricarboxylic acid transmembrane transport,BP,1
GO:1990564,1,0.944575222,0,5,protein polyufmylation,BP,1
GO:1990569,1,0.956057984,0,4,UDP-N-acetylglucosamine transmembrane transport,BP,1
GO:1990573,1,0.881420471,0,12,potassium ion import across plasma membrane,BP,1
GO:1990575,1,0.977453218,0,2,mitochondrial L-ornithine transmembrane transport,BP,1
GO:1990579,1,0.988662931,0,1,peptidyl-serine trans-autophosphorylation,BP,1
GO:1990592,1,0.944575222,0,5,protein K69-linked ufmylation,BP,1
GO:1990603,1,0.988662931,0,1,dark adaptation,BP,1
GO:1990613,1,0.977453374,0,2,mitochondrial membrane fusion,BP,1
GO:1990619,1,0.988662916,0,1,histone H3-K9 deacetylation,BP,1
GO:1990636,1,0.988662931,0,1,reproductive senescence,BP,1
GO:1990637,1,0.93656862,0,6,response to prolactin,BP,1
GO:1990638,1,0.988662951,0,1,response to granulocyte colony-stimulating factor,BP,1
GO:1990641,1,0.966369344,0,3,response to iron ion starvation,BP,1
GO:1990643,1,0.988662951,0,1,cellular response to granulocyte colony-stimulating factor,BP,1
GO:1990646,1,0.966451566,0,3,cellular response to prolactin,BP,1
GO:1990654,1,0.991056435,0,1,sebum secreting cell proliferation,BP,1
GO:1990679,1,0.988662918,0,1,histone H4-K12 deacetylation,BP,1
GO:1990680,1,0.988662915,0,1,response to melanocyte-stimulating hormone,BP,1
GO:1990697,1,0.988662931,0,1,protein depalmitoleylation,BP,1
GO:1990705,1,0.965683871,0,4,cholangiocyte proliferation,BP,1
GO:1990709,1,0.97808535,0,2,presynaptic active zone organization,BP,1
GO:1990729,1,0.98866293,0,1,primary miRNA modification,BP,1
GO:1990736,1,0.9899866,0,1,regulation of vascular smooth muscle cell membrane depolarization,BP,1
GO:1990737,1,0.967985719,0,3,response to manganese-induced endoplasmic reticulum stress,BP,1
GO:1990739,1,0.994210854,0,1,granulosa cell proliferation,BP,1
GO:1990743,1,0.956240647,0,4,protein sialylation,BP,1
GO:1990744,1,0.98866293,0,1,primary miRNA methylation,BP,1
GO:1990758,1,0.988662893,0,1,mitotic sister chromatid biorientation,BP,1
GO:1990764,1,0.988662843,0,1,myofibroblast contraction,BP,1
GO:1990765,1,0.978312674,0,2,colon smooth muscle contraction,BP,1
GO:1990767,1,0.988662843,0,1,prostaglandin receptor internalization,BP,1
GO:1990768,1,0.988662843,0,1,gastric mucosal blood circulation,BP,1
GO:1990770,1,0.989532094,0,1,small intestine smooth muscle contraction,BP,1
GO:1990773,1,0.98866292,0,1,matrix metallopeptidase secretion,BP,1
GO:1990774,1,0.758006581,0,25,tumor necrosis factor secretion,BP,1
GO:1990784,1,0.97833171,0,2,response to dsDNA,BP,1
GO:1990785,1,0.966785235,0,3,response to water-immersion restraint stress,BP,1
GO:1990786,1,0.97833171,0,2,cellular response to dsDNA,BP,1
GO:1990787,1,0.988715289,0,1,negative regulation of hh target transcription factor activity,BP,1
GO:1990791,1,0.967618029,0,3,dorsal root ganglion development,BP,1
GO:1990809,1,0.968169487,0,3,endoplasmic reticulum tubular network membrane organization,BP,1
GO:1990822,1,0.933874355,0,6,basic amino acid transmembrane transport,BP,1
GO:1990828,1,0.988662931,0,1,hepatocyte dedifferentiation,BP,1
GO:1990831,1,0.988662931,0,1,cellular response to carcinoembryonic antigen,BP,1
GO:1990832,1,0.977453375,0,2,slow axonal transport,BP,1
GO:1990834,1,0.923698655,0,7,response to odorant,BP,1
GO:1990839,1,0.945285832,0,5,response to endothelin,BP,1
GO:1990840,1,0.988663984,0,1,response to lectin,BP,1
GO:1990858,1,0.988663984,0,1,cellular response to lectin,BP,1
GO:1990859,1,0.966736038,0,3,cellular response to endothelin,BP,1
GO:1990882,1,0.988662931,0,1,rRNA acetylation,BP,1
GO:1990884,1,0.988662931,0,1,RNA acetylation,BP,1
GO:1990910,1,0.915159479,0,8,response to hypobaric hypoxia,BP,1
GO:1990911,1,0.988669408,0,1,response to psychosocial stress,BP,1
GO:1990926,1,0.988766385,0,1,short-term synaptic potentiation,BP,1
GO:1990938,1,0.989508562,0,1,peptidyl-aspartic acid autophosphorylation,BP,1
GO:1990953,1,0.988662931,0,1,intramanchette transport,BP,1
GO:1990966,1,0.946119986,0,5,ATP generation from poly-ADP-D-ribose,BP,1
GO:1990967,1,0.977453373,0,2,multi-organism toxin transport,BP,1
GO:1990983,1,0.988662931,0,1,tRNA demethylation,BP,1
GO:2000003,1,0.988662931,0,1,positive regulation of DNA damage checkpoint,BP,1
GO:2000008,1,0.689440935,0,34,regulation of protein localization to cell surface,BP,1
GO:2000009,1,0.895619019,0,10,negative regulation of protein localization to cell surface,BP,1
GO:2000010,1,0.822575316,0,18,positive regulation of protein localization to cell surface,BP,1
GO:2000011,1,0.977453249,0,2,regulation of adaxial/abaxial pattern formation,BP,1
GO:2000015,1,0.955414036,0,4,regulation of determination of dorsal identity,BP,1
GO:2000016,1,0.988662671,0,1,negative regulation of determination of dorsal identity,BP,1
GO:2000017,1,0.966373107,0,3,positive regulation of determination of dorsal identity,BP,1
GO:2000018,1,0.955411028,0,4,regulation of male gonad development,BP,1
GO:2000019,1,0.977453275,0,2,negative regulation of male gonad development,BP,1
GO:2000020,1,0.977453375,0,2,positive regulation of male gonad development,BP,1
GO:2000036,1,0.76769545,0,24,regulation of stem cell population maintenance,BP,1
GO:2000040,1,0.988662931,0,1,regulation of planar cell polarity pathway involved in axis elongation,BP,1
GO:2000041,1,0.988662931,0,1,negative regulation of planar cell polarity pathway involved in axis elongation,BP,1
GO:2000042,1,0.905200966,0,9,negative regulation of double-strand break repair via homologous recombination,BP,1
GO:2000043,1,0.988665047,0,1,regulation of cardiac cell fate specification,BP,1
GO:2000047,1,0.916092342,0,8,regulation of cell-cell adhesion mediated by cadherin,BP,1
GO:2000048,1,0.966369756,0,3,negative regulation of cell-cell adhesion mediated by cadherin,BP,1
GO:2000049,1,0.947986765,0,5,positive regulation of cell-cell adhesion mediated by cadherin,BP,1
GO:2000050,1,0.874986171,0,12,regulation of non-canonical Wnt signaling pathway,BP,1
GO:2000051,1,0.957765305,0,4,negative regulation of non-canonical Wnt signaling pathway,BP,1
GO:2000052,1,0.924072204,0,7,positive regulation of non-canonical Wnt signaling pathway,BP,1
GO:2000053,1,0.977717063,0,2,regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,1
GO:2000054,1,0.977717063,0,2,negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,1
GO:2000059,1,0.639661168,0,40,negative regulation of ubiquitin-dependent protein catabolic process,BP,1
GO:2000064,1,0.935117175,0,6,regulation of cortisol biosynthetic process,BP,1
GO:2000065,1,0.956695069,0,4,negative regulation of cortisol biosynthetic process,BP,1
GO:2000066,1,0.98866283,0,1,positive regulation of cortisol biosynthetic process,BP,1
GO:2000074,1,0.955573932,0,4,regulation of type B pancreatic cell development,BP,1
GO:2000078,1,0.988662749,0,1,positive regulation of type B pancreatic cell development,BP,1
GO:2000079,1,0.988662931,0,1,regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,1
GO:2000080,1,0.988662931,0,1,negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,1
GO:2000095,1,0.925655048,0,7,"regulation of Wnt signaling pathway, planar cell polarity pathway",BP,1
GO:2000096,1,0.96657338,0,3,"positive regulation of Wnt signaling pathway, planar cell polarity pathway",BP,1
GO:2000097,1,0.966548782,0,3,regulation of smooth muscle cell-matrix adhesion,BP,1
GO:2000098,1,0.988845897,0,1,negative regulation of smooth muscle cell-matrix adhesion,BP,1
GO:2000105,1,0.920239455,0,8,positive regulation of DNA-dependent DNA replication,BP,1
GO:2000108,1,0.779536651,0,23,positive regulation of leukocyte apoptotic process,BP,1
GO:2000109,1,0.924300521,0,7,regulation of macrophage apoptotic process,BP,1
GO:2000110,1,0.945630732,0,5,negative regulation of macrophage apoptotic process,BP,1
GO:2000111,1,0.988662931,0,1,positive regulation of macrophage apoptotic process,BP,1
GO:2000114,1,0.815498385,0,19,regulation of establishment of cell polarity,BP,1
GO:2000118,1,0.966369796,0,3,regulation of sodium-dependent phosphate transport,BP,1
GO:2000120,1,0.977453256,0,2,positive regulation of sodium-dependent phosphate transport,BP,1
GO:2000121,1,0.923273782,0,7,regulation of removal of superoxide radicals,BP,1
GO:2000124,1,0.977453455,0,2,regulation of endocannabinoid signaling pathway,BP,1
GO:2000137,1,0.984043212,0,2,negative regulation of cell proliferation involved in heart morphogenesis,BP,1
GO:2000138,1,0.934922107,0,6,positive regulation of cell proliferation involved in heart morphogenesis,BP,1
GO:2000142,1,0.692261827,0,33,"regulation of DNA-templated transcription, initiation",BP,1
GO:2000143,1,0.956389785,0,4,"negative regulation of DNA-templated transcription, initiation",BP,1
GO:2000144,1,0.748715146,0,26,"positive regulation of DNA-templated transcription, initiation",BP,1
GO:2000148,1,0.990997407,0,1,regulation of planar cell polarity pathway involved in ventricular septum morphogenesis,BP,1
GO:2000149,1,0.990997407,0,1,negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis,BP,1
GO:2000150,1,0.990997407,0,1,regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,BP,1
GO:2000151,1,0.990997407,0,1,negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,BP,1
GO:2000152,1,0.955674022,0,4,regulation of ubiquitin-specific protease activity,BP,1
GO:2000156,1,0.977834293,0,2,"regulation of retrograde vesicle-mediated transport, Golgi to ER",BP,1
GO:2000157,1,0.977452991,0,2,negative regulation of ubiquitin-specific protease activity,BP,1
GO:2000158,1,0.977722671,0,2,positive regulation of ubiquitin-specific protease activity,BP,1
GO:2000159,1,0.990997407,0,1,regulation of planar cell polarity pathway involved in heart morphogenesis,BP,1
GO:2000160,1,0.990997407,0,1,negative regulation of planar cell polarity pathway involved in heart morphogenesis,BP,1
GO:2000161,1,0.990997407,0,1,regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis,BP,1
GO:2000162,1,0.990997407,0,1,negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis,BP,1
GO:2000163,1,0.990997407,0,1,regulation of planar cell polarity pathway involved in outflow tract morphogenesis,BP,1
GO:2000164,1,0.990997407,0,1,negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis,BP,1
GO:2000165,1,0.990997407,0,1,regulation of planar cell polarity pathway involved in pericardium morphogenesis,BP,1
GO:2000166,1,0.990997407,0,1,negative regulation of planar cell polarity pathway involved in pericardium morphogenesis,BP,1
GO:2000167,1,0.990997407,0,1,regulation of planar cell polarity pathway involved in neural tube closure,BP,1
GO:2000168,1,0.990997407,0,1,negative regulation of planar cell polarity pathway involved in neural tube closure,BP,1
GO:2000169,1,0.946194948,0,5,regulation of peptidyl-cysteine S-nitrosylation,BP,1
GO:2000171,1,0.779064716,0,23,negative regulation of dendrite development,BP,1
GO:2000172,1,0.935621109,0,6,regulation of branching morphogenesis of a nerve,BP,1
GO:2000173,1,0.977473785,0,2,negative regulation of branching morphogenesis of a nerve,BP,1
GO:2000174,1,0.988975156,0,1,regulation of pro-T cell differentiation,BP,1
GO:2000176,1,0.988975156,0,1,positive regulation of pro-T cell differentiation,BP,1
GO:2000178,1,0.803615995,0,20,negative regulation of neural precursor cell proliferation,BP,1
GO:2000180,1,0.98866283,0,1,negative regulation of androgen biosynthetic process,BP,1
GO:2000182,1,0.977453348,0,2,regulation of progesterone biosynthetic process,BP,1
GO:2000192,1,0.939198185,0,6,negative regulation of fatty acid transport,BP,1
GO:2000194,1,0.937258092,0,6,regulation of female gonad development,BP,1
GO:2000195,1,0.988662925,0,1,negative regulation of female gonad development,BP,1
GO:2000196,1,0.967272767,0,3,positive regulation of female gonad development,BP,1
GO:2000199,1,0.988662927,0,1,positive regulation of ribonucleoprotein complex localization,BP,1
GO:2000200,1,0.988662927,0,1,regulation of ribosomal subunit export from nucleus,BP,1
GO:2000202,1,0.988662927,0,1,positive regulation of ribosomal subunit export from nucleus,BP,1
GO:2000206,1,0.988662927,0,1,regulation of ribosomal small subunit export from nucleus,BP,1
GO:2000208,1,0.988662927,0,1,positive regulation of ribosomal small subunit export from nucleus,BP,1
GO:2000211,1,0.982938894,0,2,regulation of glutamate metabolic process,BP,1
GO:2000213,1,0.988662931,0,1,positive regulation of glutamate metabolic process,BP,1
GO:2000224,1,0.98866283,0,1,regulation of testosterone biosynthetic process,BP,1
GO:2000225,1,0.98866283,0,1,negative regulation of testosterone biosynthetic process,BP,1
GO:2000229,1,0.988662928,0,1,regulation of pancreatic stellate cell proliferation,BP,1
GO:2000230,1,0.988662928,0,1,negative regulation of pancreatic stellate cell proliferation,BP,1
GO:2000232,1,0.873684028,0,12,regulation of rRNA processing,BP,1
GO:2000233,1,0.98866344,0,1,negative regulation of rRNA processing,BP,1
GO:2000234,1,0.902895207,0,9,positive regulation of rRNA processing,BP,1
GO:2000243,1,0.641701814,0,40,positive regulation of reproductive process,BP,1
GO:2000249,1,0.734625677,0,28,regulation of actin cytoskeleton reorganization,BP,1
GO:2000251,1,0.864524906,0,13,positive regulation of actin cytoskeleton reorganization,BP,1
GO:2000252,1,0.988900204,0,1,negative regulation of feeding behavior,BP,1
GO:2000253,1,0.971793301,0,3,positive regulation of feeding behavior,BP,1
GO:2000254,1,0.95541022,0,4,regulation of male germ cell proliferation,BP,1
GO:2000255,1,0.977453041,0,2,negative regulation of male germ cell proliferation,BP,1
GO:2000256,1,0.977452783,0,2,positive regulation of male germ cell proliferation,BP,1
GO:2000257,1,0.839901682,0,16,regulation of protein activation cascade,BP,1
GO:2000258,1,0.916608202,0,8,negative regulation of protein activation cascade,BP,1
GO:2000259,1,0.957821233,0,4,positive regulation of protein activation cascade,BP,1
GO:2000266,1,0.988662904,0,1,"regulation of blood coagulation, intrinsic pathway",BP,1
GO:2000269,1,0.861577538,0,14,regulation of fibroblast apoptotic process,BP,1
GO:2000270,1,0.933223456,0,7,negative regulation of fibroblast apoptotic process,BP,1
GO:2000271,1,0.944574994,0,5,positive regulation of fibroblast apoptotic process,BP,1
GO:2000272,1,0.772224648,0,23,negative regulation of signaling receptor activity,BP,1
GO:2000273,1,0.777155214,0,24,positive regulation of signaling receptor activity,BP,1
GO:2000275,1,0.955916493,0,4,regulation of oxidative phosphorylation uncoupler activity,BP,1
GO:2000276,1,0.988662897,0,1,negative regulation of oxidative phosphorylation uncoupler activity,BP,1
GO:2000277,1,0.977453142,0,2,positive regulation of oxidative phosphorylation uncoupler activity,BP,1
GO:2000282,1,0.978515099,0,2,regulation of cellular amino acid biosynthetic process,BP,1
GO:2000283,1,0.989736892,0,1,negative regulation of cellular amino acid biosynthetic process,BP,1
GO:2000284,1,0.988662773,0,1,positive regulation of cellular amino acid biosynthetic process,BP,1
GO:2000286,1,0.966381256,0,3,receptor internalization involved in canonical Wnt signaling pathway,BP,1
GO:2000295,1,0.978665732,0,2,regulation of hydrogen peroxide catabolic process,BP,1
GO:2000296,1,0.988662826,0,1,negative regulation of hydrogen peroxide catabolic process,BP,1
GO:2000297,1,0.97837351,0,2,negative regulation of synapse maturation,BP,1
GO:2000298,1,0.955634764,0,4,regulation of Rho-dependent protein serine/threonine kinase activity,BP,1
GO:2000299,1,0.966392265,0,3,negative regulation of Rho-dependent protein serine/threonine kinase activity,BP,1
GO:2000301,1,0.956670883,0,4,negative regulation of synaptic vesicle exocytosis,BP,1
GO:2000302,1,0.960362473,0,4,positive regulation of synaptic vesicle exocytosis,BP,1
GO:2000303,1,0.915103044,0,8,regulation of ceramide biosynthetic process,BP,1
GO:2000304,1,0.946963735,0,5,positive regulation of ceramide biosynthetic process,BP,1
GO:2000310,1,0.902652664,0,10,regulation of NMDA receptor activity,BP,1
GO:2000311,1,0.959838913,0,5,regulation of AMPA receptor activity,BP,1
GO:2000312,1,0.99035067,0,1,regulation of kainate selective glutamate receptor activity,BP,1
GO:2000313,1,0.978040212,0,2,regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,1
GO:2000314,1,0.978040212,0,2,negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,1
GO:2000316,1,0.91519481,0,8,regulation of T-helper 17 type immune response,BP,1
GO:2000317,1,0.957756105,0,4,negative regulation of T-helper 17 type immune response,BP,1
GO:2000318,1,0.966511461,0,3,positive regulation of T-helper 17 type immune response,BP,1
GO:2000319,1,0.925671362,0,7,regulation of T-helper 17 cell differentiation,BP,1
GO:2000320,1,0.957756105,0,4,negative regulation of T-helper 17 cell differentiation,BP,1
GO:2000321,1,0.966511461,0,3,positive regulation of T-helper 17 cell differentiation,BP,1
GO:2000324,1,0.962029772,0,4,positive regulation of glucocorticoid receptor signaling pathway,BP,1
GO:2000325,1,0.933861966,0,6,regulation of nuclear receptor transcription coactivator activity,BP,1
GO:2000326,1,0.988662823,0,1,negative regulation of nuclear receptor transcription coactivator activity,BP,1
GO:2000327,1,0.955411154,0,4,positive regulation of nuclear receptor transcription coactivator activity,BP,1
GO:2000331,1,0.977721263,0,2,regulation of terminal button organization,BP,1
GO:2000338,1,0.988662958,0,1,regulation of chemokine (C-X-C motif) ligand 1 production,BP,1
GO:2000342,1,0.977456892,0,2,negative regulation of chemokine (C-X-C motif) ligand 2 production,BP,1
GO:2000344,1,0.991140072,0,1,positive regulation of acrosome reaction,BP,1
GO:2000345,1,0.863742197,0,14,regulation of hepatocyte proliferation,BP,1
GO:2000346,1,0.955866834,0,4,negative regulation of hepatocyte proliferation,BP,1
GO:2000347,1,0.923314585,0,8,positive regulation of hepatocyte proliferation,BP,1
GO:2000348,1,0.988662917,0,1,regulation of CD40 signaling pathway,BP,1
GO:2000353,1,0.910565534,0,9,positive regulation of endothelial cell apoptotic process,BP,1
GO:2000354,1,0.978366506,0,2,regulation of ovarian follicle development,BP,1
GO:2000361,1,0.98918315,0,1,regulation of prostaglandin-E synthase activity,BP,1
GO:2000363,1,0.98918315,0,1,positive regulation of prostaglandin-E synthase activity,BP,1
GO:2000367,1,0.989195603,0,1,regulation of acrosomal vesicle exocytosis,BP,1
GO:2000369,1,0.895795448,0,10,regulation of clathrin-dependent endocytosis,BP,1
GO:2000370,1,0.956091598,0,4,positive regulation of clathrin-dependent endocytosis,BP,1
GO:2000371,1,0.957073701,0,4,regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,1
GO:2000373,1,0.957073701,0,4,positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,1
GO:2000374,1,0.977453373,0,2,regulation of oxygen metabolic process,BP,1
GO:2000376,1,0.98866293,0,1,positive regulation of oxygen metabolic process,BP,1
GO:2000378,1,0.554266066,0,53,negative regulation of reactive oxygen species metabolic process,BP,1
GO:2000380,1,0.924378481,0,7,regulation of mesoderm development,BP,1
GO:2000381,1,0.978368599,0,2,negative regulation of mesoderm development,BP,1
GO:2000382,1,0.977455899,0,2,positive regulation of mesoderm development,BP,1
GO:2000383,1,0.96727249,0,3,regulation of ectoderm development,BP,1
GO:2000384,1,0.96727249,0,3,negative regulation of ectoderm development,BP,1
GO:2000386,1,0.978366506,0,2,positive regulation of ovarian follicle development,BP,1
GO:2000389,1,0.913961565,0,8,regulation of neutrophil extravasation,BP,1
GO:2000391,1,0.913961565,0,8,positive regulation of neutrophil extravasation,BP,1
GO:2000392,1,0.921608552,0,8,regulation of lamellipodium morphogenesis,BP,1
GO:2000393,1,0.968727968,0,3,negative regulation of lamellipodium morphogenesis,BP,1
GO:2000394,1,0.95035015,0,5,positive regulation of lamellipodium morphogenesis,BP,1
GO:2000395,1,0.977453134,0,2,regulation of ubiquitin-dependent endocytosis,BP,1
GO:2000397,1,0.977453134,0,2,positive regulation of ubiquitin-dependent endocytosis,BP,1
GO:2000401,1,0.64427511,0,40,regulation of lymphocyte migration,BP,1
GO:2000402,1,0.934088963,0,6,negative regulation of lymphocyte migration,BP,1
GO:2000403,1,0.745534215,0,27,positive regulation of lymphocyte migration,BP,1
GO:2000404,1,0.711729232,0,31,regulation of T cell migration,BP,1
GO:2000405,1,0.966604941,0,3,negative regulation of T cell migration,BP,1
GO:2000406,1,0.770820092,0,24,positive regulation of T cell migration,BP,1
GO:2000407,1,0.956631731,0,4,regulation of T cell extravasation,BP,1
GO:2000409,1,0.967604402,0,3,positive regulation of T cell extravasation,BP,1
GO:2000410,1,0.988662386,0,1,regulation of thymocyte migration,BP,1
GO:2000412,1,0.988662386,0,1,positive regulation of thymocyte migration,BP,1
GO:2000416,1,0.966369794,0,3,regulation of eosinophil migration,BP,1
GO:2000417,1,0.988662931,0,1,negative regulation of eosinophil migration,BP,1
GO:2000418,1,0.977453258,0,2,positive regulation of eosinophil migration,BP,1
GO:2000422,1,0.988662851,0,1,regulation of eosinophil chemotaxis,BP,1
GO:2000424,1,0.988662851,0,1,positive regulation of eosinophil chemotaxis,BP,1
GO:2000425,1,0.931460805,0,7,regulation of apoptotic cell clearance,BP,1
GO:2000426,1,0.977453634,0,2,negative regulation of apoptotic cell clearance,BP,1
GO:2000427,1,0.942146803,0,6,positive regulation of apoptotic cell clearance,BP,1
GO:2000434,1,0.955410752,0,4,regulation of protein neddylation,BP,1
GO:2000435,1,0.96636954,0,3,negative regulation of protein neddylation,BP,1
GO:2000436,1,0.988662922,0,1,positive regulation of protein neddylation,BP,1
GO:2000437,1,0.979902314,0,2,regulation of monocyte extravasation,BP,1
GO:2000438,1,0.991140072,0,1,negative regulation of monocyte extravasation,BP,1
GO:2000439,1,0.98866259,0,1,positive regulation of monocyte extravasation,BP,1
GO:2000449,1,0.977453054,0,2,"regulation of CD8-positive, alpha-beta T cell extravasation",BP,1
GO:2000451,1,0.988662606,0,1,"positive regulation of CD8-positive, alpha-beta T cell extravasation",BP,1
GO:2000452,1,0.977453054,0,2,"regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation",BP,1
GO:2000454,1,0.988662606,0,1,"positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation",BP,1
GO:2000466,1,0.988662878,0,1,negative regulation of glycogen (starch) synthase activity,BP,1
GO:2000468,1,0.977453085,0,2,regulation of peroxidase activity,BP,1
GO:2000469,1,0.977453085,0,2,negative regulation of peroxidase activity,BP,1
GO:2000471,1,0.990663816,0,1,regulation of hematopoietic stem cell migration,BP,1
GO:2000473,1,0.990663816,0,1,positive regulation of hematopoietic stem cell migration,BP,1
GO:2000474,1,0.977838518,0,2,regulation of opioid receptor signaling pathway,BP,1
GO:2000476,1,0.988662931,0,1,positive regulation of opioid receptor signaling pathway,BP,1
GO:2000477,1,0.988662703,0,1,regulation of metanephric glomerular visceral epithelial cell development,BP,1
GO:2000478,1,0.988662703,0,1,positive regulation of metanephric glomerular visceral epithelial cell development,BP,1
GO:2000480,1,0.966369164,0,3,negative regulation of cAMP-dependent protein kinase activity,BP,1
GO:2000481,1,0.965424965,0,4,positive regulation of cAMP-dependent protein kinase activity,BP,1
GO:2000482,1,0.835072518,0,16,regulation of interleukin-8 secretion,BP,1
GO:2000483,1,0.946419603,0,5,negative regulation of interleukin-8 secretion,BP,1
GO:2000484,1,0.902768967,0,9,positive regulation of interleukin-8 secretion,BP,1
GO:2000485,1,0.988665688,0,1,regulation of glutamine transport,BP,1
GO:2000487,1,0.988665688,0,1,positive regulation of glutamine transport,BP,1
GO:2000490,1,0.977628146,0,2,negative regulation of hepatic stellate cell activation,BP,1
GO:2000491,1,0.957961359,0,4,positive regulation of hepatic stellate cell activation,BP,1
GO:2000492,1,0.989016853,0,1,regulation of interleukin-18-mediated signaling pathway,BP,1
GO:2000494,1,0.989016853,0,1,positive regulation of interleukin-18-mediated signaling pathway,BP,1
GO:2000501,1,0.955409616,0,4,regulation of natural killer cell chemotaxis,BP,1
GO:2000503,1,0.955409616,0,4,positive regulation of natural killer cell chemotaxis,BP,1
GO:2000504,1,0.955410806,0,4,positive regulation of blood vessel remodeling,BP,1
GO:2000508,1,0.933878554,0,6,regulation of dendritic cell chemotaxis,BP,1
GO:2000509,1,0.988662913,0,1,negative regulation of dendritic cell chemotaxis,BP,1
GO:2000510,1,0.944592335,0,5,positive regulation of dendritic cell chemotaxis,BP,1
GO:2000511,1,0.988662386,0,1,regulation of granzyme A production,BP,1
GO:2000513,1,0.988662386,0,1,positive regulation of granzyme A production,BP,1
GO:2000514,1,0.654352937,0,38,"regulation of CD4-positive, alpha-beta T cell activation",BP,1
GO:2000515,1,0.801802599,0,20,"negative regulation of CD4-positive, alpha-beta T cell activation",BP,1
GO:2000516,1,0.763312968,0,24,"positive regulation of CD4-positive, alpha-beta T cell activation",BP,1
GO:2000517,1,0.988662386,0,1,regulation of T-helper 1 cell activation,BP,1
GO:2000518,1,0.988662386,0,1,negative regulation of T-helper 1 cell activation,BP,1
GO:2000520,1,0.988662726,0,1,regulation of immunological synapse formation,BP,1
GO:2000521,1,0.988662726,0,1,negative regulation of immunological synapse formation,BP,1
GO:2000523,1,0.978593225,0,2,regulation of T cell costimulation,BP,1
GO:2000525,1,0.978593225,0,2,positive regulation of T cell costimulation,BP,1
GO:2000527,1,0.988662931,0,1,regulation of myeloid dendritic cell chemotaxis,BP,1
GO:2000529,1,0.988662931,0,1,positive regulation of myeloid dendritic cell chemotaxis,BP,1
GO:2000532,1,0.977470611,0,2,regulation of renal albumin absorption,BP,1
GO:2000533,1,0.988680592,0,1,negative regulation of renal albumin absorption,BP,1
GO:2000534,1,0.988662703,0,1,positive regulation of renal albumin absorption,BP,1
GO:2000535,1,0.946316223,0,5,regulation of entry of bacterium into host cell,BP,1
GO:2000536,1,0.988954145,0,1,negative regulation of entry of bacterium into host cell,BP,1
GO:2000537,1,0.978356957,0,2,regulation of B cell chemotaxis,BP,1
GO:2000538,1,0.978356957,0,2,positive regulation of B cell chemotaxis,BP,1
GO:2000539,1,0.993131088,0,1,regulation of protein geranylgeranylation,BP,1
GO:2000541,1,0.993131088,0,1,positive regulation of protein geranylgeranylation,BP,1
GO:2000542,1,0.961484744,0,4,negative regulation of gastrulation,BP,1
GO:2000543,1,0.977453618,0,2,positive regulation of gastrulation,BP,1
GO:2000544,1,0.966380091,0,3,regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,1
GO:2000545,1,0.988662786,0,1,negative regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,1
GO:2000546,1,0.988673601,0,1,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,1
GO:2000547,1,0.988662607,0,1,regulation of dendritic cell dendrite assembly,BP,1
GO:2000549,1,0.988662607,0,1,positive regulation of dendritic cell dendrite assembly,BP,1
GO:2000551,1,0.93444869,0,6,regulation of T-helper 2 cell cytokine production,BP,1
GO:2000552,1,0.988662889,0,1,negative regulation of T-helper 2 cell cytokine production,BP,1
GO:2000553,1,0.945168982,0,5,positive regulation of T-helper 2 cell cytokine production,BP,1
GO:2000554,1,0.95541021,0,4,regulation of T-helper 1 cell cytokine production,BP,1
GO:2000556,1,0.95541021,0,4,positive regulation of T-helper 1 cell cytokine production,BP,1
GO:2000557,1,0.988662386,0,1,regulation of immunoglobulin production in mucosal tissue,BP,1
GO:2000558,1,0.988662386,0,1,positive regulation of immunoglobulin production in mucosal tissue,BP,1
GO:2000559,1,0.991140072,0,1,regulation of CD24 biosynthetic process,BP,1
GO:2000560,1,0.991140072,0,1,positive regulation of CD24 biosynthetic process,BP,1
GO:2000561,1,0.904768305,0,9,"regulation of CD4-positive, alpha-beta T cell proliferation",BP,1
GO:2000562,1,0.935825022,0,6,"negative regulation of CD4-positive, alpha-beta T cell proliferation",BP,1
GO:2000563,1,0.945025706,0,5,"positive regulation of CD4-positive, alpha-beta T cell proliferation",BP,1
GO:2000564,1,0.923480247,0,7,"regulation of CD8-positive, alpha-beta T cell proliferation",BP,1
GO:2000565,1,0.988662931,0,1,"negative regulation of CD8-positive, alpha-beta T cell proliferation",BP,1
GO:2000566,1,0.966407921,0,3,"positive regulation of CD8-positive, alpha-beta T cell proliferation",BP,1
GO:2000567,1,0.977453374,0,2,regulation of memory T cell activation,BP,1
GO:2000568,1,0.977453374,0,2,positive regulation of memory T cell activation,BP,1
GO:2000574,1,0.926840706,0,7,regulation of microtubule motor activity,BP,1
GO:2000575,1,0.99165778,0,1,negative regulation of microtubule motor activity,BP,1
GO:2000576,1,0.966371481,0,3,positive regulation of microtubule motor activity,BP,1
GO:2000580,1,0.966371481,0,3,"regulation of ATP-dependent microtubule motor activity, plus-end-directed",BP,1
GO:2000582,1,0.966371481,0,3,"positive regulation of ATP-dependent microtubule motor activity, plus-end-directed",BP,1
GO:2000583,1,0.957053141,0,4,regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,1
GO:2000584,1,0.978721981,0,2,negative regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,1
GO:2000586,1,0.937257262,0,7,regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,1
GO:2000587,1,0.975008277,0,3,negative regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,1
GO:2000588,1,0.97231471,0,3,positive regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,1
GO:2000589,1,0.968948834,0,3,regulation of metanephric mesenchymal cell migration,BP,1
GO:2000590,1,0.988662703,0,1,negative regulation of metanephric mesenchymal cell migration,BP,1
GO:2000591,1,0.980061868,0,2,positive regulation of metanephric mesenchymal cell migration,BP,1
GO:2000601,1,0.92632113,0,7,positive regulation of Arp2/3 complex-mediated actin nucleation,BP,1
GO:2000609,1,0.977453354,0,2,regulation of thyroid hormone generation,BP,1
GO:2000611,1,0.988662922,0,1,positive regulation of thyroid hormone generation,BP,1
GO:2000615,1,0.926903693,0,7,regulation of histone H3-K9 acetylation,BP,1
GO:2000616,1,0.97843694,0,2,negative regulation of histone H3-K9 acetylation,BP,1
GO:2000617,1,0.958206939,0,4,positive regulation of histone H3-K9 acetylation,BP,1
GO:2000618,1,0.947337916,0,5,regulation of histone H4-K16 acetylation,BP,1
GO:2000619,1,0.966371762,0,3,negative regulation of histone H4-K16 acetylation,BP,1
GO:2000620,1,0.991551022,0,1,positive regulation of histone H4-K16 acetylation,BP,1
GO:2000622,1,0.955707214,0,4,"regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",BP,1
GO:2000623,1,0.955707214,0,4,"negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",BP,1
GO:2000625,1,0.966861263,0,3,regulation of miRNA catabolic process,BP,1
GO:2000626,1,0.988662931,0,1,negative regulation of miRNA catabolic process,BP,1
GO:2000627,1,0.97795032,0,2,positive regulation of miRNA catabolic process,BP,1
GO:2000628,1,0.88342391,0,11,regulation of miRNA metabolic process,BP,1
GO:2000629,1,0.977453375,0,2,negative regulation of miRNA metabolic process,BP,1
GO:2000630,1,0.934344713,0,6,positive regulation of miRNA metabolic process,BP,1
GO:2000631,1,0.988662839,0,1,regulation of pre-miRNA processing,BP,1
GO:2000632,1,0.988662839,0,1,negative regulation of pre-miRNA processing,BP,1
GO:2000634,1,0.988662923,0,1,regulation of primary miRNA processing,BP,1
GO:2000635,1,0.988662923,0,1,negative regulation of primary miRNA processing,BP,1
GO:2000637,1,0.806933387,0,20,positive regulation of gene silencing by miRNA,BP,1
GO:2000638,1,0.977459581,0,2,regulation of SREBP signaling pathway,BP,1
GO:2000639,1,0.988669224,0,1,negative regulation of SREBP signaling pathway,BP,1
GO:2000640,1,0.988662915,0,1,positive regulation of SREBP signaling pathway,BP,1
GO:2000641,1,0.831791001,0,17,regulation of early endosome to late endosome transport,BP,1
GO:2000642,1,0.988662546,0,1,negative regulation of early endosome to late endosome transport,BP,1
GO:2000643,1,0.917247975,0,8,positive regulation of early endosome to late endosome transport,BP,1
GO:2000644,1,0.896794779,0,10,regulation of receptor catabolic process,BP,1
GO:2000645,1,0.968568549,0,3,negative regulation of receptor catabolic process,BP,1
GO:2000646,1,0.936364525,0,6,positive regulation of receptor catabolic process,BP,1
GO:2000647,1,0.887990066,0,11,negative regulation of stem cell proliferation,BP,1
GO:2000649,1,0.728604273,0,30,regulation of sodium ion transmembrane transporter activity,BP,1
GO:2000650,1,0.912710384,0,9,negative regulation of sodium ion transmembrane transporter activity,BP,1
GO:2000651,1,0.903090276,0,10,positive regulation of sodium ion transmembrane transporter activity,BP,1
GO:2000653,1,0.97027359,0,3,regulation of genetic imprinting,BP,1
GO:2000656,1,0.988662926,0,1,regulation of apolipoprotein binding,BP,1
GO:2000657,1,0.988662926,0,1,negative regulation of apolipoprotein binding,BP,1
GO:2000659,1,0.955410937,0,4,regulation of interleukin-1-mediated signaling pathway,BP,1
GO:2000660,1,0.977453374,0,2,negative regulation of interleukin-1-mediated signaling pathway,BP,1
GO:2000661,1,0.988662926,0,1,positive regulation of interleukin-1-mediated signaling pathway,BP,1
GO:2000662,1,0.94684422,0,5,regulation of interleukin-5 secretion,BP,1
GO:2000663,1,0.990138142,0,1,negative regulation of interleukin-5 secretion,BP,1
GO:2000664,1,0.95627826,0,4,positive regulation of interleukin-5 secretion,BP,1
GO:2000665,1,0.93610508,0,6,regulation of interleukin-13 secretion,BP,1
GO:2000666,1,0.978911992,0,2,negative regulation of interleukin-13 secretion,BP,1
GO:2000667,1,0.956278222,0,4,positive regulation of interleukin-13 secretion,BP,1
GO:2000668,1,0.907002591,0,9,regulation of dendritic cell apoptotic process,BP,1
GO:2000669,1,0.944707173,0,5,negative regulation of dendritic cell apoptotic process,BP,1
GO:2000670,1,0.960106404,0,4,positive regulation of dendritic cell apoptotic process,BP,1
GO:2000671,1,0.955410547,0,4,regulation of motor neuron apoptotic process,BP,1
GO:2000672,1,0.966369405,0,3,negative regulation of motor neuron apoptotic process,BP,1
GO:2000674,1,0.90402809,0,9,regulation of type B pancreatic cell apoptotic process,BP,1
GO:2000675,1,0.957086451,0,4,negative regulation of type B pancreatic cell apoptotic process,BP,1
GO:2000676,1,0.944581527,0,5,positive regulation of type B pancreatic cell apoptotic process,BP,1
GO:2000677,1,0.73085468,0,29,regulation of transcription regulatory region DNA binding,BP,1
GO:2000678,1,0.886904442,0,11,negative regulation of transcription regulatory region DNA binding,BP,1
GO:2000679,1,0.854556994,0,14,positive regulation of transcription regulatory region DNA binding,BP,1
GO:2000690,1,0.99029846,0,1,regulation of cardiac muscle cell myoblast differentiation,BP,1
GO:2000691,1,0.99029846,0,1,negative regulation of cardiac muscle cell myoblast differentiation,BP,1
GO:2000696,1,0.904926849,0,9,regulation of epithelial cell differentiation involved in kidney development,BP,1
GO:2000697,1,0.978369747,0,2,negative regulation of epithelial cell differentiation involved in kidney development,BP,1
GO:2000698,1,0.967015307,0,3,positive regulation of epithelial cell differentiation involved in kidney development,BP,1
GO:2000705,1,0.978046244,0,2,regulation of dense core granule biogenesis,BP,1
GO:2000706,1,0.988965311,0,1,negative regulation of dense core granule biogenesis,BP,1
GO:2000707,1,0.988960075,0,1,positive regulation of dense core granule biogenesis,BP,1
GO:2000718,1,0.988662931,0,1,"regulation of maintenance of mitotic sister chromatid cohesion, centromeric",BP,1
GO:2000719,1,0.988662931,0,1,"negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric",BP,1
GO:2000721,1,0.988662931,0,1,positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,1
GO:2000727,1,0.799919917,0,21,positive regulation of cardiac muscle cell differentiation,BP,1
GO:2000730,1,0.988663097,0,1,regulation of termination of RNA polymerase I transcription,BP,1
GO:2000738,1,0.837709728,0,16,positive regulation of stem cell differentiation,BP,1
GO:2000739,1,0.937775035,0,6,regulation of mesenchymal stem cell differentiation,BP,1
GO:2000740,1,0.988965311,0,1,negative regulation of mesenchymal stem cell differentiation,BP,1
GO:2000741,1,0.95545443,0,4,positive regulation of mesenchymal stem cell differentiation,BP,1
GO:2000742,1,0.98866293,0,1,regulation of anterior head development,BP,1
GO:2000744,1,0.98866293,0,1,positive regulation of anterior head development,BP,1
GO:2000752,1,0.988706839,0,1,regulation of glucosylceramide catabolic process,BP,1
GO:2000753,1,0.988706839,0,1,positive regulation of glucosylceramide catabolic process,BP,1
GO:2000754,1,0.988706839,0,1,regulation of sphingomyelin catabolic process,BP,1
GO:2000755,1,0.988706839,0,1,positive regulation of sphingomyelin catabolic process,BP,1
GO:2000757,1,0.829016484,0,17,negative regulation of peptidyl-lysine acetylation,BP,1
GO:2000763,1,0.988662368,0,1,positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process,BP,1
GO:2000764,1,0.988662368,0,1,positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis,BP,1
GO:2000765,1,0.803969496,0,20,regulation of cytoplasmic translation,BP,1
GO:2000766,1,0.938394387,0,6,negative regulation of cytoplasmic translation,BP,1
GO:2000767,1,0.927405958,0,7,positive regulation of cytoplasmic translation,BP,1
GO:2000768,1,0.978106342,0,2,positive regulation of nephron tubule epithelial cell differentiation,BP,1
GO:2000769,1,0.977454492,0,2,regulation of establishment or maintenance of cell polarity regulating cell shape,BP,1
GO:2000771,1,0.977454492,0,2,positive regulation of establishment or maintenance of cell polarity regulating cell shape,BP,1
GO:2000772,1,0.743410108,0,27,regulation of cellular senescence,BP,1
GO:2000773,1,0.881415516,0,12,negative regulation of cellular senescence,BP,1
GO:2000774,1,0.944574588,0,5,positive regulation of cellular senescence,BP,1
GO:2000777,1,0.97745832,0,2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia,BP,1
GO:2000778,1,0.7904127,0,21,positive regulation of interleukin-6 secretion,BP,1
GO:2000780,1,0.849117057,0,15,negative regulation of double-strand break repair,BP,1
GO:2000782,1,0.988662792,0,1,regulation of establishment of cell polarity regulating cell shape,BP,1
GO:2000784,1,0.988662792,0,1,positive regulation of establishment of cell polarity regulating cell shape,BP,1
GO:2000785,1,0.726643797,0,29,regulation of autophagosome assembly,BP,1
GO:2000786,1,0.907716168,0,9,positive regulation of autophagosome assembly,BP,1
GO:2000790,1,0.978722356,0,2,regulation of mesenchymal cell proliferation involved in lung development,BP,1
GO:2000791,1,0.978722356,0,2,negative regulation of mesenchymal cell proliferation involved in lung development,BP,1
GO:2000793,1,0.972885611,0,3,cell proliferation involved in heart valve development,BP,1
GO:2000794,1,0.946009688,0,5,regulation of epithelial cell proliferation involved in lung morphogenesis,BP,1
GO:2000795,1,0.988663082,0,1,negative regulation of epithelial cell proliferation involved in lung morphogenesis,BP,1
GO:2000797,1,0.988965311,0,1,regulation of amniotic stem cell differentiation,BP,1
GO:2000798,1,0.988965311,0,1,negative regulation of amniotic stem cell differentiation,BP,1
GO:2000804,1,0.988662931,0,1,"regulation of termination of RNA polymerase II transcription, poly(A)-coupled",BP,1
GO:2000806,1,0.988662931,0,1,"positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled",BP,1
GO:2000807,1,0.956852877,0,4,regulation of synaptic vesicle clustering,BP,1
GO:2000808,1,0.988662832,0,1,negative regulation of synaptic vesicle clustering,BP,1
GO:2000809,1,0.967828162,0,3,positive regulation of synaptic vesicle clustering,BP,1
GO:2000810,1,0.859155698,0,14,regulation of bicellular tight junction assembly,BP,1
GO:2000811,1,0.874817061,0,13,negative regulation of anoikis,BP,1
GO:2000812,1,0.955410882,0,4,regulation of barbed-end actin filament capping,BP,1
GO:2000813,1,0.988662931,0,1,negative regulation of barbed-end actin filament capping,BP,1
GO:2000814,1,0.977453195,0,2,positive regulation of barbed-end actin filament capping,BP,1
GO:2000815,1,0.977547384,0,2,regulation of mRNA stability involved in response to oxidative stress,BP,1
GO:2000819,1,0.966370169,0,3,regulation of nucleotide-excision repair,BP,1
GO:2000820,1,0.988662923,0,1,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,1
GO:2000821,1,0.993236819,0,1,regulation of grooming behavior,BP,1
GO:2000822,1,0.950501514,0,5,regulation of behavioral fear response,BP,1
GO:2000823,1,0.966368905,0,3,regulation of androgen receptor activity,BP,1
GO:2000825,1,0.966368905,0,3,positive regulation of androgen receptor activity,BP,1
GO:2000827,1,0.988662931,0,1,mitochondrial RNA surveillance,BP,1
GO:2000828,1,0.966612278,0,3,regulation of parathyroid hormone secretion,BP,1
GO:2000830,1,0.977698531,0,2,positive regulation of parathyroid hormone secretion,BP,1
GO:2000833,1,0.945657648,0,5,positive regulation of steroid hormone secretion,BP,1
GO:2000843,1,0.966838638,0,3,regulation of testosterone secretion,BP,1
GO:2000844,1,0.988664396,0,1,negative regulation of testosterone secretion,BP,1
GO:2000845,1,0.977925988,0,2,positive regulation of testosterone secretion,BP,1
GO:2000848,1,0.96657364,0,3,positive regulation of corticosteroid hormone secretion,BP,1
GO:2000852,1,0.977759617,0,2,regulation of corticosterone secretion,BP,1
GO:2000853,1,0.98897287,0,1,negative regulation of corticosterone secretion,BP,1
GO:2000855,1,0.93405903,0,6,regulation of mineralocorticoid secretion,BP,1
GO:2000857,1,0.96657364,0,3,positive regulation of mineralocorticoid secretion,BP,1
GO:2000858,1,0.93405903,0,6,regulation of aldosterone secretion,BP,1
GO:2000860,1,0.96657364,0,3,positive regulation of aldosterone secretion,BP,1
GO:2000864,1,0.970767682,0,3,regulation of estradiol secretion,BP,1
GO:2000866,1,0.978366117,0,2,positive regulation of estradiol secretion,BP,1
GO:2000870,1,0.967272762,0,3,regulation of progesterone secretion,BP,1
GO:2000871,1,0.988662925,0,1,negative regulation of progesterone secretion,BP,1
GO:2000872,1,0.978366506,0,2,positive regulation of progesterone secretion,BP,1
GO:2000909,1,0.931543884,0,7,regulation of sterol import,BP,1
GO:2000910,1,0.977452879,0,2,negative regulation of sterol import,BP,1
GO:2000911,1,0.963972196,0,4,positive regulation of sterol import,BP,1
GO:2000969,1,0.989356482,0,2,positive regulation of AMPA receptor activity,BP,1
GO:2000970,1,0.988663177,0,1,regulation of detection of glucose,BP,1
GO:2000971,1,0.988663177,0,1,negative regulation of detection of glucose,BP,1
GO:2000975,1,0.988662931,0,1,positive regulation of pro-B cell differentiation,BP,1
GO:2000979,1,0.989874949,0,1,positive regulation of forebrain neuron differentiation,BP,1
GO:2000983,1,0.988662519,0,1,regulation of ATP citrate synthase activity,BP,1
GO:2000984,1,0.988662519,0,1,negative regulation of ATP citrate synthase activity,BP,1
GO:2000987,1,0.967952724,0,3,positive regulation of behavioral fear response,BP,1
GO:2001012,1,0.988662833,0,1,mesenchymal cell differentiation involved in renal system development,BP,1
GO:2001013,1,0.968723171,0,3,epithelial cell proliferation involved in renal tubule morphogenesis,BP,1
GO:2001015,1,0.988663015,0,1,negative regulation of skeletal muscle cell differentiation,BP,1
GO:2001016,1,0.977594609,0,2,positive regulation of skeletal muscle cell differentiation,BP,1
GO:2001017,1,0.988662923,0,1,regulation of retrograde axon cargo transport,BP,1
GO:2001019,1,0.988662923,0,1,positive regulation of retrograde axon cargo transport,BP,1
GO:2001023,1,0.572509762,0,50,regulation of response to drug,BP,1
GO:2001024,1,0.745614537,0,26,negative regulation of response to drug,BP,1
GO:2001025,1,0.837063413,0,16,positive regulation of response to drug,BP,1
GO:2001027,1,0.961259509,0,4,negative regulation of endothelial cell chemotaxis,BP,1
GO:2001029,1,0.988679414,0,1,regulation of cellular glucuronidation,BP,1
GO:2001031,1,0.988679414,0,1,positive regulation of cellular glucuronidation,BP,1
GO:2001033,1,0.977459695,0,2,negative regulation of double-strand break repair via nonhomologous end joining,BP,1
GO:2001034,1,0.891163163,0,11,positive regulation of double-strand break repair via nonhomologous end joining,BP,1
GO:2001038,1,0.739224906,0,27,regulation of cellular response to drug,BP,1
GO:2001039,1,0.815686407,0,18,negative regulation of cellular response to drug,BP,1
GO:2001040,1,0.924935693,0,7,positive regulation of cellular response to drug,BP,1
GO:2001044,1,0.877827551,0,12,regulation of integrin-mediated signaling pathway,BP,1
GO:2001045,1,0.97809457,0,2,negative regulation of integrin-mediated signaling pathway,BP,1
GO:2001046,1,0.918221726,0,8,positive regulation of integrin-mediated signaling pathway,BP,1
GO:2001053,1,0.956100825,0,4,regulation of mesenchymal cell apoptotic process,BP,1
GO:2001054,1,0.956100825,0,4,negative regulation of mesenchymal cell apoptotic process,BP,1
GO:2001056,1,0.35372714,0,94,positive regulation of cysteine-type endopeptidase activity,BP,1
GO:2001106,1,0.959057881,0,4,regulation of Rho guanyl-nucleotide exchange factor activity,BP,1
GO:2001107,1,0.977453375,0,2,negative regulation of Rho guanyl-nucleotide exchange factor activity,BP,1
GO:2001108,1,0.992277621,0,1,positive regulation of Rho guanyl-nucleotide exchange factor activity,BP,1
GO:2001112,1,0.99037958,0,1,regulation of cellular response to hepatocyte growth factor stimulus,BP,1
GO:2001113,1,0.99037958,0,1,negative regulation of cellular response to hepatocyte growth factor stimulus,BP,1
GO:2001135,1,0.925622954,0,7,regulation of endocytic recycling,BP,1
GO:2001136,1,0.988760247,0,1,negative regulation of endocytic recycling,BP,1
GO:2001137,1,0.955814951,0,4,positive regulation of endocytic recycling,BP,1
GO:2001138,1,0.927746628,0,7,regulation of phospholipid transport,BP,1
GO:2001140,1,0.927746628,0,7,positive regulation of phospholipid transport,BP,1
GO:2001144,1,0.988662891,0,1,"regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity",BP,1
GO:2001145,1,0.988662891,0,1,"negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity",BP,1
GO:2001151,1,0.988662878,0,1,regulation of renal water transport,BP,1
GO:2001153,1,0.988662878,0,1,positive regulation of renal water transport,BP,1
GO:2001160,1,0.967698666,0,3,regulation of histone H3-K79 methylation,BP,1
GO:2001161,1,0.988662931,0,1,negative regulation of histone H3-K79 methylation,BP,1
GO:2001162,1,0.978797249,0,2,positive regulation of histone H3-K79 methylation,BP,1
GO:2001163,1,0.988678072,0,1,regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,1
GO:2001165,1,0.988678072,0,1,positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,1
GO:2001166,1,0.947611718,0,5,regulation of histone H2B ubiquitination,BP,1
GO:2001168,1,0.958481758,0,4,positive regulation of histone H2B ubiquitination,BP,1
GO:2001173,1,0.988662931,0,1,regulation of histone H2B conserved C-terminal lysine ubiquitination,BP,1
GO:2001176,1,0.988665517,0,1,regulation of mediator complex assembly,BP,1
GO:2001178,1,0.988665517,0,1,positive regulation of mediator complex assembly,BP,1
GO:2001179,1,0.914165631,0,8,regulation of interleukin-10 secretion,BP,1
GO:2001180,1,0.978911923,0,2,negative regulation of interleukin-10 secretion,BP,1
GO:2001181,1,0.944583562,0,5,positive regulation of interleukin-10 secretion,BP,1
GO:2001182,1,0.923696623,0,7,regulation of interleukin-12 secretion,BP,1
GO:2001183,1,0.977453307,0,2,negative regulation of interleukin-12 secretion,BP,1
GO:2001184,1,0.955853292,0,4,positive regulation of interleukin-12 secretion,BP,1
GO:2001185,1,0.854646859,0,14,"regulation of CD8-positive, alpha-beta T cell activation",BP,1
GO:2001186,1,0.955411064,0,4,"negative regulation of CD8-positive, alpha-beta T cell activation",BP,1
GO:2001187,1,0.925545192,0,7,"positive regulation of CD8-positive, alpha-beta T cell activation",BP,1
GO:2001188,1,0.966369597,0,3,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,1
GO:2001189,1,0.988662726,0,1,negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,1
GO:2001190,1,0.977453262,0,2,positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,1
GO:2001197,1,0.947307024,0,5,basement membrane assembly involved in embryonic body morphogenesis,BP,1
GO:2001198,1,0.944575545,0,5,regulation of dendritic cell differentiation,BP,1
GO:2001199,1,0.977453061,0,2,negative regulation of dendritic cell differentiation,BP,1
GO:2001200,1,0.977453601,0,2,positive regulation of dendritic cell differentiation,BP,1
GO:2001201,1,0.98284093,0,2,regulation of transforming growth factor-beta secretion,BP,1
GO:2001202,1,0.98284093,0,2,negative regulation of transforming growth factor-beta secretion,BP,1
GO:2001204,1,0.945766703,0,6,regulation of osteoclast development,BP,1
GO:2001205,1,0.973710478,0,3,negative regulation of osteoclast development,BP,1
GO:2001206,1,0.977452946,0,2,positive regulation of osteoclast development,BP,1
GO:2001212,1,0.909277346,0,9,regulation of vasculogenesis,BP,1
GO:2001213,1,0.980594038,0,2,negative regulation of vasculogenesis,BP,1
GO:2001214,1,0.937712528,0,6,positive regulation of vasculogenesis,BP,1
GO:2001222,1,0.740113972,0,31,regulation of neuron migration,BP,1
GO:2001223,1,0.938089692,0,6,negative regulation of neuron migration,BP,1
GO:2001224,1,0.842468124,0,18,positive regulation of neuron migration,BP,1
GO:2001225,1,0.955750057,0,4,regulation of chloride transport,BP,1
GO:2001228,1,0.99168613,0,2,regulation of response to gamma radiation,BP,1
GO:2001229,1,0.996590538,0,1,negative regulation of response to gamma radiation,BP,1
GO:2001235,1,0.19911698,0,144,positive regulation of apoptotic signaling pathway,BP,1
GO:2001238,1,0.595385342,0,47,positive regulation of extrinsic apoptotic signaling pathway,BP,1
GO:2001241,1,0.859139958,0,14,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,1
GO:2001244,1,0.536055142,0,55,positive regulation of intrinsic apoptotic signaling pathway,BP,1
GO:2001245,1,0.945763343,0,5,regulation of phosphatidylcholine biosynthetic process,BP,1
GO:2001246,1,0.98929702,0,1,negative regulation of phosphatidylcholine biosynthetic process,BP,1
GO:2001247,1,0.966964871,0,3,positive regulation of phosphatidylcholine biosynthetic process,BP,1
GO:2001248,1,0.988662931,0,1,regulation of ammonia assimilation cycle,BP,1
GO:2001250,1,0.988662931,0,1,positive regulation of ammonia assimilation cycle,BP,1
GO:2001253,1,0.970665243,0,3,regulation of histone H3-K36 trimethylation,BP,1
GO:2001255,1,0.981675036,0,2,positive regulation of histone H3-K36 trimethylation,BP,1
GO:2001256,1,0.916599441,0,8,regulation of store-operated calcium entry,BP,1
GO:2001257,1,0.515767669,0,63,regulation of cation channel activity,BP,1
GO:2001258,1,0.834293325,0,17,negative regulation of cation channel activity,BP,1
GO:2001259,1,0.744832293,0,29,positive regulation of cation channel activity,BP,1
GO:2001260,1,0.988662368,0,1,regulation of semaphorin-plexin signaling pathway,BP,1
GO:2001262,1,0.988662368,0,1,positive regulation of semaphorin-plexin signaling pathway,BP,1
GO:2001263,1,0.98866239,0,1,regulation of C-C chemokine binding,BP,1
GO:2001264,1,0.98866239,0,1,negative regulation of C-C chemokine binding,BP,1
GO:2001267,1,0.874387222,0,12,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,1
GO:2001268,1,0.955410891,0,4,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,1
GO:2001269,1,0.915224546,0,8,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,1
GO:2001270,1,0.966369633,0,3,regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,1
GO:2001271,1,0.977453362,0,2,negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,1
GO:2001272,1,0.988662662,0,1,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,1
GO:2001279,1,0.895211725,0,10,regulation of unsaturated fatty acid biosynthetic process,BP,1
GO:2001280,1,0.915875994,0,8,positive regulation of unsaturated fatty acid biosynthetic process,BP,1
GO:2001286,1,0.958444585,0,4,regulation of caveolin-mediated endocytosis,BP,1
GO:2001287,1,0.988662844,0,1,negative regulation of caveolin-mediated endocytosis,BP,1
GO:2001288,1,0.980556342,0,2,positive regulation of caveolin-mediated endocytosis,BP,1
GO:2001293,1,0.974923849,0,3,malonyl-CoA metabolic process,BP,1
GO:2001294,1,0.988662931,0,1,malonyl-CoA catabolic process,BP,1
GO:2001295,1,0.986104633,0,2,malonyl-CoA biosynthetic process,BP,1
GO:2001311,1,0.977453486,0,2,lysobisphosphatidic acid metabolic process,BP,1
GO:0009988,1,0.722049783,0,29,cell-cell recognition,BP,1
GO:0002823,1,0.739743737,0,27,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,1
GO:0048011,1,0.774954111,0,24,neurotrophin TRK receptor signaling pathway,BP,1